Form 1-A Issuer Information UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-A
REGULATION A OFFERING STATEMENT
UNDER THE SECURITIES ACT OF 1933
OMB APPROVAL

FORM 1-A

OMB Number: 3235-0286


Estimated average burden hours per response: 608.0

1-A: Filer Information

Issuer CIK
0001786286
Issuer CCC
XXXXXXXX
DOS File Number
Offering File Number
Is this a LIVE or TEST Filing? LIVE TEST
Would you like a Return Copy?
Notify via Filing Website only?
Since Last Filing?

Submission Contact Information

Name
Phone
E-Mail Address

1-A: Item 1. Issuer Information

Issuer Infomation

Exact name of issuer as specified in the issuer's charter
Draganfly Inc.
Jurisdiction of Incorporation / Organization
BRITISH COLUMBIA, CANADA
Year of Incorporation
2018
CIK
0001786286
Primary Standard Industrial Classification Code
AIRCRAFT
I.R.S. Employer Identification Number
00-0000000
Total number of full-time employees
22
Total number of part-time employees
0

Contact Infomation

Address of Principal Executive Offices

Address 1
2108 St. George Ave
Address 2
City
Saskatoon
State/Country
SASKATCHEWAN, CANADA
Mailing Zip/ Postal Code
S7M 0C7
Phone
306-955-9907

Provide the following information for the person the Securities and Exchange Commission's staff should call in connection with any pre-qualification review of the offering statement.

Name
Paul Sun
Address 1
Address 2
City
State/Country
Mailing Zip/ Postal Code
Phone

Provide up to two e-mail addresses to which the Securities and Exchange Commission's staff may send any comment letters relating to the offering statement. After qualification of the offering statement, such e-mail addresses are not required to remain active.

Financial Statements

Industry Group (select one) Banking Insurance Other

Use the financial statements for the most recent period contained in this offering statement to provide the following information about the issuer. The following table does not include all of the line items from the financial statements. Long Term Debt would include notes payable, bonds, mortgages, and similar obligations. To determine "Total Revenues" for all companies selecting "Other" for their industry group, refer to Article 5-03(b)(1) of Regulation S-X. For companies selecting "Insurance", refer to Article 7-04 of Regulation S-X for calculation of "Total Revenues" and paragraphs 5 and 7 of Article 7-04 for "Costs and Expenses Applicable to Revenues".

Balance Sheet Information

Cash and Cash Equivalents
$ 2429375.00
Investment Securities
$ 0.00
Total Investments
$
Accounts and Notes Receivable
$ 224695.00
Loans
$
Property, Plant and Equipment (PP&E):
$ 115141.00
Property and Equipment
$
Total Assets
$ 3221783.00
Accounts Payable and Accrued Liabilities
$ 894357.00
Policy Liabilities and Accruals
$
Deposits
$
Long Term Debt
$ 0.00
Total Liabilities
$ 1030430.00
Total Stockholders' Equity
$ 2191353.00
Total Liabilities and Equity
$ 3221783.00

Statement of Comprehensive Income Information

Total Revenues
$ 1380427.00
Total Interest Income
$
Costs and Expenses Applicable to Revenues
$ 218800.00
Total Interest Expenses
$
Depreciation and Amortization
$ 49636.00
Net Income
$ -11095057.00
Earnings Per Share - Basic
$ -0.23
Earnings Per Share - Diluted
$ -0.23
Name of Auditor (if any)
Dale Matheson Carr-Hilton Labonte LLP Chartered Professional Accounts

Outstanding Securities

Common Equity

Name of Class (if any) Common Equity
Common Shares
Common Equity Units Outstanding
69670613
Common Equity CUSIP (if any):
26142Q106
Common Equity Units Name of Trading Center or Quotation Medium (if any)
n/a

Preferred Equity

Preferred Equity Name of Class (if any)
Preferred Equity Units Outstanding
0
Preferred Equity CUSIP (if any)
Preferred Equity Name of Trading Center or Quotation Medium (if any)

Debt Securities

Debt Securities Name of Class (if any)
Debt Securities Units Outstanding
0
Debt Securities CUSIP (if any):
Debt Securities Name of Trading Center or Quotation Medium (if any)

1-A: Item 2. Issuer Eligibility

Issuer Eligibility

Check this box to certify that all of the following statements are true for the issuer(s)

1-A: Item 3. Application of Rule 262

Application Rule 262

Check this box to certify that, as of the time of this filing, each person described in Rule 262 of Regulation A is either not disqualified under that rule or is disqualified but has received a waiver of such disqualification.

Check this box if "bad actor" disclosure under Rule 262(d) is provided in Part II of the offering statement.

1-A: Item 4. Summary Information Regarding the Offering and Other Current or Proposed Offerings

Summary Infomation

Check the appropriate box to indicate whether you are conducting a Tier 1 or Tier 2 offering Tier1 Tier2
Check the appropriate box to indicate whether the financial statements have been audited Unaudited Audited
Types of Securities Offered in this Offering Statement (select all that apply)
Equity (common or preferred stock)
Debt
Option, warrant or other right to acquire another security
Does the issuer intend to offer the securities on a delayed or continuous basis pursuant to Rule 251(d)(3)? Yes No
Does the issuer intend this offering to last more than one year? Yes No
Does the issuer intend to price this offering after qualification pursuant to Rule 253(b)? Yes No
Will the issuer be conducting a best efforts offering? Yes No
Has the issuer used solicitation of interest communications in connection with the proposed offering? Yes No
Does the proposed offering involve the resale of securities by affiliates of the issuer? Yes No
Number of securities offered
20000000
Number of securities of that class outstanding
0

The information called for by this item below may be omitted if undetermined at the time of filing or submission, except that if a price range has been included in the offering statement, the midpoint of that range must be used to respond. Please refer to Rule 251(a) for the definition of "aggregate offering price" or "aggregate sales" as used in this item. Please leave the field blank if undetermined at this time and include a zero if a particular item is not applicable to the offering.

Price per security
$
The portion of the aggregate offering price attributable to securities being offered on behalf of the issuer
$ 0.00
The portion of the aggregate offering price attributable to securities being offered on behalf of selling securityholders
$ 0.00
The portion of the aggregate offering price attributable to all the securities of the issuer sold pursuant to a qualified offering statement within the 12 months before the qualification of this offering statement
$ 0.00
The estimated portion of aggregate sales attributable to securities that may be sold pursuant to any other qualified offering statement concurrently with securities being sold under this offering statement
$ 0.00
Total (the sum of the aggregate offering price and aggregate sales in the four preceding paragraphs)
$ 0.00

Anticipated fees in connection with this offering and names of service providers

Underwriters - Name of Service Provider
Underwriters - Fees
$ 0.00
Sales Commissions - Name of Service Provider
Dalmore Group, LLC
Sales Commissions - Fee
$ 25000.00
Finders' Fees - Name of Service Provider
Finders' Fees - Fees
$ 0.00
Audit - Name of Service Provider
Dale Matheson Carr-Hilton Labonte LLP Chartered Professional Accounts
Audit - Fees
$ 10000.00
Legal - Name of Service Provider
Greenberg Traurig PA & Gowlings WLG
Legal - Fees
$ 120000.00
Promoters - Name of Service Provider
CDMG
Promoters - Fees
$ 0.00
Blue Sky Compliance - Name of Service Provider
Various States
Blue Sky Compliance - Fees
$ 28000.00
CRD Number of any broker or dealer listed:
Estimated net proceeds to the issuer
$ 0.00
Clarification of responses (if necessary)

1-A: Item 5. Jurisdictions in Which Securities are to be Offered

Jurisdictions in Which Securities are to be Offered

Using the list below, select the jurisdictions in which the issuer intends to offer the securities

Selected States and Jurisdictions
ALASKA
ALABAMA
ARKANSAS
ARIZONA
CALIFORNIA
COLORADO
CONNECTICUT
DISTRICT OF COLUMBIA
DELAWARE
FLORIDA
GEORGIA
HAWAII
IOWA
IDAHO
ILLINOIS
INDIANA
KANSAS
KENTUCKY
LOUISIANA
MASSACHUSETTS
MARYLAND
MAINE
MICHIGAN
MINNESOTA
MISSOURI
MISSISSIPPI
MONTANA
NORTH CAROLINA
NORTH DAKOTA
NEBRASKA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEVADA
NEW YORK
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VIRGINIA
VERMONT
WASHINGTON
WISCONSIN
WEST VIRGINIA
WYOMING
ALBERTA, CANADA
BRITISH COLUMBIA, CANADA
MANITOBA, CANADA
NEW BRUNSWICK, CANADA
NEWFOUNDLAND, CANADA
NOVA SCOTIA, CANADA
ONTARIO, CANADA
PRINCE EDWARD ISLAND, CANADA
QUEBEC, CANADA
SASKATCHEWAN, CANADA
YUKON, CANADA
CANADA (FEDERAL LEVEL)

Using the list below, select the jurisdictions in which the securities are to be offered by underwriters, dealers or sales persons or check the appropriate box

None
Same as the jurisdictions in which the issuer intends to offer the securities
Selected States and Jurisdictions

ALASKA
ALABAMA
ARKANSAS
ARIZONA
CALIFORNIA
COLORADO
CONNECTICUT
DISTRICT OF COLUMBIA
DELAWARE
FLORIDA
GEORGIA
HAWAII
IOWA
IDAHO
ILLINOIS
INDIANA
KANSAS
KENTUCKY
LOUISIANA
MASSACHUSETTS
MARYLAND
MAINE
MICHIGAN
MINNESOTA
MISSOURI
MISSISSIPPI
MONTANA
NORTH CAROLINA
NORTH DAKOTA
NEBRASKA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEVADA
NEW YORK
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VIRGINIA
VERMONT
WASHINGTON
WISCONSIN
WEST VIRGINIA
WYOMING
ALBERTA, CANADA
BRITISH COLUMBIA, CANADA
MANITOBA, CANADA
NEW BRUNSWICK, CANADA
NEWFOUNDLAND, CANADA
NOVA SCOTIA, CANADA
ONTARIO, CANADA
PRINCE EDWARD ISLAND, CANADA
QUEBEC, CANADA
SASKATCHEWAN, CANADA
YUKON, CANADA
CANADA (FEDERAL LEVEL)

1-A: Item 6. Unregistered Securities Issued or Sold Within One Year

Unregistered Securities Issued or Sold Within One Year

None

Unregistered Securities Issued

As to any unregistered securities issued by the issuer of any of its predecessors or affiliated issuers within one year before the filing of this Form 1-A, state:

(a)Name of such issuer
Draganfly Inc.
(b)(1) Title of securities issued
Common Shares
(2) Total Amount of such securities issued
1868050
(3) Amount of such securities sold by or for the account of any person who at the time was a director, officer, promoter or principal securityholder of the issuer of such securities, or was an underwriter of any securities of such issuer.
0
(c)(1) Aggregate consideration for which the securities were issued and basis for computing the amount thereof.
USD $1,868,050 at C$0.50 per share.
(2) Aggregate consideration for which the securities listed in (b)(3) of this item (if any) were issued and the basis for computing the amount thereof (if different from the basis described in (c)(1)).

Unregistered Securities Act

(e) Indicate the section of the Securities Act or Commission rule or regulation relied upon for exemption from the registration requirements of such Act and state briefly the facts relied upon for such exemption
Sales to accredited investors under Rule 506(b) of Regulation D.

PART II – INFORMATION REQUIRED IN OFFERING CIRCULAR

 

An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Preliminary Offering Circular is subject to completion or amendment. These securities may not be sold nor may offers to buy be accepted before the Offering Statement filed with the Commission is qualified. This Preliminary Offering Circular shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sales of these securities in any state in which such offer, solicitation or sale would be unlawful before registration or qualification under the laws of any such state. We may elect to satisfy our obligation to deliver a Final Offering Circular by sending you a notice within two business days after the completion of our sale to you that contains the URL where the Final Offering Circular or the Offering Statement in which such Final Offering Circular was filed may be obtained.

 

REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933

 

PRELIMINARY OFFERING CIRCULAR JUNE 15, 2020, SUBJECT TO COMPLETION

 

 

 

DRAGANFLY INC.

 

● Units Consisting of

● Common Share and ● Common Share Purchase Warrant

 

● Common Shares and ● Warrants Contained in the Units

● Common Shares Underlying the Warrants

 

2108 St. George Avenue,

Saskatoon, SK, S7M 0K7

1-306-955-9907

www.draganfly.com

 

Draganfly Inc., a company organized under the laws of British Columbia, Canada (the “Company”, “we,” or “our”), is offering up to units (the “Units”) consisting of Common Shares and Warrants (each as defined below) and offering up to Common Shares underlying the Warrants (the “Maximum Offering”) of the Company, to be sold in this offering (the “Offering”). Each Unit offered at a purchase price of US$ per Unit is comprised of common share in the capital of the Company, with no par value (a “Common Share”) and Common Share purchase warrant (each a whole warrant, a “Warrant” and collectively, the “Warrants”) to purchase additional Common Share (a “Warrant Share”). One Warrant is required to purchase additional Warrant Share at an exercise price of US$ per Warrant, subject to certain adjustments. The Warrants are exercisable immediately and terminating on the date that is the ___ year anniversary of the listing of the additional common shares sold in this offering on the Canadian Securities Exchange or other recognized securities exchange. The Units are being offered on a “best efforts” basis. The Common Shares and Warrants will be separately transferable following the termination of (i) any transfer hold periods under applicable law and (ii) the following contractual lock-up period: Our investors are required to enter into a -day “lock-up” from the closing date of the Offering relating to our Units, Common Shares, and Warrants purchased in the Offering. This means that, for a period of days following the closing date of this Offering, such persons may not, with limited exceptions, sell or agree to sell any of the Units or components thereof - the Common Shares or Warrants - or enter into any agreement or arrangement to transfer to another, in whole or in part, any of the economic consequences of ownership of the Units, Common Shares or Warrants, without the prior written consent of the Company, and pursuant to the terms of the lock-up agreements. We are selling our Shares through a Tier 2 offering pursuant to Regulation A (Regulation A+) under the Securities Act of 1933, as amended (the “Securities Act”), and we intend to sell the Units either directly to investors or through registered broker-dealers who are paid commissions. The Company has engaged Dalmore Group, LLC, a New York limited liability company and FINRA/SIPC registered broker-dealer (“Dalmore”), to provide broker-dealer services in connection with this Offering. This Offering will terminate on the earlier of (i) __________ __, 2022, (ii) the date on which the Maximum Offering is sold, or (iii) when the Board of Directors of the Company elects to terminate the Offering (in each such case, the “Termination Date”). There is no escrow established for this Offering. We will hold closings upon the receipt of investors’ subscriptions and acceptance of such subscriptions by the Company. If, on the initial closing date, we have sold less than the Maximum Offering, then we may hold one or more additional closings for additional sales, until the earlier of: (i) the sale of the Maximum Offering, or (ii) the Termination Date. There is no aggregate minimum requirement for the Offering to become effective; therefore, we reserve the right, subject to applicable securities laws, to begin applying “dollar one” of the proceeds from the Offering towards our business strategy, including, without limitation, research and development expenses, offering expenses, working capital and general corporate purposes and other uses as more specifically set forth in the “Use of Proceeds to Issuer” section of this offering circular (the “Offering Circular”). We expect to commence the sale of the Units as of the date on which the Offering Statement of which this Offering Circular is a part (the “Offering Statement”) is qualified by the United States Securities and Exchange Commission (the “SEC”).

 

 
- 1 -

 

  

We expect to commence the sale of the Units as of the date on which this offering circular is declared qualified by the SEC.

 

Investing in our Securities involves a high degree of risk. These are speculative securities. You should purchase these securities only if you can afford a complete loss of your investment. See “Risk Factors” starting on page 11 for a discussion of certain risks that you should consider in connection with an investment in our Units.

 

THE SEC DOES NOT PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS. THESE SECURITIES ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE SECURITIES OFFERED ARE EXEMPT FROM REGISTRATION.

 

 

 

Price to Public

 

Underwriting

Discount and Commissions

 

 

Proceeds to

the

Company (2)

 

● Unit (● Common Share and ● Warrant)

 

$

 

 

(1)

 

$

 

Exercise for Common Share underlying Warrant

 

$

 

 

(1)

 

$

 

Total Maximum Offering (3)

 

$

 

 

(1)

 

$

 

 

(1)

The minimum investment amount for each subscription is Units or $. The Offering is being made directly to investors by the management of the Company on a “best efforts” basis. We reserve the right to offer the Units through broker-dealers who are registered with the Financial Industry Regulatory Authority (“FINRA”). The Company has engaged Dalmore to provide broker-dealer services and has agreed to pay a 1% commission on the aggregate amount raised by the Company from investors. This will only start after FINRA Corporate Finance issues a No Objection Letter for the Offering. The Company will also pay a one time set up fee of $5,000 and a consulting fee of $20,000 payable once FINRA issues a No Objection Letter and the Company receives SEC Qualification.

(2)

The amounts shown in the “Proceeds to the Company” are before deducting organization and offering costs to us, which include legal, accounting, printing, due diligence, marketing, selling and other costs incurred in the Offering of the Units. (See “Use of Proceeds” and “Plan of Distribution and Selling Securityholders.”). The estimated offering expenses will be approximately $.

(3)

The Units are being offered pursuant to Regulation A of Section 3(b) of the Securities Act for Tier 2 offerings. The Units are only issued to purchasers who satisfy the requirements set forth in Regulation A. We have the option in our sole discretion to accept less than the minimum investment.

  

 
- 2 -

 

  

GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN TEN PERCENT (10%) OF THE GREATER OF YOUR ANNUAL INCOME OR YOUR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A+. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV.

 

This Offering Circular contains all of the representations by us concerning this Offering, and no person shall make different or broader statements than those contained herein. Investors are cautioned not to rely upon any information not expressly set forth in this Offering Circular.

 

Sale of our Units will commence on approximately __________ __, 2020.

 

The Company is following the “Offering Circular” format of disclosure under Regulation A+.

 

The date of this Preliminary Offering Circular is June 15, 2020, subject to completion.

 

 
- 3 -

 

 

TABLE OF CONTENTS

 

 

Page

 

 

 

IMPORTANT INFORMATION ABOUT THIS OFFERING CIRCULAR

5

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

5

 

SUMMARY

7

 

RISK FACTORS

11

 

DILUTION

24

 

PLAN OF DISTRIBUTION AND SELLING SECURITYHOLDERS

25

 

USE OF PROCEEDS TO ISSUER

26

 

DESCRIPTION OF BUSINESS

27

 

DESCRIPTION OF PROPERTY

33

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

36

 

DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES

40

 

COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS

46

 

SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITYHOLDERS

49

 

INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS

50

 

SECURITIES BEING OFFERED

51

 

WHERE YOU CAN FIND MORE INFORMATION

59

 

Part F/S

60

 

INDEX TO FINANCIAL STATEMENTS

 

 

Part III - Exhibits

 

INDEX TO EXHIBITS

 

 

SIGNATURES

 

 

 

 
- 4 -

Table of Contents

 

IMPORTANT INFORMATION ABOUT THIS OFFERING CIRCULAR

 

We are offering to sell, and seeking offers to buy, our securities only in jurisdictions where such offers and sales are permitted. Please carefully read the information in this offering circular and any accompanying offering circular supplements, which we refer to collectively as the “Offering Circular.” You should rely only on the information contained in this Offering Circular. We have not authorized anyone to provide you with any information other than the information contained in this Offering Circular. The information contained in this Offering Circular is accurate only as of its date or as of the respective dates of any documents or other information incorporated herein by reference, regardless of the time of its delivery or of any sale or delivery of our securities. Neither the delivery of this Offering Circular nor any sale or delivery of our securities shall, under any circumstances, imply that there has been no change in our affairs since the date of this Offering Circular. This Offering Circular will be updated and made available for delivery to the extent required by the federal securities laws.

 

This Offering Circular is part of an offering statement (the “Offering Statement”) that we filed with the Securities and Exchange Commission (the “SEC”) using a continuous offering process. Periodically, we may provide an offering circular supplement that would add, update or change information contained in this Offering Circular. Any statement that we make in this Offering Circular will be modified or superseded by any inconsistent statement made by us in a subsequent offering circular supplement. The Offering Statement we filed with the SEC includes exhibits that provide more detailed descriptions of the matters discussed in this Offering Circular. You should read this Offering Circular and the related exhibits filed with the SEC and any offering circular supplement, together with additional information contained in our annual reports, semi-annual reports and other reports and information statements that we will file periodically with the SEC. The Offering Statement and all supplements and reports that we have filed or will file in the future can be read at the SEC website, www.sec.gov.

 

Unless otherwise indicated, data contained in this Offering Circular concerning the business of the Company are based on information from various public sources. Although we believe that these data are generally reliable, such information is inherently imprecise, and our estimates and expectations based on these data involve a number of assumptions and limitations. As a result, you are cautioned not to give undue weight to such data, estimates or expectations.

 

In this Offering Circular, unless the context indicates otherwise, references to the “Company,” “we,” “our,” and “us” refer to the activities of and the assets and liabilities of the business and operations of Draganfly Inc., a company organized under the laws of British Columbia, Canada, and its subsidiaries.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Some of the statements under “Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Our Business” and elsewhere in this Offering Circular constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” “will” and “would” or the negatives of these terms, or other comparable terminology.

 

You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Offering Circular, including in “Risk Factors” and elsewhere, identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:

 

 

·

Economic conditions in Canada, the United States of America and globally;

 

 

 

 

·

Unpredictable events, such as the COVID-19 outbreak, and associated business disruptions;

 

 

 

 

·

Operational risks;

 

 

 

 

·

The market price of Common Shares may not be high enough to create a positive return for current investors;

 

 

 

 

·

High level of price and volume volatility in the capital markets;

 

 
- 5 -

Table of Contents

  

 

·

No dividends for the foreseeable future;

 

 

 

 

·

Our reliance on management and key employees;

 

 

 

 

·

Risks associated with foreign operations in other countries;

 

 

 

 

·

Risks associated with acquisitions;

 

 

 

 

·

Exposure to information systems security threats;

 

 

 

 

·

Lack of sufficient insurance;

 

 

 

 

·

Changes in laws, regulations, and guidelines relating to our business, including tax and accounting requirements;

 

 

 

 

·

Conflicts of interests of our directors and officers;

 

 

 

 

·

Competition in our industry;

 

 

 

 

·

Uncertainty and adverse changes in the economy;

 

 

 

 

·

Expenses as a public company and having public company disclosure obligations;

 

 

 

 

·

Dilution as a result of future sale of Common Shares;

 

 

 

 

·

Evolving market and difficulty of evaluating future prospects;

 

 

 

 

·

Rapid technological change in our industry;

 

 

 

 

·

Having defective products;

 

 

 

 

·

Failure to obtain or maintain required regulatory approvals;

 

 

 

 

·

The regulatory regime the Company operates in;

 

 

 

 

·

Possibility of data breaches and inadequacy of consumer protection and data privacy policies;

 

 

 

 

·

Increased research and development costs and reduced profitability as a result;

 

 

 

 

·

Lack of outside funding available for research and development;

 

 

 

 

·

Shipping products outside of Canada and approvals required for exporting;

 

 

 

 

·

Potential litigation;

 

 

 

 

·

Reliance on business partners;

 

 

 

 

·

Failure to protect and maintain and the consequential loss of intellectual property rights;

 

 

 

 

·

Adverse impacts on our reported results of operations as a result of adopting new accounting standards or interpretations;

  

 
- 6 -

Table of Contents

  

 

·

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters;

 

 

 

 

·

The explanatory paragraph from our auditors regarding the Company’s ability to continue as a going concern; and 

 

 

 

 

·

Risks related to our history of losses and the possibility we will not become profitable.

  

Although the forward-looking statements in this Offering Circular are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material and adverse. We undertake no obligation, other than as may be required by law, to re-issue this Offering Circular or otherwise make public statements updating our forward-looking statements.

 

SUMMARY

 

The following highlights information contained elsewhere in this Offering Circular, and it may not contain all of the information that is important to you. You should read this entire Offering Circular carefully, including the section entitled “Risk Factors,” before making an investment decision. References to “we,” “us,” “our,” “our company,” “the Company”, and “Draganfly” refers to Draganfly Inc., and its subsidiaries, a company incorporated under the Business Corporations Act (British Columbia).

 

Company Information

 

Draganfly Inc. (the “Company,” “we,” “our,” and “us”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia) (the “BCBCA”). On August 15, 2019, the Company completed a going public transaction and on November 5, 2019 listed its common shares on the Canadian Securities Exchange (see “Description of Business – Overview”, starting on page 27). On April 30, 2020, the Company completed the acquisition of Dronelogics Systems Inc. (“Dronelogics”) by acquiring all of the shares of Dronelogics, resulting in Dronelogics becoming a wholly-owned subsidiary of the Company.

 

Our head office is located at 2108 St. George Avenue, Saskatoon, Saskatchewan, S7M 0K7. Our telephone number is 1-(306)-955-9907 and our website address is www.draganfly.com. The information contained therein or accessible thereby shall not be deemed to be incorporated into this Offering Circular.

 

Intercorporate Relationships

 

The Company has three wholly-owned subsidiaries:

 

1.

Draganfly Innovations Inc. (“Draganfly Innovations”), a corporation continued under the BCBCA on August 19, 2019. Draganfly’s head office is located at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7;

 

 

2.

Draganfly Innovations USA Inc. (“Draganfly Innovations USA”), a corporation incorporated in the state of Delaware on January 27, 2020. Draganfly Innovations USA’s head office is located at 1017 Maine Campus Drive, Raleigh, NC, 27606; and

 

 

3.

Dronelogics, a corporation incorporated under the BCBCA on January 13, 2009. Dronelogics’ head office is located at 319-2999 Underhill Avenue, Burnaby, British Columbia V5A 3C2.

 

Our Business

 

The Company has three wholly-owned subsidiaries, Draganfly Innovations, Draganfly Innovations USA, and Dronelogics.

 

 
- 7 -

Table of Contents

  

The business of Draganfly Innovations and Draganfly Innovations USA is the provision of engineering services and manufacture of commercial unmanned aerial vehicles (“UAV”), remotely piloted aircraft systems (“RPAS”), and unmanned vehicle systems (“UVS”) and software, serving the public safety, agriculture, industrial inspections, and mapping and surveying markets.

 

Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide scope of services including sales, training, rentals, maintenance, flying and data processing services.

 

Description of Property

 

Draganfly Innovations’ products are manufactured at its machine shop within its leased head office based in Saskatoon, Saskatchewan, Canada. Raw materials for the Company’s products consist of a combination of its original equipment manufacturer parts and third-party components. Draganfly Innovations USA has leased two suites within the North Carolina State University Campus that serves as a management office and place to store some inventory. Dronelogic’s services are provided through its leased space in Burnaby, British Columbia, Canada.

 

Intellectual Property

 

With 18 fundamental UAV patents in its portfolio and with six (6) more pending in the application stage, the Company will continue to expand and grow its intellectual property docket. By virtue of being the first commercial UAV company in the industry, our subsidiary, Draganfly Innovations, holds valuable commercial patents. In addition, Draganfly Innovations, Inc. is the owner of 18 registered trademarks with five (5) more trademark applications pending in both the US and Canada.

 

Product/Services Pipeline

 

We can provide our customers with an entire suite of products and services, including the following: quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, flight training, and software used for tracking, live streaming and data collection.

 

Although we have a number of distribution partners, the majority of our product sales are sold directly to the customer. We conduct little outbound sales and marketing promotional activities as customers around the world reach out to us through our website, which is still our primary method of sales.

 

Draganfly Innovations is recognized as the first commercial multi-rotator manufacturer and has a legacy for its innovation and superior customer service. Draganfly Innovations USA Inc was created in January, 2020 to offer the same services as Draganfly Innovations but to expand its reach directly to the US market. Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide scope of services including sales, training, rentals, maintenance, flying and data processing services. Dronelogics provides insights into inventory metrics, asset management, volume-metric calculation and digitizing assets, among many other applications.

 

Competition

 

Our industry is subject to rapid and intense technological and regulatory changes. We face, and will continue to face, competition in the development and marketing of our products and services from drone companies, retail and distribution companies, research institutions and academic institutions engaged in manufacturing, research and development, distribution and retail. Competition may arise from, among other things:

 

 

·

New competitors emerging throughout the world as the drone market matures;

 

 

 

 

·

The incumbent drone player increasing its market share further than its reputed 75% market share due to their aggressive price points;

 

 

 

 

·

Drone as a service typically is not proprietary with relatively low barriers to entry;

 

 

 

 

·

Well capitalized companies will have an advantage in the industry; and

 

 

 

 

·

Technological developments elsewhere may render our existing products non-competitive.

 

 
- 8 -

Table of Contents

  

Risks Related to Our Business

 

Our business and our ability to execute our business strategy are subject to a number of risks, which are more fully described in the section titled “Risk Factors” beginning on page 11. These risks include, among others:

 

 

·

Our ability to raise sufficient capital and the availability of future financing;

 

 

 

 

·

Unpredictable events, such as the COVID-19 outbreak, and associated business disruptions;

 

 

 

 

·

The explanatory paragraph from our auditors regarding the Company’s ability to continue as a going concern; and 

 

 

 

 

·

Our ability to develop and protect our intellectual property and to develop, maintain and enhance a strong brand;

 

 

 

 

·

Our ability to compete and succeed in a highly competitive industry; and

 

 

 

 

·

Our ability to manage our research, development, expansion, growth and operating expenses.

 

Our financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Since inception, we have funded operations exclusively with proceeds from bridge and equity financings. Our future viability is largely dependent upon our ability to raise additional capital to finance our operations. Our management expects that future sources of funding may include sales of equity, obtaining loans, or other strategic transactions. Although our management continues to pursue these plans, there is no assurance that we will be successful with this Offering or in obtaining sufficient financing on terms acceptable to us to continue to finance our operations, if at all. These circumstances raise substantial doubt on our ability to continue as a going concern, and our financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

REGULATION A+

 

We are offering our Units pursuant to rules of the SEC mandated under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). These offering rules are often referred to as “Regulation A+.” We are relying upon “Tier 2” of Regulation A+, which allows us to offer of up to $50 million in a 12-month period.

 

In accordance with the requirements of Tier 2 of Regulation A+, we are required to publicly file annual, semiannual, and current event reports with the SEC.

 

 
- 9 -

Table of Contents

 

THE OFFERING

 

Issuer:

 

Draganfly Inc., a company incorporated under the BCBCA.

 

 

  

Shares Offered:

 

A maximum of ● units (the “Units”), each Unit being comprised of ● common share in the capital of the Company (each, a “Common Share”) and ● common share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder thereof to purchase ● additional Common Share (each, a “Warrant Share”) at a price of $● for a period of ___ months from the date of issue.

 

·    ● common share in the capital of the Company, with no par value per share (a “Common Share”); and

 

·    ● Common Share purchase warrant (each whole, a “Warrant”) to purchase one additional Common Share (a “Warrant Share).

 

● Warrant is required to purchase ● additional Common Share at an exercise price of $● per Warrant, subject to certain adjustments. The minimum investment amount for each subscription is ● Units or $●, which minimum may be waived in our discretion.

 

Warrant Shares Offered:

 

A maximum of ● Warrant Shares at an exercise price of $● per Warrant Share, subject to customary adjustments. The Warrants are exercisable immediately and terminating on the date that is the ___ year anniversary of the listing of the additional common shares sold in this offering on the Canadian Securities Exchange or other recognized securities exchange.

 

Common Shares Outstanding before the Offering (1):

 

77,506,051 shares of Common Shares.

 

Common Shares to be Outstanding after the Offering(1):

 

● Common Shares, if all our Units are sold and all our Warrants are exercised in full and the maximum Warrant Shares are sold and issued.

 

Price per Unit:

 

$●

 

Price per Warrant Share:

 

$●

 

Maximum Offering:

 

● Units, at an offering price of $● per Unit, for total gross proceeds of $● (including the exercise of the Warrants in full of the Warrants to purchase ● Warrant Shares with a exercise price of $● per Warrant Share).

 

Use of Proceeds:

 

If we sell all of the ● Units being offered, and all of the ● Warrant Shares underlying the Units being offered, our net proceeds (after estimated Offering expenses) will be approximately $●. We will use these net proceeds for research and development expenses, offering expenses, working capital and general corporate purposes, and such other purposes described in the “Use of Proceeds to Issuer section of this Offering Circular.

 

Hold period:

 

The Common Shares and Warrants will be separately transferable following the termination of (i) any transfer hold periods under applicable law and (ii) the following contractual lock-up period: Our investors are required to enter into a -day “lock-up” from the closing date of the Offering relating to our Units, Common Shares, and Warrants purchased in the Offering. This means that, for a period of days following the closing date of this Offering, such persons may not, with limited exceptions, sell or agree to sell any of the Units or components thereof - the Common Shares or Warrants - or enter into any agreement or arrangement to transfer to another, in whole or in part, any of the economic consequences of ownership of the Units, Common Shares or Warrants, without the prior written consent of the Company, and pursuant to the terms of the lock-up agreements.

 

Risk Factors:

 

Investing in our Units involves a high degree of risk. See “Risk Factorsstarting on page 11.

 

(1)

In addition, there are 7,181,210 of our common shares reserved for issuance under our Share Compensation Plan, of which 3,550,000 of our common shares will be issuable upon vesting of restricted share unit grants and 4,770,000 will be issuable upon exercise of outstanding stock option grants at $0.50 per share. Additionally, 13,641,499 of our common shares are reserved for issuance to warrant holders whose warrants can be exercised to purchase our common shares at $0.50 per share.

  

 
- 10 -

Table of Contents

 

RISK FACTORS

 

An investment in our Units involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this Offering Circular, before making an investment decision. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. In that case, the price of our Common Shares could decline and you may lose all or part of your investment. See “Cautionary Statement Regarding Forward-Looking Statements” above for a discussion of forward-looking statements and the significance of such statements in the context of this Offering Circular.

 

Risks Related to our Business and Industry

 

The Company will be affected by operational risks and may not be adequately insured for certain risks.

 

The Company will be affected by a number of operational risks and the Company may not be adequately insured for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other acts of social activism; changes in the regulatory environment; impact of non-compliance with laws and regulations; natural phenomena, such as inclement weather conditions, floods, earthquakes and ground movements. There is no assurance that the foregoing risks and hazards will not result in damage to, or destruction of, the Company’s technologies, personal injury or death, environmental damage, adverse impacts on the Company’s operation, costs, monetary losses, potential legal liability and adverse governmental action, any of which could have an adverse impact on the Company’s future cash flows, earnings and financial condition. Also, the Company may be subject to or affected by liability or sustain loss for certain risks and hazards against which the Company cannot insure or which the Company may elect not to insure because of the cost. This lack of insurance coverage could have an adverse impact on the Company’s future cash flows, earnings, results of operations and financial condition.

 

There is no assurance that resale of the Company’s Common Shares will result in a positive return for existing investors.

 

The Company’s common shares are currently publicly traded on the Canadian Securities Exchange and the OTCQB Venture Market of the OTC markets. There can be no assurance that the publicly-traded market price of the Common Shares will be high enough to create a positive return for the existing investors. Further, there can be no assurance that the Common Shares will be sufficiently liquid so as to permit investors to sell their position in the Company without adversely affecting the stock price. In such event, the probability of resale of the Common Shares would be diminished. As well, the continued operation of the Company will be dependent upon its ability to procure additional financing in the short term and to generate operating revenues in the longer term. There can be no assurance that any such financing can be obtained or that revenues can be generated. If the Company is unable to obtain such additional financing or generate such revenues, investors may be unable to sell their Common Shares and any investment in the Company may be lost.

 

The market for securities has experienced a high level of price and volume volatility and market prices are subject to wide fluctuations.

 

In recent years, the securities markets in the United States and Canada have experienced a high level of price and volume volatility, and the market prices of securities of many companies have experienced wide fluctuations in price which have not necessarily been related to the operating performance, underlying asset values or prospects of such companies. There can be no assurance that continuing fluctuations in price will not occur. It may be anticipated that any quoted market for the Common Shares will be subject to market trends generally, notwithstanding any potential success of the Company in creating revenues, cash flows or earnings. The value of the Common Shares will be affected by such volatility.

 

The Company has not paid any dividends to date.

 

To date, the Company has not paid any dividends on its outstanding shares. Any decision to pay dividends on the shares of the Company will be made by its board of directors on the basis of its earnings, financial requirements and other conditions.

 

 
- 11 -

Table of Contents

  

The Company has a history of losses.

 

The Company has incurred net losses from the inception of its business until the date of this Offering Circular. The Company cannot assure that it can become profitable or avoid net losses in the future or that there will not be any earnings or revenue declines for any future quarterly or other periods. The Company expects that its operating expenses will increase as it grows its business, including expending substantial resources for research and development and marketing. As a result, any decrease or delay in generating revenues could result in material operating losses.

 

Our inability to retain management and key employees could impair the future success of the Company.

 

The Company’s future success depends substantially on the continued services of its executive officers and its key development personnel. If one or more of its executive officers or key development personnel were unable or unwilling to continue in their present positions, the Company might not be able to replace them easily or at all. In addition, if any of its executive officers or key employees joins a competitor or forms a competing company, the Company may lose know-how, key professionals and staff members as well as partners. These executive officers and key employees could develop drone technologies that could compete with and take customers and market share away from the Company.

 

A significant growth in the number of personnel would place a strain upon the Company’s management and resources.

 

The Company may experience a period of significant growth in the number of personnel that will place a strain upon its management systems and resources. Its future will depend in part on the ability of its officers and other key employees to implement and improve financial and management controls, reporting systems and procedures on a timely basis and to expand, train, motivate and manage the workforce. The Company’s current and planned personnel, systems, procedures and controls may be inadequate to support its future operations.

 

The Company may be subject to the risks associated with foreign operations in other countries.

 

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the Company may expand to markets outside of North America and become subject to risks normally associated with conducting business in other countries. The Company cannot predict government positions on such things as foreign investment, intellectual property rights or taxation. A change in government positions on these issues could adversely affect the Company’s business.

 

The Company may be subject to the risks associated with future acquisitions.

 

As part of the Company’s overall business strategy, the Company may pursue select strategic acquisitions that would provide additional product or service offerings, additional industry expertise, and a stronger industry presence in both existing and new jurisdictions. Future acquisitions may expose it to potential risks, including risks associated with: (a) the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the diversion of resources from the Company’s existing business and technology; (d) potential inability to generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss of or harm to relationships with both employees and existing users resulting from its integration of new businesses. In addition, any proposed acquisitions may be subject to regulatory approval.

 

The Company may be subject to electronic communication security risks.

 

A significant potential vulnerability of electronic communications is the security of transmission of confidential information over public networks. Anyone who is able to circumvent the Company’s security measures could misappropriate proprietary information or cause interruptions in its operations. The Company may be required to expend capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

 

 
- 12 -

Table of Contents

  

There is no assurance that the Company’s insurance coverage will be sufficient to cover all claims to which the Company may become subject.

 

Although the Company believes that the events and amounts of liability covered by its insurance policies will be reasonable, taking into account the risks relevant to its business, there can be no assurance that such coverage will be available or sufficient to cover claims to which the Company may become subject. If insurance coverage is unavailable or insufficient to cover any such claims, the Company’s financial resources, results of operations and prospects could be adversely affected.

 

There are tax risks the Company may be subject to in carrying on business in Canada.

 

The Company will be considered to have been carrying on business in Canada for purposes of the Income Tax Act (Canada). There is risk that foreign governments may look to increase their tax revenues or levy additional taxes to level the playing field for perceived disadvantages to the traditional brick and mortar business. While the Company does not foresee any adverse tax affects, there is no guarantee that governments will not impose such additional adverse taxes in the future.

 

The Company’s directors and officers may have a conflicts of interest in conducting their duties.

 

Because directors and officers of the Company are or may become directors or officers of other reporting companies or have significant shareholdings in other technology companies, the directors and officers of the Company may have a conflict of interest in conducting their duties. The Company and its directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from voting for or against the approval of such participation or such terms. In appropriate cases the Company will establish a special committee of independent directors to review a matter in which several directors, or officers, may have a conflict. In determining whether or not the Company will participate in a particular program and the interest therein to be acquired by it, the directors will primarily consider the potential benefits to the Company, the degree of risk to which the Company may be exposed and its financial position at that time. Other than as indicated, the Company has no other procedures or mechanisms to deal with conflicts of interest.

 

Executive officers and directors may have rights to indemnification including directors’ and officers’ liability insurance that will survive consummation of their agreements.

 

The Company operates in a competitive market.

 

The Company faces competition and new competitors will continue to emerge throughout the world. Services offered by the Company’s competitors may take a larger share of consumer spending than anticipated, which could cause revenue generated from the Company’s products and services to fall below expectations. It is expected that competition in these markets will intensify.

 

If competitors of the Company develop and market more successful products or services, offer competitive products or services at lower price points, or if the Company does not produce consistently high-quality and well-received products and services, revenues, margins, and profitability of the Company will decline.

 

The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing of services and equipment, quality of customer service, development of new and enhanced products and services in response to customer demands and changing technology, reach and quality of sales and distribution channels and capital resources. Competition could lead to a reduction in the rate at which the Company adds new customers, a decrease in the size of the Company’s market share and a decline in its customers. Examples include but are not limited to competition from other companies in the UAV industry.

 

In addition, the Company could face increased competition should there be an award of additional licenses in jurisdictions in which the Company operates in.

 

 
- 13 -

Table of Contents

  

The Company faces uncertainty and adverse changes in the economy.

 

Adverse changes in the economy could negatively impact the Company’s business. Future economic distress may result in a decrease in demand for the Company’s products, which could have a material adverse impact on the Company’s operating results and financial condition. Uncertainty and adverse changes in the economy could also increase costs associated with developing and publishing products, increase the cost and decrease the availability of sources of financing, and increase the Company’s exposure to material losses from bad debts, any of which could have a material adverse impact on the financial condition and operating results of the Company.

 

The recent COVID-19 outbreak or similar global health crises could affect our ability to access sources of capital.

 

The extent to which COVID-19 could impact our operations, financial condition, liquidity, results of operations, and cash flows is highly uncertain and cannot be predicted. Negative financial results, uncertainties in the market, and a tightening of credit markets, caused by COVID-19, or a recession, could have a material adverse effect on our liquidity.

 

COVID-19 or similar pandemics could adversely impact our business and/or our ability to complete reporting obligations.

 

If a pandemic, epidemic, or outbreak of an infectious disease including the recent outbreak off respiratory illness caused by a novel coronavirus (COVID-19) or other public health crisis were to affect our facilities, staff, accountants or advisors, our business could be adversely affected. Such a pandemic can result in mandatory social distancing, travel bans, and quarantine, and this may limit access to our employees and professional advisors. These factors may hamper our efforts to comply with our filing obligations with the SEC and the Canadian Securities Exchange.

 

We will incur increased expenses as a result of being a recently listed public company in Canada on the Canadian Securities Exchange and also trading in the United States on the OTCQB Venture Market of the OTC markets and our current resources may not be sufficient to fulfill our public company obligations.

 

We expect to incur significant legal, accounting, insurance and other expenses as a result of being a recently listed Canadian public company on the Canadian Securities Exchange (CSE) in Canada and our quotation on the OTCQB in the United States, which may negatively impact our performance and could cause our results of operations and financial condition to suffer. Compliance with applicable securities laws in Canada and the rules of the Canadian Securities Exchange substantially increases our expenses, including our legal and accounting costs, and makes some activities more time consuming and costly. Reporting obligations as a public company and our anticipated growth may place a strain on our financial and management systems, processes and controls, as well as on our personnel. We also expect these laws, rules and regulations to make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified persons to serve on our board of directors or as officers. As a result of the foregoing, we expect a substantial increase in legal, accounting, insurance and certain other expenses in the future, which will negatively impact our financial performance and could cause our results of operations and financial condition to suffer. We are responsible for establishing and maintaining adequate internal control over financial reporting, which is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS. Because of our inherent limitations and the fact that we are a new public company and are implementing new financial control and management systems, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A failure to prevent or detect errors or misstatements may result in a decline in the market price of our Common Shares and harm our ability to raise capital in the future.

 

If our management is unable to certify the effectiveness of our internal controls or if material weaknesses in our internal controls are identified, we could be subject to regulatory scrutiny and a loss of public confidence, which could harm our business and cause a decline in the price of our Common Shares. In addition, if we do not maintain adequate financial and management personnel, processes and controls, we may not be able to accurately report our financial performance on a timely basis, which could cause a decline in the market price of our Common Shares and harm our ability to raise capital. Failure to accurately report our financial performance on a timely basis could also jeopardize our listing on the Canadian Securities Exchange or any other stock exchange on which our Common Shares may be listed. Delisting of our Common Shares on any exchange would reduce the liquidity of the market for our Common Shares, which would reduce the price of and increase the volatility of the market price of our Common Shares.

 

 
- 14 -

Table of Contents

  

We do not expect that our disclosure controls and procedures and internal controls over financial reporting will prevent all error or fraud. A control system, no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within an organization are detected. The inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by individual acts of certain persons, by collusion of two or more people or by management override of the controls. Due to the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and may not be detected in a timely manner or at all. If we cannot provide reliable financial reports or prevent fraud, our reputation and operating results could be materially adversely effected, which could also cause investors to lose confidence in our reported financial information, which in turn could result in a reduction in the trading price of the Common Shares.

 

Our senior management team has limited experience managing a public company, and regulatory compliance may divert its attention from the day to day management of our business.

 

The individuals who now constitute our senior management team have relatively limited experience managing a publicly traded company and limited experience complying with the increasingly complex laws pertaining to public companies compared to senior management of other publicly traded companies. Our senior management team may not successfully or efficiently manage our transition as a recently listed public company subject to significant regulatory oversight and reporting obligations under Canadian securities laws. In particular, these new obligations will require substantial attention from our senior management and could divert their attention away from the day‑to‑day management of our business.

 

A shareholder’s holding in the Company may be diluted if we issue additional Common Shares in the future.

 

We may issue additional Common Shares in the future, which may dilute a shareholder’s holding in the Company. Our articles will permit the issuance of an unlimited number of Common Shares, and shareholders will have no pre-emptive rights in connection with such further issuances. The directors of the Company have the discretion to determine if an issuance of Common Shares is warranted, the price at which such issuance is effected and the other terms of issue of Common Shares. Also, we may issue additional Common Shares upon the exercise of options to acquire Common Shares under our option plan, which will result in further dilution to the shareholder. Potential future acquisitions may also divert Management’s attention and result in further dilution to the shareholder.

 

Risks Related to Our Company

 

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and future prospects.

 

The Company’s UAVs are sold in rapidly evolving markets. The commercial UAV market is in early stages of customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact the Company’s ability to do the following:

 

 

·

generate sufficient revenue to maintain profitability;

 

·

acquire and maintain market share;

 

·

achieve or manage growth in operations;

 

·

develop and renew contracts;

  

 
- 15 -

Table of Contents

  

 

·

attract and retain additional engineers and other highly-qualified personnel;

 

·

successfully develop and commercially market new products;

 

·

adapt to new or changing policies and spending priorities of governments and government agencies; and

 

·

access additional capital when required and on reasonable terms.

  

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results of operations and financial condition would be materially harmed.

 

The Company’s adoption of new business models could fail to produce desired financial returns.

 

Forecasting the Company’s revenues and profitability for these new business models is inherently uncertain and volatile. The Company’s actual revenues and profits for these business models may be significantly greater or less than the Company’s forecasts. Additionally, these new business models could fail for one or more of the Company’s products and/or services, resulting in the loss of Company’s investment in the development and infrastructure needed to support these new business models, and the opportunity cost of diverting management and financial resources away from more successful businesses.

 

If critical components or raw materials used to manufacture the Company’s products become scarce or unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could damage its business.

 

The Company obtains hardware components, various subsystems and systems from a limited group of suppliers. The Company does not have long-term agreements with any of these suppliers that obligate it to continue to sell components, subsystems, systems or products to the Company. The Company’s reliance on these suppliers involves significant risks and uncertainties, including whether its suppliers will provide an adequate supply of required components, subsystems, or systems of sufficient quality, will increase prices for the components, subsystems or systems and will perform their obligations on a timely basis.

 

In addition, certain raw materials and components used in the manufacture of the Company’s products are periodically subject to supply shortages, and its business is subject to the risk of price increases and periodic delays in delivery. Similarly, the market for electronic components is subject to cyclical reductions in supply. If the Company is unable to obtain components from third-party suppliers in the quantities and of the quality that it requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or cost-effective basis to its customers, which could cause customers to terminate their contracts with the Company, increase the Company’s costs and seriously harm its business, results of operations and financial condition. Moreover, if any of the Company’s suppliers become financially unstable, then it may have to find new suppliers. It may take several months to locate alternative suppliers, if required, or to redesign the Company’s products to accommodate components from different suppliers. The Company may experience significant delays in manufacturing and shipping its products to customers and incur additional development, manufacturing and other costs to establish alternative sources of supply if the Company loses any of these sources or is required to redesign its products. The Company cannot predict if it will be able to obtain replacement components within the time frames that it requires at an affordable cost, if at all.

 

The markets in which the Company competes are characterized by rapid technological change, which requires the Company to develop new products and product enhancements, and could render the Company’s existing products obsolete.

 

Continuing technological changes in the market for the Company’s products could make its products less competitive or obsolete, either generally or for particular applications. The Company’s future success will depend upon its ability to develop and introduce a variety of new capabilities and enhancements to its existing product and service offerings, as well as introduce a variety of new product offerings, to address the changing needs of the markets in which it offers products. Delays in introducing new products and enhancements, the failure to choose correctly among technical alternatives or the failure to offer innovative products or enhancements at competitive prices may cause existing and potential customers to purchase the Company’s competitors’ products.

 

 
- 16 -

Table of Contents

  

If the Company is unable to devote adequate resources to develop new products or cannot otherwise successfully develop new products or enhancements that meet customer requirements on a timely basis, its products could lose market share, its revenue and profits could decline, and the Company could experience operating losses.

 

If the Company releases defective products or services, its operating results could suffer.

 

Products and services designed and published by the Company involve extremely complex software programs, and are difficult to develop and distribute. While the Company has quality controls in place to detect defects in its products and services before they are released. Nonetheless, these quality controls are subject to human error, overriding, and reasonable resource constraints. Therefore, these quality controls and preventative measures may not be effective in detecting defects in the Company’s products and services before they have been released into the marketplace. In such an event, the Company could be required to or may find it necessary to voluntarily suspend the availability of the product or service, which could significantly harm its business and operating results.

 

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not seen as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.

 

The rate of privacy law-making is accelerating globally and interpretation and application of consumer protection and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, contradictory and in flux. As business practices are being challenged by regulators, private litigants, and consumer protection agencies around the world, it is possible that these laws may be interpreted and applied in a manner that is inconsistent with the Company’s data and/or consumer protection practices. If so, this could result in increased litigation government or court imposed fines, judgments or orders requiring that the Company change its practices, which could have an adverse effect on its business and reputation. Complying with these various laws could cause the Company to incur substantial costs or require it to change its business practices in a manner adverse to its business.

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from expanding sales of its small UAV to non-military customers in Canada.

 

The regulation of small UAV for commercial use in Canada is undergoing substantial change and the ultimate treatment is uncertain. Currently, the operation of UAVs with a maximum takeoff weight not exceeding 2kg., operated within visual line-of-sight are exempt from the regulations promulgated under the Aeronautics Act (Canada). Transport Canada is responsible for establishing, managing, and developing safety and security standards and regulations for civil aviation in Canada, and includes unmanned civil aviation. Civil operations include law enforcement, scientific research, or use by private sector companies for commercial purposes.

 

UAV operations for civil or commercial purposes are only authorized to fly with a Special Flight Operations Certificate (“SFOC”) issued by Transport Canada. The Canadian Aviation Regulations (“CARs”) govern civil aviation safety and security in Canada, and by extension govern operation of UAVs in Canada to an equivalent level of safety as manned aircraft. According to section 602.41 of the CARs, “no person shall operate an unmanned air vehicle in flight except in accordance with a SFOC, or an air operator certificate.”

 

As the name implies, SFOCs are intended to be an authorization for flight under special cases that are specific to a geographical area and for a specific mission. An SFOC may be issued to authorize a UAV to operate for any civil purpose, including for surveillance. The information that must be contained in an application for an SFOC includes details such as: type and purpose of the operation; description of the aircraft; dates and times of the proposed flight; security plans and emergency contingency plans; and a detailed plan describing how the operation will be carried out including: altitude and routes where the operation will be carried out, the location of any obstacles, and the exact boundaries of the area for the operation.

 

 
- 17 -

Table of Contents

  

While Transport Canada has been a world leader in the development of regulations for the commercial use of UAVs, it has acknowledged that the current regulatory regime in Canada has not kept pace with the rapid development in technology and the growing demand for commercial UAV use. In 2010, the Canadian Aviation Regulation Advisory Council (“CARAC”) established the Unmanned Aircraft System Program Design Working Group to develop new regulations to increase the safety, scope and regulatory efficiency of commercial UAV applications in Canada. In 2012, the working group released its phase 1 report which outlines the overall proposed revisions to the Canadian regulatory regime. The working group is currently in the process of drafting the revised regulations contemplated in the phase 1 report with the objective of introducing the new regulations before 2017. The new regulations are intended to be consistent with the international UAV regulatory model established by the International Commercial Aviation Organization (“ICAO”). There will likely be significant advance notice and consultation with the public before the new regulations are implemented.

 

There are risks associated with the regulatory regime and permitting requirements of our Business.

 

A significant portion of the Company’s business is based on the operation of remotely piloted aircraft systems (“RPAS”). The operation of RPAS’ poses a risk or hazard to airspace users as well as personnel on the ground. As the RPAS industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the Company could find itself to be in non-compliance with these new regulations. While the Company endeavours to take all necessary action to reduce the risks associated with the operations of RPAS’ and to remain well-informed and up-to-date on any addendums and changes to the applicable regulations, there is no assurance that an incident involving an RPAS or the Company’s non-compliance would not create a significant current or future liability for the company.

 

The regulation of RPAS operations within the Canadian Domestic Airspace (CDA) is still evolving and is expected to continue to change with the proliferation of RPAS’, advancements in technology, and standardization within the industry. Changes to the regulatory regime may be disruptive and result in the Company needing to adopt significant changes in its operations and policies, which may be costly and time-consuming, and may materially adversely affect our ability to manufacture and make delivery of our Company’s products and services in a timely fashion.

 

Our business and research and development activities are subject to oversight by Transport Canada, the federal institution responsible for transportation policies and programs, including the rules in the Canadian Aviation Regulations (CARs). Currently, Transport Canada requires that any non-recreational operators of RPAS’ have a Special Flight Operations Certificate (SFOC). Our ability to develop, test, demonstrate, and sell products and services depends on the Company’s ability to acquire and maintain a valid SFOC.

 

In addition, there exists public concern regarding the privacy implications of Canadian commercial and law enforcement use of small UAV. This concern has included calls to develop explicit written policies and procedures establishing usage limitations. There is no assurance that the response from regulatory agencies, customers and privacy advocates to these concerns will not delay or restrict the adoption of small UAV by non-military customers.

 

This discussion of the risks associated with the regulatory regime and permitting requirements affecting our Company does not take into account the new rules publicly announced by the Minister of Transport (Canada) on January 9, 2019, which will come into force on June 1, 2019 (the “New Rules”). The New Rules are intended to simplify the regulatory regime, including in respect of the requirement to obtain an SFOC under common operation conditions. With the new regulations, there appears to be intention to place more emphasis on Compliant Design Type aircraft as well as individual pilot certification, recurrent testing, and a monetized regulatory regime, which will require operators to pay for aircraft registration and pilot certifications. The Company does expect the new regulations to affect its need to employ and retain personnel with valid pilot certificates. The Company takes all necessary action to remain within compliance of the current and upcoming regulations.

 

The Company expects to incur substantial research and development costs and devote significant resources to identifying and commercializing new products and services, which could significantly reduce its profitability and may never result in revenue to the Company.

 

The Company’s future growth depends on penetrating new markets, adapting existing products to new applications, and introducing new products and services that achieve market acceptance. The Company plans to incur substantial research and development costs as part of its efforts to design, develop and commercialize new products and services and enhance existing products. The Company believes that there are significant investment opportunities in a number of business areas. Because the Company accounts for research and development as an operating expense, these expenditures will adversely affect its earnings in the future. Further, the Company’s research and development programs may not produce successful results, and its new products and services may not achieve market acceptance, create additional revenue or become profitable, which could materially harm the Company’s business, prospects, financial results and liquidity.

 

 
- 18 -

Table of Contents

 

The Company’s products and services are complex and could have unknown defects or errors, which may give rise to claims against the Company, diminish its brand or divert its resources from other purposes.

 

The Company’s UAV rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, electromechanical designs to accomplish their missions. Despite testing, the Company’s products have contained defects and errors and may in the future contain defects, errors or performance problems when first introduced, when new versions or enhancements are released, or even after these products have been used by the Company’s customers for a period of time. These problems could result in expensive and time-consuming design modifications or warranty charges, delays in the introduction of new products or enhancements, significant increases in the Company’s service and maintenance costs, exposure to liability for damages, damaged customer relationships and harm to the Company’s reputation, any of which could materially harm the Company’s results of operations and ability to achieve market acceptance. In addition, increased development and warranty costs could be substantial and could reduce the Company’s operating margins.

 

The existence of any defects, errors, or failures in the Company’s products or the misuse of the Company’s products could also lead to product liability claims or lawsuits against it. A defect, error or failure in one of the Company’s UAV could result in injury, death or property damage and significantly damage the Company’s reputation and support for its UAV in general. The Company anticipates this risk will grow as its UAV begins to be used in Canadian domestic airspace and urban areas. The Company’s UAV test systems also have the potential to cause injury, death or property damage in the event that they are misused, malfunction or fail to operate properly due to unknown defects or errors.

 

Although the Company maintains insurance policies, it cannot provide assurance that this insurance will be adequate to protect the Company from all material judgments and expenses related to potential future claims or that these levels of insurance will be available in the future at economical prices or at all. A successful product liability claim could result in substantial cost to us. Even if the Company is fully insured as it relates to a claim, the claim could nevertheless diminish the Company’s brand and divert management's attention and resources, which could have a negative impact on the Company’s business, financial condition and results of operations.

 

Shortfalls in available external research and development funding could adversely affect the Company.

 

The Company depends on its research and development activities to develop the core technologies used in its UAV products and for the development of the Company’s future products. A portion of the Company’s research and development activities depend on funding by commercial companies and the Canadian government. Canadian government and commercial spending levels can be impacted by a number of variables, including general economic conditions, specific companies' financial performance and competition for Canadian government funding with other Canadian government-sponsored programs in the budget formulation and appropriation processes. Moreover, the Canadian, federal and provincial governments provide energy rebates and incentives to commercial companies, which directly impact the amount of research and development that companies appropriate for energy systems. To the extent that these energy rebates and incentives are reduced or eliminated, company funding for research and development could be reduced. Any reductions in available research and development funding could harm the Company’s business, financial condition and operating results.

 

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain Canadian government authorization regarding the export of its products, or if current or future export laws limit or otherwise restrict the Company’s business.

 

The Company must comply with Canadian federal and provincial laws regulating the export of its products. In some cases, explicit authorization from the Canadian government is needed to export its products. The export regulations and the governing policies applicable to the Company’s business are subject to change. The Company cannot provide assurance that such export authorizations will be available for its products in the future. Compliance with these laws has not significantly limited the Company’s operations or sales in the recent past, but could significantly limit them in the future. Non-compliance with applicable export regulations could potentially expose the Company to fines, penalties and sanctions. If the Company cannot obtain required government approvals under applicable regulations, the Company may not be able to sell its products in certain international jurisdictions, which could adversely affect the Company’s financial condition and results of operations.

 

 
- 19 -

Table of Contents

  

From time to time, the Company may become involved in legal proceedings, which could adversely affect the Company.

 

The Company may, from time to time in the future, become subject to legal proceedings, claims, litigation and government investigations or inquiries, which could be expensive, lengthy, and disruptive to normal business operations. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be difficult to predict and could have a material adverse effect on the Company’s business, operating results, or financial condition.

 

The Company relies on its business partners, and they may be given access to sensitive and proprietary information in order to provide services and support to the Company’s teams.

 

The Company relies on various business partners, including third-party service providers, vendors, licensing partners, development partners, and licensees, among others, in some areas of the Company’s business. In some cases, these third parties are given access to sensitive and proprietary information in order to provide services and support to the Company’s teams. These third parties may misappropriate the Company’s information and engage in unauthorized use of it. The failure of these third parties to provide adequate services and technologies, or the failure of the third parties to adequately maintain or update their services and technologies, could result in a disruption to the Company’s business operations. Further, disruptions in the financial markets and economic downturns may adversely affect the Company’s business partners and they may not be able to continue honoring their obligations to the Company. Alternative arrangements and services may not be available to the Company on commercially reasonable terms or the Company may experience business interruptions upon a transition to an alternative partner or vendor. If the Company loses one or more significant business partners, the Company’s business could be harmed.

 

Risks Related to Intellectual Property

 

If the Company fails to protect, or incur significant costs in defending, its intellectual property and other proprietary rights, the Company’s business, financial condition, and results of operations could be materially harmed.

 

The Company’s success depends, in large part, on its ability to protect its intellectual property and other proprietary rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and unfair competition laws, as well as license agreements and other contractual provisions, to protect the Company’s intellectual property and other proprietary rights. However, a portion of the Company’s technology is not patented, and the Company may be unable or may not seek to obtain patent protection for this technology. Moreover, existing Canadian legal standards relating to the validity, enforceability and scope of protection of intellectual property rights offer only limited protection, may not provide the Company with any competitive advantages, and may be challenged by third parties. The laws of countries other than Canada may be even less protective of intellectual property rights. Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing upon or misappropriating its intellectual property or otherwise gaining access to the Company’s technology. Unauthorized third parties may try to copy or reverse engineer the Company’s products or portions of its products or otherwise obtain and use the Company’s intellectual property. Moreover, many of the Company’s employees have access to the Company’s trade secrets and other intellectual property. If one or more of these employees leave to work for one of the Company’s competitors, then they may disseminate this proprietary information, which may as a result damage the Company’s competitive position. If the Company fails to protect its intellectual property and other proprietary rights, then the Company’s business, results of operations or financial condition could be materially harmed. From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact the Company’s results of operations.

 

In addition, affirmatively defending the Company’s intellectual property rights and investigating whether the Company is pursuing a product or service development that may violate the rights of others may entail significant expense. Any of the Company’s intellectual property rights may be challenged by others or invalidated through administrative processes or litigation. If the Company resorts to legal proceedings to enforce its intellectual property rights or to determine the validity and scope of the intellectual property or other proprietary rights of others, then the proceedings could result in significant expense to the Company and divert the attention and efforts of the Company’s management and technical employees, even if the Company prevails.

 

 
- 20 -

Table of Contents

  

Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.

 

The Canadian Intellectual Property Office (“CIPO”) and various foreign national or international patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. Periodic maintenance fees on any issued patent are due to be paid to CIPO and various foreign national or international patent agencies in several stages over the lifetime of the patent. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which non‑compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file national and regional stage patent applications based on our international patent application, failure to respond to official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our product candidates, our competitors might be able to enter the market, which would have a material adverse effect on our business.

 

While a patent may be granted by a national patent office, there is no guarantee that the granted patent is valid. Options exist to challenge the validity of the patent which, depending upon the jurisdiction, may include re-examination, opposition proceedings before the patent office, and/or invalidation proceedings before the relevant court. Patent validity may also be the subject of a counterclaim to an allegation of patent infringement.

 

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third parties can typically submit prior art material to patentability for review by the patent examiner. Regarding Patent Cooperation Treaty applications, a positive opinion regarding patentability issued by the International Searching Authority does not guarantee allowance of a national application derived from the Patent Cooperation Treaty application. The coverage claimed in a patent application can be significantly reduced before the patent is issued, and the patent’s scope can be modified after issuance. It is also possible that the scope of claims granted may vary from jurisdiction to jurisdiction.

 

The grant of a patent does not have any bearing on whether the invention described in the patent application would infringe the rights of earlier filed patents. It is possible to both obtain patent protection for an invention and yet still infringe the rights of an earlier granted patent.

 

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be costly, time-consuming and limit the Company’s ability to use certain technologies in the future.

 

The Company may become subject to claims that its technologies infringe upon the intellectual property or other proprietary rights of third parties. Any claims, with or without merit, could be time-consuming and expensive, and could divert the Company’s management's attention away from the execution of its business plan. Moreover, any settlement or adverse judgment resulting from these claims could require the Company to pay substantial amounts or obtain a license to continue to use the disputed technology, or otherwise restrict or prohibit the Company’s use of the technology. The Company cannot assure that it would be able to obtain a license from the third party asserting the claim on commercially reasonable terms, if at all, that the Company would be able to develop alternative technology on a timely basis, if at all, or that the Company would be able to obtain a license to use a suitable alternative technology to permit the Company to continue offering, and the Company’s customers to continue using, the Company’s affected product. An adverse determination also could prevent the Company from offering its products to others. Infringement claims asserted against the Company may have a material adverse effect on its business, results of operations or financial condition.

 

 
- 21 -

Table of Contents

  

We may not be able to protect our intellectual property rights throughout the world.

 

Filing, prosecuting, and defending patents on all of our product candidates throughout the world would be prohibitively expensive. Therefore, we have filed applications and/or obtained patents only in key markets including the United States and Canada. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and their products may compete with ours.

 

Risks Related to Financial Reporting

 

We may experience adverse effects on our reported results of operations as a result of adopting new accounting standards or interpretations.

 

Our implementation of and compliance with changes in accounting rules, including new accounting rules and interpretations, could adversely affect our reported financial position or operating results or cause unanticipated fluctuations in our reported operating results in future periods.

 

Failure to adhere to our financial reporting obligations and other public company requirements could adversely affect the market price of our Common Shares.

 

Upon receiving a final receipt for the non-offering final prospectus dated October 23, 2019, we became subject to reporting and other obligations under applicable Canadian securities laws and rules of any stock exchange on which the Common Shares are then‑listed, including National Instrument 52‑109—Certification of Disclosure in Issuers’ Annual and Interim Filings. These reporting and other obligations will place significant demands on our Management, administrative, operational and accounting resources. If we are unable to accomplish any such necessary objectives in a timely and effective manner, our ability to comply with our financial reporting obligations and other rules applicable to reporting issuers could be impaired. Moreover, any failure to maintain effective internal controls could cause us to fail to satisfy our reporting obligations or result in material misstatements in our financial statements. If we cannot provide reliable financial reports or prevent fraud, its reputation and operating results could be materially adversely affected which could also cause investors to lose confidence in our reported financial information, which could result in a reduction in the trading price of the Common Shares.

 

We do not expect that our disclosure controls and procedures and internal controls over financial reporting will prevent all error or fraud. A control system, no matter how well‑designed and implemented, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within an organization are detected. The inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by individual acts of certain persons, by collusion of two or more people or by management override of the controls. Due to the inherent limitations in a control system, misstatements due to error or fraud may occur and may not be detected in a timely manner or at all.

 

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our reported financial results or financial condition.

 

Generally accepted accounting principles and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters that are relevant to our business, including but not limited to revenue recognition, impairment of goodwill and intangible assets, inventory, income taxes and litigation, are highly complex and involve many subjective assumptions, estimates and judgments. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments could significantly change our reported financial performance or financial condition in accordance with generally accepted accounting principles.

 

 
- 22 -

Table of Contents

  

Risks Related to the Offering

 

Additional funding will be required for the Company to meet its requirements and carry out its operations.

 

The Company will require additional financing from external sources, such as joint ventures, debt financing or equity financing, in order to meet its requirements and carry out operations. The success and the pricing of any such capital raising and/or debt financing will be dependent upon the prevailing market conditions at that time and upon the ability of a company with projects that are non‑producing to attract significant amounts of debt and/or equity. There can be no assurance that such financing will be available to the Company or, if it is, that it will be offered on acceptable terms. If additional financing is raised through the issuance of equity or convertible debt securities of the Company, this may have a depressive effect on the price of the Company’s securities and the interests of shareholders in the net assets of the Company may be diluted. Any failure by the Company to obtain required financing on acceptable terms could cause the Company to delay development of its material projects and could have a material adverse effect on the Company’s financial condition, results of operations and liquidity.

 

The market price of the Common Shares is subject to fluctuations.

 

In recent years, the securities markets in the United States and Canada have experienced a high level of price and volume volatility, and the market prices of securities of many technology companies have experienced wide fluctuations in price which have not necessarily been related to the operating performance, underlying asset values or prospects of such companies. The price of the Common Shares underlying the Units is also significantly affected by short term changes in the Company’s financial condition or results of operations as reflected in its quarterly financial reports. Other factors unrelated to the Company’s performance that may have an effect on the price of its Common Shares include the following: the extent of analytical coverage available to investors concerning the Company’s business may be limited if investment banks with research capabilities do not follow the Company’s securities; lessening in trading volume and general market interest in the Company’s securities may affect an investor’s ability to trade significant numbers of the Common Shares; and the market price of the Common Shares and size of the Company’s public float may limit the ability of some institutions to invest in the Company’s securities. If an active market for the Common Shares does not continue, the liquidity of an investor’s investment may be limited and the price of the Common Shares may decline. If an active market does not continue, investors may lose their entire investment in the Common Shares. As a result of any of these factors, the market price of the Common Shares at any given point in time may not accurately reflect the long‑term value of the Company.

 

The Company cannot provide absolute assurance on the reliability of its financial statements.

 

In the preparation of financial statements, management may need to rely upon assumptions, make estimates or use their best judgment in determining the financial condition of the Company. Significant accounting details are described in more detail in the notes to the Company’s annual consolidated financial statements for the year ended December 31, 2019. In order to have a reasonable level of assurance that financial transactions are properly authorized, assets are safeguarded against unauthorized or improper use and transactions are properly recorded and reported, the Company has implemented and continues to analyze its internal control systems for financial reporting. Although the Company believes its financial reporting and financial statements are prepared with reasonable safeguards to ensure reliability, it cannot provide absolute assurance in that regard.

 

There may be potential dilution of present and prospective shareholdings.

 

In order to finance future operations and development efforts, the Company may raise funds through the issue of Common Shares or the issue of securities convertible into or exercisable for Common Shares. The Company cannot predict the size of future issues of Common Shares or the issue of securities convertible into or exercisable for Common Shares or the effect, if any, that future issues and sales of the Common Shares will have on the market price of the Common Shares. Any transaction involving the issue of previously unissued shares, or securities convertible into or exercisable for shares, would result in dilution, which may be substantial, to existing holders of shares.

 

 
- 23 -

Table of Contents

  

There have been no dividends payments on the Company’s Common Shares to date.

 

No dividends on the Common Shares have been paid to date. The Company currently plans to retain earnings and other cash resources, if any, for the future operation and development of its business. Payment of any future dividends, if any, will be at the discretion of the Board of Directors after taking into account many factors, including the Company’s operating results, financial condition, and current and anticipated cash needs.

 

The Company has discretion in the use of the net proceeds from an Offering.

 

The Company intends to allocate the net proceeds it will receive from the Offering as described under “Use of Proceeds” in this Offering Circular, however, the Company will have discretion in the actual application of the net proceeds. The Company may elect to allocate the net proceeds differently from that described in “Use of Proceeds” in this Offer Circular if the Company believes it would be in the Company’s best interests to do so. The Company’s investors may not agree with the manner in which the Company chooses to allocate and spend the net proceeds from the offering. The failure by the Company to apply these funds effectively could have a material adverse effect on the business of the Company.

 

DILUTION

 

The following table summarizes the differences between the total consideration and the weighted-average price per share of our Common Shares paid by, on the one hand, officers, directors, and affiliates of the Company who have acquired the Common Shares prior to the date of this Offering Statement and on, the other hand, investors participating in this Offering, before deducting estimated offering expenses, assuming that the maximum gross cash proceeds from the offering of $● are raised and that the number of Common Shares presented on the cover of the Offering Statement are sold. As at date of this Offering Circular, an aggregate of 77,506,051 of our common shares are issued and outstanding, and an aggregate of 13,641,499 Common Share Purchase Warrants issued and outstanding. In addition, there are 3,550,000 restricted share units (“RSUs”) awarded under the Company’s share compensation plan to directors, officers, employees, and consultants of the Company. Each RSU represents a right to receive one common share of the Company, following the vesting of such restricted share units over a three‑year period. As of the date of this Offering Circular, there are 4,770,000 stock options (“Options”) outstanding under the Company’s Share Compensation Plan of which 4,770,000 of our common shares will be issuable upon exercise of outstanding awards at $0.50 per share.

 

The Share Compensation Plan is a 20% “rolling” plan pursuant to which the number of our common shares may be issued pursuant to RSUs and Options. The total number of our common shares that may be issued on exercise of RSUs and Options, together with any other share compensation of the Company, shall not exceed 20% of the number of issued and outstanding common shares from time to time. Future awards could be granted at per share prices above or below the offering price.

 

Future awards could be issued at per share prices above or below the Offering Price.

 

 

Shares Purchased

 

Total Consideration

 

Weighted-Average Price

 

Number

 

Percentage

 

Amount

 

Percentage

 

per Share

 

Existing stockholders before this offering

 

 

%

 

$

 

%

 

$

 

New Investors in this offering

 

 

%

 

$

(1)

 

%

 

$

 

Total

 

 

%

 

$

 

%

 

$

__________

(1)

Assumes the sale of ● shares of Common Shares at $● per share for gross proceeds of $● plus ● warrants of common shares exercised at $● per common share for gross proceeds of $●.

 

 
- 24 -

Table of Contents

 

PLAN OF DISTRIBUTION AND SELLING SECURITYHOLDERS

 

The Units are being offered pursuant to Regulation A of Section 3(b) of the Securities Act of 1933, as amended (the “Securities Act”), for Tier 2 offerings, by the management of the Company on a “best-efforts” basis directly to purchasers who satisfy the requirements set forth in Regulation A. We have the option in our sole discretion to accept less than the minimum investment. There is no aggregate minimum to be raised in order for the Offering to become effective and therefore the Offering will be conducted on a “rolling basis.” There is no arrangement for the return of funds to investors if all of the Units offered are not sold in the Offering. This means we are entitled to begin applying “dollar one” of the proceeds from the Offering towards our business strategy, research and development expenses, offering expenses (which include legal, accounting, printing, due diligence, marketing, selling and other costs incurred in the Offering of the Units), commissions, working capital, reimbursements, and other uses as more specifically set forth in the “Use of Proceeds to Issuer” starting on page 26.

 

Our Offering will expire on the first to occur of (a) the sale of all ● shares of Units offered hereby, (b) ●, 2022 or (c) when our Board of Directors (the “Board”) elects to terminate the Offering.

 

There is no arrangement to address the possible effect of the Offering on the price of our Units.

 

The Common Shares and Warrants will be separately transferable following the termination of (i) any transfer hold periods under applicable law and (ii) the following contractual lock-up period: Our investors are required to enter into a -day “lock-up” from the closing date of the Offering relating to our Units, Common Shares, and Warrants purchased in the Offering. This means that, for a period of days following the closing date of this Offering, such persons may not, with limited exceptions, sell or agree to sell any of the Units or components thereof - the Common Shares or Warrants - or enter into any agreement or arrangement to transfer to another, in whole or in part, any of the economic consequences of ownership of the Units, Common Shares or Warrants, without the prior written consent of the Company, and pursuant to the terms of the lock-up agreements.

 

We reserve the right to offer the shares through broker-dealers who are registered with FINRA. The Company has engaged Dalmore Group, LLC (“Dalmore”), a New York limited liability company and broker-dealer registered with the SEC and a member of FINRA, to provide broker-dealer services in connection with this Offering. Dalmore’s services include the review of investor information, including Know Your Customer data, Anti-Money Laundering and other compliance checks, and the review of subscription agreements and investor information. As compensation for these services, the Company has agreed to pay Dalmore a one-time payment for out of pocket expenses of $5,000, plus a 1% commission on the aggregate amount raised by the Company in this Offering, as described in the Broker-Dealer Agreement between the Company and Dalmore. This will only start after FINRA Corporate Finance issues a No Objection Letter for the Offering. The Company has authorized Dalmore to deduct the fee directly from Dalmore’s third party escrow or payment account. The Company has also engaged Dalmore as a consultant to provide ongoing general consulting services relating to the Offering such as coordination with third party vendors and general guidance with respect to the Offering. The Client has agreed to pay a one time consulting fee of $20,000 which will be due and payable immediately after FINRA issues a No Objection Letter and the Client receives SEC Qualification.

 

Generally speaking, Rule 3a4-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with an issuer that participate in an offering of the issuer’s securities. None of our officers or directors are subject to any statutory disqualification, as that term is defined in Section 3(a)(39) of the Exchange Act. None of our officers or directors will be compensated in connection with his participation in the Offering by the payment of commissions or other remuneration based either directly or indirectly on transactions in our securities. None of our officers or directors are, or have been within the past 12 months, a broker or dealer, and none of them are, or have been within the past 12 months, an associated person of a broker or dealer. At the end of the Offering, our officers and directors will continue to primarily perform substantial duties for the Company or on its behalf otherwise than in connection with transactions in securities. Our officers and directors will not participate in selling an offering of securities for any issuer more than once every 12 months other than in reliance on Exchange Act Rule 3a4-1(a)(4)(i) or (iii), except that for securities issued pursuant to Rule 415 under the Securities Act, the 12 months shall begin with the last sale of any security included within one Rule 415 registration.

 

 
- 25 -

Table of Contents

  

Selling Security Holders

 

No securities are being sold for the account of security holders; all net proceeds of this offering will go to the Company.

 

USE OF PROCEEDS TO ISSUER

 

The maximum gross proceeds from the sale of our Units is $●. The net proceeds from the total maximum offering are expected to be approximately $●, after the payment of offering costs (including legal, accounting, printing, due diligence, marketing, selling and other costs incurred in the Offering). Our estimated offering costs of $● include a deduction of 1% of the total gross proceeds for commissions payable to Dalmore Group, LLC on all the Units being offered, which will only start after FINRA Corporate Finance issues a No Objection Letter for the Offering. The Company will also pay a one time set up fee of $5,000 and a consulting fee of $20,000 payable once FINRA issues a No Objection Letter and the Company receives SEC Qualification. The estimate of the budget for offering costs is an estimate only and the actual offering costs may differ. We expect from time to time to evaluate the acquisition of businesses, intellectual property, products and technologies for which a portion of the net proceeds may be used, although we currently are not planning or negotiating any such transactions. The following table represents management’s best estimate of the uses of the net proceeds received from the sale of Units.

 

Percentage of Offering Sold

 

 

Business Objectives

 

$

 

Research and Development

 

$

 

Sales and Marketing

 

$

 

Capex/Facility Expansion

 

$

 

Inventory/Purchasing

 

$

 

General and administrative costs

 

$

 

Cost to complete the offering

 

$

 

TOTAL

 

$

 

We began operations in June 1, 2018 and have a very limited operating history. Our plan of operations for the next few years includes the following: (i) hiring engineers to perform more engineering service work, to complete contracts on a timelier basis, and to perform R&D for the company’s next generation of products; (ii) hiring sales/marketing employees for our product lines and engineering services work; (iii) hiring sales/marketing employees for further expansion into services (e.g. drone as a service); (iv) diversifying and expanding business lines organically and by potential acquisitions; (v) updating machinery used for manufacturing and production; (vi) continuing to patent innovative ideas for new products; (vii) developing and increasing current product offering to various niche industries that are not currently being served; and (viii) considering potential acquisition opportunities.

 

The amounts set forth above are our current estimates for such development activities, and we cannot be certain that actual costs will not vary from these estimates. Our management has significant flexibility and broad discretion in applying the net proceeds received in this Offering. We cannot assure you that our assumptions, expected costs and expenses and estimates will prove to be accurate or that unforeseen events, problems or delays will not occur that would require us to seek additional debt and/or equity funding, which may not be available on favorable terms, or at all. See “Risk Factors” starting on page 11 for more information regarding the risks associated with an investment in our Units.

 

The Company intends to use a portion of the proceeds raised in this Offering to fund the compensation payable to its Chief Executive Officer and Chief Financial Officer, as described under “Executive Compensation” below. The Company does not currently pay its directors cash compensation and does not expect to compensate them with the proceeds of the Offering.

  

This expected use of the net proceeds from this Offering represents our intentions based upon our current financial condition, results of operations, business plans and conditions. As of the date of this Offering Circular, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the closing of this Offering or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors. As a result, our management will retain broad discretion over the allocation of the net proceeds from this Offering, and reserves the right to change the estimated allocation of net proceeds set forth above. Additionally, we reserve the right to use proceeds for repayment of Company indebtedness .

 

 
- 26 -

Table of Contents

  

Although our business does not presently generate positive cash flow, we believe that if we raise the maximum amount in this Offering, that we will have sufficient capital to finance our operations for at least the next 12 months. However, if we do not sell the maximum number of Shares offered in this Offering, or if our operating and development costs are higher than expected, we will need to obtain additional financing prior to that time. Further, we expect that during or after such 12-month period, we will be required to raise additional funds to finance our operations until such time that we can conduct profitable revenue-generating activities.

 

Pending our use of the net proceeds from this Offering, we intend to invest the net proceeds in a variety of capital preservation investments, including short-term, investment grade, and interest bearing instruments. We may also use a portion of the net proceeds for the repayment of outstanding loans, investment in strategic partnerships and possibly the acquisition of complementary businesses, products or technologies, although we have no present commitments or agreements for any specific acquisitions or investments.

 

DESCRIPTION OF BUSINESS

 

Overview

 

The Company was incorporated on June 1, 2018 under the BCBCA. Effective July 17, 2019, the Company amended its articles (“Articles”) to remove various classes of authorized but unissued preferred shares and replace them with only one class of preferred shares. On August 15, 2019, the Company completed a going public transaction pursuant to an amalgamation agreement entered into among the Company, Drone Acquisition Corp. and 1187607 B.C. Ltd., 2300 (the “Amalgamation Agreement”), and changed its name to Draganfly Inc. On August 22, 2019, the Company amended the Articles to re-designate its Class A Common Shares as Common Shares. On April 30, 2020, the Company completed the acquisition of Dronelogics by acquiring all of the shares of Dronelogics, making it a wholly-owned subsidiary of the Company.

 

Pursuant to our Articles of Incorporation, we are authorized to issue (i) an unlimited number of shares of Common Shares and (ii) an unlimited number of shares of Preferred Shares. As of June 15, 2020, we have (i) 77,506,051 shares of Common Shares outstanding and (ii) no shares of Preferred Shares outstanding.

 

The Company has three wholly-owned subsidiaries, as follows:

 

1.

Draganfly Innovations Inc. (“Draganfly Innovations”), a corporation continued under the BCBCA on August 19, 2019. Draganfly’s head office is located at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7;

 

 

2.

Draganfly Innovations USA Inc. (“Draganfly Innovations USA”), a corporation incorporated in the state of Delaware on January 27, 2020. Draganfly Innovations USA’s head office is located at 1017 Maine Campus Drive, Raleigh, NC, 27606; and

 

 

3.

Dronelogics, a corporation incorporated under the BCBCA on January 13, 2009. Dronelogics’ head office is located at 319-2999 Underhill Avenue, Burnaby, British Columbia V5A 3C2.

  

The business of Draganfly Innovations and Draganfly Innovations USA is the provision of engineering services and manufacture of commercial UAVs, RPASs, and UVSs and software, serving the public safety, agriculture, industrial inspections, and mapping and surveying markets.

 

Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide scope of services including sales, training, rentals, maintenance, flying and data processing services.

 

 
- 27 -

Table of Contents

  

Inter-corporate Relationships

 

The following chart identifies the Company’s material wholly-owned subsidiaries, their applicable governing jurisdictions and the percentage of their voting securities which are beneficially owned, or controlled or directed, directly or indirectly, by the Company:

 

Draganfly Inc.

(British Columbia)

 

  

100%

 

100%

 

100%

Draganfly Innovations Inc.

 

(British Columbia)

 

 

Draganfly Innovations USA Inc.

 

(Delaware)

 

Dronelogics Systems Inc.

  

(British Columbia)

 

Company Overview and History

 

The Company was incorporated under the BCBCA on June 1, 2018. On August 15, 2019, the Company completed a going public transaction pursuant to the Amalgamation Agreement and changed its name to “Draganfly Inc.”

 

In connection with the going public transaction, the Company completed certain private placement offerings on May 22, 2019 and August 6, 2019 (pursuant to prospectus and registration exemptions in Canada, the United States, and in other jurisdictions) raising aggregate gross proceeds of CAD$7,025,749.50 through the issuance of 13,051,499 subscription receipts (the “Subscription Receipts”) at a price of CAD$0.50 per Subscription Receipt. The said private placement offering was required in order to satisfy closing conditions of the going public transaction. At closing of the going public transaction, each Subscription Receipt automatically converted, without payment of additional consideration and without any further action on the part of the holder, into one unit of the Company, subject to adjustment in certain circumstances, consisting of one (1) Common Share and one common share purchase warrant (the “2019 Warrant”). Each 2019 Warrant entitling the holder to purchase one (1) Common Share at a price of CAD$0.50 for a period of twelve (12) months following the issuance of the 2019 Warrants.

 

The Company completed the listing of its Common Shares for trading on the Canadian Securities Exchange under the symbol “DFLY” on November 5, 2019. The Company completed the listing of its Common Shares for trading on the OTCQB Venture Market of the OTC Markets under the symbol “DFLYF” on January 9, 2020.

 

Certain of our common shares held by the new directors and officers of the Company are subject to escrow (the “Escrow”) that prohibits transfer for up to a three‑year period following the Listing pursuant to the policies of the Canadian Securities Exchange. In addition, as part of the going public transaction, shareholders of Draganfly Innovations Inc. and former shareholders of the Company have agreed that certificates representing their respective Common Shares held by former shareholder of Former Draganfly will be subject to trading restrictions (the “Voluntary Restriction”) for up to a three‑year period following the Listing. Notwithstanding the Escrow and the Voluntary Restriction, the shareholders holding these Common Shares will otherwise have all of the normal rights associated with Common Shares, such as entitlement to dividends, voting powers and participation in assets upon dissolution or winding up, until they are released from escrow.

 

On April 30, 2020, the Company completed a share purchase transaction with the shareholders of Dronelogics (the “Dronelogics Sellers”), acquiring all of the shares of Dronelogics for cash and Common Shares, pursuant to a share purchase agreement dated January 15, 2020 between the Company and the Dronelogics Sellers (the “Share Purchase Agreement”). On closing of the Dronelogics acquisition, the Company: (i) paid the Dronelogics Sellers CAD$2.0 million, consisting of a cash payment of CAD$500,000, subject to a post-closing working capital adjustment; (ii) issued the Dronelogics Sellers 3,225,438 Common Shares in satisfaction of the balance of the purchase price and payment of certain management bonuses at a deemed price of CAD$0.50 per Common Share; (iii) appointed Mr. Justin Hannewyk, President of Dronelogics, to the Board of Directors of the Company; and (iv) issued 200,000 Common Shares to a finder in connection with the Dronelogics acquisition. The Common Shares issued under the Dronelogics acquisition are subject to resale restrictions in the form of pooling terms providing for release of such shares over a period of 24 months and a right to place in favor of the Company during the same 24-month period.

 

 
- 28 -

Table of Contents

  

Three Year History

 

Historically, the main business of Draganfly Innovations Inc. was to operate as a manufacturing company offering commercial UAVs directly to its customer base across various industry verticals such as public safety, agriculture, industrial, etc. The main product offering of the Company now consists of quadcopters such as The Commander, X4, and Guardian. The Commander is the most recent and most advanced of the quadcopter line up. The Commander quadcopter is a professional quality, powerful, easy to fly aerial platform delivering high quality aerial photography and video with one of the World’s longest flight time capabilities (with a 400g payload) of 55 minutes on a single battery charge. The Commander can fly 100+ acres on a single charge – this is the coverage of some of the Company’s fixed wing competitors. The Company has also developed a fixed wing drone, called The Tango2 which has recently been available to customers. The ideal use of the Tango2 fixed wing is for search and rescue, inspection and any application that requires loitering in the air for extended time periods, covering large surface area. The Company has also designed and produced a ground based robot, The DraganScout ground based robot, which has not been commercialized as of yet but has received expressions of interest for applications within public safety and agricultural inspection. With continued R&D funding, the intention is to fully complete development of the DraganScout and make it available for sale.

 

Over the last 3 years, the Company has started to do engineering procurement for certain customers in an industry vertical that it does not currently serve, such as military applications (e.g., high value product delivery on the battlefield, surveillance and capture drones). The rationale is three-fold: engage in long term contracts that tend to be recurring in nature, gain exposure to an industry that the Company otherwise did not have access to, and leverage our innovation learnings into other products that can be sold in other industries.

 

This progression occurred due to shifts in the commercial UAV space, the area the company is known for being an industry pioneer. As businesses and other commercial users became more comfortable using UAVs, most tend to test their use case by buying lower cost consumer drones. Over time, one large company has become the dominant leader in both consumer and commercial drone sales. The phenomenon has moved the Company’s focus to niche markets which organically created engineering service work, With the Company’s strength in innovation, this shift lends very well to developing custom products for specific clients’ needs as well as integration and customization work.

 

The Company works with its customers to customize a product or platform from idea (R&D) to completion and testing. A work plan is created with timelines and budget which includes materials, travel, testing, and engineering time. This plan is signed off on by the customer before work begins. To date, the majority of this work is considered proprietary and secret in nature. In some cases, Draganfly effectively acts as a subcontractor to a larger military focused drone company, for example, creating new products and applications to their specifications.

 

We are driven by passion, ingenuity and the need to provide efficient solutions and first-class services to our customers around the world with the goal of saving time, money, and lives.

 

With the acquisition of Dronelogics, a drone integrator and service provider that has been in business for over 10 years, we have expanded our offerings in a complementary business and have expanded our product offering in the integration and engineering segments, expanding our total addressable market and enhancing our position as a leader in the UAV and UVS industry.

 

Our Business

 

The business of the Company is conducted through three wholly-owned subsidiaries: (i) Draganfly Innovations; (ii) Draganfly Innovations USA; and (ii) Dronelogics.

 

 
- 29 -

Table of Contents

  

Draganfly Innovations is an award-winning, industry-leading manufacturer within the UAV and UVS space, recognized as being at the forefront of technology for over two decades. Draganfly Innovation’s business is creating quality, cutting-edge UVS and software. Draganfly Innovations provides engineering services and manufactures commercial UAVs, RPASs, and UVSs and software, serving the public safety, agriculture, industrial inspections, and mapping and surveying markets.

 

Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide scope of services including sales, training, rentals, maintenance, flying and data processing services. The wide variety of services, products and innovations that Dronelogics provides results in a unique one-stop-shop solution for its clients which aids in higher customer retention, diversified revenue streams, repeat business and protection against market volatility.

 

Dronelogics’ customer base comprises well over 10,000 independent names and the company enjoys high repeat business due to its expertise, unique focus on service and broad scope of offerings.

 

Our Products and Services

 

Founded in 1998, Draganfly Innovations is recognized as the first commercial multi-rotor manufacturer and has a legacy for its innovation and superior customer service. Draganfly Innovations has sold products and services to over 50 countries. To date, Draganfly Innovations, has sold over 9,000 of its drones primarily to police forces around the world. Zenon Dragan is one of the founders of the Company and is a recognized leading expert on UAVs. Draganfly Innovations is positioning itself as an integrated solutions provider to the UAV industry.

 

The Company can provide its customers with an entire suite of products and services that include: quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, flight training, and software used for tracking, live streaming, and data collection. The Company’s products are manufactured at its machine shop within its head office based in Saskatoon, Saskatchewan. Raw materials for the Company’s products consist of a combination of its original equipment manufacturer parts and third-party components.

 

Dronelogics, a complementary business to Draganfly, expands the Company’s product offering in the integration and engineering segments, thereby broadening the Company’s total addressable market and enhancing its position as a leader in the UAV and UVS industry. As a trusted drone service provider, Dronelogics provides insights into asset management, volume-metric calculation and digitizing assets, among many other applications. It is a solutions integrator for custom robotics, hardware and software that provides a wide scope of services including sales, training, rentals, maintenance, flying and data processing services.

 

Our integrated UAV system is equipped for automated take-offs and landings with altitude and return to home functions as well as in-house created survey software. The Company’s standard features combined with custom fit camera payloads ranging from third-party multi-spectral, hyper-spectral, LIDAR, thermal, and infrared allows the Company to offer a truly unique solution to clients. The Company has also partnered with companies such as Waterloo based, Dejero, who provide a live streaming solution that the Company can offer to its customers and share in monthly usage fees.

 

The Company’s patented high quality folding frame on its quadcopters means customers have a strong aerial platform that can easily pack into the back seat or trunk of an automobile. The easier the aircraft is to transport, the faster users can get from one job to another. When packed in its rugged transport case, the complete quadcopter system meets airline baggage size requirements. Constructed from high quality carbon fiber, the strength-to weight ratio of the aircraft is very high, coupled with a strong folding frame helps reduce damage in the event of a hard landing or hitting an obstruction.

 

Because the Company’s system is designed and manufactured in-house, the Company controls the quality, design, software and systems integration, delivering a helicopter system that is inherently stable. The onboard computer and 11 sensors keep the helicopter level in real-time and pointed in the right direction, so when a user “parks” the helicopter in the air using the GPS position hold function, the user can shift their attention to getting the photos they need. Even in a GPS position hold, one can reposition the aircraft, continue shooting photos and meanwhile, in real-time, the telemetry data system is monitoring aircraft battery health, heading, bearing, altitude, and both audibly and visually alerting the user to any aircraft warnings.

 

 
- 30 -

Table of Contents

  

Although the Company has a number of distribution partners, the majority of its product sales are sold directly to the customer. The Company does very little outbound sales and marketing promotional activities with customers around the world reaching out to the Company through its website which is still its primary method of selling.

 

The global market for commercial applications of drone technology, currently estimated at about $2 billion, is expected to balloon to as much as $127 billion by 2020, according to a report by PricewaterhouseCoopers LLP1. Consumer and prosumer drones are ideal for certain aerial filming applications, but enterprises looking to use drones for advanced applications will generally turn to high‑end UAV manufactures with longer flight times, better sensor capabilities and analytic functionalities. The high‑end commercial UAV market, which is defined as drones >$5,000, is one of the fastest-growing markets within the broader UAV space.

 

Although the higher end commercial UAV market is growing quickly, the commercial industry is shifting towards using lower cost consumer type drones for their business. As a result, the Company has started offering engineering service and customization work. All engineering, customization, and integration work takes place at its facility within its head office. In some cases, travel to customers’ locations is required to understand the scope of a project. In some cases, Draganfly uses lower cost third party off the shelf UAVs and integrates higher end sensors or customizes the UAV to handle niche applications not offered by standard UAVs. The Company takes a small margin on the third party equipment and charges for the engineering service work involved in the integration. In more complex situations, the Company will create an entirely new product for a very specific application. Given Draganfly’s core competence is its ability to innovate, engineering services is a natural evolution for the Company.

 

Product sales accounted for 31% of revenues in the financial year ended December 31, 2018 with the balance made up of engineering services. In the financial year ended December 31, 2019, engineering services revenues represented 82% with the balance being made up of product sales. The bulk of engineering service work is for one large US‑based customer that subcontracts to Draganfly. The customer’s clients tend to be the U.S. government and military. Although the Company does not anticipate a slowdown in government and military spending, the recent U.S. government shutdown and COVID-19 outbreak has impacted the timing of certain projects for Draganfly.

 

The Company has a list of ideas that could become products but given its current resources, are not actively working on anything. Following Listing, with access to research and development (“R&D”) funding and more engineering personnel, the Company continues to work on enlarging its product offering.

 

Draganfly Innovations introduced its first systems in 1999 and has evolved and has since shaped the UAV industry. The aircraft are widely used by public safety agencies worldwide and one of the first small Unmanned Aerial Systems (“sUAS”) to receive a Federal Aviation Administration (“FAA”) Certificate of Authorization (“COA”) in the fall of 2009 with the Mesa County Colorado Sheriff’s Office. In 2012, the Royal Canadian Mounted Police (“RCMP”) flew the X4-ES system to locate and save the life of an accident victim. The RCMP system is on permanent display at the Smithsonian National Air and Space Museum. Their aircrafts have achieved many industry firsts, including:

 

 

·

The first public safety sUAS to shoot aerial photos documenting a manned aircraft accident in an urban area;

 

 

 

 

·

The first sUAS operated by a public safety organization flown at night to locate and save a life;

 

 

 

 

·

The first sUAS helicopter to be granted a county wide U.S. FAA COA,

 

 

 

 

·

Was recently named as a test platform at one of the U.S. FAA certified test sites.

 

 

 

 

·

Draganfly has the largest Canadian SFOC and USA FAA COA “approved” installed sUAS customer base in North America.

 

On April 10, 2015, the FAA issued to the Company an FAA Section 333 Exemption and Certificate of Authorization (COA) to operate commercially and conduct research in the U.S.

__________________

1 “Clarity from above,” PwC global report on the commercial applications of drone technology, May 2016

  

 
- 31 -

Table of Contents

  

The exemption covers the Commander, Draganflyer X4-P, Draganflyer X4-ES, Draganflyer X6, and Draganflyer Guardian aircraft for use in aerial data collection such as mapping, agriculture, surveying, aerial photography, and inspections.

 

The Company had 4 of the first 6 Compliance certifications for their products issued by Transport Canada (TC). At the time, to be deemed a Compliant Drone, a company had to self-declare that their product’s capabilities meet Transport Canada’s specific safety measures. TC had to review and accept each self-declaration. All four of our then-current systems (Guardian, X4P, X4ES, and Commander) were approved so when TC announced the first 6 compliant certificates, Draganfly products made up four of them.

 

Competition

 

Although Draganfly is acknowledged as the pioneer that first developed the commercial multi rotor helicopter, there are now many drone hardware companies in the World. Draganfly has sold products and services to over 50 countries but predominantly focuses on the North American market given its geographical location. As technology has improved and costs for hardware and software have come down, the line between consumer and commercial drones has blurred. Historically, Draganfly has serviced early adopters in the public safety industry. At this stage of the commercial drone adoption curve, the average public safety organization (local, regional, and even federal law enforcement, for example), are quite budget conscious. Hence, these organizations tend to use lower cost drones that have become quite sophisticated that can accomplish most of their use cases. The obvious dominant player is DJI, the Chinese drone company that is reputed to own over 70% of the consumer and now commercial drone market. The majority of DJI’s drones are geared towards broad applications involving the masses. Draganfly has moved away from competing directly with DJI and has chosen to serve niche markets outside of where DJI tends to be. There are also some organizations that tend to be US based that either prefer or are mandated to not use foreign drones such as those produced by DJI. Some of these organizations are sensitive to their work being exposed to that of overseas governments which has at least for the time being, created a niche market for players such as Draganfly. As Draganfly has evolved to move with the industry trends, the Company now uses DJI drones as part of some of its customization and engineering services work. Draganfly has also moved into innovative engineering procurement which is very specialized and is currently not aware of any Canadian and US companies focusing on this industry or its existing customers. As the drone industry matures, this may bring more players to this space or the Company’s customers may choose to develop the in-house expertise to do the work that they currently outsource to Draganfly. However, it is the Company’s view that there will be a growing customer base that will require very specialized work that only a handful of companies can do.

 

It became evident to Management that funds needed to be raised to execute a sales and marketing strategy to capitalize on industry demand for its product and services.

 

Management determined in mid-2018 the best course of action to secure additional capital, grow its brand and expand its reach was to secure a public listing on a reputable exchange. To that end, the Company completed a go public transaction and listed on the Canadian Securities Exchange.

 

Compliance with Government Regulation

 

The operation of Remotely Piloted Aircraft Systems (“RPAS”) or UAVs within Canada for any intended application is governed by regulations developed and managed by Transport Canada. The Canadian Aviation Regulations (“CARs”) developed by Transport Canada clearly detail the rules and regulations that are directly applicable to all civil aviation operations, both manned and unmanned, within the Canadian Domestic Airspace (“CDA”). Civil aviation encompasses all applications and purposes other than those operated by military organizations. Transport Canada currently has provisions that allow exemptions and relief from specific sections of CARs for recreational operators with an additional set of restrictions and limitations. However, no business or corporation is permitted to operate an RPAS under these recreational exemptions and must adhere to the full CARs. Commercial / non-recreational operations of RPAS within CDA can only be safely and legally accomplished through the issuance of a Special Flight Operations Certificate (“SFOC”) granted by Transport Canada. An SFOC is intended to be a temporary authorization for flight operations that have clear, defined, and specific geographical areas, dates and times, intended applications, and flight profile limitations. SFOC’s are granted by Transport Canada inspectors on a case-by-case basis and must be applied for in advance of the intended flight operations. The SFOC application must include details such as the type and purpose of operations, description of the aircraft, dates and times of intended flights, security and emergency plans, and detailed standard operating procedures to explain how the flight operations will be conducted. Currently any flight operations conducted for non-recreational purposes can only be performed under the authority of an SFOC. An SFOC can be granted for operation of any RPAS make and model and can be granted to the business or organization rather than a specific individual or pilot. This allows for a company to self-certify a number of approved pilots rather than requiring individual licensing for each pilot. Transport Canada offers an advanced authorization called a Compliant SFOC, which is available only to operators of RPAS that have been recognized by Transport Canada as meeting the safety standards of a Compliant Design Type. The Compliant SFOC provides the operator with additional allowances including, but not limited to, operations in a wider geographical operating area. Failure to obtain the necessary regulatory approvals such as the granting of an SFOC or limitations put on the use of RPAS’ may prevent the company from developing, testing, and demonstrating its products and services and/or expanding its sales and services.

 

 
- 32 -

Table of Contents

  

New RPAS came into force on June 1, 2019. The Company expected the regulations to affect its need to employ and retain personnel with valid pilot certificates. The Company takes all necessary action to ensure that it remains compliant with current and upcoming regulations.

 

Employees

 

The Company currently has 22 full-time employees and engages two (2) to three (3) contractors on a regular basis. Ideally, the Company would like to add to its engineering bench and marketing team to help build the Company’s engineering services offering. We do not currently have any pension, annuity, insurance, and profit-sharing plans, although we may choose to adopt such plans in the future.

 

Corporate Information

 

Our head office is located at 2108 St. George Avenue, Saskatoon, Saskatchewan, S7M 0K7, and our telephone number is 1-(306)-955-9907. Our website address is www.draganfly.com. The information contained therein or accessible thereby shall not be deemed to be incorporated into this Offering Circular.

 

DESCRIPTION OF PROPERTY

 

The Company’s products are manufactured at its machine shop within its leased head office based in Saskatoon, Saskatchewan. Raw materials for the Company’s products consist of a combination of its original equipment manufacturer parts and third-party components.

 

United States Operations

  

The Company, through its wholly-owned subsidiary, Draganfly Innovations USA Inc., has a management office in Raleigh, North Carolina that currently conducts business in the state of North Carolina in the United States.

 

Raleigh Management Office – Draganfly Innovations USA Inc. operates a management office in Raleigh, North Carolina pursuant to a Member License Agreement with HQ Raleigh, LLC (“Licensor”). Pursuant to a Lease Agreement, dated January 25, 2019, between C21, LLC (“C21”) and the State of North Carolina, C21 leases from the State of North Carolina a building located at 1017 Main Campus Drive, Raleigh, NC 27606, together with non-exclusive rights to use common areas of the building (the “Master Leased Premises”). Licensor and C21 have entered into separate agreement whereby Licensor has been granted rights to manage and operate a portion of the Master Leased Premises, including the right to grant licenses permitting use of the Master Leased Premises by third parties. Pursuant to the Member License Agreement, Licensor grants Draganfly Innovations USA a license permitting use of a portion of the Master Leased Premises, which includes Suite 2306 and Suite 2310 of the building (the “Raleigh Management Office”). Draganfly Innovations USA Inc. operates the Raleigh Management Office under a one (1) year lease, commencing on February 1, 2020. After one year, the lease will continue on a month-to-month basis until terminated by either the State of North Carolina or Draganfly Innovations USA Inc. Draganfly Innovations USA currently pays $500 for Suite 2306 and $1200 for Suite 2310 per month in rent, subject to 3% yearly increases.

 

 
- 33 -

Table of Contents

  

Canada Operations

 

Draganfly Innovations’ products are manufactured at its machine shop within its leased head office based in Saskatoon, Saskatchewan, Canada. Dronelogic’s services are provided through its leased space in Burnaby, British Columbia, Canada.

 

Saskatoon Facility – Draganfly Innovations Inc. operates a fully operational facility located at 2108 St. George Avenue, Saskatoon, SK S7M 0K7 (The “Saskatoon Facility”). The Saskatoon Facility is to be used only for the purposes of Draganfly Innovations Inc. operating its business of design, development, production, distribution, sale and/or licensing of drones or robots, or such other use as permitted by the landlord from time to time. Draganfly Innovations Inc. operates the Saskatoon Facility under a two (2) year lease, commencing on December 1, 2019 and ending on December 1, 2021. Draganfly Innovations Inc. currently pays $43,000.00 per annum plus GST to be paid in monthly installments of $3,583.33 plus GST. The Company has the option to renew the lease for six (6) successive one (1) year periods.

 

Burnaby Facility – Dronelogics leases Unit 319 in a building on that certain parcel of land located at 2999 Underhill Avenue situated in Burnaby, British Columbia (the “Burnaby Facility”). Dronelogics operates the Burnaby Facility under a five (5) year lease commencing on, November 1, 2016, and expiring on October 31, 2021. Dronelogics currently pays $2,981.33 per month in rent. Subject to the terms of the lease, Dronelogics may be granted a renewal lease for a further term of five (5) years.

 

Intellectual Property

 

With 18 fundamental UAV patents in its portfolio and with six (6) more pending in the application stage, the Company will continue to expand and grow its intellectual property docket. By virtue of being the first commercial UAV company in the industry, our subsidiary, Draganfly Innovations, holds valuable commercial patents.

 

Below is a chart summarizing the Company’s patents:

 

US Issued Patents

Law Firm

Docket / File #

Patent #

Date Issued

Patent Name

MLT

040065-0007

8,052,081

November 8, 2011

Dual Rotor Helicopter with Tilted Rotational Axes

MLT

040065-0011

8,292,215

October 23, 2012

Helicopter with Folding Rotor Arms

MLT

040065-0027

8,753,155

June 17, 2014

Wheel with Folding Segments

MLT

040065-0028

8,991,740

March 31, 2015

Vehicle with Aerial and Ground Mobility

Suiter Swantz

TLN 14-7-2

9,442,485

September 13, 2016

Pixel Based Image Tracking System for Unmanned Aerial Vehicle (UAV) Action Camera System

Suiter Swantz

TLN 14-2-2

9,489,937

November 8, 2016

Real-Time Noise Reduction System for Dynamic Motor Frequencies Aboard an Unmanned Aerial Vehicle (UAV)

Suiter Swantz

TLN 14-6-2

9,511,878

December 6, 2016

System and Method for Adaptive Y-Axis Power Usage and Non-Linear Battery Usage for UAV Equipped with Action Camera System

MLT

040065-0033

9,598,171

March 21, 2017

Vehicle with Aerial and Ground Mobility (Divisional Patent)

Suiter Swantz

TLN 14-1-2

9,710,709

July 18, 2017

Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)

Suiter Swantz

TLN 13-1-2

9,769,387

September 19, 2017

Action Camera System for Unmanned Aerial Vehicle

Suiter Swantz

TLN 14-7-3

9,785,147

October 10, 2017

Pixel Based Image Tracking System for Unmanned Aerial Vehicle (UAV) Action Camera System (Continuation Patent)

Suiter Swantz

TLN 14-1-3

9,892,322

February 13, 2018

Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV) (Continuation Patent)

Furman IP

145-037

10,035,581

July 31, 2018

Multi-Rotor UAV with Compact Folding Rotor Arms

Suiter Swantz

DRAG 15-1-2

10,059,442

August 28, 2018

Vertical Takeoff and Landing Unmanned Aircraft System

Suiter Swantz

TLN 13-1-3

10,187,580

January 22, 2019

Action Camera System for Unmanned Aerial Vehicle (Continuation Patent)

CDN Issued Patents

Law Firm

Docket / File #

Patent #

Date Issued

Patent Name

MLT

040065-0014

2,787,279

October 22, 2013

Vehicle with Aerial and Ground Mobility

MLT

040065-0015

2,787,075

October 29, 2013

Wheel with Folding Segments

Furman IP

145-036

2,917,434

April 23, 2019

Multi-Rotor UAV with Compact Folding Rotor Arms

Suiter Swantz

TLN 14-9-2

14/939,369

November 12, 2015

Visually Intelligent Camera Device with Peripheral Control Outputs

Suiter Swantz

DRAG 16-1-2

15/584,815

May 2, 2017

Tandem-Wing Aircraft System with Shrouded Propeller

Suiter Swantz

TLN 14-1-4

15/894,292

February 12, 2018

Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV) (Continuation Patent)

Suiter Swantz

DRAG 16-2-2

15/706,158

September 15, 2017

Vertical Take-Off and Landing (VTOL) Aircraft Having Variable Center of Gravity

Furman IP

145-020

2,876,630

January 2, 2015

Unmanned Rotary Wing Aircraft with Compact Folding Rotor Arms

Suiter Swantz

DRAG 15-1-1CA

2,935,793

July 11, 2016

Vertical Takeoff and Landing Unmanned Aircraft System

 

 
- 34 -

Table of Contents

  

Below is a chart summarizing Draganfly Innovation Inc.’s registered trademarks and pending applications:

 

Description

Name / Title

Official No.

Governmental Entity

Trademark Application (Status: Filed)

DRAGANFLY

1,972,336

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLYER EXPLORE

TMA1,025,742

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLYER APEX

TMA1,025,624

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLYER COMMANDER

TMA1,008,809

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFUEL

TMA997,118

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLY INNOVATIONS

TMA908,564

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLYER

TMA906,939

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLY & DESIGN  

TMA905,935

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLY

TMA1,071,582

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLY

TMA1,069,670

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANFLYER GUARDIAN

TMA904,883

Canadian Intellectual Property Office (CIPO)

Registered Trademark

DRAGANVIEW

TMA886,217

Canadian Intellectual Property Office (CIPO)

Trademark Application (Status: Application Accepted, Published for Opposition)

DRAGANFLYER APEX

86750092

United States Patent and Trademark Office (USPTO)

Trademark Application (Status: Application Accepted, Published for Opposition)

DRAGANFLYER EXPLORE

86750101

United States Patent and Trademark Office (USPTO)

Trademark Application (Status: Application Accepted, Under Examination)

DRAGANFLY

86648412

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANFLYER COMMANDER

5760146

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANFUEL

5563360

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANFLY INNOVATIONS

5130969

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANFLYER

4920316

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANFLY & Design

5130970

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANFLYER GUARDIAN

4995725

United States Patent and Trademark Office (USPTO)

Registered Trademark

DRAGANVIEW

4920317

United States Patent and Trademark Office (USPTO)

Trademark Application (Status: Application Accepted, Under Examination)

DRAGANFLY

88488410

United States Patent and Trademark Office (USPTO)

 

 
- 35 -

Table of Contents

  

We believe it is important to our success that we:

 

 

·

obtain and maintain patent and other legal protections for the proprietary technology, inventions and improvements we consider important to our business;

 

 

 

 

·

prosecute our patent applications and defend our issued patents;

 

 

 

 

·

preserve the confidentiality of our trade secrets; and

 

 

 

 

·

operate without infringing the patents and proprietary rights of third parties.

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The Company’s Management’s Discussion and Analysis provides an analysis of the Company’s financial results for the financial periods December 31, 2019 and December 31, 2018 and the notes thereto.

 

The following Management’s Discussion and Analysis (“MD&A”) is prepared as at December 31, 2019 in accordance with National Instrument 51-102F1 and should be read together with the audited consolidated financial statements for the years ended December 31, 2019 and December 31, 2018 and the notes related thereto, which are prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards. The financial statements are compliant and up to date with all new financial accounting standards, as noted per IFRS. The Company has elected to not delay compliance with any new or revised financial accounting standard. The Company’s fiscal year end is December 31. Additional information regarding the Company will be available through the SEDAR website at www.sedar.com. Certain information included in this MD&A may constitute forward-looking statements. Statements in this report that are not historical facts are forward-looking statements involving known and unknown risks and uncertainties, which could cause actual results to vary considerably from these statements.

 

All dollar amounts are expressed in United States currency, unless otherwise indicated, that Canadian currency is used.

 

Cautionary Note Regarding Forward-Looking Statements

 

Certain information included in this MD&A may constitute forward-looking statements. Statements in this report that are not historical facts are forward-looking statements involving known and unknown risks and uncertainties, which could cause actual results to vary considerably from these statements.

 

Forward-looking statements are statements about the future and are inherently uncertain, and actual achievements of the Company may differ materially from those reflected in forward-looking statements due to a variety of risks, uncertainties and other factors. The Company’s forward-looking statements are based on the beliefs, expectations and opinions of management on the date the statements are made, and the Company does not assume any obligation to update forward-looking statements if circumstances or management’s beliefs, expectations or opinions should change except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

 

The Company’s forward-looking statements are based on the Company’s beliefs and assumptions which are based on information available at the time these assumptions are made. The forward-looking statements contained herein are as of the date of this listing document, and are subject to change after this date, and the Company assumes no obligation to publicly update or revise the statements to reflect new events or circumstances, except as may be required pursuant to applicable laws. Although management believes that the expectations represented by such forward-looking information or statements are reasonable, there is significant risk that the forward-looking information or statements may not be achieved, and the assumptions underlying such information or statements will not prove to be accurate.

 

 
- 36 -

Table of Contents

  

Actual results or events could differ materially from the plans, intentions and expectations expressed or implied in any forward-looking information or statements, as a result of numerous risks, uncertainties and other factors such as those described above and in “Risks and Uncertainties” below.

 

Key Business Activities

 

2019 was another milestone year for Draganfly. The company solidified its engineering services business to not only offset a reduction in manufactured goods due to industry pricing shifts created by Chinese competition but to make this its primary business. Although, the Company’s products are still well regarded in the industry, the commercial UAV space as a whole has been impacted by lower priced consumer drones that can now offer similar functionality. The Company recognized their opportunity of engineering procurement for those customers that either choose not to buy Chinese UAVs or are restricted from doing so due to information sensitivity concerns.

 

Given the Company’s impressive history and deep engineering talent, a natural evolution was to outsource in-house capabilities to customers. Doing this leverages the Company’s core skill set of innovation that tends to lead to future projects, bringing in more consistent revenue.

 

Results of Operations for the Years Ended December 31, 2019 and December 31, 2018

 

Revenues

 

Our revenue was C$1,380,427 for the year ended December 31, 2019, compared to C$1,387,013 for the year ended December 31, 2018.

 

C$1,131,488 represents engineering services work while the balance of revenue is from hardware sales. Securing clients in this business line was key to its consistent revenue achieved by the Company in 2019. These clients were important for revenue and continued validation of the technology, but more importantly they demonstrate that the Company’s customized product designs have global applicability. Total revenue for the year ended December 31, 2019 decreased by $6,586 or 0.5% as compared to 2018. The decrease in revenue is due to the Company’s shrinking product sales business partially offset by the continued increase in engineering services.

 

Gross profit is the difference between the revenue received and the direct cost of that revenue. Gross margin is gross profit divided by revenue and is often presented as a percent. As a result of reduced product sales, the Company’s Gross Profit increased by $227,013 or 24.3%. As a percentage of sales, gross margin increased from 67.4% in 2018 to 84.1% in 2019. Again, the higher gross margins realized in 2019 was the result of a major shift to engineering service work which has a higher gross margin than the legacy manufacturing gross margin.

 

Research and Development Expenses

 

Our research and development expenses were C$16,883 for the year ended December 31, 2019, compared to C$16,158 for the year ended December 31, 2018. Research and development expenses to date consist primarily of contract research fees, manufacturing, consultant fees, preclinical studies, and study related costs.

 

General and Administrative Expenses

 

Our general and administrative expenses were C$4,450,154 for the year ended December 31, 2019, compared to C$1,477,474 for the year ended December 31, 2018. General and administrative expenses consist primarily of personnel, legal fees, and travel and office expenses. The largest contributor to the increase is marketing and investor relations expenses.

 

 
- 37 -

Table of Contents

  

Net Loss

 

Our net loss was C$11,095,057 for the year ended December 31, 2019, compared to C$601,729 for the year ended December 31, 2018. The increased loss was largely the result of a listing expense resulting from the amalgamation as well as increased marketing and investor relations expenses to create awareness of the Company

 

Liquidity and Capital Resources

 

To date, we have generated negative cash flows from operating activities. All costs in connection with our formation, development, legal services and support have been funded by revenues, equity and debt placements.

 

The Company’s liquidity risk is on its loans, accounts payable and accrued liabilities, as it may encounter difficulty discharging its obligations. The Company attempts to mitigate this risk by managing its debt holders as well as ensuring there is capital coming into the company for its operations. As at December 31, 2019, the Company has a working capital of $2,037,906 (December 31, 2018 had a deficit of $4,353,261).

 

The Company considers the items included in capital to include shareholders’ equity. The Company manages its capital structure and makes adjustments to it in light of changes in economic and business conditions, financing environment and the risk characteristics of the underlying assets. The Company does not have any contracted or committed capital expenditures as of the date of these financial statements. The Company utilizes its credit card facilities from time to time to make various purchases for their operations. In order to maintain or adjust its capital structure, the Company may issue new shares, new debt, or scale back the size and nature of its operations. The Company is not subject to externally imposed capital requirements. As at December 31, 2019, shareholders’ equity was $2,191,353 and at December 31, 2018, shareholder’s deficit was $4,132,609.

 

Our future expenditures and capital requirements will depend on numerous factors, including the success of this Offering and the progress of our research and development efforts.

 

Our business does not presently generate positive cash flow. We believe that if we raise $● (the Maximum Amount) in this Offering, we will have sufficient capital to finance our operations for at least the next 12 months; however, if we do not sell the Maximum Amount or if our operating and development costs are higher than expected, we will need to obtain additional financing prior to that time. We do not have any track record for self-underwritten Regulation A+ offerings, and there can be no assurance we will raise the Maximum Amount or any other amount. Further, we expect that after such 12-month period, we will be required to raise additional funds to finance our operations until such time that we can conduct profitable revenue-generating activities. However, no assurances can be made that we will be successful obtaining additional equity or debt financing, or that ultimately, we will achieve profitable operations and positive cash flow.

 

Going Concern

 

Our financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company’s ability to continue as a going concern is contingent upon its ability to raise additional capital as required. During the period from January 1, 2019 through December 31, 2019, the Company incurred net losses of C$11,095,057. Initially, we intend to finance our operations through equity and debt financings.

 

Capital Expenditures

 

We do not have any contractual obligations for ongoing capital expenditures at this time.

 

Off-Balance Sheet Arrangements

 

We did not have, during the periods presented, and we do not currently have, any off-balance sheet arrangements.

 

 
- 38 -

Table of Contents

  

Contractual Obligations, Commitments and Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company, in consultation with legal counsel, evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is probable, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. We are not aware of any matters which result in a loss contingency.

 

Relaxed Ongoing Reporting Requirements

 

Regulation A+ provides that a filer can take advantage of an extended transition period for complying with new or revised accounting standards.

 

Plan of Operations

 

As noted above, the continuation of our current plan of operations requires us to raise significant additional capital. If we are successful in raising capital through the sale of shares offered for sale in this Offering Circular, we believe that the Company will have sufficient cash resources to fund its plan of operations for the next 12 months. If we are unable to do so, we may have to curtail and possibly cease some operations.

 

We are a UAV manufacturer, custom engineering, and UAV services company and began operations in 1998. Our plan of operations for the next few years includes: hire engineers to perform more engineering service work, to complete contracts on a timelier basis, and to perform R&D for the company’s next generation of products; hire sales/marketing people for our product lines and engineering services work; hire sales/marketing people for further expansion into services (e.g. drone as a service); diversify and expand business lines organically and by potential acquisitions; update/capex machinery used for manufacturing and production; continue to patent innovative ideas for new products; develop and increase its current product offering to various niche industries that aren’t being served now; consider potential acquisition opportunities. Provided the full offering is completed, the company should not have to raise capital within six months.

 

We continually evaluate our plan of operations to determine the manner in which we can most effectively utilize our limited cash resources. The timing of completion of any aspect of our plan of operations is highly dependent upon the availability of cash to implement that aspect of the plan and other factors beyond our control. There is no assurance that we will successfully obtain the required capital or revenues, or, if obtained, that the amounts will be sufficient to fund our ongoing operations.

 

These circumstances raise substantial doubt on our ability to continue as a going concern. Our financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

 

Trend Information

 

Although Draganfly is acknowledged as the pioneer that first developed the commercial multi rotor helicopter, there are now many drone hardware companies in the world. As technology has improved and costs for hardware and software have come down, the line between consumer and commercial drones has blurred. Historically, Draganfly has serviced early adopters in the public safety industry. At this stage of the commercial drone adoption curve, the average public safety organization (local, regional, and even federal law enforcement, for example), are quite budget conscious. Hence, these organizations tend to use lower cost drones that have become quite sophisticated that can accomplish most of their use cases. Draganfly has moved away from competing directly with lower priced, foreign manufactured drones and has chosen to serve niche markets outside of where they tend to service. Our facility is ideal for custom engineering and niche type production where we keep limited inventory. There are also some organizations that tend to be US based that either prefer or are mandated to not use foreign drones. Some of these organizations are sensitive to their work being exposed to that of overseas governments which has at least for the time being, created a niche market for players such as Draganfly.

 

 
- 39 -

Table of Contents

  

In light of the recent COVID-19 pandemic, there could possibly be an impact on sourcing materials that are used to manufacture our products. Additionally, COVID-19 has caused significant disruptions to the global financial markets, which could impact our ability to raise additional capital. The ultimate impact on us and our significant suppliers and manufacturers is unknown, but our operations and financial condition could suffer in the event of any of these types of unpredictable events. Further, any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our business, results of operations, financial condition and cash flows. Currently, our operations remain materially unaffected by the sudden outbreak of COVID-19. Our facilities in Saskatchewan and British Columbia are large enough where employees can maintain safe distances from each other while working. Employees can also work remotely should an employee fall ill. Further, the Company adheres to rules and regulations by their governing jurisdictions to ensure the health of its employees and customers are prioritized.

 

As Draganfly has evolved to move with the industry trends, the Company now uses DJI drones as part of some of its customization and engineering services work. Draganfly has also moved into innovative engineering procurement which is very specialized and is currently not aware of any Canadian and US companies focusing on this industry or its existing customers. As the drone industry matures, this may bring more players to this space or the Company’s customers may choose to develop the in-house expertise to do the work that they currently outsource to Draganfly. However, it is the Company’s view that there will be a growing customer base that will require very specialized work that only a handful of companies can do.

 

The global market for commercial applications of drone technology, currently estimated at about $2 billion, is expected to balloon to as much as $127 billion by 2020, according to a report by PricewaterhouseCoopers LLP2. Consumer and prosumer drones are ideal for certain aerial filming applications, but enterprises looking to use drones for advanced applications will generally turn to high‑end UAV manufactures with longer flight times, better sensor capabilities and analytic functionalities. The high‑end commercial UAV market, which is defined as drones >$5,000, is one of the fastest-growing markets within the broader UAV space, a space where Draganfly is positioned.

 

DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES

 

As of June 15, 2020, our directors, executive officers and significant employees were as follows:

 

Name

 

Position

 

Age

 

Term of Office

 

Approximate hours per week
for part-time employees

Executive Officers:

 

Cameron Chell

 

Chairman, CEO, and Director

 

52

 

Aug 14, 2019 – Present

 

15 hours

Paul Sun

 

CFO and Corporate Secretary

 

48

 

August 14, 2019 – Present

 

Patrick Imbasciani

 

Chief Operating Officer

 

47

 

October 22, 2019

 

Directors:

 

Scott Larson

 

Director and Lead Independent Director

 

48

 

August 14, 2019 – Present

 

Olen Aasen

 

Director

 

37

 

August 14, 2019 – Present

 

Denis Silva

 

Director

 

40

 

August 14, 2019 – Present

 

Andrew Hill Card, Jr.

 

Director

 

73

 

November 7, 2019 – Present

 

Justin Hannewyk

 

Director

 

35

 

April 30, 2020 – Present

 

John M. Mitnick

 

Director

 

58

 

June 18, 2020

_______________ 

2 “Clarity from above,” PwC global report on the commercial applications of drone technology, May 2016

 

 
- 40 -

Table of Contents

  

Business Experience

 

Cameron Chell, CEO and Director – Mr. Chell is the CEO of the Company and CEO and Co-Founder of Business Instincts Group, Inc. Mr. Chell became an entrepreneur at age 14, and has since spent his career growing a diverse collection of high-potential ideas into revolutionary companies that have changed the way we experience the world. At 14, Mr. Cameron launched his first company by building irrigation valves, but as a junior high student, he was consistently turned down by manufacturers and distributors. Undeterred, he bid on irrigation contracts instead, landing deals and building his first business. By 17, Mr. Cameron had launched several other companies including a computer assembly and reseller operation. Later in life, while working as a stockbroker tasked with seeding high-tech companies, building Boards and raising capital, Mr. Cameron realized he could turn his passion for creating companies into a career. He quickly left to quench his thirst for building businesses himself. From October 2007 to present, Mr. Cameron served as the Chief Executive Officer of Business Instincts Group (“BIG”). As the CEO of BIG, Mr. Cameron takes a very hands-on leadership position in client projects, infusing his principles of clarity, alignment and measurement into the culture of every BIG partner. That leadership was critical to the success of UrtheCast, which he co-founded, Cold Bore Technologies (Mr. Cameron served as Co-Founder from February 2013 to Present), Slyce (Mr. Cameron Served as Director from January 2012 to January 2017), Raptor Rig (Mr. Cameron served as Director from February 2015 to Present), Draganfly (Mr. Cameron Served as Director and Chief Executive Officer from May 2013 to Present) and TraxOne Inc (Mr. Cameron served as Director from September 2016 to Present). Most recently, Mr. Cameron has served as an advisor to KodakCoin (Mr. Cameron served as a Director from May 2017 to Present), believed to be one of the first compliant cryptocurrencies developed in partnership between Business Instincts Group, WENN Digital and CurrencyWorks Inc (Mr. Cameron served as Chairman from November 2017 to Present). Mr. Cameron is an Olympic decathlete, a cancer survivor, and the author of Sustainable Startup, a guide for scaling small businesses and their teams. In addition to his work with BIG, Mr. Cameron speaks publicly on topics including technology, culture and overcoming adversity.

 

Paul Sun, Chief Financial Officer and Corporate Secretary – Mr. Sun has over 20 years of business experience and has held numerous senior roles at investment banks including Scotia Capital, Desjardins, and Beacon Securities. Mr. Sun has provided financial solutions to small start-ups to billion dollar market-cap companies and has been involved in many transactions across the entire capital structure. He has also held project and operations management positions at a number of private and publicly traded companies. He officially joined Draganfly in June, 2015. He was awarded his Bachelor of Applied Science and Engineering from The University of Toronto and his Master of Business Administration from the Schulich School of Business. He holds the Professional Engineer and Certified Financial Analyst designations. Mr. Sun’s business knowledge, experience, and education has provided him with an understanding of financial reporting sufficient to enable him to act as a member of the Audit Committee.

 

Patrick Imbasciani, Chief Operating OfficerMr. Imbasciani is a seasoned business professional with over 20 years of experience infusing technology and building enduring relationships in domestic and international markets. In the 1990's and early 2000's, he served his country as Sergeant in the United States Marine Corps. Later, Mr. Imbasciani went on to serve the international community as Director of Health and Education Programs for the United Nations Pan American Health Organization Foundation in Washington DC. From 2014-2018, Mr. Imbasciani served as Senior Director of international Business Development for world renown drone company PrecisionHawk. Prior to joining Draganfly in 2019, Mr. Imbasciani served as the interim COO of an interstate construction company located in the southeastern US. Mr. Imbasciani brings a disciplined leadership and industry experience to Draganfly, and a wealth of proven drone experience, which he cultivated while at PrecisionHawk. While there, Mr. Imbasciani created new distribution channels to deliver UAS to enterprise and end customers in agriculture, insurance, and energy among other industries. Mr. Imbasciani expanded the company into 10 countries outside of the United States, championed and oversaw numerous new proof-of-concepts with enterprise partners including solar inspections and post catastrophe insurance reporting, and personally led emergency response efforts to collect data with drones in Ecuador, the US, and The Bahamas, following a deadly earthquake, mass floods, and Hurricanes. Today, Mr. Imbasciani has developed a sound go to market business, marketing, and operations strategy for Draganfly, and Mr. Imbasciani works tirelessly to deliver the company to profitability and scale.

 

 
- 41 -

Table of Contents

  

Olen Aasen, Director – Mr. Aasen is a corporate and securities lawyer with more than 14 years of experience in corporate, securities and regulatory matters. Mr. Aasen has been Executive Vice President & General Counsel at King & Bay West Management Corp. from February 2011 to the present. King & Bay is a merchant bank that provides services to companies in the mineral resource, aviation and technology sectors. Prior to King & Bay, Mr. Aasen was an associate with Blake, Cassels & Graydon LLP from May 2007 to February 2011. Mr. Aasen obtained a J.D. from the University of British Columbia in 2006 and was called to the British Columbia Bar in 2007. Mr. Aasen was also appointed to the 2016 Legal 500 GC Powerlist for Canada.

 

Scott Larson, Director and Lead Independent Director – Mr. Larson brings over 20 years of combined corporate finance, technology development and entrepreneurial experience to the Board. From January 2019 to March 2020, Mr. Larson was the CEO of Kater Technologies, a Vancouver-based mobility as a service (MaaS) company building out an integrated intermodal transportation platform incorporating public transportation, buses, taxis and ride hailing vehicles into a single service. Prior to that, from 2016 to 2019, Mr. Larson was CEO and co-founder of Helios Wire, a satellite company building out a space-enabled IoT/M2M network. In 2019, Helios Wire was sold to a strategic acquirer. From 2010 to 2015, Mr. Larson was also the CEO/Co-Founder of UrtheCast. Mr. Larson helped scale the company from its inception, taking it public on the Toronto Stock Exchange, raising $200 million, and leading the company to 250 employees over five years with seven offices around the world.

 

Denis Silva, Director – Mr. Silva is a corporate and securities partner with 12 years of experience in corporate, securities, mining and regulatory legal experience (since 2009) and has acted for a wide variety of companies listed on Canadian and US exchanges, with a focus on technology and mining. Mr. Silva holds a BA from the University of British Columbia, MPA from Queen’s University and LLB from University of Windsor.

 

Andrew Hill Card, Jr., Director Andrew H. Card, Jr. was named Interim CEO of the George & Barbara Bush Foundation in June 2020. He continues to serve as Chairman of the National Endowment for Democracy (NED), a non-profit organization dedicated to the growth and strengthening of democratic institutions around the world, a position he assumed in January 2018. Mr. Card has also held numerous positions at senior levels of government under three Presidents throughout the years, including Chief of Staff to President George W. Bush, where Mr. Card became the second longest tenured White House Chief of Staff. Mr. Card served as Deputy Chief of Staff to President George H.W. Bush, as well as U.S. Secretary of Transportation, and served President Ronald Reagan as a Deputy Assistant to the President for Intergovernmental Affairs.

 

Mr. Card served as President of Franklin Pierce University in New Hampshire from January 2015 through July 2016. Prior to this, Mr. Card served as Executive Director of the Office of the Provost and Vice President for Academic Affairs at Texas A&M University from August 2013 until December 2014. He served as Acting Dean of The Bush School of Government and Public Service at Texas A&M from July 2011, until Dean Ryan Crocker's return from service as the U.S. Ambassador to Afghanistan on August 1, 2013.

 

Mr. Card serves on the Board of Directors of public corporation Union Pacific, on the Board of Directors of the Edward M. Kennedy Institute for the United States Senate, on the Board of Directors of Draganfly, on the Business Advisory Board of BrainStorm Cell Therapeutics, and on the non-publicly traded Board for Energy Security Partners, and on a number of non-profit boards. Mr. Card previously served on the Advisory Board of the U.S. Chamber of Commerce. He is also a professional speaker represented by the Washington Speakers Bureau.

 

While Chief of Staff to President George W. Bush, Mr. Card coordinated the priorities of the Administration’s agenda, the development of policies, and appointments of Cabinet Secretaries and senior officials throughout the government. On September 11, 2001, Mr. Card is the one who whispered in President Bush’s ear while the President was sitting in a classroom in Florida, that terrorists had attacked the United States. Mr. Card then led a government-wide reorganization to best allocate resources to deal with the aftermath of 9-11 and the new terrorist environment.

 

Prior to his tenure as White House Chief of Staff, Mr. Card managed and ran the Republican National Convention in Philadelphia at the request of nominee Texas Governor George W. Bush. Before that, Mr. Card was Vice President-Government Relations for General Motors Corporation, one of the world’s largest automobile manufacturers. In this role Mr. Card directed the company’s international, national, state and local government affairs activities and represented GM on matters of public policy before the U.S. Congress and the Administration. From 1993 to 1998, Mr. Card was President and Chief Executive Officer of the American Automobile Manufacturers Association, the trade association whose members were Chrysler Corporation, Ford Motor Company, and General Motors Corporation. When Chrysler became part of Daimler Corporation, Mr. Card oversaw the dissolution of the nearly 100 year old trade association.

 

 
- 42 -

Table of Contents

  

In August 1992, at the request of President Bush, Secretary Mr. Card coordinated the Administration’s disaster relief efforts in the wake of the massive Hurricane Andrew. He also directed President Bush’s transition office during the transition from the Bush Administration to the Clinton Administration. Prior to that he served as Special Assistant (1983 to 1987) and later as Deputy Assistant to the President and Director of Intergovernmental Affairs for President Ronald Reagan (1988) where he was liaison to governors, statewide elected officials, state legislators, mayors and other elected officials. From March 1987 until March 1988, Mr. Card ran the successful New Hampshire Presidential Primary Campaign for George H. W. Bush.

 

He is a graduate of the University of South Carolina with a B.S. in Engineering. He also attended the U.S. Merchant Marine Academy and the John F. Kennedy School of Government at Harvard University. Mr. Card served in the U.S. Navy from 1965 to 1967. Mr. Card has been the recipient of many honorary degrees and awards.

 

Mr. Card is a native of Holbrook, Massachusetts and got his start in politics as an elected official in Holbrook and then as Member of the Massachusetts House of Representatives from 1975-1983. He served as a Minority Whip from 1977-1983. In 1982 he was named Legislator of the Year by the National Republican Legislators Association and received the Distinguished Legislator Award from the Massachusetts Municipal Association. He was a candidate for the Republican Nomination for Governor of Massachusetts in 1982. He and his wife, The Reverend Kathleene (Bryan) Card, also from Holbrook, Massachusetts, have three children and six grandchildren.

 

Justin Hannewyk, Director – Mr. Hannewyk, President of Dronelogicsis, is the co-founder of Dronelogics Systems and has been consulting with enterprise clients on the integration of drones for over a decade. Working closely with international companies in industries such as mining, forestry, energy and entertainment as well as advising governmental bodies, Mr. Hannewyk oversees the design and delivery of systems to meet client's needs. A progressive and forward-thinker, Mr. Hannewyk draws from industry insight to recognize customer requirements and pinpoint areas where technology can be leveraged to make better business decisions.

 

John M. Mitnick, Director – Mr. Mitnick is an American attorney with 32 years of experience serving at the highest levels of government and the private sector. From February 2018 until September 2019, he served as the General Counsel of the U.S. Department of Homeland Security (DHS), having been confirmed for that position unanimously by the U.S. Senate. In that capacity, Mr. Mitnick served as the chief legal officer of a federal security and law enforcement agency with over 240,000 employees, was responsible for providing legal advice and counsel to DHS and all of its components, and supervised over 2,500 attorneys. From March 2014 to February 2018, he served as Senior Vice President, General Counsel, and Secretary of The Heritage Foundation, an influential think tank, and from November 2007 to April 2013 he served as Vice President, General Counsel, and Secretary of a Raytheon division with over $3 billion in annual sales, over 9,000 employees, and business operations in over 40 countries and on all continents.

 

Mr. Mitnick’s recent tenure at DHS was a continuation of his homeland security public service. Beginning in November 2002, he assisted in establishing DHS and then served as Associate General Counsel for Science and Technology until August 2004, when he moved to the White House. He served in the White House Counsel’s Office as Deputy Counsel of the Homeland Security Council from August 2004 until April 2005, and then as Associate Counsel to the President, with responsibility for the entire homeland security portfolio, until October 2007. He began his legal career in 1988 at the law firm now known as Kilpatrick Townsend & Stockton LLP, where he was a partner specializing in mergers and acquisitions, strategic alliances, commercial contracts, and business start-ups.

 

Mr. Mitnick has also served on the Board of Directors of Valaurum, Inc., a private mint, from March 2016 to February 2018 and since October 2019. He received his Juris Doctor degree from the University of Virginia School of Law and a Bachelor of Arts degree in Jurisprudence from the University of Oxford. He also holds a Bachelor of Arts degree in History and Political Science (summa cum laude) from Emory University.

 

 
- 43 -

Table of Contents

  

Corporate Cease Trade Orders or Bankruptcies

 

Other than as disclosed herein, none of the proposed directors (or any of their personal holding companies) of the Company:

 

 

(a)

is, as at the date of this Offering Circular, or has been, within 10 years before the date of this Offering Circular, a director, chief executive officer or chief financial officer of any company, including the Company, that: (i) was subject to a cease trade order or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days while that person was acting in the capacity as director, chief executive officer or chief financial officer; or (ii) was the subject of a cease trade or similar order or an order that denied the issuer access to any exemption under securities legislation in each case for a period of 30 consecutive days, that was issued after the person ceased to be a director, chief executive officer or chief financial officer in the company and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer; or

 

 

 

 

(b)

is as at the date of this Offering Circular or has been within the 10 years before the date of this Offering Circular, a director or executive officer of any company, including the Company, that while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets; or

 

 

 

 

(c)

has, within the 10 years before the date of this Offering Circular, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangements or compromise with creditors, or had a receiver, receiver manager as trustee appointed to hold the assets of the proposed director.

  

None of the proposed directors (or any of their personal holding companies) has been subject to: (a) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or (b) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable securityholder in deciding whether to vote for a proposed director.

 

Penalties or Sanctions

 

Other than as provided herein, no Director or executive officer of the Company or shareholder holding sufficient securities of the Company to affect materially the control of the Company has been:

 

 

·

been subject to any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or

 

 

 

 

·

been subject to any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable investor making an investment decision.

  

Pursuant to a settlement agreement (the “Settlement Agreement”) dated November 6, 1998 that Cameron Chell signed with the Alberta Stock Exchange (the “ASE”), Mr. Chell agreed to the following sanctions:

 

 

·

prohibition against ASE Approval (as defined in the General By-law of the ASE) in any capacity for a period of five years commencing November 6, 1998;

 

 

 

 

·

a fine in the sum of $25,000;

 

 

 

 

·

strict supervision for a period of two years following re-registration in any capacity; and

 

 

 

 

·

close supervision for a period of one year following the period of strict supervision described above.

  

 
- 44 -

Table of Contents

  

The matters respecting the Settlement Agreement are as set forth in an ASE Notice to Members dated November 12, 1998, which provides that:

 

 

·

representations were made by the promoter of a company to one of Mr. Chell’s clients that he would only be permitted to purchase securities in the initial public offering of that company if he would agree to purchase additional securities in the secondary market following the listing on the Alberta Stock Exchange and, in or around March or April, 1996, Mr. Chell disclosed confidential information to the promoter of that company concerning a client’s account with respect to a cheque returned NSF to Mr. Chell’s employer;

 

 

 

 

·

the investment objectives for two of Mr. Chell’s clients were amended without prior knowledge or consent of such clients and purchases and sales of securities were subsequently executed in the accounts of such clients which were unsuitable for the clients given the stated investment objectives for the accounts prior to the amendment of such investment objectives;

 

 

 

 

·

Mr. Chell executed a total of 21 transactions in the accounts of two of Mr. Chell’s clients without prior knowledge or authorization of such clients;

 

 

 

 

·

the signature on the new client account form for one of Mr. Chell’s clients, which purported to be that of the client was not in fact the signature of the client nor did such client have any knowledge of any changes made to the investment objectives for his account(s);

 

 

 

 

·

on or about June 10, 1996, the address for the account of one of Mr. Chell’s clients was changed to Mr. Chell’s local post office box address without such client’s knowledge and while the client was resident in Ontario. As a result, during the period of June 10 to and including September, 1996, the client did not receive any trade confirmations or accounts statements with respect to her accounts with Mr. Chell;

 

 

 

 

·

on or about March 19, 1996, Mr. Chell permitted one of his clients to acquire approximately 4% of the total initial public offering by a company, contrary to the rules of the Alberta Stock Exchange;

 

 

 

 

·

on or about October 19, 1996, Mr. Chell purchased securities of a company in the account of one of his clients without disclosing the involvement of his brother as president of that company;

 

 

 

 

·

on or about June 23, 1996, the private placement questionnaire & undertaking completed in connection with the purchase by one of Mr. Chell’s clients and filed with the Alberta Stock Exchange disclosed that Mr. Chell’s client was a resident of Alberta when in fact such client was a resident of Ontario. Mr. Chell knew or ought to have known that it contained a misstatement of fact in that regard;

 

 

 

 

·

during the period of the summer, 1996 to and including May 1997, Mr. Chell’s day to day involvement as the president and chairman of Coffee.Com Interactive Café Corp. (“Coffee.Com”) as well as being a shareholder was not disclosed to Mr. Chell’s employer.

 

 

 

 

·

Further, Mr. Chell purchased securities offerings via private placement by Coffee.Com for certain of his clients without fully disclosing his involvement with that company to such clients;

 

 

 

 

·

on or about March 18 and June 19, 1996, Mr. Chell executed purchase of securities for Ontario residents. At the time of such purchases, Mr. Chell knew or ought to have known that he was not registered in the province of Ontario;

 

 

 

 

·

During the summer of 1996, Mr. Chell represented to the Alberta Stock Exchange that certain purchasers of securities offered via private placement were close friends and business associates when he knew or ought to have known that such representations were untrue; and

 

 

 

 

·

During the period of June 19, 1996 and to and including May 1, 1997, Mr. Chell failed to obtain the prior approval of his employer for advertisements and sales literature distributed by Mr. Chell regarding Coffee.Com.

  

 
- 45 -

Table of Contents

  

Conflicts of Interest

 

The directors of the Company are required by law to act honestly and in good faith with a view to the best interests of the Company and to disclose any interests, which they may have in any project or opportunity of the Company. If a conflict of interest arises at a meeting of the Board, any director in a conflict will disclose his interest and abstain from voting on such matter.

 

To the best of the Company’s knowledge, and other than as disclosed herein, there are no known existing or potential conflicts of interest among the Company, its promoters, directors and officers or other members of management of the Company or of any proposed promoter, director, officer or other member of management as a result of their outside business interests except that certain of the directors and officers serve as directors and officers of other companies, and therefore it is possible that a conflict may arise between their duties to the Company and their duties as a director or officer of such other companies.

 

Advance Notice Provisions

 

We have included certain advance notice provisions with respect to the election of our directors in our Articles (the “Advance Notice Provisions”). The Advance Notice Provisions are intended to: (i) facilitate orderly and efficient annual general meetings or, where the need arises, special meetings; (ii) ensure that all Shareholders receive adequate notice of Board nominations and sufficient information with respect to all nominees; and (iii) allow Shareholders to register an informed vote. Only persons who are nominated by Shareholders in accordance with the Advance Notice Provisions will be eligible for election as directors at any annual meeting of Shareholders, or at any special meeting of Shareholders if one of the purposes for which the special meeting was called was the election of directors.

 

Under the Advance Notice Provisions, a Shareholder wishing to nominate a director would be required to provide us notice, in the prescribed form, within the prescribed time periods. These time periods include, (i) in the case of an annual meeting of Shareholders (including annual and special meetings), not less than 30 nor more than 65 days prior to the date of the annual meeting of Shareholders; provided, that if the first public announcement of the date of the annual meeting of Shareholders (the “Notice Date”) is less than 50 days before the meeting date, notice must be given not later than the close of business on the 10th day following the Notice Date; and (ii) in the case of a special meeting (which is not also an annual meeting) of Shareholders called for the purpose of electing directors (whether or not called for other purposes), not later than the close of business on the 15th day following the Notice Date, provided that, in either instance, if notice and access (as defined in National Instrument 54-101— Communication with Beneficial Owners of Securities of a Reporting Issuer) is used for delivery of proxy related materials in respect of a meeting described above, and the Notice Date in respect of the meeting is not less than 50 days prior to the date of the applicable meeting, the notice must be received not later than the close of business on the 40th day before the applicable meeting.

 

COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS

 

Statement of Executive Compensation

 

For the purposes of this Offering Circular, a “Named Executive Officer”, or “NEO”, means each of the following individuals:

 

 

(a)

each individual who, during any part of the Company’s financial year ended December 31, 2019, served as chief executive officer (“CEO”) of the Company, including an individual performing functions similar to a CEO;

 

 

 

 

(b)

each individual who, during any part of the Company’s financial year ended December 31, 2019, served as chief financial officer (“CFO”) of the Company, including an individual performing functions similar to a CFO;

 

 

 

 

(c)

the most highly compensated executive officers of the Company and its subsidiaries, other than the individuals identified in paragraphs (a) and (b), as at December 31, 2019 whose total compensation was more than $150,000, as determined in accordance with subsection 1.3(5) of Form 51‑102F6, for the financial year ended December 31, 2019; and

 

 

 

 

(d)

each individual who would be a NEO under paragraph (c) above but for the fact that the individual was not an executive officer of the Company, and was not acting in a similar capacity, as at December 31, 2019.

  

 
- 46 -

Table of Contents

  

Based on the foregoing definitions, the Company has 3 Named Executive Officers: Cameron Chell, the Company’s CEO, Paul Sun, the Company’s CFO, and Patrick Imbasciani – Chief Operating Officer (the (“COO”). The summary compensation table below provides information for the two most recently completed financial years ended December 31, 2019 regarding compensation paid to or earned by each of the Named Executive Officers.

 

Director and Named Executive Officer Compensation, Excluding Compensation Securities

 

The following table represents information regarding the total compensation for the directors and the executive officers of the Company as of December 31, 2019:

 

Name and Capacity in which

 

Cash Compensation

 

 

Other Compensation

 

 

Total Compensation

 

Compensation was Received

 

($)

 

 

($)(1)

 

 

($)

 

Cameron Chell(2)

Chairman, CEO, and Director

 

$ 9,000.00

 

 

$

Nil

 

 

$ 9,000.00

 

Paul Sun

CFO

 

$ 133,813.74

 

 

$ 6,576.92 (3)

 

$ 140,390.66

 

Patrick Imbasciani

 

$ 37,365.63

 

 

$Nil

 

 

$ 37,365.63

 

Scott Larson

Director and Lead Independent Director

 

Nil

 

 

Nil

 

 

Nil

 

Olen Aasen

Director

 

Nil

 

 

Nil

 

 

Nil

 

Denis Silva

Director

 

Nil

 

 

Nil

 

 

Nil

 

Andrew Hill Card, Jr.

 

Nil

 

 

Nil

 

 

Nil

 

Justin Hannewyk(4)

 

Nil

 

 

Nil

 

 

Nil

 

John Mitnick(5)

 

Nil

 

 

Nil

 

 

Nil

 

 

(1)

Any values reported in the “Other Compensation” column, if applicable, represents the aggregate grant date fair value, computed in accordance with Accounting Standards Codification (ASC) 718 Share Based Payments, of grants of stock options to each of our named executive officers and directors.

(2)

Mr. Chell provides his services through the Chell Consulting Agreement. See below “Employment, Consulting, and Management Agreements”.

(3)

Comprised of vacation accrual.

(4)

Mr. Hannewyk was appointed to the Board on April 30, 2020.

(5)

Mr. Mitnick is set to become appointed to the Board on June 18, 2020.

  

 
- 47 -

Table of Contents

  

Stock Options and Other Compensation Securities

 

The following table sets out all compensation securities granted or issued to all Named Executive Officers and directors by the Company or any of its subsidiaries during the fiscal year ended December 31, 2019 for services provided or to be provided, directly or indirectly, to the Company or any of its subsidiaries:

 

 

Name and position

Type of compensation security

Number of compensation securities, number of underlying securities, and percentage of class

Date of issue or grant

Issue,
conversion or
exercise price
CAD($)

Closing price of security on date of grant
CAD($)

Closing Price of Security on date at year end
CAD($)

Expiry Date

Cameron Chell
Chairman, CEO and Director

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Paul Sun
CFO

Stock options

RSUs

500,000(1)

500,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Patrick Imbasciani
COO

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Scott Larson Director and Lead Independent Director

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Olen Aasen
Director

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Denis Silva
Director

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Andrew Hill Card, Jr
Director

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Justin Hannewyk(3)
Director

Stock options

RSUs

Nil

Nil

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

John Mitnick
Director(4)

Stock options

RSUs

250,000(1)

250,000(2)

Oct 30, 2019

Oct 30, 2019

$0.50

$0.50

N/A

N/A

$0.62

$0.62

Oct 30, 2029

Oct 30, 2022

Notes

 

(1)

These stock options vest 1/3 on the grant date, 1/3 on the first anniversary of the grant date and 1/3 on the second anniversary of the grant date.

 

(2)

These RSUs are deliverable as to 1/3 on October 30, 2020, 1/3 on October 30, 2021 and 1/3 on October 30, 2022.

 

(3)

Mr. Hannewyk was appointed to the Board effective April 30, 2020 and was granted 250,000 stock options at an exercise price of CAD$0.50 expiring on April 30, 2030 and 250,000 RSUs at a deemed price of CAD$0.50 expiring on April 30, 2023.

 

(4)

Mr. Mitnick is set to become appointed to the Board effective June 18, 2020 and his RSUs and Options were previously granted to him in anticipation of him officially joining the board and as part of his advisory role with the Company.

  

Exercise of Compensation Securities by Directors and Named Executive Officers

 

No compensation securities were exercised by the Company’s Named Executive Officers and directors during the fiscal year ended December 31, 2019.

 

Director Compensation

 

Effective June 18, 2020, we have seven (7) directors. We currently do not pay our directors any cash compensation for their services as board members.

 

 
- 48 -

Table of Contents

  

During the financial year ended December 31, 2019, none of the directors of the Company were paid, awarded or granted any compensation with respect to activities performed in their capacity as directors except as noted above, see “Statement of Executive Compensation – Director and Named Executive Officer Compensation, Excluding Compensation Securities”. Directors are eligible to participate in the Share Compensation Plan. Directors are also entitled to be reimbursed for expenses incurred by them in their capacity as directors.

 

Employment, Consulting, and Management Agreements

 

Except as disclosed herein, there were no agreements or arrangements under which compensation was provided during the most recently completed financial year or is payable in respect of services provided to the Company or any of its subsidiaries that were: (a) performed by a director or named executive officer; or (b) performed by any other party but are services typically provided by a director or a named executive officer.

 

The Company’s consulting agreement (the “Chell Consulting Agreement”) with 1502372 Alberta Ltd. (the “Consultant”) whereby the Company pays monthly fees of $10,000 ($3,000 from October 1, 2019-December 31, 2019) for the provision by of executive services by the Consultant to the Company, and in this regard, has Cameron Chell hold the position of Chairman and Chief Executive Officer contains the following provisions: (a) where termination notice is given by the Company, other than for certain specified reasons as set out in the Chell Consulting Agreement, the Company shall give the Consultant at least 60 days’ advance notice in writing; and (b) where termination is given by the Consultant, the Consultant shall give the Company 60 days’ advance notice in writing. If the Chell Consulting Agreement is terminated pursuant to either (a) or (b) above, then the Consultant will be entitled to the fees earned to the effective date of termination and any expenses incurred on behalf of the Company prior to the effective date of termination which are otherwise reimbursable by the Company pursuant to the terms of the Chell Consulting Agreement. The Consultant is a private company controlled by Cameron Chell, Chairman, Chief Executive Officer and Director of the Company.

 

Mr. Imbasciani has entered into an executive employment agreement (the “Imbasciani Employment Agreement”) with the Company, dated October 21, 2019. Pursuant to the Imbasciani Employment Agreement, Mr. Imbasciani has agreed to perform certain services as Chief Operating Officer of the Company. The Imbasciani Employment Agreement provides that Mr. Imbasciani shall receive an annual base salary of USD $118,800. Mr. Imbasciani is eligible for annual commissions and cash bonuses based on the achievement by the Company of certain objectives in its business plan and on sales revenue generated by Mr. Imbasciani. The executive employment agreement also grants Mr. Imbasciani an issuance of 500,000 options in the Company option pool, with vesting criteria in line with Company policy. It further provides Mr. Imbasciani with certain standard employment benefits, such as health insurance, paid vacation and business expense reimbursement. The executive employment agreement is at will and may be terminated by Mr. Imbasciani or the Company at any time for any reason with or without cause.

 

SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITYHOLDERS

 

The following table shows the beneficial ownership of our Common Shares as of the date of this Offering Circular held by (i) each person known to us to be the beneficial owner of more than 10% of any class of our shares; and (ii) all directors and executive officers as a group. As of the date of this Offering Circular, there were 77,506,051 shares of our common shares issued and outstanding.

 

Beneficial ownership is determined in accordance with the rules of the SEC, and generally includes voting power and/or investment power with respect to the securities held. Shares of Common Shares subject to options and warrants currently exercisable or which may become exercisable within 60 days of the date of this Offering Circular, are deemed outstanding and beneficially owned by the person holding such options or warrants for purposes of computing the number of shares and percentage beneficially owned by such person, but are not deemed outstanding for purposes of computing the percentage beneficially owned by any other person. Except as indicated in the footnotes to this table, the persons or entities named have sole voting and investment power with respect to all shares of Common Shares shown as beneficially owned by them.

 

The percentages below are based on fully diluted shares of our common shares as of the date of this Offering Circular. Unless otherwise indicated, the business address of each person listed is c/o Draganfly Inc., 2108 St. George Avenue, Saskatoon, SK, S7M 0K7.

 

 
- 49 -

Table of Contents

  

Name and Address of Beneficial Owner

 

Amount

and Nature of Beneficial Ownership

 

 

Amount

and Nature of Beneficial Ownership Acquirable (2)

 

 

Percent
of
Class (1)

 

Directors and Officers:

 

 

 

 

 

 

 

 

 

All executive officers and directors as a group

 

 

8,933,606

 

 

 

833,331

 

 

 

12.46 %

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater than 10% Securityholders:

 

 

 

 

 

 

 

 

 

 

 

 

None.

 

 

 

 

 

 

 

 

 

 

 

 

________  

(1)

This Offering Statement does not contemplate that any of our current listed stockholders will acquire any additional Common Shares as part of this Offering.

 

 

(2)

Includes 833,331 of our common shares which could be issued within the next 60 days to our executive officers and directors upon exercise of vested options. 

 

 

INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS

 

Transactions with Related Persons

 

Except as described below and except for employment arrangements which are described under “executive compensation,” since the last complete fiscal year, there has not been, nor is there currently proposed, any transaction in which we are or were a participant, the amount involved exceeds the lesser of $120,000 or 1% of the total assets at year end for the last completed fiscal year, and any of our directors, executive officers, holders of more than 5% of our common shares or any immediate family member of any of the foregoing had or will have a direct or indirect material interest.

 

We have also entered into indemnification agreements with each of our directors and executive officers. In general, these indemnification agreements require the Company to indemnify a director to the fullest extent permitted by law against liabilities that may arise by reason of his or her service for the Company.

 

Review, Approval and Ratification of Related Party Transactions

 

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. On a moving forward basis, our Directors will continue to approve any related party transaction.

 

On July 17, 2015, the Company issued a note payable for $600,000 CDN with the former owner of the Company in connection with the sale of all of Draganfly Innovation Inc.’s issued and outstanding shares. The note payable bears interest at 5% per annum, was due on December 1, 2015 and is secured against the intellectual property as at the effective date. During the year ended December 31, 2019, the Company repaid the balance owing of $378,770 CDN (2018 - $nil). As at December 31, 2019, $nil (2018 - $364,655 CDN) in notes payable plus accrued interest is outstanding. For the year ended December 31, 2019, the Company recognized interest expense of $15,153 CDN (2018 - $17,748).

 

On December 17, 2015, Business Instincts Group, Inc. ("BIG"), a company controlled by Mr. Chell, loaned $160,000 CDN evidenced by a promissory note executed by Trace Live Networks Inc. (“Trace”), a company founded, in part, by Cameron Chell in 2014. In July 2015, Trace acquired Draganfly Innovations Inc. At the beginning of 2017, Trace and Draganfly Innovations Inc. vertically amalgamated with the resulting company being named Draganfly Innovations Inc. During the year ended December 31, 2017, the balance outstanding of $160,000 CDN in favor of BIG was applied against a subscription receivable from BIG. This subscription receivable was settled in the year ended December 31, 2019.

 

 
- 50 -

Table of Contents

  

During the year ended December 31, 2018, the Company entered into a series of ten (10) promissory notes totaling $273,500 CDN with Business Instincts Group, Inc., a company controlled by Mr. Chell. The promissory notes are interest bearing at 12% per annum, unsecured and due within 60 days from the date of advance and have been repaid in full.

 

Indebtedness of Directors and Executive Officers

 

At any time during the Company’s last completed financial year, no director, executive officer, employee, proposed management nominee for election as a director of the Company nor any associate of any such director, executive officer, or proposed management nominee of the Company or any former director, executive officer or employee of the Company or any of its subsidiaries is or has been indebted to the Company or any of its subsidiaries or is or has been indebted to another entity where such indebtedness is or has been the subject of a guarantee, support agreement, letter of credit or other similar arrangement or understanding provided by the Company or any of its subsidiaries, other than routine indebtedness.

 

Interest of Informed Persons In Material Transactions

 

Other than as set forth herein and other than transactions carried out in the ordinary course of business of the Company or any of its subsidiaries, none of the directors or executive officers of the Company, a director or executive officer of a person or company that is itself an informed person or subsidiary of the Company, nor any shareholder beneficially owning, directly or indirectly, common shares of the Company, or exercising control or direction over common shares of the Company, or a combination of both, carrying more than 10% of the voting rights attached to the outstanding shares of the Company nor an associate or affiliate of any of the foregoing persons has since the commencement of the Company’s most recently completed financial year any material interest, direct or indirect, in any transactions which materially affected or would materially affect the Company or any of its subsidiaries.

 

The Company has entered into a Business Services Agreement with Business Instincts Group, Inc., a company controlled by Mr. Chell, providing the Company with corporate development, human resources, administrative and business services on a fee for services basis as set out in the agreement. This agreement may be terminated by either party upon provision of a 90 days’ written notice.

 

SECURITIES BEING OFFERED

 

The following is a summary of the rights of our capital shares as provided in our Articles and Notice of Articles. For more detailed information, please see our Articles and Notice of Articles which have been filed as exhibits to the Offering Statement of which this Offering Circular is a part.

 

General

 

The Company’s Notice of Articles provide that our authorized capital consists of an unlimited number of Common Shares, without par value, which do not have any special rights or restrictions.

 

As of the date of this Offering Circular, the Company has 77,506,051 Common Shares issued and outstanding.

 

Rights, Preferences and Restrictions Attaching to Our Common Shares

 

The BCBCA provides the following rights, privileges, restrictions and conditions attaching to our Common Shares:

 

 

·

to vote at meetings of shareholders, except meetings at which only holders of a specified class of shares are entitled to vote;

 

 

 

 

·

subject to the rights, privileges, restrictions and conditions attaching to any other class of shares of our company, to share equally in the remaining property of our company on liquidation, dissolution or winding-up of our company; and

 

 

 

 

·

the Common Shares are entitled to receive dividends if, as, and when declared by the Board of Directors.

  

 
- 51 -

Table of Contents

  

The provisions in our Articles attaching to our Common Shares may be altered, amended, repealed, suspended or changed by affirmative vote of the holders of not less than two-thirds of the outstanding Common Shares.

 

With the exception of special resolutions (i.e. resolutions in respect of fundamental changes to our company, including: the sale of all or substantially all of our assets, a merger or other arrangement or an alteration to our authorized capital that is not allowed by resolution of the directors) that require the approval of holders of two-thirds of the outstanding Common Shares entitled to vote at a meeting, either in person or by proxy, resolutions to approve matters brought before a meeting of our shareholders require approval by a simple majority of the votes cast by shareholders entitled to vote at a meeting, either in person or by proxy.

 

Shareholder Meetings

 

The BCBCA provides that: (i) a general meetings of shareholders must be held in British Columbia, or may be held at a location outside British Columbia since our Articles do not restrict our company from approving a location outside of British Columbia for the holding of the general meeting and the location for the meeting is approved by ordinary resolution, or the location for the meeting is approved in writing by the British Columbia Registrar of Companies before the meeting is held; (ii) directors must call an annual meeting of shareholders not later than 18 months after the date of incorporation and no later than 15 months after the last preceding annual meeting; (iii) for the purpose of determining shareholders entitled to receive notice of or vote at meetings of shareholders, the directors may fix in advance a date as the record date for that determination, provided that such date shall not precede by more than two months or by less than 21 days, if we are a public company, otherwise 10 days, the date on which the meeting is to be held; (iv) the holders of not less than 5% of the issued shares entitled to vote at a meeting may requisition the directors to call a meeting of shareholders for the purposes stated in the requisition; (v) only shareholders entitled to vote at the meeting, our directors and our auditor are entitled to be present at a meeting of shareholders; and (vi) upon the application of a director or shareholder entitled to vote at the meeting, the British Columbia Supreme Court may order a meeting to be called, held and conducted in a manner that the Court directs.

 

Pursuant to our Articles, the quorum for the transaction of business at a meeting of our shareholders is at least two persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least five percent of the issued shares entitled to be voted at the meeting.

 

Fully Paid and Non-assessable

 

All outstanding shares of Common Shares are, and the Common Shares to be outstanding upon completion of this Offering will be, duly authorized, validly issued, fully paid and non-assessable.

 

Share Compensation Plan

 

Compensation of Directors and Executive Officers

 

Each of the executive officers and directors listed above is eligible to receive equity compensation at the discretion of our Board. In October 2019, the Company granted options to purchase 2,000,000 shares of Common Shares at $0.50 per share with one third (1/3) of the options vesting on the first, one third (1/3) of the options vesting on the second, and one third (1/3) of the options vesting on the third anniversary of the date of grant. In October 2019, the Company granted 2,000,000 RSUs, deliverable as to one third (1/3) on October 30, 2020, one third (1/3) deliverable on October 30, 2021, and one third (1/3) deliverable on October 30, 2022. Mr. Hannewyk was appointed to the Board effective April 30, 2020 and was granted 250,000 stock options at an exercise price of $0.50 expiring on April 30, 2030 and 250,000 RSUs at a deemed price of $0.50 expiring on April 30, 2023.

 

Upon completion of this Offering, our executive officers and directors will be eligible to receive equity awards under our equity incentive plans at any time at the discretion of our Board of Directors.

 

Share Compensation Plan and Other Incentive Plans

 

The Board has previously adopted the Company’s share compensation plan (the “Share Compensation Plan”), prepared in accordance with the policies of the Canadian Securities Exchange, that provides for the granting of RSUs and Options on such terms and conditions as prescribed by the Share Compensation Plan. The Share Compensation Plan is a “rolling” plan, pursuant to which the maximum number of common shares issuable under the Share Compensation Plan and any other share compensation arrangement of the Company including the RSUs that may be awarded under the Share Compensation Plan, is 20% of the common shares of the Company then issued and outstanding. The Share Compensation Plan was adopted effective August 19, 2019.

 

 
- 52 -

Table of Contents

  

The Share Compensation Plan provides participants (each, a “Participant”), who may include participants who are citizens or residents of the United States (each, a “US Participant”), with the opportunity, through RSUs and Options, to acquire an ownership interest in the Company. The RSUs will rise and fall in value based on the value of the Company’s common shares. Unlike the Options, the RSUs will not require the payment of any monetary consideration to the Company. Instead, each RSU represents a right to receive one common share following the attainment of vesting criteria determined at the time of the award. See “Restricted Share Units – Vesting Provisions” below. The Options, on the other hand, are rights to acquire common shares upon payment of monetary consideration (i.e., the exercise price), subject also to vesting criteria determined at the time of the grant. See “Options – Vesting Provisions” below.

 

Purpose of the Share Compensation Plan

 

The stated purpose of the Share Compensation Plan is to advance the interests of the Company and its subsidiaries, and its shareholders by: (a) ensuring that the interests of Participants are aligned with the success of the Company and its subsidiaries; (b) encouraging stock ownership by such persons; and (c) providing compensation opportunities to attract, retain and motivate such persons.

 

Eligible Persons

 

The following people are eligible to participate in the Share Compensation Plan: any officer or employee of the Company or any officer or employee of any subsidiary of the Company and, solely for purposes of the grant of Options, any director of the Company or any director of any subsidiary of the Company, and any Consultant (defined under the Share Compensation Plan as an individual (other than an employee or a director of the Company) or a corporation that is not a U.S. Person that: (A) is engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services to the Company or to an affiliate of the Company, other than services provided in relation to an offer or sale of securities of the Company in a capital raising transaction, or services that promote or maintain a market for the Company’s securities; (B) provides the services under a written contract between the Company or the affiliate and the individual or the Company, as the case may be; (C) in the reasonable opinion of the Company, spends or will spend a significant amount of time and attention on the affairs and business of the Company or an affiliate of the Company; and (D) has a relationship with the Company or an affiliate of the Company that enables the individual to be knowledgeable about the business and affairs of the Company.

 

Administration of the Share Compensation Plan

 

The Share Compensation Plan is administered by the Board or such other persons as may be designated by the Board (the “Administrators”) based on the recommendation of the Board or the compensation committee of the Board, if applicable. The Administrators determine the eligibility of persons to participate in the Share Compensation Plan, when RSUs and Options will be awarded or granted, the number of RSUs and Options to be awarded or granted, the vesting criteria for each award of RSUs and grant of Options and all other terms and conditions of each award and grant, in each case in accordance with applicable securities laws and the requirements of the Canadian Securities Exchange.

 

Restrictions on the Award of RSUs and Grant of Options

 

The awards of RSUs and grants of Options under the Share Compensation Plan is subject to a number of restrictions:

 

 

(a)

the total number of common shares issuable to insiders under the Share Compensation Plan and any other share compensation arrangements of the Company cannot exceed 20% of the common shares then outstanding; and

 

 

 

 

(b)

the aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of common shares issued during any consecutive 12 month period will not exceed the greatest of the following: (i) U.S.$1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares, measured at the Company’s most recent balance sheet date.

  

 
- 53 -

Table of Contents

  

In the event of any declaration by the Company of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of the Common Shares, reclassification or conversion of the Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Company, distribution (other than normal course cash dividends) of Company assets to holders of Common Shares, or any other corporate transaction or event involving the Company or the Common Shares, the Administrators may in their sole discretion make such changes or adjustments, if any, as the Administrators consider fair or equitable to reflect such change or event including, without limitation, adjusting the number of Options and RSUs outstanding under the Share Compensation Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under the Share Compensation Plan, provided that the value of any Option or RSU immediately after such an adjustment shall not exceed the value of such Option or RSU prior thereto.

 

Restricted Share Units

 

The total number of Common Shares that may be issued on exercise of Options and RSUs, together with any other share compensation arrangements of the Company, shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

Mechanics for RSUs

 

RSUs awarded to Participants under the Share Compensation Plan are credited to an account that is established on their behalf and maintained in accordance with the Share Compensation Plan. After the relevant date of vesting of any RSUs awarded under the Share Compensation Plan, a Participant shall be entitled to receive and the Company shall issue or pay (at its discretion): (i) a lump sum payment in cash equal to the number of vested RSUs recorded in the Participant’s account multiplied by the volume weighted average price of the Common Shares traded on the Canadian Securities Exchange for the five (5) consecutive trading days prior to the payout date; (ii) the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s RSUs in the Participant’s account will be, duly issued as fully paid and non‑assessable shares and such Participant shall be registered on the books of the Company as the holder of the appropriate number of Common Shares; or (iii) any combination of thereof.

 

Vesting Provisions

 

The provides that: (i) at the time of the award of RSUs, the Administrators will determine the vesting criteria applicable to the awarded RSUs; (ii) vesting of RSUs may include criteria such as performance vesting; (iii) each RSU shall be subject to vesting in accordance with the terms set out in an agreement evidencing the award of the RSU attached as Exhibit A to the Share Compensation Plan (or in such form as the Administrators may approve from time to time) (each an “RSU Agreement”); and (iv) all vesting and issuances or payments in respect of an RSU shall be completed no later than December 15 of the third calendar year commencing after the award date for such RSU.

 

It is the current intention that RSUs may be awarded with both time based vesting provisions as a component of the Company’s annual incentive compensation program, and performance based vesting provisions as a component of the Company’s long term incentive compensation program.

 

Under the Share Compensation Plan, should the date of vesting of an RSU fall within a blackout period or within nine business days following the expiration of a blackout period, the date of vesting will be automatically extended to the tenth business day after the end of the blackout period.

 

 
- 54 -

Table of Contents

  

Termination, Retirement and Other Cessation of Employment in connection with RSUs

 

A person participating in the Share Compensation Plan will cease to be eligible to participate in the following circumstances: (i) receipt of any notice of termination of employment or service (whether voluntary or involuntary and whether with or without cause); (ii) retirement; and (iii) any cessation of employment or service for any reason whatsoever, including disability and death (an “Event of Termination”). In such circumstances, any vested RSUs will be issued (and with respect to each RSU of a US Participant, such RSU will be settled and shares issued as soon as practicable following the date of vesting of such RSU as set forth in the applicable RSU Agreement, but in all cases within 60 days following such date of vesting; and unless otherwise determined by the Administrators in their discretion, any unvested RSUs will be automatically forfeited and cancelled (and with respect to any RSU of a US Participant, if the Administrators determine, in their discretion, to waive vesting conditions applicable to an RSU that is unvested at the time of an Event of Termination, such RSU shall not be forfeited or cancelled, but instead will be deemed to be vested and settled and shares delivered following the date of vesting date of such RSU as set forth in the applicable RSU Agreement). Notwithstanding the above, if a person retires in accordance with the Company’s retirement policy at such time, the pro rata portion of any unvested performance based RSUs will not be forfeited or cancelled and instead shall be eligible to become vested in accordance with the vesting conditions set forth in the applicable RSU Agreement after such retirement (as if retirement had not occurred), but only if the performance vesting criteria, if any, have been met on the applicable date. For greater certainty, if a person is terminated for just cause, all unvested RSUs will be forfeited and cancelled.

 

Options

 

The total number of Common Shares that may be issued on exercise of Options and RSUs, together with any other share compensation arrangements of the Company, shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

Mechanics for Options

 

Each Option granted pursuant to the Share Compensation Plan will entitle the holder thereof to the issuance of one Common Share upon achievement of the vesting criteria and payment of the applicable exercise price. Options granted under the Share Compensation Plan will be exercisable for Common Shares issued from treasury once the vesting criteria established by the Administrators at the time of the grant have been satisfied. However, the Company will continue to retain the flexibility through the amendment provisions in the Share Compensation Plan to satisfy its obligation to issue Common Shares by making a lump sum cash payment of equivalent value (i.e., pursuant to a cashless exercise), provided there is a full deduction of the number of underlying Common Shares from the Share Compensation Plan’s reserve.

 

Vesting Provisions

 

The Share Compensation Plan provides that the Administrators may determine when any Option will become exercisable and may determine that Options shall be exercisable in instalments or pursuant to a vesting schedule. The Option agreement will disclose any vesting conditions prescribed by the Administrators.

 

Termination, Retirement and Other Cessation of Employment in connection with Options

 

A person participating in the Share Compensation Plan will cease to be eligible to participate where there is an Event of Termination. In such circumstances, unless otherwise determined by the Administrators in their discretion, any unvested Options will be automatically cancelled, terminated and not available for exercise and any vested Options may be exercised only before the earlier of: (i) the termination of the Option; and (ii) six months after the date of the Event of Termination. If a person is terminated for just cause, all Options will be (whether or not then exercisable) automatically cancelled.

 

Other Terms

 

The Administrators will determine the exercise price and term/expiration date of each Option, provided that the exercise price in respect of that Option shall not be less than the Market Price on the date of grant. “Market Price” is defined in the Share Compensation Plan, as of any date, the closing price of the Common Shares on the Canadian Securities Exchange for the last market trading day prior to the date of grant of the Option or if the Common Shares are not listed on a stock exchange, the Market Price shall be determined in good faith by the Administrators.

 

 
- 55 -

Table of Contents

  

No Option shall be exercisable after ten years from the date the Option is granted. Under the Share Compensation Plan, should the term of an Option expire on a date that falls within a blackout period or within nine business days following the expiration of a blackout period, such expiration date will be automatically extended to the tenth business day after the end of the blackout period.

 

Unless otherwise determined by the Board, in the event of a change of control, any surviving or acquiring corporation shall assume any Option outstanding under the Share Compensation Plan on substantially the same economic terms and conditions or substitute or replace similar options for those Options outstanding under the Share Compensation Plan on substantially the same economic terms and conditions.

 

Transferability

 

RSUs awarded and Options granted under the Share Compensation Plan or any rights of a Participant cannot be transferred, assigned, charged, pledged or hypothecated, or otherwise alienated, whether by operation of law or otherwise.

 

Reorganization and Change of Control Adjustments

 

In the event of any declaration by the Company of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of Common Shares, reclassification or conversion of the Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Company, distribution (other than normal course cash dividends) of Company assets to holders of Common Shares, or any other corporate transaction or event involving the Company or the Common Shares, the Administrators may make such changes or adjustments, if any, as they consider fair or equitable, to reflect such change or event including adjusting the number of Options and RSUs outstanding under the Share Compensation Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under the Share Compensation Plan, provided that the value of any Option or RSU immediately after such an adjustment shall not exceed the value of such Option or RSU prior thereto.

 

Amendment Provisions in the Share Compensation Plan

 

The Board may amend the Share Compensation Plan or any RSU or Option at any time without the consent of any Participant provided that such amendment shall:

 

 

(a)

not adversely alter or impair any RSU previously awarded or any Option previously granted, except as permitted by the adjustment provisions of the Share Compensation Plan and with respect to RSUs and Options of US Participants;

 

 

 

 

(b)

be subject to any regulatory approvals including, where required, the approval of the Canadian Securities Exchange; and

 

 

 

 

(c)

be subject to shareholder approval, where required, by the requirements of the Canadian Securities Exchange, provided that shareholder approval shall not be required for the following amendments:

  

 

(i)

amendments of a “housekeeping nature”, including any amendment to the Share Compensation Plan or an RSU or Option that is necessary to comply with applicable laws, tax or accounting provisions or the requirements of any regulatory authority, stock exchange or quotation system and any amendment to the Share Compensation Plan or an RSU or Option to correct or rectify any ambiguity, defective provision, error or omission therein, including any amendment to any definitions therein;

  

 
- 56 -

Table of Contents

  

 

(ii)

amendments that are necessary or desirable for RSUs or Options to qualify for favourable treatment under any applicable tax law;

 

 

 

 

(iii)

amendments to the vesting provisions of any RSU or any Option (including any alteration, extension or acceleration thereof), providing such amendments do not adversely alter or impair such RSU or Option;

 

 

 

 

(iv)

amendments to the termination provisions of any Option (e.g., relating to termination of employment, resignation, retirement or death) that does not entail an extension beyond the original expiration date (as such date may be extended by virtue of a blackout period) providing such amendments do not adversely alter or impair such Option;

 

 

 

 

(v)

amendments to the Share Compensation Plan that would permit the Company to retain a broker and make payments for the benefit of Participants to such broker who would purchase Common Shares for such persons, instead of issuing Common Shares from treasury upon the vesting of the RSUs;

 

 

 

 

(vi)

amendments to the Share Compensation Plan that would permit the Company to make lump sum cash payments to Participants, instead of issuing Common Shares from treasury upon the vesting of the RSUs;

 

 

 

 

(vii)

the amendment of the cashless exercise feature set out in the Share Compensation Plan; and

 

 

 

 

(viii)

change the application of the Change of Control provisions in section 6.2 or the Reorganization Adjustments provisions in section 6.3).

  

For greater certainty, shareholder approval will be required in circumstances where an amendment to the Share Compensation Plan would:

 

 

(a)

increase the fixed maximum percentage of issued and outstanding Common Shares issuable under the Share Compensation Plan, other than by virtue of the adjustment provisions in the Share Compensation Plan, or change from a fixed maximum percentage of issued and outstanding Common Shares to a fixed maximum number of Common Shares;

 

 

 

 

(b)

increase the limits referred to above under “Restrictions on the Award of RSUs and Grant of Options”;

 

 

 

 

(c)

reduce the exercise price of any Option (including any cancellation of an Option for the purpose of reissuance of a new Option at a lower exercise price to the same person);

 

 

 

 

(d)

extend the term of any Option beyond the original term (except if such period is being extend by virtue of a blackout period); or

 

 

 

 

(e)

amend the amendment provisions in Section 6.4 of the Share Compensation Plan.

  

Oversight and Description of Named Executive Officer and Director Compensation

 

The Board is responsible for the oversight of the Company’s strategy, policies and programs on the compensation and development of senior management and directors.

 

The Company’s executive compensation program is intended to provide an appropriate overall compensation package that permits the Company to attract and retain highly qualified and experienced senior executives and to encourage superior performance by the Company. The Company’s compensation policies are intended to motivate individuals to achieve and to award compensation based on corporate and individual results. The compensation of the Company’s executive officers is established based on a relatively equal weighing of each of these considerations.

 

 
- 57 -

Table of Contents

  

Compensation for the Company’s executive officers is intended to reflect a fair evaluation of overall performance and is intended to be competitive in aggregate with levels of compensation of comparable companies. The Company’s compensation structure is primarily composed of two components: base salary and options and RSUs to purchase common shares. The Company generally strives to use long term incentives, such as the grant of stock options, as performance incentives for executive management and to provide the opportunity for overall compensation of employees, including executives, to be above industry average levels as well as to increase the alignment of interests between employees, executive management and shareholders. Executive officers and directors are eligible to be granted stock options and RSUs under the Share Compensation Plan, and previous grants of options and / or RSUs are taken into consideration when considering new grants. The Share Compensation Plan is intended to provide long term rewards linked directly to the market value of the common shares. The Company is of the view that the Share Compensation Plan is in the best interests of the Company and will assist the Company to attract, motivate and retain talented and capable board members and executive management.

 

The Share Compensation Plan also allows the Company to grant from time to time RSUs to non-employee directors, employees and/or consultants of the Company or its designated affiliates on such terms and conditions as prescribed by the Share Compensation Plan. As of the date of this Offering Circular, there are 3,550,000 RSUs awarded under the Company’s share compensation plan to directors, officers, employees and consultants of the Company. Each RSU represents a right to receive one common share of the Company, following the vesting of such restricted share units over a three year period. The RSUs are exercisable for three (3) years. As of the date of this Offering Circular, there are 4,770,000 stock options outstanding under the Company’s Share Compensation Plan.

 

The following table provides information regarding compensation plans under which equity securities of the Company are authorized for issuance in effect as of the end of the Company’s most recently completed financial year:

 

Plan Category

 

Number of Securities to
be Issued Upon Exercise
of Outstanding Options,
Warrants and Rights
(a)

 

 

Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights
(b)

 

 

Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation
Plans (Excluding
Securities Reflected in Column (a))
(c)

 

Equity Compensation Plans Approved By Shareholders

 

 

N/A

 

 

 

N/A

 

 

 

N/A

 

Equity Compensation Plans Not Approved By Shareholders

 

 

6,900,000 (1)

 

$ 0.50

 

 

 

7,034,122

 

Total:

 

 

6,900,000

 

 

 

N/A

 

 

 

7,034,122

 

Note:

(1) Includes RSUs and Options granted pursuant to the Plan. See above “Share Compensation Plan and Other Incentive Plans”.

 

The Company does not have a pension plan benefit program nor a non-equity incentive plan in place. Therefore, there were no payments or benefits in connection with a defined benefit or a defined contribution plan and no annual incentive plan or long term incentive plan awards offered to the Named Executive Officers (as defined below) during the Company’s most recently completed financial year.

 

Given the current stage of development and the limited elements of executive compensation, the Board believes it has effective risk management and regulatory compliance relating to its compensation policies used in determining executive compensation. Risks related to compensation are taken into consideration as part of the general review and determination of executive compensation by the Board. Inappropriate and excessive risks by executives are mitigated by regular Board meetings during which financial and other information of the Company is reviewed, and which information includes executive compensation. Interested directors declare their interest and abstain from voting on compensation matters. No risks have been identified arising from the Company’s compensation policies and practices that are reasonably likely to have a material adverse effect on the Company.

 

 
- 58 -

Table of Contents

  

The Company does not permit its Named Executive Officers or directors to purchase financial instruments, including, for greater certainty, prepaid variable forward contracts, equity swaps, collars or units of exchange funds, that are designed to hedge or offset a decrease in market value of equity securities granted as compensation or held, directly or indirectly, by the Named Executive or director.

 

Penny Stock Regulation

 

The SEC has adopted regulations which generally define “penny stock” to be any equity security that has a market price of less than $5.00 per share or an exercise price of less than $5.00 per share. Such securities are subject to rules that impose additional sales practice requirements on broker-dealers who sell them. For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchaser of such securities and have received the purchaser’s written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction, of a disclosure schedule prepared by the SEC relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, among other requirements, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. As our Common Shares immediately following this Offering may be subject to such penny stock rules, purchasers in this Offering will in all likelihood find it more difficult to sell their Common Shares in the secondary market.

 

Public Market

 

The Company is an alternative reporting company under Regulation A+, Tier 2 of the Securities Act. The Company’s Common Shares are listed on the Canadian Securities Exchange under the symbol “DFLY” and the OTCQB Venture Market of the OTC Markets under the symbol “DFLYF”.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a Regulation A+ Offering Statement on Form 1-A under the Securities Act with respect to the Units offered hereby. This Offering Circular, which constitutes a part of the Offering Statement, does not contain all of the information set forth in the Offering Statement or the exhibits and schedules filed therewith. For further information about us and the Units offered hereby, we refer you to the Offering Statement and the exhibits and schedules filed therewith. Statements contained in this Offering Circular regarding the contents of any contract or other document that is filed as an exhibit to the Offering Statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the Offering Statement. We are required to file periodic reports and other information with the SEC pursuant to the Regulation A, Tier 2 rules and regulation under the Securities Act. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, including us, that file electronically with the SEC. The address of this site is www.sec.gov.

 

 
- 59 -

Table of Contents

  

PART F/S

       

 

Page

 

 

 

Cover Page to the Consolidated Financial Statements for Years Ended December 31, 2019 and 2018.

F-1

 

 

 

 

Independent Auditor’s Report to the Consolidated Financial Statements for Years Ended December 31, 2019 and 2018.

F-2

 

 

 

 

Consolidated Statements of Financial Position for Years Ended December 31, 2019 and 2018 (Expressed in Canadian Dollars).

F-3

 

 

 

 

Consolidated Statements of Comprehensive Loss for Years Ended December 31, 2019 and 2018 (Expressed in Canadian Dollars).

F-4

 

 

 

 

Consolidated Statements of Changes in Shareholders’ Equity for Years Ended December 31, 2019 and 2018 (Expressed in Canadian Dollars).

F-5

 

 

 

 

Consolidated Statements of Changes in Cash Flows for Years Ended December 31, 2019 and 2018 (Expressed in Canadian Dollars).

F-6

 

 

 

 

Notes to the Consolidated Financial Statements For Years Ended December 31, 2019 and 2018.

F-7

 

   

 
- 60 -

Table of Contents

 

 

 

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

 

Consolidated Financial Statements

 

Years Ended December 31, 2019 and 2018

 

(Expressed in Canadian Dollars)

 

 
F-1

Table of Contents

 

 

INDEPENDENT AUDITOR’S REPORT

 

To the Shareholders of Draganfly Inc. (formerly Drone Acquisition Corp.)

 

Report on the Financial Statements

 

We have audited the accompanying consolidated financial statements of Draganfly Inc. (formerly Drone Acquisition Corp.) (the "Company"), which comprise the consolidated statements of financial position as at December 31, 2019 and 2018, and the consolidated statements of comprehensive loss, changes in shareholders’ equity and cash flows for the years then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies (collectively referred to as the “financial statements”).

 

Management's Responsibility for the Financial Statements

 

Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error. 

 

 Auditors' Responsibility

 

Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

 

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as at December 31, 2019 and 2018, and the consolidated statements of comprehensive loss, changes in shareholders’ equity and cash flows for the years then ended in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

Emphasis of Matter Regarding Going Concern 

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company incurred losses and negative cash flows from operations from inception that has primarily been funded through financing activities and has stated that substantial doubt exists about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter. 

 

/s/ DMCL

 

DALE MATHESON CARR-HILTON LABONTE LLP
CHARTERED PROFESSIONAL ACCOUNTANTS
 Vancouver, BC

June 10, 2020

 

 
F-2

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)              

Consolidated Statements of Financial Position

Expressed in Canadian Dollars

 

 

 

 

 

December 31,

 

 

December 31,

 

As at

Notes

 

 

2019

 

 

2018

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash

 

 

 

$ 2,429,375

 

 

$ 101,787

 

Accounts receivable

 

4

 

 

 

224,695

 

 

 

97,896

 

Inventory

 

5

 

 

 

48,563

 

 

 

61,185

 

Prepaid expenses and deposits

 

6

 

 

 

272,630

 

 

 

23,305

 

 

 

 

 

 

 

2,975,263

 

 

 

284,173

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current Assets

 

 

 

 

 

 

 

 

 

 

 

Subscription receivable

 

4

 

 

 

-

 

 

 

153,566

 

Equipment

 

8

 

 

 

115,141

 

 

 

55,178

 

Intellectual property

 

9

 

 

 

1,385

 

 

 

11,908

 

Right of use asset

 

10

 

 

 

129,994

 

 

 

-

 

TOTAL ASSETS

 

 

 

 

$ 3,221,783

 

 

$ 504,825

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

 

 

 

Trade payables and accrued liabilities

 

12

 

 

$ 894,357

 

 

$ 2,586,087

 

Notes payable

 

13

 

 

 

-

 

 

 

844,304

 

Convertible debentures

 

14

 

 

 

-

 

 

 

1,207,043

 

Lease liability

 

11

 

 

 

43,000

 

 

 

-

 

 

 

 

 

 

 

937,357

 

 

 

4,637,434

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current Liabilities

 

 

 

 

 

 

 

 

 

 

 

Lease liability

 

11

 

 

 

93,073

 

 

 

-

 

TOTAL LIABILITIES

 

 

 

 

 

1,030,430

 

 

 

4,637,434

 

 

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Share capital

 

15

 

 

 

27,786,517

 

 

 

12,561,342

 

Equity reserve

 

15

 

 

 

2,508,233

 

 

 

882,180

 

Accumulated deficit

 

 

 

 

 

(28,103,397 )

 

 

(17,576,131 )

TOTAL SHAREHOLDERS’ EQUITY

 

 

 

 

 

2,191,353

 

 

 

(4,132,609 )

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

$ 3,221,783

 

 

$ 504,825

 

 

Nature of continuance and operations (Note 1)

Contingency (Note 18)

Subsequent events (Notes 13 and 24)

 

Approved and authorized for issuance by the Board of Directors on June 10, 2020.

  

“Scott Larson”

 

“Cameron Chell”

Director

 

Director

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
F-3

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Consolidated Statements of Comprehensive Loss

Expressed in Canadian Dollars

 

 

 

 

For the years ended December 31,

 

 

Note

 

 

2019

 

 

2018

 

 

 

 

 

 

 

 

 

 

Revenue from sales of goods

 

16

 

 

$ 248,939

 

 

$ 423,705

 

Revenue from provision of services

 

16

 

 

 

1,131,488

 

 

 

963,308

 

TOTAL REVENUE

 

 

 

 

 

1,380,427

 

 

 

1,387,013

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF SALES

 

5

 

 

 

(218,800 )

 

 

(452,399 )

 

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

 

 

 

 

1,161,627

 

 

 

934,614

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

9

 

 

$ 8,386

 

 

$ 15,534

 

Depreciation

 

8,10

 

 

 

41,250

 

 

 

22,521

 

Office and miscellaneous

 

 

 

 

 

2,127,632

 

 

 

328,292

 

Professional fees

 

 

 

 

 

524,101

 

 

 

131,028

 

Research and development

 

 

 

 

 

16,883

 

 

 

16,158

 

Share-based compensation

 

15

 

 

 

761,559

 

 

 

-

 

Travel

 

 

 

 

 

30,896

 

 

 

17,817

 

Wages and salaries

 

 

 

 

 

989,083

 

 

 

984,179

 

 

 

 

 

 

 

(4,499,790 )

 

 

(1,515,529 )

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

Finance and other costs

 

22

 

 

 

(171,905 )

 

 

(145,271 )

Foreign exchange gain

 

 

 

 

 

5,803

 

 

 

2,971

 

Gain on disposal of assets

 

8

 

 

 

28,651

 

 

 

-

 

Gain on settlement of debt

 

12,15

 

 

 

198,976

 

 

 

-

 

Listing expense

 

3

 

 

 

(7,804,859 )

 

 

-

 

Loss on write-off loan receivable

 

7

 

 

 

(13,560 )

 

 

-

 

Other income

 

 

 

 

 

-

 

 

 

8,130

 

Scientific research and development credit

 

 

 

 

 

-

 

 

 

113,356

 

NET AND COMPREHENSIVE LOSS

 

 

 

 

$ (11,095,057 )

 

$ (601,729 )

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

 

 

 

 

Basic/Diluted

 

 

 

 

$ (0.23 )

 

$ (0.02 )

Weighted average number of common shares outstanding

 

 

 

 

 

47,647,977

 

 

 

39,344,881

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
F-4

Table of Contents

    

Draganfly Inc. (formerly Drone Acquisition Corp.)

Consolidated Statements of Changes in Shareholders’ Equity

Expressed in Canadian Dollars

 

 

 

Number of

Shares

 

 

Share Capital

 

 

Equity Reserve

 

 

Deficit

 

 

Total

Shareholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2017

 

 

39,332,455

 

 

$ 12,550,942

 

 

$ 1,215,206

 

 

$ (17,297,428 )

 

$ (3,531,280 )

Shares issued for exercise of warrants

 

 

14,352

 

 

 

10,400

 

 

 

(10,000 )

 

 

-

 

 

 

400

 

Expired options

 

 

-

 

 

 

-

 

 

 

(323,026 )

 

 

323,026

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(601,729 )

 

 

(601,729 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2018

 

 

39,346,807

 

 

 

12,561,342

 

 

 

882,180

 

 

 

(17,576,131 )

 

 

(4,132,609 )

Shares issued for settlement of notes payable

 

 

1,291,549

 

 

 

645,775

 

 

 

-

 

 

 

-

 

 

 

645,775

 

Shares issued as transactions fees

 

 

2,000,000

 

 

 

1,000,000

 

 

 

-

 

 

 

-

 

 

 

1,000,000

 

Recapitalization of Draganfly Inc.

 

 

10,500,001

 

 

 

5,250,001

 

 

 

1,645,193

 

 

 

-

 

 

 

6,895,194

 

Shares issued of settlement of trades payable

 

 

45,325

 

 

 

22,662

 

 

 

-

 

 

 

-

 

 

 

22,662

 

Shares issued for settlement of convertible debentures and accrued interest

 

 

2,118,492

 

 

 

1,059,246

 

 

 

-

 

 

 

-

 

 

 

1,059,246

 

Shares issued for exercise of warrants

 

 

316,940

 

 

 

221,741

 

 

 

(212,908 )

 

 

-

 

 

 

8,833

 

Reclassification of unexercised conversion feature

 

 

-

 

 

 

-

 

 

 

(567,791 )

 

 

567,791

 

 

 

-

 

Shares and warrants issued on private placement

 

 

14,051,499

 

 

 

7,025,750

 

 

 

-

 

 

 

-

 

 

 

7,025,750

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

761,559

 

 

 

-

 

 

 

761,559

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(11,095,057 )

 

 

(11,095,057 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2019

 

 

69,670,613

 

 

$ 27,786,517

 

 

$ 2,508,233

 

 

$ (28,103,397 )

 

$ 2,191,353

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
F-5

Table of Contents

    

Draganfly Inc. (formerly Drone Acquisition Corp.)

Consolidated Statements of Changes in Cash Flows

Expressed in Canadian Dollars 

 

 

 

For the years ended December 31,

 

 

 

2019

 

 

2018

 

 

 

 

 

 

 

 

OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$ (11,095,057 )

 

$ (601,729 )

Adjustments for:

 

 

 

 

 

 

 

 

Amortization

 

 

8,386

 

 

 

15,534

 

Depreciation

 

 

41,250

 

 

 

22,521

 

Finance and other costs

 

 

171,905

 

 

 

145,271

 

Gain on settlement of debt

 

 

(198,976 )

 

 

-

 

Gain on disposal of assets

 

 

(28,651 )

 

 

-

 

Expense of non-financial asset

 

 

15,389

 

 

 

-

 

Listing expense

 

 

7,804,859

 

 

 

-

 

Share-based compensation

 

 

761,559

 

 

 

-

 

 

 

 

(2,519,336 )

 

 

(418,404 )

Net changes in non-cash working capital items:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(126,799 )

 

 

(35,150 )

Inventory

 

 

12,622

 

 

 

94,761

 

Prepaid expenses

 

 

(249,325 )

 

 

(2,833 )

Trade payables and accrued liabilities

 

 

(1,005,121 )

 

 

100,069

 

Funds used in operations activities

 

 

(3,887,959 )

 

 

(261,556 )

 

 

 

 

 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Cash assumed from the Amalgamation

 

 

28,538

 

 

 

-

 

Purchase of equipment

 

 

(87,785 )

 

 

(12,535 )

Disposal of equipment

 

 

31,500

 

 

 

10,755

 

Funds used in investing activities

 

 

(27,747 )

 

 

(1,780 )

 

 

 

 

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from issuance of notes payable

 

 

1,137,978

 

 

 

373,243

 

Repayment of notes payable

 

 

(882,770 )

 

 

(137,854 )

Repayment of convertible debentures

 

 

(486,131 )

 

 

-

 

Repayment of lease liability

 

 

(38,000 )

 

 

-

 

Proceeds from issuance of common shares

 

 

6,534,583

 

 

 

400

 

Funds provided by financing activities

 

 

6,265,660

 

 

 

235,789

 

 

 

 

 

 

 

 

 

 

Effects of exchange rate changes on cash

 

 

(22,366 )

 

 

(882 )

Change in cash

 

 

2,349,954

 

 

 

(27,547 )

Cash, beginning

 

 

101,787

 

 

 

130,216

 

Cash, ending

 

$ 2,429,375

 

 

$ 101,787

 

 

 

 

 

 

 

 

 

 

Supplemental cash flow disclosure (Note 23)

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
F-6

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (formerly Drone Acquisition Corp.) (the “Company”) was incorporated by articles of incorporation dated June 1, 2018 under the Business Corporations Act (British Columbia). Effective November 5, 2019, the Company’s shares began trading on the Canadian Securities Exchange (the “CSE”) under the symbol “DFLY”.

 

The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2300 – 550 Burrard Street, Vancouver, BC, V6C 2B5.

 

On August 15, 2019, the Company and 1187607 B.C. Ltd. (“Merger Co.”), a wholly-owned subsidiary of the Company, completed a Business Combination Agreement (the “BCA”) with Draganfly Innovations Inc. (“Draganfly Innovations”) (the “Amalgamation”). Under the Amalgamation, shareholders of Draganfly Innovations received 1.794 fully paid and non-assessable common shares in the authorized share structure of the Company for each Draganfly Innovations share. Consequently, the Company owns 100% of Draganfly Innovations and the Draganfly Innovations shareholders became shareholders of the Company. Draganfly is an operational business of developing and manufacturing multi-rotor helicopters, industrial aerial video systems and civilian small unmanned aerial systems or vehicles. Pursuant to the Amalgamation the Company changed its name to “Draganfly Inc.”.

 

The Company has incurred losses and negative cash flows from operations from inception that has primarily been funded through financing activities. The Company will need to raise additional capital during the next twelve months and beyond to support current operations and planned development. These factors indicate the existence of a material uncertainty that may cast significant doubt as to the Company’s ability to continue as a going concern. Management intends to finance operating costs over the next twelve months with cash on hand, convertible debentures and through private placement of common shares. These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. These consolidated financial statements do not reflect the adjustments to the carrying values of assets and liabilities, the reporting revenues and expenses, and the statements of financial position classifications used, that would be necessary if the Company were unable to realize its assets and settle its liabilities as a going concern in the normal course of operations. Such adjustments could be material.

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION

 

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

 

These consolidated financial statements were authorized for issue by the Board of Directors on June 10, 2020.

 

Basis of preparation

 

The consolidated financial statements of the Company have been prepared on a historical cost basis, modified where applicable. In addition, the consolidated financial statements have been prepared using the accrual basis of accounting except for cash flow information.

 

 
F-7

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Significant estimates and assumptions

 

The preparation of financial statements in accordance with IFRS requires the Company to use judgment in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions.

 

Contingencies

 

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

 

 
F-8

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Other Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

 

 

The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;

 

the classification of financial instruments;

 

the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;

 

the determination of whether a set of assets acquired and liabilities assumed constitute a business; and

 

the determination of the functional currency of the company.

    

Foreign currency translation

 

The functional currency of each entity is measured using the currency of the primary economic environment in which that entity operates. The consolidated financial statements are presented in Canadian dollars which is the functional and presentation currency of the Company and its subsidiary.

 

Transactions and balances:

 

Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the date of the transaction. Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange rate at the date when fair values were determined.

 

Exchange differences arising on the translation of monetary items or on settlement of monetary items are recognized in the statement of comprehensive loss in the period in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge.

 

Exchange differences arising on the translation of non-monetary items are recognized in other comprehensive income to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive income. Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit or loss.

 

 
F-9

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Share-based payments

 

The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

 

Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.

 

Restricted Share Units

 

The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. A liability for outstanding RSUs is measured at fair value on the grant date and is subsequently adjusted for changes in fair value at each reporting date until settlement. The liability is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted loss per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period.

 

Financial Instruments

 

All financial assets are initially recorded at fair value and classified into one of four categories: fair value through profit or loss (“FVTPL”), fair value through other comprehensive income (“FVTOCI”) and at amortized costs. All financial liabilities are initially recorded at fair value and classified as either FVTPL or other financial liabilities. Financial instruments comprise cash and accounts payable and accrued liabilities.

 

a) Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

 
F-10

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

     

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.

 

 
F-11

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

b) Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Accounts payable and accrued liabilities, and convertible debentures, are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.

 

Derecognition of financial liabilities

Financial liabilities are derecognized when its contractual obligations are discharged or cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

 

Impairment of assets

 

The carrying amount of the Company’s non-financial assets (which include equipment and intangible assets) is reviewed at each reporting date to determine whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss. An impairment loss is recognized whenever the carrying amount of an asset or its cash generating unit exceeds its recoverable amount. Impairment losses are recognized in the statement of comprehensive loss.

 

The recoverable amount of assets is the greater of an asset’s fair value less cost to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects the current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

 

An impairment loss is only reversed if there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. Any reversal of impairment cannot increase the carrying value of the asset to an amount higher than the carrying amount that would have been determined had no impairment loss been recognized in previous years. Assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment.

 

Income taxes

 

Current income tax:

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

 
F-12

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred income tax:

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and li abilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset

is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

Inventory

 

Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Convertible debentures

 

The components of the compound financial instrument (convertible debenture) issued by the Company are classified separately as financial liabilities and equity in accordance with the substance of the contractual arrangement and the definitions of a financial liability and an equity instrument. The conversion option that will be settled by the exchange of a fixed amount in cash for a fixed number of equity instruments of the Company is classified as an equity instrument. At the issue date, the liability component is recognized at fair value, which is estimated using the effective interest rate on the market for similar nonconvertible instruments. Subsequently, the liability component is measured at amortized cost using the effective interest rate until it is extinguished on conversion or maturity. Upon maturity, the equity portion of the expired unexercised conversion option is reclassified to deficit.

 

The value of the conversion option classified as equity is determined at the issue date, by deducting the amount of the liability component from the fair value of the compound instrument as a whole. This amount is recognized in equity, net of tax effects, and is not revised subsequently. When the conversion option is exercised, the equity component of the convertible debentures will be transferred to share capital. No profit or gain is recognized to the conversion or expiration of the conversion option.

 

Transaction costs related to the issuance of the convertible debentures are allocated to the liability and equity components in proportion to the initial carrying amounts. Transaction costs related to the equity component are recognized directly in equity. Transaction costs relating to the liability component are included in the carrying value of the liability component and amortized over the estimated useful life of the debentures using the effective interest rate method.

 

 
F-13

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.

 

A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

 

Consulting services

 

The Company provides consulting, custom engineering and investigating and solving on a project by project basis under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spend relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.

 

Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

 

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.

 

 
F-14

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets includes intellectual property, which consists of patent and trademark applications.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized straight-line over their estimated useful lives from the date they are available for use. The amortization period of the Company’s intellectual property is 5 years.

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

 

Depreciation is calculated on a straight-line method to write off the cost of the assets to their residual values over their estimated useful lives. The depreciation rates applicable to each category of equipment are as follows:

 

Class of equipment

 

Depreciation rate

 

Computer equipment

 

 

30 %

Furniture and equipment

 

 

20 %

Software

 

 

30 %

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

   

 
F-15

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

  

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

SR&ED Investment tax credits

 

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

 

The Company claims provincial (Alberta) investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as Alberta SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

 
F-16

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

Adoption of new accounting standard

 

The Company adopted the requirements of IFRS 16 effective January 1, 2019. This new standard replaces IAS 17 Leases and the related interpretative guidance. IFRS 16 applies a control model to the identification of leases, distinguishing between a lease and a service contract on the basis of whether the customer controls the asset being leased.

 

For those assets determined to meet the definition of a lease, IFRS 16 introduces significant changes to the accounting by lessees, introducing a single, on-balance sheet accounting model that is similar to the current accounting for finance leases, with limited exceptions for short-term leases or leases of low value assets. Lessor accounting is substantially unchanged.

 

On adoption, the Company’s lease consisted of an office lease. The Company transitioned to the new standard using the modified retrospective approach and:

 

 

o

Measured the lease liability based on the present value of the remaining lease payments discounted using the Company’s incremental borrowing rate at January 1, 2019;

 

o

Measured the right-of-use asset based on the present value of the liability at the commencement date of the lease less any incentives received from the lessor; and

 

o

Recording the cumulative difference to deficit.

 

The following is a reconciliation of total operating lease commitments at December 31, 2018 to the lease liabilities recognized at January 1, 2019:

 

Lease liability before discounting

 

$ 38,000

 

Renewal options

 

 

133,000

 

Discounted using incremental borrowing rate

 

 

(39,366 )

Lease liability

 

$ 131,634

 

 

For any new contracts entered into on or after January 1, 2019, the Company considers whether a contract is, or contains a lease. A lease is defined as ‘a contract, or part of a contract, that conveys the right to use an asset (the underlying asset) for a period of time in exchange for consideration’. To apply this definition the Company assesses whether the contract meets three key evaluations which are whether:

 

 

i.

the contract contains an identified asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made available to the Company

 

ii.

the Company has the right to obtain substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within the defined scope of the contract

 

iii.

the Company has the right to direct the use of the identified asset throughout the period of use. The Company assess whether it has the right to direct ‘how and for what purpose’ the asset is used throughout the period of use.

 

included under non-current assets and lease liabilities have been included under current and non-current liabilities.

 

 
F-17

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

3. AMALGAMATION

 

On January 31, 2019, the Company and Draganfly Innovations entered into the BCA providing for a three-cornered amalgamation among the Company, Draganfly Innovations, and Merger Co. As of August 15, 2019, the Amalgamation closed and the Company acquired, on a one for 1.794 basis, all of the issued and outstanding Draganfly Innovations shares (the “Draganfly Innovations Shares”) in exchange for 42,638,356 common shares of the Company.

 

This resulted in a reverse take-over, of the Company, by the shareholders of Draganfly Innovations. At the time of the Amalgamation, the Company did not constitute a business as defined under IFRS 3; therefore, the Amalgamation is accounted under IFRS 2, where the difference between the consideration given to acquire the Company and the net asset value of the Company is recorded as a listing expense to net loss. As Draganfly Innovations is deemed to be the accounting acquirer for accounting purposes, these consolidated financial statements present the historical financial information of Draganfly Innovations up to the date of the Amalgamation.

 

Number of shares of Draganfly Inc.

 

 

10,500,001

 

Fair value of common shares in concurrent financing

 

$ 0.50

 

Fair value of shares of Draganfly Inc.

 

$ 5,250,001

 

Fair value of warrants

 

 

1,645,193

 

Fair value of shares issued for transaction fees

 

 

1,000,000

 

Net assets acquired

 

$ (90,335 )

Listing expense

 

$ 7,804,859

 

 

Fair value of the Company acquired, net of liabilities

 

 

 

Cash

 

$ 28,538

 

Accounts receivable

 

 

4,991

 

Loans receivable

 

 

963,269

 

Accounts payable and accrued liabilities

 

 

(406,463 )

Subscription receipts

 

 

(500,000 )

 

 

$ 90,335

 

 

The fair value of 10,500,001 issued common shares of the Company was estimated to be $0.50 per share using the price of a subscription receipts financing that was completed concurrently (Note 15).

 

Prior to the closing of the Amalgamation, Draganfly Innovations issued 2,000,000 common shares with a value of $1,000,000 as transaction fees for the Amalgamation to related parties.

 

The Company assumed 4,000,000 share purchase warrants exercisable at a price of $0.10 per share expiring on February 4, 2021. The fair value of share-purchase warrants was $1,645,193, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Risk-free interest rate

 

 

0.86 %

Estimate life

 

1.48 years

 

Expected volatility

 

 

100 %

Expected dividend yield

 

 

0 %

 

 
F-18

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

3. AMALGAMATION (CONT’D)

 

As at August 15, 2019, the Company received $7,025,750 in proceeds to issue subscription receipts (the “Subscription Receipts”) at a price of $0.50 per Subscription Receipt. Each Subscription Receipt was automatically converted, without payment of additional consideration and without any further action on the part of the holder, into one unit of the Company (a “Unit”) on completion of the Amalgamation and the Company becoming reporting issuer in the Province of Saskatchewan and obtaining conditional approval of a listing of the common shares on the CSE (the “Transaction”). Each Unit consists of one common share and one warrant. Each warrant will entitle the holder to purchase one common share at a price of $0.50 for a period of 12 months following the issuance of warrants. The proceeds of the private placement were released to the Company on November 5, 2019 (Note 15).

 

4. ACCOUNTS RECEIVABLE

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Trade accounts receivable

 

$ 146,194

 

 

$ 66,295

 

GST input tax credits

 

 

54,885

 

 

 

7,985

 

SR&ED receivable

 

 

23,616

 

 

 

23,616

 

 

 

$ 224,695

 

 

$ 97,896

 

 

Subscriptions receivable

 

During the year ended December 31, 2017, the Company agreed to settle subscriptions receivable of $160,000 by way of offsetting the amounts against amounts owing on certain notes payable. As at December 31, 2018, the outstanding balance is $153,566 in subscription receivables relating to shares issued in a prior year. During the year ended December 31, 2019, this receivable was settled against certain notes payable (Note 13).

 

5. INVENTORY

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Parts

 

$ 48,563

 

 

$ 61,185

 

 

During the year ended December 31, 2019, the Company recorded a provision to value its inventory for obsolete and slow-moving inventory, recognizing an expense in cost of sales of $nil (2018: $80,135).

 

During the year ended December 31, 2019, $96,463 (2018: $271,511) of inventory was sold and recognized in cost of sales.

 

6. PREPAID EXPENSES AND DEPOSITS

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Insurance

 

$ 35,703

 

 

$ 11,352

 

Prepaid marketing services

 

 

227,459

 

 

 

-

 

Prepaid subscriptions

 

 

1,583

 

 

 

1,526

 

WCB Premiums

 

 

916

 

 

 

853

 

Deposits

 

 

6,969

 

 

 

9,574

 

 

 

$ 272,630

 

 

$ 23,305

 

 

 
F-19

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

7. NOTE RECEIVABLE

 

On September 30, 2019, the Company issued a note receivable to a vendor of the Company for USD $10,000. The note began to accrue interest on December 22, 2019. As at December 31, 2019, the balance of the note receivable was $13,232, including $328 of interest. The loan is unsecured, bears interest of 10% per annum and was due on December 22, 2019. As at December 31, 2019, the note receivable was deemed uncollectable and the Company recognized a loss of write off of loan receivable of $13,560.

 

8. EQUIPMENT

 

 

 

Computer Equipment

 

 

Furniture and Equipment

 

 

Software

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2018

 

$ 163,255

 

 

$ 202,556

 

 

$ 72,499

 

 

$ 438,310

 

Additions

 

 

440

 

 

 

140

 

 

 

11,955

 

 

 

12,535

 

Disposals

 

 

(420 )

 

 

(21,334 )

 

 

(114 )

 

 

(21,868 )

Balance at December 31, 2018

 

 

163,275

 

 

 

181,362

 

 

 

84,340

 

 

 

428,977

 

Additions

 

 

-

 

 

 

87,785

 

 

 

-

 

 

 

87,785

 

Disposals

 

 

(1,056 )

 

 

(31,647 )

 

 

-

 

 

 

(32,703 )

Impairment

 

 

(155,219 )

 

 

(95,327 )

 

 

(54,373 )

 

 

(304,919 )

Balance at December 31, 2019

 

$ 7,000

 

 

$ 142,173

 

 

$ 29,967

 

 

$ 179,140

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2018

 

$ 147,074

 

 

$ 149,840

 

 

$ 65,477

 

 

$ 362,391

 

Charge for the year

 

 

3,341

 

 

 

14,854

 

 

 

4,326

 

 

 

22,521

 

Eliminated on disposal

 

 

(389 )

 

 

(10,695 )

 

 

(29 )

 

 

(11,113 )

Balance at December 31, 2018

 

 

150,026

 

 

 

153,999

 

 

 

69,774

 

 

 

373,799

 

Charge for the year

 

 

103

 

 

 

7,028

 

 

 

4,574

 

 

 

11,705

 

Eliminated on disposal

 

 

(1,654 )

 

 

(26,770 )

 

 

-

 

 

 

(28,424 )

Impairment

 

 

(141,714 )

 

 

(96,313 )

 

 

(55,054 )

 

 

(293,081 )

Balance at December 31, 2019

 

$ 6,761

 

 

$ 37,944

 

 

$ 19,294

 

 

$ 63,999

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net book value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

$ 13,249

 

 

$ 27,363

 

 

$ 14,566

 

 

$ 55,178

 

December 31, 2019

 

$ 239

 

 

$ 104,229

 

 

$ 10,673

 

 

$ 115,141

 

  

During the year ended December 31, 2019, the Company sold computer equipment for a gain on disposal of assets of $28,651 (December 31, 2018 - $nil).

 

 
F-20

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

9. INTELLECTUAL PROPERTY

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2018

 

 

 

 

 

 

 

 

 

 

$ 71,805

 

Balance at December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

71,805

 

Impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(29,874 )

Balance at December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

$ 41,931

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

$ 44,362

 

 Charge for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,534

 

Balance at December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

59,896

 

Charge for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,386

 

Impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(27,736 )

Balance at December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

$ 40,546

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net book value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

$ 11,908

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

$ 1,385

 

 

10. RIGHT OF USE ASSETS

 

The Company’s right-of-use asset relates to the lease of office space.

 

On adoption of IFRS 16, the group recognized lease liability which had previously been classified as ‘operating leases’ under IAS 17 Leases. These liabilities were measured at the present value of the remaining lease payments and discounted using the lessee’s incremental borrowing rate as of January 1, 2019. The weighted average lessee’s incremental borrowing rate applied to the lease liabilities on January 1, 2019 was 12%.

 

On December 1, 2019, the Company entered into an amendment for the lease agreement, where the lease was amended with a change in annual payments. As there was no change to the underlying asset, the modification was not accounted for as a separate lease.

 

 

 

 

 

 

 

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

Balance at January 1, 2019, on adoption of IFRS 16

 

 

 

 

 

 

 

$ 131,634

 

Lease modification

 

 

 

 

 

 

 

 

 

 

27,905

 

Balance at December 31, 2019

 

 

 

 

 

 

 

 

 

$ 159,539

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2019, on adoption of IFRS 16

 

 

 

 

 

 

 

 

 

$ -

 

Charge for the period

 

 

 

 

 

 

 

 

 

 

29,545

 

Balance at December 31, 2019

 

 

 

 

 

 

 

 

 

$ 29,545

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net book value:

 

 

 

 

 

 

 

 

 

 

 

 

January 1, 2019, on adoption of IFRS 16

 

 

 

 

 

 

 

 

 

$ 131,634

 

December 31, 2019

 

 

 

 

 

 

 

 

 

$ 129,994

 

 

 
F-21

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

11. LEASE LIABILITY

 

 

 

 

 

 

 

Total

 

Balance at January 1, 2019, on adoption of IFRS 16

 

 

 

 

 

 

 

$ 131,634

 

Interest expense

 

 

 

 

 

 

 

 

 

 

14,534

 

Lease payments

 

 

 

 

 

 

 

 

 

 

(38,000 )

Lease modification

 

 

 

 

 

 

 

 

 

 

27,905

 

Balance at December 31, 2019

 

 

 

 

 

 

 

 

 

$ 136,073

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Which consists of:

 

 

 

 

 

 

 

 

 

 

 

 

Current lease liability

 

 

 

 

 

 

 

 

 

$ 43,000

 

Non-current lease liability

 

 

 

 

 

 

 

 

 

 

93,073

 

Balance at December 31, 2019

 

 

 

 

 

 

 

 

 

$ 136,073

 

 

12. TRADES PAYABLE AND ACCRUED LIABILITIES

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Trades payable

 

$ 688,309

 

 

$ 1,593,377

 

Accrued liabilities

 

 

162,658

 

 

 

106,220

 

Contingent liabilities (Note 18)

 

 

-

 

 

 

15,000

 

Due to related parties (Note 20)

 

 

9,681

 

 

 

837,781

 

Government grant payable (Note 17)

 

 

33,709

 

 

 

33,709

 

 

 

$ 894,357

 

 

$ 2,586,087

 

 

During the year ended December 31, 2019, the Company settled $1,030,714 in trades payable through repayment of $512,492 and recognized a gain on settlement of debt of $518,222 (2018 - $nil).

 

13. NOTES PAYABLE

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Opening balance

 

$ 844,304

 

 

$ 571,675

 

Issuance of notes payable

 

 

1,137,978

 

 

 

373,243

 

Repayment of notes payable (1)

 

 

(1,036,336 )

 

 

(137,854 )

Settlement of notes payable

 

 

(62,000 )

 

 

-

 

Foreign exchange

 

 

(22,366 )

 

 

(882 )

Interest accrued

 

 

101,689

 

 

 

38,122

 

Eliminated on consolidation

 

 

(963,269 )

 

 

-

 

Ending balance

 

$ -

 

 

$ 844,304

 

 

(1)

Includes the application of $153,566 of subscription receivable (Note 4).

 

The Company had no notes payable outstanding as at December 31, 2019.

 

During the year ended December 31, 2019, the following new notes were executed:

 

 

-

Note 13 was entered into with a company controlled by a director of the Company, bear interest at 12% per annum and are unsecured. Note 13 was settled during the year ended December 31, 2019.

 

 
F-22

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

13. NOTES PAYABLE (CONT’D)

 

 

-

Notes 14 through 17, were entered into between the Company and Draganfly Innovations for $930,000, interest bearing at 10% per annum, calculated annually, and due at the earlier of 30 days from the date the Amalgamation is completed and one year from the date of the advance. Upon closing of the Amalgamation (Note 3), Notes 14 through 17 were eliminated upon consolidation.

 

 

 

 

-

Note 18 was entered into with an individual for USD$125,000, interest bearing at 18% per annum, and is unsecured. The notes had a maturity date of October 29, 2019 and was repaid during the year ended December 31, 2019. This note also bore a USD$6,250 due diligence fee and a USD$6,250 closing fee that are being recognized over the life of the note as additional interest.

 

The Company’s notes payable outstanding as at December 31, 2018 were as follows:

 

 

 

Start Date

 

Maturity Date

 

Rate

 

 

Principal

 

 

Interest

 

 

Total

 

Note 1

 

2015-03-26

 

2015-07-17

 

 

0 %

 

$ 124,000

 

 

$ -

 

 

$ 124,000

 

Note 2

 

2015-07-17

 

2015-12-01

 

 

5 %

 

 

278,570

 

 

 

87,249

 

 

 

365,819

 

Note 3

 

2018-02-05

 

2018-04-30

 

 

12 %

 

 

25,000

 

 

 

2,704

 

 

 

27,704

 

Note 4

 

2018-05-28

 

2018-07-31

 

 

12 %

 

 

60,000

 

 

 

4,281

 

 

 

64,281

 

Note 5

 

2018-06-25

 

2018-07-31

 

 

12 %

 

 

40,000

 

 

 

2,486

 

 

 

42,486

 

Note 6

 

2018-07-09

 

2018-08-06

 

 

12 %

 

 

12,000

 

 

 

690

 

 

 

12,690

 

Note 7

 

2018-07-23

 

2018-08-23

 

 

12 %

 

 

23,000

 

 

 

1,217

 

 

 

24,217

 

Note 8

 

2018-09-17

 

2018-10-31

 

 

12 %

 

 

40,000

 

 

 

1,381

 

 

 

41,381

 

Note 9

 

2018-10-15

 

2018-11-30

 

 

12 %

 

 

32,000

 

 

 

810

 

 

 

32,810

 

Note 10

 

2018-11-26

 

2018-12-31

 

 

12 %

 

 

2,000

 

 

 

23

 

 

 

2,023

 

Note 11

 

2018-12-04

 

2018-12-31

 

 

12 %

 

 

2,500

 

 

 

21

 

 

 

2,521

 

Note 12

 

2018-12-07

 

2019-03-05

 

 

18 %

 

 

99,743

 

 

 

4,629

 

 

 

104,372

 

Total

 

 

 

 

 

 

 

 

 

$ 738,813

 

 

$ 105,491

 

 

$ 844,304

 

 

14. CONVERTIBLE DEBENTURES

 

 

 

September 2015

(1)

 

 

August

2016

(2 and 3)

 

 

December 2016

(4)

 

 

January

2017

 (5 and 6)

 

 

March

2017

(7)

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2018

 

$ 550,000

 

 

$ 200,000

 

 

$ 160,784

 

 

$ 51,202

 

 

$ 154,236

 

 

$ 1,116,222

 

Accretion

 

 

-

 

 

 

-

 

 

 

39,216

 

 

 

13,047

 

 

 

38,558

 

 

 

90,821

 

Balance at December 31, 2018

 

$ 550,000

 

 

$ 200,000

 

 

$ 200,000

 

 

$ 64,249

 

 

$ 192,794

 

 

$ 1,207,043

 

Repayments

 

 

(275,000 )

 

 

(208,131 )

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(486,131 )

Settled for shares

 

 

(275,000 )

 

 

-

 

 

 

(200,000 )

 

 

(65,000 )

 

 

(200,000 )

 

 

(740,000 )

Accretion and interest

 

 

-

 

 

 

8,131

 

 

 

-

 

 

 

751

 

 

 

7,206

 

 

 

16,088

 

Balance at December 31, 2019

 

$ -

 

 

$ -

 

 

$ -

 

 

$ -

 

 

$ -

 

 

$ -

 

 

The Company had no convertible debentures outstanding as at December 31, 2019.

 

During the year ended December 31, 2019, half of Debenture 1 and the entire portion of Debentures 2 and 3 were repaid.

 

During the year ended December 31, 2019, the Company settled the remaining portion of Debenture 1 and Debentures 4 through 7 by issuing 2,118,492 common shares of the Company (Note 15 and 23).

 

 
F-23

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

15. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

For the year ended December 31, 2019,

 

 

-

Prior to the closing of the Amalgamation (Note 3), Draganfly Innovations issued 719,927 (pre-consolidation) common shares to a company controlled by a director of the Company for settlement of $799,341 in accounts payable and application of $153,566 in subscription receivable (Note 4).

 

-

Prior to the closing of the Amalgamation (Note 3), Draganfly Innovations issued 1,114,827 (pre-consolidation) common shares with a value of $1,000,000 as transaction fees for the Amalgamation to related parties.

 

-

On August 15, 2019, the Amalgamation (Note 3) was completed and the Company acquired, on a 1.794 for 1 basis, all issued and outstanding shares of Draganfly Innovations in exchange for 42,638,356 common shares of the Company.

 

-

On August 15, 2019, the Company issued 45,325 common shares for settlement of $22,662 in trades payables at a value of $0.50 per share.

 

-

On August 15, 2019, the Company issued 2,118,492 common shares for settlement of $740,000 in convertible debentures and interest. As a result of the settlement, the Company recognized loss on settlement of debt of $319,246 in the statement of loss and comprehensive loss.

 

-

On August 23, 2019, the Company issued 316,940 common shares for exercise of share purchase warrants of the Company for proceeds of $8,833. As a result of the exercise, $212,909 from reserve was reclassification to share capital.

 

-

On October 25, 2019, the Company issued 14,051,499 units per the private placement (Note 3). Each unit consists of one common share and one warrant. These warrants have an exercise price of $0.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020.

 

For the year ended December 31, 2018,

 

 

-

The Company issued 8,000 shares for proceeds of $400 for exercise of warrants. In relation, $10,000 in equity reserve was reclassified to share capital.

 

Stock options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. Such options will be exercisable for a period of up to 10 years from the date of grant. The aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) U.S.$1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date; and The number of common shares issuable pursuant to the exercise of options under the plan within a 12 month period to all eligible persons retained to provide investor relations activities (together with those common shares that are issued pursuant to any other share compensation arrangement) shall not, at any time, exceed 1% of the issued and outstanding common shares.

 

 
F-24

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

15. SHARE CAPITAL (CONT’D)

 

As at December 31, 2019, the Company had the following options outstanding and exercisable:

 

Grant Date

 

Expiry Date

 

Exercise Price

 

 

Remaining Contractual

Life (years)

 

 

Number of

Options Outstanding

 

 

Number of

Options

Exercisable

 

October 30, 2019

 

October 30, 2029

 

$ 0.50

 

 

 

9.84

 

 

 

3,075,000

 

 

 

1,024,992

 

November 19, 2019

 

November 19, 2029

 

$ 0.50

 

 

 

9.89

 

 

 

650,000

 

 

 

83,333

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,725,000

 

 

 

1,108,325

 

 

The following is a summary of the Company’s stock option activity:

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise Price

 

Outstanding, December 31, 2017

 

 

300,000

 

 

$ 1.25

 

Expired

 

 

(300,000 )

 

 

1.25

 

Outstanding, December 31, 2018

 

 

-

 

 

$ -

 

Granted

 

 

3,725,000

 

 

 

0.50

 

Outstanding, December 31, 2019

 

 

3,725,000

 

 

$ 0.50

 

 

During the year ended December 31, 2019,

 

 

-

The Company granted 2,925,000 options to employees. Each option is exercisable at $0.50 per share for a period of 10 years from the grant date.

 

 

 

 

-

The Company issued 800,000 options to consultants. Each option is exercisable at $0.50 per share for a period of 10 years from the grant date.

 

During the year ended December 31, 2018, the fair value of 300,000 expired options of $323,026 was reclassified from reserves to deficit.

 

During the year ended December 31, 2019, the Company recorded $599,701 in stock-based compensation for stock options, based on the fair values of stock options granted which were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

 

 

Year ended December 31, 2019

 

Risk free interest rate

 

1.45%-1.46

%

Expected volatility

 

 

100 %

Expected life

 

7.5 years

 

Expected dividend yield

 

 

0 %

Exercise price

 

$ 0.50

 

 

The weighted average grant date fair value of options granted during the year ended December 31, 2019 was $0.46 per option.

 

 
F-25

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

15. SHARE CAPITAL (CONT’D)

 

Restricted share units (RSUs)

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

 

The aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of common shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) USD $1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the common shares of the Company, measured at the Company’s most recent balance sheet date. At the election of the Board of Directors, upon each vesting date, participants receive (a) the issuance of common shares from treasury equal to the number of RSUs vesting, or (b) a cash payment equal to the number of vested RSUs multiplied by the fair market value of a common share, calculated as the closing price of the common shares on the CSE for the trading day immediately preceding such payment date; or (c) a combination of (a) and (b).

 

On the grant date of RSUs, the Company determines whether it has a present obligation to settle in cash. If the Company has a present obligation to settle in cash, the RSUs are accounted for as liabilities, with the fair value remeasured at the end of each reporting period and at the date of settlement, with any changes in fair value recognized in profit or loss for the period. The Company has a present obligation to settle in cash if the choice of settlement in shares has no commercial substance, or the Company has a past practice or a stated policy of setting in cash, or generally settles in cash whenever the counterparty asks for cash settlement. If no such obligation exists, RSUs are accounted for as equity settled share-based payments and are valued using the share price on grant date. Upon settlement:

 

 

a)

If the Company elects to settle in cash, the cash payment is accounted for as the repurchase of an equity interest (i.e. as a deduction from equity), except as noted in (c) below.

 

b)

If the Company elects to settle by issuing shares, the value of RSUs initially recognized in reserves is reclassified to share capital, except as noted in (c) below.

 

c)

If the Company elects the settlement alternative with the higher fair value, as at the date of settlement, the Company recognizes an additional expense for the excess value given (i.e. the difference between the cash paid and the fair value of shares that would otherwise have been issued, or the difference between the fair value of the shares and the amount of cash that would otherwise have been paid, whichever is applicable).

 

During the year ended December 31, 2019, the Company committed to grant 3,175,000 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date. The Company at its discretion elected to grant the employees and consulting common shares rather than paying cash. As a result, the Company recorded share-based payment expense of $161,858 in stock-based compensation for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

 
F-26

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

15. SHARE CAPITAL (CONT’D)

 

As at December 31, 2019 the Company had the following RSUs outstanding:

 

Grant Date

 

Number of RSUs Outstanding

 

October 30, 2019

 

 

2,925,000

 

November 19, 2019

 

 

250,000

 

 

 

 

3,175,000

 

 

Warrants

 

The following is the summary of the Company’s warrant activity:

 

 

 

Number of Warrants

 

 

Weighted Average Exercise Price

 

Outstanding, December 31, 2017

 

 

784,232

 

 

$ 0.30

 

Exercised

 

 

(14,352 )

 

 

0.03

 

Outstanding, December 31, 2018

 

 

770,030

 

 

$ 0.27

 

Warrants of the Company at time of Amalgamation (Note 3)

 

 

4,000,000

 

 

 

0.10

 

Expired

 

 

(453,090 )

 

 

0.03

 

Exercised

 

 

(316,940 )

 

 

0.03

 

Issued

 

 

14,051,499

 

 

 

0.50

 

Outstanding, December 31, 2019

 

 

18,051,499

 

 

$ 0.41

 

 

As at December 31, 2019, the Company had the following warrants outstanding:

 

Date Issued

 

Expiry Date

 

Exercise Price

 

 

Number of Warrants Outstanding

 

February 4, 2019

 

February 4, 2021

 

$ 0.10

 

 

 

4,000,000

 

November 5, 2019

 

November 5, 2020

 

$ 0.50

 

 

 

14,051,499

 

 

 

 

 

 

 

 

 

 

18,051,499

 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2019 was 0.90 years (December 31, 2018 - 0.84 years).

 

 
F-27

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

16. REVENUE

 

The Company sub-classifies revenue within the following components: product revenue and consulting revenue. Product revenue comprises of sales of internally assembled multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Consulting revenue consists of fees charged for custom engineering and training and simulation consulting.

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Product sales

 

$ 248,939

 

 

$ 423,705

 

Consulting

 

 

1,131,488

 

 

 

963,308

 

 

 

$ 1,380,427

 

 

$ 1,387,013

 

 

Consulting revenue:

On May 22, 2017, the Company executed a standard consulting agreement, whereby the Company would provide consulting, custom engineering and investigating and solving on a project by project basis. The Company shall be responsible for the development, design, procurement, fabrication, assembly, integration, checkout, integration and test of hardware, software, and firmware necessary to produce a complete system per each project. The consideration for the services performed are based on the labor cost incurred on an hourly basis and minimal preapproved expenditures.

 

The Company operates in an international market within one reportable industry segment. Geographic revenue segmentation is as follows:

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Canada

 

$ 127,118

 

 

$ 249,595

 

United States

 

 

1,251,199

 

 

 

1,131,940

 

International

 

 

2,110

 

 

 

5,478

 

 

 

$ 1,380,427

 

 

$ 1,387,013

 

 

The Company derives significant revenues from one customer, which exceeds 10% of total revenues for either the year ended December 31, 2019 at 81%. During the year ended December 31, 2018, there were three customers that provided significant revenues that exceeded 10% (2018 – 63%).

 

17. GOVERNMENT ASSISTANCE

 

During the year ended December 31, 2019, the Company received $nil (December 31, 2018 – $89,740) in government assistance for the purchase of research related to scientific research and experimental development tax credit, the entire amount is included in other income. In addition, the Company recorded $nil (December 31, 2018 - $23,816) in SR&ED receivable for current year SR&ED claim.

 

In February 2016, the Company and an Alberta based government funded not-for-profit organization (the “Organization”) entered into a funding agreement, whereby the Organization would fund 50% of the total costs, up to $375,000 to the Company for the development of a new product. During the year ended December 31, 2016, the Company received $75,000 in funding. On February 28, 2017, the Company and the Organization entered into a repayment agreement, where the Company would refund and repay a portion of the Organization’s initial funding. The repayment agreement set out the terms and conditions upon which the Company was to pay $41,292 over a 12-month repayment plan. During the year ended December 31, 2018, the Company made its final repayment of $13,764.

 

In addition, the Company will pay the Organization $33,709 if the Company ever sells a product that the Organization’s funding contributed to, recorded in accounts payable and accrued liabilities.

 

 
F-28

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

18. CONTINGENCY

  
On January 15, 2018, the Company entered into a settlement agreement with a vendor pursuant to an action filed under the Ontario Court. Per the agreement, the Company is to pay the settlement amount of $75,000 in 15 equal installments on a monthly basis. During the year ended December 31, 2019, the Company repaid $15,000 (2018 - $60,000) of the settlement amount.

 

19. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables. The majority of cash is deposited in bank accounts held with major bank in Canada. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does not have any past due outstanding receivables and the expected loss rate for undue balance is estimated to be nominal.

 

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

 

Foreign exchange risk

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

Interest rate risk

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash equivalents as these instruments have original maturities of three months or less and are therefore exposed to interest rate fluctuations on renewal.

 

Fair value

The fair value of the Company’s financial assets and liabilities approximates the carrying amount.

 

Capital Management

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of cash and equity comprised of issued share capital, and share-based payment reserve.

   

 
F-29

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

  

19. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2018.

 

20. RELATED PARTY TRANSACTIONS

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of members of the Company’s Board of Directors and corporate officers.

 

Loans:

 

 

 

On July 17, 2015, the Company issued a note payable for $600,000 with the former owner of the Company. The note payable bears interest at 5% per annum, was due on December 1, 2015 and is secured against the intellectual property as at the effective date. During the year ended December 31, 2019, the Company repaid the balance owing of $378,770 (2018 - $nil). As at December 31, 2019, $nil (2018 - $364,655) in notes payable plus accrued interest is outstanding. For the year ended December 31, 2019, the Company recognized interest expense of $15,153 (2018 - $17,748).

 

 

 

 

i.

On December 17, 2015, the Company issued a $160,000 note payable to a company controlled by a director of the Company. During the year ended December 31, 2017, the balance outstanding of $160,000 was applied against a subscription receivable (note 3). This subscription receivable was settled in the year ended December 31, 2019.

 

 

 

 

ii.

During the year ended December 31, 2018, the Company issued into various promissory notes of $273,500 with a company controlled by a director of the Company. The promissory notes are interest bearing at 12% per annum, unsecured and due within 60 days from the date of advance.

 

During the year ended December 31, 2019, the company repaid the balance owing of $290,973 (2018 - $37,086). As at December 31, 2019, $nil in promissory notes plus accrued interest is outstanding (2018 - $253,995). For the year ended December 31, 2019, the Company recorded interest expense of $13,860 (2018 - $17,581).

 

Trade payables and accrued liabilities:

 

During the year ended December 31, 2019, the Company had $9,681 (2018 - $837,781) payable to related parties outstanding that were included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2019 and 2018 included:

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Contract work, in office and miscellaneous

 

$ 420,039

 

 

$ -

 

Salaries

 

 

289,450

 

 

 

280,000

 

Share-based payments

 

 

480,158

 

 

 

-

 

Total

 

$ 1,189,647

 

 

$ 280,000

 

 

 
F-30

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

21. INCOME TAXES

 

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2019 and 2018:

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Loss before income taxes

 

$ 11,095,507

 

 

$ 601,729

 

Canadian statutory rates

 

 

27 %

 

 

27 %

Expected income tax

 

 

2,996,000

 

 

 

162,000

 

Non-deductible items

 

 

(2,043,000 )

 

 

-

 

Adjustments to prior years provision versus statutory tax returns

 

 

(388,000 )

 

 

-

 

Differences between prior year provision and final tax return

 

 

(18,000 )

 

 

(20,000 )

Change in deferred tax asset not recognized

 

 

(547,000 )

 

 

(142,000 )

Income tax

 

$ -

 

 

$ -

 

 

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Deferred income tax assets (liabilities):

 

 

 

 

 

 

Share issuance costs

 

$ -

 

 

$ 1,000

 

Non-capital losses

 

 

2,439,000

 

 

 

1,849,000

 

Property and equipment

 

 

581,000

 

 

 

650,000

 

Intangible assets

 

 

-

 

 

 

(27,000 )

Scientific Research and Experimental Development

 

 

49,000

 

 

 

49,000

 

Total deferred income tax assets

 

$ 3,069,000

 

 

$ 2,522,000

 

Deferred income tax not recognized

 

 

(3,069,000 )

 

 

(2,522,000 )

Net deferred tax assets

 

$ -

 

 

$ -

 

 

The Company has non-capital loss carry forward of approximately $7,743,000 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2033 to 2039.

 

22. FINANCE AND OTHER COSTS

 

 

 

December 31, 2019

 

 

December 31, 2018

 

Accretion and interest expense (note 14)

 

$ 16,088

 

 

$ 90,821

 

Interest expense for notes payable (note 13)

 

 

101,689

 

 

 

38,122

 

Interest expense on lease liabilities (note 11)

 

 

14,534

 

 

 

-

 

Interest on outstanding trade payables and bank charges

 

 

39,594

 

 

 

16,328

 

 

 

$ 171,905

 

 

$ 145,271

 

 

23. SUPPLEMENTAL CASH FLOW DISCLOSURES

 

During the year ended December 31, 2019:

 

 

·

Settlement of $822,003 in accounts payable and application of $153,566 in subscription receivable through issuance of shares (Note 15); and

 

·

Settlement of $740,000 of convertible debentures (Note 15).

 

 
F-31

Table of Contents

 

Draganfly Inc. (formerly Drone Acquisition Corp.)

Notes to the Consolidated Financial Statements

For the Years Ended December 31, 2019 and 2018

Expressed in Canadian Dollars 

 

24. SUBSEQUENT EVENTS

 

The following reportable events occurred subsequent to the year ended December 31, 2019:

 

 

·

On April 30, 2020, the Company completed the acquisition of Dronelogics Systems Inc. (“Dronelogics”) by acquiring all of the shares of Dronelogics, resulting in Dronelogics becoming a wholly-owned subsidiary of the Company. Dronelogics is a solutions integrator for custom robotics, hardware and software that provides a wide scope of services including sales, training, rentals, maintenance, flying and data processing services.

 

 

o

On closing of the Dronelogics acquisition, the Company: (i) paid the Dronelogics shareholders $2,000,000, consisting of a cash payment of $500,000, subject to a post-closing working capital adjustment; (ii) issued the Dronelogics shareholders 3,225,438 common shares in satisfaction of the balance of the purchase price and payment of certain management bonuses at a deemed price of 0.50 per common share; (iii) appointed Mr. Justin Hannewyk, President of Dronelogics, to the Board of Directors of the Company; and (iv) issued 200,000 Common Shares to a finder in connection with the Dronelogics acquisition. The common shares issued under the Dronelogics acquisition are subject to resale restrictions in the form of pooling terms providing for release of such shares over a period of 24 months and a right to place in favor of the Company during the same 24-month period.

      

 

·

The recent outbreak of the coronavirus, also known as “COVID-19”, has spread across the globe and is impacting worldwide economic activity. Conditions surrounding the coronavirus continue to rapidly evolve and government authorities have implemented emergency measures to mitigate the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to business globally resulting in an economic slowdown. Global equity markets have experienced significant volatility and weakness. Governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. There are significant uncertainties with respect to future developments and impact to the Company related to the COVID-19 pandemic, including the duration, severity and scope of the outbreak and the measures taken by governments and businesses to contain the pandemic. While the impact of COVID-19 is expected to be temporary, the current circumstances are dynamic and the impacts of COVID-19 on the Company’s business operations cannot be reasonably estimated at this time. As at the financial statement approval date, the outbreak and the related mitigation measures have had the following impacts on the Company’s operations, among others: temporary closure of business locations, supply chain issues, and decrease in sales. The extent to which these events may impact the Company’s business activities will depend on future developments, such as the ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions, business disruptions, and the effectiveness of actions taken in Canada and other countries to contain and treat the disease. These events are highly uncertain and as such, the Company cannot determine the ultimate financial impacts at this time. Any deterioration in the current situation could have an adverse impact on our business, results of operations, financial position and cash flows in 2020.

 

 
F-32

Table of Contents

 

PART III – EXHIBITS

 

Exhibit No.

 

Description

 

 

EX1A-2.1†

 

Notice of Articles of Draganfly Inc., dated November 4, 2019

 

EX1A-2.2†

 

Articles of Drone Acquisition Corp., dated June 1, 2018.

 

EX1A-2.3†

 

Certificate of Incorporation of Drone Acquisition Corp., dated June 1, 2018.

 

EX1A-2.4†

 

Certificate of Change of Name from Drone Acquisition Corp. to Draganfly Inc., dated August 15, 2019.

 

EX1A-4.1†

 

Form of Subscription Agreement.

 

EX1A-4.2†

 

Form of Common Share Purchase Warrant.

 

EX1A-4.3†

Form of Indemnity Agreement.

 

 

EX1A-6.1†

 

Independent Consulting Agreement, dated October 1, 2019, between Draganfly Inc., 1502372 Alberta Ltd., and Cameron Chell.

 

EX1A-6.2†

 

Employment Agreement, dated October 21, 2019, between Draganfly Innovations Inc. and Patrick Imbasciani.

 

EX1A-6.3†

 

Share Purchase Agreement, dated January 15, 2020, between Draganfly Inc., Dronelogics Systems Inc., and each person identified as a “Seller” in Schedule A thereto.

 

EX1A-6.4†

 

Business Combination Agreement, dated January 31, 2019, between Drone Acquisition Corp., Draganfly Innovations Inc., and 1187607 B.C. Ltd.

 

EX1A-6.5†

 

Broker Dealer Agreement, dated June 10, 2020, between Draganfly Inc. and Dalmore Group, LLC.

 

EX1A-6.6†

 

Share Compensation Plan of Draganfly Inc., including Form of Stock Option Agreement and Form of Restricted Share Agreement

 

EX1A-10.1†

 

Power of Attorney (included on signature page).

 

EX1A-11.1†

 

Consent of Dale Matheson Carr-Hilton Labonte LLP (Auditors).

 

EX1A-12.1†

 

Opinion of Gowling WLG (Canada) LLP (Canadian Legal Counsel).

 

EX1A-14.1†

 

Appointment of Agent for Service of Process.

 

† Filed herewith.

# Previously filed.

 

* Portions of this exhibit containing confidential information have been omitted pursuant to a request for confidential treatment filed with the SEC pursuant to Rule 406 under the Securities Act. Confidential information has been omitted from the exhibit in places marked “[*****]”and has been filed separately with the SEC.

 

 

III-1

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Regulation A+, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this offering statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Saskatoon, Province of Saskatchewan, Country of Canada, on June 15, 2020.

 

 

Draganfly Inc.

 

 

 

By:

/s/ Cameron Chell

 

 

Name: Cameron Chell

 

 

Title: Chief Executive Officer

 

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Cameron Chell and Paul Sun, or any of them, his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Form 1-A offering statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and ratifying and confirming all that said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

 

This offering statement has been signed by the following persons in the capacities and on the dates indicated.

 

/s/ Cameron Chell

 

Date: June 15, 2020

 

Name: Cameron Chell

Title: Chief Executive Officer and Chairman of the Board

 

 

 

 

/s/ Paul Sun

 

Date: June 15, 2020

 

Name: Paul Sun

Title: Chief Financial Officer

 

 

 

 

/s/ Scott Larson

 

Date: June 15, 2020

 

Name: Scott Larson

Title: Director

 

 

 

 

/s/ Olen Aasen

 

Date: June 15, 2020

 

Name: Olen Aasen

Title: Director

 

 

 

 

/s/ Denis Silva

Date: June 15, 2020

 

Name: Denis Silva

Title: Director

 

 

 

 

 

 

 

/s/ Andrew Hill Card, Jr.

Date: June 15,2020

 

Name: Andrew Hill Card, Jr.

 

 

 

Title: Director

 

 

 

 

/s/ Justin Hannewyk

Date: June 15, 2020

 

Name: Justin Hannewyk

Title: Director

 

 

_____________

 

 

- 61 -

 

EXHIBIT 2.1

 

 

 
 

 

 

 

 
 

 

 

 

 
 

 

EXHIBIT 2.2

 

Incorporation number:

 

Draganfly Inc.
(the “Company”)

 

The Company has as its articles the following articles.

 

Full name and signature of Director

Date of signing

 
/s/ Denis Silva                                                                                     

DENIS SILVA

 
June 1, 2018
_______________________

  

 

ARTICLES

 

1.

Interpretation

2

 

2.

Shares and Share Certificates

2

 

3.

Issue of Shares

5

 

4.

Share Registers

6

 

5.

Share Transfers

6

 

6.

Transmission of Shares

7

 

7.

Purchase of Shares

8

 

8.

Borrowing Powers

8

 

9.

Alterations

9

 

10.

Meetings of Shareholders

10

 

11.

Proceedings at Meetings of Shareholders

12

 

12.

Votes of Shareholders

16

 

13.

Directors

20

 

14.

Election and Removal of Directors

21

 

15.

Alternate Directors

26

 

16.

Powers and Duties of Directors

28

 

17.

Interests of Directors and Officers

29

 

18.

Proceedings of Directors

30

 

19.

Executive and Other Committees

32

 

20.

Officers

34

 

21.

Indemnification

35

 

22.

Dividends

36

 

23.

Documents, Records and Reports

38

 

24.

Notices

38

 

25.

Seal

40

 

26.

Prohibitions

41

 

27.

Special Rights And Restrictions – Common Shares

41

 

28.

Special Rights And Restrictions – Preferred

42

 

  

 

 

  

1.

Interpretation

 

 

1.1

Definitions

 

 

In these Articles, unless the context otherwise requires:

 

 

(1)

appropriate person” has the meaning assigned in the Securities Transfer Act;

 

 

(2)

board of directors”, “directors” and “board” mean the directors or sole director of the Company for the time being;

 

 

(3)

Business Corporations Act” means the Business Corporations Act (British Columbia) from time to time in force and all amendments thereto and includes all regulations and amendments thereto made pursuant to that Act;

 

 

(4)

Interpretation Act” means the Interpretation Act (British Columbia) from time to time in force and all amendments thereto and includes all regulations and amendments thereto made pursuant to that Act;

 

 

(5)

legal personal representative” means the personal or other legal representative of a shareholder;

 

 

(6)

protected purchaser” has the meaning assigned in the Securities Transfer Act;

 

 

(7)

registered address” of a shareholder means the shareholder’s address as recorded in the central securities register;

 

 

(8)

seal” means the seal of the Company, if any;

 

 

(9)

securities legislation” means statutes concerning the regulation of securities markets and trading in securities and the regulations, rules, forms and schedules under those statutes, all as amended from time to time, and the blanket rulings and orders, as amended from time to time, issued by the securities commissions or similar regulatory authorities appointed under or pursuant to those statutes; “Canadian securities legislation” means the securities legislation in any province or territory of Canada and includes the Securities Act (British Columbia); and “U.S. securities legislation” means the securities legislation in the federal jurisdiction of the United States and in any state of the United States and includes the Securities Act of 1933 and the Securities Exchange Act of 1934; and

 

 

(10)

Securities Transfer Act” means the Securities Transfer Act (British Columbia) from time to time in force and all amendments thereto and includes all regulations and amendments thereto made pursuant to that Act.

 

 

1.2

Business Corporations Act and Interpretation Act Definitions Applicable

 

 

2.

Shares and Share Certificates

 

 

The definitions in the Business Corporations Act and the definitions and rules of construction in the Interpretation Act, with the necessary changes, so far as applicable, and unless the context requires otherwise, apply to these Articles as if they were an enactment. If there is a conflict between a definition in the Business Corporations Act and a definition or rule in the Interpretation Act relating to a term used in these Articles, the definition in the Business Corporations Act will prevail in relation to the use of the term in these Articles. If there is a conflict or inconsistency between these Articles and the Business Corporations Act, the Business Corporations Act will prevail.

  

 
- 2 -

 

  

2.1

Authorized Share Structure

 

 

The authorized share structure of the Company consists of shares of the class or classes and series, if any, described in the Notice of Articles of the Company.

 

 

2.2

Form of Share Certificate

 

 

Each share certificate issued by the Company must comply with, and be signed as required by, the Business Corporations Act.

 

 

2.3

Shareholder Entitled to Certificate or Acknowledgment

 

 

Unless the shares of which the shareholder is the registered owner are uncertificated shares, each shareholder is entitled, without charge, to (a) one share certificate representing the shares of each class or series of shares registered in the shareholder’s name or (b) a non-transferable written acknowledgment of the shareholder’s right to obtain such a share certificate, provided that in respect of a share held jointly by several persons, the Company is not bound to issue more than one share certificate or acknowledgment and delivery of a share certificate or an acknowledgment to one of several joint shareholders or to a duly authorized agent of one of the joint shareholders will be sufficient delivery to all.

 

 

2.4

Delivery by Mail

 

 

Any share certificate or non-transferable written acknowledgment of a shareholder’s right to obtain a share certificate may be sent to the shareholder by mail at the shareholder’s registered address and neither the Company nor any director, officer or agent of the Company is liable for any loss to the shareholder because the share certificate or acknowledgement is lost in the mail or stolen.

 

 

2.5

Replacement of Worn Out or Defaced Certificate or Acknowledgement

 

 

If the directors are satisfied that a share certificate or a non-transferable written acknowledgment of the shareholder’s right to obtain a share certificate is worn out or defaced, they must, on production to them of the share certificate or acknowledgment, as the case may be, and on such other terms, if any, as they think fit:

 

 

(1)

order the share certificate or acknowledgment, as the case may be, to be cancelled; and

 

 

(2)

issue a replacement share certificate or acknowledgment, as the case may be.

 

 

2.6

Replacement of Lost, Destroyed or Wrongfully Taken Certificate

 

 

If a person entitled to a share certificate claims that the share certificate has been lost, destroyed or wrongfully taken, the Company must issue a new share certificate, if that person:

  

 
- 3 -

 

  

(1)

so requests before the Company has notice that the share certificate has been acquired by a protected purchaser;

 

 

(2)

provides the Company with an indemnity bond sufficient in the Company’s judgment to protect the Company from any loss that the Company may suffer by issuing a new certificate; and

 

 

(3)

satisfies any other reasonable requirements imposed by the directors.

 

 

A person entitled to a share certificate may not assert against the Company a claim for a new share certificate where a share certificate has been lost, apparently destroyed or wrongfully taken if that person fails to notify the Company of that fact within a reasonable time after that person has notice of it and the Company registers a transfer of the shares represented by the certificate before receiving a notice of the loss, apparent destruction or wrongful taking of the share certificate.

 

 

2.7

Recovery of New Share Certificate

 

 

If, after the issue of a new share certificate, a protected purchaser of the original share certificate presents the original share certificate for the registration of transfer, then in addition to any rights on the indemnity bond, the Company may recover the new share certificate from a person to whom it was issued or any person taking under that person other than a protected purchaser.

 

 

2.8

Splitting Share Certificates

 

 

If a shareholder surrenders a share certificate to the Company with a written request that the Company issue in the shareholder’s name two or more share certificates, each representing a specified number of shares and in the aggregate representing the same number of shares as represented by the share certificate so surrendered, the Company must cancel the surrendered share certificate and issue replacement share certificates in accordance with that request.

 

 

2.9

Certificate Fee

 

 

There must be paid to the Company, in relation to the issue of any share certificate under Articles 2.5, 2.6 or 2.8, the amount, if any and which must not exceed the amount prescribed under the Business Corporations Act, determined by the directors.

 

 

2.10

Recognition of Trusts

 

 

Except as required by law or statute or these Articles, no person will be recognized by the Company as holding any share upon any trust, and the Company is not bound by or compelled in any way to recognize (even when having notice thereof) any equitable, contingent, future or partial interest in any share or fraction of a share or (except as required by law or statute or these Articles or as ordered by a court of competent jurisdiction) any other rights in respect of any share except an absolute right to the entirety thereof in the shareholder.

  

 
- 4 -

 

  

3.

Issue of Shares

 

 

3.1

Directors Authorized

 

 

Subject to the Business Corporations Act and the rights, if any, of the holders of issued shares of the Company, the Company may issue, allot, sell or otherwise dispose of the unissued shares, and issued shares held by the Company, at the times, to the persons, including directors, in the manner, on the terms and conditions and for the issue prices (including any premium at which shares with par value may be issued) that the directors may determine. The issue price for a share with par value must be equal to or greater than the par value of the share.

 

 

3.2

Commissions and Discounts

 

 

The Company may at any time, pay a reasonable commission or allow a reasonable discount to any person in consideration of that person purchasing or agreeing to purchase shares of the Company from the Company or any other person or procuring or agreeing to procure purchasers for shares of the Company.

 

 

3.3

Brokerage

 

 

The Company may pay such brokerage fee or other consideration as may be lawful for or in connection with the sale or placement of its securities.

 

 

3.4

Conditions of Issue

 

 

Except as provided for by the Business Corporations Act, no share may be issued until it is fully paid. A share is fully paid when:

  

(1)

consideration is provided to the Company for the issue of the share by one or more of the following:

  

 

(a)

past services performed for the Company;

 

 

 

 

(b)

property;

 

 

 

 

(c)

money; and

   

(2)

the value of the consideration received by the Company equals or exceeds the issue price set for the share under Article 3.1.

  

3.5

Share Purchase Warrants and Rights

 

 

Subject to the Business Corporations Act, the Company may issue share purchase warrants, options and rights upon such terms and conditions as the directors determine, which share purchase warrants, options and rights may be issued alone or in conjunction with debentures, debenture stock, bonds, shares or any other securities issued or created by the Company from time to time.

   

 
- 5 -

 

  

4.

Share Registers

 

 

4.1

Central Securities Register

 

 

As required by and subject to the Business Corporations Act, the Company must maintain in British Columbia a central securities register. The directors may, subject to the Business Corporations Act, appoint an agent to maintain the central securities register. The directors may also appoint one or more agents, including the agent which keeps the central securities register, as transfer agent for its shares or any class or series of its shares, as the case may be, and the same or another agent as registrar for its shares or such class or series of its shares, as the case may be. The directors may terminate such appointment of any agent at any time and may appoint another agent in its place.

 

 

4.2

Closing Register

 

 

The Company must not at any time close its central securities register.

 

 

5.

Share Transfers

 

 

5.1

Registering Transfers

 

 

Subject to the Business Corporations Act, a transfer of a share of the Company must not be registered unless the Company or the transfer agent or registrar for the class or series of share to be transferred has received:

 

 

(1)

in the case of a share certificate that has been issued by the Company in respect of the share to be transferred, that share certificate and a written instrument of transfer (which may be on a separate document or endorsed on the share certificate) made by the shareholder or other appropriate person or by an agent who has actual authority to act on behalf of that person;

 

 

(2)

in the case of a non-transferable written acknowledgment of the shareholder’s right to obtain a share certificate that has been issued by the Company in respect of the share to be transferred, a written instrument of transfer that directs that the transfer of the shares be registered, made by the shareholder or other appropriate person or by an agent who has actual authority to act on behalf of that person;

 

 

(3)

in the case of a share that is an uncertificated share, a written instrument of transfer that directs that the transfer of the share be registered, made by the shareholder or other appropriate person or by an agent who has actual authority to act on behalf of that person; and

 

 

(4)

such other evidence, if any, as the Company or the transfer agent or registrar for the class or series of share to be transferred may require to prove the title of the transferor or the transferor’s right to transfer the share, that the written instrument of transfer is genuine and authorized and that the transfer is rightful or to a protected purchaser.

  

 
- 6 -

 

  

5.2

Form of Instrument of Transfer

 

 

The instrument of transfer in respect of any share of the Company must be either in the form, if any, on the back of the Company’s share certificates or in any other form that may be approved by the directors or the transfer agent for the class or series of shares to be transferred.

 

 

5.3

Transferor Remains Shareholder

 

 

Except to the extent that the Business Corporations Act otherwise provides, the transferor of shares is deemed to remain the holder of the shares until the name of the transferee is entered in a securities register of the Company in respect of the transfer.

 

 

5.4

Signing of Instrument of Transfer

 

 

If a shareholder, or his or her duly authorized attorney, signs an instrument of transfer in respect of shares registered in the name of the shareholder, the signed instrument of transfer constitutes a complete and sufficient authority to the Company and its directors, officers and agents to register the number of shares specified in the instrument of transfer or specified in any other manner, or, if no number is specified, all the shares represented by the share certificates or set out in the written acknowledgments deposited with the instrument of transfer:

 

 

(1)

in the name of the person named as transferee in that instrument of transfer; or

 

 

(2)

if no person is named as transferee in that instrument of transfer, in the name of the person on whose behalf the instrument is deposited for the purpose of having the transfer registered.

 

 

5.5

Enquiry as to Title Not Required

 

 

Neither the Company nor any director, officer or agent of the Company is bound to inquire into the title of the person named in the instrument of transfer as transferee or, if no person is named as transferee in the instrument of transfer, of the person on whose behalf the instrument is deposited for the purpose of having the transfer registered or is liable for any claim related to registering the transfer by the shareholder or by any intermediate owner or holder of the shares, of any interest in the shares, of any share certificate representing such shares or of any written acknowledgment of a right to obtain a share certificate for such shares.

 

 

5.6

Transfer Fee

 

 

There must be paid to the Company, in relation to the registration of any transfer, the amount, if any, determined by the directors.

 

 

6.

Transmission of Shares

 

 

6.1

Legal Personal Representative Recognized on Death

 

 

In the case of the death of a shareholder, the legal personal representative of the shareholder, or in the case of shares registered in the shareholder’s name and the name of another person in joint tenancy, the surviving joint holder, will be the only person recognized by the Company as having any title to the shareholder’s interest in the shares. Before recognizing a person as a legal personal representative of a shareholder, the directors may require the original grant of probate or letters of administration or a court certified copy of them or the original or a court certified or authenticated copy of the grant of representation, will, order or other instrument or other evidence of the death under which title to the shares or securities is claimed to vest.

  

 
- 7 -

 

  

6.2

Rights of Legal Personal Representative

 

 

The legal personal representative of a shareholder has the same rights, privileges and obligations that attach to the shares held by the shareholder, including the right to transfer the shares in accordance with these Articles, if appropriate evidence of appointment or incumbency within the meaning of s. 87 of the Securities Transfer Act has been deposited with the Company. This Article 6.2 does not apply in the case of the death of a shareholder with respect to shares registered in the shareholder’s name and the name of another person in joint tenancy.

 

 

7.

Purchase of Shares

 

 

7.1

Company Authorized to Purchase Shares

 

 

Subject to Article 7.2, the special rights and restrictions attached to the shares of any class or series and the Business Corporations Act, the Company may, if authorized by the directors, purchase or otherwise acquire any of its shares at the price and upon the terms specified in such resolution.

 

 

7.2

Purchase When Insolvent

 

 

The Company must not make a payment or provide any other consideration to purchase or otherwise acquire any of its shares if there are reasonable grounds for believing that:

 

 

(1)

the Company is insolvent; or

 

 

(2)

making the payment or providing the consideration would render the Company insolvent.

 

 

7.3

Sale and Voting of Purchased Shares

 

 

If the Company retains a share redeemed, purchased or otherwise acquired by it, the Company may sell, gift or otherwise dispose of the share, but, while such share is held by the Company, it:

 

 

(1)

is not entitled to vote the share at a meeting of its shareholders;

 

 

(2)

must not pay a dividend in respect of the share; and

 

 

(3)

must not make any other distribution in respect of the share.

 

 

8.

Borrowing Powers

 

 

The Company, if authorized by the directors, may:

 

 

(1)

borrow money in the manner and amount, on the security, from the sources and on the terms and conditions that they consider appropriate;

  

 
- 8 -

 

  

(2)

issue bonds, debentures and other debt obligations either outright or as security for any liability or obligation of the Company or any other person and at such discounts or premiums and on such other terms as they consider appropriate;

 

 

(3)

guarantee the repayment of money by any other person or the performance of any obligation of any other person; and

 

 

(4)

mortgage, charge, whether by way of specific or floating charge, grant a security interest in, or give other security on, the whole or any part of the present and future assets and undertaking of the Company.

 

 

9.

Alterations

 

 

9.1

Alteration of Authorized Share Structure

 

 

Subject to Article 9.2 and the Business Corporations Act, the Company may:

 

 

(1)

by ordinary resolution:

 

 

 

(a)

create one or more classes or series of shares or, if none of the shares of a class or series of shares are allotted or issued, eliminate that class or series of shares;

 

 

 

 

(b)

increase, reduce or eliminate the maximum number of shares that the Company is authorized to issue out of any class or series of shares or establish a maximum number of shares that the Company is authorized to issue out of any class or series of shares for which no maximum is established;

 

 

 

 

(c)

if the Company is authorized to issue shares of a class of shares with par value:

 

 

 

 

(i)

decrease the par value of those shares; or

 

 

 

 

(ii)

if none of the shares of that class of shares are allotted or issued, increase the par value of those shares;

 

 

 

 

(d)

alter the identifying name of any of its shares; or

 

 

 

 

(e)

otherwise alter its shares or authorized share structure when required or permitted to do so by the Business Corporations Act.

 

 

 

(2)

by resolution of the directors, subdivide or consolidate all or any of its unissued, or fully paid issued, shares.

 

 

and, if applicable, alter its Notice of Articles and, if applicable, its Articles, accordingly.

 

 

9.2

Special Rights and Restrictions

 

 

Subject to the Business Corporations Act, the Company may by ordinary resolution:

 

 

(1)

create special rights or restrictions for, and attach those special rights or restrictions to, the shares of any class or series of shares, whether or not any or all of those shares have been issued;
  
 
- 9 -

 

  

(2)

vary or delete any special rights or restrictions attached to the shares of any class or series of shares, whether or not any or all of those shares have been issued; or

 

 

(3)

change all or any of its unissued, or fully paid issued, shares with par value into shares without par value or any of its unissued shares without par value into shares with par value.

 

 

and alter its Notice of Articles accordingly.

 

 

9.3

Change of Name

 

 

The Company may by a resolution of the directors authorize an alteration of its Notice of Articles in order to change its name or adopt or change any translation of that name.

 

 

9.4

Other Alterations

 

 

If the Business Corporations Act does not specify the type of resolution and these Articles do not specify another type of resolution, the Company may by ordinary resolution alter these Articles.

 

 

10.

Meetings of Shareholders

 

 

10.1

Annual General Meetings

 

 

Unless an annual general meeting is deferred or waived in accordance with the Business Corporations Act, the Company must hold its first annual general meeting within 18 months after the date on which it was incorporated or otherwise recognized, and after that must hold an annual general meeting at least once in each calendar year and not more than 15 months after the last annual reference date at such time and place as may be determined by the directors.

 

 

10.2

Resolution Instead of Annual General Meeting

 

 

If all the shareholders who are entitled to vote at an annual general meeting consent by a unanimous resolution under the Business Corporations Act to all of the business that is required to be transacted at that annual general meeting, the annual general meeting is deemed to have been held on the date of the unanimous resolution. The shareholders must, in any unanimous resolution passed under this Article 10.2, select as the Company’s annual reference date a date that would be appropriate for the holding of the applicable annual general meeting.

 

 

10.3

Calling of Meetings of Shareholders

 

 

The directors may, whenever they think fit, call a meeting of shareholders.

 

 

10.4

Location of Meetings of Shareholders

 

 

Subject to the Business Corporations Act, a meeting of shareholders may be held in or outside of British Columbia as determined by a resolution of the directors.

  

 
- 10 -

 

  

10.5

Notice for Meetings of Shareholders

 

 

The Company must send notice of the date, time and location of any meeting of shareholders, in the manner provided in these Articles, or in such other manner, if any, as may be prescribed by ordinary resolution (whether previous notice of the resolution has been given or not), to each shareholder entitled to attend the meeting, to each director and to the auditor of the Company, unless these Articles otherwise provide, at least the following number of days before the meeting:

 

 

(1)

if and for so long as the Company is a public company, 21 days;

 

 

(2)

otherwise, 10 days.

 

 

10.6

Record Date for Notice

 

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to notice of any meeting of shareholders. The record date must not precede the date on which the meeting is to be held by more than two months or, in the case of a general meeting requisitioned by shareholders under the Business Corporations Act, by more than four months. The record date must not precede the date on which the meeting is held by fewer than:

 

 

(1)

if and for so long as the Company is a public company, 21 days;

 

 

(2)

otherwise, 10 days.

 

 

If no record date is set, the record date is 5 p.m. on the day immediately preceding the first date on which the notice is sent or, if no notice is sent, the beginning of the meeting.

 

 

10.7

Record Date for Voting

 

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to vote at any meeting of shareholders. The record date must not precede the date on which the meeting is to be held by more than two months or, in the case of a general meeting requisitioned by shareholders under the Business Corporations Act, by more than four months. If no record date is set, the record date is 5 p.m. on the day immediately preceding the first date on which the notice is sent or, if no notice is sent, the beginning of the meeting.

 

 

10.8

Failure to Give Notice and Waiver of Notice

 

 

The accidental omission to send notice of any meeting to, or the non-receipt of any notice by, any of the persons entitled to notice does not invalidate any proceedings at that meeting. Any person entitled to notice of a meeting of shareholders may, in writing or otherwise, waive or reduce the period of notice of such meeting.

 

 

10.9

Notice of Special Business at Meetings of Shareholders

 

 

If a meeting of shareholders is to consider special business within the meaning of Article 11.1, the notice of meeting must:

 

 

(1)

state the general nature of the special business; and

  

 
- 11 -

 

  

(2)

if the special business includes considering, approving, ratifying, adopting or authorizing any document or the signing of or giving of effect to any document, have attached to it a copy of the document or state that a copy of the document will be available for inspection by shareholders:

 

 

 

(a)

at the Company’s records office, or at such other reasonably accessible location in British Columbia as is specified in the notice; and

 

 

 

 

(b)

during statutory business hours on any one or more specified days before the day set for the holding of the meeting.

 

 

 

11.

Proceedings at Meetings of Shareholders

 

 

11.1

Special Business

 

 

At a meeting of shareholders, the following business is special business:

 

 

(1)

at a meeting of shareholders that is not an annual general meeting, all business is special business except business relating to the conduct of or voting at the meeting;

 

 

(2)

at an annual general meeting, all business is special business except for the following:

 

 

 

(a)

business relating to the conduct of or voting at the meeting;

 

 

 

 

(b)

consideration of any financial statements of the Company presented to the meeting;

 

 

 

 

(c)

consideration of any reports of the directors or auditor;

 

 

 

 

(d)

the setting or changing of the number of directors;

 

 

 

 

(e)

the election or appointment of directors;

 

 

 

 

(f)

the appointment of an auditor;

 

 

 

 

(g)

the setting of the remuneration of an auditor;

 

 

 

 

(h)

business arising out of a report of the directors not requiring the passing of a special resolution or an exceptional resolution;

 

 

 

 

(i)

any other business which, under these Articles or the Business Corporations Act, may be transacted at a meeting of shareholders without prior notice of the business being given to the shareholders.

 

 

 

11.2

Special Majority

 

 

 

The majority of votes required for the Company to pass a special resolution at a meeting of shareholders is two-thirds (2/3) of the votes cast on the resolution.

  
 
- 12 -

 

   

11.3

Quorum

 

 

Subject to the special rights and restrictions attached to the shares of any class or series of shares, and Article 11.4, the quorum for the transaction of business at a meeting of shareholders is two persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least 5% of the issued shares entitled to be voted at the meeting.

 

 

11.4

One Shareholder May Constitute Quorum

 

 

If there is only one shareholder entitled to vote at a meeting of shareholders:

 

 

(1)

the quorum is one person who is, or who represents by proxy, that shareholder, and

 

 

(2)

that shareholder, present in person or by proxy, may constitute the meeting.

 

 

11.5

Other Persons May Attend

 

 

In addition to those person who are entitled to vote at a meeting of shareholders, the only other persons entitled to be present at the meeting are the directors, the president (if any), the secretary (if any), the assistant secretary (if any), any lawyer for the Company, the auditor of the Company and any other persons invited to be present at the meeting by the directors or by the chair of the meeting and any persons entitled or required under the Business Corporations Act or these Articles to be present at the meeting; but if any of those persons does attend the meeting, that person is not to be counted in the quorum and is not entitled to vote at the meeting unless that person is a shareholder or proxy holder entitled to vote at the meeting.

 

 

11.6

Requirement of Quorum

 

 

No business, other than the election of a chair of the meeting and the adjournment of the meeting, may be transacted at any meeting of shareholders unless a quorum of shareholders entitled to vote is present at the commencement of the meeting, but such quorum need not be present throughout the meeting.

 

 

11.7

Lack of Quorum

 

 

If, within one-half hour from the time set for the holding of a meeting of shareholders, a quorum is not present:

 

 

(1)

in the case of a general meeting requisitioned by shareholders, the meeting is dissolved, and

 

 

(2)

in the case of any other meeting of shareholders, the meeting stands adjourned to the same day in the next week at the same time and place.

 

 

11.8

Lack of Quorum at Succeeding Meeting

 

 

If, at the meeting to which the meeting referred to in Article 11.7(2) was adjourned, a quorum is not present within one-half hour from the time set for the holding of the meeting, the person or persons present and being, or representing by proxy, one or more shareholders entitled to attend and vote at the meeting constitute a quorum.

  

 
- 13 -

 

  

11.9

Chair

 

 

The following individual is entitled to preside as chair at a meeting of shareholders:

 

 

(1)

the chair of the board, if any;

 

 

(2)

if the chair of the board is absent or unwilling to act as chair of the meeting, the president, if any; or

 

 

(3)

a vice-president, if any.

 

 

11.10

Selection of Alternate Chair

 

 

If, at any meeting of shareholders, there is no chair of the board or president present within 15 minutes after the time set for holding the meeting, or if the chair of the board and the president are unwilling to act as chair of the meeting, or if the chair of the board and the president have advised the secretary, if any, or any director present at the meeting, that they will not be present at the meeting, the directors present must choose one of their number to be chair of the meeting or if all of the directors present decline to take the chair or fail to so choose or if no director is present, the shareholders entitled to vote at the meeting who are present in person or by proxy may choose any person present at the meeting to chair the meeting.

 

 

11.11

Adjournments

 

 

The chair of a meeting of shareholders may, and if so directed by the meeting must, adjourn the meeting from time to time and from place to place, but no business may be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place.

 

 

11.12

Notice of Adjourned Meeting

 

 

It is not necessary to give any notice of an adjourned meeting or of the business to be transacted at an adjourned meeting of shareholders except that, when a meeting is adjourned for 30 days or more, notice of the adjourned meeting must be given as in the case of the original meeting.

 

 

11.13

Decisions by Show of Hands or Poll

 

 

Subject to the Business Corporations Act, every motion put to a vote at a meeting of shareholders will be decided on a show of hands unless a poll, before or on the declaration of the result of the vote by show of hands, is directed by the chair or demanded by at least one shareholder entitled to vote who is present in person or by proxy.

 

 

11.14

Declaration of Result

 

 

The chair of a meeting of shareholders must declare to the meeting the decision on every question in accordance with the result of the show of hands or the poll, as the case may be, and that decision must be entered in the minutes of the meeting. A declaration of the chair that a resolution is carried by the necessary majority or is defeated is, unless a poll is directed by the chair or demanded under Article 11.13, conclusive evidence without proof of the number or proportion of the votes recorded in favour of or against the resolution.

  

 
- 14 -

 

  

11.15

Motion Need Not be Seconded

 

 

No motion proposed at a meeting of shareholders need be seconded unless the chair of the meeting rules otherwise, and the chair of any meeting of shareholders is entitled to propose or second a motion.

 

 

11.16

Casting Vote

 

 

In the case of an equality of votes, the chair of a meeting of shareholders, on a show of hands and on a poll, has a second or casting vote in addition to the vote or votes to which the chair may be entitled as a shareholder.

 

 

11.17

Manner of Taking Poll

 

 

Subject to Article 11.18, if a poll is duly demanded at a meeting of shareholders:

 

 

(1)

the poll must be taken:

  

 

(a)

at the meeting, or within seven days after the date of the meeting, as the chair of the meeting directs; and

 

 

 

 

(b)

in the manner, at the time and at the place that the chair of the meeting directs;

  

(2)

the result of the poll is deemed to be the decision of the meeting at which the poll is demanded; and

 

 

(3)

the demand for the poll may be withdrawn by the person who demanded it.

 

 

11.18

Demand for Poll on Adjournment

 

 

A poll demanded at a meeting of shareholders on a question of adjournment must be taken immediately at the meeting.

 

 

11.19

Chair Must Resolve Dispute

 

 

In the case of any dispute as to the admission or rejection of a vote given on a poll, the chair of the meeting must determine the dispute, and his or her determination made in good faith is final and conclusive.

 

 

11.20

Casting of Votes

 

 

On a poll, a shareholder entitled to more than one vote need not cast all the votes in the same way.

 

 

11.21

No Demand for Poll on Election of Chair

 

 

No poll may be demanded in respect of the vote by which a chair of a meeting of shareholders is elected.

  

 
- 15 -

 

  

11.22

Demand for Poll Not to Prevent Continuance of Meeting

 

 

The demand for a poll at a meeting of shareholders does not, unless the chair of the meeting so rules, prevent the continuation of a meeting for the transaction of any business other than the question on which a poll has been demanded.

 

 

11.23

Retention of Ballots and Proxies

 

 

The Company must, for at least three months after a meeting of shareholders, keep each ballot cast on a poll and each proxy voted at the meeting, and, during that period, make them available for inspection during normal business hours by any shareholder or proxyholder entitled to vote at the meeting. At the end of such three month period, the Company may destroy such ballots and proxies.

 

 

12.

Votes of Shareholders

 

 

12.1

Number of Votes by Shareholder or by Shares

 

 

Subject to any special rights or restrictions attached to any shares and to the restrictions imposed on joint shareholders under Article 12.3:

 

 

(1)

on a vote by show of hands, every person present who is a shareholder or proxy holder and entitled to vote on the matter has one vote; and

 

 

(2)

on a poll, every shareholder entitled to vote on the matter has one vote in respect of each share entitled to be voted on the matter and held by that shareholder and may exercise that vote either in person or by proxy.

 

 

12.2

Votes of Persons in Representative Capacity

 

 

A person who is not a shareholder may vote at a meeting of shareholders, whether on a show of hands or on a poll, and may appoint a proxy holder to act at the meeting, if, before doing so, the person satisfies the chair of the meeting, or the directors, that the person is a legal personal representative or a trustee in bankruptcy for a shareholder who is entitled to vote at the meeting.

 

 

12.3

Votes by Joint Holders

 

 

If there are joint shareholders registered in respect of any share:

 

 

(1)

any one of the joint shareholders may vote at any meeting, either personally or by proxy, in respect of the share as if that joint shareholder were solely entitled to it; or

 

 

(2)

if more than one of the joint shareholders is present at any meeting, personally or by proxy, and more than one of them votes in respect of that share, then only the vote of the joint shareholder present whose name stands first on the central securities register in respect of the share will be counted.

 

 

12.4

Legal Personal Representatives as Joint Shareholders

 

 

Two or more legal personal representatives of a shareholder in whose sole name any share is registered are, for the purposes of Article 12.3, deemed to be joint shareholders.

  

 
- 16 -

 

  

12.5

Representative of a Corporate Shareholder

 

 

If a corporation, that is not a subsidiary of the Company, is a shareholder, that corporation may appoint a person to act as its representative at any meeting of shareholders of the Company, and:

 

 

(1)

for that purpose, the instrument appointing a representative must:

 

 

(a)

be received at the registered office of the Company or at any other place specified, in the notice calling the meeting, for the receipt of proxies, at least the number of business days specified in the notice for the receipt of proxies, or if no number of days is specified, two business days before the day set for the holding of the meeting or any adjourned meeting; or

 

  

 

 

(b)

be provided, at the meeting or any adjourned meeting, to the chair of the meeting or adjourned meeting or to a person designated by the chair of the meeting or adjourned meeting;

  

(2)

if a representative is appointed under this Article 12.5:

  

 

(a)

the representative is entitled to exercise in respect of and at that meeting the same rights on behalf of the corporation that the representative represents as that corporation could exercise if it were a shareholder who is an individual, including, without limitation, the right to appoint a proxy holder; and

 

 

 

 

(b)

the representative, if present at the meeting, is to be counted for the purpose of forming a quorum and is deemed to be a shareholder present in person at the meeting.

  

Evidence of the appointment of any such representative may be sent to the Company by written instrument, fax or any other method of transmitting legibly recorded messages.

  

 

12.6

When Proxy Holder Need Not Be Shareholder

   

 

A person must not be appointed as a proxy holder unless the person is a shareholder, although a person who is not a shareholder may be appointed as a proxy holder if:

 

 

(1)

the person appointing the proxy holder is a corporation or a representative of a corporation appointed under Article 12.5;

 

 

(2)

the Company has at the time of the meeting for which the proxy holder is to be appointed only one shareholder entitled to vote at the meeting;

 

 

(3)

the shareholders present in person or by proxy at and entitled to vote at the meeting for which the proxy holder is to be appointed, by a resolution on which the proxy holder is not entitled to vote but in respect of which the proxy holder is to be counted in the quorum, permit the proxy holder to attend and vote at the meeting; or

 

 

(4)

the Company is a public company, or is a pre‑existing reporting company which has the Statutory Reporting Company Provisions as part of these Articles or to which the Statutory Reporting Company Provisions apply.

  

 
- 17 -

 

  

12.7

Proxy Provisions Do Not Apply to All Companies

 

 

If and for so long as the Company is a public company or a pre‑existing reporting company which has the Statutory Reporting Company Provisions as part of its Articles or to which the Statutory Reporting Company Provisions apply, Articles 12.8 to 12.15 apply only insofar as they are not inconsistent with any Canadian securities legislation applicable to the Company or any U.S. securities legislation applicable to the Company or any rules of an exchange on which securities of the Company are listed.

 

 

12.8

Appointment of Proxy Holders

 

 

Every shareholder of the Company, including a corporation that is a shareholder but not a subsidiary of the Company, entitled to vote at a meeting of shareholders of the Company may, by proxy, appoint one or more (but not more than five) proxy holders to attend and act at the meeting in the manner, to the extent and with the powers conferred by the proxy.

 

 

12.9

Alternate Proxy Holders

 

 

A shareholder may appoint one or more alternate proxy holders to act in the place of an absent proxy holder.

 

 

12.10

Deposit of Proxy

 

 

A proxy for a meeting of shareholders must:

 

 

(1)

be received at the registered office of the Company or at any other place specified, in the notice calling the meeting, for the receipt of proxies, at least the number of business days specified in the notice, or if no number of days is specified, two business days before the day set for the holding of the meeting or any adjourned meeting; or

 

 

(2)

unless the notice provides otherwise, be provided, at the meeting, to the chair of the meeting or to a person designated by the chair of the meeting or adjourned meeting.

 

 

A proxy may be sent to the Company by written instrument, fax or any other method of transmitting legibly recorded messages.

 

 

12.11

Validity of Proxy Vote

 

 

A vote given in accordance with the terms of a proxy is valid notwithstanding the death or incapacity of the shareholder giving the proxy and despite the revocation of the proxy or the revocation of the authority under which the proxy is given, unless notice in writing of that death, incapacity or revocation is received:

 

 

(1)

at the registered office of the Company, at any time up to and including the last business day before the day set for the holding of the meeting at which the proxy is to be used; or

 

 

(2)

at the meeting or any adjourned meeting, by the chair of the meeting or adjourned meeting, before any vote in respect of which the proxy has been given has been taken.

  

 
- 18 -

 

  

12.12

Form of Proxy

  

A proxy, whether for a specified meeting or otherwise, must be either in the following form or in any other form approved by the directors or the chair of the meeting:

 

[name of company]
(the “Company”)

 

The undersigned, being a shareholder of the Company, hereby appoints [name] or, failing that person, [name], as proxy holder for the undersigned to attend, act and vote for and on behalf of the undersigned at the meeting of shareholders of the Company to be held on [month, day, year] and at any adjournment of that meeting.

 

Number of shares in respect of which this proxy is given (if no number is specified, then this proxy if given in respect of all shares registered in the name of the shareholder): ___________________________________

 

 

Signed [month, day, year]

 

 

 

     
[Signature of shareholder]

 

 
   
  [Name of shareholder—printed]  

  

12.13

Revocation of Proxy

 

 

Subject to Article 12.14, every proxy may be revoked by an instrument in writing that is:

 

 

(1)

received at the registered office of the Company at any time up to and including the last business day before the day set for the holding of the meeting or any adjourned meeting at which the proxy is to be used; or

 

 

(2)

provided, at the meeting or any adjourned meeting, by the chair of the meeting or adjourned meeting, before any vote in respect of which the proxy has been taken.

 

 

12.14

Revocation of Proxy Must Be Signed

 

 

An instrument referred to in Article 12.13 must be signed as follows:

 

 

(1)

if the shareholder for whom the proxy holder is appointed is an individual, the instrument must be signed by the shareholder or his or her legal personal representative or trustee in bankruptcy;

 

 

(2)

if the shareholder for whom the proxy holder is appointed is a corporation, the instrument must be signed by the corporation or by a representative appointed for the corporation under Article 12.5.

 

 

12.15

Chair May Determine Validity of Proxy

 

 

The chair of any meeting of shareholders may determine whether or not a proxy deposited for use at the meeting, which may not strictly comply with the requirements of this Part 12 as to form, execution, accompanying documentation, time of filing or otherwise, shall be valid for use at such meeting and any such determination made in good faith shall be final, conclusive and binding upon such meeting.

  

 
- 19 -

 

  

12.16

Production of Evidence of Authority to Vote

 

 

The chair of any meeting of shareholders may, but need not, inquire into the authority of any person to vote at the meeting and may, but need not, demand from that person production of evidence as to the existence of the authority to vote.

 

 

13.

Directors

 

 

13.1

First Directors; Number of Directors

 

 

The first directors are the persons designated as directors of the Company in the Notice of Articles that applies to the Company when it is recognized under the Business Corporations Act. The number of directors, excluding additional directors appointed under Article 14.8, is set at:

 

 

(1)

subject to paragraphs (2) and (3), the number of directors that is equal to the number of the Company’s first directors;

 

 

(2)

if the Company is a public company, the greater of three and the most recently set of:

  

 

(a)

the number of directors set by ordinary resolution (whether or not previous notice of the resolution was given); and

 

 

 

 

(b)

the number of directors set under Article 14.4;

  

(3)

if the Company is not a public company, the most recently set of:

  

 

(a)

the number of directors set by ordinary resolution (whether or not previous notice of the resolution was given); and

 

 

 

 

(b)

the number of directors set under Article 14.4.

  

13.2

Change in Number of Directors

 

 

If the number of directors is set under Articles 13.1(2)(a) or 13.1(3)(a), subject to Article 14.1:

 

 

(1)

the shareholders may elect or appoint the directors needed to fill any vacancies in the board of directors up to that number;

 

 

(2)

if the shareholders do not elect or appoint the directors needed to fill any vacancies in the board of directors up to that number contemporaneously with the setting of that number, then the directors may appoint, subject to Article 14.8, or the shareholders may elect or appoint, directors to fill those vacancies.

 

 

13.3

Directors’ Acts Valid Despite Vacancy

 

 

An act or proceeding of the directors is not invalid merely because fewer than the number of directors set or otherwise required under these Articles is in office.

   

 
- 20 -

 

   

13.4

Qualifications of Directors

   

A director is not required to hold a share in the capital of the Company as qualification for his or her office but must be qualified as required by the Business Corporations Act to become, act or continue to act as a director.

 

 

13.5

Remuneration of Directors

  

 

The directors are entitled to the remuneration for acting as directors, if any, as the directors may from time to time determine. If the directors so decide, the remuneration of the directors, if any, will be determined by the shareholders. That remuneration may be in addition to any salary or other remuneration paid to any officer or employee of the Company as such, who is also a director.

 

 

13.6

Reimbursement of Expenses of Directors

 

 

The Company must reimburse each director for the reasonable expenses that he or she may incur in and about the business of the Company.

 

 

13.7

Special Remuneration for Directors

 

 

If any director performs any professional or other services for the Company that in the opinion of the directors are outside the ordinary duties of a director, or if any director is otherwise specially occupied in or about the Company’s business, he or she may be paid remuneration fixed by the directors, or, at the option of that director, fixed by ordinary resolution, and such remuneration may be either in addition to, or in substitution for, any other remuneration that he or she may be entitled to receive.

 

 

13.8

Gratuity, Pension or Allowance on Retirement of Director

 

 

Unless otherwise determined by ordinary resolution, the directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any director who has held any salaried office or place of profit with the Company or to his or her spouse or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.

 

 

14.

Election and Removal of Directors

 

 

14.1

Election at Annual General Meeting

 

 

(1)

At each annual general meeting of the Company all the directors whose term of office expire at such annual general meeting shall cease to hold office immediately before the election of directors at such annual general meeting and the shareholders entitled to vote thereat shall elect to the board of directors, directors as otherwise permitted by any securities legislation in any province or territory of Canada or in the federal jurisdiction of the United States or in any states of the United States that is applicable to the Company and all regulations and rules made and promulgated under that legislation and all administrative policy statements, blanket orders and rulings, notices and other administrative directions issued by securities commissions or similar authorities appointed under that legislation as set out below. A retiring director shall be eligible for re‑election;

  

 
- 21 -

 

  

(2)

Each director may be elected for a term of office of one or more years of office as may be specified by ordinary resolution at the time he is elected. In the absence of any such ordinary resolution, a director’s term of office shall be one year of office. No director shall be elected for a term of office exceeding five years of office. The shareholders may, by resolution of not less than 3/4 of the votes cast on the resolution vary the term of office of any director; and

 

 

(3)

A director elected or appointed to fill a vacancy shall be elected or appointed for a term expiring immediately before the election of directors at the annual general meeting of the Company when the term of the director whose position he is filling would expire.

 

 

14.2

Consent to be a Director

 

 

No election, appointment or designation of an individual as a director is valid unless:

 

 

(1)

that individual consents to be a director in the manner provided for in the Business Corporations Act;

 

 

(2)

that individual is elected or appointed at a meeting at which the individual is present and the individual does not refuse, at the meeting, to be a director; or

 

 

(3)

with respect to first directors, the designation is otherwise valid under the Business Corporations Act.

 

 

14.3

Failure to Elect or Appoint Directors

 

 

If:

 

 

(1)

the Company fails to hold an annual general meeting, and all the shareholders who are entitled to vote at an annual general meeting fail to pass the unanimous resolution contemplated by Article 10.2, on or before the date by which the annual general meeting is required to be held under the Business Corporations Act; or

 

 

(2)

the shareholders fail, at the annual general meeting or in the unanimous resolution contemplated by Article 10.2, to elect or appoint any directors;

 

 

then each director then in office continues to hold office until the earlier of:

 

 

(3)

the date on which his or her successor is elected or appointed; and

 

 

(4)

the date on which he or she otherwise ceases to hold office under the Business Corporations Act or these Articles.

 

 

14.4

Places of Retiring Directors Not Filled

 

 

If, at any meeting of shareholders at which there should be an election of directors, the places of any of the retiring directors are not filled by that election, those retiring directors who are not re‑elected and who are asked by the newly elected directors to continue in office will, if willing to do so, continue in office to complete the number of directors for the time being set pursuant to these Articles until further new directors are elected at a meeting of shareholders convened for that purpose. If any such election or continuance of directors does not result in the election or continuance of the number of directors for the time being set pursuant to these Articles, the number of directors of the Company is deemed to be set at the number of directors actually elected or continued in office.

  

 
- 22 -

 

  

14.5

Directors May Fill Casual Vacancies

 

 

Any casual vacancy occurring in the board of directors may be filled by the directors.

 

 

14.6

Remaining Directors’ Power to Act

 

 

The directors may act notwithstanding any vacancy in the board of directors, but if the Company has fewer directors in office than the number set pursuant to these Articles as the quorum of directors, the directors may only act for the purpose of appointing directors up to that number or of summoning a meeting of shareholders for the purpose of filling any vacancies on the board of directors or, subject to the Business Corporations Act, for any other purpose.

 

 

14.7

Shareholders May Fill Vacancies

 

 

If the Company has no directors or fewer directors in office than the number set pursuant to these Articles as the quorum of directors, the shareholders may elect or appoint directors to fill any vacancies on the board of directors.

 

 

14.8

Additional Directors

 

 

Notwithstanding Articles 13.1 and 13.2, between annual general meetings or unanimous resolutions contemplated by Article 10.2, the directors may appoint one or more additional directors, but the number of additional directors appointed under this Article 14.8 must not at any time exceed one‑third of the number of the current directors who were elected or appointed as directors other than under this Article 14.8.

 

 

Any director so appointed ceases to hold office immediately before the next election or appointment of directors under Article 14.1(1), but is eligible for re‑election or re‑appointment.

 

 

14.9

Ceasing to be a Director

 

 

A director ceases to be a director when:

 

 

(1)

the term of office of the director expires;

 

 

(2)

the director dies;

 

 

(3)

the director resigns as a director by notice in writing provided to the Company or a lawyer for the Company; or

 

 

(4)

the director is removed from office pursuant to Articles 14.10 or 14.11.

 

 

14.10

Removal of Director by Shareholders

 

 

The Company may remove any director before the expiration of his or her term of office by a resolution of not less than 3/4 of the votes cast on such resolution. In that event, the shareholders may elect, or appoint by ordinary resolution, a director to fill the resulting vacancy. If the shareholders do not elect or appoint a director to fill the resulting vacancy contemporaneously with the removal, then the directors may appoint or the shareholders may elect, or appoint by ordinary resolution, a director to fill that vacancy.

  

 
- 23 -

 

  

14.11

Removal of Director by Directors

 

 

The directors may remove any director before the expiration of his or her term of office if the director is convicted of an indictable offence, or if the director ceases to be qualified to act as a director of a company and does not promptly resign, and the directors may appoint a director to fill the resulting vacancy.

 

 

14.12

Nomination of Directors

 

 

(1)

Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Company. Nominations of persons for election to the board of directors of the Company may be made at any annual meeting of shareholders, or at any special meeting of shareholders if one of the purposes for which the special meeting was called was the election of directors:

 

 

 

(a)

by or at the direction of the board, including pursuant to a notice of meeting;

 

 

 

 

(b)

by or at the direction or request of one or more shareholders pursuant to a “proposal” made in accordance with Division 7 of Part 5 of the Business Corporations Act (British Columbia) (the “Act”), or a requisition of the shareholders made in accordance with section 167 of the Act; or

 

 

 

 

(c)

by any person (a “Nominating Shareholder”): (i) who, at the close of business on the date of the giving by the Nominating Shareholder of the notice provided for below in this Article 14.12 and at the close of business on the record date for notice of such meeting, is entered in the securities register of the Company as a holder of one or more shares carrying the right to vote at such meeting or who beneficially owns shares that are entitled to be voted at such meeting; and (ii) who complies with the notice procedures set forth below in this Article 14.12.

 

 

 

(2)

In addition to any other requirements under applicable laws, for a nomination to be made by a Nominating Shareholder, the Nominating Shareholder must have given notice thereof that is both timely (in accordance with paragraph (3) below) and in proper written form (in accordance with paragraph (4) below) to the Corporate Secretary of the Company at the head office of the Company.

 

 

(3)

To be timely, a Nominating Shareholder’s notice to the Corporate Secretary of the Company must be made:

 

 

 

(a)

in the case of an annual meeting of shareholders, not less than 30 nor more than 65 days prior to the date of the annual meeting of shareholders; provided, however, that in the event that the annual meeting of shareholders is to be held on a date that is less than 50 days after the date (the “Notice Date”) on which the first public announcement of the date of the annual meeting was made, notice by the Nominating Shareholder may be made not later than the close of business on the 10th day following the Notice Date; and
   
 
- 24 -

 

  

 

(b)

in the case of a special meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not called for other purposes), not later than the close of business on the 15th day following the day on which the first public announcement of the date of the special meeting of shareholders was made.

  

 

 

 

The time periods for the giving of a Nominating Shareholder’s notice set forth above shall in all cases be determined based on the original date of the applicable annual meeting or special meeting of shareholders, and in no event shall any adjournment or postponement of a meeting of shareholders or the announcement thereof commence a new time period for the giving of such notice.

   

(4)

To be in proper written form, a Nominating Shareholder’s notice to the Corporate Secretary of the Company must set forth:

   

 

(a)

as to each person whom the Nominating Shareholder proposes to nominate for election as a director: (i) the name, age, business address and residential address of the person; (ii) the present principal occupation, business or employment of the person within the preceding 5 years, as well as the name and principal business of any company in which such employment is carried on; (iii) the citizenship of such person; (iv) the class or series and number of shares in the capital of the Company which are controlled or which are owned beneficially or of record by the person as of the record date for the meeting of shareholders (if such date shall then have been made publicly available and shall have occurred) and as of the date of such notice; (v) confirmation that the person meets the qualifications of directors set out in the Act; and (vi) any other information relating to the person that would be required to be disclosed in a dissident’s proxy circular in connection with solicitations of proxies for election of directors pursuant to the Act and Applicable Securities Laws (as defined below); and

  

 

 

 

(b)

as to the Nominating Shareholder giving the notice, full particulars regarding any proxy, contract, agreement, arrangement or understanding pursuant to which such Nominating Shareholder has a right to vote or direct the voting of any shares of the Company and any other information relating to such Nominating Shareholder that would be required to be made in a dissident’s proxy circular in connection with solicitations of proxies for election of directors pursuant to the Act and Applicable Securities Laws (as defined below).

 

 

 

 

The Company may require any proposed nominee to furnish such other information as may reasonably be required by the Company to determine the eligibility of such proposed nominee to serve as an independent director of the Company or that could be material to a reasonable shareholder’s understanding of the independence, or lack thereof, of such proposed nominee.

   

(5)

No person shall be eligible for election as a director of the Company unless nominated in accordance with the provisions of this Article 14.12; provided, however, that nothing in this Article 14.12 shall be deemed to preclude discussion by a shareholder (as distinct from the nomination of directors) at a meeting of shareholders of any matter that is properly before such meeting pursuant to the provisions of the Act or the discretion of the Chairman. The Chairman of the meeting shall have the power and duty to determine whether a nomination was made in accordance with the procedures set forth in the foregoing provisions and, if any proposed nomination is not in compliance with such foregoing provisions, to declare that such defective nomination shall be disregarded.

  

 
- 25 -

 

   

(6)

For purposes of this Article 14.12:

 

 

 

(a)

Applicable Securities Laws” means the applicable securities legislation of each province and territory of Canada in which the Company is a reporting issuer, as amended from time to time, the rules, regulations and forms made or promulgated under any such statute and the published national instruments, multilateral instruments, policies, bulletins and notices of the securities commission and similar regulatory authority of each province and territory of Canada; and

 

 

 

 

(b)

public announcement” shall mean disclosure in a press release reported by a national news service in Canada, or in a document publicly filed by the Company under its profile on the System of Electronic Document Analysis and Retrieval at www.sedar.com.

 

 

 

(7)

Notwithstanding any other provision of this Article 14.12, notice given to the Corporate Secretary of the Company pursuant to this Article 14.12 may only be given by personal delivery, facsimile transmission or by email (at such email address as may be stipulated from time to time by the Corporate Secretary of the Company for purposes of this notice), and shall be deemed to have been given and made only at the time it is served by personal delivery to the Corporate Secretary at the address of the head office of the Company, email (at the address as aforesaid) or sent by facsimile transmission (provided that receipt of confirmation of such transmission has been received); provided that if such delivery or electronic communication is made on a day which is a not a business day or later than 5:00 p.m. (Vancouver time) on a day which is a business day, then such delivery or electronic communication shall be deemed to have been made on the next following day that is a business day.

 

 

(8)

Notwithstanding the foregoing, the board may, in its sole discretion, waive any requirement in this Article 14.12.

 

 

15.

Alternate Directors

 

 

15.1

Appointment of Alternate Director

 

 

Any director (an “appointor”) may by notice in writing received by the Company appoint any person (an “appointee”) who is qualified to act as a director to be his or her alternate to act in his or her place at meetings of the directors or committees of the directors at which the appointor is not present unless (in the case of an appointee who is not a director) the directors have reasonably disapproved the appointment of such person as an alternate director and have given notice to that effect to his or her appointor within a reasonable time after the notice of appointment is received by the Company. Every alternate director shall have a direct and personal duty to the Company arising from his alternate directorship, independent of the duties of the director who appointed him.

   
 
- 26 -

 

  

15.2

Notice of Meetings

 

 

Every alternate director so appointed is entitled to notice of meetings of the directors and of committees of the directors of which his or her appointor is a member and to attend and vote as a director at any such meetings at which his or her appointor is not present.

 

 

15.3

Alternate for More Than One Director Attending Meetings

 

 

A

person may be appointed as an alternate director by more than one director, and an alternate director:

 

 

(1)

will be counted in determining the quorum for a meeting of directors once for each of his or her appointors and, in the case of an appointee who is also a director, once more in that capacity;

 

 

(2)

has a separate vote at a meeting of directors for each of his or her appointors and, in the case of an appointee who is also a director, an additional vote in that capacity;

 

 

(3)

will be counted in determining the quorum for a meeting of a committee of directors once for each of his or her appointors who is a member of that committee and, in the case of an appointee who is also a member of that committee as a director, once more in that capacity;

 

 

(4)

has a separate vote at a meeting of a committee of directors for each of his or her appointors who is a member of that committee and, in the case of an appointee who is also a member of that committee as a director, an additional vote in that capacity.

 

 

15.4

Consent Resolutions

 

 

Every alternate director, if authorized by the notice appointing him or her, may sign in place of his or her appointor any resolutions to be consented to in writing.

 

 

15.5

Alternate Director Not an Agent

 

 

Every alternate director is deemed not to be the agent of his or her appointor and shall be deemed not to have any conflict arising out of any interest, property or office held by the appointor. An alternate director shall be deemed to be a director for all purposes of these Articles, with full power to act as a director, subject to any limitations in the instrument appointing him, and an alternate director shall be entitled to all of the indemnities and similar protections afforded directors by the Business Corporations Act and under these Articles. A director shall have no liability arising out of any act or omission by his alternate director to which the appointor was not a party, nor shall an alternate director have liability for any such act or omission by the appointor. Without limiting the foregoing, no duty to account to the Company shall be imposed upon an alternate director merely because he voted in respect of a contract or transaction in which the appointor was interested or which the appointor failed to disclose, nor shall any such duty be imposed upon an appointor merely because he voted in respect of a contract or transaction in which his alternate director was interested or which such alternate director failed to disclose.

  

 
- 27 -

 

  

15.6

Revocation of Appointment of Alternate Director

 

 

An appointor may at any time, by notice in writing received by the Company, revoke the appointment of an alternate director appointed by him or her.

 

 

15.7

Ceasing to be an Alternate Director

 

 

The appointment of an alternate director ceases when:

 

 

(1)

his or her appointor ceases to be a director and is not promptly re-elected or re-appointed;

 

 

(2)

the alternate director dies;

 

 

(3)

the alternate director resigns as an alternate director by notice in writing provided to the Company or a lawyer for the Company;

 

 

(4)

the alternate director ceases to be qualified to act as a director; or

 

 

(5)

his or her appointor revokes the appointment of the alternate director.

 

 

15.8

Remuneration and Expenses of Alternate Director

 

 

The Company may reimburse an alternate director for the reasonable expenses that would be properly reimbursed if he or she were a director, and the alternate director is entitled to receive from the Company such proportion, if any, of the remuneration otherwise payable to the appointor as the appointor may from time to time direct.

 

 

16.

Powers and Duties of Directors

 

 

16.1

Powers of Management

 

 

The directors must, subject to the Business Corporations Act and these Articles, manage or supervise the management of the business and affairs of the Company and have the authority to exercise all such powers of the Company as are not, by the Business Corporations Act or by these Articles, required to be exercised by the shareholders of the Company.

 

 

16.2

Appointment of Attorney of Company

 

 

The directors may from time to time, by power of attorney or other instrument, under seal if so required by law, appoint any person to be the attorney of the Company for such purposes, and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the directors under these Articles and excepting the power to fill vacancies in the board of directors, to remove a director, to change the membership of, or fill vacancies in, any committee of the directors, to appoint or remove officers appointed by the directors and to declare dividends) and for such period, and with such remuneration and subject to such conditions as the directors may think fit. Any such power of attorney may contain such provisions for the protection or convenience of persons dealing with such attorney as the directors think fit. Any such attorney may be authorized by the directors to sub‑delegate all or any of the powers, authorities and discretions for the time being vested in him or her.

  

 
- 28 -

 

  

16.3

Remuneration of Auditor

 

 

The

directors may set the remuneration of the auditor of the Company.

 

 

17.

Interests of Directors and Officers

 

 

17.1

Obligation to Account for Profits

 

 

A director or senior officer who holds a disclosable interest (as that term is used in the Business Corporations Act) in a contract or transaction into which the Company has entered or proposes to enter is liable to account to the Company for any profit that accrues to the director or senior officer under or as a result of the contract or transaction only if and to the extent provided in the Business Corporations Act.

 

 

17.2

Restrictions on Voting by Reason of Interest

 

 

A director who holds a disclosable interest in a contract or transaction into which the Company has entered or proposes to enter is not entitled to vote on any directors’ resolution to approve that contract or transaction, unless all the directors have a disclosable interest in that contract or transaction, in which case any or all of those directors may vote on such resolution.

 

 

17.3

Interested Director Counted in Quorum

 

 

A director who holds a disclosable interest in a contract or transaction into which the Company has entered or proposes to enter and who is present at the meeting of directors at which the contract or transaction is considered for approval may be counted in the quorum at the meeting whether or not the director votes on any or all of the resolutions considered at the meeting.

 

 

17.4

Disclosure of Conflict of Interest or Property

 

 

A director or senior officer who holds any office or possesses any property, right or interest that could result, directly or indirectly, in the creation of a duty or interest that materially conflicts with that individual’s duty or interest as a director or senior officer, must disclose the nature and extent of the conflict as required by the Business Corporations Act.

 

 

17.5

Director Holding Other Office in the Company

 

 

A director may hold any office or place of profit with the Company, other than the office of auditor of the Company, in addition to his or her office of director for the period and on the terms (as to remuneration or otherwise) that the directors may determine.

 

 

17.6

No Disqualification

 

 

No director or intended director is disqualified by his or her office from contracting with the Company either with regard to the holding of any office or place of profit the director holds with the Company or as vendor, purchaser or otherwise, and no contract or transaction entered into by or on behalf of the Company in which a director is in any way interested is liable to be voided for that reason.

  

 
- 29 -

 

  

17.7

Professional Services by Director or Officer

 

 

Subject to the Business Corporations Act, a director or officer, or any person in which a director or officer has an interest, may act in a professional capacity for the Company, except as auditor of the Company, and the director or officer or such person is entitled to remuneration for professional services as if that director or officer were not a director or officer.

 

 

17.8

Director or Officer in Other Corporations

 

 

A director or officer may be or become a director, officer or employee of, or otherwise interested in, any person in which the Company may be interested as a shareholder or otherwise, and, subject to the Business Corporations Act, the director or officer is not accountable to the Company for any remuneration or other benefits received by him or her as director, officer or employee of, or from his or her interest in, such other person.

 

 

18.

Proceedings of Directors

 

 

18.1

Meetings of Directors

 

 

The directors may meet together for the conduct of business, adjourn and otherwise regulate their meetings as they think fit, and meetings of the directors held at regular intervals may be held at the place, at the time and on the notice, if any, as the directors may from time to time determine.

 

 

18.2

Voting at Meetings

 

 

Questions arising at any meeting of directors are to be decided by a majority of votes and, in the case of an equality of votes, the chair of the meeting does not have a second or casting vote.

 

 

18.3

Chair of Meetings

 

 

The following individual is entitled to preside as chair at a meeting of directors:

 

 

(1)

the chair of the board, if any;

 

 

(2)

in the absence of the chair of the board, the president, if any, if the president is a director; or

 

 

(3)

any other director chosen by the directors if:

 

 

 

(a)

neither the chair of the board nor the president, if a director, is present at the meeting within 15 minutes after the time set for holding the meeting;

 

 

 

 

(b)

neither the chair of the board nor the president, if a director, is willing to chair the meeting; or

 

 

 

 

(c)

the chair of the board and the president, if a director, have advised the secretary, if any, or any other director, that they will not be present at the meeting.
  
 
- 30 -

 

  

18.4

Meetings by Telephone or Other Communications Medium

 

 

A director may participate in a meeting of the directors or of any committee of the directors in person or by telephone if all directors participating in the meeting, whether in person or by telephone or other communications medium, are able to communicate with each other. A director may participate in a meeting of the directors or of any committee of the directors by a communications medium other than telephone if all directors participating in the meeting, whether in person or by telephone or other communications medium, are able to communicate with each other and if all directors who wish to participate in the meeting agree to such participation. A director who participates in a meeting in a manner contemplated by this Article 18.4 is deemed for all purposes of the Business Corporations Act and these Articles to be present at the meeting and to have agreed to participate in that manner.

 

 

18.5

Calling of Meetings

 

 

A director may, and the secretary or an assistant secretary of the Company, if any, on the request of a director must, call a meeting of the directors at any time.

 

 

18.6

Notice of Meetings

 

 

Other than for meetings held at regular intervals as determined by the directors pursuant to Article 18.1, or as provided in Article 18.7, reasonable notice of each meeting of the directors, specifying the place, day and time of that meeting must be given to each of the directors and the alternate directors by any method set out in Article 24.1 or orally or by telephone.

 

 

18.7

When Notice Not Required

 

 

It is not necessary to give notice of a meeting of the directors to a director or an alternate director if:

 

 

(1)

the meeting is to be held immediately following a meeting of shareholders at which that director was elected or appointed, or is the meeting of the directors at which that director is appointed;

 

 

(2)

the director or alternate director, as the case may be, has waived notice of the meeting; or

 

 

(3)

the director or alternate director, as the case may be, is not, at the time, in the province of British Columbia.

 

 

18.8

Meeting Valid Despite Failure to Give Notice

 

 

The accidental omission to give notice of any meeting of directors to, or the non-receipt of any notice by, any director or alternate director, does not invalidate any proceedings at that meeting.

 

 

18.9

Waiver of Notice of Meetings

 

 

Any director or alternate director may send to the Company a document signed by him or her waiving notice of any past, present or future meeting or meetings of the directors and may at any time withdraw that waiver with respect to meetings held after that withdrawal. After sending a waiver with respect to all future meetings and until that waiver is withdrawn, no notice of any meeting of the directors need be given to that director and, unless the director otherwise requires by notice in writing to the Company, to his or her alternate director, and all meetings of the directors so held are deemed not to be improperly called or constituted by reason of notice not having been given to such director or alternate director.

  

 
- 31 -

 

  

18.10

Quorum

 

 

The quorum necessary for the transaction of the business of the directors may be set by the directors and, if not so set, is deemed to be set at two directors or, if the number of directors is set at one, is deemed to be set at one director, and that director may constitute a meeting.

 

 

18.11

Validity of Acts Where Appointment Defective

 

 

Subject to the Business Corporations Act, an act of a director or officer is not invalid merely because of an irregularity in the election or appointment or a defect in the qualification of that director or officer.

 

 

18.12

Consent Resolutions in Writing

 

 

A resolution of the directors or of any committee of the directors may be passed without a meeting:

 

 

(1)

in all cases, if each of the directors entitled to vote on the resolution consents to it in writing; or

 

 

(2)

in the case of a resolution to approve a contract or transaction in respect of which a director has disclosed that he or she has or may have a disclosable interest, if each of the other directors who are entitled to vote on the resolution consent to it in writing.

 

 

A consent in writing under this Article may be by signed document, fax, email or any other method of transmitting legibly recorded messages. A consent in writing may be in two or more counterparts which together are deemed to constitute one consent in writing. A resolution of the directors or of any committee of the directors passed in accordance with this Article 18.12 is effective on the date stated in the consent in writing or on the latest date stated on any counterpart and is deemed to be a proceeding at a meeting of directors or of the committee of the directors and to be as valid and effective as if it had been passed at a meeting of the directors or of the committee of the directors that satisfies all the requirements of the Business Corporations Act and all the requirements of these Articles relating to meetings of the directors or of a committee of the directors.

 

 

19.

Executive and Other Committees

 

 

19.1

Appointment and Powers of Executive Committee

 

 

The directors may, by resolution, appoint an executive committee consisting of the director or directors that they consider appropriate, and this committee has, during the intervals between meetings of the board of directors, all of the directors’ powers, except:

 

 

(1)

the power to fill vacancies in the board of directors;

 

 

(2)

the power to remove a director;

  

 
- 32 -

 

  

(3)

the power to change the membership of, or fill vacancies in, any committee of the directors; and

 

 

(4)

such other powers, if any, as may be set out in the resolution or any subsequent directors’ resolution.

 

 

19.2

Appointment and Powers of Other Committees

 

 

The directors may, by resolution:

 

 

(1)

appoint one or more committees (other than the executive committee) consisting of the director or directors that they consider appropriate;

 

 

(2)

delegate to a committee appointed under paragraph (1) any of the directors’ powers, except:

  

 

(a)

the power to fill vacancies in the board of directors;

 

 

 

 

(b)

the power to remove a director;

 

 

 

 

(c)

the power to change the membership of, or fill vacancies in, any committee of the directors; and

 

 

 

 

(d)

the power to appoint or remove officers appointed by the directors; and

  

(3)

make any delegation referred to in paragraph (2) subject to the conditions set out in the resolution or any subsequent directors’ resolution.

 

 

19.3

Obligations of Committees

 

 

Any committee appointed under Articles 19.1 or 19.2, in the exercise of the powers delegated to it, must:

 

 

(1)

conform to any rules that may from time to time be imposed on it by the directors; and

 

 

(2)

report every act or thing done in exercise of those powers at such times as the directors may require.

 

 

19.4

Powers of Board

 

 

The directors may, at any time, with respect to a committee appointed under Articles 19.1 or 19.2:

 

 

(1)

revoke or alter the authority given to the committee, or override a decision made by the committee, except as to acts done before such revocation, alteration or overriding;

 

 

(2)

terminate the appointment of, or change the membership of, the committee; and

 

 

(3)

fill vacancies in the committee.

  

 
- 33 -

 

  

19.5

Committee Meetings

 

 

Subject to Article 19.3(1) and unless the directors otherwise provide in the resolution appointing the committee or in any subsequent resolution, with respect to a committee appointed under Articles 19.1 or 19.2:

 

 

(1)

the committee may meet and adjourn as it thinks proper;

 

 

(2)

the committee may elect a chair of its meetings but, if no chair of a meeting is elected, or if at a meeting the chair of the meeting is not present within 15 minutes after the time set for holding the meeting, the directors present who are members of the committee may choose one of their number to chair the meeting;

 

 

(3)

a majority of the members of the committee constitutes a quorum of the committee; and

 

 

(4)

questions arising at any meeting of the committee are determined by a majority of votes of the members present, and in case of an equality of votes, the chair of the meeting does not have a second or casting vote.

 

 

20.

Officers

 

 

20.1

Directors May Appoint Officers

 

 

The directors may, from time to time, appoint such officers, if any, as the directors determine and the directors may, at any time, terminate any such appointment.

 

 

20.2

Functions, Duties and Powers of Officers

 

 

The directors may, for each officer:

 

 

(1)

determine the functions and duties of the officer;

 

 

(2)

entrust to and confer on the officer any of the powers exercisable by the directors on such terms and conditions and with such restrictions as the directors think fit; and

 

 

(3)

revoke, withdraw, alter or vary all or any of the functions, duties and powers of the officer.

 

 

20.3

Qualifications

 

 

No officer may be appointed unless that officer is qualified in accordance with the Business Corporations Act. One person may hold more than one position as an officer of the Company. Any person appointed as the chair of the board or as the managing director must be a director. Any other officer need not be a director.

 

 

20.4

Remuneration and Terms of Appointment

 

 

All appointments of officers are to be made on the terms and conditions and at the remuneration (whether by way of salary, fee, commission, participation in profits or otherwise) that the directors think fit and are subject to termination at the pleasure of the directors, and an officer may in addition to such remuneration be entitled to receive, after he or she ceases to hold such office or leaves the employment of the Company, a pension or gratuity.

  

 
- 34 -

 

  

21.

Indemnification

 

 

21.1

Definitions

 

 

In this Article 21:

 

 

(1)

eligible penalty” means a judgment, penalty or fine awarded or imposed in, or an amount paid in settlement of, an eligible proceeding;

 

 

(2)

eligible proceeding” means a legal proceeding or investigative action, whether current, threatened, pending or completed, in which a director, former director or alternate director of the Company (an “eligible party”) or any of the heirs and legal personal representatives of the eligible party, by reason of the eligible party being or having been a director or alternate director of the Company:

  

 

(a)

is or may be joined as a party; or

 

 

 

 

(b)

is or may be liable for or in respect of a judgment, penalty or fine in, or expenses related to, the proceeding;

  

(3)

“expenses” has the meaning set out in the Business Corporations Act.

 

 

21.2

Mandatory Indemnification of Directors and Former Directors

 

 

Subject to the Business Corporations Act, the Company must indemnify a director, former director or alternate director of the Company and his or her heirs and legal personal representatives against all eligible penalties to which such person is or may be liable, and the Company must, after the final disposition of an eligible proceeding, pay the expenses actually and reasonably incurred by such person in respect of that proceeding. Each director and alternate director is deemed to have contracted with the Company on the terms of the indemnity contained in this Article 21.2.

 

 

21.3

Indemnification of Other Persons

 

 

Subject to any restrictions in the Business Corporations Act, the Company may indemnify any person.

 

 

21.4

Non-Compliance with Business Corporations Act

 

 

The

failure of a director, alternate director or officer of the Company to comply with the Business Corporations Act or these Articles does not invalidate any indemnity to which he or she is entitled under this Part.

 

 

21.5

Company May Purchase Insurance

 

 

The Company may purchase and maintain insurance for the benefit of any person (or his or her heirs or legal personal representatives) who:

  

 
- 35 -

 

  

(1)

is or was a director, alternate director, officer, employee or agent of the Company;

 

 

(2)

is or was a director, alternate director, officer, employee or agent of a corporation at a time when the corporation is or was an affiliate of the Company;

 

 

(3)

at the request of the Company, is or was a director, alternate director, officer, employee or agent of a corporation or of a partnership, trust, joint venture or other unincorporated entity;

 

 

(4)

at the request of the Company, holds or held a position equivalent to that of a director, alternate director or officer of a partnership, trust, joint venture or other unincorporated entity;

 

 

against any liability incurred by him or her as such director, alternate director, officer, employee or agent or person who holds or held such equivalent position.

 

 

22.

Dividends

 

 

22.1

Payment of Dividends Subject to Special Rights

 

 

The provisions of this Article 22 are subject to the rights, if any, of shareholders holding shares with special rights as to dividends.

 

 

22.2

Declaration of Dividends

 

 

Subject to the Business Corporations Act, the directors may from time to time declare and authorize payment of such dividends as they may deem advisable.

 

 

22.3

No Notice Required

 

 

The directors need not give notice to any shareholder of any declaration under Article 22.2.

 

 

22.4

Record Date

 

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to receive payment of a dividend. The record date must not precede the date on which the dividend is to be paid by more than two months. If no record date is set, the record date is 5 p.m. on the date on which the directors pass the resolution declaring the dividend.

 

 

22.5

Manner of Paying Dividend

 

 

A resolution declaring a dividend may direct payment of the dividend wholly or partly by the distribution of specific assets or of fully paid shares or of bonds, debentures or other securities of the Company, or in any one or more of those ways.

 

 

22.6

Settlement of Difficulties

 

 

If any difficulty arises in regard to a distribution under Article 22.5, the directors may settle the difficulty as they deem advisable, and, in particular, may:

 

 

(1)

set the value for distribution of specific assets;

  

 
- 36 -

 

  

(2)

determine that cash payments in substitution for all or any part of the specific assets to which any shareholders are entitled may be made to any shareholders on the basis of the value so fixed in order to adjust the rights of all parties; and

 

 

(3)

vest any such specific assets in trustees for the persons entitled to the dividend.

 

 

22.7

When Dividend Payable

 

 

Any dividend may be made payable on such date as is fixed by the directors.

 

 

22.8

Dividends to be Paid in Accordance with Number of Shares

 

 

All dividends on shares of any class or series of shares must be declared and paid according to the number of such shares held.

 

 

22.9

Receipt by Joint Shareholders

 

 

If several persons are joint shareholders of any share, any one of them may give an effective receipt for any dividend, bonus or other money payable in respect of the share.

 

 

22.10

Dividend Bears No Interest

 

 

No dividend bears interest against the Company.

 

 

22.11

Fractional Dividends

 

 

If a dividend to which a shareholder is entitled includes a fraction of the smallest monetary unit of the currency of the dividend, that fraction may be disregarded in making payment of the dividend and that payment represents full payment of the dividend.

 

 

22.12

Payment of Dividends

 

 

Any dividend or other distribution payable in cash in respect of shares may be paid by cheque, made payable to the order of the person to whom it is sent, and mailed to the address of the shareholder, or in the case of joint shareholders, to the address of the joint shareholder who is first named on the central securities register, or to the person and to the address the shareholder or joint shareholders may direct in writing. The mailing of such cheque will, to the extent of the sum represented by the cheque (plus the amount of the tax required by law to be deducted), discharge all liability for the dividend unless such cheque is not paid on presentation or the amount of tax so deducted is not paid to the appropriate taxing authority.

 

 

22.13

Capitalization of Retained Earnings or Surplus

 

 

Notwithstanding anything contained in these Articles, the directors may from time to time capitalize any retained earnings or surplus of the Company and may from time to time issue, as fully paid, shares or any bonds, debentures or other securities of the Company as a dividend representing the retained earnings or surplus or any part of the retained earnings or surplus so capitalized or any part thereof.

  

 
- 37 -

 

  

23.

Documents, Records and Reports

 

 

23.1

Recording of Financial Affairs

 

 

The directors must cause adequate accounting records to be kept to record properly the financial affairs and condition of the Company and to comply with the Business Corporations Act.

 

 

23.2

Inspection of Accounting Records

 

 

Unless the directors determine otherwise, or unless otherwise determined by ordinary resolution, no shareholder of the Company is entitled to inspect or obtain a copy of any accounting records of the Company.

 

 

24.

Notices

 

 

24.1

Method of Giving Notice

 

 

Unless the Business Corporations Act or these Articles provides otherwise, a notice, statement, report or other record required or permitted by the Business Corporations Act or these Articles to be sent by or to a person may be sent by any one of the following methods:

 

 

(1)

mail addressed to the person at the applicable address for that person as follows:

  

 

(a)

for a record mailed to a shareholder, the shareholder’s registered address;

 

 

 

 

(b)

for a record mailed to a director or officer, the prescribed address for mailing shown for the director or officer in the records kept by the Company or the mailing address provided by the recipient for the sending of that record or records of that class;

 

 

 

 

(c)

in any other case, the mailing address of the intended recipient;

  

(2)

delivery at the applicable address for that person as follows, addressed to the person:

  

 

(a)

for a record delivered to a shareholder, the shareholder’s registered address;

 

 

 

 

(b)

for a record delivered to a director or officer, the prescribed address for delivery shown for the director or officer in the records kept by the Company or the delivery address provided by the recipient for the sending of that record or records of that class;

 

 

 

 

(c)

in any other case, the delivery address of the intended recipient;

  

(3)

sending the record by fax to the fax number provided by the intended recipient for the sending of that record or records of that class;

 

 

(4)

sending the record by email to the email address provided by the intended recipient for the sending of that record or records of that class;

 

 

(5)

physical delivery to the intended recipient; or

 

 

(6)

as otherwise permitted by any securities legislation in any province or territory of Canada or in the federal jurisdiction of the United States or in any states of the United States that is applicable to the Company and all regulations and rules made and promulgated under that legislation and all administrative policy statements, blanket orders and rulings, notices and other administrative directions issued by securities commissions or similar authorities appointed under that legislation.

  

 
- 38 -

 

  

24.2

Deemed Receipt of Mailing

 

 

A notice, statement, report or other record that is:

 

 

(1)

mailed to a person by ordinary mail to the applicable address for that person referred to in Article 24.1 is deemed to be received by the person to whom it was mailed on the day (Saturdays, Sundays and holidays excepted) following the date of mailing;

 

 

(2)

faxed to a person to the fax number provided by that person referred to in Article 24.1 is deemed to be received by the person to whom it was faxed on the day it was faxed; and

 

 

(3)

emailed to a person to the email address provided by that person referred to in Article 24.1 is deemed to be received by the person to whom it was emailed on the day it was emailed.

 

 

24.3

Certificate of Sending

 

 

A certificate signed by the secretary, if any, or other officer of the Company or of any other corporation acting in that capacity on behalf of the Company stating that a notice, statement, report or other record was addressed as required by Article 24.1, prepaid and mailed or otherwise sent as permitted by Article 24.1 is conclusive evidence of that fact.

 

 

24.4

Notice to Joint Shareholders

 

 

A notice, statement, report or other record may be provided by the Company to the joint shareholders of a share by providing the notice to the joint shareholder first named in the central securities register in respect of the share.

 

 

24.5

Notice to Trustees

 

 

A notice, statement, report or other record may be provided by the Company to the persons entitled to a share in consequence of the death, bankruptcy or incapacity of a shareholder by:

 

 

(1)

mailing the record, addressed to them:

  

 

(a)

by name, by the title of the legal personal representative of the deceased or incapacitated shareholder, by the title of trustee of the bankrupt shareholder or by any similar description; and

 

 

 

 

(b)

at the address, if any, supplied to the Company for that purpose by the persons claiming to be so entitled; or

  

 
- 39 -

 

  

(2)

if an address referred to in paragraph (1)(b) has not been supplied to the Company, by giving the notice in a manner in which it might have been given if the death, bankruptcy or incapacity had not occurred.

 

 

24.6

Undelivered Notices

 

 

If on two consecutive occasions, a notice, statement, report or other record is sent to a shareholder pursuant to Article 24.1 and on each of those occasions any such record is returned because the shareholder cannot be located, the Company shall not be required to send any further records to the shareholder until the shareholder informs the Company in writing of his or her new address.

 

 

25.

Seal

 

 

25.1

Who May Attest Seal

 

 

Except as provided in Articles 25.2 and 25.3, the Company’s seal, if any, must not be impressed on any record except when that impression is attested by the signatures of:

 

 

(1)

any two directors;

 

 

(2)

any officer, together with any director;

 

 

(3)

if the Company only has one director, that director; or

 

 

(4)

any one or more directors or officers or persons as may be determined by the directors.

 

 

25.2

Sealing Copies

 

 

For the purpose of certifying under seal a certificate of incumbency of the directors or officers of the Company or a true copy of any resolution or other document, despite Article 25.1, the impression of the seal may be attested by the signature of any director or officer or the signature of any other person as may be determined by the directors.

 

 

25.3

Mechanical Reproduction of Seal

 

 

The directors may authorize the seal to be impressed by third parties on share certificates or bonds, debentures or other securities of the Company as they may determine appropriate from time to time. To enable the seal to be impressed on any share certificates or bonds, debentures or other securities of the Company, whether in definitive or interim form, on which facsimiles of any of the signatures of the directors or officers of the Company are, in accordance with the Business Corporations Act or these Articles, printed or otherwise mechanically reproduced, there may be delivered to the person employed to engrave, lithograph or print such definitive or interim share certificates or bonds, debentures or other securities one or more unmounted dies reproducing the seal and the chair of the board or any senior officer together with the secretary, treasurer, secretary-treasurer, an assistant secretary, an assistant treasurer or an assistant secretary-treasurer may in writing authorize such person to cause the seal to be impressed on such definitive or interim share certificates or bonds, debentures or other securities by the use of such dies. Share certificates or bonds, debentures or other securities to which the seal has been so impressed are for all purposes deemed to be under and to bear the seal impressed on them.

  

 
- 40 -

 

  

26.

Prohibitions

 

 

26.1

Definitions

 

 

In this Part 26:

 

 

(1)

security” has the meaning assigned in the Securities Act (British Columbia);

 

 

(2)

transfer restricted security” means:

  

 

(a)

a share of the Company;

 

 

 

 

(b)

a security of the Company convertible into shares of the Company;

 

 

 

 

(c)

any other security of the Company which must be subject to restrictions on transfer in order for the Company to satisfy the requirement for restrictions on transfer under the “private issuer” exemption of Canadian securities legislation or under any other exemption from prospectus or registration requirements of Canadian securities legislation similar in scope and purpose to the “private issuer” exemption.

  

26.2

Application

 

 

Article 26.3 does not apply to the Company if and for so long as it is a public company or a pre-existing reporting company which has the Statutory Reporting Company Provisions as part of these Articles or to which the Statutory Reporting Company Provisions apply.

 

 

26.3

Consent Required for Transfer of Shares or Transfer Restricted Securities

 

 

No share or other transfer restricted security may be sold, transferred or otherwise disposed of without the consent of the directors and the directors are not required to give any reason for refusing to consent to any such sale, transfer or other disposition.

 

 

27.

Special Rights And Restrictions – Common Shares

 

 

The

Common Shares without par value in the authorized share structure of the Company (“Common Shares”) have attached to them the special rights and restrictions set out in this Part 27.

 

 

27.1

Voting Rights

 

 

Except as required by law or by these Articles, the holders of the Common Shares, as such, are entitled to receive notice of every meeting of shareholders of the Company and are entitled to vote at those meetings in person or by proxy.

 

 

27.2

Dividends

 

 

(1)

Except as otherwise provided in these Articles, the holders of the Common Shares, as such, are entitled to receive on the date fixed for payment, and the Company will pay, such dividends as the directors may in their sole and absolute discretion declare from time to time.

   

 
- 41 -

 

  

(2)

Except as otherwise provided in these Articles, the directors may, in their sole and absolute discretion, at any time:

  

 

(a)

declare and pay, or set apart for payment, a dividend on the Common Shares independently of any dividend on, and without also declaring or paying or setting apart for payment any dividend (whether or not of a similar amount or similar kind) on, any one or more other classes of shares in the Company; and

 

 

 

 

(b)

declare and pay, or set apart for payment, dividends on shares of any one or more classes of shares in the Company other than the Common Shares independently of any dividend on, and without also declaring or paying or setting apart for payment any dividend (whether or not of a similar amount or similar kind) on, the Common Shares.

  

27.3

Winding Up

 

 

In the event of the liquidation or dissolution of the Company, or of any distribution of property and assets of the Company among its shareholders for the purpose of winding up its affairs, the holders of the Common Shares, as such, will, subject to the rights of the holders of the Preferred Shares and any other class of shares in the Company entitled to receive property and assets of the Company upon such a distribution in priority to the holders of the Common Shares and any other class of shares in the Company ranking pari passu with the Common Shares on a liquidation, dissolution or winding up, as such, on a share‑for‑share basis, in all remaining property and assets of the Company.

 

 

28.

Special Rights And Restrictions – Preferred

 

 

The Preferred Shares without par value in the authorized share structure of the Company (“Preferred Shares”) have attached to them the special rights and restrictions set out in this Part 28.

 

 

28.1

Preferred Share – Series Shares

 

 

(1)

The Directors of the Company may issue the Preferred shares at any time and from time to time in one or more series.

 

 

(2)

Subject to the Business Corporations Act, the directors may from time to time, by resolution, if none of the Preferred Shares of any particular series are issued, alter these Articles and authorize the alteration of the Notice of Articles of the Company, as the case may be, to do one or more of:

  

 

(a)

determine the maximum number of shares of that series that the Company is authorized to issue, determine that there is no such maximum number, or alter any such determination;

 

 

 

 

(b)

create an identifying name for the shares of that series, or alter any such identifying name; and

  

 
- 42 -

 

  

 

(c)

attach special rights or restrictions to the shares of that series, including, but without limiting or restricting the generality of the foregoing, the rate or amount of dividends (whether cumulative, non-cumulative or partially cumulative), the dates and places of payment thereof, the consideration for, and the terms and conditions, of, any purchase for cancellation or redemption thereof (including redemption after a fixed term or at a premium), conversion or exchange rights, the terms and conditions of any share purchase plan or sinking fund, restrictions respecting payment of dividends on, or the repayment of capital in respect of, any other shares of the Company and voting rights and restrictions; or alter any such special rights or restrictions, but no such special right or restriction shall contravene the provisions of Article 28.2 and Article 28.3 of this Article 28.

     

28.2

Winding Up

 

 

The holders of Preferred Shares shall be entitled, on the liquidation or dissolution of the Company, whether voluntary or involuntary, or on any other distribution of its assets among its shareholders for the purpose of winding up its affairs, to receive, before any distribution is made to the holders of the Common Shares or any other shares of the company ranking junior to the Preferred Shares with respect to repayment with respect to repayment of capital on the liquidation or dissolution of the Company, whether voluntary or involuntary, or on any other distribution of its assets among its shareholders for the purpose of winding up its affairs, the amount paid up with respect to each Preferred Share held by them, together with the fixed premium (if any) thereon, all accrued and unpaid cumulative dividends (if any and if preferential) thereon, which for such purpose shall be calculated as if such dividends were accruing on a day-to-day basis up to the date of such distribution, whether or not earned or declared, and all declared and unpaid non-cumulative dividends (if any and if preferential) thereon. After payment to the holders of Preferred Shares of the amounts so payable to them, they shall not, as such, be entitled to share in any further distribution of the property or assets of the Company except as specifically provided in the special rights and restrictions attached to any particular series.

 

 

28.3

Dividends/Voting

 

 

Except for such rights relating to the election of directors on a default in payment of dividends as may be attached to any series of the Preferred Shares by the directors, holders of the Preferred Shares shall not be entitled, as such, to receive notice of, or to attend or vote at, any general meeting of shareholders of the company.

 

 

Under the Business Corporation Act and the Articles of the Company, a simple majority of the votes cast at the meeting (in person or by proxy) is required to pass the foregoing resolution.

  

 
- 43 -

 

EXHIBIT 2.3

 

 

 

 

EXHIBIT 2.4

 

 

 

 

EXHIBIT 4.3

 

INDEMNITY AGREEMENT

 

THIS INDEMNITY AGREEMENT is dated                                        , 20__.

 

BETWEEN:

 

DRAGANFLY INC., a company existing under the laws of British Columbia

 

(the “Company”)

 

- and -

 

[] of []

 

(the “Indemnified Party”)

 

Context

 

A.

The Company is a company governed by the Act.

 

 

B.

The Indemnified Party has, at the request of the Company, accepted the position of director of the Company and may, at the request of the Company, accept the position of officer of the Company or act as a director or officer, or act in an equivalent capacity, of one or more Associated Corporations.

 

 

C.

The articles of the Company provide that the Company will indemnify a director or officer in certain circumstances.

  

THEREFORE, the Parties agree as follows:

 

1.

Definitions

  

In this Agreement, in addition to terms defined elsewhere in this Agreement, the following terms have the following meanings:

 

1.1

Act” means the Business Corporations Act (British Columbia).

 

 

1.2

Agreement” means this agreement, as it may be confirmed, amended, modified, supplemented or restated by written agreement between the Parties.

 

 

1.3

Associated Corporation” means:

  

 

1.3.1

a corporation of which the Indemnified Party is or was a director or officer at a time when that corporation is or was an affiliate of the Company;

 

 

 

 

1.3.2

any other corporation of which the Indemnified Party is or was a director or officer at the request of the Company; and

 

 

 

 

1.3.3

any other partnership, trust, joint venture or other unincorporated entity for which the Indemnified Party is or was a director or officer, or holds or held a position equivalent to director or officer, at the request of the Company.

 

 

 

   

1.4

Business Day” means any day other than a Saturday, Sunday or statutory holiday in the Province of British Columbia.

 

 

1.5

Company” is defined in the recital of the Parties above.

 

 

1.6

Derivative Action” means an Eligible Proceeding by or on behalf of the Company or any Associated Corporation brought against the Indemnified Party.

 

 

1.7

Eligible Penalty” means a judgment, penalty or fine awarded or imposed in, or an amount paid in settlement of, an Eligible Proceeding.

 

 

1.8

Eligible Proceeding” means any legal proceeding or investigative action, whether current, threatened, pending or completed, in which the Indemnified Party or any of the heirs and personal or other legal representatives of the Indemnified Party:

 

 

1.8.1

is or may be joined as a party; or

 

 

 

 

1.8.2

is or may be liable for or in respect of a judgment, penalty or fine in, or expenses related to, that legal proceeding or investigative action,

 

 

 

 

by reason of the Indemnified Party being or having been a director or officer of, or holding or having held a position equivalent to that of a director or officer of, the Company or any Associated Corporation, and includes any action to establish a right to indemnification under this Agreement.

  

1.9

Expenses” includes costs, charges and expenses, including legal and other fees, but does not include judgments, penalties, fines or amounts paid in settlement of a proceeding.

 

 

1.10

Indemnified Party” is defined in the recital of the Parties above.

 

 

1.11

Parties” means the Company and the Indemnified Party collectively, and “Party” means any one of them.

 

2.

General Indemnity

 

Subject to Sections 3, 6, and 7, the Company, to the extent permitted by law, indemnifies the Indemnified Party from and against all Eligible Penalties and all Expenses actually and reasonably incurred by the Indemnified Party in respect of any Eligible Proceeding.

 

3.

Indemnification in Derivative Actions

  

In respect of any Derivative Action, the Company will, at the Indemnified Party’s request, apply at the Company’s own expense to a court of competent jurisdiction for approval to indemnify the Indemnified Party against all Eligible Penalties and all Expenses actually and reasonably incurred by the Indemnified Party in connection with that Derivative Action, as well as for approval to advance money to the Indemnified Party under Section 4.

 

 
- 2 -

 

  

4.

Advance of Expenses

  

Subject to Sections 6 and 7, the Company will, prior to the final disposition of an Eligible Proceeding, advance moneys to the Indemnified Party:

 

4.1

for the Expenses referred to in Section 2, provided that at the time of the advance of those Expenses, the Company does not have reasonable grounds to believe that the Indemnified Party has not met the conditions of Section 6.1; and

 

 

4.2

for the Expenses referred to in Section 3, provided the Company receives the approval of a court of competent jurisdiction as contemplated by Section 3.

  

It will not be necessary for the Indemnified Party to pay those Expenses and then seek reimbursement; the Indemnified Party may provide invoices, bills and statements of account for those Expenses to the Company for direct payment by the Company, and the Company will pay those amounts.

 

5.

Scope and Survival

  

This Agreement will:

 

5.1

have effect as of the first date that the Indemnified Party acted for the Company or any Associated Corporation in an Indemnified Capacity; and

 

 

5.2

survive any resignation by the Indemnified Party from any Indemnified Capacity, and any other circumstance by reason of which the Indemnified Party will cease to act in an Indemnified Capacity.

  

6.

Limitation

  

6.1

The Company will not indemnify the Indemnified Party under this Agreement unless the Indemnified Party:

  

 

6.1.1

in relation to the subject matter of the Eligible Proceeding, acted honestly and in good faith with a view to the best interests of the Company or of the Associated Corporation, as the case may be; and

 

 

 

 

6.1.2

in the case of an Eligible Proceeding other than a civil proceeding, had reasonable grounds for believing that the Indemnified Party’s conduct in respect of which the Eligible Proceeding was brought was lawful.

  

6.2

The Company will not indemnify the Indemnified Party under this Agreement for:

  

 

6.2.1

any Eligible Penalties or Expenses incurred in the course of any action or other proceeding initiated by the Indemnified Party with respect to any claim the Indemnified Party has against the Company or any Associated Corporation;

 

 

 

 

6.2.2

any Eligible Penalties or Expenses related to any action or proceeding initiated by the Indemnified Party against any other person or entity unless the Company or Associated Corporation has joined with the Indemnified Party in, or consented to, the initiation of that action or proceeding;

 

 

 

 

6.2.3

any Eligible Penalties or Expenses related to claims by the Company or Associated Corporation for the forfeiture and recovery by the Company or Associated Corporation, as applicable, of bonuses or other compensation received by the Indemnified Party from the Company or Associated Corporation due to the Indemnified Party’s violation of applicable securities laws or other laws.

 

 
- 3 -

 

   

7.

Repayment of Indemnification Payments

  

7.1

If, at the conclusion of any Eligible Proceeding with respect to which indemnification is provided under this Agreement:

  

 

7.1.1

there is a final judicial or quasi-judicial determination establishing that the Indemnified Party has not fulfilled the conditions of Section 6.1 in respect of any amounts advanced or paid by the Company; or

 

 

 

 

7.1.2

the payment of any amounts advanced or paid by the Company is otherwise prohibited by section 163 of the Act;

 

 

 

 

the Indemnified Party undertakes to pay, and will pay, those amounts to the Company.

  

7.2

If the Indemnified Party receives indemnification or reimbursement from a source other than the Company for all or part of any Eligible Penalties or Expenses already advanced or paid by the Company to the Indemnified Party, then the amount received by the Indemnified Party from that other source will be paid by the Indemnified Party to the Company.

 

 

7.3

The Indemnified Party will repay to the Company all advances of Eligible Penalties or Expenses under this Agreement not actually required or used by the Indemnified Party.

 

 

7.4

All amounts payable by the Indemnified Party to the Company under this Agreement will be paid within 30 Business Days of the Company’s written request for payment and will bear interest after their due date until paid in full at the variable annual interest rate announced and adjusted from time to time by Bank of Montreal as its reference rate for determining interest rates on Canadian dollar commercial loans made by it in Canada, and which it may refer to as its “prime rate” or “prime lending rate”, plus 2%.

  

8.

General

 

 

 

Entire Agreement. This Agreement constitutes the entire agreement between the Parties pertaining to the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, of the Parties and there are no representations, warranties or other agreements between the Parties in connection with the subject matter of this Agreement except as specifically set out in this Agreement.  No Party has been induced to enter into this Agreement in reliance on, and there will be no liability assessed, either in tort or contract, with respect to, any warranty, representation, opinion, advice or assertion of fact, except to the extent it has been reduced to writing and included as a term in this Agreement.

  

8.1

Notice of a Claim. Promptly, and in any event no later than ten Business Days after receipt by the Indemnified Party of a written notice of a claim or threatened claim against it which may result in a demand for indemnification under this Agreement, the Indemnified Party will give written notice to the Company of the claim or threatened claim. A notice delivered under this Section will include a description of the claim or threatened claim, a summary of the facts giving rise to the claim or threatened claim and, if possible, an estimate of any potential liability arising under the claim or threatened claim. Failure by the Indemnified Party to notify the Company of any claim or threatened claim will not relieve the Company from its obligations under this Agreement or otherwise limit its liability, except to the extent that the claim includes legal proceedings and the failure of the Indemnified Party to notify the Company within the required time limits prejudices the defence of the claim.

 

 
- 4 -

 

 

8.2

Notices. Any notice or other communication required or permitted by this agreement to be given or made to a party must be in writing and either delivered personally or by courier, sent by prepaid registered mail, or transmitted by e-mail to that party addressed as follows:

 

to the Corporation at:

 

Draganfly Inc.

550 Burrard Street

Suite 2300, Bentall 5

Vancouver, British Columbia

V6B 2B5

 

Attention:        

E-mail:            

 

with a copy to:

 

Gowling WLG (Canada) LLP

550 Burrard Street

Suite 2300, Bentall 5

Vancouver, British Columbia

V6C 2B5

 

Attention:         Denis Silva

E-mail:                denis.silva@gowlingwlg.com

 

to the Indemnified Party at:

 

[]

 

E-mail:

[]

 

or at any other address as any party may at any time advise the other by notice in writing given in accordance with this Section 8.2. Any notice or other communication delivered to the party to whom it is addressed will be deemed to have been given and received on the day it is delivered at that party’s address, provided that if that day is not a Business Day or if it is received after 5:00 p.m. (local time of the recipient) then the notice or other communication will be deemed to have been given and received on the next Business Day. Any notice or other communication sent by prepaid registered mail will be deemed to have been given and received on the fifth Business Day after which it is mailed. If a strike or lockout of postal employees is then in effect, or generally known to be impending, every notice or other communication must be delivered personally, by courier or transmitted by e-mail. Any notice or communication transmitted by e-mail will be deemed to have been given and received on the day on which it is transmitted; but if the notice or communication is transmitted on a day which is not a Business Day or after 5:00 p.m. (local time of the recipient), it will be deemed to have been given and received on the next Business Day.

 

8.3

Headings. The division of this Agreement into sections and subsections and the insertion of headings are for convenience of reference only and will not affect the construction or interpretation of this Agreement.

 

 
- 5 -

 

  

8.4

References. References in this Agreement to a section, subsection or paragraph are to be construed as references to a section, subsection or paragraph of this Agreement unless the context requires otherwise.

 

 

8.5

Successors and Assigns. This Agreement and the rights and obligations under it are not assignable by either Party without the prior written consent of the other Party.

 

 

8.6

Enurement. This Agreement will enure to the benefit of and be binding upon the Parties and their respective heirs, legal representatives, successors and permitted assigns.

 

 

8.7

Severability. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction will not invalidate the remaining provisions of this Agreement, and any such invalid or unenforceable provision will be deemed to be severed. The prohibition against or unenforceability of a provision in one jurisdiction will not invalidate that provision or render it unenforceable in any other jurisdiction.

 

 

8.8

Further Assurances. The Parties will, with reasonable diligence, do all things and provide all reasonable assurances as may be required to, and each Party will provide any further documents or instruments required by the other Party as may be reasonably necessary or desirable to, give effect to this Agreement and carry out its provisions.

 

 

8.9

Governing Law. This Agreement is governed by, and is to be construed in accordance with, the laws of the Province of British Columbia and the laws of Canada applicable in that Province.

 

 

8.10

Counterparts. This Agreement may be executed by the Parties in one or more counterparts, each of which when so executed and delivered will be an original, and those counterparts together will constitute one and the same instrument. Delivery of this Agreement by e-mail constitutes valid and effective delivery.

 

 

8.11

Acknowledgement—Independent Legal Advice. Each Party acknowledges that it has:

  

 

8.11.1

had the opportunity to receive independent legal advice from its own lawyers with respect to the terms of this Agreement before its execution;

 

 

 

 

8.11.2

read this Agreement, understands it, and agrees to be bound by its terms and conditions; and

 

 

 

 

8.11.3

received a copy of this Agreement.

  

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

 

 
- 6 -

 

 

Each of the Parties has executed and delivered this Agreement as of the date noted at the beginning of the Agreement.

 

 

 

DRAGANFLY INC.

       
Per: 

 

Name:

 
  Title:  
       

 

 

 

 

[]

 

 

 

 

- 7 -

 

EXHIBIT 4.1

 

DRAGANFLY INC. SUBSCRIBER QUESTIONNAIRE

 

In connection with subscribing for the securities (the “Securities”) issued by Draganfly Inc., a company incorporated under the laws of the Province of British Columbia, Canada (the “Company”), please complete the following Subscriber Questionnaire. The Company intends to use the proceeds of this offering for a variety of uses including without limitation research and development expenses, offering expenses, working capital and general corporate purposes as further described in the offering circular pursuant to which the Securities are being offered under Regulation A (“Regulation A”) under the Securities Act of 1933 (“Securities Act”) in effect as of the date hereof (the “Offering Circular”). The potential subscriber in the Securities shall be referred to in this Agreement as the “Subscriber.” This Subscriber Questionnaire should be completed either by the Subscriber or, if the Subscriber is an entity, by an authorized representative of the Subscriber.

 

The Subscriber Questionnaire and the Subscription Agreement are collectively referred to as the “Agreement.” If the Subscriber Questionnaire indicates that any Subscriber’s response to a question requires further information, the Subscriber should contact the Company as soon as possible. Subscribers must complete and return all other additional required documentation, including an IRS Form W-9.

 

1.

U.S., Canadian or Other Foreign Person or Entity Status.

  

 

I represent and warrant that the “U.S. Subscriber” is a United States citizen or resident or a corporation, partnership, limited liability company, trust, or equivalent legal entity organized under the laws of any state of the United States.

 

 

 

 

I represent and warrant that the “Canadian Subscriber” is a Canadian citizen or resident or a corporation, partnership, limited liability company, trust, or equivalent legal entity organized under the laws of any province or territory of Canada.

 

 

 

 

I represent and warrant that the “International Subscriber” is neither a United States nor Canadian citizen or resident, corporation, partnership, limited liability company, trust, or equivalent legal entity organized under the laws of any state of the United States or province or territory of Canada.

  

2.

Accredited Investor or Qualified Purchaser Status.

  

To invest in this offering, the Subscriber must either be an “accredited investor,” within the meaning of Rule 501(a) under the Securities Act, or the Subscriber must be a “qualified purchaser,” within the meaning of Regulation A under the Securities Act or the Subscriber must be an “accredited investor,” as defined in National Instrument 45-106 Prospectus Exemptions of the Canadian Securities Administrators (“NI 45-106”) under Canadian securities laws.

 

 

U.S. Accredited Investor Status. I represent and warrant that the Subscriber is an “accredited investor,” within the meaning of Rule 501(a) under the Securities Act.

 

 

 

 

Canadian Accredited Investor Status. I represent and warrant that the Subscriber is an “accredited investor,” as defined in NI 45-106.

  

 

If you are a Canadian “accredited investor”:

 

 

 

 

a.

complete and sign the Accredited Investor Certificate attached as Schedule A to Annex 1 of the Subscription Agreement and,

 

 

 

 

b.

if you are an individual relying on category (j), (k) or (l) of the Accredited Investor Certificate (and do not meet the higher financial asset threshold set out in paragraph (j.1) of the Accredited Investor Certificate), complete and sign the Form 45 106F9 – Form for Individual Accredited Investors attached as Schedule A-1 to Annex 1 of the Subscription Agreement.

  

 

 

  

 

Qualified Purchaser Status. I represent and warrant that the Subscriber is a “qualified purchaser,” as defined in Regulation A of the Securities Act, based on the fact that either:

  

 

a.

I am the Subscriber and I am a natural person. I am not investing more than the greater of either 10% of my net worth1 or 10% of my annual income2; or

 

 

 

 

b.

The Subscriber is not a natural person, and the Subscriber is not investing more than the greater of the following, as calculated for the most recently completed fiscal year end:

  

 

(a)

10% of the Subscriber’s revenue; or

 

 

 

 

(b)

10% of the Subscriber’s net assets.

  

3.

ERISA.

 

Benefit Plan Investor Status. I represent and warrant that the Subscriber is not, and neither I nor the Subscriber is acting (directly or indirectly) on behalf of, any of the following:

 

☐ An employee benefit plan (within the meaning of Section 3(3) of the Employee Retirement Income Security Act (“ERISA”)), whether or not the plan is subject to Title I of ERISA; a plan, individual retirement account or other arrangement that is subject to Section 4975 of the Internal Revenue Code (“Code”); a “benefit plan investor” within the meaning of 29 C.F.R. Section 2510.3-101; a “governmental plan” within the meaning of Section 3(32) of ERISA; or a person that is deemed to hold “plan assets” under the ERISA plan assets regulations, and consequently subject to regulation under ERISA.

 

☐ An entity 25% or more of the value of any class of equity of which is held by entities described in the paragraph above; provided that for purposes of making the determination, the value of any equity interest held by a person (other than an entity described in the beginning of this item) who has discretionary authority or control with respect to the assets of the entity or a person who provides investment advice for a fee (direct or indirect) with respect to those assets, or any affiliate of that person, will be disregarded.

 

☐ A “benefit plan investor” based on the immediately preceding item, that is subject to Title I of ERISA or Section 4975 of the Code.

 

4.

Additional Information.

  

  BY PURCHASING THE SECURITIES, THE SUBSCRIBER EXPRESSLY ACKNOWLEDGES AND ASSUMES THESE RISKS.

 

☐ The Subscriber acknowledges that the Subscription Information has been prepared without taking into account the Subscriber’s objectives, financial situation, or needs, or those of any other person. The Subscriber acknowledges that it is recommended that the Subscriber seek independent legal, financial, accounting, and taxation advice before making a decision to acquire, subscribe for, or purchase the Securities.

 

_________________

1 For purposes of this paragraph, “net worth” must be calculated as set forth in Rule 501(a) under the Securities Act of 1933, as amended. In general, “net worth” means the excess of total assets at fair market value over total liabilities. For the purposes of determining “net worth,” the primary residence owned by an individual shall be excluded as an asset. Any liabilities secured by the primary residence should be included in total liabilities only if and to the extent that: (1) such liabilities exceed the fair market value of the residence; or (2) such liabilities were incurred within 60 days before the sale of the Securities (other than as a result of the acquisition of the primary residence).

 

2 For purposes of this paragraph, “annual income” must be calculated as set forth in Rule 501(a) under the Securities Act of 1933, as amended, which requires natural persons to consider their income in the two most recent years and a reasonable expectation of income for the current year.

 

 

 

  

☐ The Subscriber agrees that at any time in the future at which the Subscriber may acquire the Securities, the Subscriber shall be deemed to have reaffirmed, as of the date of acquisition of the Securities, each and every representation and warranty made by the Subscriber in this Agreement or any other instrument provided by the Subscriber to the Company in connection with that acquisition, except to the extent modified in writing by the Subscriber and consented to by the Company.

 

☐ The Subscriber agrees on behalf of the Subscriber and the Subscriber’s successors and assigns, without further consideration, to prepare, execute, acknowledge, file, record, publish and deliver any other instruments, documents and statements and to take any other actions as the Company may determine to be necessary or appropriate to comply with applicable law and to effectuate and carry out the purposes of this Agreement. The Subscriber further agrees that the Company may, in its sole discretion, refuse to sell me a Security if, among other things, the Subscriber refuses to comply with this provision.

 

5.

Review of Subscription Information.

  

☐ The Subscriber acknowledges and agrees that the Subscriber has received, and should read and carefully review, the following documents (collectively, the “Subscription Information”) in connection with submitting this Subscriber Questionnaire:

 

 

a.

The Offering Circular;

 

 

 

 

b.

All exhibits to the offering circular, including all “testing the waters” materials filed therewith in compliance with Rule 255 under the Securities Act; and

 

 

 

 

c.

This Agreement, which sets forth the terms governing my subscription to the Securities, and sets forth certain representations I am making in connection with my subscription to the Securities.

  

6.

Subscriber Information.

  

Signatory name:

   

Signatory title (if applicable):

    

Entity address:

Entity Name:

   

E-Mail Address:

  

 

Aggregate Investment (USD value):

 

 

 

Price per Unit in general sale:

$ [●]

 

 

Price per Common Share underlying Warrant in general sale:

$ [●]

 

 

Payment Method (USD):

 

 

 

  

 

I represent and warrant to the Company that the answers provided in this Subscriber Questionnaire are current, true, correct and complete and may be relied upon by the Company and its respective affiliates in evaluating my eligibility, or the eligibility of the entity that I represent, as a Subscriber and determining whether to accept this Agreement. I will notify the Company of any change to the information provided in this Subscriber Questionnaire promptly, but in any event within fifteen days of such change.

 

 

 

 

I agree to be bound (or, if I am an authorized representative of the Subscriber, I agree that the Subscriber will be bound) by any affirmation, assent or agreement that I transmit to or through this website by computer or other electronic device, including internet, telephonic and wireless devices, including, but not limited to, any consent I give to receive communications from the Company or any of its affiliates solely through electronic transmission. I agree that when I click on an “I Agree,” “I Consent” or other similarly worded button or entry field with my mouse, keystroke or other device, my agreement or consent will be legally binding and enforceable against me (or, if I am an authorized representative of the Subscriber, against the Subscriber) and will be the legal equivalent of my handwritten signature on an agreement that is printed on paper. I agree that the Company and any of their affiliates will send me electronic copies of any and all communications associated with my subscription to the Securities, as provided in Section 6 of this Subscriber Questionnaire and Section 11 below of the Subscription Agreement.

 

 

 

 

I represent and warrant to the Company that all questions and responses provided by the Subscriber in the course of completing the “purchase flow” process, including without limitation, the information reflected in this Subscriber Questionnaire, as well as Subscriber’s contact information, address, and account information, Subscriber’s social security number if Subscriber is a natural person, and, if Subscriber is an entity, Subscriber’s tax identification number and whether Subscriber is an S Corporation, C Corporation, Grantor Trust, Limited Partnership, General Partnership, Limited Liability Partnership, Limited Liability Company, Estate, or other type of entity, is current, true, correct and complete and may be relied upon by the Company and its respective affiliates. I will notify the Company of any change to this information promptly, but in any event within fifteen days of such change.

  

7.

Insider or Registrant of the Company.

  

The Subscriber is either:

 

an “insider” as such term is defined in the Securities Act (British Columbia)3;

 

 

a “registrant” as such term is defined in the Securities Act (British Columbia); or

 

 

is not an “insider” nor a “registrant”.

  

______________________

3 As set out in the Securities Act (British Columbia), “insider” means:

 

(a) a director or an officer of an issuer,

(b) a director or an officer of a person that is itself an insider or a subsidiary of an issuer,

(c) a person that has

(i) beneficial ownership of, or control or direction over, directly or indirectly, or

(ii) a combination of beneficial ownership of, and control or direction over, directly or indirectly,

securities of an issuer carrying more than 10% of the voting rights attached to all the issuer's outstanding voting securities, excluding, for the purpose of the calculation of the percentage held, any securities held by the person as underwriter in the course of a distribution,

(d) an issuer that has purchased, redeemed or otherwise acquired a security of its own issue, for so long as it continues to hold that security,

(e) a person designated as an insider in an order made under section 3.2, or

(f) a person that is in a prescribed class of persons.

   

 

 

 

8.

Present Ownership of Securities.

  

The Subscriber either:

 

owns directly or indirectly, or exercises control or direction over, no Common Shares or securities convertible into Common Shares; or

 

 

owns directly or indirectly, or exercises control or direction over, ________________ Common Shares and convertible securities entitling the Subscriber to acquire an additional ________________ Common Shares.

 

 

 

 

 

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATUTES OR REGULATIONS OF NON-U.S. JURISDICTIONS OR ANY STATE SECURITIES OR BLUE SKY LAWS, AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND APPLICABLE STATE SECURITIES OR BLUE SKY LAWS. ALTHOUGH AN OFFERING CIRCULAR ON FORM 1-A FOR A TIER II OFFERING HAS BEEN FILED AND QUALIFIED WITH THE SECURITIES AND EXCHANGE COMMISSION, THAT OFFERING STATEMENT DOES NOT INCLUDE THE SAME INFORMATION THAT WOULD BE INCLUDED IN A REGISTRATION STATEMENT UNDER THE ACT.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement (the “Agreement”) applies to the initial subscription to the Units (defined hereunder) and the Common Shares underlying the Warrants (each as defined hereunder), issued by Draganfly Inc., a company incorporated under the laws of British Columbia, Canada (the “Company”) and is made and entered into by and between the undersigned (the “Subscriber”) and the Company. Subject to the terms and conditions provided in this Agreement, and to the terms of the other Subscriber Agreements, as defined below, the Subscriber wishes to irrevocably subscribe for and purchase (subject to acceptance of such subscription by the Company) certain Securities (as defined below), as set forth in Section 1, offered pursuant to the offering circular with respect to the offer and sale of the Securities in effect and filed with the Securities and Exchange Commission (“SEC”) under Regulation A (“Regulation A”) under the Securities Act of 1933, as amended (“Securities Act”) as of the date hereof (the “Offering Circular”). Each “Unit” of securities is comprised of [●] common share[s] in the capital of the Company, with no par value per share (a “Common Share”), and [●] Common Share purchase warrant (each whole warrant, a “Warrant”), attached hereto as Exhibit A, to purchase [●] additional Common Shares (a “Warrant Share”) at an exercise price of $[●] USD per Warrant Share, subject to certain adjustments, over an [●]-month exercise period following the date of issuance of the Warrant. The Units and the Common Shares underlying the Warrants are collectively referenced herein as the “Securities”. Each Unit is being offered at a purchase price of $[●] USD per Unit on a “best efforts” basis and each Common Share underlying a Warrant is being offered at a purchase price of $[●] USD.

 

A. The Company is a company incorporated under the laws of the Province of British Columbia, Canada.

 

B. The offering of the Securities (the “Offering”) is described in the Offering Circular that is available through the online website platform located at www.draganfly.com (the “Site”), which is owned and operated by the Company, as well as on the SEC EDGAR website and the SEDAR website. It is the responsibility of the Subscriber to read the Offering Circular and all other Subscription Information (defined below). While these documents are subject to change, the Company advises the Subscriber to print and retain a copy of these documents for the Subscriber’s records. By signing this Agreement electronically, Subscriber agrees to be bound by the terms of the Subscriber Agreements, as defined below, with respect to Subscriber’s subscription to the Securities, and Subscriber agrees that by signing this Agreement electronically, Subscriber is also deemed to have signed each of the remaining Subscriber Agreements, to consent to the Company’s Privacy Notice, and to agree to transact business with the Company and to receive communications relating to the Securities electronically.

 

C. The Subscriber hereby represents that he, she or it is (i) either (1) a United States citizen or resident or a corporation, partnership, limited liability company, trust, or equivalent legal entity organized under the laws of any state of the United States, (2) a Canadian citizen or resident or a corporation, partnership, limited liability company, trust, or equivalent legal entity organized under the laws of any province or territory of Canada, or (3) neither a United States nor Canadian citizen or resident or a corporation, partnership, limited liability company, trust, or equivalent legal entity organized under the laws of any state of the United States or any province or territory of Canada; and (ii) is either (1) an “accredited investor,” as that term is defined under Regulation D under the Securities Act, (2) is a “qualified purchaser,” as that term is defined under Regulation A under the Securities Act, or (3) is an “accredited investor,” as defined in NI 45-106.

 

D. Except as the context otherwise requires, any reference in this Agreement to:

 

1. “Subscription Information” shall mean collectively:

 

a. The Subscriber Agreements;

 

 

 

  

b. The Offering Circular;

 

c. All exhibits to the offering circular, including all “testing the waters” materials filed therewith in compliance with Rule 255 under the Securities Act; and

 

2. “Draganfly Parties” shall mean the Company and any of its affiliates, and each of their respective directors, managers, officers, shareholders, members, partners, employees or agents.

 

3. “Subscriber” shall mean the natural person (whether individually or jointly with another person) or entity subscribing for the Securities and also includes the Canadian Subscriber and the International Subscriber unless otherwise indicated.

 

4. “Subscriber Agreements” shall mean collectively:

 

a. The questions and responses provided by the Subscriber in the course of completing the “invest flow” process, including without limitation the account information questionnaire, on the Site (the “Subscriber Questionnaire”);

 

b. The terms of use for the website operated by the Company located at www.draganfly.com (the “Terms of Use”); and

 

c. This Agreement, which sets forth the terms governing a subscription to the Securities, and sets forth certain representations made in connection with a subscription to the Securities.

 

SUBSCRIBER’S REPRESENTATIONS, WARRANTIES AND COVENANTS

 

1. Subscription for and Purchase of the Securities

  

1.1 Subject to the express terms and conditions of this Agreement, the Subscriber hereby irrevocably subscribes for and agrees to purchase the Securities (the “Purchase”) in the amount of the purchase price (the “Purchase Price”) set forth in the Subscriber Questionnaire.

 

1.2 The Subscriber must initially purchase at least the minimum number of Securities established by the Company as specified in the Offering Circular. There is no minimum subscription requirement on additional purchases once the Subscriber has purchased this minimum number of Securities.

 

1.3 Once the Subscriber’s subscription to purchase the Securities is accepted by the Company (as evidenced by the Company’s counter signature to this Agreement), the commitment is irrevocable (except pursuant to Section 16 herein) until the Securities are issued, the Purchase is rejected by the Company, or the Company otherwise determines not to consummate the transaction.

 

1.4 The Company has the right to reject this Agreement in whole or in part for any reason. Once the Agreement is accepted by the Company, the Subscriber may not cancel, terminate or revoke this Agreement (except pursuant to Section 16 herein), which, in the case of an individual, shall survive his death or disability and shall be binding upon the Subscriber, his heirs, trustees, beneficiaries, executors, personal or legal administrators or representatives, successors, transferees and assigns.

 

1.5 The Purchase Price for the Securities shall be paid concurrently with the electronic execution and delivery to the Company of this Subscription Agreement. Subscriber shall deliver the Purchase Price to the Company, in accordance with the instructions set forth in the Subscriber Questionnaire. The Subscriber understands that the Company will not accept this Agreement until the full amount of the Purchase Price has been delivered to the Company.

 

1.6 If this Agreement is accepted by the Company, the Subscriber agrees to comply fully with the terms of the Subscriber Agreements. The Subscriber further agrees to execute any other necessary documents or instruments in connection with this subscription and the Subscriber’s purchase of the Securities.

 

 

 

  

1.7 Subscriber understands and acknowledges that the Purchase Price for the Securities will be immediately available to the Company acceptance of the subscription by the Company. If this Agreement is accepted by the Company, the Subscriber hereby authorizes the Company to utilize the cash proceeds in the Company’s sole discretion in accordance with the use of proceeds provided in the Offering Circular (the “Closing”).

 

1.8 In the event that (i) this Agreement is rejected in full or (ii) this Agreement is terminated in accordance with Section 16 following its acceptance (in full or in part), the Company will direct any payment made by the Subscriber to the Company for the Securities that has not previously been refunded to be refunded to the Subscriber by the Company without interest and without deduction, and all of the obligations of the Subscriber hereunder shall terminate. To the extent that this Agreement is rejected in part, the Company shall refund to the Subscriber any payment made by the Subscriber to the Company with respect to the rejected portion of this subscription without interest and without deduction, and all of the obligations of Subscriber hereunder shall remain in full force and effect except for those obligations with respect to the rejected portion of this subscription, which shall terminate.

 

1.9 Upon acceptance of this Agreement by the Company and payment of the Purchase Price by the Subscriber and receipt of the Purchase Price by the Company, the Company agrees to deliver the Securities to the Subscriber at the Closing as described in the Offering Circular, subject to the terms of this Agreement, and in all cases understanding that the Company has full discretion to accept or reject this Agreement at any time prior to Closing.

 

2. Subscriber’s Review of Information and Subscription Decision.

 

2.1 The Subscriber acknowledges and understands that it is solely the Subscriber’s responsibility to read the Subscription Information and make a determination to subscribe to the Securities. The Subscriber and/or the Subscriber’s advisers, who are not affiliated with and not compensated directly or indirectly by any of the Draganfly Parties, have such knowledge and experience in business and financial matters as will enable them to utilize the information which they have received in connection with the Company and its business to evaluate the merits and risks of a subscription, to make an informed decision and to protect Subscriber’s own interests in connection with the Purchase. The Subscriber understands that Greenberg Traurig, LLP acts as counsel only to the Company and does not represent the Subscriber or any other person by reason of purchasing the Securities.

 

2.2 The Subscriber is subscribing for and purchasing the Securities without being furnished any offering literature other than the Subscription Information, and is making this subscription decision solely in reliance upon the information contained in the Subscription Information and upon any investigation made by the Subscriber or Subscriber’s advisers, but not on any recommendation to subscribe to the Securities by any Draganfly Party.

 

2.3 The Subscriber’s subscription to the Securities is consistent with the purposes, objectives and cash flow requirements of the Subscriber.

 

2.4 The Subscriber understands that the Securities being purchased are a speculative purchase that involves a substantial degree of risk of loss of the Subscriber’s entire purchase price in the Securities, and the Subscriber understands and is fully cognizant of the risk factors related to the purchase of the Securities. The Subscriber has received and has had the opportunity to review the Subscription Information including the risk factors set forth in the Offering Circular. Neither the Company nor anyone on its behalf has made any representations (whether written or oral) to the Subscriber (i) regarding the future value or utility of the Securities or (ii) that the past business performance and experience of the Draganfly Parties will in any way predict the current or future value or utility of the Securities.

 

2.5 The Subscriber understands that any forecasts or predictions as to the Company’s performance are based on estimates, assumptions and forecasts that the Company believes to be reasonable but that may prove to be materially incorrect, and no assurance is given that actual results will correspond with the results contemplated by the various forecasts.

 

2.6 At no time has it been expressly or implicitly represented, guaranteed or warranted to the Subscriber by the Company, any other Draganfly Party, or any other person that:

 

 

 

  

2.6.1 a percentage of profit and/or amount or type of gain or other consideration will be realized as a result of this subscription; or

 

2.6.2 the past performance or experience of any other purchase sponsored by any Draganfly Party in any way indicates the predictable or probable results of the ownership of the Securities or the overall venture.

 

2.7 The Subscriber represents and agrees that none of the Draganfly Parties have recommended or suggested the acquisition of Securities to the Subscriber.

 

3. Subscriber’s Representations Related to a Subscription in the Securities.

  

3.1 The Subscriber, if an entity, is, and shall at all times while it holds the Securities remain, duly organized, validly existing and in good standing under the laws of the state, province or other jurisdiction of the country of its incorporation or organization, having full power and authority to own its properties and to carry on its business as conducted. The Subscriber, if a natural person, is eighteen years of age or older, competent to enter into a contractual obligation, and, if a U.S. Subscriber or Canadian Subscriber, a citizen or resident of the United States of America or Canada, respectively. The principal place of business or principal residence of the Subscriber is as shown in the Subscriber Questionnaire.

 

3.2 The Subscriber has the requisite power and authority to deliver this Agreement, perform his, her or its obligations set forth in this Agreement, and consummate the transactions contemplated in this Agreement. The Subscriber has duly executed and delivered this Agreement and has obtained the necessary authorization to execute and deliver this Agreement and to perform his, her or its obligations in this Agreement and to consummate the transactions contemplated in this Agreement. This Agreement, assuming the due execution and delivery hereof by the Company, is a legal, valid and binding obligation of the Subscriber enforceable against the Subscriber in accordance with its terms.

 

3.3 The Subscriber is subscribing for and purchasing the Securities solely for the Subscriber’s own account, and not with a view toward or in connection with resale, distribution (other than to its shareholders or members, if any), subdivision or fractionalization thereof. The Subscriber has no agreement or other arrangement, formal or informal, with any person or entity to sell, transfer or pledge any part of the Securities, or which would guarantee the Subscriber any profit, or insure against any loss with respect to the Securities, and the Subscriber has no plans to enter into any such agreement or arrangement.

 

3.4 The Subscriber represents and warrants that the execution and delivery of this Agreement, the consummation of the transactions contemplated in this Agreement and the performance of the obligations outlined in this Agreement will not conflict with or result in any violation of or default under any provision of any other agreement or instrument to which the Subscriber is a party or any license, permit, franchise, judgment, order, writ or decree, or any statute, rule or regulation, applicable to the Subscriber. The Subscriber confirms that the consummation of the transactions envisioned in this Agreement, including, but not limited to, the Subscriber’s Purchase, will not violate any domestic or foreign law and that such transactions are lawful in the Subscriber’s country of citizenship and residence.

 

3.5 The Subscriber is able to bear the economic risk of this purchase and, without limiting the generality of the foregoing, is able to hold the Securities for an indefinite period of time. The Subscriber has adequate means to provide for the Subscriber’s current needs and personal contingencies and has a sufficient net worth to sustain the loss of the Subscriber’s entire subscription in the Securities.

 

3.6 Neither (i) the Subscriber, (ii) any of its directors, executive officers, other officers that may serve as director or officer of any company in which it invests, general partners or managing partners, nor (iii) any beneficial owner of the Company’s voting equity securities (in accordance with Rule 262 of the Securities Act) held by the Subscriber is subject to any Disqualifying Event1 except for Disqualifying Events covered by Rule 262(b)(2) or (3) or Rule 262(c) under the Securities Act and disclosed reasonably in advance of the Purchase in writing in reasonable detail to the Company.

 

____________________

1 “Disqualifying Event” means the following: 

 

 

 

  

3.7 The Subscriber understands that no state, federal or foreign authority has scrutinized this Agreement or the Securities offered pursuant hereto, has made any finding or determination relating to the fairness for purchase of the Securities, or has recommended or endorsed the Securities, and that the Securities have not been registered under the Securities Act or any state or foreign securities laws, in reliance upon exemptions from registration thereunder.

______________________

(1) within the past ten years, conviction of a felony or misdemeanor (i) in connection with the purchase or sale of any security; (ii) involving the making of any false filing with the SEC or (iii) arising out of the conduct of the business of being an underwriter, broker, dealer, municipal securities dealer, investment advisor or paid solicitor of purchasers of securities;

 

(2) was the subject to an order, judgment or decree of any court of competent jurisdiction, entered within the prior five years, that restrains or enjoins the Subscriber from engaging or continuing to engage in any conduct or practice (i) in connection with the purchase or sale of any security; (ii) involving the making of any false filings with the SEC; or (iii) arising out of the conduct of the business of being an underwriter, broker, dealer, municipal securities dealer, investment advisor or paid solicitor of purchasers of securities;

 

(3) the subject of a final order of a state securities commission (or an agency or officer of a state performing like functions); a state authority that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer of a state performing like functions); an appropriate federal banking agency; the U.S. Commodity Futures Trading Commission; or the National Credit Union Administration that (i) bars the Subscriber from (a) association with an entity regulated by such commission, authority, agency, or officer, (b) engaging in the business of securities, insurance or banking or (c) engaging in savings association or credit union activities; or (ii) constitutes a final order based on a violation of any law or regulation that prohibits fraudulent, manipulative, or deceptive conduct entered within the past ten years;

 

(4) subject to an order of the SEC entered pursuant to section 15(b) or 15B(c) of the Securities Exchange Act of 1934 or section 203(e) or (f) of the Investment Advisers Act of 1940 that (i) suspends the Subscriber’s registration as a broker, dealer, municipal securities dealer or investment adviser; (ii) places limitations on the Subscriber’s activities, functions or operations of, or imposes civil money penalties on the Subscriber; or (iii) bars the Subscriber from being associated with any entity or from participating in the offering of any penny stock;

 

(5) subject to any order of SEC entered within the prior five years that orders the Subscriber to cease and desist from committing or causing a violation or future violation of (i) any scienter-based anti-fraud provision of the federal securities laws or (ii) Section 5 of the Securities Act;

 

(6) suspension or expulsion from membership in, or suspension or bar from association with a member of, a registered national securities exchange or a registered national or affiliated securities association for any act or omission to act constituting conduct inconsistent with just and equitable principles of trade;

 

(7) having filed (as a registrant or issuer), or named as an underwriter in any registration statement or Regulation A offering statement filed with the SEC that, within the past five years, was the subject of a refusal order, stop order, or order suspending the Regulation A exemption, or is currently the subject of an investigation or proceeding to determine whether a stop order or suspension order should be issued; and

 

(8) was subject to a United States Postal Services (“USPS”) false representation order entered within the previous five years, or currently is subject to a temporary restraining order or preliminary injunction with respect to conduct alleged by the USPS to constitute a scheme or device for obtaining money or property through the mail by means of false representations.

  

 

 

 

3.8 Subscriber represents and warrants that Subscriber: (a) (1) is not located or domiciled; (2) does not have a place of business; or (3) is not a Resident of, or located in, a jurisdiction that is subject to U.S. or other sovereign country sanctions or embargoes, or (2) an individual, or an individual employed by or associated with an entity, identified on the U.S. Department of Commerce’s Denied Persons or Entity List, the U.S. Department of Treasury’s Specially Designated Nationals or Blocked Persons Lists, or the U.S. Department of State’s Debarred Parties List. Subscriber agrees that if Subscriber’s country of residence or other circumstances change such that the above representations are no longer accurate, Subscriber will immediately cease using the Securities. Subscriber further represents and warrants that if Subscriber is purchasing the right to receive the Securities on behalf of a legal entity: (1) such legal entity is duly organized and validly existing under the applicable laws of the jurisdiction of its organization, and (2) Subscriber is duly authorized by such legal entity to act on its behalf.

 

4. Information Provided by Subscriber.

  

4.1 The information that the Subscriber has furnished in the Investor Questionnaire, including (without limitation) the information furnished by the Subscriber to the Company regarding whether Subscriber qualifies as (i) an “accredited investor” as that term is defined in Rule 501 under Regulation D under the Securities Act, (ii) a “qualified purchaser” as that term is defined in Rule 256 under Regulation A under the Securities Act and/or (iii) an “accredited investor” as defined under NI 45-106, is correct and complete as of the date of this Agreement and will be correct and complete on the date, if any, that the Company accepts this Agreement. Further, the Subscriber shall immediately notify the Company of any change in any statement made in this Agreement prior to the Subscriber’s receipt of the Company’s acceptance of this Agreement, including, without limitation, Subscriber’s status as an “accredited investor” and/or a “qualified purchaser.” The representations and warranties made by the Subscriber may be fully relied upon by the Company, and any other Draganfly Party, and by any investigating party relying on them. The Subscriber acknowledges and agrees that the Subscriber shall be liable for any loss, liability, claim, damage and expense whatsoever (including all expenses incurred in investigating, preparing or defending against any claim whatsoever) arising out of or based upon any inaccuracy in the representations and warranties in the information provided by the Subscriber.

 

4.2 The Subscriber confirms that all information and documentation provided to the Company, including but not limited to all information regarding the Subscriber’s identity and source of funds to be used to purchase the Securities, is true, correct and complete. The Subscriber is currently a bona fide resident of the state or jurisdiction set forth in the current address provided to the Company. The Subscriber has no present intention of becoming a resident of any other state or jurisdiction.

 

4.3 The representations, warranties, agreement, undertakings and acknowledgments made by the Subscriber in this Agreement will be relied upon by the Draganfly Parties and counsel to the Company in determining, among other things, whether to allow the Subscriber to purchase the Securities. The representations, warranties, agreements, undertakings and acknowledgments made by the Subscriber in this Agreement shall survive the Subscriber’s purchase of the Securities. The Subscriber agrees to notify the Company immediately if any of the Subscriber’s representations, warranties and covenants contained in this Agreement become untrue or incomplete in any respect.

 

4.4 The Draganfly Parties may rely conclusively upon and shall incur no liability in respect of any action taken upon any notice, consent, request, instructions or other instrument believed in good faith to be genuine or to be signed by properly authorized persons of the Subscriber.

 

5. Rights to Use Subscriber Information.

  

5.1 The Subscriber agrees and consents that the Draganfly Parties and any administrator appointed from time to time with respect to the Company (the “Administrator”) may obtain, hold, use, disclose, transfer, and otherwise process the Subscriber’s data, including but not limited to the contents of the Subscription Agreements:

 

 

 

  

5.1.1 as the Draganfly Parties or the Administrator reasonably deem necessary or appropriate to facilitate the acceptance, management and administration of the Subscriber’s subscription for the Securities, on an ongoing basis;

 

5.1.2 to provide notice of, and/or to seek consent to uses or disclosures of such data for specific purposes;

 

5.1.3 for any specific purposes where the Subscriber has given specific consent to do so;

 

5.1.4 to carry out statistical analysis and market research, whereby the products of such statistical analysis or market research are not disclosed outside of the Draganfly Parties or the Administrator on a basis in which Subscriber is identifiable without the Subscriber’s specific consent;

 

5.1.5 as the Draganfly Parties or the Administrator reasonably deem necessary or appropriate to comply with legal process, court orders, or other legal, regulatory, or self-regulatory requirements, requests, or investigations applicable to the Draganfly Parties, the Administrator or the Subscriber, including, but not limited to, in connection with anti-money laundering and similar laws, or to establish the availability under any applicable law of an exemption from registration of the Securities or to establish compliance with applicable law generally by the Draganfly Parties;

 

5.1.6 for disclosure or transfer to third parties, including the Subscriber’s financial adviser (where appropriate), regulatory bodies, auditors or technology providers to any of the Draganfly Parties or the Administrator, as reasonably necessary for the purposes described in this Section 5.1; and

 

5.1.7 for any other purposes described in the Privacy Notice or the Subscriber Agreements.

 

5.2 The Subscriber agrees and consents to disclosure by the Draganfly Parties or the Administrator to relevant third parties of information pertaining to the Subscriber in respect of disclosure and compliance policies or information requests related thereto.

 

5.3 The Subscriber authorizes the Draganfly Parties and any of their agents to disclose the Subscriber’s nonpublic personal information to comply with regulatory and contractual requirements applicable to the Draganfly Parties. Any such disclosure shall, to the fullest extent permitted by law, be permitted notwithstanding any privacy policy or similar restrictions regarding the disclosure of the Subscriber’s nonpublic personal information.

 

6. Relationship Between Subscriber and the Draganfly Parties.

 

6.1 Subscriber acknowledges and agrees that the purchase and sale of the Securities pursuant to this Agreement is an arms-length transaction between the Subscriber and the Company. In connection with the purchase and sale of the Securities, none of the Company nor any other Draganfly Party is acting as the Subscriber’s agent or fiduciary. The Draganfly Parties assume no advisory or fiduciary responsibility in connection with the Securities. The Draganfly Parties have not provided Subscriber with any legal, accounting, regulatory or tax advice with respect to the Securities, and Subscriber has consulted its own respective legal, accounting, regulatory and tax advisers to the extent Subscriber deems appropriate.

 

7. Regulatory Limitations and Requirements.

  

7.1 The Subscriber understands, acknowledges and agrees that the sale of the Securities contemplated in this Agreement is not fully registered with the SEC because it is being made in reliance on Regulation A under the Securities Act, which exempts the Company from certain reporting and other requirements related to the Company, the Securities and their sale, and that the Company is not registered or licensed with any federal or state regulator as an investment adviser, broker-dealer, or under the Investment Advisers Act of 1940, as amended (the “Advisers Act”) or the Investment Company Act of 1940 (“1940 Act”). As a result, the Subscriber will not be afforded the full set of protections provided to the clients and customers of such entities under the Securities Act, the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Advisers Act or the 1940 Act.

 

 

 

  

7.2 The Subscriber understands and agrees that if, at any time, it is determined that the Company is not in compliance with the Securities Act, the Exchange Act, the Advisers Act, or the 1940 Act, or is otherwise not in compliance with applicable law, the Company may take any corrective action it determines is appropriate, in its sole and absolute discretion.

 

7.3 The Subscriber understands that the Securities are not legal tender, are not backed by the government, and accounts and value balances are not subject to Federal Deposit Insurance Corporation or Securities Purchaser Protection Corporation protections.

 

7.4 The Subscriber understands that he or she may be barred from purchasing the Securities if the Subscriber is (i) an employee benefit plan that is subject to the fiduciary responsibility standards and prohibited transaction restrictions of part 4 of Title I of U.S. Employee Retirement Income Security Act of 1974, as amended (“ERISA”), (ii) any plan to which Section 4975 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”) applies, (iii) a private investment fund or other entity whose assets are treated as “plan assets” for purposes of ERISA and Section 4975 of the Code or (iv) an insurance company, whose general account assets are treated as “plan assets” for purposes of ERISA and Section 4975 of the Code. The Subscriber has notified the Company if it falls into (i) — (iv) of this paragraph.

 

7.5. THE SUBSCRIBER REPRESENTS AND WARRANTS THAT IT WILL REVIEW AND CONFIRM THE INFORMATION PROVIDED ON AN INTERNAL REVENUE SERVICE (THE “IRS”) FORM W-9, WHICH WILL BE GENERATED AND PROVIDED TO THE COMPANY VIA THE SITE. THE SUBSCRIBER CERTIFIES THAT THE FORM W-9 INFORMATION CONTAINED IN THE EXECUTED COPY (OR COPIES) OF IRS FORM W-9 (AND ANY ACCOMPANYING REQUIRED DOCUMENTATION), AS APPLICABLE, WHEN SUBMITTED TO THE COMPANY WILL BE TRUE, CORRECT AND COMPLETE. THE SUBSCRIBER SHALL (I) PROMPTLY INFORM THE COMPANY OF ANY CHANGE IN SUCH INFORMATION, AND (II) FURNISH TO THE COMPANY A NEW PROPERLY COMPLETED AND EXECUTED FORM, CERTIFICATE OR ATTACHMENT, AS APPLICABLE, AS MAY BE REQUIRED UNDER THE INTERNAL REVENUE SERVICE INSTRUCTIONS TO SUCH FORM W-9, THE CODE OR ANY APPLICABLE TREASURY REGULATIONS OR AS MAY BE REQUESTED FROM TIME TO TIME BY THE COMPANY.

 

7.5.1 THE CANADIAN SUBSCRIBER AND/OR THE INTERNATIONAL SUBSCRIBER, AS APPLICABLE, REPRESENTS AND WARRANTS THAT HE/SHE/IT HAS REVIEWED THE CANADIAN AND INTERNATIONAL SUPPLEMENT ATTACHED HERETO AS ANNEX I AND THAT HE/SHE/IT IS IN COMPLIANCE WITH ANY REQUIREMENTS OF THE NON-U.S. JURISDICTION (THE “INTERNATIONAL JURISDICTION”) IN WHICH HE/SHE/IT RESIDES OR IS DOMICILED AND WILL NOTIFY THE COMPANY IF NO LONGER IN COMPLIANCE WITH THE REQUIREMENTS OF SUCH INTERNATIONAL JURISDICTION.

 

7.6 If the Subscriber is not a United States person (as defined by Section 7701(a)(30) of the Code), the Subscriber hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Securities or any use of this Subscription Agreement, including (i) the legal requirements within its jurisdiction for the Purchase of the Securities, (ii) any foreign exchange restrictions applicable to the Purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Securities. The Subscriber’s subscription and payment for and continued beneficial ownership of the Securities will not violate any applicable securities or other laws of the Subscriber’s jurisdiction.

 

7.7 It is the intent of the Draganfly Parties to comply with all applicable federal, state and local laws designed to combat money laundering and similar illegal activities. Subscriber hereby represents, covenants, and agrees that, to the best of Subscriber’s knowledge based on reasonable investigation:

 

7.7.1 None of the Subscriber’s funds tendered for the Purchase Price (whether payable in cash or otherwise) shall be derived from money laundering or similar activities deemed illegal under federal laws and regulations.

 

 

 

  

7.7.2 To the extent within the Subscriber’s control, none of the Subscriber’s funds tendered for the Purchase Price (whether payable in cash or otherwise) will cause any Draganfly Party to be in violation of federal anti-money laundering laws or regulations.

 

7.7.3 When requested by the Company, the Subscriber will provide any and all additional information, and the Subscriber understands and agrees that the Company or any other Draganfly Party may release confidential information about the Subscriber and, if applicable, any underlying beneficial owner or Related Person2 to U.S. regulators and law enforcement authorities, deemed reasonably necessary to ensure compliance with all applicable laws and regulations concerning money laundering and similar activities. The Company reserves the right to request any information as is necessary to verify the identity of the Subscriber and the source of any payment to the Company. In the event of delay or failure by the Subscriber to produce any information required for verification purposes, a subscription by the Subscriber may be refused.

 

7.7.4 Neither the Subscriber, nor any person or entity controlled by, controlling or under common control with the Subscriber, nor any of the Subscriber’s beneficial owners, nor any person for whom the Subscriber is acting as agent or nominee in connection with this subscription, nor, in the case of a Subscriber which is an entity, any Related Person is:

 

a. a Prohibited Subscriber;3

 

b. a Senior Foreign Political Figure,4 any member of a Senior Foreign Political Figure’s “immediate family,” which includes the figure’s parents, siblings, spouse, children and in-laws, or any Close Associate of a Senior Foreign Political Figure,5 or a person or entity resident in, or organized or chartered under, the laws of a Non-Cooperative Jurisdiction;6 or

 

c. a person or entity resident in, or organized or chartered under, the laws of a jurisdiction that has been designated by the U.S. Secretary of the Treasury under Section 311 of the Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 as warranting special measures due to money laundering concerns.

 

___________________ 

2 “Related Person” shall mean, with respect to any entity, any interest holder, director, senior officer, trustee, beneficiary or grantor of such entity; provided that in the case of an entity that is a publicly traded company or a tax qualified pension or retirement plan in which at least 100 employees participate that is maintained by an employer that is organized in the U.S. or is a U.S. government entity, the term “Related Person” shall exclude any interest holder holding less than 5% of any class of securities of such publicly traded company and beneficiaries of such plan.

 

3 “Prohibited Subscriber” shall mean a person or entity whose name appears on (i) the List of Specially Designated Nationals and Blocked Persons maintained by the U.S. Office of Foreign Assets Control; (ii) other lists of prohibited persons and entities as may be mandated by applicable law or regulation; or (iii) such other lists of prohibited persons and entities as may be provided to any Draganfly Party in connection therewith.

 

4 “Senior Foreign Political Figure” shall mean a senior official in the executive, legislative, administrative, military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political party, or a senior executive of a foreign government-owned corporation. In addition, a Senior Foreign Political Figure includes any corporation, business or other entity that has been formed by, or for the benefit of, a Senior Foreign Political Figure.

 

5 “Close Associate of a Senior Foreign Political Figure” shall mean a person who is widely and publicly known internationally to maintain an unusually close relationship with the Senior Foreign Political Figure, and includes a person who is in a position to conduct substantial domestic and international financial transactions on behalf of the Senior Foreign Political Figure.

 

6 “Non-Cooperative Jurisdiction” shall mean any foreign country that has been designated as non-cooperative with international anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force, of which the U.S. is a member and with which designation the U.S. representative to the group or organization continues to concur.

 

 

 

  

7.7.5 The Subscriber hereby agrees to immediately notify the Company if the Subscriber knows, or has reason to suspect, that any of the representations in this Section 7.7 have become incorrect or if there is any change in the information affecting these representations and covenants.

 

7.7.6 The Subscriber agrees that, if at any time it is discovered that any of the foregoing anti-money laundering representations are incorrect, or if otherwise required by applicable laws or regulations, the Company may undertake appropriate actions, and the Subscriber agrees to cooperate with such actions, to ensure compliance with such laws or regulations.

 

7.7.7 The Subscriber acknowledges and agrees that the Company, in complying with anti-money laundering statutes, regulations and goals, may file any information with governmental and law enforcement agencies to identify transactions and activities that the Company or its agents reasonably determines to be suspicious, or as otherwise required by law.

 

8. Tax Requirements.

 

8.1 The Subscriber certifies that the Subscriber has completed and submitted any required waiver of local privacy laws that could otherwise prevent disclosure of information to the Company, the IRS or any other governmental authority for purposes of Chapter 3, Chapter 4 or Chapter 61 of the Internal Revenue Code (the “Code”) (including without limitation in connection with FATCA, as defined below) or any intergovernmental agreement entered into in connection with the implementation of the FATCA (an “IGA”), and any other documentation required to establish an exemption from, or reduction in, withholding tax or to permit the Company to comply with information reporting requirements pursuant to Chapter 3, Chapter 4 or Chapter 61 of the Code (including, without limitation, in connection with FATCA or any IGA).

 

8.2 The Subscriber further certifies that the Subscriber will provide to the Company prior to the Closing an IRS Form W-9, appropriate IRS Form W-8 or other applicable IRS Forms and any additional documentation required by the Company for purposes of satisfying the Company’s obligations under the Code, and in any event the Company may require such documentation prior to the delivery of the Securities to the Subscriber.

 

8.3 The Subscriber will (a) provide, upon request, prompt written notice to the Company, and in any event within 30 days of such request, of any change in the Subscriber’s U.S. tax or withholding status, and (b) execute properly and provide to the Company, within 30 days of written request by the Company, any other tax documentation or information that may be reasonably required by the Company in connection with the operation of the Company to comply with applicable laws and regulations (including, but not limited to, the name, address and taxpayer identification number of any “substantial U.S. owner” (as defined in the Code) of the Subscriber or any other document or information requested by the Company in connection with the Company complying with FATCA and/or any IGA or as required to reduce or eliminate any withholding tax directly or indirectly imposed on or collected by or with respect to the Company), and (c) execute and properly provide to the Company, within 30 days of written request by the Company, any tax documentation or information that may be requested by the Company.

 

8.4 The Subscriber further consents to the reporting of the information provided pursuant to this Section 8, in addition to certain other information, including, but not limited to, the value of the Subscriber’s purchase of the Securities to the IRS or any other governmental authority if the Company is required to do so under FATCA.

 

8.5 As used in this Agreement, “FATCA” means one or more of the following, as the context requires: (i) Sections 1471 through 1474 of the Code and any associated legislation, regulations or guidance, or similar legislation, regulations or guidance enacted in any other jurisdiction which seeks to implement equivalent tax reporting, financial or tax information sharing, and/or withholding tax regimes, (ii) any intergovernmental agreement, treaty or any other arrangement between the United States and an applicable foreign country, entered into to facilitate, implement, comply with or supplement the legislation, regulations or guidance described in the foregoing clause (i), and (iii) any legislation, regulations or guidance implemented in a jurisdiction to give effect to the foregoing clauses (i) or (ii).

 

 

 

 

8.6 By executing this Agreement, the Subscriber understands and acknowledges that (i) the Company may be required to provide the identities of the Subscriber’s direct and indirect beneficial owners to a governmental entity, and (ii) the Subscriber hereby waives any provision of law and/or regulation of any jurisdiction that would, absent a waiver, prevent the Company from compliance with the foregoing and otherwise with applicable law as described in this Section 8.

 

8.7 The Subscriber confirms that the Subscriber has been advised to consult with the Subscriber’s independent attorney regarding legal matters concerning the Company and to consult with independent tax advisers regarding the tax consequences of purchasing the Securities. The Subscriber acknowledges that Subscriber has received a copy of the Offering Circular regarding certain tax consequences of purchasing the Securities, subject to adoption of new laws or regulations or amendments to existing laws or regulations. The Subscriber acknowledges and agrees that none of the Draganfly Parties are providing any warranty or assurance regarding the tax consequences to the Subscriber by reason of the Purchase.

 

9. Other Risks.

 

9.1 The Subscriber (i) is able to bear the economic cost of holding the Securities for an indefinite period of time; (ii) has adequate means of providing for his, her, or its current needs and possible personal contingencies even in the event that the Securities lose all of their value; and (iii) has no need for liquidity of the Securities. The Subscriber’s purchase of the Securities is consistent with the objectives and cash flow requirements of the Subscriber and will not adversely affect the Subscriber’s overall need for diversification and liquidity.

 

9.2 The Subscriber is solely responsible for reviewing, understanding and considering the risks above and any additional risks, including without limitation those described in the Offering Circular. The Company’s operations, financial condition, and results of operations could be materially and adversely affected by any one or more of those risk factors, as could the underlying value of each Subscriber’s Securities, which may lead to the Securities losing all value.

 

10. Transfer and Storage of Personal Data.

 

10.1 The Subscriber understands and agrees that in connection with the services provided by the Company, its personal data may be transferred and/or stored in various jurisdictions in which the Draganfly Parties have a presence, including in or to jurisdictions that may not offer a level of personal data protection equivalent to the Subscriber’s country of residence.

 

10.2 The Subscriber further understands and agrees that, although the Draganfly Parties will use their reasonable efforts to maintain the confidentiality of the information provided in the Subscriber Questionnaire, the Draganfly Parties may disclose or transfer the Subscriber Agreements, and disclose or transfer other data of Subscriber, as described in Section 5.1. Any disclosure, use, storage or transfer of information for these purposes shall not be treated as a breach of any restriction upon the disclosure, use, storage or transfer of information imposed on any person by law or otherwise.

 

11. Consent to Electronic Delivery of Notices, Disclosures and Forms.

 

11.1 The Subscriber understands that, to the fullest extent permitted by law, any notices, disclosures, forms, privacy statements, reports or other communications (collectively, “Communications”) regarding the Company, the Subscriber’s purchase of the Securities (including annual and other updates and tax documents) may be delivered by electronic means, such as by e-mail. The Subscriber hereby consents to electronic delivery as described in the preceding sentence. In so consenting, the Subscriber acknowledges that e-mail messages are not secure and may contain computer viruses or other defects, may not be accurately replicated on other systems or may be intercepted, deleted or interfered with, with or without the knowledge of the sender or the intended recipient. The Subscriber also acknowledges that an e-mail from the Draganfly Parties may be accessed by recipients other than the Subscriber and may be interfered with, may contain computer viruses or other defects and may not be successfully replicated on other systems. No Draganfly Party gives any warranties in relation to these matters. The Subscriber further understands and agrees to each of the following:

 

 

 

  

11.1.1 Other than with respect to tax documents in the case of an election to receive paper versions, none of the Draganfly Parties or the Administrator will be under any obligation to provide the Subscriber with paper versions of any Communications.

 

11.1.2 Electronic Communications may be provided to the Subscriber via e-mail or a website of a Draganfly Party upon written notice of such website’s internet address to such Subscriber. In order to view and retain the Communications, the Subscriber’s computer hardware and software must, at a minimum, be capable of accessing the Internet, with connectivity to an internet service provider or any other capable communications medium, and with software capable of viewing and printing a portable document format (PDF) file created by Adobe Acrobat. Further, the Subscriber must have a personal e-mail address capable of sending and receiving e-mail messages to and from the Draganfly Parties or the Administrator. To print the documents, the Subscriber will need access to a printer compatible with his or her hardware and the required software.

 

11.1.3 If these software or hardware requirements change in the future, a Draganfly Party will notify the Subscriber through the Site or other written notification.

 

11.1.4 To facilitate these services, the Subscriber must provide the Company with his or her current e-mail address and update that information as necessary. Unless otherwise required by law, the Subscriber will be deemed to have received any electronic Communications that are sent to the most current e-mail address that the Subscriber has provided to the Company in writing.

 

11.1.5 None of the Draganfly Parties or the Administrator will assume liability for non-receipt of notification of the availability of electronic Communications in the event the Subscriber’s e-mail address on file is invalid; the Subscriber’s e-mail or Internet service provider filters the notification as “spam” or “junk mail”; there is a malfunction in the Subscriber’s computer, browser, internet service or software; or for other reasons beyond the control of the Draganfly Parties or the Administrator.

 

11.2 Solely with respect to the provision of tax documents by a Draganfly Party, the Subscriber agrees to each of the following:

 

11.2.1 If the Subscriber does not consent to receive tax documents electronically, a paper copy will be provided.

 

11.2.2 The Subscriber’s consent to receive tax documents electronically continues for every tax year of the Company until the Subscriber withdraws its consent by notifying the Company in writing.

 

12. Bankruptcy.

  

In the event that the Subscriber files or enters bankruptcy, insolvency or other similar proceeding, Subscriber agrees to use the best efforts possible to avoid any Draganfly Parties being named as a party or otherwise involved in the bankruptcy proceeding. Furthermore, this Agreement should be interpreted so as to prevent, to the maximum extent permitted by applicable law, any bankruptcy trustee, receiver or debtor-in-possession from asserting, requiring or seeking that (i) Subscriber be allowed to return the Securities to the Company for a refund or (ii) the Company being mandated or ordered to redeem or withdraw the Securities held or owned by Subscriber.

 

13. Limitations on Damages.

  

13.1 IN NO EVENT SHALL THE COMPANY OR ANY OTHER DRAGANFLY PARTY BE LIABLE TO THE SUBSCRIBER FOR ANY LOST PROFITS OR SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, EVEN IF INFORMED OF THE POSSIBILITY OF SUCH DAMAGES. THE FOREGOING SHALL BE INTERPRETED AND HAVE EFFECT TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, RULE OR REGULATION.

 

13.2 IN NO EVENT WILL THE AGGREGATE LIABILITY OF THE COMPANY AND THE DRAGANFLY PARTIES (JOINTLY), WHETHER IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE, WHETHER ACTIVE, PASSIVE OR IMPUTED), OR OTHER THEORY, ARISING OUT OF OR RELATING TO THESE TERMS EXCEED THE AMOUNT SUBSCRIBER PAYS TO THE COMPANY FOR THE SECURITIES.

 

 

 

  

14. Arbitration. PLEASE READ SECTIONS 14.1 THROUGH 14.9 CAREFULLY BECAUSE THEY CONTAIN ADDITIONAL PROVISIONS APPLICABLE ONLY TO INDIVIDUALS LOCATED, RESIDENT OR DOMICILED IN THE UNITED STATES. IF THE SUBSCRIBER IS LOCATED, RESIDENT OR DOMICILED IN THE UNITED STATES, THIS SECTION REQUIRES THE SUBSCRIBER TO ARBITRATE CERTAIN DISPUTES AND CLAIMS WITH THE COMPANY AND LIMITS THE MANNER IN WHICH A SUBSCRIBER CAN SEEK RELIEF FROM THE COMPANY.

 

14.1 Either party may, at its sole election, require that the sole and exclusive forum and remedy for resolution of a Claim be final and binding arbitration pursuant to this Section 14 (this “Arbitration Provision”). The arbitration shall be conducted in Los Angeles, California. As used in this Arbitration Provision, “Claim” shall include any past, present, or future claim, dispute, or controversy involving Subscriber (or persons claiming through or connected with Subscriber), on the one hand, and any of the Draganfly Parties (or persons claiming through or connected with the Draganfly Parties), on the other hand, relating to or arising out of this Agreement, any Securities, the Site, and/or the activities or relationships that involve, lead to, or result from any of the foregoing, including (except to the extent provided otherwise in the last sentence of Section 14.5 below) the validity or enforceability of this Arbitration Provision, any part of this Arbitration Provision, or the entire Agreement; provided, however, that “Claims” shall not be deemed to include any claims or disputes arising out of alleged breaches or violations of the federal and state securities laws of the United States. Claims are subject to arbitration regardless of whether they arise from contract; tort (intentional or otherwise); a constitution, statute, common law, or principles of equity; or otherwise. Claims include (without limitation) matters arising as initial claims, counter-claims, cross-claims, third-party claims, or otherwise. The scope of this Arbitration Provision is to be given the broadest possible interpretation that is enforceable.

 

 

14.2 The party initiating arbitration shall do so with the American Arbitration Association or the Judicial Arbitration and Mediation Services, in accordance with their rules governing commercial arbitrations. Provided however, that the parties hereby agree that only one arbitrator shall hear and determine their dispute. In the case of a conflict between the rules and policies of the administrator and this Arbitration Provision, this Arbitration Provision shall control, subject to countervailing law, unless all parties to the arbitration consent to have the rules and policies of the administrator apply.

 

14.3 Each party shall bear the expense of its own attorney’s fees, except as otherwise provided by law. If a statute gives Subscriber the right to recover any of these fees, these statutory rights shall apply in the arbitration notwithstanding anything to the contrary in this Agreement, and the parties hereby consent to a determination by the arbitrator of a party’s entitlement to recover fees and the reasonable amount thereof.

 

14.4 Within 30 days of a final award by the arbitrator, a party may appeal the award for reconsideration by a three-arbitrator panel selected according to the rules of the arbitrator administrator. In the event of such an appeal, an opposing party may cross-appeal within 30 days after notice of the appeal. The panel will reconsider de novo all aspects of the initial award that are appealed. Costs and conduct of any appeal shall be governed by this Arbitration Provision and the administrator’s rules, in the same way as the initial arbitration proceeding. Any award by the individual arbitrator that is not subject to appeal, and any panel award on appeal, shall be final and binding, except for any appeal right under the Federal Arbitration Act (the “FAA”), and may be entered as a judgment in any court of competent jurisdiction.

 

14.5 The Draganfly Parties agree not to invoke their right to arbitrate an individual Claim that Subscriber may bring in Small Claims Court or an equivalent court, if any, so long as the Claim is pending only in that court. EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, NO ARBITRATION SHALL PROCEED ON A CLASS, REPRESENTATIVE, OR COLLECTIVE BASIS (INCLUDING AS PRIVATE ATTORNEY GENERAL ON BEHALF OF OTHERS), EVEN IF THE CLAIM OR CLAIMS THAT ARE THE SUBJECT OF THE ARBITRATION HAD PREVIOUSLY BEEN ASSERTED (OR COULD HAVE BEEN ASSERTED) IN A COURT AS CLASS REPRESENTATIVE, OR COLLECTIVE ACTIONS IN A COURT.

 

14.6 Unless otherwise provided in this Agreement or consented to in writing by all parties to the arbitration, no party to the arbitration may join, consolidate, or otherwise bring claims for or on behalf of two or more individuals or unrelated corporate entities in the same arbitration unless those persons are parties to a single transaction. Unless consented to in writing by all parties to the arbitration, an award in arbitration shall determine the rights and obligations of the named parties only, and only with respect to the claims in arbitration, and shall not (i) determine the rights, obligations, or interests of anyone other than a named party, or resolve any Claim of anyone other than a named party, or (ii) make an award for the benefit of, or against, anyone other than a named party. No administrator or arbitrator shall have the power or authority to waive, modify, or fail to enforce this Section 14.6 and any attempt to do so, whether by rule, policy, arbitration decision or otherwise, shall be invalid and unenforceable. Any challenge to the validity of this Section 14.6 shall be determined exclusively by a court and not by the administrator or any arbitrator.

 

 

 

  

14.7 This Arbitration Provision is made pursuant to a transaction involving interstate commerce and shall be governed by and enforceable under the FAA. The arbitrator will apply substantive law consistent with the FAA and applicable statutes of limitations. The arbitrator may award damages or other types of relief permitted by applicable substantive law, subject to the limitations set forth in this Arbitration Provision. The arbitrator will not be bound by judicial rules of procedure and evidence that would apply in a court. The arbitrator shall take steps to reasonably protect confidential information.

 

14.8 This Arbitration Provision shall survive (i) suspension, termination, revocation, closure, or amendments to this Agreement and the relationship of the parties; (ii) the bankruptcy or insolvency of any party hereto or other party; and (iii) any transfer of any Securities to any other party. If any portion of this Arbitration Provision other than Section 14.6 is deemed invalid or unenforceable, the remaining portions of this Arbitration Provision shall nevertheless remain valid and in force. If arbitration is brought on a class, representative, or collective basis, and the limitations on such proceedings in Section 14.5 are finally adjudicated pursuant to the last sentence of Section 14.6 to be unenforceable, then no arbitration shall be had and any award issued shall be void and enforceable. In no event shall any invalidation be deemed to authorize an arbitrator to determine Claims or make awards beyond those authorized in this Arbitration Provision.

 

14.9 THE PARTIES ACKNOWLEDGE THAT THEY HAVE A RIGHT TO LITIGATE CLAIMS THROUGH A COURT BEFORE A JUDGE, BUT WILL NOT HAVE THAT RIGHT IF ANY PARTY DEMANDS ARBITRATION PURSUANT TO THIS ARBITRATION PROVISION. THE PARTIES HEREBY KNOWINGLY AND VOLUNTARILY WAIVE THEIR RIGHTS TO LITIGATE SUCH CLAIMS IN A COURT UPON DEMAND OF ARBITRATION BY ANY PARTY. THE PARTIES HERETO WAIVE A TRIAL BY JURY IN ANY LITIGATION RELATING TO THIS AGREEMENT OR ANY OTHER AGREEMENTS RELATED TO IT.

 

14.10 The Draganfly Parties agree and acknowledge that nothing in this Agreement shall be deemed to constitute a waiver of any Draganfly Party’s compliance with the federal securities laws and the rules and regulations thereunder, nor shall it constitute a waiver by the Subscriber of any of the Subscriber’s legal rights under applicable U.S. federal securities laws or any other laws whose applicability is not permitted to be contractually waived. In addition, this Arbitration Provision shall not apply to claims arising under the U.S. federal securities laws.

 

15. Additional Information and Subsequent Changes in the Foregoing Representations, Warranties and Covenants.

 

15.1 The Subscriber agrees to provide any additional documentation the Company may reasonably request, including documentation as may be required by the Company to form a reasonable basis that the Subscriber qualifies as an “accredited investor” as that term is defined in Rule 501 under Regulation D promulgated under the Securities Act, or otherwise as a “qualified purchaser” as that term is defined in Regulation A promulgated under the Securities Act, or as may be required by the securities administrators or regulators of any state, to confirm that the Subscriber meets any applicable minimum financial suitability standards and has satisfied any applicable maximum investment limits.

 

15.2 Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of each of the parties hereto.

 

 

 

  

15.3 The parties agree to execute and deliver such further documents and information as may be reasonably required in order to effectuate the purposes of this Agreement.

 

15.4 The Subscriber acknowledges and agrees that it will provide additional information or take such other actions as may be necessary or advisable for the Draganfly Parties (in the sole and absolute judgment of such party or parties) to comply with any disclosure and compliance policies, related legal process or appropriate requests (whether formal or informal), tax reporting and/or withholding requirements or otherwise.

 

16. Termination.

 

16.1 In addition to any other event or development described in this Agreement as permitting or requiring termination, each of the following events will cause this Agreement to terminate and expire:

 

16.1.1 At the discretion of the Company, any breach of any provision of this Agreement (including, without limitation, through any inaccuracy, omission, or incompleteness of a representation or warranty of the Subscriber in this Agreement); and/or

 

16.1.2 At the discretion of the Company, any determination by the Company that the Subscription in any way results in a material violation of applicable law.

 

16.2 In the event of termination, Sections 5 (Rights to Use Subscriber Information), 6 (Relationship between Subscriber and the Draganfly Parties), 10 (Transfer and Storage of Personal Data), 11 (Consent to Electronic Delivery of Notices, Disclosures and Forms), 13 (Limitations on Damages), 14 (Arbitration), 16 (Termination), and 17 (Miscellaneous Provisions) shall survive.

 

16.2.1 Upon delivery of the Securities to Subscriber pursuant to this Agreement, Subscriber’s obligations, pursuant to the Subscriber Questionnaire and Section 4 of this Agreement, to inform the Company of any changes in any statements made in this Agreement, shall terminate with respect to any such changes that relate solely to the period after the delivery of the Securities.

 

17. Miscellaneous Provisions.

 

17.1 Governing Law; Consent to Jurisdiction; Venue and Service of Process. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be construed under the laws of the State of Delaware. To the extent permissible under applicable law, the Subscriber hereby irrevocably agrees that any suit, action or proceeding (“Action”) with respect to this Agreement may, but need not, be resolved, whether by arbitration or otherwise, within the State of California. Accordingly, the parties consent and submit to the non-exclusive jurisdiction of the federal and state courts. The Subscriber agrees and consents that service of process as provided by U.S. federal and Delaware state law may be made upon the Subscriber in any such Action brought in any of said courts, and may not claim that any such suit, action or proceeding has been brought in an inconvenient forum. Notwithstanding the foregoing or anything to the contrary, the Subscriber and Company agree that no provisions under federal laws and regulations, including the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended, respective to jurisdiction, venue and/or forum, shall be waived.

  

17.2 E-Mail Communications. All notices and communications to be given or otherwise made to the Subscriber shall be deemed to be sufficient if sent by e-mail to such address provided by the Subscriber via the Site. Unless otherwise specified in this Agreement, Subscriber shall send all notices or other communications required to be given hereunder to the Company via e-mail at [●]. Any such notice or communication shall be deemed to have been delivered and received on the first business day following that on which the e-mail has been sent (assuming that there is no error in delivery). As used in this Section 17.2, “business day” shall mean any day other than a day on which banking institutions in the State of California or the City of Saskatoon, in British Columbia, are legally closed for business.

  

17.3 Assignability. This Agreement, or the rights, obligations or interests of the Subscriber hereunder, may not be assigned, transferred or delegated without the prior written consent of the Company. Any such assignment, transfer or delegation in violation of this Section 17.3 shall be null and void.

 

 

 

  

17.4 Severability. If any provision of this Agreement is invalid or unenforceable under any applicable law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such applicable law. Any provision hereof that may be held invalid or unenforceable under any applicable law shall not affect the validity or enforceability of any other provisions hereof, and to this extent the provisions hereof shall be severable.

 

17.5 Reimbursement of Costs Related to an Action. In the event that either party hereto shall commence any suit, action or other proceeding to interpret this Agreement, or determine to enforce any right or obligation created in this Agreement, then such party, if it prevails in such action, shall recover its reasonable costs and expenses incurred in connection therewith, including, but not limited to, reasonable attorney’s fees and expenses and costs of appeal, if any.

 

17.6 Entire Agreement. This Agreement (including the exhibits and schedules attached to this Agreement) and the documents referred to in this Agreement constitute the entire agreement among the parties and shall constitute the sole documents setting forth terms and conditions of the Subscriber’s contractual relationship with the Company with regard to the matters set forth in this Agreement. This Agreement supersedes any and all prior or contemporaneous communications, whether oral, written or electronic, between the Company and the Subscriber. Irrespective of the foregoing, the Subscriber and the Company may enter into a separate agreement for each of Subscriber’s purchase in the general offering and the voucher program, as such terms are defined in the Offering Circular, as applicable.

 

17.7 Third-Party Beneficiaries. The parties acknowledge that there are no third-party beneficiaries of this Agreement, except for any affiliates of the Company that may be involved in the issuance or servicing of the Securities on the Site, which the parties expressly agree shall be third-party beneficiaries hereof.

 

17.8 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

[Signature Page to Follow]

 

 

 

 

E-SIGNATURE PAGE

 

☐ By checking this box and clicking the “I Agree” button, I agree to comply with and be bound by all terms of this Agreement. I acknowledge and accept that all purchases of the Securities under this Agreement are final, and there are no refunds or cancellations except as may be required by this Agreement, applicable law or regulation. I further acknowledge and accept that the Company reserves the right to refuse, cancel or accept or, subject to Section 16, cancel this Agreement at any time in its sole discretion.

 

Entity Name:

________________________________

By:

/s/                                                             

Name:

________________________________

Title:

________________________________

Submission Date:

 

  

 

Total Purchase Amount:

$                                                               

 

 

Number of Units _______:

   

Number of Common Shares Underlying Warrants _______:

 

 

 

AGREED AND ACCEPTED BY

  

THE COMPANY:

 

 

 

By:

Name:

________________________________

Title:

________________________________

Effective Date:

________________________________

  

 

 

 

ANNEX I

 

CANADIAN AND INTERNATIONAL SUPPLEMENT

 

In connection with the purchase by the above-signed Subscriber of the Subscriber’s Securities as a “Canadian Subscriber” or an “International Subscriber”, the Subscriber hereby represents, warrants, covenants and certifies to the Company (and acknowledges that the Company and its counsel are relying thereon) that:

 

 

i.

the Subscriber is knowledgeable of, or has been independently advised as to, the applicable securities laws of the International Jurisdiction which would apply to this Subscription Agreement, if any;

 

 

 

 

ii.

the Subscriber is purchasing the Subscriber’s Securities pursuant to exemptions from the prospectus and registration requirements under the applicable securities laws of that International Jurisdiction or, if such is not applicable, the Subscriber is permitted to purchase the Subscriber’s Securities under the applicable securities laws of the International Jurisdiction without the need to rely on an exemption;

 

 

 

 

iii.

the applicable securities laws of the International Jurisdiction do not require the Company to file a prospectus, offering memorandum or similar document or to register or qualify the distribution of the Securities or for the Company to be registered with or to make any filings or seek any approvals of any kind whatsoever from any governmental or regulatory authority of any kind whatsoever in the International Jurisdiction;

 

 

 

 

iv.

the delivery of this Subscription Agreement, the acceptance of it by the Company and the issuance of the Subscriber’s Securities to the Subscriber complies with all applicable laws of the Subscriber’s jurisdiction of residence or domicile and all other applicable laws and will not cause the Company to become subject to or comply with any continuous disclosure, prospectus or other periodic filing or reporting requirements under any such applicable laws, nor does it require the Company to attorn to the jurisdiction of any governmental authority or regulator in such International Jurisdiction or require any translation of documents by the Company;

 

 

 

 

v.

the Subscriber will not sell, transfer or dispose of the Subscriber’s Securities except in accordance with all applicable securities laws of the International Jurisdiction, and the Subscriber acknowledges that the Company shall have no obligation to register any such purported sale, transfer or disposition which violates securities laws;

 

 

 

 

vi.

the Subscriber will provide such evidence of compliance with all such matters as the Company or its respective counsel may reasonably request;

 

 

 

 

vii.

the Canadian Subscriber acknowledges, represents, warrants, covenants and certifies that the Canadian Subscriber has been advised by the Company that the Company is relying on exemptions from the requirements under the applicable Canadian securities laws to provide the Canadian Subscriber with a prospectus or registration statement, and no prospectus or registration statement has been filed by the Company in connection with the issuance of the Securities, and as a consequence:

  

 

1.

the Canadian Subscriber is restricted from using most of the civil remedies available under the Canadian securities laws and certain protections, rights and remedies provided by the securities laws, including statutory rights of rescission or damages, will not be available to the Canadian Subscriber;

 

 

 

 

2.

the Canadian Subscriber may not receive information that would otherwise be required to be provided to the Canadian Subscriber under the Canadian securities laws; and

 

 

 

 

3.

the Company is relieved from certain obligations that would otherwise apply under the Canadian securities laws;

  

 

viii.

the Canadian Subscriber acknowledges, represents, warrants, covenants and certifies that the Canadian Subscriber is purchasing the Securities as principal for its own and not for the benefit of any other person;

 

 

 

 

ix.

the Canadian Subscriber acknowledges, represents, warrants, covenants and certifies, if the Canadian Subscriber is not an individual, the Canadian Subscriber pre-existed the offering of the Securities and has a bona fide business purpose other than the investment in the Securities and was not created, formed or established solely or primarily to acquire Securities, or to permit purchases of securities without a prospectus, in reliance on an exemption from the prospectus requirements of applicable Canadian securities laws; and

  

 

 

  

 

x.

The Canadian Subscriber acknowledges that the certificates representing the Securities will bear a legend in substantially the following form and with the necessary information inserted:

 

 

 

 

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE _______, 2020” [the date which is four months and one day after the closing date of the offering will be inserted]

 

provided that subsequent to the date which is four months and one day after the closing date of the offering, the certificates representing the Securities may be exchanged for certificates bearing no such legends.

 

The Canadian Subscriber also acknowledges that it has been advised to consult its own independent legal advisor with respect to the applicable resale restrictions; that it is solely responsible for complying with such restrictions; and that the Company is not responsible for ensuring compliance by the Canadian Subscriber of the applicable resale restrictions.

  

 

 

 

 

Schedule A to Annex 1

 

Schedule A ACCREDITED INVESTOR CERTIFICATE
(for Canadian residents only)

 

TO:            Draganfly Inc. (the “Company”)

 

Capitalized terms used in this Schedule A and defined in the Agreement to which this Schedule A is attached have the meaning defined in the Agreement unless otherwise defined herein.

 

The Subscriber is an “accredited investor” as defined in subsection 1.1 of NI 45‑106. The undersigned has indicated below the categories which the undersigned, satisfies in order to qualify as an “accredited investor”.

 

The undersigned understands that the Company and its counsel are relying upon this information in determining to sell securities to the undersigned in a manner exempt from the prospectus and registration requirements of applicable securities laws.

 

The undersigned or through the undersigned acting as its agent, represents, warrants and certifies that it, he or she is: [initial or place a checkmark above the line to the left of each applicable item]

 

_____

 

(a)

a Canadian financial institution, or a Schedule I, II or III bank under the Bank Act (Canada);

_____

 

(b)

the Business Development Bank of Canada incorporated under the Business Development Bank of Canada Act (Canada);

 

_____

(c)

 

a subsidiary of any person referred to in paragraphs (a) to (b), if the person owns all of the voting securities of the subsidiary, except the voting securities required by law to be owned by directors of that subsidiary;

_____

 

(d)

 

a person registered under the securities legislation of a jurisdiction of Canada as an adviser or dealer;

 

_____

 

(e)

 

an individual registered under the securities legislation of a jurisdiction of Canada as a representative of a person referred to in paragraph (d);

 

_____

 

(e.1)

 

an individual formerly registered under the securities legislation of a jurisdiction of Canada, other than an individual formerly registered solely as a representative of a limited market dealer under one or both of the Securities Act (Ontario) or the Securities Act (Newfoundland and Labrador)

 

_____

 

(f)

 

the Government of Canada or a jurisdiction of Canada, or any crown corporation, agency or wholly owned entity of the Government of Canada or a jurisdiction of Canada;

 

_____

 

(g)

 

a municipality, public board or commission in Canada and a metropolitan community, school board, the Comité de gestion de la taxe scolaire de l’île de Montréal or an intermunicipal management board in Québec;

 

_____

 

(h)

 

any national, federal, state, provincial, territorial or municipal government of or in any foreign jurisdiction, or any agency of that government;

 

_____

 

(i)

 

a pension fund that is regulated by either the Office of the Superintendent of Financial Institutions (Canada) or a pension commission or similar regulatory authority of a jurisdiction of Canada;

 

 

 

 

 

_____

 

(j)

 

an individual who, either alone or with a spouse, beneficially owns financial assets having an aggregate realizable value that, before taxes, but net of any related liabilities, exceeds $1,000,000;

 

Note: Financial assets include cash and securities, but do not include a personal residence – see the definition of “financial assets” later in this certificate. Financial assets are generally liquid or relatively easy to liquidate. You must subtract any liabilities related to your financial assets to calculate your net financial assets—see the definition of “related liabilities”. Financial assets held in a group RRSP under which you do not have the ability to acquire the financial assets and deal with them directly are not considered to be beneficially owned by you. If you meet the higher financial asset threshold set out in paragraph (j.1), then initial paragraph (j.1) instead of this paragraph (j).

 

Note: If you are an accredited investor described in this paragraph (j), do not meet the higher financial asset threshold set out in paragraph (j.1), you must deliver a completed Form 45‑106F9 – Form for Individual Accredited Investors (Schedule A‑1 to Annex 1).

 

_____

 

(j.1)

 

an individual who beneficially owns financial assets having an aggregate realizable value that, before taxes but net of any related liabilities, exceeds $5,000,000;

 

Note: The financial assets of your spouse (including financial assets in a spousal RRSP) cannot be included in the calculation of net financial assets under this paragraph (j.1).

 

_____

 

(k)

 

an individual whose net income before taxes exceeded $200,000 in each of the two most recent calendar years or whose net income before taxes combined with that of a spouse exceeded $300,000 in each of the two most recent calendar years and who, in either case, reasonably expects to exceed that net income level in the current calendar year;

 

Note: If you are an accredited investor described in this paragraph (k), you must deliver a completed Form 45‑106F9 – Form for Individual Accredited Investors (Schedule A‑1 to Annex 1).

 

_____

 

(l)

 

an individual who, either alone or with a spouse, has net assets of at least $5,000,000;

 

Note: To calculate net assets, take the value of your total assets (which may include a personal residence) and subtract your total liabilities (which may include a mortgage). The value attributed to assets should reasonably reflect their estimated fair value. Income tax should be considered a liability if the obligation to pay it is outstanding at the time of the subscription.

 

Note: If you are an accredited investor described in this paragraph (l, you must deliver a completed Form 45‑106F9 – Form for Individual Accredited Investors (Schedule A‑1 to Annex 1).

 

_____

 

(m)

 

a person, other than an individual or investment fund, that has net assets of at least $5,000,000 as shown on its most recently prepared financial statements;

 

_____

 

(n)

 

an investment fund that distributes or has distributed its securities only to:

 

(i)

 

a person that is or was an accredited investor at the time of the distribution,

 

(ii)

 

a person that acquires or acquired securities in the circumstances referred to in sections 2.10 Minimum amount investment, or 2.19 Additional investment in investment funds of NI 45‑106; or

 

(iii)

 

a person described in paragraph (i) or (ii) that acquires or acquired securities under section 2.18 Investment fund reinvestment of NI 45‑106;

 

_____

 

(o)

 

an investment fund that distributes or has distributed securities under a prospectus in a jurisdiction of Canada for which the regulator or, in Québec, the securities regulatory authority, has issued a receipt;

 

 

 

 

 

_____

 

(p)

 

a trust company or trust corporation registered or authorized to carry on business under the Trust and Loan Companies Act (Canada) or under comparable legislation in a jurisdiction of Canada or a foreign jurisdiction, acting on behalf of a fully‑managed account managed by the trust company or trust corporation, as the case may be;

 

_____

 

(q)

 

a person acting on behalf of a fully‑managed account managed by that person, if that person:

 

(i) is registered or authorized to carry on business as an adviser or the equivalent under the securities legislation of a jurisdiction of Canada or a foreign jurisdiction; and

 

(ii) in Ontario, is purchasing a security that is not a security of an investment fund;

 

_____

 

(r)

 

a registered charity under the Income Tax Act (Canada) that, in regard to the trade, has obtained advice from an eligibility adviser or an adviser registered under the securities legislation of the jurisdiction of the registered charity to give advice on the securities being traded;

 

_____

 

(s)

 

an entity organized in a foreign jurisdiction that is analogous to any of the entities referred to in paragraphs (a) through (d) or paragraph (i) in form and function;

 

_____

 

(t)

 

a person in respect of which all of the owners of interests, direct, indirect or beneficial, except the voting securities required by law to be owned by directors, are persons that are accredited investors;

 

{Note: If you have initialed this paragraph (t), name each owner of an interest, and indicate the category of accredited investor into which that person fits (by reference to the paragraph numbers in this Schedule A. If a person named below is a director required by law to own a voting security, and that person is not an accredited investor, indicate “director” under Category.}

 

Name                                                                                   Category

 

_______________________________                     _______________

 

_______________________________                     _______________

 

_______________________________                     _______________

 

_______________________________                     _______________

 

_____

 

(u)

 

an investment fund that is advised by a person registered as an adviser or a person that is exempt from registration as an adviser;

 

_____

 

(v)

 

a person that is recognized or designated by the securities regulatory authority or, except in Ontario and Québec, the regulator as an accredited investor; or

 

_____

 

(w)

 

on or after May 5, 2015, a trust established by an accredited investor for the benefit of the accredited investor’s family members of which a majority of the trustees are accredited investors and all of the beneficiaries are the accredited investor’s spouse, a former spouse of the accredited investor or a parent, grandparent, brother, sister, child or grandchild of that accredited investor, of that accredited investor’s spouse or of that accredited investor’s former spouse.

 

{Note: If you have initialled this paragraph (w), name the person who established the trust and each trustee, and indicate the category of accredited investor into which that person fits (by reference to the paragraph numbers in this Schedule A). If a person named below is not an accredited investor, indicate “N/A” under Category.}

 

 

 

 

Name

 

Category

 

 

 

 

 

 

 

Person who established trust:

 

 

 

 

 

 

 

 

 

 

 

 

Trustee:

 

 

 

 

 

 

 

 

 

 

 

 

 

Trustee:

 

 

 

 

 

 

 

 

 

 

 

 

 

Trustee:

 

 

 

 

 

 

 

 

 

 

 

 

  

The Subscriber has executed this certificate as of the ______ day of ____________, 2020.

 

If a trust, partnership or other entity:

 

If an individual:

 

 

 

 

Name of Entity

 

 

 

Signature

 

Type of Entity

 

 

 

Name of Individual

 

Signature of person Signing

 

 

 

Title of person Signing

 

 

 

 

  

As used in this Certificate, the following terms have the following meanings:

 

An issuer is an “affiliate” of another issuer if:

 

 

(a)

one of them is the subsidiary of the other, or

 

 

 

 

(b)

each of them is controlled by the same person;

  

Canadian financial institution” means:

 

 

(a)

an association governed by the Cooperative Credit Associations Act (Canada) or a central cooperative credit society for which an order has been made under section 473(1) of that Act; or

 

 

 

 

(b)

a bank, loan corporation, trust company, trust corporation, insurance company, treasury branch, credit union, caisse populaire, financial services cooperative, or league that, in each case, is authorized by an enactment of Canada or a jurisdiction of Canada to carry on business in Canada or a jurisdiction of Canada;

  

control person” has the meaning ascribed to that term in securities legislation except in Ontario, Québec and Nova Scotia where “control person” means any person that holds or is one of a combination of persons that holds:

 

 

(a)

a sufficient number of any of the securities of an issuer so as to affect materially the control of the issuer, or

 

 

 

 

(b)

more than 20% of the outstanding voting securities of an issuer except where there is evidence showing that the holding of those securities does not affect materially the control of the issuer;

  

eligibility adviser” means:

 

 

(a)

a person that is registered as an investment dealer and authorized to give advice with respect to the type of security being distributed; and

 

 

 

 

(b)

in Saskatchewan or Manitoba, also means a lawyer who is a practicing member in good standing with a law society of a jurisdiction of Canada or a public accountant who is a member in good standing of an institute or association of chartered accountants, certified general accountants or certified management accountants in a jurisdiction of Canada provided that the lawyer or public accountant must not:

  

 

(i)

have a professional business or personal relationship with the issuer, or any of its directors, executive officers, founders or control persons, and

 

 

 

 

(ii)

have acted for or been retained personally or otherwise as an employee, executive officer, director, associate or partner of a person that has acted for or been retained by the issuer or any of its directors, executive officers, founders or control persons within the previous 12 months;

  

financial assets” means cash, securities, or a contract of insurance, a deposit or an evidence of a deposit that is not a security for the purposes of securities legislation;

 

foreign jurisdiction” means a country other than Canada or a political subdivision of a country other than Canada;

 

fully managed account” means an account of a client for which a person makes the investment decisions if that person has full discretion to trade in securities for the account without requiring the client’s express consent to a transaction;

 

investment fund” has the same meaning as in National Instrument 81‑106 Investment Fund Continuous Disclosure and means a mutual fund or a non‑redeemable investment fund;

 

jurisdiction” means a province or territory of Canada except when used in the term foreign jurisdiction;

 

 

 

  

local jurisdiction” means the jurisdiction in which the Canadian securities regulatory authority is situated;

 

non‑redeemable investment fund” has the same meaning as in National Instrument 81‑106 Investment Fund Continuous Disclosure and means an issuer:

 

 

(a)

whose primary purpose is to invest money provided by its securityholders;

 

 

 

 

(b)

that does not invest:

  

 

(i)

for the purpose of exercising or seeking to exercise control of an issuer, other than an issuer that is a mutual fund or a non‑redeemable investment fund; or

 

 

 

 

(ii)

for the purpose of being actively involved in the management of any issuer in which it invests, other than an issuer that is a mutual fund or a non‑redeemable investment fund; and

  

 

(c)

that is not a mutual fund;

  

regulator” means, for the local jurisdiction, the Executive Director as defined under securities legislation of the local jurisdiction;

 

related liabilities” means:

 

 

(a)

liabilities incurred or assumed for the purpose of financing the acquisition or ownership of financial assets; or

 

 

 

 

(b)

liabilities that are secured by financial assets;

  

securities legislation” means securities legislation as such term is defined in National Instrument 14‑101 Definitions;

 

spouse” means, an individual who:

 

 

(a)

is married to another individual and is not living separate and apart within the meaning of the Divorce Act (Canada), from the other individual;

 

 

 

 

(b)

is living with another individual in a marriage‑like relationship, including a marriage‑like relationship between individuals of the same gender; or

 

 

 

 

(c)

in Alberta, is an individual referred to in paragraph (a) or (b), or is an adult interdependent partner within the meaning of the Adult Interdependent Relationships Act (Alberta); and

  

subsidiary” means an issuer that is controlled directly or indirectly by another issuer and includes a subsidiary of that subsidiary.

 

Calculation of purchaser’s net assets: To calculate a purchaser’s net assets under paragraph (a) of the “accredited investor” definition, subtract the purchaser’s total liabilities from the purchaser’s total assets. The value attributed to assets should reasonably reflect their estimated fair value. Income tax should be considered a liability if the obligation to pay it is outstanding at the time of the trade.

 

 

 

 

Schedule A-1 to Annex 1

 

{This Schedule A‑1 to Annex 1 is in the form required under applicable Canadian securities laws and must be completed if the Subscriber:

 

 

·

is subscribing under the “accredited investor” exemption set out in Section 6(d)(i) of the Agreement;

 

 

 

 

·

is an individual relying on category (j), (k) or (l) of the Accredited Investor Certificate (Schedule A to Annex 1); and

 

 

 

 

·

does not meet the higher financial asset threshold set out in paragraph (j.1) of the Accredited Investor Certificate.}

 

Form 45‑106F9
Form for Individual Accredited Investors

 

 

WARNING!

 

This investment is risky. Don’t invest unless you can afford to lose
all the money you pay for this investment.

 

SECTION 1 TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER

1. About your investment

Type of securities: Common Shares

Issuer: Draganfly Inc.

Purchased from: Draganfly Inc.

SECTIONS 2 TO 4 TO BE COMPLETED BY THE PURCHASER

2. Risk acknowledgement

This investment is risky. Initial that you understand that:

Your

initials

Risk of loss – You could lose your entire investment of $__________________. {Instruction: Insert the total dollar amount of the investment.}

 

Liquidity risk – You may not be able to sell your investment quickly – or at all.

 

Lack of Information – You may receive little or no information about your investment.

 

Lack of advice – You will not receive advice from the salesperson about whether this investment is suitable for you unless the salesperson is registered. The salesperson is the person who meets with, or provides information to, you about making this investment. To check whether the salesperson is registered, go to www.aretheyregistered.ca.

 

3. Accredited investor status

You must meet at least one of the following criteria to be able to make this investment. Initial the statement that applies to you. (You may initial more than one statement.) The person identified in section 6 is responsible for ensuring that you meet the definition of accredited investor. That person, or the salesperson identified in section 5, can help you if you have questions about whether you meet these criteria.

Your

initials

· Your net income before taxes was more than $200,000 in each of the 2 most recent calendar years, and you expect it to be more than $200,000 in the current calendar year. (You can find your net income before taxes on your personal income tax return.)

 

· Your net income before taxes combined with your spouse’s was more than $300,000 in each of the 2 most recent calendar years, and you expect your combined net income before taxes to be more than $300,000 in the current calendar year

 

· Either alone or with your spouse, you own more than $1 million in cash and securities, after subtracting any debt related to the cash and securities.

 

 

 

 

 

· Either alone or with your spouse, you have net assets worth more than $5 million. (Your net assets are your total assets (including real estate) minus your total debt.)

 

4. Your name and signature

By signing this form, you confirm that you have read this form and you understand the risks of making this investment as identified in this form.

First and last name (please print):

Signature:

Date:

SECTION 5 TO BE COMPLETED BY THE SALESPERSON

5. Salesperson information

{Instruction: the salesperson is the person who meets with, or provides information to, the purchaser with respect to making this investment. That could include a representative of the issuer or selling security holder, a registrant or a person who is exempt from the registration requirement.}

First and last name of salesperson (please print):

Telephone:

Email:

Name of firm (if registered):

SECTION 6 TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER

6. For more information about this investment

Draganfly Inc.

2108 St. George Avenue,

Saskatoon, SK, S7M 0K7 Canada

Attention:              Paul Sun
Phone:                   1-306-955-9906
Email:                    paul.sun@draganfly.com
Website:                www.draganfly.com

 

For more information about prospectus exemptions, contact your local securities regulator. You can find contact information at www.securities‑administrators.ca.

 

{The Subscriber should keep one copy of this form (signed by the Subscriber) for the Subscriber’s records.}

 

 

 

  EXHIBIT 4.2

 

THE WARRANTS REPRESENTED HEREBY AND THE UNDERLYING SECURITIES ISSUABLE UPON EXERCISE HEREUNDER HAVE BEEN QUALIFIED BY THE U.S. SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REGULATION A.  TIER 2, OFFERING STATEMENT IN AN EXEMPT OFFERING UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  RESALES OF THE SECURITIES HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LEGISLATION AND THEREFORE RESALES OF THE WARRANTS MAY, IN SOME STATES BE LIMITED BY STATE SECURITIES LEGISLATION UNLESS AN EXEMPTION FROM REGISTRATION OR QUALIFICATION IS AVAILABLE UNDER THAT STATES' SECURITIES LAWS.

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE _______________, 202_ [INSERT DATE THAT IS 4 MONTHS AND A DAY AFTER THE DISTRIBUTION DATE].

 

THE WARRANTS REPRESENTED HEREBY WILL BE VOID AND OF NO VALUE AFTER 5:00 PM (VANCOUVER TIME) ON _______________, 202_.

 

WARRANT CERTIFICATE

 

DRAGANFLY INC.
(a British Columbia Company)

 

Certificate Number: __    

 

**______** Warrants to Purchase
**_ ** Shares

 

COMMON SHARE PURCHASE WARRANTS

 

THIS IS TO CERTIFY THAT, for value received, ____________ of _________________________________or his lawful assignee (the “Holder”) is the registered holder of ____________ (______) warrants (the “Warrants”) of Draganfly Inc. (the “Company”). Each Warrant shall entitle the Holder to subscribe for and purchase one fully paid and non-assessable common shares without par value (collectively the “Shares” and individually, a “Share”) in the authorized capital of the Company at any time on or before 5:00 p.m. Vancouver time on ______________, 20___, (the “Expiry Date”), at a price of US$● per Share, subject, however, to the provisions and upon the Terms and Conditions attached hereto as Schedule “A.” 

 

The rights represented by this Warrant Certificate may be exercised by the Holder, in whole or in part (but not as to a fraction of a Share) by surrender of this Warrant Certificate (properly endorsed as required), together with a Warrant Exercise Form in the form attached hereto as Appendix “B”, duly completed and executed, to the Company at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 (Attention: Chief Financial Officer), or such other address as the Company may from time to time in writing direct, together with a certified cheque or bank draft payable to or to the order of the Company in payment of the purchase price of the number of Shares subscribed for.  The Holder is advised to read “Instruction to Holders” attached hereto as Appendix “A” for details on how to complete the Warrant Exercise Form (as such term is defined in Schedule “A”).

 

 

 

  

IN WITNESS WHEREOF the Company has caused this Warrant Certificate to be executed by its duly authorized officer, this ___ day of ________, 20__.

 

 

DRAGANFLY INC.

 

 

Per:                                                                 
            Authorized Signatory

 

 

 

 

SCHEDULE “A”

 

TERMS AND CONDITIONS
ATTACHED TO COMMON SHARE PURCHASE WARRANTS
ISSUED BY DRAGANFLY INC.
(the “Company”)

 

Each Warrant of the Company, whether single or part of a series, is subject to these Terms and Conditions as they were at the date of issue of the Warrant.

 

 

 

 

PART 1

 

DEFINITIONS AND INTERPRETATION

 

Definitions

 

1.1 In these Terms and Conditions, except as otherwise expressly provided herein, the following words and phrases will have the following meanings:

 

(a) “Company” means Draganfly Inc. and includes any successor corporations;

 

(b) “Company’s auditor” means the accountant duly appointed as auditor of the Company;

 

(c) “Exchange” has the meaning ascribed thereto in §3.3;

 

(d) “Exercise Price” means US$● per Share or as may be adjusted as per Part 5;

 

(e) “Expiry Date” means the date defined as such on the face page of the Warrant Certificate;

 

(f) “Expiry Time” means 5:00 p.m. Vancouver time on the Expiry Date;

 

(g) “Holder” means the registered holder of a Warrant;

 

(h) “Joint Actors” has the meaning ascribed thereto in §7.1;

 

(i) “person” means an individual, corporation, partnership, trustee or any unincorporated organization, and words importing persons have a similar meaning;

 

(j) “Shares” or “shares” means the common shares in the capital of the Company as constituted at the date of issue of a Warrant and any shares resulting from any event referred to in §4.7;

 

(k) “Warrant” means a warrant as evidenced by the certificate, one Warrant entitles the holder to purchase one (1) Share of the Company (subject to adjustment) on or before the Expiry Date at the Exercise Price set forth on the Warrant Certificate;

 

(l) “Warrant Certificate” means the certificate evidencing the Warrant;

 

(m) “Warrant Exercise Form” means Appendix “B” hereof; and

 

(n) “Warrant Transfer Form” means Appendix “C” hereof.

 

 

 

   

General

 

1.2 In these Terms and Conditions, except as otherwise expressly provided herein:

 

(a) the words “herein”, “hereof”, and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Part, clause, subclause or other subdivision;

 

(b) a reference to a Part means a Part of these Terms and Conditions and the symbol § followed by a number or some combination of numbers and letters refers to the section, paragraph or subparagraph of these Terms and Conditions so designated;

 

(c) the headings are for convenience only, do not form a part of these Terms and Conditions and are not intended to interpret, define or limit the scope, extent or intent of these Terms and Conditions or any of its provisions;

 

(d) all dollar amounts referred to herein are expressed in United States funds;

 

(e) time will be of the essence hereof; and

 

(f) words importing the singular number include the plural and vice versa, and words importing the masculine gender include feminine and neuter genders.

 

(g) this Warrant Certificate shall enure to the benefit of and be binding upon the parties hereto and their respective successors and assigns.

 

Applicable Law

 

1.3 This Warrant shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, without reference to its principles governing the choice or conflict of laws.

 

PART 2

 

ISSUE OF WARRANTS

 

Additional Warrants

 

2.1 The Company may at any time and from time to time issue Warrants or grant options or similar rights to purchase shares of in its capital.

 

Issue in Substitution for Lost Warrants

 

2.2 In case a Warrant Certificate will become mutilated, lost, destroyed or stolen, the Company in its discretion may issue and deliver a new Warrant Certificate of like date and tenor as the one mutilated, lost, destroyed or stolen in exchange for, and in place of, and upon cancellation of such mutilated Warrant Certificate, or in lieu of and in substitution for such lost, destroyed or stolen Warrant Certificate, and the Warrants represented by such substituted Warrant Certificate will be entitled to the benefit hereof and rank equally in accordance with its terms with all other Warrants of the same issue. The Company may charge a reasonable fee for the issuance and delivery of a new Warrant Certificate.

 

 

 

 

2.3 The applicant for the issue of a new Warrant Certificate pursuant hereto will bear the cost of the issue thereof and in the case of loss, destruction or theft furnish to the Company such evidence of ownership, and of loss, destruction or theft of the Warrant Certificate so lost, destroyed or stolen as will be satisfactory to the Company in its discretion; and such applicant may also be required to furnish indemnity in amount and form satisfactory to the Company in its discretion and will pay the reasonable charges of the Company in connection therewith.

  

Holder not a Shareholder

 

2.4 The holding of a Warrant will not constitute the Holder a shareholder of the Company, nor entitle the Holder to any right or interest in respect thereof, except as expressly provided in the Warrant Certificate.

 

Canadian Securities Law Exemption

 

2.5 The Holder acknowledges and agrees that the Warrants and any Shares issued pursuant to the exercise of any Warrants have been or will be issued pursuant to an exemption from the registration and prospectus requirements of applicable Canadian securities law and that the Company has no obligation to, and does not intend to, file any prospectus or registration statement in any jurisdiction in order to qualify any of such Warrants and/or Shares for resale.

 

U.S. Securities Law Matters

 

2.6 Neither the Warrants nor the Shares issuable upon exercise hereof have been or will be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or U.S. state securities laws. The Warrants and the Shares issuable upon exercise hereof have been qualified in an exempt Regulation A. Tier 2 offering pursuant to Section 3(b) of the U.S. Securities Act. The Warrants and Shares issuable hereunder are not "restricted securities" as defined in Rule 144 of the U.S. Securities Act. Notwithstanding the foregoing the Warrants and the Shares issuable thereunder may not be transferred or resold in the United States without an exemption under applicable state securities legislation and regulations thereunder.

  

PART 3

 

OWNERSHIP AND TRANSFER OF WARRANT

 

Exchange of Warrants

 

3.1 A Warrant Certificate in any authorized denomination, upon compliance with the reasonable requirements of the Company, may be exchanged for a Warrant Certificate(s) in any other authorized denomination of the same issue entitling the Holder to purchase an equal aggregate number of Shares at the same Exercise Price and on the same terms as the Warrant Certificate so exchanged.

 

3.2 Warrants may be exchanged only with the Company. Any Warrants tendered for exchange will be surrendered to the Company and cancelled.

 

3.3 Subject to applicable securities legislation and the rules, policies, notices and orders issued by applicable securities regulatory authorities, including the Canadian Securities Exchange, or such other stock exchange as the Shares may then be listed and posted for trading on (the “Exchange”), the Warrants are transferable on the terms and conditions contained herein and by the Holder completing and submitting to the Company a completed and duly executed Warrant Transfer Form and provision of such additional documents as may be reasonably requested by the Company. Subject to the foregoing, the Company shall issue and mail as soon as practicable, and in any event within 5 business days of receipt of this Warrant certificate, together with a duly completed and executed Warrant Transfer Form attached hereto, a new Warrant certificate (with or without legends as may be appropriate) registered in the name of the transferee or as the transferee may direct and shall take all other necessary actions to effect the transfer as directed.

 

 

 

  

Charges for Exchange

 

3.4 On exchange of Warrants, the Company, except as otherwise herein provided, may charge a reasonable fee for each new Warrant Certificate issued, and payment of any transfer taxes or governmental or other charges required to be paid will be made by the party requesting such exchange.

 

Ownership of Warrants

 

3.5 The Company may deem and treat the Holder of a Warrant as the absolute owner of such Warrant for all purposes and will not be affected by any notice or knowledge to the contrary.

 

Notice to Holder

 

3.6 Unless herein otherwise expressly provided, any notice to be given hereunder to a Holder will be deemed to be validly given, if mailed to the address of the Holder as set out on the Warrant Certificate. Any notice so given will be deemed to have been received 5 days from the date of mailing to the Holder or any market intermediary then holding the Warrants of the Holder in any trust account.

 

PART 4

 

EXERCISE OF WARRANTS

 

Method of Exercise of Warrants

 

4.1 The right to purchase Shares conferred by a Warrant may be exercised by the Holder surrendering the Warrant Certificate, together with a duly completed and executed Warrant Exercise Form and a certified cheque or bank draft payable to, or to the order of Company at the address as set out on the Warrant Certificate, for the purchase price applicable at the time of surrender in respect of the shares subscribed for in lawful money of the United States to the Company at the address as set out on the Warrant Exercise Form.

 

Effect of Exercise of Warrants

 

4.2 Upon surrender and payment as aforesaid, the shares so subscribed for will be deemed to have been issued, and the Holder will be deemed to have become the holder of such shares on the date of such surrender and payment, and such shares will be issued at the Exercise Price as may be adjusted in the events and in the manner described herein.

 

4.3 Within 10 business days after surrender and payment as aforesaid, the Company will forthwith cause to be delivered to the person in whose name the shares are directed to be registered as specified in such Warrant Exercise Form, or if no such direction is given, the Holder, a certificate for the appropriate number of shares not exceeding those which the Holder is entitled to purchase pursuant to the Warrant Certificate surrendered.

 

Subscription for Less than Entitlement

 

4.4 A Holder may purchase a number of Shares less than the number which the Holder is entitled to purchase pursuant to the surrendered Warrant Certificate. In the event of any purchase of a number of Shares less than the number which can be purchased pursuant to a Warrant Certificate, the Holder, upon exercise thereof, will, in addition to certificates representing Shares issued on such exercise, and be entitled to receive a new Warrant Certificate in respect of the balance of the Shares which the Holder was entitled to purchase pursuant to the surrendered Warrant Certificate but which were not then purchased.

 

 

 

  

4.5 The Company shall not be required to issue fractional Shares upon the exercise of the Warrants evidenced hereby and the Holder shall not be entitled to any cash payment or compensation in lieu of a fractional Share.

 

Expiration of Warrants

 

4.6 After the Expiry Date, all rights under the Warrants will wholly cease and terminate, and the Warrants will thereupon be void and of no effect.

 

Exercise Price

 

4.7 The price per share which must be paid to exercise a Warrant is the Exercise Price, as may be adjusted in the events and in the manner described herein.

 

Legends on Shares

 

4.8 In addition to the other legends that may be required by applicable law, the certificates representing Shares issued upon exercise of Warrants will bear the following legend:

 

“UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE ____________, 202__ [INSERT DATE THAT IS 4 MONTHS AND A DAY AFTER THE DISTRIBUTION DATE];

 

provided that at any time subsequent to [INSERT DATE THAT IS FOUR MONTHS AND A DAY AFTER THE DISTRIBUTION DATE], any certificate representing such Shares may be exchanged for a certificate bearing no such legends.

 

4.8 U.S. Legends: The certificates representing Shares underlying the Warrants shall bear such legend, if any, as may be required under applicable U.S. state securities laws until such time as is no longer required under the applicable requirements of such state securities laws, with such determination based upon the opinion of United States counsel acceptable to the Company.

 

PART 5

 

ADJUSTMENTS

 

Adjustments

 

5.1 If and whenever the Shares will be subdivided into a greater or consolidated into a lesser number of shares, or in the event of any payment by the Company of a stock dividend (other than a dividend paid in the ordinary course), or in the event that the Company conducts a rights offering to its shareholders, the exercise price will be decreased or increased proportionately as the case may be. Upon any such subdivision, consolidation, payment of a stock dividend or rights offering, subject to the consent of the Exchange (if required), the number of shares deliverable upon the exercise of a Warrant and the exercise price of the Warrant will be increased or decreased proportionately as the case may be.

 

 

 

  

5.2 In case of any reclassification of the capital of the Company, or in the case of the merger, reorganization or amalgamation of the Company with, or into any other company or of the sale of substantially all of the property and assets of the Company to any other company, each Warrant will, after such reclassification of capital, merger, amalgamation or sale, confer the right to purchase that number of shares or other securities or property of the Company or of the company resulting from such reclassification, merger, amalgamation, or to which such sale will be made, as the case may be, which the Holder would then hold if the Holder had exercised the Holder’s rights under the Warrant before reclassification of capital, merger, amalgamation or sale; and in any such case, if necessary, appropriate adjustments will be made in the application of the provisions set forth in this Part 5 with respect to the rights and interest thereafter of the Holders to the end that the provisions set forth in this Part 5 will thereafter correspondingly be made applicable as nearly as may reasonably be in relation to any Shares or other securities or property thereafter deliverable on the exercise of a Warrant, subject to any approvals required by the Exchange.

  

5.3 The adjustments provided for in this Part 5 are cumulative.

 

Determination of Adjustments

 

5.4 If any question will at any time arise with respect to any adjustments to be made under §5.1 and §5.2, such question will be conclusively determined by the Company’s auditor, or, if the Company’s auditor declines to so act, any other chartered accountant in the Province of British Columbia that the Company may designate (acting reasonably) and who will have access to all appropriate records, and such determination will be binding upon the Company and the Holder.

 

Hold Period

 

5.5 The Shares received by the Holder upon the exercise of the Warrants is subject to a hold period as determined by the Securities Act (British Columbia). There may be further restrictions on resale in accordance with the requirements of any exchange, including the Canadian Securities Exchange, and/or other applicable securities laws.

 

PART 6

 

COVENANTS BY THE COMPANY

 

Reservation of Shares

 

6.1 The Company will reserve, and there will remain unissued out of its authorized capital, a sufficient number of shares to satisfy the rights of purchase provided for in all Warrants from time to time outstanding.

 

Securities Qualification Requirements

 

6.2 If, in the opinion of counsel for the Company, any filing is required to be filed with or any permission is required to be obtained from any securities regulatory body or any other step is required under any Federal or Provincial law before any shares which the Holder is entitled to purchase pursuant to the Holder’s Warrant may properly and legally be issued upon exercise thereof, the Company covenants that it will take such action.

 

 

 

 

PART 7

 

RESTRICTION ON EXERCISE

 

Blocking Language

 

7.1 Notwithstanding anything contained herein to the contrary, the rights represented by this Warrant Certificate will not be exercisable by the Holder, in whole or in part, and the Company will not give effect to any such exercise, if, after giving effect to such exercise, the Holder, together with any person or company acting jointly or in concert with the Holder (the “Joint Actors”) would in the aggregate beneficially own, or exercise control or direction over that number of voting securities of the Company which is twenty percent (20%) or greater of the total issued and outstanding voting securities of the Company, immediately after giving effect to such exercise. For greater certainty, the rights represented by this Warrant Certificate will not be exercisable by the Holder, in whole or in part, and the Company will not give effect to any such exercise, if, after giving effect to such exercise, the Holder, together with its Joint Actors, would be deemed to hold a number of voting securities sufficient to materially affect the control of the Company.

 

7.2 Notwithstanding any provision to the contrary contained herein, no Shares will be issued pursuant to the exercise of any Warrant if the issuance of such securities would constitute a violation of the securities laws of any applicable jurisdiction, and the certificates evidencing the Shares thereby issued may bear such legend as may, in the opinion of legal counsel to the Company, be necessary in order to avoid a violation of any securities laws of any applicable jurisdiction or to comply with the requirements of any stock exchange on which the Shares of the Company are listed, provided that, at any time, in the opinion of legal counsel to the Company, such legends are no longer necessary in order to avoid a violation of any such laws, or the holder of any such legended certificate, at that holder's expense, provides the Company with evidence satisfactory in form and substance to the Company (which may include an opinion of legal counsel satisfactory to the Company) to the effect that such holder is entitled to sell or otherwise transfer such Shares in a transaction in which such legends are not required, such legended certificate may thereafter be surrendered to the Company in exchange for a certificate which does not bear such legend.

 

PART 8

 

MODIFICATION OF TERMS, SUCCESSORS

 

Modification of Terms and Conditions for Certain Purposes

 

8.1 From time to time the Company may, subject to the provisions of the Warrant Certificate and approval of the Exchange, when so directed by the Holders, modify the terms and conditions hereof, for any one or more or all of the following purposes:

 

(a) adding to the provisions hereof such additional covenants and enforcement provisions as, in the opinion of counsel for the Company, are necessary or advisable in the circumstances;

 

(b) making such provisions not inconsistent herewith as may be necessary or desirable with respect to matters or questions arising hereunder or for the purpose of obtaining a listing or quotation of Warrants on any stock exchange or house;

 

 

 

 

(c) adding to or altering the provisions hereof in respect of the registration of Warrants making provision for the exchange of Warrant Certificates of different denominations; and making any modification in the form of Warrant Certificates which does not affect the substance thereof;

 

(d) for any other purpose not inconsistent with the terms hereof, including the correction or rectification of any ambiguities, defective provisions, errors or omissions herein; and

 

(e) to evidence any succession of any corporation and the assumption by any successor of the covenants of the Company herein and in the Warrants contained as provided hereafter in this Part 8.

 

Company may Amalgamate on Certain Terms

 

8.2 Nothing herein contained will prevent any amalgamation or merger of the Company with or into any other company, or the sale of the property or assets of the Company to any company lawfully entitled to acquire the same; provided however that the company formed by such merger or amalgamation or which acquires by conveyance or transfer all or substantially all the properties and assets of the Company will be a company organized and existing under the laws of Canada or of the United States of America or any Province, State, District or Territory thereof, which will, simultaneously with such amalgamation, merger, conveyance or transfer, assume the due and punctual performance and observance of all the covenants and conditions hereof to be performed or observed by the Company and will succeed to and be substituted for the Company, and such changes in phraseology and form (but not in substance) may be made in the Warrant Certificate as may be appropriate in view of such amalgamation, merger or transfer.

 

Additional Financings

 

8.3 Nothing herein contained will prevent the Company from issuing any other securities or rights with respect thereto during the period within which a Warrant is exercisable, upon such terms as the Company may deem appropriate.

 

[End of Schedule “A”]

 

 

 

 

 

APPENDIX “A”

 

INSTRUCTIONS TO HOLDERS

 

TO EXERCISE:

 

To exercise Warrants, the Holder must complete, sign and deliver the Warrant Exercise Form, attached as Appendix “B” and deliver the Warrant Certificate(s) to the Company, indicating the number of common shares to be acquired.

 

TO TRANSFER:

 

To transfer Warrants, the Holder must complete, sign and deliver the Warrant Transfer Form, attached as Appendix “C” and deliver the Warrant Certificate(s) to the Company.  The Company may require such other certificates or opinions to evidence compliance with applicable securities legislation in Canada.

 

To transfer Warrants, the Warrant Holder's signature on the Warrant Transfer Form must be guaranteed by an authorized officer of a chartered bank, trust company or an investment dealer who is a member of a recognized stock exchange.

 

GENERAL:

 

If forwarding any documents by mail, registered mail must be employed.

 

If the Warrant Exercise Form is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a corporation or any person acting in a fiduciary or representative capacity, the Warrant Certificate must also be accompanied by evidence of authority to sign satisfactory to the Company.

 

The address of the Company is:

Draganfly Inc.

2108 St. George Avenue

Saskatoon, Saskatchewan, S7M 0K7

Attention: Chief Financial Officer

Telephone: +1 (306)-955-9907

 

[End of Appendix “A”]

 

 

 

 

APPENDIX “B”

 

WARRANT EXERCISE FORM

 

TO:

Draganfly Inc.

 

2108 St. George Avenue

Saskatoon, Saskatchewan, S7M 0K7

Attention: Chief Financial Officer

Telephone: +1 (306)-955-9907

 

The undersigned Holder of the within Warrants hereby subscribes for ____________ common shares (the “Shares”) of DRAGANFLY INC. (the “Company”) pursuant to the within Warrants on the terms and price specified in the Warrants.  This subscription is accompanied by a certified cheque or bank draft payable to or to the order of the Company for the whole amount of the purchase price of the Shares.

 

The undersigned hereby directs that the Shares be registered as follows:

 

NAME(S) IN FULL

ADDRESS(ES)

NUMBER OF SHARES

 

 

 

 

 

 

 

The undersigned Holder represents and warrants that he or she is an “accredited investor”, as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (a “U.S. Accredited Investor”), and has completed the U.S. Accredited Investor Status Certificate in the form attached to this exercise form; OR Holder is a “qualified investor” meaning the aggregate exercise price you pay is not more than ten percent (10%) of the greater of your annual income or your net worth. DIFFERENT RULES MAY APPLY TO NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A+.

 

STOP:

 

COMPLETE THE FOLLOWING ONLY IF THE WARRANTS AND/OR THE UNDERLYING SHARES ARE NOT QUALIFIED UNDER REGULATION A, TIER 2.

 

Unless the Shares have been registered or qualified under Regulation A under the U.S. Securities Act, and the applicable state securities legislation, as at the time of exercise hereunder, the undersigned Warrantholder represents, warrants and certifies as follows (check one):

 

 

(A)

☐ the undersigned Warrantholder at the time of exercise of the Warrant is not in the United States, is not a “U.S. person” as defined in Regulation S under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), and is not exercising the Warrant for the account or benefit of a U.S. person or a person in the United States (as defined in Regulation S), and did not execute or deliver this exercise form in the United States; OR

 

 

 

 

 

(B)

¨ the undersigned Warrantholder is resident in the United States, is a U.S. person, or is exercising the Warrant for the account or benefit of a U.S. person or a person in the United States (a “U.S. Holder”), and is an “accredited investor”, as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (a “U.S. Accredited Investor”), and has completed the U.S. Accredited Investor Status Certificate in the form attached to this exercise form; OR

 

 

 

 

(C)

¨ if the undersigned Warrantholder is a U.S. Holder, the undersigned Warrantholder has delivered to the Company and the Company’s transfer agent an opinion of counsel (which will not be sufficient unless it is in form and substance satisfactory to the Company) or such other evidence satisfactory to the Company to the effect that with respect to the common shares to be delivered upon exercise of the Warrant, the issuance of such securities has been registered under the U.S. Securities Act and applicable state securities laws, or an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws is available.

    

Note:  Unless the Shares have been registered or qualified under Regulation A under the U.S. Securities Act and the applicable state securities legislation certificates representing Shares will not be registered or delivered to an address in the United States unless box (B) or (C) immediately above is checked.

 

If the undersigned Warrantholder has indicated that the undersigned Warrantholder is a U.S. Accredited Investor by marking box (B) above, the undersigned Warrantholder additionally represents and warrants to the Company that:

 

 

1

the undersigned Warrantholder has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Common Shares, and the undersigned is able to bear the economic risk of loss of his or her entire investment;

 

 

 

 

2.

the undersigned is: (i) purchasing the Shares for his or her own account or for the account of one or more U.S. Accredited Investors with respect to which the undersigned is exercising sole investment discretion, and not on behalf of any other person; (ii) is purchasing the Shares for investment purposes only and not with a view to resale, distribution or other disposition in violation of United States federal or state securities laws; and (iii) in the case of the purchase by the undersigned of the Shares as agent or trustee for any other person or persons (each a “Beneficial Owner”), the undersigned Warrantholder has due and proper authority to act as agent or trustee for and on behalf of each such Beneficial Owner in connection with the transactions contemplated hereby; provided that: (x) if the undersigned Warrantholder, or any Beneficial Owner, is a corporation or a partnership, syndicate, trust or other form of unincorporated organization, the undersigned Warrantholder or each such Beneficial Owner was not incorporated or created solely, nor is it being used primarily to permit purchases without a prospectus or registration statement under applicable law; and (y) each Beneficial Owner, if any, is a U.S. Accredited Investor; and

 

 

 

 

3.

the undersigned has not exercised the Warrants as a result of any form of general solicitation or general advertising (as such terms are used in Rule 502 of Regulation D under the U.S. Securities Act), including advertisements, articles, notices or other communications published in any newspaper, magazine or similar media, or broadcast over radio, television, the Internet or other form of telecommunications, or any seminar or meeting whose attendees have been invited by general solicitation or general advertising.

 

 

 

  

If the undersigned has indicated that the undersigned is a U.S. Accredited Investor by marking box (B) above, the undersigned also acknowledges and agrees that:

 

 

1.

the Company has provided to the undersigned the opportunity to ask questions and receive answers concerning the terms and conditions of the offering, and the undersigned has had access to such information concerning the Company as the undersigned has considered necessary or appropriate in connection with the undersigned’s investment decision to acquire the Shares;

 

 

 

 

2.

if the undersigned decides to offer, sell or otherwise transfer any of the Shares, the undersigned must not, and will not, offer, sell or otherwise transfer any of such Shares directly or indirectly, unless:

  

 

(a)

the sale is to the Company;

 

 

 

 

(b)

the sale is made outside the United States in a transaction meeting the requirements of Rule 904 of Regulation S under the U.S. Securities Act and in compliance with applicable local laws and regulations;

 

 

 

 

(c)

the sale is made pursuant to the exemption from the registration requirements under the U.S. Securities Act provided by Rule 144 thereunder, if available, and in accordance with any applicable state securities or “blue sky” laws; or

 

 

 

 

(d)

the Shares are sold in a transaction that does not require registration under the U.S. Securities Act or any applicable state laws and regulations governing the offer and sale of securities,

 

 

 

 

and in the case of (c) or (d) above, it has prior to such sale furnished to the Company an opinion of counsel reasonably satisfactory to the Company;

 

 

3.

the Shares are “restricted securities” under applicable federal securities laws and that the U.S. Securities Act and the rules of the United States Securities and Exchange Commission provide in substance that the undersigned may dispose of the Shares only pursuant to an effective registration statement under the U.S. Securities Act or an exemption therefrom;

 

 

 

 

4.

the Company has no obligation to register any of the Shares or to take action so as to permit sales pursuant to the U.S. Securities Act (including Rule 144 thereunder);

 

 

 

 

5.

the certificates representing the Shares (and any certificates issued in exchange or substitution for the Shares) will bear a legend stating that such securities have not been registered under the U.S. Securities Act or the securities laws of any state of the United States, and may not be offered for sale or sold unless registered under the U.S. Securities Act and the securities laws of all applicable states of the United States, or unless an exemption from such registration requirements is available;

 

 

 

 

6.

the legend may be removed by delivery to the registrar and transfer agent and the Company of an opinion of counsel, reasonably satisfactory to the Company, that such legend is no longer required under applicable requirements of the U.S. Securities Act or state securities laws;

 

 

 

  

 

7.

there may be material tax consequences to the undersigned of an acquisition or disposition of the Shares;

 

 

 

 

8.

the Company gives no opinion and makes no representation with respect to the tax consequences to the undersigned under United States, state, local or foreign tax law of the undersigned’s acquisition or disposition of any Shares; in particular, no determination has been made whether the Company will be a “passive foreign investment company” (commonly known as a “PFIC”) within the meaning of Section 1297 of the United States Internal Revenue Code;

 

 

 

 

9.

funds representing the subscription price for the Shares which will be advanced by the undersigned to the Company upon exercise of the Warrants will not represent proceeds of crime for the purposes of the United States Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act (the “PATRIOT Act”), and the undersigned acknowledges that the Company may in the future be required by law to disclose the undersigned’s name and other information relating to this exercise form and the undersigned’s subscription hereunder, on a confidential basis, pursuant to the PATRIOT Act. No portion of the subscription price to be provided by the undersigned (i) has been or will be derived from or related to any activity that is deemed criminal under the laws of the United States of America, or any other jurisdiction, or (ii) is being tendered on behalf of a person or entity who has not been identified to or by the undersigned, and it shall promptly notify the Company if the undersigned discovers that any of such representations ceases to be true and provide the Company with appropriate information in connection therewith; and

 

 

 

 

10.

the undersigned consents to the Company making a notation on its records or giving instructions to any transfer agent of the Company in order to implement the restrictions on transfer set forth and described in this subscription form.

  

In the absence of instructions to the contrary, the securities or other property will be issued in the name of or to the Warrantholder hereof and will be sent by first class mail to the last address of the Warrantholder appearing on the register maintained for the Warrants.

 

DATED this _________ day of _______________, 20_____.

 

In the presence of:        

 

 

 

 

 

       
Signature of Witness      Signature of Holder  

 

 

 

 

 

 

 

 

 

 

Witness’s Name     Name and Title of Authorized Signatory for the Holder  

 

 

 

 

Please print below your name and address in full.

     
Legal Name

 

 

 

Address  

 

 

 

 

   
     

 

INSTRUCTIONS FOR SUBSCRIPTION

 

The signature to the subscription must correspond in every particular with the name written upon the face of the Warrant Certificate without alteration.  If the registration in respect of the certificates representing the Shares to be issued upon exercise of the Warrants differs from the registration of the Warrant Certificates the signature of the registered holder must be guaranteed by an authorized officer of a Canadian chartered bank, or of a major Canadian trust company, or by a medallion signature guarantee from a member recognized under the Signature Medallion Guarantee Program, or from a similar entity in the United States, if this transfer is executed in the United States, or in accordance with industry standards.

 

In the case of persons signing by agent or attorney or by personal representative(s), the authority of such agent, attorney or representative(s) to sign must be proven to the satisfaction of the Company.

 

If the Warrant Certificate and the form of subscription are being forwarded by mail, registered mail must be employed.

 

 

 

 

U.S. ACCREDITED INVESTOR STATUS CERTIFICATE

                  

In connection with the exercise of certain outstanding warrants of DRAGANFLY INC. (the “Company”) by the Warrantholder, the Warrantholder hereby represents and warrants to the Company that the Warrantholder, and each beneficial owner (each a “Beneficial Owner”), if any, on whose behalf the Warrantholder is exercising such warrants, satisfies one or more of the following categories of Accredited Investor (please write “W/H” for the undersigned Warrantholder, and “B/O” for each beneficial owner, if any, on each line that applies):

 

_______ (1)

Any bank as defined in Section 3(a)(2) of the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the U.S. Securities Act whether acting in its individual or fiduciary capacity; any broker or dealer registered pursuant to Section 15 of the U.S. Securities Exchange Act of 1934; any insurance company as defined in Section 2(a)(13) of the U.S. Securities Act; any investment company registered under the U.S. Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the U.S. Small Business Investment Act of 1958; any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of US$5,000,000; any employee benefit plan within the meaning of the U.S. Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of US$5,000,000, or, if a self-directed plan, with investment decisions made solely by persons that are “accredited investors” (as such term is defined in Rule 501 of Regulation D of the U.S. Securities Act);

 

 

_______ (2)

Any private business development company as defined in Section 202(a)(22) of the U.S. Investment Advisers Act of 1940;

 

 

_______ (3)

Any organization described in Section 501(c)(3) of the U.S. Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of US$5,000,000;

 

 

_______ (4)

Any trust with total assets in excess of US$5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person (being defined as a person who has such knowledge and experience in financial and business matters that he or she is capable of evaluating the merits and risks of the prospective investment);

 

 

 

 

_______ (5)

A natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of purchase, exceeds US$1,000,000 (for the purposes of calculating net worth, (i) the person’s primary residence shall not be included as an asset; (ii) indebtedness that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of this certification, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of this certification exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and (iii) indebtedness that is secured by the person’s primary residence in excess of the estimated fair market value of the primary residence shall be included as a liability);

 

 

_______ (6)

A natural person who had annual gross income during each of the last two full calendar years in excess of US$200,000 (or together with his or her spouse in excess of US$300,000) and reasonably expects to have annual gross income in excess of US$200,000 (or together with his or her spouse in excess of US$300,000) during the current calendar year, and no reason to believe that his or her annual gross income will not remain in excess of US$200,000 (or that together with his or her spouse will not remain in excess of US$300,000) for the foreseeable future;

 

 

_______ (7)

Any director or executive officer of the Company; or

 

 

_______ (8)

Any entity in which all of the equity owners meet the requirements of at least one of the above categories (if this alternative is selected you must identify each equity owner and provide statements for each demonstrating how they qualify as an accredited investor).

 

__________

 

 

[End of Appendix “B”]

 

 

 

 

APPENDIX “C”

 

WARRANT TRANSFER FORM

 

TO:

Draganfly Inc.

 

2108 St. George Avenue

Saskatoon, Saskatchewan, S7M 0K7

Attention: Chief Financial Officer

Telephone: +1 (306)-955-9907

  

FOR VALUE RECEIVED, the undersigned holder of the within Warrants hereby sells, assigns and transfers to _______________________________, ________________ Warrants of Draganfly Inc. (the “Company”) registered in the name of the undersigned on the records of the Company and irrevocably appoints ________________ the attorney of the undersigned to transfer the said securities on the books or register with full power of substitution.

 

The undersigned hereby directs that the Warrants hereby transferred be issued and delivered as follows:

 

NAME IN FULL

ADDRESS

NUMBER OF WARRANTS

 

 

 

 

DATED this _________ day of _______________, 20____.

 

 

 

 

 

 

Signature of Warrant Holder

 

Signature Guaranteed

 

 

INSTRUCTIONS FOR TRANSFER

 

Signature of the Warrant Holder must be the signature of the person appearing on the face of this Warrant Certificate.

 

If the Transfer Form is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a corporation or any person acting in a fiduciary or representative capacity, the certificate must be accompanied by evidence of authority to sign satisfactory to the Company.

 

The signature on the Transfer Form must be guaranteed by a chartered bank or trust company, or a member firm of an approved signature guarantee medallion program.  The guarantor must affix a stamp bearing the actual words: “SIGNATURE GUARANTEED”.

 

The Warrants will only be transferable in accordance with applicable laws.  The Warrants and the common shares issuable upon exercise thereof not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or under the securities laws of any state of the United States, and may not be transferred to or for the account or benefit of a U.S. person or any person in the United States without registration under the U.S. Securities Act and applicable state securities laws, or compliance with the requirements of an exemption from registration.  “United States” and “U.S. person” are as defined in Regulation S under the U.S. Securities Act.

 

[End of Appendix “C”]

 

 

 

 

EXHIBIT 6.1

 

INDEPENDENT CONSULTANT AGREEMENT

 

This Independent Consultant Agreement (“Agreement”) is dated effective as of the 1st day of October, 2019 (the “Effective Date”).

 

BETWEEN:

 

DRAGANFLY INC., a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7

 

(“Company”)

 

AND:

 

1502372 ALBERTA LTD., a corporation having an address at L120, 2303 – 4 Street SW, Calgary, AB T2S 2S7

 

(“Consultant”)

 

AND:

CAMERON CHELL, the principal of the Consultant

 

(“Principal”)

 

WHEREAS:

 

A. The Consultant has considerable expertise in the general management of start-ups, financial and business matters; and

 

B. The Company wishes to obtain, and the Consultant wishes to provide, certain services to the Company on the terms and conditions set out in this Agreement;

 

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and for other good and valuable consideration (including but not limited to a signing bonus paid by the Company to the Consultant for this Agreement in the amount of CAD $50.00), the receipt and sufficiency of which are hereby acknowledged, the Company, the Consultant and the Principal covenant and agree as follows:

 

1.

SERVICES TO BE PROVIDED

 

 

1.1

Commencing on the Effective Date, the Consultant shall provide executive services to the Company and, in this regard, the Consultant shall have the Principal hold the position of Chairman and Chief Executive Officer at the Company. Furthermore, commencing on the Effective Date the Consultant shall provide such services to the Company as are described in Schedule A to this Agreement (the “Services”). The Consultant shall also provide any other services not specifically mentioned in Schedule A, but which, by reason of the Consultant’s capability, the Consultant knows or ought to know are necessary to ensure that the best interests of the Company are maintained.

  

 

 

  

1.2

The Consultant shall provide all of the Services through the Principal, unless otherwise agreed in writing by the Company. The Consultant and the Principal undertake to make the Principal available to perform the Services required under this Agreement.

 

 

1.3

The Consultant shall perform the Services to the level of competence and skill one would reasonably expect from a company with the skills and experience similar to that of the Consultant. The Consultant shall devote sufficient working time, attention and ability in a timely manner to the Business of the Company (as defined herein), and to any associated company, as is reasonably necessary for the proper performance of the Services pursuant to this Agreement.

 

 

1.4

The Consultant will faithfully, honestly and diligently serve the Company, use its best efforts to promote the best interests of the Company and co-operate with the Company, and utilize maximum professional skill and care to ensure that the Services are rendered to the satisfaction of the Company.

 

 

1.5

The Consultant will comply with all applicable rules, laws and regulations, and all applicable Company policies (to the extent they have been provided to the Consultant by the Company), having application to the carrying out and performance of its obligations under this Agreement.

 

 

1.6

At all times while on the Company’s premises or representing the Company in any other location in connection with the provision of the Services, the Consultant will observe the Company’s rules and regulations with respect to conduct, health, safety and protection of persons and property.

 

 

2.

INDEPENDENT CONSULTANT RELATIONSHIP

 

 

2.1

It is expressly agreed that the Consultant’s relationship with the Company is that of an independent contractor in performing the Services under this Agreement, and nothing in this Agreement is intended to, or shall be construed to, create a partnership, agency, joint venture, employment or similar relationship either between the Consultant and the Company, or the Principal and the Company.

 

 

2.2

The Consultant and, where applicable, the Principal, shall file on a timely basis, all tax returns and payments required to be filed with or made to any federal or provincial tax authority with respect to the performance of the Services and the consideration therefor under this Agreement.

 

 

2.3

The Consultant is solely responsible for, and must maintain adequate records of, expenses incurred in the course of performing the Services.

 

 

2.4

The Consultant represents and warrants that the Consultant has the right to provide the Services to the Company without violation of obligations to others and that any advice, information and documents given by the Consultant to the Company under this Agreement may be used fully and freely by the Company, unless otherwise so designated orally or in writing by the Consultant at the time of communication of such information.

  

 
- 2 -

 

  

2.5

The Consultant and the Principal agree to indemnify and save harmless the Company and its directors, officers, employees, administrators and agents from:

  

 

(a)

any and all liability for any premium, contribution, remittance, tax, assessment, penalty, interest, wages or any other amount of any kind whatsoever, arising under one or more statutes relating to income tax, Employment Insurance, Canada Pension Plan, workers' compensation, employment standards, human rights or any other similar statute of Canada or the Province of British Columbia that may arise in connection with the performance of the Services under this Agreement; and

 

 

 

 

(b)

any and all costs, charges, legal fees and expenses reasonably incurred by the Company or such persons identified in this section in connection with defending any civil, criminal, statutory or administrative action, proceeding or other remedy with respect to any such alleged liability.

  

2.6

The Company will not be liable to the Consultant for any damages, liabilities, penalties, interest or costs suffered by the Consultant's failure to make the statutorily required deductions or payments.

 

 

3.

CONSIDERATION FOR SERVICES

 

 

3.1

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay to the Consultant a consulting fee in the amount of CAD $3,000 per month for the first four months, and then CAD $10,000 per month for the remainder of this Agreement or until any change is mutually agreed upon. All fees will be paid on a monthly basis upon submission of an invoice.

 

 

4.

TERM AND TERMINATION

 

 

4.1

This Agreement will commence on the Effective Date and will continue for twelve (12) months (“Term”), unless terminated in accordance with Section 4.3 or renewed in accordance with Section 4.2.

 

 

4.2

Notwithstanding Section 4.1, this Agreement will automatically be renewed for subsequent terms of twelve (12) months unless the Company provides written notice to the Consultant by no later than sixty (60) days prior to the last day of the applicable Term of its intention to not renew this Agreement. If this Agreement is renewed, the Company’s board of directors (“Board”) shall perform an annual review of compensation paid to the Consultant, at around the time of any renewal.

  

 
- 3 -

 

  

4.3

Notwithstanding Section 4.1, and notwithstanding any renewal under Section 4.2, this Agreement may be terminated at any time by:

  

 

(a)

the Consultant giving at least sixty (60) days’ advance notice in writing to the Company;

 

 

 

 

(b)

the Company by giving at least sixty (60) days advance notice in writing to the Consultant; or

 

 

 

 

(c)

the Company without notice in the event that the Consultant: (i) breaches any term of this Agreement, (ii) neglects the Services or any other duty to be performed by the Consultant under this Agreement, (iii) engages in any conduct which is dishonest, or damages the reputation or standing of the Company, (iv) is convicted of any criminal act, (v) engages in any act of moral turpitude, (vi) files a voluntary petition in bankruptcy, or (vii) is adjudicated as bankrupt or insolvent.

  

4.4

Upon termination of this Agreement for any reason, the Consultant shall promptly deliver the following in accordance with the directions of the Company:

  

 

(a)

a final accounting, reflecting the balance of expenses incurred on behalf of the Company as of the date of termination;

 

 

 

 

(b)

all documents pertaining to the Company or this Agreement, including, but not limited to, all Confidential Information, books of account, correspondence and contracts; and

 

 

 

 

(c)

all equipment and any other property belonging to the Company.

  

4.5

If this Agreement is terminated for any reason set forth in Section 4, then the Consultant will be entitled to the fees earned to the effective date of termination and any expenses incurred on behalf of the Company prior to the effective date of termination which are otherwise reimbursable by the Consultant pursuant to the terms of this Agreement.

 

 

4.6

The definitions contained in this Agreement and the rights and obligations contained in this Section 4 and in Sections 5, 6, 7 and 8 will survive any termination or expiration of this Agreement.

 

 

4.7

Upon the termination of this Agreement for whatever reason, upon the request of the Company, the Consultant shall cause the Principal to immediately resign, and the Principal shall so resign, without claim for compensation or severance of any kind whatsoever, from all offices and directorships held by the Principal in the Company or any affiliated company and in the event of their respective failure to do so the Company is hereby irrevocably authorized to appoint its designated person in their respective names and on their behalf to execute any documents and to do all things requisite to give effect thereto.

 

 

4.8

The Consultant shall not, at any time after the termination of this Agreement, represent itself as being in any way connected with or interested in the business of the Company.

  

 
- 4 -

 

  

5.

CONFIDENTIALITY

 

 

5.1

For the purposes of this Agreement, “Confidential Information” means information, whether or not originated by the Consultant, that relates to the business or affairs of the Company, its affiliates, clients, sales personnel or suppliers and is confidential or proprietary to, about or created by the Company, its affiliates, clients or suppliers (whether or not reduced to writing or designated or marked as confidential), including, but not limited to, the following:

  

 

(a)

any technical and non-technical information related to the Company’s business and current, future and proposed products and services of the Company, including, without limitation, Company Innovations (as defined herein), Company Property (as defined herein) and the Company’s information concerning research, development, design and product details and specifications, financial information, procurement requirements, engineering and manufacturing information, and business plans;

 

 

 

 

(b)

information relating to strategies, research, communications, business plans and financial data of the Company;

 

 

 

 

(c)

any information of or regarding the Company and its business which is not readily publicly available;

 

 

 

 

(d)

work product resulting from or related to work or projects performed, or to be performed, for the Company or its affiliates, including, but not limited to, the methods, processes, procedures, analysis, techniques and audits used in connection therewith;

 

 

 

 

(e)

any intellectual property contributed to the Company, and any other technical and business information of the Company and its affiliates which is of a confidential, trade secret and/or proprietary character;

 

 

 

 

(f)

marketing and development plans, price and cost data, price and fee amounts, pricing and billing policies, quoting procedures, marketing techniques, methods of obtaining business, forecasts and forecast assumptions and volumes, current and prospective client lists, and future plans and potential strategies of the Company that have been or are being discussed;

 

 

 

 

(g)

information belonging to third parties or which is claimed by third parties to be confidential or proprietary and which the Company has agreed to keep confidential; and

 

 

 

 

(h)

any other information that becomes known to the Consultant as a result of this Agreement or the services performed hereunder, including information received by the Company from others, that the Consultant, acting reasonably, believes is confidential information or that the Company takes measures to protect.

  

 
- 5 -

 

  

5.2

The Consultant’s obligations under this Section 5 do not apply to any Confidential Information that the Consultant can demonstrate: (a) was in the public domain at or subsequent to the time the Confidential Information was communicated to the Consultant by the Company through no fault of the Consultant; (b) was rightfully in the Consultant’s possession free of any obligation of confidence at or subsequent to the time the Confidential Information was communicated to the Consultant by the Company; or (c) was independently developed by the Consultant without use of, or reference to, any Confidential Information communicated to the Consultant by the Company. A disclosure of any Confidential Information by Consultant in response to a valid order by a court or other governmental body or as otherwise required by law will not be considered to be a breach of this Agreement or a waiver of confidentiality for other purposes, provided, however, that the Consultant provides prompt prior written notice thereof to the Company to enable the Company to seek a protective order or otherwise prevent the disclosure

 

 

5.3

The Consultant acknowledges that the Confidential Information is a valuable and unique asset of the Company and that the Confidential Information is and will remain the exclusive property of the Company. The Consultant agrees to maintain securely and hold in strict confidence all Confidential Information received, acquired or developed by the Consultant or disclosed to the Consultant as a result of or in connection with the Services. The Consultant and the Principal agree that, both during and after the termination of this Agreement, the Consultant and the Principal will not, directly or indirectly, divulge, communicate, use, copy or disclose or permit others to use, copy or disclose, any Confidential Information to any person, except as such disclosure may be consented to by prior written authorization of the board of directors of the Company.

 

 

5.4

The Consultant may use the Confidential Information solely to perform the Services for the benefit of Company. The Consultant shall treat all Confidential Information with the same degree of care as the Consultant accords to the Consultant’s own confidential information, but in no case shall the Consultant use less than reasonable care. The Consultant shall immediately give notice to the Company of any unauthorized use or disclosure of the Confidential Information. The Consultant shall assist the Company in remedying any unauthorized use or disclosure of the Confidential Information.

 

 

5.5

All Confidential Information and any materials and items (including, without limitation, software, equipment, tools, artwork, documents, drawings, papers, diskettes, tapes, models, apparatus, sketches, designs and lists) that the Company furnishes to the Consultant, whether delivered to the Consultant by the Company or made by the Consultant in the performance of the Services, and whether or not they contain or disclose Confidential Information (collectively, the “Company Property”), are the sole and exclusive property of the Company or the Company’s affiliates, suppliers or customers. The Consultant agrees to treat the Company Property with the same degree of care as the Consultant treats its own property, but in no case shall the Consultant use less than reasonable care. Within five (5) days after any request by the Company, the Consultant shall destroy or deliver to the Company, at the Company’s option: (a) all Company Property and (b) all materials and items in the Consultant’s possession or control that contain or disclose any Confidential Information. The Consultant will provide the Company a written certification of the Consultant’s compliance with the Consultant’s obligations under this Section 5.5.

  

 
- 6 -

 

  

5.6

During the term of this Agreement, the Consultant will not accept work, enter into a contract or accept an obligation in breach of the Consultant’s obligations under Section 7 of this Agreement, or the scope of the Services to be rendered for the Company under this Agreement. The Consultant warrants that, to the best of the Consultant’s knowledge, there is no other existing contract or duty on the Consultant’s part that conflicts with or is inconsistent with this Agreement.

 

 

5.7

The Consultant represents and warrants that the Consultant has not used and will not use, while performing the Services, any materials or documents of another company which the Consultant is under a duty not to disclose. The Consultant understands that, while performing the Services, the Consultant shall not breach any obligation or confidence or duty the Consultant may have to any current or former client or employer. The Consultant represents and warrants that it will not, to the best of its knowledge and belief, use or cause to be incorporated in any of the Consultant’s work product, any data software, information, designs, techniques or know-how which the Consultant or the Company does not have the right to use.

 

 

5.8

The Consultant will indemnify and hold harmless the Company from and against any and all third party claims, suits, actions, demands and proceedings against the Company and all losses, costs, damages, expenses, fees and liabilities related thereto arising out of or related to: (a) an allegation that any item, material or other deliverable delivered by the Consultant under this Agreement infringes any intellectual property rights or publicity rights of a third party; (b) an alleged breach by the Consultant of any agreement between the Consultant and any third party; or (c) any negligence by the Consultant or any other act or omission of the Consultant, including, without limitation, any breach of this Agreement by the Consultant.

 

 

6.

DISCLOSURE AND ASSIGNMENT OF WORK RESULTING FROM PROVISION OF SERVICES.

 

 

6.1

In this Agreement, “Innovations” means all discoveries, designs, developments, improvements, inventions (whether or not protectable under patent laws), works of authorship, information fixed in any tangible medium of expression (whether or not protectable under copyright laws), trade secrets, know-how, ideas (whether or not protectable under trade secret laws), mask works, trademarks, service marks, trade names and trade dress. “Company Innovations” means Innovations that: (a) result or derive from the provision of the Services or from the Consultant’s knowledge or use of Confidential Information; (b) are conceived or made by the Consultant (individually or in collaboration with others) in the course of provision of the Services; (c) result from or derive from the use or application of the resources of the Company, its affiliates or suppliers; (d) relate to the Business of the Company or to actual or demonstrably anticipated research and development by the Company or its affiliates; or (e) the Consultant, solely or jointly with others, creates, derives, conceives, develops, makes or reduces to practice during the Term.

  

 
- 7 -

 

  

6.2

All Company Innovations shall be the exclusive property of the Company and the Company shall have sole discretion to deal with Company Innovations. The Consultant agrees that no intellectual property rights in the Company Innovations are or shall be retained by the Consultant. For greater certainty, all work done during the Term by the Consultant for the Company or its affiliates is the sole property of the Company or its affiliates, as the case may be, as the first author for copyright purposes and in respect of which all copyright shall vest in the Company or the relevant affiliate, as the case may be.

 

 

6.3

The Consultant agrees to maintain adequate and current records of all Company Innovations, which records shall be and remain the property of the Company. The Consultant agrees to promptly disclose and describe to the Company all Company Innovations. The Consultant hereby does and will irrevocably assign to the Company or the Company’s designee all of the Consultant’s right, title and interest in and to any and all Company Innovations and all associated records.

 

 

6.4

In consideration of the benefits to be received by the Consultant under the terms of this Agreement, the Consultant hereby irrevocably sells, assigns and transfers, and agrees in the future to sell, assign and transfer all right, title and interest in and to the Company Innovations and intellectual property rights therein, including, without limitation, all patents, copyright, industrial design, circuit topography and trademarks, and any goodwill associated therewith in Canada, the United States and worldwide to the Company and the Consultant shall hold all the benefits of the rights, title and interest mentioned above in trust for the Company prior to the assignment to the Company, save and except for any moral rights which the Consultant shall waive. To the extent any of the rights, title and interest in and to Company Innovations cannot be assigned by the Consultant to the Company, the Consultant hereby grants to the Company an exclusive, royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit those non-assignable rights, title and interest, including, but not limited to, the right to make, use, sell, offer for sale, import, have made, and have sold, the Company Innovations. To the extent any of the rights, title and interest in and to the Company Innovations can neither be assigned nor licensed by the Consultant to the Company, the Consultant hereby irrevocably waives and agrees never to assert the non-assignable and non-licensable rights, title and interest against the Company, any of the Company’s successors in interest, or any of the Company’s customers.

 

 

6.5

The Consultant agrees to perform, during and after the Term, all acts that the Company deems necessary or desirable to permit and assist the Company, at its expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the Company Innovations as provided to the Company under this Agreement. If the Company is unable for any reason to secure the Consultant’s signature to any document required to file, prosecute, register or memorialize the assignment of any rights under any Company Innovations as provided under this Agreement, the Consultant hereby irrevocably designates and appoints the Company and the Company’s duly authorized officers and agents as the Consultant’s agents and attorneys-in-fact to act for and on the Consultant’s behalf and instead of the Consultant to take all lawfully permitted acts to further the filing, prosecution, registration, memorialization of assignment, issuance and enforcement of rights in, to and under the Company Innovations, all with the same legal force and effect as if executed by the Consultant. The foregoing is deemed a power coupled with an interest and is irrevocable.

  

 
- 8 -

 

  

6.6

If the Consultant incorporates or permits to be incorporated any Innovations relating in any way, at the time of conception, reduction to practice, creation, derivation, development or making of the Innovation, to the Company’s business or actual or demonstrably anticipated research or development but which were conceived, reduced to practice, created, derived, developed or made by the Consultant (solely or jointly) either unrelated to the Consultant’s work for Company under this Agreement or prior to the Effective Date (collectively, the “Out-of-Scope Innovations”) into any of the Company Innovations, then the Consultant hereby grants to the Company and the Company’s designees a royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit all patent, copyright, moral right, mask work, trade secret and other intellectual property rights relating to the Out-of-Scope Innovations. Notwithstanding the foregoing, the Consultant agrees that the Consultant shall not incorporate, or permit to be incorporated, any Innovations conceived, reduced to practice, created, derived, developed or made by others or any Out-of-Scope Innovations into any Company Innovations without the Company’s prior written consent.

 

 

7.

NON-INTERFERENCE WITH BUSINESS

 

 

7.1

In this Agreement, “Business of the Company” means the business of manufacturing search and navigation equipment within the commercial UAV space.

 

 

7.2

The Consultant agrees that, during the Term, the Consultant will not, on its own behalf or on behalf of or in connection with any third party, directly or indirectly, in any capacity whatsoever, including, without limitation, as an employer, employee, principal, agent, director, officer, joint venturer, partner, shareholder or other equity holder, lender or other debt holder, independent contractor, licensor, licensee, franchisor, franchisee, distributor, consultant, financier, supplier or trustee, or by or through any company, cooperative, partnership, trust, unincorporated association or otherwise, anywhere in North America:

  

 

(a)

carry on, be engaged in, have any financial or other interest in or be otherwise commercially involved in any endeavour, activity or business which is in competition with the Business of the Company;

 

 

 

 

(b)

canvass or solicit the business of (or procure or assist the canvassing or soliciting of the business of) any customer, prospective customer or supplier of the Company to supply or purchase any goods or services that are substantially the same as or in competition with goods or services supplied in the Business of the Company;

 

 

 

 

(c)

accept (or procure or assist the acceptance of) any business from any customer, prospective customer, sales personnel or supplier that is substantially the same as or in competition with the Business of the Company; or

 

 

 

 

(d)

supply (or procure or assist the supply of) any goods or services to any customer, prospective customer, sales personnel or supplier that are substantially the same as or in competition with the goods or services supplied in the Business of the Company.

  

 
- 9 -

 

  

7.3

During the Term, and for a period of twelve (12) months immediately following the termination or expiration of this Agreement, the Consultant agrees not to solicit or induce any customer, prospective customer, supplier, sales personnel, employee or independent contractor involved with the Company to terminate or breach any employment, contractual or other relationship with Company, or to otherwise discontinue or alter such third party’s relationship with the Company.

 

 

7.4

During the Term, and for a period of twelve (12) months immediately following the termination or expiration of this Agreement, the Consultant agrees not to, on its own behalf or on behalf of or in connection with any third party, directly or indirectly, in any capacity whatsoever, engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including without limitation the repetition or distribution of derogatory rumours, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity, reputation or goodwill of the Company or any of its affiliates, officers, directors, employees, consultants or advisors.

 

 

8.

GENERAL

 

 

8.1

This Agreement contains the entire Agreement and obligation between the parties with respect to its subject matter. No amendment to this Agreement will be valid or effective unless in writing and signed by all of the parties.

 

 

8.2

The Principal undertakes to ensure the Consultant fulfills all of its obligations under this Agreement, and not to do anything which would impair or prejudice the Consultant’s ability to do so. The Principal shall be jointly and severally liable with the Consultant for any breach by the Consultant of this Agreement. The Principal agrees that he is bound, along with the Consultant, in respect of the Consultant’s obligations in Sections 5, 6 and 7 of this Agreement.

 

 

8.3

The Consultant’s obligations under this Agreement are of a unique character that gives them particular value, and that the breach of any of these obligations will cause irreparable and continuing damage to the Company for which money damages are insufficient. The Company is entitled to injunctive relief, a decree for specific performance, and all other relief as may be proper (including money damages if appropriate), without the need to post a bond.

 

 

8.4

The Consultant and the Principal acknowledge that the restrictions contained in Sections 5, 6 and 7 are, in view of the nature of the Business of the Company, reasonable and necessary to protect the legitimate interests of the Company, that the Company would not have entered into this Agreement in the absence of such restrictions and that any violation of any provision of those Sections could result in irreparable injury to the Company. The Consultant agrees that, in the event it violates any of the restrictions referred to in Section 5, 6 and 7, the Company shall be entitled to such injunctive relief or other remedies at law or in equity which the Court deems fit.

  

 
- 10 -

 

  

8.5

The Consultant expressly acknowledges that this Agreement is reasonable and valid in all respects and irrevocably waives (and irrevocably agrees not to raise) as a defence any issue of reasonableness in any proceeding to enforce any provision of this Agreement, the intention of the parties being to provide for the legitimate and reasonable protection of the interests of the Company by providing, without limitation, for the broadest scope, the longest duration and the widest territory allowable by law.

 

 

8.6

The Consultant agrees to indemnify the Company from all losses, claims, actions, damages, assessments or demands (including reasonable legal fees and expenses) which result from negligent acts or omissions of the Consultant in providing the Services. Notwithstanding the foregoing, the Company agrees that the Consultant will be covered by the Company’s Directors & Officers and Employment Practices Liability Insurance, once such insurance is obtained by the Company.

 

 

8.7

Any notice, request, demand or other communication hereunder shall be in writing and shall be delivered as follows, with notice deemed given as indicated: (a) by personal delivery, when actually delivered; (b) by overnight courier, upon written verification of receipt; (c) by facsimile or email, when sent, if sent during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business day; or (e) by certified or registered mail, return receipt requested, upon verification of receipt. Notice to the Principal may be given at the same address as shown for the Consultant. Notice shall be sent to the addresses set forth on the first page of this Agreement or to such other address as the parties may advise each other in writing from time to time in accordance with this Section 8.7.

 

 

8.8

The Company and the Consultant will be responsible for all of their own expenses, legal and other professional fees, disbursements, and all other costs incurred in connection with the negotiation, preparation, execution and delivery of this Agreement and all documents and instruments relating hereto. The parties agree that they have had adequate opportunity to seek independent legal advice with respect to the subject matter of this Agreement, and have either obtained such advice or consciously chosen not to do so with full knowledge of the risks associated with not obtaining such legal advice.

 

 

8.9

If any provision of this Agreement, including as to term or geographical area, is held to be illegal, invalid or unenforceable under present or future laws by any court of competent jurisdiction, such illegality, invalidity or unenforceability shall not affect the legality, enforceability or validity of any other provisions of this Agreement or of the same provision as applied to any other fact or circumstance, and such illegal, unenforceable or invalid provision shall be modified to the minimum extent necessary to make such provision legal, valid or enforceable.

 

 

8.10

Time shall be of the essence of this Agreement.

  

 
- 11 -

 

  

8.11

Except as specifically permitted herein, the Consultant will not sell, assign or transfer any rights or interests created under this Agreement or delegate any of the Consultant’s duties without the prior written consent of the Company.

 

 

8.12

The headings in this Agreement are inserted for convenience of reference only and shall not affect the construction or interpretation of this Agreement. Wherever the singular or masculine or neuter is used in this Agreement, the same shall be construed as meaning the plural or feminine or a body politic or corporate and vice versa where the context so requires.

 

 

8.13

The parties agree that this Agreement is effective as of the Effective Date, and the parties agree that there is fresh, sufficient consideration for this Agreement. The parties waive the ability to claim that: (i) this Agreement is void for lack of fresh, sufficient consideration, and (ii) this Agreement is not effective as of the Effective Date.

 

 

8.14

This Agreement will be governed by and construed in accordance with the laws of the Province of British Columbia, and the federal laws of Canada applicable therein, and each of the parties irrevocably submit to the exclusive jurisdiction of courts of competent jurisdiction in the Province of British Columbia, without reference to its conflicts of law jurisprudence, in respect of any dispute or claim arising out of this Agreement or any legal obligation between the parties. Notwithstanding the foregoing, the Company may enforce any obligation of the Consultant or the Principal which continues after the Consultant ceases providing the Services under this Agreement in any court of competent jurisdiction.

 

 

8.15

This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which taken together shall be deemed to constitute one and the same instrument. Counterparts may be executed either in original or electronic form and each of the parties to this Agreement agree that any signature delivered by electronic transmission will be deemed to be the original signature of the delivering party.

 

 

8.16

Unless otherwise provided, all dollar amounts referred to in this Agreement are in lawful money of Canadian.

 

(Signature page follows)

 

 
- 12 -

 

 

IN WITNESS WHEREOF, the parties have signed this Agreement as of the day and year first written above.

 

DRAGANFLY INC.

 

1502372 ALBERTA LTD.

by its authorized signatory

 

by its authorized signatory

 

 

 

/s/ Paul Sun

 

/s/ Cameron Chell

Name: Paul Sun
Title: Chief Financial Officer

Name: Cameron Chell

Title:

 

 

 

 

 

 /s/ Cameron Chell

 

 

CAMERON CHELL

 

 

Principal of 1502372 ALBERTA LTD.

 

 
- 13 -

 

 

SCHEDULE A

 

SERVICES

 

Defined terms used but not otherwise defined in this Schedule A have the meaning ascribed thereto in the Independent Consultant Agreement dated effective October 1, 2019 (the “Agreement”) between Cameron Chell (“Consultant”) and Draganfly Innovations Inc. (the “Company”) of which this Schedule A forms part.

 

The Services to be provided by the Consultant under the Agreement are as follows:

 

 

1.

Communicating, on behalf of the Company, with shareholders, government entities, and the public

 

2.

Leading the development of the Company’s short- and long-term strategy

 

3.

Creating and implementing the Company or organization’s vision and mission

 

4.

Maintaining awareness of the competitive market landscape, expansion opportunities, industry developments, etc.

 

5.

Ensuring that the Company maintains high social responsibility wherever it does business

 

6.

Assessing risks to the Company and ensuring they are monitored and minimized

 

7.

Setting strategic goals and making sure they are measurable and describable

  

 

 

EXHIBIT  6.2

 

 

October 21, 2019

 

Patrick Imbasciani

9010 Grassington Way

Raleigh NC 27615

 

Dear Patrick,

 

This letter confirms that Draganfly Innovations Inc. (“Company”) has offered you employment on the following terms, to begin October 21, 2019:

 

 

1.

Your initial position will be Chief Operating Officer, Draganfly Inc.

 

 

 

 

2.

Your annual compensation shall be $118,800 USD. To be reviewed annually based on the responsibilities outlined in Schedule A.

 

 

 

 

3.

Initial commission structure is 5% of Draganfly Innovations Inc. overall new sales where the margin is over 35%. Management commits to reviewing commission structure such that it's reflective of individual and company sales on an annual basis. Commission structure will also be reviewed when a new sales person is hired by end of Q1 2020.

 

 

 

 

4.

A $5,000 bonus payable upon meeting the board-approved Draganfly Innovations Inc. annual sales goal, and an extra $5,000 if new Draganfly Innovations Inc. sales revenue generated by you is over $1M.

 

 

 

 

5.

Participation in the Company option pool with an issuance of 500,000 options. Vesting criteria will be in line with company policy.

 

 

 

 

6.

The Company shall pay for or provide you with the standard-market health insurance benefits.

 

 

 

 

 

You acknowledge and understand that all benefits of employment, including long-term disability coverage, will cease as of your last day actively at work for the Company, regardless of the reason for the cessation of your employment, and further, the Company has no liability for any damages caused by the cessation of such benefits.

 

 

 

 

 

 

7.

As an employee of the Company, you will receive fifteen paid vacation days annually.

 

 

 

 

8.

You shall be reimbursed for reasonable and necessary business expenses authorized and verified to the Company’s satisfaction.

 

 

 

 

9.

Your employment is at will. Either you or the Company may terminate this employment relationship at any time for any reason with or without cause. Two weeks notice would be expected from you and would be given to you (or pay in lieu of notice) absent unusual circumstances.

 

 

 

 

10.

Your employment is contingent upon your execution of the Company’s Non-Disclosure Agreement.

 

 

 

 

11.

The Company and you hereby mutually agree to arbitrate any and all differences, claims, or disputes of every kind (statutory or other) arising out of your employment or its termination. Such arbitration would be in Raleigh, North Carolina, or another mutually agreed upon location, before the American Arbitration Association, and in lieu of any court action.

 

 

 

 

12.

Your employment shall be governed by North Carolina labor law.

 

No other promises or representations have been made to you.

 

Please sign in the space provided below to indicate your acceptance of this offer and return it by October 25, 2019.

 

Please note that this offer is subject to board approval.

 

Sincerely,

 

Cameron Chell

Chairman

cameron@businessinstincts.com

 (310)658-4413

 

 

            October 22, 2019                   

By signing, I accept the above engagement.                         Date

 

 

 

 

 

SCHEDULE A

 

JOB DESCRIPTION

 

Responsibilities include:

 

Job Duties

 

 

Chief Operating Officer

 

 

 

 

·

Working with the Board and Draganfly’s Chief Executive Officer (“CEO”) to develop the strategy for the Company’s future growth.

 

 

 

 

·

Working with key members of the Draganfly team including executive team and operating subsidiaries to ensure operating excellence.

 

 

 

 

·

·Oversight and management of customer billing and management.

 

 

 

 

·

Employing various initiatives to coach employees to optimize their capabilities and promote culture.

 

 

 

 

·

Work with the finance team as needed as a senior executive of the company.

 

 

 

 

·

Overseeing marketing initiatives and implementing better business practices.

 

 

 

 

·

Delegating responsibilities to ensure staff members grow as capable participants.

 

 

 

 

·

Completing performance reviews in a prudent manner.

 

 

 

 

·

Assessing and implementing improved processes and new technologies, and collaborating with management regarding the implementation of these improvements.

 

 

 

 

·

Working with Draganfly’s executive to identify opportunities for value-enhancing strategic sales initiatives, joint ventures, and strategically important relationships, and working with the CEO and Senior Executives on strategic matters on the pursuit of such strategic initiatives.

 

 

 

 

·

Taking the lead in developing and maintaining Draganfly relationships with future strategic partners and investors whose capital, influence, and knowledge could add significantly to the Company’s value and its share price.

 

 

Sales Role

 

 

 

 

·

Work with members of the executive to build and execute on our sales strategy.

 

 

 

 

·

Actively manage and mentor members of the sales team to hit targets and manage prospective customers through sales life cycle.

 

 

 

 

·

Recruiting, growing, and managing the sales team.

 

 

 

 

·

Actively prospect and qualify new business opportunities with new and existing clients.

 

 

 

 

·

Ongoing follow up with clients to detail satisfaction and ongoing business.

 

 

 

 

·

Grow and manage an active sales pipeline.

 

 

 

 

·

Identify key decision-makers in existing and potential clients.

 

 

 

 

·

Attend networking events to meet with future customers.

 

 

 

 

·

Develop and measure sales KPIs.

 

 

 

 

·

Provide required reporting on sales pipeline.

 

 

  EXHIBIT 6.3

 

Execution Version

 

 

SHARE PURCHASE AGREEMENT

 

BETWEEN

 

EACH PERSON IDENTIFIED AS A “SELLER” IN SCHEDULE A

 

– and –

 

DRAGANFLY INC.

 

– and –

 

DRONELOGICS SYSTEMS INC.

 

JANUARY 15, 2020

 

 

 

 

TABLE OF CONTENTS

   

 

 

Page

 

 

 

 

 

 

ARTICLE 1 INTERPRETATION

1

 

 

 

 

 

 

1.1

Definitions

 

1

 

1.2

Certain Rules of Interpretation

 

9

 

1.3

Governing Law

 

9

 

1.4

Entire Agreement

 

9

 

1.5

Schedules, Exhibits and Disclosure Letter

 

10

 

 

 

 

 

 

ARTICLE 2 PURCHASE AND SALE

10

 

 

 

 

 

 

2.1

Agreement of Purchase and Sale

 

10

 

2.2

Purchase Price

 

10

 

2.3

Allocation of Payments

 

11

 

2.4

Payment of Purchase Price

 

11

 

2.5

Estimated Closing Date Working Capital

 

11

 

2.6

Final Closing Date Working Capital

 

12

 

2.7

Disputes

 

12

 

2.8

Purchase Price Adjustment

 

12

 

2.9

Adjustment Payments

 

13

 

2.10

Payment of Management Bonuses

 

13

 

2.11

Excluded Business

 

13

 

 

 

 

 

 

ARTICLE 3 REPRESENTATIONS AND WARRANTIES

14

 

 

 

 

 

 

3.1

Representations Relating to the Sellers

 

14

 

3.2

Representations Relating to the Corporation

 

15

 

3.3

Representations Relating to the Buyer

 

22

 

 

 

 

 

 

ARTICLE 4 COVENANTS

24

 

 

 

 

 

 

4.1

Conduct of Business Before Closing

 

24

 

4.2

Consents Under Material Contracts

 

24

 

4.3

Actions to Satisfy Closing Conditions

 

25

 

4.4

Notification of Change

 

25

 

4.5

Exclusivity

 

25

 

4.6

Confidential Information

 

26

 

4.7

Personal Information

 

26

 

4.8

Indemnification

 

27

 

4.9

Right to Place and Trading Restrictions on the Consideration Shares

 

27

 

4.10

Nomination Right

 

29

 

4.11

Access to Books and Records

 

29

 

4.12

Review of Interim Financial Statements

 

30

 

4.13

Completion of Cinematography Spinout – Pre-Closing

 

30

 

4.14

Grant of Stock Options to Certain Employees of the Corporation – Post-Closing

 

30

 

4.15

CSE Filing

 

30

 

 

-i-

 

 

TABLE OF CONTENTS

(continued)

  

 

 

Page

 

 

 

 

 

 

ARTICLE 5 CLOSING CONDITIONS

30

 

 

 

 

 

 

5.1

Conditions for the Benefit of the Buyer

 

30

 

5.2

Conditions for the Benefit of the Sellers

 

32

 

5.3

Mutual Conditions Precedent

 

33

 

 

 

 

 

 

ARTICLE 6 CLOSING ARRANGEMENTS

34

 

 

 

 

 

 

6.1

Closing

 

34

 

6.2

Closing Deliveries

 

34

 

 

 

 

 

 

ARTICLE 7 TERMINATION

34

 

 

 

 

 

 

7.1

Termination Rights

 

34

 

7.2

Effect of Termination

 

35

 

 

 

 

 

 

ARTICLE 8 INDEMNIFICATION AND SURVIVAL

35

 

 

 

 

 

 

8.1

Indemnification by the Sellers

 

35

 

8.2

Indemnification by the Buyer

 

36

 

8.3

Survival Periods for Claims by Buyer Indemnified Parties

 

36

 

8.4

Survival Periods for Claims by Seller Indemnified Parties

 

37

 

8.5

Amount Limitations on Indemnification Obligations

 

37

 

8.6

Rules Relating to Indemnification Obligations

 

38

 

8.7

Notice of Indemnity Claims

 

39

 

8.8

Payment of Claims

 

39

 

8.9

Exclusive Remedy

 

40

 

8.10

Third Party Indemnification

 

40

 

 

 

 

 

 

ARTICLE 9 GENERAL

40

 

 

 

 

 

 

9.1

Time of Essence

 

40

 

9.2

Notices

 

40

 

9.3

Severability

 

42

 

9.4

Submission to Jurisdiction

 

42

 

9.5

Amendment and Waiver

 

42

 

9.6

Further Assurances

 

42

 

9.7

Assignment and Enurement

 

43

 

9.8

Counterparts and Electronic Delivery

 

43

 

9.9

Payment and Currency

 

43

 

9.10

No Contra Proferentem

 

43

 

9.11

Public Announcements

 

43

 

9.12

Cost and Expenses

 

43

 

 

-ii-

 

 

SHARE PURCHASE AGREEMENT

 

THIS AGREEMENT is dated as of January 15, 2020

 

BETWEEN:

 

Each Person identified as a “Seller” in Schedule A

 

(each, a “Seller” and, collectively, the “Sellers”)

 

- and -

 

DRAGANFLY INC., a company incorporated under the laws of British Columbia

 

(the “Buyer”)

 

- and -

 

DRONELOGICS SYSTEMS INC., a company incorporated under the laws of British Columbia

 

(the “Corporation”)

 

CONTEXT:

 

A.

The Sellers collectively own all of the issued and outstanding shares in the capital of the Corporation.

 

 

B.

The Sellers want to sell to the Buyer and the Buyer wants to purchase from the Sellers all of the issued and outstanding shares in the capital of the Corporation, on the terms and subject to the conditions set out in this Agreement.

 

 

C.

The offer to acquire the issued and outstanding shares in the capital of the Corporation is an exempt takeover bid in accordance with Section 4.3 of National Instrument 62-104 – Take-Over Bids and Issuer Bids

 

THEREFORE, for valuable consideration the receipt and sufficiency of which are hereby acknowledged by the Parties, the Parties covenant and agree as follows:

 

ARTICLE 1
INTERPRETATION

 

1.1

Definitions

 

In this Agreement, in addition to terms defined elsewhere in this Agreement, the following terms have the following meanings:

 

1.1.1

Accounting Principles” means IFRS, applied on a basis consistent with the preparation of the Financial Statements, but to the extent that there is any inconsistency between IFRS and the basis on which the Financial Statements were prepared, “Accounting Principles” means consistent with the basis on which the Financial Statements were prepared.

 

 

 

- 2 -

 

 

1.1.2

Advisory Fee” means an advisory fee of $60,000 payable by the Buyer to financial advisors engaged by the Buyer.

 

 

1.1.3

Agreement” means this agreement, including all Schedules, Exhibits and the Disclosure Letter, as it may be confirmed, amended, supplemented or restated by written agreement between the Parties.

 

 

1.1.4

Alternate Nominee” is defined in Section 4.10.4.

 

 

1.1.5

Audit Expenses” means cost and expenses of the Corporation’s audit fees to be completed by DMCL.

 

 

1.1.6

Annual Financial Statements” means the audited financial statements of the Corporation as at and for the year ended December 31, 2018, attached as Schedule C to this Agreement.

 

 

1.1.7

Books and Records” means all books and records of the Corporation within the control of the Sellers relating to the Corporation, including but not limited to contracts, books, customer and supplier lists, employee lists, technical reports, data, accounts, records, filings, maps, documents, files and all other information (and including all such books and records stored in electronic format or any other media form), other than those relating to the Excluded Assets.

 

 

1.1.8

Broker” is defined in Section 2.4.1.2.

 

 

1.1.9

Business” means the business of selling unmanned aerial vehicles and related services carried on by the Corporation, which, for greater certainty, excludes the Excluded Business.

 

 

1.1.10

Business Day” means any day excluding a Saturday, Sunday or statutory holiday in the Province of British Columbia.

 

 

1.1.11

Buyer” is defined in the recital of the Parties above.

 

 

1.1.12

Buyer Board” is defined in Section 4.10.1.

 

 

1.1.13

Buyer Shares” is defined in Section 2.2.2.

 

 

1.1.14

Buyer Shareholders” is defined in Section 4.10.1.

 

 

1.1.15

Buyer Indemnified Parties” means the Buyer and its directors, officers, shareholders, agents and employees.

 

 

1.1.16

Cash Amount” is defined in Section 2.2.1.

 

 

1.1.17

Cinematography Spinout” is defined in Section 2.11.1.

 

 

1.1.18

Closing” means the completion of the transaction of purchase and sale contemplated by this Agreement.

 

 

1.1.19

Closing Certificates” means the certificates to be delivered under Sections 5.1.5.1, 5.1.5.2 and 5.2.4.1.

 

 

 

- 3 -

 

 

1.1.20

Closing Date” means the date that is five (5) Business Days following the date on which the last of the conditions of Closing set out in Article 5 (other than those conditions that by their nature can only be satisfied on the Closing Date) have been satisfied or waived by the applicable Party, or any other date that the Parties may otherwise agree to in writing.

 

 

1.1.21

Closing Time” means 10:00 a.m. (Vancouver time) on the Closing Date or any other time on the Closing Date as may be agreed in writing by the Parties.

 

 

1.1.22

Communication” means any notice, demand, request, consent, approval or other communication which is required or permitted by this Agreement to be given or made by a Party.

 

 

1.1.23

Confidential Information” means all information, in whatever form communicated or maintained, whether orally, in writing, electronically, in computer readable form or otherwise, of the Sellers and the Corporation, including: (i) information that contains or otherwise reflects information concerning its businesses, affairs, financial condition, assets, liabilities, operations, prospects or activities, budgets, business plans, business results, customer lists, forecasts, evaluations, legal opinions, names of partners and contractual parties; and (ii) all plans, proposals, reports, analyses, notes, studies, forecasts, compilations or other information, that are derived from or contain any Confidential Information regardless of the identity of the Person preparing the same.

 

 

1.1.24

Consideration Shares” is defined in Section 2.2.

 

 

1.1.25

Corporation” is defined in the recital of the Parties above.

 

 

1.1.26

CSE” means the Canadian Securities Exchange.

 

 

1.1.27

Current Assets” means the current assets of the Corporation, calculated in accordance with the Accounting Principles, provided that Current Assets will not include the Excluded Assets.

 

 

1.1.28

Current Liabilities” means the current liabilities of the Corporation, calculated in accordance with the Accounting Principles.

 

 

1.1.29

Decrease” is defined in Section 2.8.1.

 

 

1.1.30

Disclosure Letter” means the disclosure letter dated the date of this Agreement and delivered by the Sellers to the Buyer with this Agreement, as it may be amended pursuant to Section 4.4.

 

 

1.1.31

Dispute Notice” is defined in Section 2.6.

 

 

1.1.32

DMCL” means Dale Matheson Carr-Hilton Labonte LLP, Chartered Professional Accountants.

 

 

1.1.33

Encumbrance” means any security interest, mortgage, charge, pledge, hypothec, lien, encumbrance, restriction, option, adverse claim or other encumbrance of any kind.

 

 

1.1.34

Estimated Closing Date Working Capital” is defined in Section 2.5.

 

 

 

- 4 -

 

 

1.1.35

Excluded Assets” means certain cinematography assets of the Corporation that will be excluded from the assets of the Corporation prior to Closing pursuant to the Cinematography Spinout, as set out in Schedule B.

 

 

1.1.36

Excluded Business” means the business of: (i) providing cinematography, scanning services related to cinematography and virtual reality and game design related solely to cinematography in Canada, including by using drones, and (ii) development and sale of associated hardware world-wide (including the VersaArm and other camera arms) and accessories, other than drones; and in each case, related services carried on by the Corporation, for which the Excluded Assets are used, and which, for greater certainty, will not be acquired by the Buyer under this Agreement.

 

 

1.1.37

Final Closing Date Working Capital” is defined in Section 2.6.

 

 

1.1.38

Final Interim Financial Statements” is defined in Section 4.12.

 

 

1.1.39

Final Financial Statements” is defined in Section 4.12.

 

 

1.1.40

Financial Statements” means:

 

 

1.1.40.1

the Annual Financial Statements; and

 

 

 

 

1.1.40.2

the Interim Financial Statements,

 

 

 

 

in each case, as may be adjusted to carve out the Excluded Business.

 

1.1.41

Finder’s Fee” means the finder’s fee payable to David Martin in the amount of $100,000 payable in 200,000 Buyer Shares at a deemed price of $0.50 per share.

 

 

1.1.42

Fundamental Contract” means a Material Contract except reference to $20,000 in 1.1.58.1 is replaced with $50,000.

 

 

1.1.43

Free-trading Shares” is defined in Section 4.9.1.

 

 

1.1.44

Governmental Authority” means:

 

 

1.1.44.1

any federal, provincial, state, local, municipal, regional, territorial, aboriginal, or other government, governmental or public department, branch, ministry, or court, domestic or foreign, including any district, agency, commission, board, arbitration panel or authority and any subdivision of any of them exercising or entitled to exercise any administrative, executive, judicial, ministerial, prerogative, legislative, regulatory, or taxing authority or power of any nature; and

 

 

 

 

1.1.44.2

any quasi-governmental or private body exercising any regulatory, expropriation or taxing authority under or for the account of any of them, and any subdivision of any of them.

 

1.1.45

IFRS” means the International Financial Reporting Standards.

 

 

1.1.46

Increase” is defined in Section 2.8.2.

 

 

 

- 5 - 

 

 

1.1.47

Indemnified Party” means a Buyer Indemnified Party or a Seller Indemnified Party.

 

 

1.1.48

Indemnifying Party” means the Party providing indemnification under any provision of Article 8.

 

 

1.1.49

Indemnity Claim” is defined in Section 8.7.

 

 

1.1.50

Indemnity Notice” is defined in Section 8.7.

 

 

1.1.51

Intellectual Property” means domestic and foreign intellectual property rights, including: (i) patents, applications for patents and reissues, divisions, continuations, renewals, extensions and continuations-in-part of patents or patent applications; (ii) copyrights, copyright registrations and applications for copyright registration; (iii) mask works, mask work registrations and applications for mask work registrations; (iv) designs, design registrations, design registration applications and integrated circuit topographies and (v) trade names, business names, corporate names, domain names, website names and world wide web addresses, common law trade-marks, trade-mark registrations, trade mark applications, trade dress and logos, and the goodwill associated with any of the foregoing.

 

 

1.1.52

Interim Financial Statements” means the unaudited interim financial statements of the Corporation as at and for the nine-month period ended September 30, 2019, a draft version of which is attached as Schedule C to this Agreement.

 

 

1.1.53

ITA” means the Income Tax Act (Canada).

 

 

1.1.54

Knowledge of the Sellers” means the knowledge that each of Richard Cochrane or Justin Hannewyk either has, or would have obtained, after having made or caused to be made all reasonable inquiries necessary to obtain informed knowledge, including inquiries of the records and of management employees who are reasonably likely to have knowledge of the relevant matter.

 

 

1.1.55

Loss” means any losses, damages, penalties, liabilities, costs, charges and expenses (including, without limitation, reasonable legal fees and expenses).

 

 

1.1.56

made available” means: (i) delivered to Buyer in paper copy; or (ii) uploaded in electronic form to Seller’s data room on DropBox at least two (2) Business Days prior to the date of this Agreement; or (iii) delivered to Buyer’s legal counsel, Gowling WLG (Canada) LLP, at least two (2) Business Days prior to the date of this Agreement.

 

 

1.1.57

Material Adverse Effect” means an effect resulting from any change, event, occurrence or state of facts, either individually or in the aggregate, that:

 

 

1.1.57.1

is or would reasonably be expected to be, material and adverse to the business, condition (financial or otherwise), properties, assets (tangible or intangible), liabilities (whether absolute, accrued, conditional, contingent or otherwise), capitalization, operations, or results of operations of the Corporation; or

 

 

 

 

1.1.57.2

would, or would reasonably be expected to, materially impair or delay the consummation of the transactions contemplated by this Agreement,

 

 

 

- 6 -

 

 

 

except that:

 

 

1.1.57.3

any change, event, occurrence or state of facts relating to:

 

 

1.1.57.3.1

conditions affecting the industry of the Corporation generally or conditions affecting the industry of the Corporation in jurisdictions in which the Corporation carries on business, including changes in commodity prices, generally accepted accounting principles, laws or taxes;

 

 

 

 

1.1.57.3.2

general economic conditions, or financial, credit, currency exchange, securities or commodities markets in general; or

 

 

 

 

1.1.57.3.3

war, armed hostilities or acts of terrorism,

 

 

 

 

will not result in a Material Adverse Effect unless it adversely affects the Corporation disproportionately, compared to other businesses of similar size operating in the same industry as the Corporation;

 

 

1.1.57.4

the failure of the Corporation to meet any internal or published projections or estimates of revenues, cash flow or earnings, in and of itself, will not constitute or result in a Material Adverse Effect (but the state of facts underlying that failure may be considered to determine whether that state of facts results in a Material Adverse Effect);

 

 

 

 

1.1.57.5

any change, event, occurrence or state of facts resulting from or connected to the transfer of the Excluded Business pursuant to the Cinematography Spinout will not result in a Material Adverse Effect; and

 

 

 

 

1.1.57.6

any action taken (or not taken) by a Seller or the Corporation that is required to be taken (or not taken) under this Agreement or that is consented to by the Buyer in writing will not result in a Material Adverse Effect.

 

1.1.58

Material Contract” means a contract to which the Corporation is a party or is bound that:

 

 

1.1.58.1

involves or would result in the payment of money or money’s worth by or to the Corporation in an amount in excess of $20,000;

 

 

 

 

1.1.58.2

has an unexpired term of more than one (1) year (including renewals);

 

 

 

 

1.1.58.3

cannot be terminated by the Corporation without penalty upon less than 30 days’ notice; or

 

 

 

 

1.1.58.4

the termination of which, or under which the loss of rights, would result in a Material Adverse Effect.

 

1.1.59

Nominee” is defined in Section 4.10.1.

 

 

1.1.60

Notice” is defined in Section 4.9.3.1.

 

 

1.1.61

Offer Period” is defined in Section 4.9.3.3.

 

 

 

- 7 -

 

 

1.1.62

ordinary course”, “ordinary course of business” or any similar reference, means with respect to an action taken by the Corporation, that such action is consistent with the past practice of the Corporation and is taken in the ordinary course of the normal day-to-day business and operations of the Corporation.

 

 

1.1.63

Outside Date” means March 16, 2020.

 

 

1.1.64

Parties” means the Sellers, the Corporation and the Buyer, collectively, and “Party” means any one of them.

 

 

1.1.65

Permits” means the authorizations, registrations, permits, certificates of approval, approvals, grants, licences, quotas, consents, commitments, rights or privileges (other than those relating to Intellectual Property) issued or granted by any Governmental Authority to the Corporation.

 

 

1.1.66

Permitted Encumbrances” means:

 

 

1.1.66.1

unregistered liens for municipal taxes, assessments or similar charges incurred by the Corporation in the ordinary course of the Business that are not yet due and payable;

 

 

 

 

1.1.66.2

inchoate mechanic’s, construction and carrier’s liens and other similar liens arising by operation of law or statute in the ordinary course of the Business for obligations which are not delinquent and will be paid or discharged in the ordinary course of the Business;

 

 

 

 

1.1.66.3

unregistered Encumbrances of any nature claimed or held by Her Majesty The Queen in Right of Canada, Her Majesty The Queen in right of any province of Canada in which the real property owned or leased by the Corporation is located, or any Governmental Authority under any applicable law, except for unregistered liens for unpaid realty taxes, assessments and public utilities;

 

 

 

 

1.1.66.4

title defects which are of a minor nature and in the aggregate do not materially impair the value or use of the real property owned or leased by the Corporation, or any of the premises located on that real property;

 

 

 

 

1.1.66.5

any right of expropriation conferred upon, reserved to or vested in Her Majesty The Queen in Right of Canada, Her Majesty The Queen in right of any province of Canada in which the real property owned or leased by the Corporation is located, or any Governmental Authority under any applicable law;

 

 

 

 

1.1.66.6

zoning restrictions, easements and rights of way or other similar Encumbrances or privileges in respect of real property which in the aggregate do not materially impair the value or use of the real property owned or leased by the Corporation, or any of the premises located on that real property;

 

 

 

 

1.1.66.7

Encumbrances created by others upon other lands over which there are easements, rights-of-way, licences or other rights of user in favour of the real property owned or leased by the Corporation, or any of the premises located on that real property, and which do not materially impede the use of the easements, rights-of-way, licences or other rights of user for the purposes for which they are held;

 

 

 

- 8 -

 

 

 

1.1.66.8

any Encumbrance which the Buyer has expressly agreed to assume or accept under this Agreement;

 

 

 

 

1.1.66.9

the reservations, limitations, provisos, conditions, restrictions and exceptions in the letters patent or grant, as the case may be, from the Crown and statutory exceptions to title; or

 

 

 

 

1.1.66.10

those instruments registered on title to or against the real property leased by the Corporation or any of the premises located on that real property, and described in the Disclosure Letter.

 

1.1.67

Person” means an individual, partnership, limited partnership, limited liability partnership, corporation, limited liability company, unlimited liability company, joint stock company, trust, unincorporated association, joint venture or other entity or Governmental Authority, and pronouns have a similarly extended meaning.

 

 

1.1.68

Personal Information” means information about an individual who can be identified by the Person who holds that information.

 

 

1.1.69

Placee Shareholder” is defined in Section 4.9.3.1.

 

 

1.1.70

Pro Rata Share” means, with respect to any Seller, the percentage set out in Schedule A opposite that Seller’s name under the heading “Pro Rata Share of Seller”.

 

 

1.1.71

Public Record” means all information filed by or on behalf of the Buyer or any predecessor entity with the Canadian securities regulatory authorities in compliance, or intended compliance, with applicable securities laws, including under the Buyer’s profile on SEDAR at www.sedar.com.

 

 

1.1.72

Purchase Price” is defined in Section 2.2.

 

 

1.1.73

Purchased Shares” means all of the issued and outstanding shares of the Corporation.

 

 

1.1.74

Seller” and “Sellers” are defined in the recital of the Parties above.

 

 

1.1.75

Seller Indemnified Parties” means each Seller and, as applicable, their respective agents and Successors.

 

 

1.1.76

Shareholders Agreement” means the shareholders agreement dated June 1, 2016 between the Sellers and the Corporation.

 

 

1.1.77

Subject Shares” is defined in Section 4.9.3.2.

 

 

1.1.78

Successors” means, as applicable, the heirs, executors, administrators, estate trustees, trustees, personal or legal representatives, affiliates, successors and permitted assigns of a Person.

 

 

 

- 9 - 

 

 

1.1.79

Target Closing Working Capital” means $186,312.

 

 

1.1.80

Third Party Claim” means a claim made against an Indemnified Party by a Person who is not a Party.

 

 

1.1.81

Transition Services Agreement” is defined in Section 2.11.3.

 

 

1.1.82

Working Capital Dispute” is defined in Section 2.6.

 

 

1.2

Certain Rules of Interpretation

 

 

1.2.1

Gender, etc. In this Agreement, words signifying the singular number include the plural and vice versa, and words signifying gender include all genders.

 

 

1.2.2

Including. Every use of the words “including” or “includes” in this Agreement is to be construed as meaning “including, without limitation” or “includes, without limitation”, respectively.

 

 

1.2.3

Division and Headings. The division of this Agreement into Articles and Sections, the insertion of headings and the inclusion of a table of contents are for convenience of reference only and do not affect the construction or interpretation of this Agreement.

 

 

1.2.4

Articles, Sections, etc. References in this Agreement to an Article, Section, Schedule or Exhibit are to be construed as references to an Article, Section, Schedule or Exhibit of or to this Agreement unless otherwise specified.

 

 

1.2.5

Statutory Instruments. Unless otherwise specified, any reference in this Agreement to any statute includes all regulations and subordinate legislation made under or in connection with that statute at any time, and is to be construed as a reference to that statute as amended, restated, supplemented, extended, re-enacted, replaced or superseded at any time.

 

 

1.2.6

Non-Business Days. Whenever payments are to be made or an action is to be taken on a day which is not a Business Day, such payment shall be made or such action shall be taken on or not later than the next succeeding Business Day.

 

1.3

Governing Law

 

This Agreement is governed by and is to be construed and interpreted in accordance with the laws of the Province of British Columbia and the laws of Canada applicable in that Province.

 

1.4

Entire Agreement

 

This Agreement constitutes the entire agreement between the Parties pertaining to the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, of the Parties, and there are no representations, warranties or other agreements between the Parties, express or implied, in connection with the subject matter of this Agreement except as specifically set out in this Agreement. No Party has been induced to enter into this Agreement in reliance on, and there will be no liability assessed, either in tort or contract, with respect to, any warranty, representation, opinion, advice or assertion of fact, except to the extent it has been reduced to writing and included in this Agreement.

 

 

 

- 10 -

 

 

1.5

Schedules, Exhibits and Disclosure Letter

 

The Disclosure Letter forms an integral part of this Agreement for all purposes of it. The following is a list of Schedules and Exhibits:

 

Schedule

 

Subject Matter

 

Schedule A

 

Sellers

 

Schedule B

 

Excluded Assets

 

Schedule C

 

Financial Statements

 

Schedule D

 

Target Closing Working Capital

 

Schedule E

 

Cinematography Spinout Related Steps

 

Schedule G

 

List of Employees of the Corporation being granted Stock Options at Closing

 

Schedule F

 

Transition Services Agreement Commercial Terms

 

Exhibit

 

Subject Matter

 

5.1.5.5

 

Form of Employment Agreements

 

5.1.5.7

Form of Mutual Release

 

ARTICLE 2
PURCHASE AND SALE

 

2.1

Agreement of Purchase and Sale

 

Subject to the terms and conditions of this Agreement, on the Closing Date, the Sellers will sell, and the Buyer will purchase, the Purchased Shares.

 

2.2

Purchase Price

 

The aggregate purchase price (the “Purchase Price”) payable by the Buyer to the Sellers for the Purchased Shares will be $2,000,000, plus the amount, if any, by which the Estimated Closing Date Working Capital exceeds the Target Closing Working Capital determined in accordance with Section 2.2.3, plus any Buyer Shares issuable in accordance with Section 2.10, and to be paid as follows:

 

 

2.2.1

$500,000 in cash (the “Cash Amount”);

 

 

 

 

2.2.2

3,000,000 common shares in the authorized capital of the Buyer (the “Buyer Shares”) at a deemed price of $0.50 per share;

 

 

 

 

2.2.3

Plus the amount by which the Estimated Closing Date Working Capital exceeds the Target Closing Working Capital, if any, in Buyer Shares at the price per share determined in accordance with Section 2.2.2 above; and

 

 

 

 

2.2.4

Plus Buyer shares at the price per share determined in accordance with Section 2.2.2 above as payment of the management bonuses, as contemplated in Section 2.10;

 

 

 

 

 

(the Buyer Shares issuable to the Sellers under 2.2.2, 2.2.3 and 2.2.4 are collectively referred to as the “Consideration Shares”),

 

 

 

- 11 -

 

 

subject to adjustment for any Increase or Decrease after the Closing in accordance with Section 2.8 (Purchase Price Adjustment).

 

2.3

Allocation of Payments

 

The Purchase Price will be allocated to each Seller based on that Seller’s Pro Rata Share. other than with respect to the payment of the management bonuses pursuant to Section 2.2.4, which shall be allocated to the respective Sellers. Any payments or issuance of Buyer Shares made by or to the Sellers under this Article 2 must be made by or to each Seller in accordance with Section 2.4.

 

2.4

Payment of Purchase Price

 

The Buyer will pay and satisfy the Purchase Price, subject to adjustment after the Closing in accordance with Section 2.8 (Purchase Price Adjustment), as follows:

 

2.4.1

at the Closing Time, the Buyer will make the following deliveries and payments to the Sellers:

 

 

2.4.1.1

a cash payment in the amount of $250,000 by wire transfer or certified bank draft of immediately available funds to Justin Hannewyk;

 

 

 

 

2.4.1.2

2,100,000 of the Consideration Shares set out in Section 2.2.2 plus 65% of that number of Consideration Shares as determined in accordance with Section 2.2.3, if any, plus the Consideration Shares set out in Section 2.2.4 issuable to him in accordance with Section 2.10.1.1, all registered in the name of Justin Hannewyk and delivered in accordance with the instructions provided by Justin Hannewyk in writing and deposited with Rod Clark at Mackie Research Capital Corporation or such other broker agreeable with the Buyer, acting reasonably (the “Broker”);

 

 

 

 

2.4.1.3

a cash payment in the amount of $250,000 by wire transfer or certified bank draft of immediately available funds to Richard Cochrane; and

 

 

 

 

2.4.1.4

900,000 of the Consideration Shares set out in Section 2.2.2 plus 35% of that number of Consideration Shares as determined in accordance with Section 2.2.3, if any, plus the Consideration Shares set out in Section 2.2.4 issuable to him in accordance with Section 2.10.1.2, all registered in the name of Richard Cochrane and delivered in accordance with the instructions provided by Richard Cochrane in writing and deposited with the Broker.

 

2.5

Estimated Closing Date Working Capital

 

Not less than 3 Business Days before the Closing Date, the Sellers will cause the Corporation to deliver to the Buyer a balance sheet of the Corporation as at the Closing Date which will reflect good faith estimates by the Corporation of the Current Assets and the Current Liabilities (the “Estimated Closing Date Working Capital”), which will be prepared in accordance with the preparation of the Target Closing Working Capital attached as Schedule D. The Estimated Closing Date Working Capital will be accompanied by a copy of the working papers of the Corporation used in its preparation, together with any other evidence supporting the amounts specified in the Estimated Closing Date Working Capital as the Buyer may reasonably request. The Corporation will provide the Buyer with a reasonable opportunity to review and provide good faith comments on a draft of the Estimated Closing Date Working Capital before the final version is delivered at Closing, and the Estimated Closing Date Working Capital will be subject to the approval of the Buyer, which approval will not be unreasonably withheld or delayed.

 

 

 

- 12 -

 

 

2.6

Final Closing Date Working Capital

 

No later than 90 days after the Closing Date, the Buyer will prepare and deliver to the Sellers a balance sheet of the Corporation as at the Closing Date, which will be prepared in a manner consistent with preparation of the Estimated Closing Date Working Capital (the “Final Closing Date Working Capital”). The Final Closing Date Working Capital will include final calculations of the Current Assets and the Current Liabilities. The Sellers (acting jointly) may notify the Buyer that they accept or dispute the Final Closing Date Working Capital at any time within 10 Business Days after receiving it, but will be deemed to have accepted it on the 11th Business Day after receipt unless they deliver a written notice signed by each Seller (the “Dispute Notice”) to the Buyer of a dispute (a “Working Capital Dispute”) within that 10‑Business Day notice period. On the date of the Sellers’ deemed acceptance, or any earlier date upon which the Buyer receives notice of the Sellers’ acceptance, the Final Closing Date Working Capital will be conclusive and binding on the Buyer and the Sellers.

 

2.7

Disputes

 

Any Dispute Notice must set out the reasons for the Working Capital Dispute, the amounts in dispute, and reasonable details of the calculation of those amounts. The Buyer and the Sellers will attempt, in good faith, to resolve the Working Capital Dispute within 10 Business Days after the Buyer’s receipt of the Dispute Notice. If the Buyer and the Sellers are unable to resolve the Working Capital Dispute within 10 Business Days, then the Buyer and the Sellers will mutually appoint an accounting firm to assist with the resolution of the Working Capital Dispute. In the event that the Buyer and the Sellers are unable to agree on appointment of an accounting firm to assist with the resolution of the Working Capital Dispute within a further 5 Business Days, then the Working Capital Dispute will be submitted to a senior partner of the accounting firm of Manning Elliott LLP (the “Accounting Firm”), whose fees and expenses will be paid by the party determined to be incorrect by the Accounting Firm and who will resolve the Working Capital Dispute acting as an expert, and not an arbitrator. The resolution of the Working Capital Dispute will be final and binding upon the Buyer and Sellers, subject to manifest error.

 

2.8

Purchase Price Adjustment

 

Upon finalization of the Final Closing Date Working Capital (based on agreement of the Buyer and the Sellers or resolution of a Working Capital Dispute), the Purchase Price will be adjusted as follows:

 

2.8.1

If the actual Final Closing Date Working Capital is less than the Estimated Closing Date Working Capital, then the Purchase Price will be decreased on a dollar for dollar basis by the extent to which the actual Final Closing Date Working Capital is less than the Estimated Closing Date Working Capital (the “Decrease”).

 

 

2.8.2

If the actual Final Closing Date Working Capital exceeds the Estimated Closing Date Working Capital, then the Purchase Price will be increased on a dollar for dollar basis by the extent to which actual Final Closing Date Working Capital is greater than the Estimated Closing Date Working Capital (the “Increase”).

 

 

 

- 13 - 

 

 

2.9

Adjustment Payments

 

2.9.1

The payments set out in this Section 2.9 must be made within 10 (ten) Business Days of the determination of the Purchase Price adjustment under Section 2.8 as follows: (Purchase Price Adjustment).

 

 

2.9.1.1

If there is a Decrease, the Sellers will pay to the Buyer, in accordance with their Pro Rata Share, a sum equal to the Decrease, which may be paid, in the sole discretion of the Sellers, in either cash money of immediately available funds or Buyer Shares at the price per share set out in Section 2.2.2; and

 

 

 

 

2.9.1.2

If there is an Increase, the Buyer will pay to the Sellers, in accordance with their Pro Rata Share, a sum equal to the Increase, which may be paid, in the sole discretion of the Buyer, in either cash money of immediately available funds or, if the CSE has approved such payment in shares, in Buyer Shares at the price per share set out in Section 2.2.2.

 

2.10

Payment of Management Bonuses

 

2.10.1

At Closing, the Buyer shall issue additional Buyer Shares to the Sellers, as follows:

 

 

2.10.1.1

to Justin Hannewyk, such number of Buyer Shares as determined by dividing the management bonus due to him by the Corporation as reflected in the Estimated Closing Date Working Capital by the deemed price per share set out in Section 2.2.2; and

 

 

 

 

2.10.1.2

to Richard Cochrane, such number of Buyer Shares as determined by dividing the management bonus due to him by the Corporation as reflected in the Estimated Closing Date Working Capital by the deemed price per share set out in Section 2.2.2.

 

2.11

Excluded Business

 

 

2.11.1

The Parties acknowledge and agree that the Buyer is not purchasing the Excluded Business and that on or before Closing, the Sellers will cause the Excluded Assets to be transferred from the Corporation to the Sellers or to an affiliate of the Sellers, as the Sellers may determine in their sole discretion, and will effect the steps described in Schedule E hereto in order to address the shareholder loans and advances payable by the Corporation to the Sellers (the “Cinematography Spinout”).

 

 

2.11.2

Any costs or taxes payable to third-parties, including any commodity or transfer taxes, arising in connection with the Cinematography Spinout shall be borne by the Sellers, and the Sellers will indemnify and hold harmless the Corporation, its successors, assigns, and each of their respective officers, directors, employees, and agents from and against all costs, taxes, or expenses payable by the Corporation to third-parties which arise in connection with, or result from, the Cinematography Spinout.

 

 

2.11.3

The Parties covenant and agree to use commercially reasonable efforts to negotiate in good faith a transition services agreement (the “Transition Services Agreement”) in form acceptable to the Buyer and the Seller, each acting reasonably, pursuant to which the Corporation will provide support services for the Excluded Business as summarized in Error! Reference source not found. of the Agreement. The Transition Services Agreement shall be for a term of twelve (12) months or such longer term that as the Parties may otherwise agree.

 

 

 

- 14 -

 

 

2.11.4

If the Parties do not settle the form of the Transition Services Agreement on or before the Closing Date, then the terms of the Transition Services Agreement set out in the foregoing paragraph shall constitute the Transition Services Agreement.

 

ARTICLE 3
REPRESENTATIONS AND WARRANTIES

 

3.1

Representations Relating to the Sellers

 

Except as set forth in the correspondingly numbered paragraph of the Disclosure Letter, each Seller, on its own behalf, severally and not jointly and severally, represents and warrants to the Buyer as follows, and acknowledges that the Buyer is relying upon these representations and warranties in connection with the purchase of the Purchased Shares and issuance of the Consideration Shares, as applicable.

 

3.1.1

Capacity and Authority. Each Seller is of the full age of majority and has the legal capacity and competence to enter into and perform its obligations under this Agreement.

 

 

3.1.2

Binding Obligation. This Agreement has been duly executed and delivered by the Seller and constitutes a valid and binding obligation of the Seller, enforceable against the Seller in accordance with its terms, subject to applicable bankruptcy, insolvency and other laws of general application limiting the enforcement of creditors’ rights generally and to the fact that equitable remedies, including specific performance, are discretionary and may not be ordered in respect of certain defaults.

 

 

3.1.3

Title to Purchased Shares. The Seller is the legal and beneficial owner of the number of Purchased Shares set out in Schedule A opposite that Seller’s name under the heading “Number of Purchased Shares Owned by Seller”, and has good title to them, free and clear of any Encumbrance except for any restriction on transfer contained in the articles of the Corporation and the Shareholders Agreement. At Closing, the Seller will have the absolute and exclusive right to sell those Purchased Shares to the Buyer as contemplated by this Agreement.

 

 

3.1.4

Residence of Seller. The Seller is not a non-resident of Canada for purposes of the ITA.

 

 

3.1.5

Absence of Conflict. None of the execution and delivery of this Agreement by the each Seller, the performance of the Seller’s obligations under this Agreement or the completion by the Seller of the transactions contemplated by this Agreement, will:

 

 

3.1.5.1

result in or constitute a breach of any term or provision of, or constitute a default under, any agreement or other commitment to which the Seller is a party or which affects the Purchased Shares owned by the Seller;

 

 

 

 

3.1.5.2

contravene any applicable law; or

 

 

 

- 15 -

 

 

 

3.1.5.3

contravene any judgment, order, writ, injunction or decree of any Governmental Authority.

 

3.1.6

Breach, Non-Performance and Non-Compliance. The Seller has not formulated the opinion that any of the representations and warranties of the Buyer in Section 3.3 are incorrect in any material respect.

 

3.2

Representations Relating to the Corporation

 

Except as set forth in the correspondingly numbered paragraph of the Disclosure Letter, each Seller, on its own behalf, severally and not jointly and severally, represents and warrants to the Buyer as follows, and acknowledges that the Buyer is relying upon these representations and warranties in connection with the purchase of the Purchased Shares.

 

3.2.1

Capacity and Authority. The Corporation has all necessary corporate power, authority and capacity to enter into and perform its obligations under this Agreement.

 

 

3.2.2

Execution and Delivery. The execution and delivery of this Agreement does not (A) violate any law or provision of the constating or organizational documents of the Corporation; or (B) result in breach of, a default or the creation of, any encumbrance on the assets of the Corporation.

 

 

3.2.3

Binding Obligation. This Agreement has been duly executed and delivered by the Corporation and constitutes a valid and binding obligation of the Corporation, enforceable against the Corporation in accordance with its terms, subject to applicable bankruptcy, insolvency and other laws of general application limiting the enforcement of creditors’ rights generally and to the fact that equitable remedies, including specific performance, are discretionary and may not be ordered in respect of certain defaults.

 

 

3.2.4

Restrictive Covenants. Except as set out in the Disclosure Letter, the Corporation is not a party to, or bound or affected by, any agreement, commitment or document containing any covenant expressly limiting its ability to compete in any line of business, or limiting its ability to transfer or move any of its assets or operations, or any covenant which could reasonably be expected to have a Material Adverse Effect.

 

 

3.2.5

Absence of Conflict. None of the execution and delivery of this Agreement by the Corporation or the performance of the Corporation’s obligations under this Agreement, will:

  

 

3.2.5.1

result in or constitute a breach of any term or provision of, or constitute a default under, the notice of articles or articles of the Corporation;

 

 

 

 

3.2.5.2

result in or constitute a breach of any term or provision of, or constitute a default under, any agreement or other commitment to which the Corporation is a party or which affects the Purchased Shares, except as disclosed in the Disclosure Letter;

 

 

 

 

3.2.5.3

constitute an event that would permit any party to any Material Contract to amend, cancel, terminate or sue for damages with respect to that Material Contract, or to accelerate the maturity of any indebtedness of the Corporation, or other obligation of the Corporation under that Material Contract, except as disclosed in the Disclosure Letter;

 

 

 

- 16 -

 

 

 

3.2.5.4

result in the creation or imposition of any Encumbrance on the Purchased Shares;

 

 

 

 

3.2.5.5

contravene any applicable law; or

 

 

 

 

3.2.5.6

contravene any judgment, order, writ, injunction or decree of any Governmental Authority.

 

3.2.6

Consents. Except as disclosed in the Disclosure Letter, there is no requirement to obtain any consent, approval or waiver of a party under any Material Contract in order to complete the transactions contemplated by this Agreement.

 

 

3.2.7

Regulatory Approvals. No authorization, approval, order or consent of, or filing with, any Governmental Authority is required on the part of the Corporation in connection with the execution, delivery and performance of this Agreement or any other documents and agreements to be delivered under this Agreement.

 

 

3.2.8

Subsidiaries. The Corporation has no subsidiaries.

 

 

3.2.9

Corporate Existence of Corporation. The Corporation has been duly incorporated and organized, and is validly existing and in good standing as a company under the Business Corporations Act (British Columbia). No proceedings have been taken or authorized by the Corporation in respect of the bankruptcy, insolvency, liquidation, dissolution or winding up of the Corporation.

 

 

3.2.10

Capacity and Powers of Corporation. The Corporation has all necessary corporate power, authority and capacity to own or lease its assets and to carry on the Business as currently being conducted.

 

 

3.2.11

Authorized and Issued Capital. The authorized share structure of the Corporation consists of an unlimited number of common shares, of which 100 common shares are issued and outstanding as fully paid and non-assessable shares.

 

 

3.2.12

No Purchase Rights. Other than under the Shareholders Agreement, no Person has any written or oral agreement or option or any right or privilege (whether by law, pre-emptive, contractual or otherwise) capable of becoming an agreement or option, including securities, warrants or convertible obligations of any kind, for:

 

 

3.2.12.1

the purchase of any securities of the Corporation; or

 

 

 

 

3.2.12.2

the purchase of any of the assets of the Corporation, other than the Excluded Assets or in the ordinary course of the Business.

 

3.2.13

Corporate Records. The minute books of the Corporation have been maintained in material compliance with all applicable statutory requirements and are complete and accurate in all material respects. The minute books of the Corporation have been made available to the Buyer.

 

 

3.2.14

Books and Records. The Books and Records are accurate and complete in all material respects.

 

 

 

- 17 -

 

 

3.2.15

Financial Statements. Copies of the Annual Financial Statements and draft Interim Financial Statement are attached hereto as Schedule C. The Annual Financial Statements have been prepared in accordance with IFRS and the Final Interim Financial Statements to be delivered at or prior to Closing in accordance with Section 4.12 will have been prepared in accordance with IFRS, except as to presentation of comparative periods. The Annual Financial Statements do, and the Final Interim Financial Statements to be delivered at or prior to Closing in accordance with Section 4.12 will, present fairly:

 

 

3.2.15.1

the assets, liabilities (whether accrued, absolute, contingent or otherwise) and financial condition of the Corporation, after adjusting to carve out the Excluded Business, as at the respective dates of the Financial Statements; and

 

 

 

 

3.2.15.2

the sales, earnings and results of the operations of the Corporation after adjusting to carve out the Excluded Business, during the periods covered by the Financial Statements,

 

 

 

 

except that the Final Interim Financial Statements will be subject to normal year-end audit adjustments.

 

3.2.16

Tax Matters. Other than as provided in the Disclosure Letter, the Corporation has filed all tax returns, reports and other tax filings required to be filed with the appropriate Governmental Authorities, and has paid, deducted, withheld or collected and remitted on a timely basis all material amounts to be paid, deducted, withheld or collected and remitted with respect to any taxes, interest and penalties as required under all applicable tax laws. Other than as provided in the Disclosure Letter or as set out in the Financial Statements, there are no tax deficiencies that have been claimed, proposed, or asserted in writing against the Corporation that have not been fully paid or finally settled, and there are no assessments, reassessments, actions, suits or proceedings in progress, pending or, to the Knowledge of the Sellers, threatened, against the Corporation, and no waivers have been granted by the Corporation, in connection with any taxes, interest or penalties. The provisions for taxes reflected in the Financial Statements are sufficient for the payment of all accrued and unpaid taxes, interest and penalties for all periods up to the applicable dates of such Financial Statements.

 

 

3.2.17

Absence of Changes. Except as disclosed in the Disclosure Letter, since December 31, 2018, there has not been any change, event or occurrence that, either individually or in the aggregate, has resulted in, or would reasonably be expected to result in, a Material Adverse Effect.

 

 

3.2.18

Absence of Undisclosed Liabilities. Except to the extent reflected or reserved in the Financial Statements, or incurred subsequent to December 31, 2018, and:

 

 

3.2.18.1

disclosed in the Disclosure Letter; or
 

 

3.2.18.2

incurred in the ordinary course of the Business,

 

 

 

 

the Corporation does not have any outstanding indebtedness or any liabilities or obligations (whether accrued, absolute, contingent or otherwise, including under any guarantee of any debt).

 

 

 

- 18 -

 

 

3.2.19

Title to Assets. Other than the Excluded Assets, the Corporation owns, possesses and has good and marketable title to all of its undertakings, property and assets (whether owned or leased), including all the undertakings, property and assets reflected in the most recent balance sheet included in the Interim Financial Statements, free and clear of all Encumbrances, other than the Permitted Encumbrances. The undertakings, property and assets of the Corporation, excluding the Excluded Assets, comprise all of the undertakings, property and assets necessary for the Corporation to carry on the Business as it is currently operated. All facilities, machinery, equipment, fixtures, vehicles and other tangible assets owned, leased or used by the Corporation, other than the Excluded Assets, are in good operating condition and repair, ordinary wear and tear excepted, and are reasonably fit and usable for the purposes for which they are being used.

 

 

3.2.20

Real Property. The Disclosure Letter lists the particulars of all leases of real property to which the Corporation is a party. The Corporation does not own any real property. To the Knowledge of the Sellers and other than as provided in the Disclosure Letter, there are no restrictive covenants or applicable laws that in any way would restrict or prohibit any part of the present use by the Corporation of any of the real property that is leased by the Corporation, other than the Permitted Encumbrances. There are no expropriation or similar proceedings, actual or threatened, of which the Corporation has received notice against any of the real property that is leased by the Corporation. All of the Corporation’s leases of real property are in full force and effect, unamended, and none of them are, to the Knowledge of the Sellers, under any threat of termination.

 

 

3.2.21

Intellectual Property.

 

 

3.2.21.1

The Disclosure Letter lists all material Intellectual Property that is owned by or licensed to the Corporation and the particulars of all registrations and applications for registration in respect of such Intellectual Property and the Corporation has made available to the Buyer copies of all registered Intellectual Property.

 

 

 

 

3.2.21.2

The Intellectual Property listed in the Disclosure Letter has not been implemented or incorporated into any of the Corporation’s products or services that the Corporation has offered to its customers and is not, as of the date hereof, used by the Corporation in any of the products or services that the Corporation has offers to its customers.

 

 

 

 

3.2.21.3

All commercially reasonable legal steps have been taken by the Corporation to preserve its rights to the Intellectual Property listed in the Disclosure Letter; for greater certainty, all Intellectual Property listed in the Disclosure Letter that is filed with or granted by a Governmental Authority is, to the Knowledge of the Sellers, in good standing, valid, and enforceable.

 

 

 

 

3.2.21.4

The Disclosure Letter also lists all material licence agreements under which the Corporation has been granted a right to use, or otherwise exploit, Intellectual Property owned by third parties. The Intellectual Property that is owned by the Corporation is owned free and clear of any Encumbrances, and no Person other than the Corporation has any right to use that Intellectual Property except as disclosed in the Disclosure Letter.

 

 

 

- 19 -

 

 

 

3.2.21.5

The use by the Corporation of any Intellectual Property owned by third parties is, to the Knowledge of the Sellers, valid, and the Corporation is not in default or breach of any licence agreement relating to that intellectual property, and, to the Knowledge of the Sellers, there exists no state of facts which, after giving notice or lapse of time or both, would constitute a material default or breach.

 

 

 

 

3.2.21.6

To the Knowledge of the Sellers, the conduct by the Corporation of the Business does not infringe the Intellectual Property of any Person, and neither the Corporation nor the Sellers have received any notice of any unauthorized use, infringement or misappropriation of the Intellectual Property rights of any third parties.

 

 

 

 

3.2.21.7

Other than as provided in the Disclosure Letter, the Corporation nor the Sellers are aware of and have received no notice of pending or threatened claims regarding any unauthorized use, infringement or misappropriation by others of any intellectual property owned by or licensed to the Corporation.

 

3.2.22

Accounts Receivable. All accounts receivable of the Corporation reflected in the Financial Statements, or which have come into existence since the date of the most recent Financial Statements, were created in the ordinary course of the Business from bona fide arm’s length transactions, and, except to the extent that they have been paid in the ordinary course of the Business since the date of the Financial Statements, are valid and enforceable and payable in full, without any right of set-off or counterclaim or any reduction for any credit or allowance made or given, except to the extent of the allowance for doubtful accounts reflected in the Financial Statements.

 

 

3.2.23

Inventories. The inventories maintained by the Corporation have been accumulated for use or sale in the ordinary course of the Business, and are in good and marketable condition. The present levels of the inventories are consistent with the levels of inventories that have been maintained by the Corporation before the date of this Agreement in the ordinary course of the Business in light of seasonal adjustments, market fluctuations and the requirements of customers of the Business.

 

 

3.2.24

Material Contracts and Fundamental Contracts. The Disclosure Letter lists all Material Contracts, and a complete and correct copy of each Material Contract, including all amendments, modifications and supplements thereto, has been made available to the Buyer. Except as disclosed in the Disclosure Letter, the Corporation is not in default or breach of any Material Contract, and there exists no state of facts which, after notice or lapse of time or both, would constitute a material default or breach under any Material Contract. To the Knowledge of the Sellers, no counterparty to any Material Contract is in default of any of its obligations under any Material Contract and the Corporation is entitled to all its benefits under each Material Contract, and the Corporation has not received any notice of termination of any Material Contract. No Fundamental Contract: (i) would be violated, contravened or breached by, or under which a default would occur; (ii) requires any consent or prior approval be obtained from any Person (including consents relating to the change of control of the Corporation) or notice to be given (prior to or following the Effective Time); (iii) would automatically terminate; (iv) or would entitle any party to terminate, adversely accelerate, adversely modify or call any obligations or rights under; in each case, as a result of the execution of this Agreement or the Closing.

 

 

 

- 20 -

 

 

3.2.25

Compliance with Laws. The Corporation is conducting the Business in material compliance with all applicable laws, and the Corporation has not received written notice of any violation by the Corporation of any laws.

 

 

3.2.26

Permits. All Permits material to the Business are listed in the Disclosure Letter. Those Permits are the only authorizations, registrations, permits, approvals, grants, licences, quotas, consents, commitments, rights or privileges (other than those relating to Intellectual Property) required to enable the Corporation to carry on the Business as currently conducted and to enable the Corporation to own, lease and operate its assets in all material respects. All such Permits are valid, subsisting, in full force and effect and unamended, and the Corporation is not in material default or breach of any Permit material to the Business; no proceeding is pending or, to the Knowledge of the Sellers, threatened to revoke or limit any material Permit, and the completion of the transactions contemplated by this Agreement will not result in the revocation of any material Permit or the breach of any term, provision, condition or limitation affecting the ongoing validity of any material Permit.

 

 

3.2.27

Environmental Conditions. Except as disclosed in the Disclosure Letter, the Corporation’s conduct of the Business, and the current use by the Corporation of the real property that is leased by the Corporation have been and are in material compliance with all applicable environmental laws, and there are no facts that would give rise to material non-compliance by the Corporation with any environmental laws in the conduct by the Corporation of the Business.

 

 

3.2.28

Suppliers. The Disclosure Letter lists each material supplier of goods and services from whom the Corporation has purchased goods or services since the beginning of the last financial year of the Corporation and the Corporation has made available to the Buyer all material written agreements between the Corporation and such supplier, other than any standard form agreements of such supplier generally available and applicable to customers of such supplier. None of the suppliers listed in the Disclosure Letter have advised the Corporation, either orally or in writing, that they are terminating or considering terminating their relationship with the Corporation.

 

 

3.2.29

Customers. The Disclosure Letter sets out a list of the Corporation’s top twenty customers for the nine-month period ended September 30, 2019, and the percentage of gross revenue of the Corporation such customers represent in the aggregate. No customer listed in the Disclosure Letter has advised the Corporation, orally or in writing, that it is terminating or considering terminating its relationship with the Corporation, or considering renegotiating its relationship with the Corporation on terms different from and less favourable to the Corporation than those which the Corporation currently enjoys, whether as a result of the completion of the transactions contemplated by this Agreement or otherwise.

 

 

3.2.30

Product Warranties. Other than as provided in the Disclosure Letter, there are no warranties given to customers of services provided by the Corporation. There are no claims, suits or proceedings against the Corporation on account of warranties or with respect to the provision of services, nor, to the Knowledge of the Sellers, is there any reasonable basis for any such claim.

 

 

 

- 21 -

 

 

3.2.31

Employees and Employment Contracts. The Corporation has made available to the Buyer complete and correct copies of all written employment agreements or summaries of any oral employment agreements with all current employees of the Corporation. The Corporation is not a party to any written or oral employment, service, pension, deferred profit sharing, benefit, bonus or other similar agreement or arrangement except as disclosed in the Disclosure Letter and none of those agreements or arrangements contains any specific agreement as to notice of termination or severance pay in lieu of notice inconsistent with the Employment Standards Act (British Columbia) except as disclosed in the Disclosure Letter. The Corporation is not in arrears in the payment of any contribution or assessment required to be made by it pursuant to any of the agreements or arrangements disclosed in the Disclosure Letter that would be expected to result in a Material Adverse Effect. Except as set out in the Disclosure Letter, all vacation pay, bonuses, commissions and other employee benefit payments and obligations with respect to the employees of the Corporation are reflected in and have been fully accrued in the Financial Statements and Books and Records in all material respects.

 

 

3.2.32

Insurance Policies. The Corporation has made available to the Buyer all material insurance policies maintained by the Corporation, other than insurance policies with ICBC. The Disclosure Letter lists all material insurance policies maintained by the Corporation, and also specifies the insurer, the amount of the coverage, the type of insurance, the policy number and any pending claims with respect to each insurance policy listed. The insurance policies maintained by the Corporation provide the Corporation with product liability in amounts that would reasonably be considered adequate and prudent, for a company of the size of the Corporation carrying on a business similar to the Business. All insurance policies are in full force and effect and the Corporation:

 

 

3.2.32.1

is not in material default, whether as to the payment of premiums or otherwise, under any material term or condition of any of the insurance policies listed herein; and

 

 

 

 

3.2.32.2

has not failed to give notice or present any claim under any of the insurance policies listed herein in a due and timely fashion.

 

3.2.33

Litigation.

 

 

3.2.33.1

Except as disclosed in the Disclosure Letter, there are no actions, suits, grievances or proceedings, whether judicial, arbitral or administrative, and whether or not purportedly on behalf of or against the Corporation, pending, commenced, or, to the Knowledge of the Sellers, threatened, that would reasonably be expected to have a Material Adverse Effect.

 

 

 

 

3.2.33.2

There is no outstanding judgment, decree, order, ruling or injunction in favour of, against or otherwise involving the Corporation or relating in any way to the transactions contemplated by this Agreement.

 

3.2.34

Brokerage Fees. The Corporation has not retained any financial advisor, broker, agent or finder, or entered into any agreement entitling any Person to any broker’s commission, finder’s fee or similar payment, relating to this Agreement or the transactions contemplated by this Agreement.

 

 

 

- 22 -

 

 

3.3

Representations Relating to the Buyer

 

The Buyer represents and warrants to the Sellers as follows, and acknowledges that the Sellers are relying upon these representations and warranties in connection with the sale of the Purchased Shares:

 

3.3.1

Corporate Existence of Buyer. The Buyer is a company duly incorporated and validly existing under the laws of British Columbia.

 

 

3.3.2

Capacity and Authority. The Buyer has all necessary corporate power, authority and capacity to enter into and perform its obligations under this Agreement.

 

 

3.3.3

Binding Obligation. This Agreement has been duly executed and delivered by the Buyer and constitutes a valid and binding obligation of the Buyer, enforceable against the Buyer in accordance with its terms, subject to applicable bankruptcy, insolvency and other laws of general application limiting the enforcement of creditors’ rights generally and to the fact that equitable remedies, including specific performance, are discretionary and may not be ordered in respect of certain defaults.

 

 

3.3.4

Absence of Conflict. None of the execution and delivery of this Agreement by the Buyer, the performance of the Buyer’s obligations under this Agreement, or the completion by the Buyer of the transactions contemplated by this Agreement, will result in or constitute a breach of any term or provision of, or constitute a default under, the notice of articles and articles of the Buyer or any agreement or other commitment to which the Buyer is a party.

 

 

3.3.5

Regulatory Approvals. No authorization, approval, order or consent of, or filing with, any Governmental Authority is required on the part of the Buyer in connection with the execution, delivery and performance of this Agreement or any other documents and agreements to be delivered under this Agreement.

 

 

3.3.6

Capitalization. The authorized share capital of the Buyer consists of an unlimited number of Buyer Shares. As at the date of this Agreement there are and as of the Closing Date there will be: (i) 69,670,613 Buyer Shares validly issued and outstanding as fully-paid and non‑assessable shares of the Buyer; (ii) outstanding warrants to purchase 18,051,499 Buyer Shares; and (iii) 3,575,000 outstanding stock options and 3,175,000 outstanding restricted share units, to purchase in aggregate 6,750,000 Buyer Shares. Except for the securities referred to in this Section 3.3.6, there are no options, warrants, conversion privileges, calls or other rights, shareholder rights plans, agreements, arrangements, commitments, or obligations of the Buyer or any of its subsidiaries to issue or sell any shares of the Buyer or of any of its subsidiaries or securities or obligations of any kind convertible into, exchangeable for or otherwise carrying the right or obligation to acquire any shares of the Buyer or any of its subsidiaries, and no Person is entitled to any pre-emptive or other similar right granted by the Buyer or any of its subsidiaries.

 

 

3.3.7

Consideration Shares. The issuance of the Consideration Shares to the Sellers contemplated by this Agreement have been duly authorized by all necessary corporate action of the Buyer and such shares, when issued in accordance with the terms of this Agreement, will be issued as fully paid and non-assessable common shares in the capital of the Buyer and will be free and clear of all Encumbrances, other than the restrictions contemplated by Section 4.9 herein.

 

 

 

- 23 -

 

 

3.3.8

Listing. The Buyer Shares are listed for trading on the CSE and the Frankfurt Stock Exchange. The Buyer has complied with its obligations to file and deliver any documents required under the CSE rules and the Buyer is not in material contravention or default of any of the CSE rules and no fact exists which may result in the foregoing.

 

 

3.3.9

Reporting Issuer Status. The Buyer is a reporting issuer not in default under the Securities Laws of British Columbia, Ontario and Saskatchewan.

 

 

3.3.10

Compliance with Laws. The Buyer is conducting the Business in material compliance with all applicable laws, and the Buyer has not received notice of any violation by the Buyer of any laws.

 

 

3.3.11

Full Disclosure.

 

 

3.3.11.1

The statements made by the Buyer and its representatives to the Sellers in connection with the transactions contemplated by this Agreement and the Public Record of the Buyer each do not, as at the time delivered or made and on the date of this Agreement, and will not at Closing: (i) contain any untrue statement of a material fact or misleading statement; or (ii) omit to state a material fact necessary in order to make the statement contained therein, in light of the circumstances in which they were made, not misleading;

 

 

 

 

3.3.11.2

the Buyer has disclosed to the Sellers all facts related to the Buyer, its business and the transactions contemplated by this Agreement, and all other matters which are material to the assessment of the nature and amount of risk inherent in an investment in Buyer Shares; and

 

 

 

 

3.3.11.3

there is no “material fact” or “material change” with respect to the Buyer (as such terms are defined in the Securities Act (British Columbia)) which have not been generally disclosed to the public.

 

3.3.12

Investment Canada Act. The Buyer is a Canadian within the meaning of the Investment Canada Act (Canada).

 

 

3.3.13

Buyer’s Financing. The Buyer has and will have at Closing all funds on hand necessary to pay the cash portion of the Purchase Price.

 

 

3.3.14

Financial Statements. The financial statements of the Buyer set out in the Public Record have been prepared in accordance with IFRS and present fairly:

 

 

3.3.14.1

the assets, liabilities (whether accrued, absolute, contingent or otherwise) and financial condition of the Buyer as at the respective dates of such financial statements; and

 

 

 

 

3.3.14.2

the sales, earnings and results of the operations of the Buyer during the periods covered by such financial statements.

 

3.3.15

Brokerage Fees. Other than the Finder’s Fee and the Advisory Fee, the Buyer has not retained any financial advisor, broker, agent or finder, or entered into any agreement entitling any Person to any broker’s commission, finder’s fee or similar payment, relating to this Agreement or the transactions contemplated by this Agreement.

 

 

 

- 24 -

 

 

3.3.16

Due Diligence by Buyer. The Buyer acknowledges that it has conducted to its satisfaction an independent investigation of the business, operations, assets, liabilities and financial condition of the Corporation and, in making the determination to proceed with the transactions contemplated by this Agreement, has relied solely on the results of its own independent investigation and the representations and warranties expressly set out in Sections 3.1 and 3.2.

 

 

3.3.17

Breach, Non-Performance and Non-Compliance. The Buyer has not formulated the opinion that any of the representations and warranties in Sections 3.1 and 3.2 are incorrect in any material respect.

 

ARTICLE 4
COVENANTS

 

4.1

Conduct of Business Before Closing

 

During the period beginning on the date of this Agreement and ending at the Closing Time, and except as expressly permitted or contemplated by this Agreement, the Corporation will:

 

4.1.1

carry on the Business only in the ordinary course of business;

 

 

4.1.2

make all commercially reasonable efforts to preserve the goodwill of the Corporation and its relationships with customers, suppliers and others having business dealings with the Corporation;

 

 

4.1.3

refrain from entering into any contract or arrangement, other than in the ordinary course of the business or with the prior written consent of the Buyer;

 

 

4.1.4

continue in full force all of its material insurance policies;

 

 

4.1.5

comply in all respects with all material laws applicable to the Business; and

 

 

4.1.6

apply for, maintain in good standing and make all commercially reasonable efforts to renew all material Permits.

 

4.2

Consents Under Material Contracts

 

The Corporation will make all commercially reasonable efforts to obtain and maintain, before the Closing, the consents, approvals and waivers disclosed in the Disclosure Letter, provided that the Corporation will be under no obligation to pay any money, incur any obligations, commence any legal proceedings, or offer or grant any accommodation (financial or otherwise) to any third party in order to obtain those consents, approvals and waivers. The Buyer will make all commercially reasonable efforts to cooperate with and assist the Corporation in obtaining and maintaining those consents, approvals and waivers, including by providing any information relating to the Buyer as is reasonably requested by a third party to grant its consent.

 

 

 

- 25 -

 

 

4.3

Actions to Satisfy Closing Conditions

 

Subject to Section 4.2, each Party will take or cause to be taken all actions that are within its power to control, and will make all commercially reasonable efforts to cause other actions to be taken which are not within its power to control, to ensure its compliance with, and satisfaction of, all conditions in Article 5 that are for the benefit of any other Party.

 

4.4

Notification of Change

 

4.4.1

Each Party agrees that it will notify the other Parties promptly in writing of the occurrence, or failure to occur, at any time from the date of this Agreement until the Closing Time, of any event or state of facts which occurrence or failure to occur would be reasonably likely to:

 

 

4.4.1.1

cause any representations or warranties in this Agreement to be inaccurate (in any material respect, if the representation or warranty is not already subject to a materiality qualifier) at the Closing Time (except for those representations and warranties made as of a specified date);

 

 

 

 

4.4.1.2

result in the failure to comply with any covenant to be complied with by that Party before the Closing Time; or

 

 

 

 

4.4.1.3

result in the failure to satisfy any of the conditions precedent in favour of any other Party,

 

4.4.2

Following notice by either the Sellers or the Buyer under Section 4.4.1, the Sellers may amend the Disclosure Letter to qualify the applicable representations and warranties. If any of the conditions in Section 5.1 would not have been satisfied without the amendment to the Disclosure Letter, the Buyer may terminate this Agreement by notice in writing to the Sellers within 5 Business Days of receiving the revised Disclosure Letter. If the Buyer does not terminate this Agreement in accordance with this Section 4.4, the Buyer is deemed to have accepted and agreed to the revised Disclosure Letter and waived in full any breach or inaccuracy of the representations and warranties of the Sellers, and any corresponding closing conditions in favour of the Buyer, addressed by the amendment to the Disclosure Letter.

 

 

4.5

Exclusivity

 

From the date of this Agreement until the earlier of the Closing Time and the date of termination of this Agreement, none of the Sellers or the Corporation will:

 

4.5.1

solicit, initiate, knowingly facilitate or encourage, or accept; or

 

 

4.5.2

participate in any discussions, conversations, negotiations or other communications regarding,

 

any offer or proposal relating to any transaction (other than the purchase and sale transaction contemplated by this Agreement) involving the sale of any shares or other securities of the Corporation, the sale of the Business, or any other business combination involving the Corporation. If an offer or proposal relating to a transaction contemplated in this Section 4.5 is made to the Corporation or any Seller, the recipient will provide prompt notice of the offer or proposal to the Buyer.

 

 

 

- 26 -

 

 

4.6

Confidential Information

 

4.6.1

Until the Closing Date or, if this Agreement is terminated in accordance with Section 7.1, then perpetually, the Buyer will, subject to Section 4.6.2, keep confidential and not disclose or use, and the Buyer will not allow any of its representatives to disclose or use, any Confidential Information, for any purpose, except as contemplated by this Agreement. If this Agreement is terminated, all Confidential Information obtained by the Buyer in connection with this Agreement, including all copies, whether in written form or stored electronically, will be returned to the Sellers and the Corporation promptly after that termination.

 

 

4.6.2

The obligation of the Buyer under Section 4.6.1 to keep confidential and not disclose or use any Confidential Information does not apply to information which:

 

 

4.6.2.1

is generally available to or known by the public, other than as a result of improper disclosure by the Buyer or any of its representatives;

 

 

 

 

4.6.2.2

was available to the Buyer on a non-confidential basis before its disclosure by any Seller, the Corporation, or any representative of a Seller;

 

 

 

 

4.6.2.3

is or was obtained by the Buyer from a source other than any Seller or the Corporation, or any representative of a Seller, if that source is not bound by a confidentiality obligation; or

 

 

 

 

4.6.2.4

the Buyer or any representative of the Buyer is required, in the opinion of outside counsel to the Buyer, by law to disclose.

 

4.7

Personal Information

 

 

4.7.1

The collection, use and disclosure of Personal Information by any of the Parties before the Closing is restricted to those purposes that relate to the transactions contemplated by this Agreement.

 

 

4.7.2

Following the Closing, the Buyer will cause the Corporation to:

 

 

4.7.2.1

use and disclose the Personal Information under its control at the time of the Closing solely for the purposes for which that Personal Information was collected or permitted to be used or disclosed before the transactions contemplated by this Agreement were completed;

 

 

 

 

4.7.2.2

neither use nor disclose any of that Personal Information for any purpose that does not relate directly to the Business;

 

 

 

 

4.7.2.3

protect that Personal Information by security safeguards appropriate to the sensitivity of the information;

 

 

 

 

4.7.2.4

notify the employees, customers, directors, officers and shareholders whose Personal Information is disclosed that the transactions contemplated by this Agreement have taken place; and

 

 

 

- 27 -

 

 

 

4.7.2.5

give effect to any withdrawal of consent made in accordance with clause 4.3.8 of Schedule 1 to the Personal Information Protection and Electronic Documents Act (Canada).

 

4.8

Indemnification

 

 

4.8.1

From and after the Closing Date and for a period of three (3) years thereafter, the Buyer shall not, and shall not permit the Corporation, or any successor or assign by amalgamation or otherwise, to amend, repeal or modify any provision in the Corporation’s constating documents relating to the exculpation or indemnification of any current or former officer or director (unless required by law), it being the intent of the Parties that the officers and directors of the Corporation continue to be entitled to such exculpation and indemnification to the full extent of the law. If the Corporation or any successor or assign (i) consolidates or amalgamates with or merges into any other Person or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provisions shall be made so that the successors and assigns of the Corporation assume all of the obligations set forth in this Section 4.8.1.

 

 

4.8.2

The provisions of this Section 4.8 are intended for the benefit of, and will be enforceable by, each indemnified person referred to in this Section 4.8 and that person’s Successors, and, for that purpose, the Sellers confirm that they are acting as agents and trustees on their behalf.

 

 

4.9

Right to Place and Trading Restrictions on the Consideration Shares

 

 

4.9.1

The Sellers hereby agree to place and deposit with the Broker the Consideration Shares (other than the Free-trading Shares) in separate pooling agreements between the Buyer, Broker and the respective Seller (the “Pooling Agreements”) to be entered into at Closing, and the Sellers and the Buyer shall deliver the certificates representing the Consideration Shares to the Broker at Closing. “Free-trading Shares” means 15% of the Consideration Shares issued to the Sellers under this Agreement. For avoidance of doubt, all Consideration Shares, including the Free-trading Shares, will be placed with the Broker in accordance with Section 2.4 hereof.

 

4.9.2

The Pooling Agreements will provide that the Consideration Shares (other than the Free-trading Shares, which will have no restrictions and will be free trading) will automatically be release to the Sellers in accordance with the following schedule:

 

 

4.9.2.1

15% of the Consideration Shares on the date that is six months following the Closing;

 

 

 

 

4.9.2.2

25% of the Consideration Shares on the date that is twelve months following the Closing;

 

 

 

 

4.9.2.3

25% of the Consideration Shares on the date that is eighteen months following the Closing; and

 

 

 

 

4.9.2.4

20% of the Consideration Shares on the date that is twenty-four months following the Closing.
 
 

 

- 28 -

 

 

 

For the purposes of this Section 4.9:

 

 

 

Released Consideration Shares” means, at the applicable time, all Consideration Shares of the Sellers (including the Free-trading Shares) that are not subject to or that have been released from the pooling restrictions of this Section 4.9.2.

 

Escrowed Consideration Shares” means, at the applicable time, all Consideration Shares acquired by the Sellers under this Agreement, other than the Free-trading Shares and the Released Consideration Shares.

 

4.9.3

Notwithstanding Section 4.9.2 of this Agreement, if a Seller wishes to sell any or all of the Consideration Shares held by him at any time, such sale by the applicable Seller shall be completed in accordance with the following:

 

 

4.9.3.1

The Seller shall give notice of its intention to sell any Consideration Shares (“Notice”) to the Buyer and the Buyer shall have the opportunity to find a purchaser or purchasers for such Consideration Shares (a “Placee Shareholder”);

 

 

 

 

4.9.3.2

The Notice shall specify the number of Consideration Shares that the applicable Seller wishes to sell (the “Subject Shares”), and shall irrevocably offer to sell the Subject Shares for cash, to the Placee Shareholder, at the price set forth in the Notice;

 

 

 

 

4.9.3.3

The Buyer shall have ten (10) Business Days, except with respect to any Released Consideration Shares for which the Buyer shall only have five (5) Business Days (in each case, the “Offer Period”), following its receipt of the Notice to find a Placee Shareholder or Placee Shareholders (the “Placement Right”) to purchase some or all of the Subject Shares;

 

 

 

 

4.9.3.4

The Buyer will advise the applicable Seller at the end of the applicable Offer Period of the identities of the Placee Shareholders and the numbers of Subject Shares each has agreed to purchase and the Seller and the Placee Shareholders will complete any agreed sale as soon as practicable thereafter and in no event more than three (3) Business Days after the end of the applicable Offer Period;

 

 

 

 

4.9.3.5

Any Subject Shares not sold to Placee Shareholders pursuant to the Placement Right within three (3) Business Days of the end of the applicable Offer Period may be sold by the Seller to any Person at any price as follows:

 

 

4.9.3.5.1

If such Subject Shares are Released Consideration Shares, at anytime and in any amount whether by private sale or in the public markets; and

 

 

 

 

4.9.3.5.2

If such Subject Shares are Escrowed Consideration Shares, on a daily basis in an amount equal to: (i) up to 10% of the trailing five-day daily trading volume (of all markets on which the Buyer’s common shares are listed and traded), during the first 12 months following the Closing, and (ii) up to 20% of the trailing five-day daily trading volume (of all markets on which the Buyer’s common shares are listed and traded) for the period from the first day after the 12‑month anniversary of the Closing to the 24‑month anniversary of the Closing. For greater certainty, any Consideration Shares that become Released Consideration Shares shall immediately cease to be subject to the restrictions of this Section 4.9.3.5.2.

 

 

 

- 29 -

 

 

4.9.4

The Parties acknowledge and agree that nothing in this Section 4.9 shall affect the ability of a Seller to transfer any Consideration Shares to an affiliate or family member of such Seller for tax or estate planning purposes.

 

 

4.10

Nomination Right

 

 

4.10.1

Following the Closing and for a period of two years thereafter or as long as Justin Hannewyk holds a senior executive position with the Corporation, if such period is greater than two years, the Sellers shall designate one person, which will initially be Justin Hannewyk, (the “Nominee”) who is qualified to serve as a director of the Buyer, to serve as a member of the board of directors of the Buyer (the “Buyer Board”) for a term expiring not earlier than the Buyer’s next annual meeting of its shareholders (the “Buyer Shareholders”) at which directors of the Buyer are to be elected provided that such Nominee consents in writing to serve as a director and is, and remains, eligible under the applicable corporate legislation to serve as a director.

 

 

4.10.2

The Buyer shall take all reasonable steps as may be necessary to appoint the Nominee to the Buyer Board as of the Closing Date, including having the Nominee as part of the Buyer’s nominated slate of directors.

 

 

4.10.3

At the first annual meeting of the Buyer Shareholders following the end of the term of the Nominee, at which directors of the Buyer are to be elected, and at each meeting of Buyer Shareholders thereafter at which directors are to be elected, the Buyer shall cause the Nominee to be included as one of the directors proposed by the Buyer to the Buyer Shareholders for election as directors.

 

 

4.10.4

If the Nominee ceases to hold office as a director of the Buyer for any reason (including, for greater certainly, pursuant to applicable corporate laws or the requirements of the CSE), the Sellers shall be entitled to nominate an individual to replace him or her (the “Alternative Nominee”) and the Buyer shall promptly take all steps as may be necessary to appoint such individual to the Buyer Board to replace the Nominee who has ceased to hold office.

 

 

4.10.5

The Buyer covenants and agrees to enter into an indemnification agreement in favor of each Nominee appointed to the Buyer Board on terms identical to those offered to the other members of the Buyer Board.

 

 

4.11

Access to Books and Records

 

For a period of seven years from the Closing Date or for such longer period as may be required by law, the Buyer will retain all original books and records relating to the Corporation existing on the Closing Date. So long as any such books and records are retained by the Buyer pursuant to this Agreement, each Seller has the right to inspect and to make copies (at its own expense) of them at any time upon reasonable request during normal business hours and upon reasonable notice for any proper purpose and without undue interference to the business operations of the Corporation. The Buyer has the right to have its representatives present during any such inspection.

 

 

 

- 30 -

 

 

4.12

Review of Interim Financial Statements

 

The Buyer and Sellers acknowledge and agree that between the date of this Agreement and the Closing Date, DMCL will complete a review of the Interim Financial Statements (such reviewed Interim Financial Statements being the “Final Interim Financial Statements” and together with Annual Financial Statements, the “Final Financial Statements”) and deliver such Final Interim Financial Statements to the Sellers. The Corporation will use its commercial reasonable efforts to cause DMCL to complete its review of the Interim Financial Statements as soon as practicable after the date of this Agreement and to notify the Buyer of any delays and provide reasonable updates of the status of such review.

 

4.13

Completion of Cinematography Spinout – Pre-Closing

 

The Corporation covenants and agrees to complete the Cinematography Spinout within five (5) Business Days of the Corporation receiving notice in writing from the Buyer (the “Closing Notice”) that the Buyer is ready to complete Closing. Upon delivery of the Closing Notice, the Buyer shall be deemed to represent that it is ready, willing and able to complete the Closing and that it is satisfied with or is prepared the waive all closing conditions in its favor contemplated by Sections 5.1 and 5.3, other than those conditions that by their nature can only be satisfied on the Closing Date. The Sellers’ obligation to complete the Cinematography Spinout shall be extended to the next succeeding Business Day to the extent the closing conditions in Section 5.3.2 and 5.3.4 have not been satisfied or waived by both Parties.

 

4.14

Grant of Stock Options to Certain Employees of the Corporation – Post-Closing

 

The Buyer covenants and agrees to, at Closing, grant stock options of the Buyer to purchase Buyer Shares in accordance with the Buyer’s Share Compensation Plan to the employees of the Corporation and in the amounts set out in Schedule F hereto, at an exercise price equal to closing price of the Buyer Shares on the CSE on the day prior to the date of this Agreement.

 

4.15

CSE Filing

 

The Buyer covenants and agrees to file the required forms with the CSE with respect to the transactions contemplated by this Agreement promptly after execution of this Agreement and to use its commercial reasonable efforts to address any comments or requests from the CSE.

 

ARTICLE 5
CLOSING CONDITIONS

 

5.1

Conditions for the Benefit of the Buyer

 

The purchase and sale of the Purchased Shares is subject to the satisfaction, or waiver by the Buyer, at or before the Closing Time, of the following conditions, which are for the sole benefit of the Buyer and which may be waived, in whole or in part, by the Buyer at any time without prejudice to the Buyer’s right to rely on any other condition precedent:

 

 

 

- 31 - 

 

 

5.1.1

Representations and Warranties. The representations and warranties of each of the Sellers and the Corporation made in this Agreement that are qualified by materiality or Material Adverse Effect will be true and accurate at the Closing Time as if made as of the Closing Time, and each of the other representations and warranties of each of the Sellers and the Corporation made in this Agreement will be true and accurate in all material respects at the Closing Time as if made as of the Closing Time (except, in each case, for any representations and warranties made as at a specified date, the accuracy of which will be determined as of that specified date instead of the Closing Time).

 

 

5.1.2

Covenants. Each of the Sellers and the Corporation will have performed in all material respects each of its obligations required to be performed at or before the Closing Time under this Agreement.

 

 

5.1.3

No Material Adverse Effect. Since the date of this Agreement, no Material Adverse Effect has occurred.

 

 

5.1.4

Consents. The notifications and consents listed in Section 5.1.4 of the Disclosure Letter must have been obtained.

 

 

5.1.5

Deliveries. The Sellers will have delivered, or cause to be delivered, to the Buyer the following in form and substance satisfactory to the Buyer:

 

 

5.1.5.1

a certificate of the Corporation, signed on its behalf by a senior officer of the Corporation, confirming the matters set out in Sections 5.1.1 (Representations and Warranties) and 5.1.2 (Covenants) that are applicable to the Corporation, dated as of the Closing Date;

 

 

 

 

5.1.5.2

a certificate of each Seller confirming the matters set out in Sections 5.1.1 (Representations and Warranties) and 5.1.2 (Covenants) that are applicable to that Seller, dated as of the Closing Date;

 

 

 

 

5.1.5.3

original share certificates representing the Purchased Shares, duly endorsed by an effective endorsement for transfer to the Buyer;

 

 

 

 

5.1.5.4

certified copies of resolutions of the directors of the Corporation authorizing the transfer of the Purchased Shares to the Buyer;

 

 

 

 

5.1.5.5

employment agreements in the form attached as Exhibit 5.1.5.5 executed by the Sellers;

 

 

 

 

5.1.5.6

the Pooling Agreements executed by the respective Sellers;

 

 

 

 

5.1.5.7

releases from each Seller of all claims they may have against the Corporation, in the form attached as Exhibit 5.1.5.7;

 

 

 

 

5.1.5.8

the consents referred to in Section 5.1.4 (Consents);

 

 

 

- 32 - 

 

 

 

5.1.5.9

all Books and Records, including copies of all of the Corporation’s insurance policies in the possession of the Sellers; and

 

 

 

 

5.1.5.10

all other documentation and evidence reasonably requested by the Buyer in order to establish the due authorization and completion by each of the Sellers and the Corporation of the transactions contemplated by this Agreement, including the taking of all corporate proceedings by the boards of directors and shareholders of the Corporation required to effectively carry out its obligations under this Agreement.

 

5.1.6

Shareholders Agreement. The Shareholders Agreement shall have been terminated.

 

 

5.1.7

Financial Statements. The Final Interim Financial Statements shall have been delivered to the Buyer and such Final Interim Financial Statements shall not disclose any change, event or occurrence that is not substantively disclosed in the Interim Financial Statements attached as Schedule C to this Agreement, solely to the extent that such change, event or occurrence, in the aggregate, would reasonably be expected to be, in the opinion of the Buyer, acting reasonably, material and adverse to the Corporation.

 

 

5.2

Conditions for the Benefit of the Sellers

 

The purchase and sale of the Purchased Shares is subject to the satisfaction, or waiver by the Sellers, at or before the Closing Time, of the following conditions, which are for the sole benefit of each Seller and which may be waived, in whole or in part, by the Sellers at any time without prejudice to any Seller’s right to rely on any other condition precedent:

 

5.2.1

Representations and Warranties. The representations and warranties of the Buyer made in this Agreement that are qualified by materiality will be true and accurate at the Closing Time as if made as of the Closing Time and each of the other representations and warranties of the Buyer made in this Agreement will be true and accurate in all material respects at the Closing Time as if made as of the Closing Time (except, in each case, for any representations and warranties made as at a specified date, the accuracy of which will be determined as of that specified date instead of the Closing Time).

 

 

5.2.2

Covenants. The Buyer will have performed in all material respects its obligations required to be performed at or before the Closing Time under this Agreement.

 

 

5.2.3

Share Price. The 10-day volume weighted average price of the Buyer Shares on the CSE as of the day before Closing is not lower than $0.50.

 

 

5.2.4

Deliveries. The Buyer will have delivered to the Sellers the following in form and substance satisfactory to the Sellers:

 

 

5.2.4.1

a certificate of the Buyer, signed on its behalf by a senior officer of the Buyer, confirming the matters set out in Sections 5.2.1 (Representations and Warranties) and 5.2.2 (Covenants), dated as of the Closing Date;

 

 

 

 

5.2.4.2

certified copies of resolutions of the directors of the Buyer authorizing the execution and delivery of this Agreement and the performance by the Buyer of its obligations hereunder, including the payment of the Purchase Price and issuance of the Consideration Shares to the Sellers;

 

 

 

- 33 - 

 

 

 

5.2.4.3

employment agreements in the form attached as Exhibit 5.1.5.5 executed by the Buyer;

 

 

 

 

5.2.4.4

the Pooling Agreements executed by the Buyer;

 

 

 

 

5.2.4.5

releases from the Buyer and the Corporation in favor of each of the Sellers of all claims they may have against the Sellers, in the form attached as Exhibit 5.1.5.7; and

 

 

 

 

5.2.4.6

all documentation and other evidence reasonably requested by any Seller in order to establish the due authorization and completion by the Buyer of the transactions contemplated by this Agreement, including the taking of all corporate proceedings by the board of directors and the shareholders of the Buyer required to effectively carry out the obligations of the Buyer under this Agreement.

 

5.3

Mutual Conditions Precedent

 

The purchase and sale of the Purchased Shares is subject to the satisfaction, or waiver by the Buyer and the Sellers, at or before the Closing Time, of each of the following conditions, which are for the mutual benefit of the Buyer and the Sellers and which may be waived, in whole or in part, by consent of the Buyer and the Sellers at any time without prejudice to any right of the Buyer or the Sellers to rely on any other condition precedent.

 

5.3.1

No Action to Restrain. No order of any Governmental Authority will be in force, and no action or proceeding will be pending or threatened by any Person:

 

 

5.3.1.1

to restrain or prohibit the completion of the transactions contemplated by this Agreement, including the sale and purchase of the Purchased Shares;

 

 

 

 

5.3.1.2

to restrain or prohibit the Corporation from carrying on the Business; or

 

 

 

 

5.3.1.3

which would have a Material Adverse Effect.

 

5.3.2

Release of Guarantees. All personal guarantees signed by the Sellers with respect to the obligations of the Corporation will have been released, on terms satisfactory to each of the Sellers and the Buyer.

 

 

5.3.3

Excluded Assets. The Cinematography Spinout shall have been completed before the Closing Date and the Buyer receives written confirmation of completion of same.

 

 

5.3.4

CSE No-Objection. The CSE shall have not issued an objection to the transactions contemplated by this Agreement.

 

 

 

- 34 -

 

 

ARTICLE 6
CLOSING ARRANGEMENTS

 

6.1

Closing

 

The Closing will take place at the Closing Time at the offices of Gowling WLG (Canada) LLP, counsel to the Buyer, at Suite 2300 – 550 Burrard Street, Vancouver, BC V6C 2B5. All required documents may be delivered as originals or may be delivered by electronic transmission, except that the share certificates representing the Purchased Shares and the Consideration Shares must be delivered in original form.

 

6.2

Closing Deliveries

 

Subject to the satisfaction or waiver by the relevant Party of the conditions of Closing, at the Closing Time:

 

6.2.1

the Buyer will make the cash payments and will issue the Consideration Shares as set out in Section 2.4 (Payment of Purchase Price);

 

 

6.2.2

the Sellers will deliver or cause to be delivered to the Buyer the documents set out in Section 5.1.5 (Deliveries), including the original share certificates representing the Purchased Shares in fully transferable form; and

 

 

6.2.3

the Buyer will deliver or cause to be delivered to the Sellers the documents set out in Section 5.2.4 (Deliveries).

 

ARTICLE 7
TERMINATION

 

7.1

Termination Rights

 

This Agreement may be terminated at any time before the Closing:

 

7.1.1

by mutual written consent of the Buyer and the Sellers;

 

 

7.1.2

by the Buyer, upon written notice to the Sellers (specifying in reasonable detail the circumstances giving rise to the Buyer’s right to terminate):

 

 

7.1.2.1

if any of the conditions set out in Section 5.1 (Conditions for the Benefit of the Buyer) or 5.3 (Mutual Conditions Precedent) which has not been waived by the Buyer is not satisfied at or before the Closing Time; or

 

 

 

 

7.1.2.2

if any of the conditions set out in Section 5.1 (Conditions for the Benefit of the Buyer) or 5.3 (Mutual Conditions Precedent) which has not been waived by the Buyer is not capable of being satisfied by the Outside Date,

 

 

 

 

in each case provided that the failure to satisfy that condition is not the result, directly or indirectly, of the Buyer’s breach of this Agreement;

 

 

 

- 35 -

 

 

7.1.3

by any of the Sellers, upon written notice to the Buyer (specifying in reasonable detail the circumstances giving rise to that Seller’s right to terminate):

 

 

7.1.3.1

if any of the conditions set out in Section 5.2 (Conditions for the Benefit of the Sellers) or 5.3 (Mutual Conditions Precedent) which has not been waived by that Seller is not satisfied at or before the Closing Time; or

 

 

 

 

7.1.3.2

if any of the conditions set out in Section 5.2 (Conditions for the Benefit of the Sellers) or 5.3 (Mutual Conditions Precedent) which has not been waived by that Seller is not capable of being satisfied by the Outside Date,

 

 

 

 

in each case provided that the failure to satisfy that condition is not the result, directly or indirectly, of the breach of this Agreement by the Seller terminating this Agreement or the Corporation; or

 

7.1.4

by the Buyer or any Seller, upon written notice to the other Parties, if the Closing does not occur by 11:59 p.m. on the Outside Date, provided that the Buyer may not terminate this Agreement under this Section 7.1.4 if the failure of the Closing to occur is the result, directly or indirectly, of the Buyer’s breach of this Agreement, and a Seller may not terminate this Agreement under this Section 7.1.4 if the failure of the Closing to occur is the result, directly or indirectly, of the breach of this Agreement by such Seller or the Corporation.

 

 

7.1.5

by the Buyer, upon written notice to the Sellers and the Corporation, under Section 4.4.

 

 

7.2

Effect of Termination

 

If this Agreement is terminated in accordance with Section 7.1, the Parties will be released from all of their obligations under this Agreement, except that:

 

7.2.1

Section 4.6 (Confidential Information) and Section 9.11 (Public Announcements) and this Section 7.2 will survive the termination of this Agreement and continue in full force and effect; and

 

 

7.2.2

the termination of this Agreement at any time before the Closing will not relieve any Party from any liability arising before that termination.

 

ARTICLE 8
INDEMNIFICATION AND SURVIVAL

 

8.1

Indemnification by the Sellers

 

Subject to the other provisions of this Article 8, each Seller will, if the Closing occurs:

 

8.1.1

severally, and proportionately to that Seller’s Pro Rata Share, indemnify and hold harmless each Buyer Indemnified Party from and against any Loss that a Buyer Indemnified Party may suffer as a result of:

 

 

8.1.1.1

any breach of any representation or warranty made by the Corporation in this Agreement; and

 

 

 

- 36 - 

 

 

 

8.1.1.2

any non-performance of any covenant or obligation of the Corporation contained in this Agreement;

 

8.1.2

severally, and proportionately to that Seller’s Pro Rata Share, indemnify and hold harmless each Buyer Indemnified Party from and against any Loss that a Buyer Indemnified Party may suffer as a result of:

 

 

8.1.2.1

any breach of any representation or warranty made by that Seller in Section 3.1 (Representations Relating to the Sellers); and

 

 

 

 

8.1.2.2

any non-performance of any covenant or agreement of that Seller contained in this Agreement.

 

8.2

Indemnification by the Buyer

 

Subject to the other provisions of this Article 8, the Buyer will, if the Closing occurs, indemnify and hold harmless each Seller Indemnified Party from and against any Loss that a Seller Indemnified Party may suffer as a result of:

 

8.2.1

any breach of any representation or warranty made by the Buyer in this Agreement; and

 

 

8.2.2

any non-performance of any covenant or agreement of the Buyer contained in this Agreement.

 

8.3

Survival Periods for Claims by Buyer Indemnified Parties

 

The covenants, representations and warranties made by the Corporation and the Sellers in this Agreement will survive the Closing and completion of the transactions contemplated by this Agreement, and will continue in full force and effect.

 

8.3.1

Subject to Section 8.3.2, a Buyer Indemnified Party may make an Indemnity Claim under Section 8.1.1.1 or 8.1.2.1 only if an Indemnity Notice of that Indemnity Claim is delivered to the relevant Indemnifying Party within 18 months after the Closing Date.

 

 

8.3.2

The notice periods set out in Section 8.3.1 will not apply to an Indemnity Claim based on intentional misrepresentation or fraud by the Corporation or the Sellers, or any of them, relating to this Agreement.

 

 

8.3.3

The notice periods set out in Section 8.3.1 will not apply to an Indemnity Claim based on any breach of the representations and warranties made in Section 3.2.16 (Tax Matters) for which the applicable notice period will be the day that is on or before 60 days after the last day upon which any of the relevant Governmental Authorities is entitled to assess or reassess the Corporation (or to raise Claims against the Buyer or the Corporation relating to that assessment or reassessment) with respect to any tax for any taxation year ending on or before the Closing Date.

 

 

 

- 37 -

 

 

8.4

Survival Periods for Claims by Seller Indemnified Parties

 

The covenants, representations and warranties made by the Buyer in this Agreement will survive the Closing and completion of the transactions contemplated by this Agreement, and will continue in full force and effect.

 

8.4.1

Subject to Section 8.4.2, a Seller Indemnified Party may make an Indemnity Claim under Section 8.2.1 only if an Indemnity Notice of that Indemnity Claim is delivered to the Buyer as Indemnifying Party within 18 months after the Closing Date.

 

 

8.4.2

The notice period set out in Section 8.4.1 will not apply to an Indemnity Claim based on intentional misrepresentation or fraud by the Buyer relating to this Agreement or the representations and warranties contained in Section 3.3.7.

 

 

8.5

Amount Limitations on Indemnification Obligations

 

 

8.5.1

Subject to Section 8.5.2:

 

 

8.5.1.1

the indemnification obligations of each of the Sellers under this Article 8 are limited in the aggregate to the amount equal to such Seller’s Pro Rata Share of $1,000,000 and may be satisfied in cash or Buyer Shares; and

 

 

 

 

8.5.1.2

the Sellers will not be required to indemnify any Buyer Indemnified Party under this Article 8 unless the aggregate of all Losses under the Indemnity Claims made by the Buyer Indemnified Parties exceeds $30,000 in which case the Sellers as Indemnifying Parties will be obligated to pay the full amount owing by them under this Article 8 in respect of all Indemnity Claims (both below and above that threshold).

 

8.5.2

If any Indemnity Claims are made by a Buyer Indemnified Party against the Sellers or any of them:

 

 

8.5.2.1

relating to the non-performance of any covenant or obligation of the Corporation or a Seller;

 

 

 

 

8.5.2.2

based on intentional misrepresentation or fraud; or

 

 

 

 

8.5.2.3

the representations and warranties contained in Section 3.1.3 (Title to Purchased Shares), as to each Seller only, or Section 3.2.16 (Tax Matters),

 

 

 

 

then:

 

 

 

 

8.5.2.4

despite Section 8.5.1.1, the indemnification obligations of the Sellers with respect to those Indemnity Claims will be unlimited, and may be satisfied in cash or Buyer Shares; and

 

 

 

 

8.5.2.5

the limitations in Section 8.5.1.2 will not apply to those Indemnity Claims.

 

 

 

- 38 -

 

 

8.5.3

Subject to Section 8.5.4,

 

 

8.5.3.1

the indemnification obligations of the Buyer under this Article 8 are limited in the aggregate to $1,000,000; and

 

 

 

 

8.5.3.2

the Buyer will not be required to indemnify any Seller Indemnified Party under this Article 8 unless the aggregate of all Losses under the Indemnity Claims made by the Seller Indemnified Parties exceeds $30,000, in which case the Buyer as an Indemnifying Party will be obligated to pay the full amount owing by it under this Article 8 in respect of all Indemnity Claims (both below and above that threshold).

 

8.5.4

If any Indemnity Claims are made by a Seller Indemnified Party against the Buyer:

 

 

8.5.4.1

relating to the non-performance of any covenant or obligation of the Buyer;

 

 

 

 

8.5.4.2

based on intentional misrepresentation or fraud; or

 

 

 

 

8.5.4.3

the representations and warranties contained in Section 3.3.7 (Consideration Shares).

 

 

 

 

then:

 

 

 

 

8.5.4.4

despite Section 8.5.3, the indemnification obligations of the Buyer with respect to those Indemnity Claims will be unlimited; and

 

 

 

 

8.5.4.5

the limitations in Section 8.5.3.2 will not apply to such Indemnity Claims.

 

8.6

Rules Relating to Indemnification Obligations

 

The following will apply to the indemnification obligations under this Article 8.

 

8.6.1

Effect of Waiver. The waiver of any condition relating to any representation, warranty or covenant (other than the obligation of the Sellers to deliver the Final Interim Financial Statements to the Buyer) will not affect the right to indemnification under this Article 8 based on that representation, warranty or covenant.

 

 

8.6.2

No Indirect Damages. The Sellers have no liability for, or obligation with respect to, any special, indirect, consequential, punitive or aggravated damages.

 

 

8.6.3

Insurance Recoveries. Before an Indemnifying Party is required to indemnify an Indemnified Party for any Loss under an Indemnity Claim, the Indemnified Party must first make all commercially reasonable efforts to seek recovery for that Loss under any applicable insurance policies held by the Indemnified Party. The amount of any Loss under an Indemnity Claim will be net of any amounts actually recovered by the Indemnified Party under insurance policies with respect to that Loss.

 

 

8.6.4

No Double Recovery. No Indemnified Party is entitled to double recovery for any Indemnity Claim even though the Indemnity Claim may have resulted from the breach or inaccuracy of more than one of the representations, warranties, covenants and obligations of the Indemnifying Party under this Agreement. No Indemnifying Party has any liability or obligation for indemnification under this Article 8 to the extent that the relevant Loss has been taken into account in the determination of the Estimated Closing Date Working Capital or the Final Closing Date Working Capital and the related adjustments to the Purchase Price have been paid.

 

 

 

- 39 -

 

 

8.6.5

Duty to Mitigate. Nothing in this Agreement in any way restricts or limits an Indemnified Party’s general obligation to mitigate any loss under common law principles in Canada and an Indemnified Party shall use commercially reasonable efforts to mitigate any loss which it may suffer or incur by reason of a breach by an Indemnifying Party of any representation, warranty, covenant or obligation of the Indemnifying Party under this Agreement.

 

 

8.6.6

Adjustment to Purchase Price. Any payment made by a Seller as an Indemnifying Party pursuant to this Article 8 will constitute a dollar-for-dollar decrease of the Purchase Price and any payment made by the Buyer as an Indemnifying Party pursuant to this Article 8 will constitute a dollar-for-dollar increase of the Purchase Price.

 

 

8.7

Notice of Indemnity Claims

 

If an Indemnified Party becomes aware of a Loss or potential Loss in respect of which an Indemnifying Party has agreed to indemnify it under this Article 8, the Indemnified Party will promptly give written notice (an “Indemnity Notice”) of its claim or potential claim for indemnification (an “Indemnity Claim”) to the Indemnifying Party. An Indemnity Notice must specify whether the Indemnity Claim arises as the result of a Third Party Claim or as a result of a Loss that was suffered directly by an Indemnified Party, and must also specify with reasonable particularity (to the extent that the information is available):

 

8.7.1

the factual basis for the Indemnity Claim; and

 

 

8.7.2

the amount of the Indemnity Claim, if known.

 

If, through the fault of the Indemnified Party, the Indemnifying Party does not receive an Indemnity Notice of an Indemnity Claim in time to effectively contest the determination of any liability capable of being contested, the Indemnifying Party will be entitled to set off against the amount claimed by the Indemnified Party the amount of any Loss incurred by the Indemnifying Party resulting from the Indemnified Party’s failure to give an Indemnity Notice on a timely basis.

 

8.8

Payment of Claims

 

 

8.8.1

The Indemnifying Party shall make all the payments in respect of claims made pursuant to this Article 8 to the Indemnified Party within thirty (30) days of the receipt of notice of each claim.

 

 

8.8.2

Each Seller will have the right, at its sole discretion, to satisfy any claim made pursuant to this Article 8 in cash or Buyer Shares or a combination thereof. If such Seller chooses to satisfy a claim made pursuant to this Article 8 in Buyer Shares, it shall do so by transferring to the Buyer such number of Buyer Shares as is necessary to cover all or a portion of such claim on a dollar‑for‑dollar basis, with such Buyer Shares having a deemed value equal to the greater of: (i) the market price of the Buyer Shares on the CSE on the last trading day before the Seller provides the Buyer written notice of its desire to satisfy the Indemnity Claim in Buyer Shares, and (ii) the deemed price per Buyer Share set out in Section 2.2.2. Upon transfer of such Buyer Shares from the applicable Seller to the Buyer, such Seller shall be deemed to have paid to the applicable Buyer Indemnified Party the equivalent of the deemed value of such transferred Buyer Shares.

 

 

 

- 40 -

 

 

8.9

Exclusive Remedy

 

 

8.9.1

Subject to Section 2.7 (Disputes) and Section 8.9.2, if the Closing occurs, the rights of indemnity in this Article 8 will be the sole and exclusive remedy of any Indemnified Party or any third party beneficiary under Section 4.8 (Indemnification) for any breach of a representation or warranty, or non-performance of any covenant or agreement, contained in this Agreement, and each Indemnified Party or such Person waives any other recourse or remedy it may have in contract, tort or otherwise.

 

 

8.9.2

Nothing in this Section 8.9 will limit or restrict an Indemnified Party from seeking:

 

 

8.9.2.1

specific performance and injunctive relief to enforce the performance of this Agreement upon application to a court of competent jurisdiction without proof of actual damage (and without requirement of posting a bond or other security); or

 

 

 

 

8.9.2.2

any remedies that may be available to an Indemnified Party in the case of fraud or intentional misrepresentation.

 

8.10

Third Party Indemnification

 

To ensure that the indemnities provided by each of the Sellers and the Buyer to any Indemnified Parties that are not parties to this Agreement are enforceable, it is agreed by the Parties that each of the Sellers is acting as agent for its Seller Indemnified Parties (that are not Parties), and the Buyer is acting as agent for its Buyer Indemnified Parties (that are not Parties), with respect to the indemnities intended to be given to those Persons under this Article 8. Each of the Sellers and the Buyer agrees that it will hold any right to indemnification that any relevant Indemnified Party is intended to have under this Article 8 in trust for that Person, and that funds received by the Sellers or the Buyer in respect of any claims under this Article 8 by the relevant Indemnified Party will be held in trust for that Person.

 

ARTICLE 9
GENERAL

 

9.1

Time of Essence

 

Time is of the essence in all respects of this Agreement.

 

9.2

Notices

 

Any Communication must be in writing and either:

 

9.2.1

delivered personally or by courier;

 

 

9.2.2

sent by prepaid registered mail; or

 

 

9.2.3

transmitted e-mail or functionally equivalent electronic means of transmission, charges, if any, prepaid.

 

 

 

- 41 -

 

 

Any Communication must be sent to the intended recipient at its address as follows:

 

 

to the Sellers at:

 

Justin Hannewyk
304 – 1126 Barclay Street
Vancouver, BC V6E 1H1

 

 

 

 

Tel. No.: 

(604) 938-4020

 

E-mail:

justinhannewyk@gmail.com

 

 

 

 

Richard Cochrane
22 – 2720 Cheakamus Way
Whistler, BC V8E 0M1

 

 

 

 

Tel. No.:  

(604) 902-1455

 

E-mail:

rich-cochrane@hotmail.com

 

 

 

 

to the Buyer or, following the Closing Date, to the Corporation at:

 

 

 

Draganfly Inc.
2108 St. George Avenue
Saskatoon, SK S7M 0K7

 

 

 

 

Attention: 

Cameron Chell

 

Tel. No.: 

Cameron.chell@draganfly.com

 

E-mail: 

(1-800) 979-9794

 

 

 

 

with a copy to:

 

 

 

Gowling WLG (Canada) LLP
Suite 2300, Bentall 5
550 Burrard Street
Vancouver, BC V6C 2B5

 

 

 

 

Attention:

Denis Silva

 

Tel. No.:

(604) 891-2261

 

E-mail:

denis.silva@gowlingwlg.com

 

or at any other address as any Party may at any time advise the others by Communication given or made in accordance with this Section 9.2. Any Communication delivered to the Party to whom it is addressed will be deemed to have been given or made and received on the day it is delivered at that Party’s address, provided that if that day is not a Business Day then the Communication will be deemed to have been given or made and received on the next Business Day. Any Communication transmitted by e-mail or other functionally equivalent electronic means of transmission will be deemed to have been given or made and received on the day on which it is transmitted; but if the Communication is transmitted on a day which is not a Business Day or after 5:00 p.m. (local time of the recipient), the Communication will be deemed to have been given or made and received on the next Business Day. Sending a copy of a Communication to a Party’s legal counsel is for information purposes only and does not constitute delivery of that Communication to that Party. The failure to send a copy of a Communication to a Party’s legal counsel does not invalidate delivery of that Communication to the Party.

 

 

 

- 42 -

 

 

9.3

Severability

 

Each Section of this Agreement is distinct and severable. If any Section of this Agreement, in whole or in part, is or becomes illegal, invalid, void, voidable or unenforceable in any jurisdiction by any court of competent jurisdiction, the illegality, invalidity or unenforceability of that Section, in whole or in part, will not affect:

 

9.3.1

the legality, validity or enforceability of the remaining Sections of this Agreement, in whole or in part; or

 

 

9.3.2

the legality, validity or enforceability of that Section, in whole or in part, in any other jurisdiction.

 

9.4

Submission to Jurisdiction

 

Without prejudice to the ability of any Party to enforce this Agreement in any other proper jurisdiction, each of the Parties irrevocably and unconditionally submits and attorns to the non-exclusive jurisdiction of the courts of the Province of British Columbia to determine all issues, whether at law or in equity, arising from this Agreement. To the extent permitted by applicable law, each of the Parties:

 

9.4.1

irrevocably waives any objection, including any claim of inconvenient forum, that it may now or in the future have to the venue of any legal proceeding arising out of or relating to this Agreement in the courts of that Province, or that the subject matter of this Agreement may not be enforced in those courts;

 

 

9.4.2

irrevocably agrees not to seek, and waives any right to, judicial review by any court which may be called upon to enforce the judgment of the courts referred to in this Section 9.4, of the substantive merits of any suit, action or proceeding; and

 

 

9.4.3

to the extent that Party has or may acquire any immunity from the jurisdiction of any court or from any legal process, whether through service or notice, attachment before judgment, attachment in aid of execution, execution or otherwise, with respect to itself or its property, irrevocably waives that immunity in respect of its obligations under this Agreement.

 

 

9.5

Amendment and Waiver

 

No amendment, discharge, restatement, supplement, termination or waiver of this Agreement or any Section of this Agreement is binding unless it is in writing and executed by the Party to be bound. No waiver of, failure to exercise or delay in exercising, any Section of this Agreement constitutes a waiver of any other Section (whether or not similar) nor does any waiver constitute a continuing waiver unless otherwise expressly provided.

 

9.6

Further Assurances

 

Each Party will execute and deliver any further agreements and documents and provide any further assurances, undertakings and information as may be reasonably required by the requesting Party to give effect to this Agreement.

 

 

 

- 43 -

 

 

9.7

Assignment and Enurement

 

Neither this Agreement nor any right or obligation under this Agreement may be assigned by any Party without the prior written consent of the other Parties. This Agreement enures to the benefit of and is binding upon the Parties and their respective Successors.

 

9.8

Counterparts and Electronic Delivery

 

This Agreement may be executed and delivered by the Parties in one or more counterparts, each of which will be an original, and each of which may be delivered by facsimile, e-mail or other functionally equivalent electronic means of transmission, and those counterparts will together constitute one and the same instrument.

 

9.9

Payment and Currency

 

Any money to be advanced, paid or tendered by any Party under this Agreement must be advanced, paid or tendered by bank draft, certified cheque or wire transfer of immediately available funds payable to the Person to whom the amount is due. Unless otherwise specified, the word “dollar” and the “$” sign refer to Canadian currency, and all amounts to be advanced, paid, tendered or calculated under this Agreement are to be advanced, paid, tendered or calculated in Canadian currency.

 

9.10

No Contra Proferentem

 

This Agreement has been reviewed by each Party’s professional advisors, and revised during the course of negotiations between the Parties. Each Party acknowledges that this Agreement is the product of their joint efforts, that it expresses their agreement, and that, if there is any ambiguity in any of its provisions, no rule of interpretation favouring one Party over another based on authorship will apply.

 

9.11

Public Announcements

 

All public announcements, press releases and publicity concerning this Agreement, or the transactions contemplated by this Agreement, must be jointly planned and co-ordinated by the Sellers, the Corporation and the Buyer, and no Party will act unilaterally in this regard without the prior consent of the other Parties unless, and only to the extent that, disclosure is required to meet the timely disclosure obligations of any Party under applicable laws in circumstances where prior consultation with the other Parties is not practicable. Nothing in this Section 9.11 will limit the ability of a Party to make any announcements to employees, clients or other Persons having business relations with a Party to the extent the Party, after consultation with the other Parties, reasonably determines in good faith that the announcement is necessary or advisable.

 

9.12

Cost and Expenses

 

Except as otherwise specified in this Agreement and except for the Audit Expenses (which will be paid for by the Buyer), and without limiting the indemnification provisions in Article 8 (Indemnification and Survival), all costs and expenses (including the fees and disbursements of accountants, financial advisors, legal counsel and other professional advisers) incurred in connection with the negotiation and settlement of this Agreement, and the completion of the transactions contemplated by this Agreement, are to be paid by the Party incurring those costs and expenses.

 

THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK

 

 

 

- 44 -

 

 

Each of the Parties has executed and delivered this Agreement as of the date noted at the beginning of this Agreement.

 

 

/s/ Justin Hannewyk

 

JUSTIN HANNEWYK

 

       

 

 

 

 

 

/s/ Richard Cochrane

 

 

RICHARD COCHRANE

 

 

 

 

 

 

DRAGANFLY INC.

 

 

 

 

 

Per: 

/s/ Cameron Chell

 

 

Name:   Cameron Chell  
    Title:     Chief Executive Officer  
       

 

DRONELOGICS SYSTEMS INC.

 

 

 

 

 

 

Per:

/s/ Justin Hannewyk

 

 

 

Name: Justin Hannewyk

 

 

 

Title:   Director

 

 

 

 

 

SCHEDULE A


TO SHARE PURCHASE AGREEMENT

 

SELLERS

 

Seller

Jurisdiction

Number of
Purchased Shares

Owned by Seller

Pro Rata Share
of Seller

Justin Hannewyk

BC, Canada

65

65%

Richard Cochrane

BC, Canada

35

35%

Total Number of Purchased Shares:

100

100%

 

 

 

 

SCHEDULE B


EXCLUDED ASSETS

 

Please see attached.

 

 

 

 

 

SCHEDULE C


FINANCIAL STATEMENTS

 

Please see attached.

 

 

 

 

 

 

SCHEDULE D

TARGET CLOSING WORKING CAPITAL

 

Please see attached.

 

 

 

 

 

 

 

SCHEDULE E
CINEMATOGRAPHY SPINOUT RELATED STEPS

 

Prior to Closing, the Corporation will spin out the Excluded Business to a new company owned by Justin Hannewyk and Richard Cochrane, which transactions will comprise part of the Cinematography Spinout, as follows:

 

 

1.

Justin Hannewyk and Richard Cochrane will incorporate a new company (the “Cine Co”) and will be sole shareholders thereof.

 

 

 

 

2.

The Excluded Assets (as defined in the Share Purchase Agreement between the Corporation and Draganfly Inc.) with a current estimated fair market value of approximately CDN$287,000 will be transferred (the “Transfer”) to Cine Co in a single no-cash transaction pursuant to an asset purchase agreement between the Corporation and Cine Co.

 

 

 

 

3.

As consideration for the Transfer, Cine Co will issue a promissory note (the “Note”) to the Corporation in the amount equal to the fair market value of the Excluded Assets.

 

 

 

 

4.

There is estimated to be approximately CDN$100,000 of existing shareholder loans and advances due to Justin Hannewyk and Richard Cochrane (the “Shareholder Accounts”) by the Corporation immediately prior to the Cinematography Spinout.

 

 

 

 

5.

The Shareholder Accounts due to Justin Hannewyk and Richard Cochrane will be offset against the obligations of Cine Co under the Note, such that the obligations of Cine Co under the Note will be reduced by the amount of the Shareholder Accounts.

 

 

 

 

6.

The Corporation will declare and pay dividends to each of Justin Hannewyk and Richard Cochrane in an aggregate amount equal to the balance due to the Corporation under the Note after setoff of the Shareholder Accounts (estimated to be approximately CAD$187,000), such that the remaining amounts due to the Corporation under the Note would be fully offset against such dividends and that a NIL balance would be due by Cine Co to the Corporation under the Note and a NIL balance would be due by the Corporation to Justin Hannewyk and Richard Cochrane.

 

 

 

 

SCHEDULE F
LIST OF EMPLOYEES OF THE CORPORATION
BEING GRANTED STOCK OPTIONS AT CLOSING

 

Employee of the Corporation

No. of Options

Adam Preston

10,000

Kyle Caelian

10,000

Russel Snow

10,000

Brendan Row

10,000

Neil Morehouse

10,000

Jacky Heshi

10,000

Cuong Dinh

10,000

 

 

 

 

SCHEDULE G

 
TRANSITION SERVICES AGREEMENT COMMERCIAL TERMS

 

Service

Cost Allocations

Facility and commercial space

40% of cost of lease

Office administration

$400 per month

Access to personnel

Cost plus 10%

Rental and/or purchase of equipment

Cost plus 10%

 

 

 

 

EXHIBIT 5.1.5.5


FORM OF EMPLOYMENT AGREEMENTS

 

Please see attached.

 

 

 

 

 

 

 

 

EXHIBIT 5.1.5.7


FORM OF MUTUAL RELEASE

 

Please see attached

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 EXHIBIT 6.4

 

Execution Version

BUSINESS COMBINATION AGREEMENT

 

BETWEEN

 

DRONE ACQUISITION CORP.

 

and

 

DRAGANFLY INNOVATIONS INC.

 

and

 

1187607 B.C. Ltd.

 

January 31, 2019

 

 

 

 

TABLE OF CONTENTS

 

 

 

Page

 

 

 

 

 

 

ARTICLE 1 INTERPRETATION

 

1

 

 

 

 

 

 

1.1

Defined Terms.

 

1

 

1.2

Gender and Number.

 

12

 

1.3

Headings, etc.

 

12

 

1.4

Currency.

 

12

 

1.5

Certain Phrases, etc.

 

13

 

1.6

Accounting Terms.

 

13

 

1.7

Schedules.

 

13

 

1.8

References to Persons and Agreements.

 

13

 

1.9

Statutes.

 

13

 

1.10

Non-Business Days.

 

13

 

 

 

 

 

 

 

ARTICLE 2 CONTINUANCE AND AMALGAMATION

 

13

 

 

 

 

 

 

2.1

Continuance and Amalgamation.

 

13

 

 

 

 

 

 

 

ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF DRAGANFLY

 

16

 

 

 

 

 

 

3.1

Representations and Warranties of Draganfly.

 

16

 

 

 

 

 

 

 

ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF DRONECORP

 

32

 

 

 

 

 

 

4.1

Representations and Warranties of DroneCorp.

 

32

 

 

 

 

 

 

 

ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF SUBCO

 

35

 

 

 

 

 

 

5.1

Representations and Warranties of Subco

 

35

 

 

 

 

 

 

 

ARTICLE 6 COVENANTS OF THE PARTIES

 

36

 

 

 

 

 

 

6.1

Non-Solicitation

 

36

 

6.2

Conduct of Business.

 

36

 

6.3

Actions to Satisfy Conditions.

 

38

 

6.4

Access for Investigation

 

39

 

6.5

Personal Information – Post-Closing

 

40

 

6.6

Escrow and Trading Restrictions of Consideration Shares

 

40

 

6.7

Name of DroneCorp Following Amalgamation

 

40

 

6.8

DroneCorp Directors And Officers – Post-Closing

 

40

 

6.9

CSE Listing – Post-Closing

 

40

 

6.10

Equity Financing – Post-Closing

 

41

 

6.11

Use Of Proceeds of Financings – Post-Closing

 

41

 

6.12

Corporate Awareness and Investor Relations Program – Post-Closing

 

41

 

6.13

OTC Listing – Post-Closing

 

41

 

6.14

Advancement of Bridge Loan

 

41

 

 

-i-

 

 

TABLE OF CONTENTS

(continued)

 

 

 

Page

 

 

 

 

 

 

ARTICLE 7 CONDITIONS

 

41

 

 

 

 

 

 

7.1

Mutual Conditions Precedent.

 

41

 

7.2

Conditions for the Benefit of DroneCorp.

 

42

 

7.3

Conditions for the Benefit of Draganfly.

 

46

 

 

 

 

 

 

 

ARTICLE 8 TERMINATION, SURVIVAL AND INDEMNIFICATION

 

47

 

 

 

 

 

 

8.1

Term.

 

47

 

8.2

Termination Rights.

 

47

 

8.3

Effect of Termination.

 

48

 

8.4

Survival and Indemnification.

 

48

 

8.5

Termination and Expense Fees

 

49

 

 

 

 

 

 

 

ARTICLE 9 MISCELLANEOUS

 

51

 

 

 

 

 

 

9.1

Dissenting Shareholders

 

51

 

9.2

Notices.

 

51

 

9.3

Time of the Essence.

 

52

 

9.4

Announcements.

 

52

 

9.5

Expenses.

 

53

 

9.6

Amendments.

 

53

 

9.7

Waiver.

 

53

 

9.8

Entire Agreement.

 

53

 

9.9

Successors and Assigns.

 

53

 

9.10

Severability.

 

53

 

9.11

Governing Law.

 

54

 

9.12

Arbitration.

 

54

 

9.13

Counterparts.

 

54

 

SCHEDULE A FORM OF AMALGAMATION AGREEMENT

 

 

A-1

 

 

 

 

 

 

SCHEDULE B FORM OF BRIDGE LOAN

 

B-1

 

 

 

 

 

SCHEDULE C DISCLOSURE SCHEDULE

 

C-1

 

 

 

 

 

SCHEDULE D DRAGANFLY FINANCIAL STATEMENTS

 

D-1

 

 

 

 

 

SCHEDULE E FORM OF COMPENSATION PLAN

 

E-1

 

 

 

 

 

SCHEDULE F LIST OF NOT NON-U.S. HOLDERS

 

F-1

 

 

 

 

 

SCHEDULE G ADJUSTMENT CLAUSE EXAMPLES

 

G-1

 

 
 

-ii-

 

 

BUSINESS COMBINATION AGREEMENT

 

This Agreement is dated for reference January 31, 2019.

 

BETWEEN:

 

DRAGANFLY INNOVATIONS INC., 2108 St. George Avenue,

Saskatoon, SK, S7M 0K7

 

(“Draganfly”)

 

AND:

 

DRONE ACQUISITION CORP., 2300 – 550 Burrard Street,

Vancouver, BC, V6C 2B5

 

(“DroneCorp”)

 

AND:

 

1187607 B.C. Ltd., 2300 – 550 Burrard Street, Vancouver, BC, V6C 2B5

 

(“Subco”).

 

WHEREAS DroneCorp intends to acquire all of the issued and outstanding common shares of Draganfly in exchange for common shares of DroneCorp, which purchase will be effected pursuant to the Amalgamation (hereinafter defined) as set forth herein and on the terms and subject to the conditions set forth in the Amalgamation Agreement (hereinafter defined);

 

AND WHEREAS DroneCorp has entered into the Voting Agreements (hereinafter defined) with the Locked-Up Shareholders (hereinafter defined), pursuant to which, among other things, such Locked-Up Shareholders have agreed, subject to the terms and conditions thereof, to vote the Draganfly Shares held by them in favour of the Amalgamation Approval.

 

NOW THEREFORE in consideration of the foregoing, and the respective covenants, agreements, representations and warranties of the Parties contained herein, and for other good and valuable consideration (the receipt and adequacy of which are acknowledged), the Parties agree as follows:

 

ARTICLE 1
INTERPRETATION

 

1.1

Defined Terms.

 

As used in this Agreement, the following terms have the following meanings:

 

ABCA” means the Business Corporations Act (Alberta), and all regulations thereunder, as amended from time to time.

 

Agreement” means this Business Combination Agreement, as such agreement may be amended, varied, modified or restated from time to time, together with all Schedules appended to the Agreement.

 

 

 

2

 

 

Amalco” means the corporation resulting from the Amalgamation of the Amalgamating Parties.

 

Amalco Shares” means the common shares of Amalco.

   

Amalgamating Parties” means, collectively, Draganfly and Subco.

 

Amalgamation” means the amalgamation of Draganfly and Subco pursuant to the BCBCA on the terms set forth in this Agreement and the Amalgamation Agreement.

 

Amalgamation Agreement” means the agreement to be entered into among Draganfly, DroneCorp and Subco in respect of the Amalgamation, in substantially the form attached hereto as Schedule A.

 

Amalgamation Application” means the amalgamation application in respect of the Amalgamation required by the BCBCA to be filed with the Registrar.

 

Amalgamation Approval” means approval of Draganfly Shareholders of the Amalgamation.

 

Ancillary Agreements” means all agreements, certificates and other instruments delivered or given pursuant to this Agreement, including without limitation, the Amalgamation Agreement.

 

Authorization” means, with respect to any Person, any order, permit, approval, consent, waiver, license or similar authorization of any Governmental Entity having jurisdiction over the Person.

 

BCBCA” means the Business Corporations Act (British Columbia) and all regulations thereunder, as amended from time to time.

 

Books and Records” means books, ledgers, files, lists, reports, plans, logs, deeds, surveys, correspondence, operating records, Tax Returns and other documents, data and information, including drawings, engineering information, manuals, sales and advertising materials, sales and purchase correspondence, trade association files, research and development records, lists of present and future customers and suppliers, personnel, employment and other records, and all data and information stored on computer-related or other electronic media, maintained with respect to the Business and Draganfly.

 

Bridge Loan” means the loan in the principal amount of $350,000, to be made by DroneCorp in favor of Draganfly, in the form attached hereto as Schedule B.

 

Business” means, with respect to Draganfly, the business of providing engineering services and manufacturing commercial UVS systems and software.

 

Business Combination” means the business combination among DroneCorp, Subco and Draganfly pursuant to which DroneCorp will acquire all of the issued and outstanding Draganfly Shares and by which Draganfly will become a wholly-owned Subsidiary of DroneCorp, and includes the Amalgamation.

 

 

 

3

 

 

Business Day” means any day of the year, other than a Saturday, Sunday or any day on which major banks are closed for business in Vancouver, British Columbia.

 

Business Instincts” means Business Instincts Group, a related party of Draganfly controlled by Cameron Chell, a director of Draganfly.

 

Business Instincts’ Debt” means amount of $645,774.68 to be repaid, and satisfied in full prior to Closing by issuing to Business Instincts 719,927 of Draganfly Shares.

 

Certificate of Amalgamation” means the certificate of amalgamation to be issued by the Registrar.

 

Closing” means the completion of the Amalgamation on the terms and subject to the conditions set forth herein and in the Amalgamation Agreement.

 

Competing Proposal” means, inquiry, expression of interest or offer (written or oral) made by any Person (other than DroneCorp) which constitutes, or may reasonably be expected to result in (in each case whether in one transaction or a series of transactions, and whether directly or indirectly):

 

 

(a)

an issuance or acquisition of 20% or more of any class of voting or equity securities of Draganfly (or rights to those securities);

 

 

 

 

(b)

a take-over bid or tender offer involving Draganfly (or other transaction which, if consummated, would result in that Person (and any Persons acting jointly or in concert) beneficially owning, or exercising control or direction over, 20% or more of any class of voting or equity securities of Draganfly);

 

 

 

 

(c)

an acquisition (or a lease, license or other arrangement having a similar economic effect as an acquisition) of assets which represent 20% or more of the assets of Draganfly or which contribute 20% or more of the revenue of Draganfly;

 

 

 

 

(d)

an amalgamation, arrangement, merger, business combination or consolidation involving Draganfly;

 

 

 

 

(e)

a recapitalization, issuer bid, liquidation, dissolution, reorganization or similar transaction involving Target; or

 

 

 

 

(f)

any other transaction involving Draganfly, the consummation of which would or could reasonably be expected to impede, interfere with, prevent or delay the transactions contemplated by this Agreement or the Amalgamation or which would or could reasonably be expected to materially reduce the benefits to DroneCorp under this Agreement or the Amalgamation.

 

Confidential Information” means information, whether in written or electronic form, or committed to memory, relating to Draganfly, DroneCorp or Subco, as the case may be.

 

Consideration Shares” has the meaning specified in Section 2.1(b)(v)(C).

 

 

 

4

 

 

Constating Documents” means, in respect of Draganfly, DroneCorp or Subco, as the case may be, the articles of incorporation, amalgamation, or continuation arrangement, articles, notices of articles, by-laws and all amendments to such articles, notices of articles or by-laws.

 

Continuance” means the continuance of Draganfly from the Province of Alberta under the Business Corporations Act (Alberta) to the Province of British Columbia under the Business Corporations Act (British Columbia).

 

Continuance Approval” means approval of Draganfly Shareholders of the Continuance.

 

Contract” means any agreement, understanding, undertaking, commitment, licence, or lease, whether written or oral, and includes any agreement, understanding, undertaking, commitment license or lease which has not been executed by the parties thereto but has been substantially agreed by the parties thereto.

 

Corporate Branding Budget” means an amount equal to 10% of the aggregate proceeds raised under the Financing (and any proceeds from the valid exercise of Subscription Receipt Warrants) allocated to corporate branding and investor marketing, subject to completion of the Financing.

 

CSE” means the Canadian Stock Exchange.

 

Debt Settlement Amount” has the meaning specified in Section 7.2(h).

 

Disclosure Schedule” means the disclosure schedule of Draganfly delivered to DroneCorp and attached hereto as Schedule C.

 

Dissenting Shares” means the Draganfly Shares and DroneCorp Shares held by Dissenting Shareholders.

 

Dissenting Shareholder” has the meaning specified in Section 7.2(l).

 

Draganfly” means Draganfly Innovations Inc., a company existing under the laws of the Province of Alberta.

 

Draganfly Amalgamation Meeting” means meeting of shareholders of Draganfly to approve the Amalgamation;

 

Draganfly Continuance Meeting” means meeting of shareholders of Draganfly to approve the Continuance;

 

Draganfly Financial Statements” means draft financial statements of Draganfly, in substantially final form, for the years ended December 31, 2017 and 2016, attached hereto as Schedule D.

 

Draganfly Overdue Debt” means Draganfly’s debt that is currently matured in the amount of $3,265,536.71.

 

Draganfly Shareholders” means the holders of Draganfly Shares from time to time.

 

 

 

5

 

 

Draganfly Shares” means common shares in the capital of Draganfly.

 

Draganfly Warrants” means common share purchase warrants entitling the holder thereof to purchase Draganfly Shares.

 

DroneCorp” means Drone Acquisition Corp., a corporation existing under the laws of the Province of British Columbia.

 

DroneCorp Shareholders” means the holders of DroneCorp Shares from time to time.

 

DroneCorp Shares” means the common shares in the capital of DroneCorp.

 

DroneCorp Warrants” means common share purchase warrants each entitling the holder thereof to purchase one DroneCorp Share at an exercise price of $0.10 per share for a period of two years from issuance.

 

Effective Date” means the date shown on the Certificate of Amalgamation issued by the Registrar giving effect to the Amalgamation, or such earlier or later date as the Parties may mutually agree in writing.

 

Encumbrance” means any security interest, mortgage, charge, pledge, hypothec, lien, encumbrance, restriction, option, adverse claim, right of others or other encumbrance of any kind.

 

ETA” means the Excise Tax Act (Canada).

 

FCAAS” means the Financial and Consumer Affairs Authority of Saskatchewan being the principal regulator of the Amalco for filing the Final Prospectus.

 

Financing” means the issuance of 10,000,000 Subscription Receipts, to be completed on or before Closing, by way of a non-brokered private placement by DroneCorp at a price of $0.50 per Subscription Receipt for a minimum aggregate gross proceeds of $5,000,000.

 

Final Prospectus” means the final non-offering prospectus of DroneCorp filed with the Principal Regulator to enable it to become a reporting issuer in the province of Saskatchewan and such other provinces of Canada as may be agreed by the Parties.

 

GAAP” means generally accepted accounting principles as set out in the Canadian Institute of Chartered Accountants Handbook – Accounting for an entity that prepares its financial statements in accordance with International Financial Reporting Standards, at the relevant time, applied on a consistent basis.

 

Governmental Entity” means (i) any international, multinational, national, federal, provincial, state, regional, municipal, local or other government, governmental or public department, central bank, court, tribunal, arbitral body, commission, board, bureau, ministry, agency or instrumentality, domestic or foreign, (ii) any subdivision or authority of any of the above, (iii) any quasi-governmental or private body exercising any regulatory, expropriation or taxing authority under or for the account of any of the foregoing or (iv) any stock exchange.

 

 

 

6

 

 

Governmental Licences” has the meaning specified in Section 3.1(cc)(i).

 

Intellectual Property” means:

 

 

(a)

trade-marks, design marks, logos, service marks, certification marks, official marks, trade names, business names, corporate names, trade dress, distinguishing guises, slogans, meta tags, keywords, adwords and other characters, brand elements or other distinguishing features used in association with wares or services, whether or not registered or the subject of an application for registration and whether or not registrable, and associated goodwill (“Trade-marks”);

 

 

 

 

(b)

inventions, arts, processes, machines, articles of manufacture, compositions of matter, business methods, formulae, developments and improvements, whether or not patented or the subject of an application for patent and whether or not patentable, methods and processes for making any of them, and related documentation (whether in written or electronic form) and know-how (“Inventions”);

 

 

 

 

(c)

software in source code or object code form, documentation, literary works, artistic works, pictorial works, graphic works, musical works, dramatic works, audio visual works, performances, sound recordings and signals, including their content, and any compilations of any of them, whether or not registered or the subject of an application for registration, or capable of being registered (“Works”);

 

 

 

 

(d)

domain names, whether registered primary domain names or secondary or other higher level domain names (“Domain Names”);

 

 

 

 

(e)

industrial designs and all variants of industrial designs, whether or not registered or the subject of an application for registration and whether or not registrable (“Designs”); and

 

 

 

 

(f)

trade secrets, technical expertise, and research data and other confidential information relating to goods and services.

 

Intellectual Property Rights” means:

 

 

(a)

any common law principle or statutory provision which may provide a right in Intellectual Property, including all:

 

 

(i)

common law rights and registrations, pending applications for registration and rights to file applications for the Trade-marks, including all rights of priority;

 

 

 

 

(ii)

patents, pending patent applications and rights to file applications for the Inventions, including all rights of priority and rights in continuations, continuations-in-part, divisions, reissues, renewals, re-examinations, exclusions and other derivative applications and patents;

 

 

 

7

 

  

 

(iii)

copyrights in Works and all registrations, pending applications for registration and rights to file applications for Works and all moral rights and benefits of waivers of moral rights in Works;

 

 

 

 

(iv)

registrations, pending applications for registration and rights to file applications for registration of Domain Names and all other common law and statutory rights in Domain Names; and

 

 

 

 

(v)

industrial design rights, design patents, design registrations, pending patent and design applications and rights to file applications for Designs, including all rights of priority and rights in continuations, continuations-in-part, divisions, re-examinations, reissues and other derivative applications;

 

 

(b)

all rights in licences, sub-licences, franchise agreements, waivers and other contractual rights in any of the items listed in Subsection (a) of this definition; and

 

 

 

 

(c)

all rights to enforce the rights and obtain remedies for a violation of any of the rights listed in Subsections (a) and (b) of this definition.

 

ITA” means the Income Tax Act (Canada).

 

Knowledge of Draganfly” means the knowledge that senior officers of Draganfly either has, or would have obtained, after having made or caused to be made all reasonable inquiries necessary to obtain informed knowledge, including inquiries of the records and its management employees who are reasonably likely to have knowledge of the relevant matter.

 

Knowledge of DroneCorp” means the knowledge that senior officers of DroneCorp either has, or would have obtained, after having made or caused to be made all reasonable inquiries necessary to obtain informed knowledge, including inquiries of the records and its management employees who are reasonably likely to have knowledge of the relevant matter.

 

Laws” means all laws, statutes, codes, ordinances, decrees, rules, regulations, by laws, statutory rules, principles of law, published policies, forms and guidelines, fee schedules, tariffs, judicial or arbitral or administrative or ministerial or departmental or regulatory judgments, orders, directives, decisions, rulings or awards, including general principles of common and civil law, and terms and conditions of any grant of approval, permission, authority or license of any Governmental Entity, statutory body or self-regulatory authority, and the term “applicable” with respect to such Laws and in the context that refers to one or more Persons, means that such Laws apply to such Person or Persons or its or their business, undertaking, property or securities and emanate from a Governmental Entity (or any other Person) having jurisdiction over the aforesaid Person or Persons or its or their business, undertaking, property or securities.

 

 

 

8

 

 

Letter of Transmittal” means the letter of transmittal to be provided by Draganfly to the Draganfly Shareholders which provides a means for the delivery of any certificates representing Draganfly Shares and for instructions to be given by such Draganfly Shareholder for the delivery of the Consideration Shares, which Letter of Transmittal shall provide for acceptance of the trading restrictions to be applied to the Consideration Shares in accordance with Section 2.1(b)(vii) of this Agreement.

 

Locked-up Shareholders” means each of the directors and senior officers of Draganfly and certain Draganfly Shareholders as agreed to by the Parties;

 

Licence Agreements” has the meaning specified in Section 3.1(x)(xiii).

 

Licenced IP” means the Intellectual Property and Intellectual Property Rights owned by Persons other than Draganfly or any Subsidiary and which Draganfly or any Subsidiary uses or intends to use, including Intellectual Property owned by those Persons relating to Technology and the Technical Information.

 

Listing” means the contemplated listing of the DroneCorp Shares on the CSE following the Closing.

 

Loss” means in respect of a person and in relation to a matter, any loss, damage, cost, expense and charges (including any fine, penalty or assessment) which such person suffers, sustains, pays or incurs in connection with such matter and includes the costs and expenses of any action, suit, proceeding, demand, assessment, judgment, settlement or compromise and all interest, fines, penalties and reasonable costs of legal counsel (on a solicitor and client basis) and disbursements, excluding special, indirect, consequential, exemplary, punitive and incidental damages.

 

Material Adverse Effect” means any event or change that, individually or in the aggregate with other events or changes, is or would reasonably be expected to be, materially adverse to the business, operations, assets, condition (financial or otherwise) or liabilities, whether contractual or otherwise, of any Party, as the case may be; provided that a Material Adverse Effect shall not include an adverse effect resulting from a change: (i) that arises out of a matter that has been publicly disclosed prior to the date of this Agreement or otherwise disclosed in writing by a Party to the other Party prior to the date of this Agreement; (ii) that results from general economic, financial, currency exchange, interest rate or securities market conditions in Canada; (iii) any changes in applicable law or GAAP; or (iv) that is a direct result of any matter permitted by this Agreement or consented to in writing by the applicable Party, provided however that with respect to clause (iii), such change does not relate primarily to the Party to which such Material Adverse Effect relates, or do not have a disproportionate effect on such Party compared to other companies of similar size, operating in the UVS industry.

 

Material Contracts” means any contract, agreement, license, franchise, lease, arrangement, commitment, understanding, joint venture, partnership or other right or obligation (written or oral) to which a Party is a party or by which such a Person is bound or under which such a Person has, or will have, any liability or contingent liability (in each case, whether written or oral, express or implied): (a) involving payments to or by such Person in excess of $100,000 annually or $100,000 in aggregate over the term of the contract; (b) involving rights or obligations that may reasonably extend beyond three years and which does not terminate or cannot be terminated without penalty on less than three months’ notice; (c) which is outside the ordinary course of business; (d) which contain covenants that: (i) in any way purport to restrict the business activity of a Party or any of its affiliates; or (ii) limit the freedom of Party or any of its affiliates to engage in any line of business or to compete with any Person; (e) which, if terminated without the consent of the Person would result in a Material Adverse Effect; or (f) is a contract pursuant to which a Party provides any indemnification for a material liability to any other Person other than in the ordinary course of business.

 

 

 

9

 

 

Meetings” has the meaning specified in Section 2.1(b)(i).

 

Misrepresentation” means an untrue statement of a material fact or an omission to state a material fact required or necessary to make the statements contained therein not misleading in light of the circumstances in which they are made.

 

Non-U.S. Holder” means a holder located outside the United States, who is not a U.S. Person, is not acting for the account or benefit of a person in the United States or a U.S. Person and otherwise would be deemed to receive the DroneCorp securities under this Agreement in an “offshore transaction” as such term is defined in Regulation S under the U.S. Securities Act.

 

Notice” has the meaning specified in Article 9.

 

Ordinary Course” means, with respect to an action taken by a Person, that such action is consistent with the past practices of the Person and is taken in the ordinary course of the normal day-to-day operations of the Person.

 

Originating Persons” means all current and former employees, officers, directors and consultants of Draganfly or any Subsidiary, including, in the case of a consultant that is not an individual, all employees, officers, directors, shareholders and partners of the consultant.

 

OTC” means the OTC QX or OTC QB quotation system of the OTC Markets Group.

 

Outside Date” means June 30, 2019 or such later date as may be agreed to in writing by the Parties.

 

Owned IP” means all Intellectual Property that is owned by Draganfly or any Subsidiary, including Intellectual Property relating to Technology and the Technical Information, as well as all Intellectual Property Rights that are owned or enforceable by Draganfly or any Subsidiary;

 

Parties” means, collectively, Draganfly, DroneCorp and Subco and any other Person who may become a party to this Agreement; and “Party” means any one of them.

 

Permits” means the authorizations, registrations, permits, certificates of approval, approvals, grants, licences, quotas, consents, commitments, rights or privileges (other than those relating to the intellectual property) issued or granted by any Governmental Entity to Draganfly.

 

Person” means a natural person, partnership, limited partnership, limited liability partnership, corporation, limited liability corporation, unlimited liability company, joint stock company, trust, unincorporated association, joint venture or other entity or Governmental Entity, and pronouns having a similarly extended meaning.

 

 

 

10

 

 

Personal Information” means information about an individual who can be identified by the Person who holds that information.

 

Personal Property” means all machinery, equipment, furniture, motor vehicles and other chattels owned or leased (including those in the possession of suppliers, customers and other third parties).

 

Post-Closing Financing” has the meaning specified in Section 6.10.

 

Principal Regulator” means the FCAAS or such other securities regulator as is determined by Multilateral System – 11-102 Passport System.

 

Public Statement” has the meaning ascribed thereto in Section 9.4 hereof.

 

Registrar” means the Registrar of Companies appointed under the BCBCA.

 

Regulatory Approval” means any consent, waiver, permit, exemption, review, order, decision or approval of, or any registration and filing with, any Governmental Entity, or the expiry, waiver or termination of any waiting period imposed by Law or a Governmental Entity.

 

Related Party” has the meaning ascribed thereto in Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions.

 

Related Party Debt” means the Business Instincts’ Debt and any other debt or liabilities owed to any Related Party of Draganfly to Draganfly.

 

Securities” has the meaning given to that term in the Securities Act (British Columbia).

 

Share Compensation Plan” means the share compensation plan of DroneCorp to be adopted following the completion of the Amalgamation in the form attached hereto as Schedule E.

 

SR&ED” has the meaning specified in Section 3.1(q).

 

Subco” means 1187607 B.C. Ltd., a company incorporated under the laws of the Province of British Columbia and a wholly-owned Subsidiary of DroneCorp.

 

Subco Shares” means the common shares in the capital of Subco as constituted on the date hereof.

 

Subscription Receipt” means the subscription receipts of DroneCorp to be issued under the Financing, with each subscription receipt being automatically convertible into one (1) DroneCorp Share and one (1) Subscription Receipt Warrant for no additional consideration in accordance with their terms upon Listing.

 

Subscription Receipt Warrants” means the issued and outstanding DroneCorp warrants to purchase an aggregate of 10,000,000 DroneCorp Shares issuable on conversion of the Subscription Receipts, each entitling the holder thereof to purchase one DroneCorp Shares at an exercise price of $0.50 per share for a period of 4 months from issuance.

 

 

 

11

 

 

Subsidiary” has the meaning specified in National Instrument 45-106 - Prospectus Exemptions as in effect on the date of this Agreement.

 

Tax” or “Taxes” means all taxes, duties, fees, premiums, assessments, imposts, levies, rates, withholdings, dues, government contributions and other charges of any kind whatsoever imposed by any Governmental Entity, whether direct or indirect, together with all interest, penalties, fines, additions to tax or other additional amounts imposed in respect thereof, including those levied on, or measured by, or referred to as income, gross income, gross receipts, net proceeds, profits, capital gains, alternative or add-on, or minimum, capital, transfer, land transfer, sales, retail sales, consumption, use, goods and services, harmonized sales, value-added, ad valorem, turnover, excise, stamp, non-resident withholding, business, franchising, business licenses, real and personal property (tangible and intangible), environmental, transfer, payroll, employee withholding, employment, health, employer health, social services, development, occupation, education or social security, and all contributions, premiums, surtaxes, all customs duties, countervail, anti-dumping, special import measures and import and export taxes, all licence, franchise and registration fees, all provincial workers’ compensation payments, and all employment insurance, health insurance and other government pension plan contributions.

 

Tax Law” means any Law that imposes Taxes or that deals with the administration or enforcement of liabilities for Taxes.

 

Tax Return” means any return, report, declaration, designation, election, undertaking, waiver, notice, filing, information return, statement, form, certificate or any other document filed or to be filed with any Governmental Entity in connection with the determination, assessment, collection or administration of Taxes.

 

Technical Information” means all technical information owned by or licensed (expressly or impliedly) to Draganfly or any Subsidiary relating to its Business or the Technology, including all:

 

 

(a)

information of a scientific or business nature, regardless of its form;

 

 

 

 

(b)

documentation with respect to research, development, demonstration or engineering work;

 

 

 

 

(c)

information that can be or is used to define a design or process, or to procure, produce, support or operate materials or equipment;

 

 

 

 

(d)

information regarding methods of production;

 

 

 

 

(e)

other drawings, blueprints, patterns, plans, flow charts, equipment parts lists, computer software and procedures, specifications, protocols, data structures, formulae, designs, technical data, descriptions, related instruction manuals, records, passwords, and procedures; and

 

 

 

 

(f)

data and databases, whether registered or unregistered.

 

Technology” means all technology owned by or licensed (expressly or impliedly) to Draganfly or any Subsidiary.

 

 

 

12

 

 

Transaction” means collectively, the Amalgamation, the Financing, obtaining receipt of the Final Prospectus and the Listing.

 

United States” means the United States of America, its territories and possessions, and State of the United States and the District of Columbia.

 

U.S. Person” means a “U.S. person” as such term is defined in Regulation S under the U.S. Securities Act.

 

U.S. Securities Act” means the United States Securities Act of 1933, as amended.

 

UVS” means unmanned vehicle systems.

 

Voting Agreements” means the voting agreements (including all amendments thereto) between DroneCorp and the Locked-up Shareholders setting forth the terms and conditions upon which they have agreed, among other things, to vote their Draganfly Shares as applicable, in favour of the Amalgamation Approval;

 

Zenon Assignment Agreement” means the assignment agreements held in escrow by Stevenson Hood Thornton Beaubier LLP between Zenon Dragan and Draganfly pursuant to which the entire interest in Zenon Patents held by Zenon Dragan will be assigned to Draganfly if the payments contemplated in the Zenon Forbearance Agreement are made in full as contemplated therein.

 

Zenon Forbearance Agreement” means the forbearance agreement dated November 5, 2018 between Draganfly, Zenon S. Dragan Jr. Family Trust, Draganfly Holdings Inc., Christine Dragan and Zenon Dragan providing for the forbearance of the indebtedness owed by Draganfly to Zenon S. Dragan Jr. Family Trust, Draganfly Holdings Inc., Christine Dragan and Zenon Dragan until Closing.

  

Zenon Patents” means all of the patents, patent applications and industrial design registrations that are listed in the Zenon Assignment Agreement.

 

1.2

Gender and Number.

 

Any reference in this Agreement or any Ancillary Agreement to gender includes all genders. Words importing the singular number only shall include the plural and vice versa.

 

1.3

Headings, etc.

 

The provision of a Table of Contents, the division of this Agreement into Articles, Sections and Schedules and the insertion of headings are for convenient reference only and are not to affect its interpretation.

 

1.4

Currency.

 

All references in this Agreement or any Ancillary Agreement to dollars, or to $ are expressed in Canadian currency unless otherwise specifically indicated.

 

 

 

13

 

 

1.5

Certain Phrases, etc.

 

In this Agreement and any Ancillary Agreement (i) the words “including”, “includes” and “include” mean “including (or includes or include) without limitation”, and (ii) the phrase “the aggregate of”, “the total of”, “the sum of”, or a phrase of similar meaning means “the aggregate (or total or sum), without duplication, of”. In the computation of periods of time from a specified date to a later specified date, unless otherwise expressly stated, the word “from” means “from and including” and the words “to” and “until” each mean “to but excluding”.

 

1.6

Accounting Terms.

 

All accounting terms not specifically defined in this Agreement are to be interpreted in accordance with GAAP.

 

1.7

Schedules.

 

The schedules attached to this Agreement form an integral part of this Agreement for all purposes of it.

 

1.8

References to Persons and Agreements.

 

Any reference in this Agreement or any Ancillary Agreement to a Person includes such Person’s heirs, administrators, executors, legal personal representatives, successors and permitted assigns. Except as otherwise provided in this Agreement or any Ancillary Agreement, the term “Agreement” and any reference in this Agreement to this Agreement, any Ancillary Agreement or any other agreement or document includes, and is a reference to, this Agreement, such Ancillary Agreement or such other agreement or document as it may have been, or may from time to time be amended, restated, replaced, supplemented or novated and includes all schedules to it.

 

1.9

Statutes.

 

Except as otherwise provided in this Agreement, any reference in this Agreement to a statute refers to such statute and all rules and regulations made under it, as it or they may have been or may from time to time be amended or re-enacted.

 

1.10

Non-Business Days.

 

Whenever payments are to be made or an action is to be taken on or not later than a day which is not a Business Day, such payment shall be made or such action shall be taken on or not later than the next succeeding Business Day.

 

ARTICLE 2
CONTINUANCE AND AMALGAMATION

 

2.1

Continuance and Amalgamation.

 

 

(a)

Each of the Parties covenants to take all such actions as are within its power to control and use commercially reasonable efforts to cause other actions to be taken which are not within its power to control, so as to complete the Continuance and Amalgamation as set forth in this Section 2.1 and otherwise on the terms, and subject to the conditions, set forth in this Agreement.

 

 

 

14

 

  

 

(b)

Each Party hereby agrees, unless such steps have already been completed, that as soon as reasonably commercially practicable after the date hereof or at such other time as is specifically indicated below in this Section 2.1, and on the applicable terms, and subject to the applicable conditions, set forth in this Agreement and the Amalgamation Agreement, it shall take the following steps:
 

 

(i)

Continuance and Amalgamation Approval of Draganfly. Prior to the Effective Date, Draganfly shall convene and hold the following two meetings (together, the “Meetings”) as soon as reasonably practicable: (i) the Draganfly Continuance meeting, to be held in accordance with the ABCA for the purpose of obtaining Continuance Approval; and (ii) the Draganfly Amalgamation meeting, to be held in accordance with the BCBCA following the completion of the Continuance for the purpose of obtaining Amalgamation Approval. Draganfly shall not adjourn or otherwise change the timing of the Draganfly Continuance meeting and the Draganfly Amalgamation meeting without the prior written consent of DroneCorp, such consent not to be unreasonably withheld. In connection with the Meetings, as promptly as reasonably practicable, Draganfly shall prepare the applicable proxy meeting materials together with any other documents required by applicable laws in connection and shall give DroneCorp the opportunity to review and comment on such materials and all such other documents and these documents shall be reasonably satisfactory to DroneCorp, acting reasonably, before they are filed or distributed to the Draganfly Shareholders entitled thereto subject to any disclosure obligations imposed on Draganfly by applicable law.

 

 

 

 

(ii)

Amalgamation Resolution of DroneCorp. Prior to the Effective Date, DroneCorp, as the sole shareholder of Subco, will execute and deliver a written special resolution authorizing Subco to, among other things, enter into the Amalgamation, the Agreement and the Ancillary Agreements, and to perform the Business Combination and the Amalgamation.

 

 

 

 

(iii)

Filing of Amalgamation Application. Subject to obtaining approval of the Draganfly Shareholders and the sole shareholder of Subco, and subject to the satisfaction or waiver of the applicable conditions of Closing as set forth in this Agreement, the Amalgamating Parties will submit the Amalgamation Application and such other documents as may be required under the BCBCA in connection therewith to give effect to the Amalgamation.

   

 

(iv)

Amalgamation Agreement. The Parties hereby acknowledge that the form of Amalgamation Agreement attached as Schedule A complies with the requirements of the BCBCA.

 

 

 

 

(v)

Amalgamation Steps. The Amalgamation shall, with such other matters as are necessary to effect the Amalgamation, and all as subject to the provisions of the Amalgamation Agreement, provide as follows:

 

 

 

15

 

 

 

(A)

DroneCorp (or as directed to be registered by DroneCorp) will receive, subject to applicable securities laws, immediately prior to the completion of the Amalgamation, up to 1,114,827 Draganfly Shares (the “Advisory Shares”) in consideration of DroneCorp’s advisory services in connection with the Transaction (subject to adjustment in accordance with section 7.2(g) of the Agreement);
 

 

(B)

the Amalgamating Parties will amalgamate and continue as Amalco;

 

 

 

 

(C)

holders of Draganfly Shares (other than Dissenting Shareholders who are ultimately entitled to be paid fair value for their Dissenting Shares) will receive 1.794 fully paid and non-assessable DroneCorp Shares for each Draganfly Share held by such Draganfly Shareholder, such ratio to be adjusted such that only a total of up to 42,000,000 DroneCorp Shares (including the Advisory Shares and subject to adjustment in accordance with section 7.2(g) of the Agreement) (the “Consideration Shares”) will be issued to Draganfly Shareholders excluding Draganfly Shares issued upon conversion of the Business Instincts’ Debt and as applicable Draganfly Overdue Debt which holders will be issued DroneCorp Shares at the foregoing ratio outside of the Consideration Shares, and the Draganfly Shares shall thereafter be cancelled;

 

 

 

 

(D)

the shares of Subco will be cancelled and replaced by Amalco Shares on the basis of one (1) Amalco Share for each share of Subco;

 

 

 

 

(E)

as consideration for the issuance of the Consideration Shares to holders of Draganfly Shares to effect the Amalgamation, Amalco will issue to its immediate shareholder, DroneCorp, one (1) Amalco Share for each Consideration Share issued to holders of Draganfly Shares;

 

 

 

 

(F)

Amalco will be a direct wholly-owned Subsidiary of DroneCorp upon completion of the Amalgamation; and

 

 

 

 

(G)

all of the property, rights, privileges and assets of the Amalgamating Parties will continue as the property, rights, privileges and assets of Amalco, and Amalco will become liable for all of the liabilities and obligations of the Amalgamating Parties.

 

 

(vi)

Trading Restrictions on Consideration Shares. The certificates representing the Considerations Shares (excluding the Advisory Shares) will be subject to trading restrictions to be effective as of the Listing and, if required, bear legends:

 

 

(A)

2,000,000 Consideration Shares with no trading restrictions;

 

 

 

 

(B)

6,000,000 Consideration Shares with a six month trading restriction;

 

 

 

16

 

 

 

(C)

6,000,000 Consideration Shares with a twelve month trading restriction;

 

 

 

 

(D)

6,000,000 Consideration Shares with a eighteen month trading restriction;

 

 

 

 

(E)

6,000,000 Consideration Shares with a twenty-four month trading restriction;

 

 

 

 

(F)

6,000,000 Consideration Shares with a thirty month trading restriction; and

 

 

 

 

(G)

8,000,000 Consideration Shares with a thirty-six month trading restriction.

 

 

(vii)

No Fractional Shares. Notwithstanding Section 2.1(b)(v)(C) of this Agreement, no Draganfly Shareholder shall be entitled to, and DroneCorp will not issue, fractions of DroneCorp Shares and no cash amount will be payable by DroneCorp in lieu thereof. To the extent any Draganfly Shareholder is entitled to receive a fractional DroneCorp Share such fraction shall be rounded down to the closest whole number of the applicable security.

 

 

 

 

(viii)

Warrants. The Parties acknowledge that upon completion of the Amalgamation, holders of Draganfly Warrants and DroneCorp Warrants will be entitled to receive, upon exercise of such warrants for the same aggregate consideration, DroneCorp Shares in lieu of shares otherwise issuable prior to the Effective Date adjusted in accordance with the terms of the agreements, plans or certificates representing such Draganfly Warrants and DroneCorp Warrants.

 

ARTICLE 3
REPRESENTATIONS AND WARRANTIES OF DRAGANFLY

 

3.1

Representations and Warranties of Draganfly.

 

Draganfly represents and warrants, as of the date of this Agreement, as follows to DroneCorp and acknowledges and confirms that DroneCorp is relying on such representations and warranties in connection with the transactions contemplated by this Agreement:

 

 

(a)

Corporate Existence of Draganfly. Draganfly is validly existing and in good standing as a corporation under the ABCA. No proceedings have been taken or authorized by Draganfly in respect of the bankruptcy, insolvency, liquidation, dissolution or winding up of Draganfly.

 

 

 

 

(b)

Capacity to Enter Agreement. Draganfly has all necessary corporate power, authority and capacity to enter into and perform its obligations under this Agreement.

 

 

 

17

 

 

 

(c)

Binding Obligation. This Agreement has been duly executed and delivered by Draganfly and constitutes a valid and binding obligation of Draganfly, enforceable against Draganfly in accordance with its terms, subject to applicable bankruptcy, insolvency and other Laws of general application limiting the enforcement of creditors’ rights generally and to the fact that equitable remedies, including specific performance, are discretionary and may not be ordered in respect of certain defaults.

 

 

 

 

(d)

Absence of Conflict. None of the execution and delivery of this Agreement and the Ancillary Agreements to which Draganfly is a party, the performance of Draganfly’s obligations under this Agreement, or the completion of the transactions contemplated by this Agreement will:
 

 

(i)

result in or constitute a breach of any term or provision of, or constitute a default under, the Constating Documents of Draganfly;

 

 

 

 

(ii)

result in or constitute a breach of any term or provision of, or constitute a default under, any Material Contract to which Draganfly is a party or by which the Draganfly Shares are bound;

 

 

 

 

(iii)

result in the creation or imposition of any Encumbrance on the Draganfly Shares or the assets of Draganfly;

 

 

 

 

(iv)

contravene any applicable Law; or

 

 

 

 

(v)

contravene any judgment, order, writ, injunction or decree of any Governmental Entity.

 

 

(e)

Change of Control. Except as disclosed in the Disclosure Schedule, Draganfly is not a party to any written management contract or employment agreements which provides for a right of payment in the event of a change of control of Draganfly.

 

 

 

 

(f)

Regulatory Approvals. No authorization, approval, order, consent of, or filing with, any Governmental Entity is required on the part of the Draganfly Shareholders in connection with the execution, delivery and performance of this Agreement or any other documents and agreements to be delivered under this Agreement where the lack of such authorization, approval, order, consent of, or filing with such Governmental Entity would have a Material Adverse Effect.

 

 

 

 

(g)

Non-Reporting Issuer Status. Draganfly is not a “reporting issuer” within the meaning of the Securities Act (British Columbia) or the Securities Act (Alberta) and does not have a similar status in any other province or territory of Canada. No securities commission or similar regulatory authority has issued any order which is currently outstanding preventing or suspending trading in any securities of Draganfly, no such proceeding is, to the Knowledge of Draganfly, pending, contemplated or threatened and Draganfly is not in default of any requirement of any securities laws, rules or policies applicable to Draganfly or its securities, other than with respect to filing reports of exempt distributions.

 

 

 

18

 

  

 

(h)

Consents. Except as disclosed in the Disclosure Schedule, there is no requirement to obtain any consent, approval or waiver of a party under any Material Contract to which Draganfly is a party in order to complete the Transaction where the lack of such consent, approval, order, or waiver of such party would have a Material Adverse Effect.

 

 

 

 

(i)

Capacity and Powers of Draganfly. Draganfly has all necessary corporate power, authority and capacity to own or lease its assets and to carry on its business, including the Business, as currently being conducted.

 

 

 

 

(j)

Authorized and Issued Capital. The authorized share structure of Draganfly consists of and excluding the Advisory Shares to be issued: (i) an unlimited number of Draganfly Shares, of which 22,294,432 Draganfly Shares are anticipated to be issued and outstanding as at Closing as fully paid shares not including those Draganfly Shares issued prior to Closing in exchange for Business Instincts’ Debt (719,927 Draganfly Shares) and, as applicable, Draganfly Overdue Debt, and are or will be legally and beneficially owned by the Draganfly Shareholders; and (ii) an unlimited number of First Preferred Shares without nominal or par value of which nil are or will be issued and outstanding as at Closing.

   

 

(k)

Subsidiary and Investments. Draganfly has no Subsidiaries. Other than as disclosed in the Disclosure Schedule, Draganfly does not own or hold, directly or indirectly, any Securities of, or have any interest in, any Person and Draganfly has not entered into any agreement to acquire any such interest.

 

 

 

 

(l)

Options, Warrants and Convertible Debentures. The Disclosure Schedule sets out a true and correct list of holders of the outstanding convertible securities of Draganfly, being 429,225 Draganfly Warrants and convertible debentures in the principal amount of $1,215,000 and no other Person has any written or oral agreement or option or any right or privilege (whether by law, pre-emptive, contractual or otherwise with Draganfly) capable of becoming an agreement or option, including Securities, warrants, convertible debentures or other convertible obligations of any nature, for:

 

 

(i)

the purchase of any Securities of Draganfly; or

 

 

 

 

(ii)

the purchase of any of the assets of Draganfly other than in the Ordinary Course of the Business.

 

 

(m)

Corporate Records. Other than as disclosed in the Disclosure Schedule, the corporate records and minute books of Draganfly contain in all material respects complete and accurate minutes of all meetings of, or all written resolutions passed by, the directors and shareholders of Draganfly, held or passed since incorporation. All those meetings were held, all those resolutions were passed, and the share certificate books, registers of shareholders, registers of transfers and registers of directors of Draganfly are complete and accurate in all material respects.

 

 

 

19

 

   

 

(n)

Books and Records. The Books and Records fairly set out and disclose the financial position of Draganfly, and all material financial transactions of Draganfly have been accurately recorded in the Books and Records.

 

 

 

 

(o)

Financial Statements. A copy of the Draganfly Financial Statements are attached hereto as Schedule D. Other than as set out in the Disclosure Schedule, the Draganfly Financial Statements have been prepared in accordance with GAAP and present fairly:
 

 

(i)

the assets, liabilities (whether accrued, absolute, contingent or otherwise) and the financial condition of Draganfly as at the respective dates of the Draganfly Financial Statements; and

 

 

 

 

(ii)

the sales, earnings and results of the operations of Draganfly during the periods covered by the Draganfly Financial Statements.

 

 

(p)

Tax Matters. Except as disclosed in the Disclosure Schedule:

 

 

(i)

All Tax Returns required by applicable Tax Law to be filed on or prior to the Effective Date by or on behalf of Draganfly have been or will be duly filed on a timely basis in compliance with their due dates under applicable Tax Law with the appropriate Governmental Entity on or before Closing. Each of those Tax Returns is or will be true, correct and complete. No position has been taken on any Tax Return with respect to the Business of Draganfly for a taxation year, or other period for which the assessment of any Taxes has not expired, that is contrary to any publicly announced position of a Governmental Entity, or that is substantially similar to any position that a Governmental Entity has successfully challenged in the course of an examination of a Tax Return of Draganfly.

   

 

(ii)

Draganfly has duly, and on a timely basis, paid or remitted all Taxes required to be paid or remitted by it on or before Closing, including all Taxes shown as due and owing on all Tax Returns, all Taxes assessed or reassessed by any Governmental Entity, all Taxes held in trust or deemed to be held in trust for any Governmental Entity, and all instalments on account of Taxes for the current year. The liabilities reflected as reserves for Taxes on the Draganfly Financial Statements are sufficient for the payment or remittance of all Taxes which may become payable or remittable by Draganfly, whether or not disputed, in respect of any period ending on or before Closing.

 

 

 

 

(iii)

There are no material liens for Taxes on any of the properties or assets of any of Draganfly, nor are such properties or assets the subject of any trust arising under Tax Law.

 

 

 

 

(iv)

Draganfly has not requested, executed, received, or entered into any Contract relating to any waiver, which is still outstanding and which provides for any extension of time in respect of:

 

 

 

20

 

 

 

(A)

the assessment, reassessment or collection of any Taxes by any Governmental Entity;

 

 

 

 

(B)

the filing of any Tax Returns in respect of any Taxes for which Draganfly is or may be liable; or

 

 

 

 

(C)

the payment or remittance of any Taxes or amounts on account of Taxes.

 

 

(v)

Draganfly has not been required, or is not currently required, to file any Tax Returns with any Governmental Entity outside Canada. No claims have ever been made by any Governmental Entity that Draganfly is or may be subject to Tax in a jurisdiction where Draganfly does not file Tax Returns. To the Knowledge of Draganfly, there is no basis for a Claim that Draganfly is subject to Tax in a jurisdiction in which it does not file Tax Returns.

 

 

 

 

(vi)

The Disclosure Schedule accurately reflects all notices of assessment and reassessment of Taxes that have been received by Draganfly from all relevant Governmental Entities with respect to the Tax liabilities of Draganfly for its fiscal year end 2017.

 

 

 

 

(vii)

There are no material Tax deficiencies that have been claimed, proposed or asserted in writing against Draganfly that have not been fully paid or finally settled and there are no discussions, audits, assertions or Claims now pending, or to the Knowledge of Draganfly, threatened, in respect of Taxes due from or with respect to Draganfly.

 

 

 

 

(viii)

All Taxes required to be deducted, withheld or remitted by Draganfly under any applicable Tax Law from amounts paid or credited by Draganfly to or for the account or benefit of any Person, including Taxes on payments to any of its present or former employees, officers or directors and Taxes on payments to any Person who is a non-resident of Canada, have been properly deducted, withheld and remitted on a timely basis to the appropriate Governmental Entities where a failure to make such deduction, withholding or remittance on a timely basis would have a Material Adverse Effect.

 

 

 

 21

 

 

 

(ix)

Copies of all Tax rulings pertaining to Draganfly have been provided to DroneCorp. To the Knowledge of Draganfly, there is no claim or threatened claim to revoke any such Tax ruling. Except as disclosed in the Disclosure Schedule, there are no Tax rulings or requests for Tax rulings pertaining to Draganfly that could affect the liability for Taxes or the amount of the taxable income or loss for any taxation year or period ending after Closing.

 

 

 

 

(x)

There are no amounts outstanding and unpaid for which Draganfly has previously claimed a deduction from income under the ITA or any other applicable Tax Law and which may be included in Draganfly’s income for any taxation year ending after Closing.

 

 

 

 

(xi)

Other than as disclosed in the Disclosure Schedule, Draganfly has not directly or indirectly, transferred property to or acquired property from or provided services to or received services from any Person with whom Draganfly was not dealing at arm’s length, for consideration the fair market value of which was less than the fair market value of the property or service at the time of (in the case of property) the disposition or acquisition thereof or (in the case of services) the provision or receipt thereof, or been a party to any contract or transaction that could result in a liability for Tax under section 160 of the ITA or any substantially similar provisions of other applicable Tax Laws. Draganfly has provided DroneCorp with copies of all Contracts, minutes, and any other documents relating to transactions entered into by it prior to the Effective Date with Persons with whom Draganfly, as the case may be, was not dealing at arm’s length at the time the transaction occurred.

 

 

 

 

(xii)

To the knowledge of Draganfly, there are no circumstances existing which could result, and the Closing will not result, in the application to Draganfly of sections 80 through 80.4 of the ITA or any substantially similar provisions of any applicable Tax Laws.

 

 

 

 

(xiii)

The Books and Records of Draganfly fairly and correctly set out and disclose, in all material respects, all liabilities and unclaimed input tax credits under Part IX of the ETA and other applicable Tax Laws. All financial transactions of Draganfly have been accurately and completely recorded in the Books and Records for Tax purposes.

 

 

 

 

(xiv)

Draganfly has provided DroneCorp with copies of all Tax Returns for all fiscal periods for which the relevant limitation period has not expired and all working papers, calculations, and schedules relating thereto, together with all material communications relating thereto from any Governmental Entity and the response, if any, of Draganfly to such communication.

 

 

 

 

(xv)

For all transactions between Draganfly and any non-resident person with whom it was not dealing at arm’s length, Draganfly has made or obtained records or documents that meet the transfer pricing requirements of paragraphs 247(4) of the ITA.

 

 

 

 

(xvi)

Draganfly has not made any elections or designations for the purposes of the ITA or the ETA or other applicable Tax Law, or for the purposes of any administrative rulings or notices or administrative practices pursuant to any Tax Law.

 

 

(xvii)

The Disclosure Schedule sets out a complete and accurate list of all loans or indebtedness outstanding made to directors, former directors, officers, shareholders or employees of Draganfly or to any Person not dealing at arm’s length with any of the foregoing.

 

 

 

22

 

 

 

(q)

Tax Incentives. Either (i) Draganfly does not participate in the federal Scientific Research and Experimental Development (“SR&ED”) Program, or (ii) Draganfly’s participation in the SR&ED Program is bona fide and Draganfly has no knowledge that the Canada Revenue Agency will disallow, reassess, or reduce any SR&ED tax incentives applied for by, or previously granted to, Draganfly;

 

 

 

 

(r)

Absence of Changes. Except as disclosed in the Disclosure Schedule and the Draganfly Financial Statements, since December 31, 2017 there has not been:

 

 

(i)

any change in the financial condition, operations, results of operations, or Business of Draganfly, nor has there been any occurrence or circumstances which with the passage of time might reasonably be expected to have a Material Adverse Effect; or

 

 

 

 

(ii)

any Loss, labour trouble, or other event, development or condition of any character (whether or not covered by insurance) suffered by Draganfly which had had, or may reasonably be expected to have, a Material Adverse Effect.

 

 

(s)

Absence of Undisclosed Liabilities. Except: (i) for the Bridge Loan; (ii) the Related-Party Debt disclosed in the Disclosure Schedule; (iii) as disclosed in the Disclosure Schedule; (iv) as reflected or reserved against in the Draganfly Financial Statements or disclosed in a note therein; or (v) for current liabilities incurred in the ordinary course of Draganfly’s business since December 31, 2017, Draganfly does not have any liabilities, obligations or commitments of the type required to be reflected on a balance sheet prepared in accordance with GAAP that could have, or could reasonably be expected to have, a Material Adverse Effect.

 

 

 

 

(t)

Projected Revenue. The projected revenue set out in the Disclosure Schedule is based on fair and reasonable estimates, has been prepared in accordance with Canadian generally accepted accounting principles applied on a consistent basis, and Draganfly is not aware of any fact or circumstance presently existing which would render the projected revenue materially incorrect or could reasonably be expected to have, a Material Adverse Effect.

 

 

 

 

(u)

Title to Assets. Other than Licensed IP, Draganfly owns, possesses and has good and marketable title to all of its undertakings, property and assets not otherwise the subject of specific representations and warranties in this Article 3 including all the undertakings, property and assets reflected in the most recent balance sheet included in the Draganfly Financial Statements free and clear of all Encumbrances except as specifically disclosed in the Disclosure Schedule. The undertakings, property and assets of Draganfly comprise all of the undertakings, property and assets necessary for it to carry on the Business as it is currently operated.

 

 

 

 

(v)

Real Property. The Disclosure Schedule lists all real property owned by Draganfly, including complete and accurate legal descriptions, and the particulars of all leases of real property to which Draganfly is a party.

 

 

 

 

(w)

Personal Property. The Disclosure Schedule lists each item of Personal Property owned by Draganfly which had a book value in the Books and Records of Draganfly at the date of the Draganfly Financial Statements, of more than $10,000 or is otherwise material to the Business. No Personal Property owned by Draganfly is in the possession of a third party and Draganfly does not have any assets on consignment. Each item of Personal Property is in good operating condition and repair, ordinary wear and tear excepted, and is reasonably fit and useable for the purpose for which it is being used in the ordinary course of the Business having regard to its use and age.

 

 

 

 23

 

 

 

(x)

Intellectual Property.

 

 

(i)

The Disclosure Schedule sets out an accurate and complete list and description of all Owned IP that is registered with any Governmental Entity (including details as to the jurisdictions, numbers, and expiry dates of all registrations), Licenced IP and related Licence Agreements, Technology and Technical Information, including sufficient particulars to identify each item of Owned IP, Licensed IP and related Licence Agreements, Technology and Technical Information, its respective owner, if that owner is not the Corporation or a Subsidiary, and the nature and jurisdictions of its use, as well as the jurisdictions and particulars of all registrations of, and applications for registration of, the Owned IP made by the Corporation or any Subsidiary that are material to, associated with, or used in, its Business.

 

 

 

 

(ii)

Draganfly is the only Person to have any right of title and interest, legal or beneficial, in any of the Owned IP, all of which is owned by Draganfly free and clear of any Encumbrances, and none of which is registered in the name of any Person other than Draganfly. No consent of any Person is necessary to make, construct, use, reproduce, translate, license, sell, modify, update, enhance or otherwise exploit any Owned IP. All Originating Persons have, by irrevocable written assignments, transferred to Draganfly all Intellectual Property Rights, and waived all moral rights, that any of them may have enjoyed with respect to any Owned IP to which they contributed.

 

 

 

 

(iii)

Except as disclosed in the Disclosure Schedule, Draganfly has not assigned, licensed or otherwise granted any interest in any Owned IP, including any right to receive royalties or other payments, to any Person.

 

 

 

 

(iv)

Except as disclosed in the Disclosure Schedule, to the Knowledge of Draganfly, no Person has infringed or misappropriated, or is infringing or misappropriating, any Intellectual Property Right in any Owned IP.

 

 

 

 

(v)

Except as disclosed in the Disclosure Schedule, Intellectual Property Rights relating to Owned IP are in full force and effect, and all required registration or other fees have been paid to maintain them all in good standing in those jurisdictions where any associated Owned IP is used.

 

 

 

 

(vi)

Each registered Trade-mark forming part of the Owned IP is used in its jurisdiction of registration, in association with all wares and services for which it is registered and in the form appearing in the applicable registration, and has been used with sufficient continuity in association with those wares and services and in that form, and any use by any licensee of any Trade-mark has been controlled and enforced by Draganfly so as to avoid any abandonment, cancellation, expungement or other such challenge against that Trade-mark associated with non-continuous use, or otherwise (including the unenforceability of the Trade-mark), in each applicable jurisdiction.

 

 

 

 24

 

 

 

(vii)

The date of first use of the Trade-mark DRAGANFLY in Canada in association with compact unmanned drones by Draganfly is at least as early as 1998 and Draganfly has evidence of such use.

 

 

 

 

(viii)

The date of first use of the Trade-mark DRAGANFLY in Canada in association with “training and educational services, namely flight training services provided to operators of unmanned aerial vehicles (drones); aerial inspection, surveying, data collection, photography and videography services using sensor-equipped and camera-equipped unmanned aerial vehicles (drones)” by Draganfly Innovations Inc. is at least as early as 2008 and Draganfly has evidence of such use.

 

 

 

 

(ix)

The date of first use of the Trade-mark DRAGANFLY in the United States in association with unmanned aerial vehicles by Draganfly is at least as early as 1998 and Draganfly has evidence of such use.

 

 

 

 

(x)

The date of first use of the Trade-mark DRAGANFLY in Canada in association with any goods or services, and not limited to those goods and services in (vii) and (viii), precedes the date of first use of the trade-mark DRAGONFLY in Canada in association with any goods or services by Dragonfly UAS.

 

 

 

 

(xi)

The date of first use of the Trade-mark DRAGANFLY in the United States in association with any goods or services, and not limited to those goods and services in (ix), precedes the date of first use of the trade-mark DRAGONFLY in the United States in association with any goods or services by Dragonfly UAS.

 

 

 

 

(xii)

The date of first use of the Trade-mark DRAGANFLY in the United States in association with any goods or services, and not limited to those goods and services in (ix), precedes the date of first use of the trade-mark DRAGONFLY in the United States in association with any goods or services by PerceptIn Inc.

 

 

 

 

(xiii)

Draganfly has entered into valid and enforceable written agreements pursuant to which Draganfly has been granted all licenses, rights and permissions to use, reproduce, translate, sub-license, sell, modify, update, enhance or otherwise exploit the Licensed IP to the extent required to conduct all aspects of its Business as it is currently conducted (including, if required, the right to incorporate the Licensed IP into the Owned IP and to create and own derivatives and modifications of the Licensed IP) (the “Licence Agreements”). Except as disclosed in the Disclosure Schedule:

 

 

 

25

 

 

 

(A)

all Licence Agreements are in full force and effect and none of Draganfly or any licensor is in default of its obligations under any Licence Agreement;

 

 

 

 

(B)

no licensor of any Licensed IP is involved in an insolvency, bankruptcy or similar proceeding or has had a receiver appointed;

 

 

 

 

(C)

except as disclosed in the Disclosure Schedule, all License Agreements for Licensed IP material to the Draganfly’s Business are irrevocable licenses granted in perpetuity and worldwide in nature;

 

 

 

 

(D)

the rights licensed under each Licence Agreement will be enforceable by Draganfly on and after the Closing to the same extent as prior to the Closing; and

 

 

(E)

no Person has infringed or misappropriated, or is infringing or misappropriating, any Intellectual Property Rights or any licensor in or to any Licensed IP of which it is the exclusive licensee.

 

 

(xiv)

Draganfly has entered into escrow agreements (including source code escrow agreements) or other arrangements as necessary to facilitate its continued use and exploitation of any Licensed IP the use and exploitation of which might be impaired in the event that the licensor of any of that Licensed IP ceases to carry on business, ceases to support or maintain that Licensed IP, or is involved in an insolvency, bankruptcy or similar proceeding.

 

 

 

 

(xv)

Except as disclosed in the Disclosure Schedule:

 

 

(A)

the past, current and proposed conduct by Draganfly of its Business (including all use or other exploitation of the Owned IP or Licensed IP by Draganfly, or any customers, distributors or other licensees of Draganfly) has not resulted in, and neither does nor will result in, any infringement, violation, misappropriation, or other conflict with any Intellectual Property Right of any Person, and there is no action or proceeding ongoing or threatened that alleges any such violation, misappropriation, or other conflict; and

 

 

 

 

(B)

there are no outstanding orders, judgments, rulings, decrees, stipulations, covenants not to sue, or agreements (including any funding or facilities agreements or grants from any college, university, or Governmental Entity) relating to any of the Owned IP or Licensed IP that restrict the conduct of the Business of Draganfly, the enforcement of any Intellectual Property Rights included in the Owned IP or the Licensed IP, or the use, exercise, practise, or other exploitation of any Owned IP and Licensed IP by Draganfly or any of its customers, distributors or other licensees.

 

 

(xvi)

The Technology, Technical Information, Licensed IP and Owned IP are sufficient to conduct the Business of Draganfly as it is currently conducted.

 

 

 

 

(xvii)

No Owned IP that incorporates any open source code is in violation of any open source code licenses.

 

 

 

26

 

   

 

(xviii)

No product sold or distributed by Draganfly has incorporated open source code in a manner that would detract from the enforceability of any of the patents and patent applications listed in the Disclosure Schedule and its Appendices, including the Zenon Patents.

 

 

 

 

(xix)

Except as disclosed in the Disclosure Schedule, no Licensed IP contains any open source code, other than the Mission Planner flight planning software. The Mission Planner flight planning software is used as a stand-alone software program and has not been integrated into any other computer program, including without limitation any of the Owned IP.

 

 

 

 

(xx)

Draganfly has in place appropriate disaster recovery plans, procedures and facilities, and has taken all reasonable steps, that are necessary to safeguard all Technology, Technical Information, Licensed IP and Owned IP that is material to its Business, and to restrict unauthorized access to it.

 

 

(xxi)

The Disclosure Schedule contains true and correct copy of the Zenon Forbearance Agreement, which is in full force and effect and perfected in accordance with applicable Law.

 

 

 

 

(xxii)

The Zenon Assignment Agreement has been executed by all relevant parties, is held in escrow with Stevenson Hood Thornton Beaubier LLP and is in full force and effect and validly assigns to Draganfly the Zenon Patents and such assignment is perfected in accordance with applicable Law. At Closing, the Zenon Assignment Agreement will be registered in the United States Patent and Trademark Office and in the Canadian Intellectual Property Office to cause the Zenon Patents to stand in the name of Draganfly as the sole registered owner.

 

 

 

 

(xxiii)

Draganfly has not transfered to any third party any rights in any of the Zenon Patents or the Owned IP, including without limitation the patents and patent applications listed in the Disclosure Schedule and its Appendices.

 

 

 

 

(xxiv)

All current and former Employees have conferred ownership of all Intellectual Property created by such Employees to Draganfly.

 

 

 

 

(xxv)

For each of Draganfly’s non-provisional United States patent applications, including both pending applications and applications that have granted as patents, and including patents and applications for which the registered owner(s) is any one of Draganfly, Zenon Dragan, Trace Live Network Inc., or the inventors, no named inventor or other person associated with the filing and prosecution of the non-provisional patent application was aware, at any time during the pendency of the application, of any prior art that was material to the patentability of any claim in the application, other than the prior art references cited by the U.S. Examiner (the “Examiner”) against the application and the prior art references disclosed to the United States Patent and Trademark Office in an Information Disclosure Statement submitted against the application. For each of the non-provisional applications that issued as United States Patent Nos. 9,710,709, 9,892,322, 9,489,937 and 9,511,878, for which no Information Disclosure Statement was filed in the United States Patent and Trademark Office, no person associated with the filing and prosecution of the application was aware of any prior art that was material to the patentability of any claim in the application at any time during the pendency of the application, other than the prior art references cited by the Examiner against the application.

 

 

 

27

 

 

 

(xxvi)

Nothing developed by Draganfly for AeroVironment Inc., pursuant to the Standard Consulting Agreement dated May 22, 2017 or any other agreements with AeroVironment Inc., has been used in Draganfly’s business or products.

 

 

 

 

(xxvii)

Draganfly no longer makes, uses or sells any product claimed in Canadian Patent No. 2,645,369 owned by Burkhard Wiggerich and/or AirRobot GMBH & Co KG.

 

 

(y)

Accounts Receivable. All accounts receivable of Draganfly reflected in the Draganfly Financial Statements, or which have come into existence since the date of the Draganfly Financial Statements, were created in the Ordinary Course of the Business from bona fide arm’s length transactions and, except to the extent that they have been paid in the Ordinary Course of the Business since the date of the Draganfly Financial Statements, are valid and enforceable and payable in full, without any right of set-off or counterclaim or any reduction for any credit or allowance made or given, except to the extent of the allowance for doubtful accounts reflected in the Draganfly Financial Statements and, in the case of accounts receivable which have come into existence since the date of the Draganfly Financial Statements, of a reasonable allowance for doubtful accounts, which allowances are, and will as of Closing be, adequate and calculated in a manner consistent with Draganfly’s previous accounting practice.

 

 

(z)

Inventories. To the Knowledge of Draganfly, the inventories maintained by Draganfly have been accumulated for use or sale in the ordinary course of the Business, and are in good and marketable condition and the present levels of the inventories are consistent with the levels of inventories that have been maintained by Draganfly before the date of this Agreement in the normal course of the Business.

 

 

 

 

(aa)

Material Contracts.

 

 

(i)

The Disclosure Schedule lists all Material Contracts to which Draganfly is a party or bound;

 

 

 

 

(ii)

the Material Contracts of Draganfly are in full force and effect (including, for avoidance of doubt, the Zenon Assignment Agreement and the Zenon Forbearance Agreement), there is no default or breach of any Material Contract by Draganfly, and there exists no state of facts which, after notice or lapse of time or both, would constitute a default or breach; and

 

 

 

 

(iii)

no counterparty to any Material Contract is in default of any of its obligations under any Material Contract; and

 

 

 

 

(iv)

Draganfly is entitled to all benefits under each Material Contract, as applicable, and Draganfly has not received any notice of termination of any Material Contract.

 

 

 

28

 

 

 

(bb)

Compliance with Laws, Permits.

 

 

(i)

Draganfly is conducting the Business in material compliance with all applicable Laws and has not been subject to any seizure, forfeiture, criminal sanction, administrative penalty or any other enforcement action by any Governmental Entity; and

 

 

 

 

(ii)

All Permits of Draganfly are listed in the Disclosure Schedule. The Permits are the only material authorizations, registrations, permits, approvals, grants, licences, quotas, consents, commitments, rights or privileges (other than those relating to intellectual property) required to enable Draganfly to carry on the Business as currently conducted and to enable it to own, lease and operate its assets, and all such Permits are valid, subsisting, in full force and effect, and Draganfly is not in default or breach of any such Permit; no proceeding is pending or threatened to revoke or limit any such Permit, and the completion of the transactions contemplated by this Agreement will not result in the revocation of any such Permit or the breach of any term, provision, condition or limitation affecting the ongoing validity of any such Permit.

   

 

(cc)

Governmental Licenses. Without limiting the generality of the representations made in Section 3.1(z):

 

 

(i)

Draganfly possesses such permits, certificates, licences, approvals, registrations, qualifications, consents, and other authorizations, including all required Special Flight Operations Certificate from Transport Canada, Transportation of Dangerous Goods Certificates from Transport Canada and Certificates of Proficiency in Radio (collectively, “Governmental Licences”), issued by the appropriate federal, provincial, state, local, or foreign regulatory agencies or bodies necessary to conduct the business now operated by it in all jurisdictions in which it carries on business, that are material to the conduct of the business of Draganfly (as such business is currently conducted);

 

 

 

 

(ii)

Draganfly is in material compliance with the terms and conditions of all such Governmental Licences;

 

 

 

 

(iii)

All of such Governmental Licences are in good standing, valid, and in full force and effect;

 

 

 

 

(iv)

Draganfly has not received any notice of proceedings relating to the revocation, suspension, termination, or modification of any such Governmental Licences, and there are no facts or circumstances, including without limitation, facts or circumstances relating to the revocation, suspension, modification, or terminations of any Governmental Licences held by others, known to Draganfly, that could lead to the revocation, suspension, modification, or termination of any such Governmental Licences if the subject of an unfavourable decision, ruling or finding, except where such revocation, suspension, modification, or termination is not in respect of a material Governmental Licence or where such revocation, suspension, modification, or termination would not, individually or in the aggregate, have a Material Adverse Effect;

 

 

 

29

 

 

 

(v)

Draganfly is not in material default with respect to filings to be effected or conditions to be fulfilled in order to maintain such Governmental Licences in good standing;

 

 

 

 

(vi)

none of such Governmental Licences contains any term, provision, condition, or limitation which has or would reasonably be expected to affect or restrict in any material respect the operations or the business of Draganfly as now carried on or proposed to be carried on; and

 

 

 

 

(vii)

Draganfly does not have reason to believe that any party granting any such Governmental Licences is considering limiting, suspending, modifying, withdrawing, or revoking the same in any material respect.

 

 

(dd)

Safety of Products. All products manufactured and services provided to customers, in whole or in part, by Draganfly, and all component parts which are supplied to Draganfly are, to the knowledge of Draganfly, manufactured or provided in full compliance with and meet industry specific standards set by all organizations which pertain to the business of Draganfly and Draganfly’s products and services have met and satisfied all product safety standards necessary to permit the sale of Draganfly’s products and services in the jurisdictions in which Draganfly currently conducts business, except where the failure to do so would not, individually or in the aggregate, have a Material Adverse Effect.

 

 

 

 

(ee)

Environmental Conditions. To the Knowledge of Draganfly, except as disclosed in the Disclosure Schedule, (i) Draganfly’s conduct of the Business, and the current use and condition of the real property that is owned or leased by Draganfly, and the premises located on that real property, have been and are in compliance with all applicable environmental Laws, and there are no facts which would give rise to non-compliance of Draganfly with any environmental Laws, either in the conduct by Draganfly of the Business, or in the current uses and condition of any of the real property that is owned or leased by Draganfly, or the premises that are located on that real property and (ii) Draganfly has all Permits required by all environmental Laws for the conduct of the Business, and Draganfly is in compliance with all those Permits.

 

 

 

30

 

 

 

(ff)

Anti-Corruption Matters. To the knowledge of Draganfly, no director, officer, employee, consultant, representative or agent of Draganfly, has (i) violated any anti-bribery or anti-corruption laws applicable to Draganfly, including but not limited to the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and the Corruption of Foreign Public Officials Act (Canada), or (ii) offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized the giving of anything of value, that goes beyond what is reasonable and customary and/or of modest value: (A) to any government official, whether directly or through any other person, for the purpose of influencing any act or decision of a government official in his or her official capacity; inducing a government official to do or omit to do any act in violation of his or her lawful duties; securing any improper advantage; inducing a government official to influence or affect any act or decision of any governmental authority; or assisting any representative of Draganfly in obtaining or retaining business for or with, or directing business to, any person; or (B) to any person in a manner which would constitute or have the purpose or effect of public or commercial bribery, or the acceptance of or acquiescence in extortion, kickbacks, or other unlawful or improper means of obtaining business or any improper advantage. To the knowledge of Draganfly, no director, officer, employee, consultant, representative or agent of Draganfly, has (i) conducted or initiated any review, audit, or internal investigation that concluded Draganfly, or any director, officer, employee, consultant, representative or agent of the foregoing violated such laws or committed any material wrongdoing, or (ii) made a voluntary, directed, or involuntary disclosure to any governmental authority responsible for enforcing anti-bribery or anti-corruption laws, in each case with respect to any alleged act or omission arising under or relating to non-compliance with any such laws, or received any notice, request, or citation from any person alleging non-compliance with any such laws.

 

 

 

 

(gg)

No Adverse Regulations. To the Knowledge of Draganfly, there is no legislation or governmental regulation currently in force which materially and adversely affects the Business, assets (including intangible assets), affairs, operations, prospects, liabilities (contingent or otherwise), capital, assets, properties, condition (financial or otherwise), or results of operations of Draganfly.

 

 

 

 

(hh)

Suppliers and Customers. The Disclosure Schedule lists each supplier of goods and services from whom Draganfly has purchased goods or services representing more than 5% of the total value of the goods and services procured by Draganfly since the beginning of the last financial year of Draganfly. To the Knowledge of Draganfly, none of the suppliers listed in the Disclosure Schedule has advised Draganfly, either orally or in writing, that it is terminating or considering terminating its relationship with Draganfly, or considering negotiating its relationship with Draganfly on terms materially different from and less attractive than those which they currently enjoy whether as a result of the completion of the transactions contemplated by this Agreement or otherwise.

 

 

 

 

 

The Disclosure Schedule lists the customers of Draganfly as of the date of this Agreement to whom Draganfly had sales greater than $50,000 for the fiscal year ended December 31, 2017. None of the customers listed in the Disclosure Schedule have advised Draganfly, orally or in writing, that it is terminating or considering terminating its relationship with any of them, or considering negotiating its relationship with any of them on terms material and adverse to those which they currently enjoy whether as a result of the completion of the transactions contemplated by this Agreement or otherwise.

 

 

 

31

 

 

 

(ii)

Rights to Use Personal Information. To the Knowledge of Draganfly, all Personal Information in the possession of Draganfly has been collected, used and disclosed in material compliance with all applicable Laws in those jurisdictions in which Draganfly conducts, or is deemed by operation of law in those jurisdictions to conduct, the Business.

 

 

(i)

Draganfly has disclosed to DroneCorp all Contracts and facts concerning the collection, use, retention, destruction and disclosure of Personal Information, and there are no other Contracts or facts which, on completion of the transactions contemplated by this Agreement, would restrict or interfere with the use of any Personal Information by Draganfly in the continued operation of the Business as conducted before Closing.

 

 

 

 

(ii)

Except as disclosed in the Disclosure Schedule, to the Knowledge of Draganfly, there are no complaints, claims, suits or proceedings pending or threatened, with respect to Draganfly’s collection, use or disclosure of Personal Information.

 

 

(jj)

Product Warranties. The Disclosure Schedule lists all warranties given to buyers of products or services supplied by Draganfly. Except as disclosed in the Disclosure Schedule, there are no claims, suits, or proceedings against Draganfly on account of warranties or with respect to the production or sale of defective or inferior products or the provision of services, nor is there any material basis for any liability to, claim against, or Loss on the part of, Draganfly arising from, relating to, or in connection with the production or sale of the products or the provision of services before the date of this Agreement.

 

 

 

 

(kk)

Employees and Employment Contracts. Draganfly is not a party to any written or oral employment, service, pension, deferred profit sharing, benefit, bonus or other similar agreement or arrangement except as disclosed in the Disclosure Schedule and none of those agreements or arrangements contains any specific agreement as to notice of termination or severance pay in lieu of notice except as disclosed in the Disclosure Schedule. Draganfly is not in arrears in the payment of any contribution or assessment required to be made by it pursuant to any of the agreements or arrangements disclosed in the Disclosure Schedule. Draganfly does not have any employee who cannot be dismissed on reasonable notice which in no event exceeds six months. All vacation pay, bonuses, commissions and other employee benefit payments and obligations with respect to the employees of Draganfly are reflected in and have been fully accrued in the Draganfly Financial Statements.

 

 

 

 

(ll)

Insurance Policies. The Disclosure Schedule lists all insurance policies, and also specifies the insurer, the amount of the coverage, the type of insurance, the policy number and any pending claims with respect to each insurance policy. The insurance policies insure all the property and assets of Draganfly against Loss by all insurable hazards of risk on a replacement cost basis, and provide Draganfly with product liability coverage in amounts that are customary, and that would reasonably be considered adequate and prudent, for a company carrying on a business similar to the Business. All insurance policies are in full force and effect and Draganfly:

 

 

(i)

is not in default, whether as to the payment of premiums or otherwise, under any material term or condition of any of the insurance policies; or

 

 

 

 

(ii)

has not failed to give notice or present any claim under any of the insurance policies in a due and timely fashion.

 

 

 

32

 

 

 

(mm)

Litigation.

 

 

(i)

Except as disclosed in the Disclosure Schedule, there are no actions, suits, grievances or proceedings, whether judicial, arbitral or administrative, pending, commenced or, to the Knowledge of Draganfly, contemplated or threatened to which Draganfly is a party or to which the assets of Draganfly are subject, which might reasonably be expected to have a Material Adverse Effect on Draganfly or which might involve the possibility of an Encumbrance against the assets of Draganfly.

 

 

 

 

(ii)

There is no outstanding judgment, decree, order, ruling or injunction involving Draganfly or relating in any way to the transactions contemplated by this Agreement.

 

 

(nn)

U.S. Securityholders. All holders of Draganfly Shares, Draganfly Warrants and Dragranfly Options who are not Non-U.S. Holders are set forth on Schedule F, with such Schedule including the registered address of each such holder, and the parties acknowledge and agree that the parties shall be relying on such information to ensure compliance with applicable securities laws, including, but not limited to, United States federal and state securities laws. Any such holders of such securities will be required to deliver such representations, warranties, covenants or agreements as may be required by DroneCorp, acting reasonably, in order to establish the availability of an exemption from the registration requirements of the U.S. Securities Act and any applicable state securities laws in connection with the issuance of the DroneCorp securities to be exchanged for their Draganfly securities.

 

 

 

 

(oo)

Disclosure. No representation or warranty or other statement made by Draganfly in this Agreement contains any untrue statement or omits to state a material fact necessary to make it, in light of the circumstances in which it was made, not misleading.

 

ARTICLE 4
REPRESENTATIONS AND WARRANTIES OF DRONECORP

 

4.1

Representations and Warranties of DroneCorp.

 

DroneCorp represents and warrants to Draganfly as follows, and acknowledges that Draganfly is relying upon these representations and warranties in connection with the sale of the Draganfly Shares.

 

 

(a)

Corporate Existence of DroneCorp. DroneCorp is a corporation duly incorporated and organized, is validly existing and in good standing under the Business Corporations Act (British Columbia).

 

 

 

 

(b)

Capacity to Enter Agreement. DroneCorp has all necessary corporate power, authority and capacity to enter into and perform its obligations under this Agreement.

 

 

 

33

 

  

 

(c)

Binding Obligation. The execution and delivery of this Agreement and the completion of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate action on the part of DroneCorp. This Agreement has been duly executed and delivered by DroneCorp and constitutes a valid and binding obligation of DroneCorp, enforceable against DroneCorp in accordance with its terms, subject to applicable bankruptcy, insolvency and other laws of general application limiting the enforcement of creditors’ rights generally and to the fact that equitable remedies, including specific performance, are discretionary and may not be ordered in respect of certain defaults.

  

 

(d)

Absence of Conflict. None of the execution and delivery of this Agreement, the performance of DroneCorp’s obligations under this Agreement, or the completion of the transactions contemplated by this Agreement, will result in or constitute a breach of any term or provision of, or constitute a default under, the notice of articles or articles of DroneCorp or any agreement or other commitment to which DroneCorp is a party.

 

 

 

 

(e)

Regulatory Approvals. No authorization, approval, order, consent of, or filing with, any Governmental Entity is required on the part of DroneCorp in connection with the execution, delivery and performance of this Agreement or any other documents and agreements to be delivered under this Agreement.

 

 

 

 

(f)

Consents. There is no requirement to obtain any consent, approval or waiver of a party under any Material Contract to which DroneCorp is a party in order to complete the Transaction where the lack of such consent, approval, order, or waiver of such party would have a Material Adverse Effect.

 

 

 

 

(g)

Authorized and Issued Capital. The authorized share structure of DroneCorp consists of an unlimited number of DroneCorp Shares, of which 10,500,000 DroneCorp Shares are or will be issued and outstanding as at Closing as fully paid shares and are or will be legally and beneficially owned by the DroneCorp Shareholders.

 

 

 

 

(h)

Options. Other than 4,000,000 DroneCorp Warrants, no Person has any written or oral agreement or option or any right or privilege (whether by law, pre-emptive, contractual or otherwise) capable of becoming an agreement or option, including Securities, warrants or convertible obligations of any nature, for:

 

 

(i)

the purchase of any Securities of DroneCorp; or

 

 

 

 

(ii)

the purchase of any of the assets of DroneCorp other than in the Ordinary Course of the Business.

 

 

 

34

 

 

 

(i)

Corporate Records. The corporate records and minute books of DroneCorp contain in all material respects complete and accurate minutes of all meetings of, and all written resolutions passed by, the directors and shareholders of Draganfly, held or passed since incorporation. All those meetings were held, all those resolutions were passed, and the share certificate books, registers of shareholders, registers of transfers and registers of directors of Draganfly DroneCorp are complete and accurate in all material respects.

 

 

 

 

(j)

Books and Records. The Books and Records fairly and correctly set out and disclose the financial position of DroneCorp, and all material financial transactions of DroneCorp have been accurately recorded in the Books and Records.

 

 

 

 

(k)

Material Contracts. To the Knowledge of DroneCorp:

 

 

(i)

other than this Agreement and the Bridge Loan to be entered into with Draganfly, there are no Material Contracts to which DroneCorp is a party or bound;

 

 

 

 

(ii)

neither DroneCorp is in default or breach of any Material Contract, and there exists no state of facts which, after notice or lapse of time or both, would constitute a default or breach; and

 

 

 

 

(iii)

no counterparty to any Material Contract is in default of any of its obligations under any Material Contract; and

 

 

(iv)

DroneCorp is entitled to all benefits under each Material Contract, as applicable, and Draganfly has not received any notice of termination of any Material Contract.

 

 

(l)

Compliance with Laws, Permits. To the Knowledge of DroneCorp, DroneCorp is conducting the Business in material compliance with all applicable Laws and has not been subject to any seizure, forfeiture, criminal sanction, administrative penalty or any other enforcement action by any Governmental Entity; and

 

 

 

 

(m)

Litigation.

 

 

(i)

There are no actions, suits, grievances or proceedings, whether judicial, arbitral or administrative, pending, commenced or, to the Knowledge of DroneCorp, contemplated or threatened to which DroneCorp is a party or to which the assets of DroneCorp are subject, which might reasonably be expected to have a Material Adverse Effect on DroneCorp or which might involve the possibility of an Encumbrance against the assets of DroneCorp.

 

 

 

 

(ii)

There is no outstanding judgment, decree, order, ruling or injunction involving DroneCorp or relating in any way to the transactions contemplated by this Agreement.

 

 

(n)

Disclosure. No representation or warranty or other statement made by DroneCorp in this Agreement contains any untrue statement or omits to state a material fact necessary to make it, in light of the circumstances in which it was made, not misleading.

 

 

 

 

(o)

Exempt Distribution. Subject to Section 2.1(b)(vi), the first trade of the Consideration Shares and DroneCorp Shares issuable pursuant to exercise of Draganfly Warrants following Closing by any Draganfly Shareholder to whom the applicable securities laws of a jurisdiction of Canada apply will not be a distribution or otherwise subject to the prospectus requirements of such securities laws provided that:

 

 

 

35

 

 

 

(i)

DroneCorp is and has been a reporting issuer in a jurisdiction of Canada for the four months immediately preceding such first trade;

 

 

 

 

(ii)

the trade is not a “control distribution” as defined in National Instrument 45-102 – Resale of Securities;

 

 

 

 

(iii)

no unusual effort is made to prepare the market or to create a demand for the Consideration Shares subject to such trade and no extraordinary commission or consideration is paid to a person or company in respect of the trade; and

 

 

 

 

(iv)

if the seller of the Consideration Shares is an “insider” or “officer” of DroneCorp (as those terms are defined in such securities laws), the seller has no reasonable grounds to believe that DroneCorp is in default of securities legislation.

 

ARTICLE 5
REPRESENTATIONS AND WARRANTIES OF SUBCO

 

5.1

Representations and Warranties of Subco

 

Subco represents and warrants, as of the date of this Agreement, as follows to Draganfly and acknowledges and confirms that Draganfly is relying on such representations and warranties in connection with the transactions contemplated by this Agreement:

 

 

(a)

Corporate Existence of Subco. Subco is a company wholly-owned by DroneCorp and duly incorporated and validly existing under the laws of the Province of British Columbia.

 

 

 

 

(b)

Capacity to Enter Agreement. Subco has all necessary corporate power, authority and capacity to enter into and perform its obligations under this Agreement.

 

 

 

 

(c)

Binding Obligation. The execution and delivery of this Agreement and the completion of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate action on the part of Subco This Agreement has been duly executed and delivered by Subco and constitutes a valid and binding obligation of Subco, enforceable against Subco in accordance with its terms, subject to applicable bankruptcy, insolvency and other laws of general application limiting the enforcement of creditors’ rights generally and to the fact that equitable remedies, including specific performance, are discretionary and may not be ordered in respect of certain defaults.

 

 

 

 

(d)

Absence of Conflict. None of the execution and delivery of this Agreement, the performance of Subco’s obligations under this Agreement, or the completion of the transactions contemplated by this Agreement, will result in or constitute a breach of any term or provision of, or constitute a default under, the notice of articles or articles of Subco or any agreement or other commitment to which Subco is a party.

 

 

 

36

 

 

ARTICLE 6
COVENANTS OF THE PARTIES

 

6.1

Non-Solicitation

 

From the date hereof until Closing, Draganfly will not, nor will it permit any of its respective directors, officers, employees, representatives or agents (including and without limitation, investments bankers, attorneys, and accountants) to take any action, directly or indirectly, to encourage, initiate or engage in discussions or negotiations with, or provide any information to any Person, other than DroneCorp, concerning the sale of any shares or material assets of Draganfly, or any amalgamation, merger, combination or similar transaction involving Draganfly which would be inconsistent with the matters contemplated by this Agreement. Draganfly will, on a no-names-basis, notify DroneCorp of any overture received from third parties relating to any proposal to acquire Draganfly or any part of the business of Draganfly, including, but not limited to, a Competing Proposal, including the material terms of any such proposal. Draganfly shall not enter into any agreement, arrangement or understanding requiring it to abandon, terminate or fail to consummate the transactions contemplated in this Agreement. Notwithstanding the foregoing, nothing herein will restrict Draganfly and its respective directors, officers, employees, representatives or agents (including without limitation, investment bankers, attorneys and accountants) from taking such actions as Draganfly determines, in good faith, may be required in order for the board of directors of Draganfly to discharge its fiduciary duties pursuant to applicable corporate.

 

6.2

Conduct of Business.

 

 

(a)

During the period between the date of this Agreement and the earlier of Closing and the termination of this Agreement in accordance with its terms, except as otherwise expressly contemplated by this Agreement, DroneCorp, Draganfly and Subco will conduct its business in the Ordinary Course.

 

 

 

 

(b)

During the period beginning on the date of this Agreement and ending at Closing, Draganfly will:

 

 

(i)

continue in full force all of its insurance policies;

 

 

 

 

(ii)

comply in all material respects with all Laws applicable to the Business; and

 

 

 

 

(iii)

apply for, maintain in good standing and renew all Permits.

 

 

(c)

Without limiting the generality of Section 6.2(a), DroneCorp, Draganfly and Subco covenants as follows, as applicable, for the period between the date of this Agreement and the earlier of Closing and the termination of this Agreement in accordance with its terms:

 

 

 

37

 

 

 

(i)

Draganfly’s business shall be conducted only in the Ordinary Course and Draganfly shall keep DroneCorp apprised of all material developments relating thereto.

 

 

 

 

(ii)

Other than as contemplated by this Agreement, each of the Parties shall not directly or indirectly do or permit to occur any of the following without consent of all other Parties:

 

 

(A)

amend its Constating Documents;

 

 

 

 

(B)

declare, set aside or pay any dividend or other distribution or payment (whether in cash, shares or property) in respect of its outstanding shares;

 

 

 

 

(C)

other than the Advisory Shares and up to 50,000 Draganfly Shares to be issued to settle certain interest payments, issue, grant, sell or pledge or agree to issue, grant, sell or pledge any shares, respectively, or securities convertible into or exchangeable or exercisable for, or otherwise evidencing a right to acquire, shares, respectively, except for securities issued pursuant to this Agreement, other than the Advisory Shares;

 

 

 

 

(D)

redeem, purchase or otherwise acquire any of its outstanding shares or other securities, except as permitted hereunder;

 

 

 

 

(E)

split, combine or reclassify any of its shares;

 

 

 

 

(F)

reduce its stated capital;

 

 

 

 

(G)

adopt a plan of liquidation or resolutions providing for the liquidation, dissolution, merger, consolidation or reorganization;

 

 

(H)

other than up to $250,000 in additional indebtedness to Business Instincts for the purposes of funding the ordinary course of business operations of Draganfly, incur, create, assume or otherwise become liable for any indebtedness for borrowed money or any other material liability or obligation or issue any debt securities, or guarantee, endorse or otherwise as an accommodation become responsible for, the obligations of any other Person or make any loans or advances;

 

 

 

 

(I)

other than as contemplated by this Agreement, pay, discharge, settle, satisfy, compromise, waive, assign or release any claims, liabilities or obligations;

 

 

 

 

(J)

incur business expenses other than in the Ordinary Course and consistent with past practice or in connection with the Amalgamation and the transactions contemplated hereby;

 

 

 

 

(K)

take any action, or refrain from taking any action, permit any action to be taken or not taken, inconsistent with this Agreement, which might directly or indirectly interfere with or adversely affect the consummation of the Amalgamation; or

 

 

 

 

(L)

enter into or modify any contract, agreement or commitment with respect to any of the foregoing.

 

 

 

38

 

 

 

(iii)

Draganfly shall not adopt or amend or make any contribution to any bonus, profit sharing, option, pension, retirement, deferred compensation, insurance, incentive compensation, other compensation or other similar plan, agreement, trust, fund or agreements for the benefit of employees, except as is necessary to comply with the law or with respect to existing provisions of any such plans, programs, or agreements.

 

 

 

 

(iv)

Draganfly shall not:

 

 

(A)

grant any officer, director, employee or consultant an increase in compensation in any form or take any action with respect to the amendment or grant of any severance or termination pay policies for any directors, officers, employees or consultants, nor adopt or amend (other than to permit accelerated vesting of options) or make any contribution to any bonus, profit sharing, option, pension, retirement, deferred compensation, insurance, incentive compensation, other compensation or other similar plan from a trust fund for the benefit of directors, officers, employees or consultants, except as is necessary to comply with applicable local Law or with respect to existing provisions of any such plans, programs, arrangements or agreements;

 

 

 

 

(B)

terminate any Employees or transferring any Employees to any other position; or

 

 

 

 

(C)

except as required by applicable law, negotiate or entering into a collective bargaining agreement with any trade union or association which might qualify as a trade union.

 

 

(v)

DroneCorp, Draganfly and Subco, respectively, shall promptly notify Draganfly and DroneCorp, as applicable, in writing of any Material Adverse Effect on DroneCorp, Draganfly and Subco, respectively, or of any material breach by DroneCorp, Draganfly and Subco of any representation or warranty provided by such Party in this Agreement with respect to itself.

  

6.3

Actions to Satisfy Conditions.

 

Each Party will take or cause to be taken all commercially reasonable actions that are within its power to control, and will make commercially reasonable efforts to cause other actions to be taken which are not within its power to control, so as to ensure its material compliance with, and satisfaction of, all conditions in Article 6 that are for the benefit of the other Party.

 

 

 

39

 

 

6.4

Access for Investigation

 

 

(a)

Draganfly will permit DroneCorp through its authorized representatives, until Closing, to have reasonable access during normal business hours to all of the real property that is owned or leased by Draganfly, and to the premises located on that real property, and to all the Books and Records of Draganfly and to the properties and assets of Draganfly. Draganfly will also furnish to DroneCorp any financial and operating data and other information with respect to Draganfly or the Business as DroneCorp reasonably requests, whether to enable confirmation of the accuracy of the matters represented and warranted in Article 3, to verify the valid ownership, validity or enforceability of any of Draganfly’s Intellectual Property, or to verify any facts relevant to this Agreement. DroneCorp will be provided ample opportunity to make a full investigation of all aspects of the financial affairs and Intellectual Property portfolio of Draganfly.

 

 

 

 

(b)

Until Closing, or, in the event of the termination of this Agreement without the completion of the transactions contemplated by this Agreement, indefinitely after this Agreement terminates, DroneCorp and Draganfly will, subject to Section 6.4(c) and Section 9.4, keep confidential and not disclose or use, nor will they allow any of their representatives to disclose or use, any Confidential Information disclosed to them, for any purpose, except as contemplated by this Agreement. If this Agreement is terminated, all Confidential Information obtained by either DroneCorp or Draganfly in connection with this Agreement, including all copies, whether in written form or stored electronically, will be returned to the owners thereof promptly after that termination.

 

 

 

 

(c)

The obligation under Section 6.4 to keep confidential and not disclose or use any Confidential Information does not apply to information which:

 

 

(i)

becomes generally available to the public other than as a result of a disclosure in violation of this Agreement;

 

 

 

 

(ii)

was available on a non-confidential basis before its disclosure hereunder;

 

 

 

 

(iii)

becomes available on a non-confidential basis from a third-party source which is not bound by a confidentiality agreement with the disclosing party; or

 

 

 

 

(iv)

is required to be disclosed by Law.

 

 

(d)

The Parties acknowledge that their computers and data storage and retrieval systems may automatically back up Confidential Information stored in electronic form. The Parties agree that to the extent that those back-up procedures automatically create electronic copies of Confidential Information (“Secondary Information”), despite any requirement under this Agreement to return or destroy Confidential Information, such Secondary Information may stay in archival storage for the normal archival period for electronic data, provided that those data are periodically and systematically overwritten or otherwise destroyed. Secondary Information will be subject to the provisions of this Agreement until destroyed and may not be accessed during its period of archival storage.

 

 

 

40

 

 

 

(e)

Draganfly authorizes all Governmental Entities having jurisdiction to release all information in their possession respecting the Business, the real property that is owned or leased by Draganfly, and the premises located on that real property, to DroneCorp, and further authorizes each of them to carry out inspections of that real property and those premises upon the request of DroneCorp. Draganfly will execute and any specific authorization pursuant to this Section 6.4 within three Business Days after being requested to do so by DroneCorp.

 

 

 

 

(f)

The collection, use and disclosure of Personal Information by any of the Parties before Closing is restricted to those purposes that relate to the transactions contemplated by this Agreement.

 

6.5

Personal Information – Post-Closing

 

DroneCorp covenants that following Closing it will cause Draganfly to use and disclose the Personal Information under its control at the time of Closing solely for the purposes for which that Personal Information was collected or permitted to be used or disclosed before the Transaction was completed.

 

6.6

Escrow and Trading Restrictions of Consideration Shares

 

The Parties agree that Consideration Shares issued on Closing may be subject to the escrow requirements of the CSE as may be applicable. The Parties further agree that the Consideration Shares issuable to Draganfly Shareholders on Closing and any replacement certificates issued by DroneCorp’s transfer agent at the time of Listing, will be subject to the trading restrictions in section 2.1(b)(vi) of this Agreement.

 

6.7

Name of DroneCorp Following Amalgamation

 

Following the Effective Date, DroneCorp will change its name to “Draganfly Innovations Inc.” or such other name as approved by the CSE and DroneCorp. Prior to the Effective Date, Draganfly shall file a name reservation with respect to the proposed name of DroneCorp as contemplated in this Section 6.7.

 

6.8

DroneCorp Directors And Officers – Post-Closing

 

At Closing, the Board of Directors of DroneCorp will be comprised of five directors, two of which will be nominees of DroneCorp and three of which will be nominees of Draganfly.

 

At Closing, the officers of DroneCorp will be comprised of such persons as may be determined by Board of Directors of DroneCorp from time to time.

 

6.9

CSE Listing – Post-Closing

 

Promptly following Closing, DroneCorp will file the Final Prospectus with the Principal Regulator to enable it to become a reporting issuer in Saskatchewan and such provinces of Canada as may be agreed by the parties, and such Final Prospectus shall comply in all material respects, to the requirement of applicable laws.

 

 

 

41

 

 

6.10

Equity Financing – Post-Closing

 

The Parties agree that within 120 days following Listing, DroneCorp will use commercially reasonable efforts to complete an equity financing of approximately $2,500,000 in the capital of DroneCorp (“Post-Closing Financing”).

 

6.11

Use Of Proceeds of Financings – Post-Closing

 

The Parties agree up to $1,750,000 from the proceeds of the Financing may be used by Draganfly to partially repay the Draganfly Overdue Debt and, if required, up to $800,000 from the proceeds of the Post-Closing Financing, may be used by Draganfly to repay in full the remaining balance of the Draganfly Overdue Debt.

 

6.12

Corporate Awareness and Investor Relations Program – Post-Closing

 

The Parties agree that following Closing, the Corporate Branding Budget shall be allocated from the proceeds of the Financing as the board of directors of DroneCorp shall allocate.

 

6.13

OTC Listing – Post-Closing

 

The Parties agree to apply for listing of the DroneCorp Shares on the OTC within 30 days of Listing.

 

6.14

Advancement of Bridge Loan

 

DroneCorp will advance the Bridge Loan to Draganfly promptly following delivery by Draganfly of Voting Agreements representing 51% of Locked-up Shareholders to DroneCorp. The Bridge Bridge Loan shall be interest bearing at a rate of 10% per annum and Draganfly will pay the unpaid portion of the Bridge Loan to DroneCorp without any requirement of DroneCorp to provide demand or notice for payment to Draganfly on the earlier of: (i) thirty (30) calendar days from the date of this Agreement is terminated, and (ii) one (1) year from the date of the advance of Bridge Loan to Draganfly.

 

ARTICLE 7
CONDITIONS

 

7.1

Mutual Conditions Precedent.

 

The Parties are not required to complete the Amalgamation unless each of the following conditions is satisfied on or prior to the Effective Date, which conditions may only be waived, in whole or in part, by the mutual consent of the Parties:

 

 

(a)

No Law is in effect that makes the consummation of the Amalgamation illegal or otherwise prohibits or enjoins Draganfly or Subco from consummating the Amalgamation.

 

 

 

42

 

 

 

(b)

There shall have been no law, statute, rule or regulation, domestic or foreign, enacted or promulgated which would prohibit or make illegal the consummation of the Amalgamation.

 

 

 

 

(c)

Each Regulatory Approval necessary to consummate the Business Combination has been made, given or obtained on terms acceptable to DroneCorp and Draganfly, each acting reasonably, and each such Regulatory Approval is in force and has not been modified.

 

 

 

 

(d)

The capital structure of DroneCorp, Draganfly and Subco immediately prior to the completion of the Amalgamation shall be as set out and described in this Agreement.

 

 

 

 

(e)

The Share Compensation Plan shall have been adopted.

 

 

 

 

(f)

The issuance of any DroneCorp securities to any holders of Draganfly Shares and Draganfly Warrants shall be exempt from the registration requirements under United States federal and state securities laws.
 

7.2

Conditions for the Benefit of DroneCorp.

 

The completion of the transactions contemplated hereunder is subject to the following conditions being satisfied at or prior to the Effective Date, which conditions are for the exclusive benefit of DroneCorp and may be waived, in whole or in part, by DroneCorp in its sole discretion:

 

 

(a)

Representations, Warranties and Covenants. The representations and warranties of Draganfly made in this Agreement, and any other agreement or document delivered pursuant to this Agreement, will be true and accurate at Closing with the same force and effect as though those representations and warranties had been made as of Closing, and for certainty, any representations and warranties made as at a date before Closing will be deemed to be made as at Closing. However, if a representation or warranty is qualified by Material Adverse Effect, it must be true and correct in all respects after giving effect to such qualification. Draganfly will have complied with all covenants and agreements to be performed or caused to be performed by it under this Agreement, and any other agreement or document delivered pursuant to this Agreement, at or before Closing. In addition, Draganfly will have delivered to DroneCorp a certificate of two senior officers (CEO and CFO) of Draganfly confirming the same. The receipt of that certificate and the completion of the Closing will not be deemed to constitute a waiver of any of the representations, warranties or covenants of Draganfly contained in this Agreement, or in any other agreement or document delivered pursuant to this Agreement.

 

 

 

 

(b)

No Material Adverse Effect. Since the date of this Agreement, there will not have been any change in any of the assets, financial condition, earnings, results of operations or prospects of Draganfly, or any other event, development or condition of any character (whether or not covered by insurance) that has, or might reasonably be expected to have, a Material Adverse Effect in respect to Draganfly. In addition, Draganfly will have delivered to DroneCorp a certificate of two senior officers (CEO and CFO) of Draganfly confirming the same.

 

 

 

43

 

   

 

(c)

Consents. All filings, notifications and consents with, to or from the parties to the Material Contracts of Draganfly, will have been made, given or obtained on terms acceptable to DroneCorp, acting reasonably, so that the transactions contemplated by this Agreement may be completed without resulting in the violation of, or a default under, or any termination, amendment or acceleration of any obligation under, any licence, Permit, lease of real property or Material Contract of Draganfly.

 

 

 

 

(d)

Completion of Investigations. The investigations contemplated in Section 6.4 will have been completed and DroneCorp will be satisfied, in its sole discretion, with the results of those investigations, including the accuracy of the matters represented and warranted in Article 3 and evidence satisfactory to DroneCorp that Draganfly owns, possesses and has good and marketable title to its Intellectual Property.

 

 

 

 

(e)

Voting Agreements. Concurrently with execution of this Agreement, each Locked-up Shareholder shall enter into a Voting Agreement with DroneCorp and Draganfly shall use commercially reasonable efforts to secure additional Voting Support Agreements from Draganfly Shareholders holding greater than 2% of the Draganfly Shares until the Effective Date.

 

 

(f)

Bridge Loan. Draganfly shall have complied with all of the terms and conditions of the Bridge Loan.

 

 

 

 

(g)

Business Instincts’ Debt. Evidence satisfactory to DroneCorp that the Business Instincts’ Debt has been satisfied in full, together with all releases.

 

 

 

 

(h)

Total Debt and Liabilities. Evidence satisfactory to DroneCorp that Draganfly shall have in the aggregate no more than $3,250,000 in debt (which, for greater certainty shall be exclusive of the Business Instincts’ Debt) and such debt shall be restructured on terms and conditions satisfactory to DroneCorp, in its sole discretion, to a maximum amount of $1,750,000 in Draganfly Overdue Debt which debt has not been restructured through the execution of forbearance agreements (using a form agreed to with DroneCorp) and that is payable in cash on Closing (the “Debt Settlement Amount”). Draganfly further covenants to use commercially reasonable efforts to negotiate in good faith with its creditors to reduce the Draganfly Overdue Debt such that it does not exceed the Debt Settlement Amount. Subject to corporate law and applicable securities laws, in the event that creditors of Draganfly have not agreed to restructure the Draganfly Overdue Debt by entering into forbearance agreements (using a form agreed to with DroneCorp) and as a result the Draganfly Overdue Debt exceeds the Debt Settlement Amount on Closing, the Advisory Shares issuable to DroneCorp (or as directed to be registered by DroneCorp) pursuant to Section 2.1(b)(v)(A) of this Agreement shall automatically increase on a dollar for dollar basis for each dollar of Draganfly debt outstanding that is in excess of the Debt Settlement Amount, calculated with reference to a price of $0.50 per Draganfly Share (the “Adjustment Clause”). For avoidance of doubt, Schedule G of this Agreement sets outs examples of how this Adjustment Clause will operate.

 

 

 

44

 

 

 

(i)

Employment Agreements. Draganfly agrees to use commercially reasonable efforts to enter into employment agreements with Paul Sun and Zenon Dragan within 60 days of executing this Agreement.

 

 

 

 

(j)

Amalgamation Approval.The Amalgamation Approval shall have been obtained.

 

 

 

 

(k)

Continuance. The Continuance shall have been completed.

 

 

 

 

(l)

Dissent. Draganfly shall not have received notices of dissent with respect to the Amalgamation from Draganfly Shareholders who collectively hold more than 5% of the issued Draganfly Shares (each a “Dissenting Shareholder”).

 

 

 

 

(m)

Draganfly Financial Statements. The audited Draganfly Financial Statements shall have completed and provided to DroneCorp, in the form satisfactory to DroneCorp.

 

 

 

 

(n)

Draganfly 2018 Audited Annual Financial Statements. The audited financial statements of Draganfly for the year ended December 31, 2018 shall have been completed and provided to DroneCorp, in form and substance satisfactory to DroneCorp.

 

 

 

 

(o)

Letters of Transmittal. Draganfly shall have received sufficient number of Letters of Transmittal from Draganfly Shareholders to allow DroneCorp to meet the distribution requirements of the CSE.

 

 

 

 

(p)

Assignment of Zenon Patents. The Zenon Assignment Agreement, which validly assigns the Zenon Patents to Draganfly, remains in full force and effect as of Closing. The Zenon Forbearance Agreement remains in full force and effect as of Closing.

   

 

(q)

Deliveries. Draganfly will have delivered to DroneCorp, on or prior to the Effective Date, the following in form and substance satisfactory to DroneCorp acting reasonably:

 

 

(i)

a certified copy of:

 

 

(A)

the Constating Documents of Draganfly;

 

 

 

 

(B)

all resolutions of the board of directors of Draganfly approving the entering into and completion of the Transaction;

 

 

 

 

(C)

all resolutions of Draganfly Shareholders approving the Continuance;

 

 

 

 

(D)

all resolutions of the Draganfly Shareholders approving the Amalgamation and the Transaction; and

 

 

 

 

(E)

a list of the directors and officers of Draganfly authorized to sign agreements together with their specimen signatures;

 

 

 

45

 

 

 

(ii)

a certificate of status, compliance, good standing or like certificate with respect to Draganfly issued by appropriate government officials of its jurisdictions of incorporation;

 

 

 

 

(iii)

an opinion of counsel to Draganfly addressed to DroneCorp and its counsel, dated as of the Closing and in form and substance reasonably satisfactory to DroneCorp, with respect to use and registerability of all trademarks, ownership of Intellectual Property by Draganfly and any other matters that DroneCorp may reasonably request;

 

 

 

 

(iv)

evidence of dates of first use for Draganfly’s Trade-mark registrations and applications in Canada and in the United States in association with the wares and services listed in the Trade-mark registrations and applications;

 

 

 

 

(v)

copies of any requests for amendment or voluntary amendments to Draganfly’s Trade-mark registrations and applications in Canada and in the United States filed with the applicable government authority prior to the Effective Date;

 

 

 

 

(vi)

evidence that dates of first use of the trade-mark DRAGONFLY in Canada and in the United States by Dragonfly UAS in association with any wares or services is after the date of first use of the Trade-mark DRAGANFLY by Draganfly in Canada and in the United States, respectively;

 

 

 

 

(vii)

evidence that dates of first use of the trade-mark DRAGONFLY in the United States by PerceptIn Inc. in association with any wares or services is after the date of first use of the Trade-mark DRAGANFLY by Draganfly in the United States;

 

 

 

 

(viii)

the Amalgamation Agreement duly executed by Draganfly;

 

 

 

 

(ix)

the consents referred to in Section 7.2(c) herein;

 

 

 

 

(x)

all Books and Records of and related to Draganfly and the Business, including copies of all of Draganfly’s insurance policies; and

 

 

 

 

(xi)

all documentation and other evidence reasonably requested by DroneCorp in order to establish the due authorization and completion of the transactions contemplated by this Agreement.

 

 

 

46

 

 

7.3

Conditions for the Benefit of Draganfly.

 

The completion of the transactions contemplated hereunder is subject to the following conditions being satisfied at or prior to the Effective Date, which conditions are for the exclusive benefit of Draganfly and may be waived, in whole or in part, by Draganfly in its sole discretion:

 

 

(a)

Representations, Warranties and Covenants. The representations and warranties of DroneCorp made in this Agreement, and any other agreement or document delivered pursuant to this Agreement, will be true and accurate at Closing with the same force and effect as though those representations and warranties had been made as of Closing, and for certainty, any representations and warranties made as at a date before Closing will be deemed to be made as at Closing. However, if a representation or warranty is qualified by Material Adverse Effect, it must be true and correct in all respects after giving effect to such qualification. DroneCorp will have complied with all covenants and agreements to be performed or caused to be performed by it under this Agreement, and any other agreement or document delivered pursuant to this Agreement, at or before Closing. In addition, DroneCorp will have delivered to Draganfly a certificate of a senior officer of DroneCorp confirming the same. The receipt of that certificate and the completion of the Closing will not be deemed to constitute a waiver of any of the representations, warranties or covenants of DroneCorp contained in this Agreement, or in any other agreement or document delivered pursuant to this Agreement.

 

 

 

 

(b)

No Material Adverse Effect. Since the date of this Agreement, there will not have been any change in any of the assets, financial condition, earnings, results of operations or prospects of DroneCorp, or any other event, development or condition of any character (whether or not covered by insurance) that has, or might reasonably be expected to have, a Material Adverse Effect in respect to DroneCorp. In addition, DroneCorp will have delivered to Draganfly a certificate of a senior officer of DroneCorp confirming the same.

 

 

 

 

(c)

Financing. The Financing shall have been completed.

 

 

 

 

(d)

Deliveries. DroneCorp shall deliver or cause to be delivered to Draganfly at or prior to the Effective Date the following in form and substance satisfactory to Draganfly acting reasonably:

 

 

(i)

a certified copy of:

 

 

(A)

the Constating Documents of DroneCorp and Subco;

 

 

 

 

(B)

all resolutions of the board of directors of DroneCorp and Subco approving the entering into and completion of the transactions contemplated by this Agreement; and

 

 

 

 

(C)

a list of the directors and officers of DroneCorp and Subco authorized to sign agreements together with their specimen signatures;

 

 

 

47

 

 

 

(ii)

a certificate of status, compliance, good standing or like certificate with respect to DroneCorp issued by appropriate government officials of its jurisdiction of incorporation;

 

 

 

 

(iii)

confirmation of DroneCorp having not more than $5,000 in outstanding liabilities on Closing (excluding costs related to the consummation of the Transaction);

 

 

 

 

(iv)

the Amalgamation Agreement duly executed by DroneCorp and Subco; and

 

 

 

 

(v)

all documentation and other evidence reasonably requested by Draganfly in order to establish the due authorization and completion of the transactions contemplated by this Agreement.

 

ARTICLE 8
TERMINATION, SURVIVAL AND INDEMNIFICATION

 

8.1

Term.

 

This Agreement shall be effective from the date hereof until the earlier of the Effective Date and the termination of this Agreement in accordance with its terms.

 

8.2

Termination Rights.

 

This Agreement may, by Notice in writing given prior to the Effective Date, be terminated:

 

 

(a)

by mutual consent of DroneCorp and Draganfly;

 

 

 

 

(b)

either DroneCorp or Draganfly if:

 

 

(i)

Amalgamation Approval is not obtained, provided that Draganfly may not terminate this Agreement pursuant to this Section 8.2(b)(i) if the failure to obtain such approval has been caused by, or is a result of, a breach by Draganfly of any of its representations or warranties or the failure of Draganfly to perform any of its covenants or agreements under this Agreement;

 

 

 

 

(ii)

after the date of this Agreement, any Law is enacted, made, enforced or amended, as applicable, that makes the consummation of the Amalgamation illegal or otherwise permanently prohibits or enjoins DroneCorp or Draganfly from consummating the Amalgamation, and such Law has, if applicable, become final and non-appealable; or

 

 

 

 

(iii)

the Effective Date does not occur on or prior to the Outside Date, provided that a Party may not terminate this Agreement pursuant to this Section 8.2(b)(iii) if the failure of the Effective Date to so occur has been caused by, or is a result of, a breach by such Party of any of its representations or warranties or the failure of such Party to perform any of its covenants or agreements under this Agreement and further provided that Draganfly may not terminate this Agreement pursuant to this Section 8.2(b)(iii) if DroneCorp has the right to terminate this Agreement pursuant to Section 8.2(c)(i) (ii), or (iii).

 

 

 

48

 

 

 

(c)

by DroneCorp if:

 

 

(i)

a breach of any representation or warranty or failure to perform any covenant, agreement or condition on the part of Draganfly under this Agreement occurs, including any condition in Section 7.1 or 7.2, and such breach or failure is incapable of being cured or is not cured on or prior to the Outside Date; provided that DroneCorp is not then in breach of this Agreement so as to cause any condition in Section 7.1 or 7.3 not to be satisfied;

 

 

 

 

(ii)

if there has been a Material Adverse Effect with respect to Draganfly;

 

 

 

 

(iii)

Draganfly breaches Section 6.1 in any material respect; or

 

 

 

 

(iv)

Draganfly accepts, approves, endorses or recommends any Competing Proposal or enters into an agreement in respect of a Competing Proposal or publicly announces its intention to do so;

 

 

(d)

by Draganfly if a breach of any representation or warranty or failure to perform any covenant, agreement or condition on the part of DroneCorp under this Agreement occurs, including any condition in Section 7.1 or 7.3, and such breach or failure is incapable of being cured or is not cured on or prior to the Outside Date; provided that Draganfly is not then in breach of this Agreement so as to cause any condition in Section 7.1 or 7.2(a) not to be satisfied.

 

8.3

Effect of Termination.

 

 

(a)

If a Party waives compliance with any of the conditions, obligations or covenants contained in this Agreement, the waiver will be without prejudice to any of its rights of termination in the event of non-fulfilment, non-observance or non-performance of any other condition, obligation or covenant in whole or in part.

 

 

 

 

(b)

If this Agreement is terminated pursuant to Section 8.2, the Parties are released from all of their respective obligations under this Agreement except that the provisions of this Section 8.3, Section 8.5 and Article 9 (other than Sections 9.4 and Section 9.5 will survive provided, however, that neither the termination of this Agreement nor anything contained in Section 8.5 or this Section 8.3 will relieve any Party from any liability for any intentional or willful breach by it of this Agreement, including any intentional or willful making of a misrepresentation in this Agreement.

 

8.4

Survival and Indemnification.

 

 

(a)

All of the covenants and representations and warranties contained in this Agreement, and in any other agreement or document delivered pursuant to this Agreement, will survive the Closing (including on termination of this Agreement).

 

 

 

49

 

   

 

(b)

Each Party agrees that if it fails to observe or perform any covenant or obligation, or breaches any representation and warranty, contained in this Agreement, or in any other agreement or document delivered pursuant to this Agreement it will indemnify the other Party and each director, officer or employee of the other Party from and against the full amount of any Loss that each may suffer as a result of that failure. Each Party also agrees to indemnify and hold harmless the other Party and each director, officer or employee of the other Party from and against the full amount of any Loss that each may suffer as a result of a third party claim, even if that third party claim is ultimately found not to be meritorious, or is settled with no verdict on its merits being reached.

 

 

 

 

(c)

Draganfly will indemnify and hold harmless DroneCorp. and each director, officer or employee of DroneCorp from and against any Loss that each may suffer resulting from the termination of this Agreement under the terms of Section 8.2, if that Loss arises from the non-fulfilment or non-performance of the relevant conditions as a result of a breach of covenant, or representation and warranty, of Draganfly.

 

 

(d)

DroneCorp. will indemnify and hold harmless Draganfly and each director, officer or employee of DroneCorp from and against any Loss that each may suffer resulting from the termination of this Agreement under the terms of Section 8.2, if that Loss arises from the non-fulfilment or non-performance of the relevant conditions as a result of a breach of covenant, or representation and warranty, of DroneCorp (other than in connection with not completing the Financing).

 

 

 

 

(e)

If the Party or other indemnified Person entitled to make a Claim for indemnification under this Agreement (an “Indemnified Party”) becomes aware of a Loss or potential Loss in respect of which the Indemnifying Party has agreed to indemnify it under this Agreement, the Indemnified Party will promptly give written notice (an “Indemnity Notice”) of its Claim or potential Claim for indemnification (an “Indemnity Claim”) to the Indemnifying Party. An Indemnity Notice must specify whether the Indemnity Claim arises as the result of a Claim made against an Indemnified Party by a Person who is not a Party (a “Third Party Claim”) or as a result of a Loss that was suffered directly by an Indemnified Party (a “Direct Claim”), and must also specify with reasonable particularity (to the extent that the information is available):

 

 

(i)

the factual basis for the Indemnity Claim; and

 

 

 

 

(ii)

the amount of the Indemnity Claim, if known.

 

8.5

Termination and Expense Fees

 

 

(a)

DroneCorp will be entitled to a payment from Draganfly of $750,000 (the “Termination Fee”):

 

 

(i)

if DroneCorp terminates this Agreement under Section 8.2(c); or

 

 

 

 

(ii)

if a Competing Proposal is made, proposed or publicly announced after the execution of this Agreement, before the termination of this Agreement, and before the Draganfly Meeting (if held) is completed, and either:

 

 

 

50

 

 

 

(A)

the Amalgamation is submitted to the Draganfly Shareholders for approval while that Competing Proposal is outstanding and the Amalgamation Approval is not obtained; or

 

 

 

 

(B)

the Amalgamation is not submitted for the approval of the Draganfly Shareholders,

 

 

 

 

and this Agreement is terminated pursuant to Section 8.2 and either:

 

 

(C)

the original Competing Proposal (as originally proposed or as amended); or

 

 

 

 

(D)

any other Competing Proposal that is made, proposed or publicly announced before the expiry or withdrawal of the original Competing Proposal (as originally proposed or as amended),

 

 

 

 

is consummated, or Draganfly shall have entered into an agreement relating to a Competing Proposal or its board of directors shall have recommended any Compeing Proposal, in all such cases on or before the date which is 12 months after the date of the termination of this Agreement,

 

 

(each, a “Termination Fee Event”), provided that Draganfly will not be obligated to make more than one payment of the Termination Fee under this Agreement, regardless of the number of Termination Fee Events which occur.

 

 

 

 

(b)

DroneCorp will be entitled to a payment from Draganfly of $250,000 (the “Expense Fee”):

 

 

(i)

if the Amalgmation Approval is not obtained by the Outside Date; or

 

 

 

 

(ii)

if DroneCorp terminates this Agreement under Section 8.2(b)(iii).

 

 

 

 

(each, an “Expense Fee Event”), provided that Draganfly will not be obligated to make more than one payment of the Expense Fee under this Agreement, regardless of the number of Expense Fee Events which occur.

 

 

(c)

Payment of a Termination Fee or Expense Fee under this Agreement will be made, within two Business Days upon written request by DroneCorp to Draganfly, to an account designated by DroneCorp.

 

 

 

 

Each Party acknowledges that all of the payment amounts set out in this Section 8.5 are payments in consideration for the disposition of DroneCorp’s rights under this Agreement and represent liquidated damages which are a genuine pre-estimate of the damages which DroneCorp will suffer or incur as a result of the event giving rise to such payment and the resultant termination of this Agreement and are not penalties. Draganfly irrevocably waives any right that it may have to raise as a defence that any such liquidated damages are excessive or punitive. For greater certainty, the Parties agree that the payment of an amount pursuant to this Section 8.5 in the manner provided herein is the sole and exclusive remedy of DroneCorp in respect of the event giving rise to such payment, provided, however, that nothing contained in this Section 8.5, and no payment of any such amount, shall relieve or have the effect of relieving Draganfly in any way from liability for damages incurred or suffered by DroneCorp as a result of an intentional or willful breach of this Agreement and nothing contained in this Section 8.5 shall preclude Draganfly from seeking injunctive relief in accordance with the Agreement or otherwise to obtain specific performance of any of such acts, covenants or agreements, without the necessity of posting a bond or security in connection therewith.

 

 

 

51

 

 

ARTICLE 9
MISCELLANEOUS

 

9.1

Dissenting Shareholders

 

On the earlier of the Effective Date and the making of an agreement between a Dissenting Shareholder Draganfly or DroneCorp, as applicable, for the purchase of their Dissenting Shares, a Dissenting Shareholder shall cease to have any rights as a shareholder of Draganfly or DroneCorp, as applicable, other than the right to be paid the fair value of its Dissenting Shares in the amount agreed to. Notwithstanding anything in this Agreement to the contrary, Dissenting Shares which are held by Dissenting Shareholders shall not be exchanged for Amalco Shares on the Effective Date. However, in the event that a Dissenting Shareholder fails to perfect or effectively withdraws the Dissenting Shareholder’s claim in accordance with the BCBCA or otherwise waives the Dissenting Shareholder’s right to make a claim in accordance with the BCBCA, the Dissenting Shareholder’s Draganfly Shares or DroneCorp Shares, as applicable, shall thereupon be deemed to have been exchanged for Amalco Shares on the basis set forth in Section 2.1 hereof.

 

9.2

Notices.

 

Any notice, direction or other communication (each a “Notice”) given regarding the matters contemplated by this Agreement or any Ancillary Agreement must be in writing, sent by personal delivery, courier or by electronic mail and addressed:

 

 

(a)

to Draganfly at:

 

 

 

 

 

Draganfly Innovations Inc.

2108 St. George Avenue
Saskatoon, SK S7M 0K7

 

 

 

 

 

Attention:                   Cameron Chell
Phone Number:          1(800) 979-9794
Email:                           Cameron@businessinstincts.com

 

 

 

 

 

and a copy to:

 

 

 

 

 

Borden Ladner Gervais LLP

1900, 520 – 3rd Ave S W,

Calgary, AB T2P 0R3

 

 

 

 

 

Attention:                   Jonathan Poirier
Phone Number:          (403) 232-9592
Email:                           JPoirier@blg.com

 

 

 

52

 

  

 

(b)

to Drone Acquisition Corp. and Subco at:

 

 

 

 

 

Drone Acquisition Corp.

1088, 999 West Hastings Street
Vancouver, BC V6C 2W2

 

 

 

 

 

Attention:                   President
Phone Number:          604-639-1221
Email:                           info@dronecorp.ca

 

 

 

 

 

and a copy to:

 

 

 

 

 

Gowling WLG (Canada) LLP

Suite 2300, 550 Burrard Street

Vancouver, BC V6C 2B5

 

 

 

 

 

Attention:                   Denis Silva

Phone Number:          (604) 891-2261

Email:                           denis.silva@gowlingwlg.com

 

A Notice is deemed to be delivered and received (i) if sent by personal delivery, on the date of delivery if it is a Business Day and the delivery was made prior to 4:00 p.m. (local time in place of receipt) and otherwise on the next Business Day, (ii) if sent by same-day service courier, on the date of delivery if sent on a Business Day and delivery was made prior to 4:00 p.m. (local time in place of receipt) and otherwise on the next Business Day, (iii) if sent by overnight courier, on the next Business Day, or (iv) if sent by e-mail or facsimile, on the Business Day following the date of confirmation of transmission by the originating facsimile. A Party may change its address for service from time to time by providing a Notice in accordance with the foregoing. Any subsequent Notice must be sent to the Party at its changed address. Any element of a Party’s address that is not specifically changed in a Notice will be assumed not to be changed. Sending a copy of a Notice to a Party’s legal counsel as contemplated above is for information purposes only and does not constitute delivery of the Notice to that Party. The failure to send a copy of a Notice to legal counsel does not invalidate delivery of that Notice to a Party.

 

9.3

Time of the Essence.

 

Time is of the essence in this Agreement.

 

9.4

Announcements.

 

No press release, public statement or announcement or other public disclosure (a “Public Statement”) with respect to this Agreement or the transactions contemplated in this Agreement may be made except with the prior written consent and joint approval of DroneCorp and Draganfly, or if required by Law or a Governmental Entity. Where the Public Statement is required by Law or a Governmental Entity, the Party required to make the Public Statement will use commercially reasonable efforts to obtain the approval of the other Party as to the form, nature and extent of the disclosure.

 

 

 

53

 

 

9.5

Expenses.

 

Each Party will pay for its own costs and expenses incurred in connection with this Agreement and the transactions contemplated herein.

 

9.6

Amendments.

 

This Agreement may only be amended, supplemented or otherwise modified by written agreement signed by the Parties.

 

9.7

Waiver.

 

No waiver of any of the provisions of this Agreement or any Ancillary Agreement will constitute a waiver of any other provision (whether or not similar). No waiver will be binding unless executed in writing by the Party to be bound by the waiver. A Party’s failure or delay in exercising any right under this Agreement will not operate as a waiver of that right. A single or partial exercise of any right will not preclude a Party from any other or further exercise of that right or the exercise of any other right.

 

9.8

Entire Agreement.

 

This Agreement, together with the Ancillary Agreements, constitutes the entire agreement between the Parties with respect to the transactions contemplated by this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, of the Parties. There are no representations, warranties, covenants, conditions or other agreements, express or implied, collateral, statutory or otherwise, between the Parties in connection with the subject matter of this Agreement, except as specifically set forth in this Agreement or any Ancillary Agreement. The Parties have not relied and are not relying on any other information, discussion or understanding in entering into and completing the transactions contemplated by this Agreement and the Ancillary Agreements. If there is any conflict or inconsistency between the provisions of this Agreement and the provisions of any Ancillary Agreement, the provisions of this Agreement shall govern.

 

9.9

Successors and Assigns.

 

 

(a)

This Agreement becomes effective only when executed by DroneCorp and Draganfly. After that time, it will be binding upon and enure to the benefit of DroneCorp and Draganfly and their respective successors and permitted assigns.

 

 

 

 

(b)

Neither this Agreement nor any of the rights or obligations under this Agreement are assignable or transferable by any Party without the prior written consent of the other Parties.

 

9.10

Severability.

 

If any provision of this Agreement is determined to be illegal, invalid or unenforceable by an arbitrator or any court of competent jurisdiction, that provision will be severed from this Agreement and the remaining provisions shall remain in full force and effect.

 

 

 

54

 

  

9.11

Governing Law.

 

 

(a)

This Agreement will be governed by and interpreted and enforced in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein.

 

 

 

 

(b)

Each Party irrevocably attorns and submits to the exclusive jurisdiction of the British Columbia courts situated in the City of Vancouver and waives objection to the venue of any proceeding in such court or that such court provides an inconvenient forum.

 

9.12

Arbitration.

 

All disputes, disagreements, controversies, questions or claims arising out of or relating to this Agreement, including, without limitation, with respect to its formation, execution, validity, application, interpretation, performance, breach, termination or enforcement, (“Disputes”), will be determined by a sole arbitrator (the “Arbitrator”) under the Arbitration Act (British Columbia) (the “Arbitration Act”). In addition:

 

 

(a)

the Parties shall agree on the Arbitrator to be appointed. If the Parties cannot agree on the Arbitrator to be appointed within 10 Business Days, the Arbitrator will be appointed by a judge of the Supreme Court of British Columbia on the application of any Party on notice to all the other Parties;

 

 

 

 

(b)

the law of British Columbia will apply to the substance of all Disputes;

 

 

 

 

(c)

the arbitration will take place in the City of Vancouver unless otherwise agreed in writing by the Parties;

 

 

 

 

(d)

the conduct of the arbitration will be in accordance with the procedural rules for domestic commercial arbitrations of the British Columbia International Commercial Arbitration Centre; and

 

 

 

 

(e)

the Arbitrator will have the right to determine all questions of law, and will have the right to decide the Dispute on legal or equitable grounds (though not on grounds of conscience or some other basis), grant legal and equitable relief including injunctive relief and the right to grant permanent and interim injunctive relief, and final and interim damages awards. The Arbitrator will also have the discretion to award costs, including reasonable legal fees and expenses, reasonable expert’s fees and expenses, reasonable witnesses’ fees and expenses pre-award and post-award interest and costs of the arbitration.

 

9.13

Counterparts.

 

This Agreement may be executed in any number of counterparts (including counterparts by facsimile) and all such counterparts taken together shall be deemed to constitute one and the same instrument.

 

[Remainder of page intentionally left blank]

 

 

 

 

IN WITNESS WHEREOF the Parties have executed this Business Combination Agreement.

 

  DRONE ACQUISITION CORP.
       
Per:

/s/ Oggy Talic

 

 

Oggy Talic  
    Director  
       

 

DRAGANFLY INNOVATIONS INC.

 

 

 

 

 

 

Per:

/s/ Cameron Chell

 

 

 

Cameron Chell

Director

 

 

 

 

 

 

1187607 B.C. LTD.

 

 

 

 

 

 

By:

/s/Oggy Talic

 

 

 

Oggy Talic

Director

 

 

 

 

 

SCHEDULE A
FORM OF AMALGAMATION AGREEMENT

 

THIS AGREEMENT is dated as of the [l] day of [l], 2019,

 

BY AND AMONG:

 

DRAGANFLY INNOVATIONS INC., a company [continued] under the laws of the Province of British Columbia
(hereinafter referred to as “Draganfly”)

 

OF THE FIRST PART;

 

‑ and ‑

 

1187607 B.C. Ltd., a company existing under the laws of the Province of British Columbia
(hereinafter referred to as “Subco”)

 

OF THE SECOND PART;

 

‑ and ‑

 

DRONE ACQUISITION CORP., a corporation existing under the laws of the Province of British Columbia
(hereinafter referred to as “DroneCorp”)

 

OF THE THIRD PART.

 

WHEREAS Draganfly and Subco wish to amalgamate pursuant to the Act and to continue as one company to be known as [“”] in accordance with the terms and conditions hereof;

 

AND WHEREAS Subco is a wholly-owned subsidiary of DroneCorp and has not carried on any active business;

 

AND WHEREAS Draganfly, DroneCorp and Subco are parties to the Business Combination Agreement which contemplates such amalgamation;

 

AND WHEREAS the parties have entered into this Agreement to provide for the matters referred to in the foregoing recitals and for other matters relating to the proposed amalgamation;

 

NOW THEREFORE THIS AGREEMENT WITNESSES that for and in consideration of the mutual covenants and agreements herein contained and other lawful and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

 

 

A-2

 

 

1.

Definitions. In this Agreement (including the recitals hereto):

 

 

a)

“Act” means the Business Corporations Act (British Columbia) as from time to time amended or re-enacted;

 

 

 

 

b)

“Agreement” means this amalgamation agreement;

 

 

c)

“Amalco” means the company formed upon the amalgamation of the Amalgamating Parties pursuant to the Amalgamation;

 

 

 

 

d)

“Amalco Shares” means the common shares in the capital of Amalco;

 

 

 

 

e)

“Amalgamating Parties” means, collectively, Draganfly and Subco;

 

 

 

 

f)

“Amalgamation” means the amalgamation of the Amalgamating Parties under the Act on the terms and conditions set forth in this Agreement;

 

 

 

 

g)

“Amalgamation Application” means the amalgamation application in respect of the Amalgamation required by section 275(1)(a) of the Act to be filed with the Registrar, together with any changes to that application as permitted under this Agreement or as agreed to by the Amalgamating Parties;

 

 

 

 

h)

“Articles” means the articles of Amalco signed by a director of Amalco;

 

 

 

 

i)

“Business Combination” means the business combination between DroneCorp, Draganfly and Subco wherein DroneCorp will acquire all of the issued and outstanding shares of Draganfly by way of the Amalgamation;

 

 

 

 

j)

“Business Combination Agreement” means the business combination agreement dated January, 2019 among DroneCorp, Draganfly and Subco governing the terms and conditions of the Business Combination, as amended from time to time;

 

 

 

 

k)

“Business Combination Date” means the date the Business Combination is completed, as evidenced by the issuance of the Certificate of Amalgamation giving effect to the Amalgamation;

 

 

 

 

l)

“Business Day” means a day other than a Saturday, Sunday or a civic or statutory holiday in the City of Vancouver, British Columbia;

 

 

 

 

m)

“Certificate of Amalgamation” means the certificate of amalgamation to be issued by the Registrar;

 

 

 

 

n)

“Effective Time” means 12:01 a.m. (Vancouver time) on the Business Combination Date;

 

 

 

 

o)

“Exchange Ratio” means , wherein each one (1) Draganfly Share shall be exchanged for fully paid and non-assessable DroneCorp Shares, in accordance with the terms of the Agreement; [NTD: Exchange Ratio to be determined prior to closing]

 

 

 

A-3

 

 

 

p)

“Draganfly Shareholders” means the holders of Draganfly Shares prior to the filing of the Amalgamation Application;

 

 

 

 

q)

“Draganfly Shares” means common shares in the capital of Draganfly;

 

 

 

 

r)

“Notice of Articles” means the notice of articles to be issued by the Registrar in respect of Amalco in the form contained in the Amalgamation Application;

 

 

 

 

s)

“Paid-up Capital” has the meaning assigned to the term “paid-up capital” in subsection 89(1) of the Income Tax Act (Canada));

 

 

t)

“Registrar” means the Registrar of Companies appointed under the Act;

 

 

 

 

u)

“DroneCorp Shareholder” means a registered holder owning DroneCorp Shares prior to the filing of the Amalgamation Application;

 

 

 

 

v)

“DroneCorp Shares” means the common shares in the capital of DroneCorp; and

 

 

 

 

w)

“Subco Shares” means the common shares in the capital of Subco.

 

2.

Amalgamation. Upon the conditions set out in this Agreement being satisfied or waived in accordance with the provisions of this Agreement and the Business Combination Agreement, including the adoption and approval by the shareholders of the Amalgamating Parties of this Agreement, the Amalgamating Parties hereby agree to:

 

 

a)

amalgamate and continue as one company under the provisions of the Act upon the terms and conditions hereinafter set out; and

 

 

 

 

b)

execute and file with the Registrar the Amalgamation Application.

 

3.

Certain Phrases, etc. In this Agreement (i) the words “including”, “includes” and “include” mean “including (or includes or include) without limitation”, and (ii) the phrase “the aggregate of”, “the total of”, “the sum of”, or a phrase of similar meaning means “the aggregate (or total or sum), without duplication, of”. In the computation of periods of time from a specified date to a later specified date, unless otherwise expressly stated, the word “from” means “from and including” and the words “to” and “until” each mean “to but excluding”.

 

 

4.

Effect of the Amalgamation. At the Effective Time, subject to the Act:

 

 

a)

the amalgamation of the Amalgamating Parties and their continuance as one company, Amalco, under the terms and conditions prescribed in this Agreement shall be effective and irrevocable;

 

 

 

 

b)

the property, rights and interests of each of the Amalgamating Parties shall continue to be the property, rights and interests of Amalco;

 

 

 

 

c)

Amalco shall become capable immediately of exercising the functions of an incorporated company;

 

 

 

A-4

 

   

 

d)

the shareholders of Amalco have the powers and the liability provided in the Act;

 

 

 

 

e)

each shareholder of the Amalgamated Parties is bound this Agreement;

 

 

 

 

f)

Amalco will be a wholly-owned Subsidiary of DroneCorp;

 

 

 

 

g)

Amalco shall continue to be liable for the liabilities and obligations of each of the Amalgamating Parties;

 

 

 

 

h)

any existing cause of action, claim or liability to prosecution with respect to either or both of the Amalgamating Parties shall be unaffected;

 

 

 

 

i)

any legal proceeding being prosecuted or pending by or against any of the Amalgamating Parties may be continued to be prosecuted, or its prosecution may be continued, as the case may be, by or against Amalco; and

 

 

j)

any conviction against, or ruling, order or judgment in favour of or against, any of the Amalgamating Parties may be enforced by or against Amalco.

 

5.

Name. The name of Amalco shall be [“].

 

 

6.

Registered Office. The mailing and delivery address of the registered office of Amalco shall be located at Suite 2300, Bentall 5, 550 Burrard Street, Vancouver, BC V6C 2B5.

 

 

7.

Records Office. The mailing and delivery address of the records office of Amalco shall be located at Suite 2300, Bentall 5, 550 Burrard Street, Vancouver, BC V6C 2B5.

 

 

8.

Authorized Share Structure. The authorized share structure of Amalco shall consist of an unlimited number of Amalco Shares, which shares shall have the rights, privileges, restrictions and conditions as set out in the Act.

 

 

9.

Restrictions on Business. There shall be no restrictions on the business which Amalco is authorized to carry on.

 

 

10.

Number of Directors. The minimum number of directors of Amalco, until changed in accordance with the Articles, will be two (2).

 

 

11.

Articles and Notice of Articles. The Notice of Articles shall be in the form of the notice of articles forming part of the Amalgamation Application and the articles of Subco shall, so far as applicable, be the Articles of Amalco until repealed or amended in the normal manner provided for in the Act.

 

 

12.

Directors. The directors of Amalco shall be the Persons whose names and addresses are set out below, who shall hold office until the first annual meeting of shareholders of Amalco or until their successors are duly elected or appointed:

 

Name

Address

Cameron Chell

[L120, 2303 4 Street SW, Calgary, AB T2S 2S7]

Glen Hawker

[315 Willow Ridge Place, Calgary, AB T2J 1N2]

 

 

 

A-5

 

 

13.

Treatment of Issued Shares. At the Effective Time:

 

 

a)

Draganfly Shares shall be exchanged for fully paid and non-assessable DroneCorp Shares (the “Replacement Shares”) on the basis of the Exchange Ratio;

 

 

 

 

b)

Draganfly Shares replaced in accordance with the provisions of Section 13(a) hereof will be cancelled;

 

 

 

 

c)

each issued and outstanding Subco Share will be cancelled and replaced by one (1) fully paid and non-assessable Amalco Share for each Subco Share held by DroneCorp;

 

 

 

 

d)

as consideration for the issuance of DroneCorp Shares in exchange for the Draganfly Shares, Amalco shall issue to DroneCorp one (1) Amalco Share for each DroneCorp Share so issued.

 

14.

No Fractional Shares or Securities upon Conversion. Notwithstanding Section 13 of this Agreement, no Draganfly Shareholder shall be entitled to, and DroneCorp will not issue, fractions of DroneCorp Shares and no cash amount will be payable by DroneCorp in lieu thereof. To the extent any Draganfly Shareholder is entitled to receive a fractional DroneCorp Share such fraction shall be rounded down to the closest whole number of the applicable security.

 

15.

Share Certificates. On the Business Combination Date:

 

 

a)

the registered holders of Draganfly Shares shall be deemed to be the registered holders of Replacement Shares to which they are entitled hereunder.

 

 

 

 

b)

DroneCorp, as the registered holder of the Subco Shares, shall be deemed to be the registered holder of the Amalco Shares to which it is entitled hereunder and, upon surrender of the certificates representing such Subco Shares to Amalco, DroneCorp shall be entitled to receive a share certificate representing the number of Amalco Shares to which it is entitled as set forth in Section 13 hereof; and

 

 

 

 

c)

share certificates evidencing Draganfly Shares shall cease to represent any claim upon or interest in Draganfly other than the right of the holder to receive, pursuant to the terms hereof and the Amalgamation, the applicable Replacement Shares in accordance with Section 13 hereof.

 

16.

Lost Certificates. In the event any certificate which subsequent to the Effective Time represented one or more outstanding Draganfly Shares that were exchanged pursuant to Section 13 shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the holder of such Draganfly Share claiming such certificate to be lost, stolen or destroyed, DroneCorp will issue in exchange for such lost, stolen or destroyed certificate, one or more certificates representing the applicable Replacement Share pursuant to Section 13. The holder to whom certificates representing Replacement Shares are to be issued shall, as a condition precedent to the issuance thereof, give a bond satisfactory to DroneCorp in such sum as DroneCorp may direct or otherwise indemnify DroneCorp in a manner satisfactory to DroneCorp against any claim that may be made against DroneCorp with respect to the certificate alleged to have been lost, stolen or destroyed.

 

 

 

A-6

 

 

17.

Amalco Shares and Shareholders. Upon the Amalgamation becoming effective, the exchange of shares under Section 13 will result in 42,000,000 Amalco Shares being issued and outstanding as fully paid and non-assessable common shares in Amalco, all of which will be held by DroneCorp.

 

 

18.

Amalco Stated Capital. The amount to be added to the stated capital account maintained in respect of the Amalco Shares in connection with the issue of Amalco Shares under Section 13 hereof on the Business Combination Date shall be the amount which is the sum of (i) the Paid-up Capital, determined immediately before the Effective Time, of all the issued and outstanding Draganfly Shares and (ii) the Paid-up Capital, determined immediately before the Effective Time, of the issued and outstanding Subco Shares converted into Amalco Shares.

 

 

19.

DroneCorp Stated Capital. DroneCorp shall add an amount to the stated capital account maintained in respect of the DroneCorp Shares an amount equal to the Paid-Up Capital of the Draganfly Shares, determined immediately prior to the Effective Time.

 

 

20.

Filings with the Registrar. The Amalgamating Parties will, on or prior to the Business Combination Date, cause the Amalgamation Application and any other documents that may be required to give effect to the Amalgamation to be filed with the Registrar.

 

21.

Covenants of Draganfly. Draganfly covenants and agrees with Subco and DroneCorp that it will:

 

 

a)

use reasonable commercial efforts to obtain the approval of the holders of Draganfly Shares authorizing the Amalgamation, this Agreement and the transactions contemplated hereby in accordance with the Act;

 

 

 

 

b)

use reasonable efforts to cause each of the conditions precedent set forth in Sections 28 and 29 hereof to be complied with; and

 

 

 

 

c)

subject to the approval of the shareholders of Draganfly and Subco being obtained for the completion of the Amalgamation and subject to all applicable regulatory approvals being obtained, thereafter jointly file with Subco the Amalgamation Application with the Registrar and such other documents as may be required to give effect to the Amalgamation upon and subject to the terms and conditions of this Agreement.

 

22.

Covenants of DroneCorp. DroneCorp covenants and agrees with Draganfly that it will:

 

 

a)

sign a resolution as sole shareholder of Subco in favour of the approval of the Amalgamation, this Agreement and the transactions contemplated hereby in accordance with the Act;

 

 

 

 

b)

use reasonable efforts to cause each of the conditions precedent set forth in Sections 28 and 30 hereof to be complied with; and

 

 

 

 

c)

subject to the approval of the holders of Draganfly Shares being obtained for the completion of the Amalgamation, and the obtaining of all applicable regulatory approvals and the issuance of the Certificate of Amalgamation, issue that number of Replacement Shares as required by Section 13(a) hereof.

 

 

 

A-7

 

 

23.

Covenants of Subco. Subco covenants and agrees with DroneCorp and Draganfly that it will not from the date of execution hereof to the Business Combination Date, except with the prior written consent of DroneCorp and Draganfly, conduct any business which would prevent Subco or Amalco from performing any of their respective obligations hereunder.

 

 

24.

Further Covenants of Subco. Subco further covenants and agrees with Draganfly that it will:

 

 

a)

use its best efforts to cause each of the conditions precedent set forth in Section 28 hereof to be complied with; and

 

 

 

 

b)

subject to the approval of the holders of Draganfly Shares and the sole shareholder of Subco being obtained and subject to the obtaining of all applicable regulatory approvals, thereafter jointly file with Draganfly the Amalgamation Application with the Registrar and such other documents as may be required to give effect to the Amalgamation upon and subject to the terms and conditions of this Agreement.

 

25.

Representation and Warranty of DroneCorp. DroneCorp hereby represents and warrants to and in favour of Draganfly and Subco and acknowledges that Draganfly and Subco are relying upon such representation and warranty, that DroneCorp is duly authorized to execute and deliver this Agreement and this Agreement is a valid and binding agreement, enforceable against DroneCorp in accordance with its terms.

 

 

26.

Representation and Warranty of Draganfly. Draganfly hereby represents and warrants to and in favour of DroneCorp and Subco, and acknowledges that DroneCorp and Subco are relying upon such representation and warranty, that Draganfly is duly authorized to execute and deliver this Agreement and this Agreement is a valid and binding agreement, enforceable against Draganfly in accordance with its terms.

 

27.

Representation and Warranty of Subco. Subco hereby represents and warrants to and in favour of Draganfly and DroneCorp, and acknowledges that Draganfly and DroneCorp are relying upon such representations and warranty, that Subco is duly authorized to execute and deliver this Agreement and this Agreement is a valid and binding agreement, enforceable against Subco in accordance with its terms.

 

 

28.

General Conditions Precedent. The respective obligations of the parties hereto to consummate the transactions contemplated hereby, and in particular the Amalgamation, are subject to the satisfaction, on or before the Business Combination Date, of the following conditions, any of which may be waived by the consent of each of the parties without prejudice to their rights to rely on any other or others of such conditions:

 

 

 

A-8

 

 

 

a)

this Agreement and the transactions contemplated hereby, including, in particular, the Amalgamation, shall be approved by the sole shareholder of Subco and by the Draganfly Shareholders in accordance with the Act;

 

 

 

 

b)

all the conditions required to close the Business Combination set out herein and in the Business Combination Agreement being met or waived; and

 

 

 

 

c)

there shall not be in force any order or decree restraining or enjoining the consummation of the transactions contemplated by this Agreement, including, without limitation, the Amalgamation.

 

29.

Conditions to Obligations of DroneCorp and Subco. The obligations of DroneCorp and Subco to consummate the transactions contemplated hereby and in particular the issue of the Replacement Shares and the Amalgamation, as the case may be, are subject to the satisfaction, on or before the Business Combination Date, of the conditions for the benefit of DroneCorp set forth in the Business Combination Agreement governing the terms and conditions of the Business Combination and of the following conditions:

 

 

 

a)

the acts of Draganfly to be performed on or before the Business Combination Date pursuant to the terms of this Agreement shall have been duly performed by it and there shall have been no material adverse change in the financial condition or business of Draganfly, taken as a whole, from and after the date hereof; and

 

 

 

 

 

 

b)

DroneCorp and Subco shall have received a certificate from a senior officer of Draganfly confirming that the conditions set forth in Section 29(a) hereof have been satisfied.

 

 

 

 

 

The conditions described above are for the exclusive benefit of DroneCorp and Subco and may be asserted by DroneCorp and Subco regardless of the circumstances or may be waived by DroneCorp and Subco in their sole discretion, in whole or in part, at any time and from time to time without prejudice to any other rights which DroneCorp and Subco may have.

 

30.

Conditions to Obligations of Draganfly. The obligations of Draganfly to consummate the transactions contemplated hereby and in particular the Amalgamation are subject to the satisfaction, on or before the Business Combination Date, of the conditions for the benefit of Draganfly set forth in the Business Combination Agreement governing the terms and conditions of the Business Combination and of the following conditions:

 

 

 

a)

each of the acts of DroneCorp and Subco to be performed on or before the Business Combination Date pursuant to the terms of this Agreement shall have been duly performed by them and there shall have been no material adverse change in the financial condition or business of DroneCorp or Subco, taken as a whole, from and after the date hereof; and

 

 

 

 

 

 

b)

Draganfly shall have received a certificate from a senior officer of DroneCorp and Subco confirming that the conditions set forth in Section 30(a) hereof have been satisfied.

 

 

 

 

 

The conditions described above are for the exclusive benefit of Draganfly and may be asserted by Draganfly regardless of the circumstances or may be waived by Draganfly in its sole discretion, in whole or in part, at any time and from time to time without prejudice to any other rights which Draganfly may have.

 

 

 

A-9

 

 

31.

Amendment and Waiver. This Agreement may at any time and from time to time be amended by written agreement of the parties hereto without, subject to applicable law, further notice to or authorization on the part of their respective shareholders and any such amendment may, without limitation:

 

 

 

a)

change the time for performance of any of the obligations or acts of the parties hereto;

 

 

 

 

 

 

b)

waive any inaccuracies or modify any representation or warranty contained herein or in any document delivered pursuant hereto;

 

 

 

 

 

 

c)

waive compliance with or modify any of the covenants contained herein and waive or modify performance of any of the obligations of the parties hereto; or

 

 

 

 

 

 

d)

waive compliance with or modify any other conditions precedent contained herein;

 

 

 

 

 

provided that no such amendment shall change the provisions hereof regarding the consideration to be received by Draganfly Shareholders in exchange for their Draganfly Shares without approval by the Draganfly Shareholders given in the same manner as required for the approval of the Amalgamation.

 

32.

Termination. This Agreement may, prior to the issuance of the Certificate of Amalgamation, be terminated by mutual agreement of the respective boards of directors of the parties hereto, without further action on the part of the shareholders of Draganfly or Subco. This Agreement shall also terminate without further notice or agreement if:

 

 

a)

the Amalgamation is not approved by the Draganfly Shareholders entitled to vote in accordance with the Act; or

 

 

 

 

b)

the Business Combination Agreement is terminated.

 

33.

Binding Effect. This Agreement shall be binding upon and enure to the benefit of the parties hereto and their successors and permitted assigns.

 

 

34.

Assignment. No party to this Agreement may assign any of its rights or obligations under this Agreement without the prior written consent of each of the other parties.

 

 

35.

Further Assurances. The parties hereto agree to execute and deliver such further instruments and to do such further reasonable acts and things as may be necessary or appropriate to carry out the intent of this Agreement.

 

 

 

A-10

 

 

36.

Notice. Any notice which a party may desire to give or serve upon another party shall be in writing and may be delivered, mailed by prepaid registered mail, return receipt requested or sent by telecopy transmission to the following addresses:
 

 

a)

to Draganfly at:

 

 

 

 

 

Draganfly Innovations Inc.

2108 St. George Avenue

Saskatoon, SK S7M 0K7

 

 

 

 

 

Attention:             Cameron Chell

Phone Number:    1-800-979-9794

Email:                     cameron@businessinstincts.com

 

 

 

 

 

and a copy to:

 

 

 

 

 

Borden Ladner Gervais LLP

1900, 520 – 3rd Ave S W,

Calgary, AB T2P 0R3

 

 

 

 

 

Attention:             Jonathan Poirier

Phone Number:    (403) 232-9592

Email:                     JPoirier@blg.com

 

 

 

 

b) 

to DroneCorp and/or Subco at:

 

 

 

 

 

Drone Acquisition Corp.

1088, 999 West Hastings Street

Vancouver, BC, V6C2W2

 

 

 

 

 

Attention:             President

Phone Number:    604-639-1221

Email:                     info@dronecorp.ca

 

 

 

 

 

and a copy to:

 

 

 

 

 

Gowling WLG (Canada) LLP

Suite 1600, 100 King Street West

Toronto, ON M5X 1G5

 

 

 

 

 

Attention:             Denis Silva

Phone Number:    (604) 891-2261

Email:                     denis.silva@gowlingwlg.com

 

or to such other address as the party to or upon whom notice is to be given or served has communicated to the other parties by notice given or served in the manner provided for in this Section. In the case of delivery or telecopy transmission, notice shall be deemed to be given on the date of delivery and in the case of mailing, notice shall be deemed to be given on the third Business Day after such mailing.

 

 

 

A-11

 

 

37.

Time of Essence. Time shall be of the essence of this Agreement.

 

 

38.

Governing Law. This Agreement shall be governed by and construed in accordance with the Laws of the Province of British Columbia and the federal Laws of Canada applicable therein.

 

 

39.

Counterparts. This Agreement may be executed and delivered by the parties in one or more counterparts, each of which will be an original, and those counterparts will together constitute one and the same instrument.

 

 

40.

Electronic Delivery. Delivery of this Agreement by facsimile, e-mail or other functionally equivalent electronic means of transmission constitutes valid and effective delivery.

 

[Remainder of page intentionally left blank]

 

 

 

A-12

 

 

IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the date first above written.

 

  DRONE ACQUISITION CORP.
       
Per:

 

 

Oggy Talic

Director

 
     
 

DRAGANFLY INNOVATIONS INC.

 

 

 

 

 

 

Per:

 

 

 

 

[l]

 

 

 

[Director]

 

 

 

 

 

 

1187607 B.C. LTD.

 

 

 

 

 

 

Per:

 

 

 

 

Oggy Talic

Director

 

 

 

 

B-1

 

 

SCHEDULE B
FORM OF BRIDGE LOAN

 

(see attached)

 

 

 

 

 

 

 C-1

 

 

SCHEDULE C
DISCLOSURE SCHEDULE

 

 

 

 

 

 

 

D-1

 

 

SCHEDULE D
DRAGANFLY FINANCIAL STATEMENTS

 

 

 

 

 

 

E-1

 

 

SCHEDULE E
FORM OF COMPENSATION PLAN

 

 

 

 

 

 

 

 

F-1

 

 

SCHEDULE F
LIST OF NOT NON-U.S. HOLDERS

 

 

 

Name

# of Shares

 

 

Paul Beard

1,900,000

 

 

John Lang

200,000

 

 

Kestrel Enterprises Inc.

106,500

 

 

Ryan Larkin

16,000

 

 

Ryan Larkin and Emiliya Larkin

8,000

 

 

Total shares

2,230,500

   

 

 

G-1

 

 

SCHEDULE G
ADJUSTMENT CLAUSE EXAMPLES

 

Adjustment Clause Examples

$250,000 in excess of Debt Settlement Amount

500,000 common shares of the resulting

issuer to the Transaction registered to

DroneCorp (or as directed to be registered

by DroneCorp)

$500,000 in excess of Debt Settlement Amount

1,000,000 common shares of the resulting

issuer to the Transaction registered to

DroneCorp (or as directed to be registered

by DroneCorp)

$750,000 in excess of Debt Settlement Amount

1,500,000 common shares of the resulting

issuer to the Transaction registered to

DroneCorp (or as directed to be registered

by DroneCorp)

$1,000,000 in excess of Debt Settlement Amount

2,000,000 common shares of the resulting

issuer to the Transaction registered to

DroneCorp (or as directed to be registered

by DroneCorp)

 

 

 

 

EXHIBIT 6.5

 

 

Broker-Dealer Agreement

 

This agreement (together with exhibits and schedules, the “Agreement”) is entered into by and between Draganfly, Inc. (“Client”), a British Columbia, Canada Corporation, and Dalmore Group, LLC., a New York Limited Liability Company (“Dalmore”). Client and Dalmore agree to be bound by the terms of this Agreement, effective as of June 10, 2020 (the “Effective Date”):

 

Whereas, Dalmore is a registered broker-dealer providing services in the equity and debt securities market, including offerings conducted via SEC approved exemptions such as Reg D 506(b), 506(c), Regulation A+, Reg CF and others;

 

Whereas, Client is offering securities directly to the public in an offering exempt from registration under Regulation A+ (the “Offering”); and

 

Whereas, Client recognizes the benefit of having Dalmore as a service provider for investors who participate in the Offering (“Investors”).

 

Now, Therefore, in consideration of the mutual promises and covenants contained herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

1. Appointment, Term, and Termination

 

a. Client hereby engages and retains Dalmore to provide operations and compliance services at Client’s discretion.

 

b. The Agreement will commence on the Effective Date and will remain in effect for a period of twelve (12) months and will renew automatically for successive renewal terms of twelve (12) months each unless any party provides notice to the other party of non-renewal at least sixty (60) days prior to the expiration of the current term. If Client defaults in performing the obligations under this Agreement, the Agreement may be terminated (i) upon sixty (60) days written notice if Client fails to perform or observe any material term, covenant or condition to be performed or observed by it under this Agreement and such failure continues to be unremedied, (ii) upon written notice, if any material representation or warranty made by either Provider or Client proves to be incorrect at any time in any material respect, (iii) in order to comply with a Legal Requirement, if compliance cannot be timely achieved using commercially reasonable efforts, after providing as much notice as practicable, or (iv) upon thirty (30) days’ written notice if Client or Dalmore commences a voluntary proceeding seeking liquidation, reorganization or other relief, or is adjudged bankrupt or insolvent or has entered against it a final and unappeable order for relief, under any bankruptcy, insolvency or other similar law, or either party executes and delivers a general assignment for the benefit of its creditors. The description in this section of specific remedies will not exclude the availability of any other remedies. Any delay or failure by Client to exercise any right, power, remedy or privilege will not be construed to be a waiver of such right, power, remedy or privilege or to limit the exercise of such right, power, remedy or privilege. No single, partial or other exercise of any such right, power, remedy or privilege will preclude the further exercise thereof or the exercise of any other right, power, remedy or privilege. All terms of the Agreement, which should reasonably survive termination, shall so survive, including, without limitation, limitations of liability and indemnities, and the obligation to pay Fees relating to Services provided prior to termination.

 

 

 

 

  

 

2. Services. Dalmore will perform the services listed on Exhibit A attached hereto and made a part hereof, in connection with the Offering (the “Services”). Unless otherwise agreed to in writing by the parties.

 

3. Compensation. As compensation for the Services, Client shall pay to Dalmore a fee equal to one hundred 100 basis points (1%) on the aggregate amount raised. This will only start after FINRA Corporate Finance issues a No Objection Letter for the offering. Client authorizes Dalmore to deduct the fee directly from the Client’s third party escrow or payment account.

 

There will also be a one time advance payment for out of pocket expenses of $5,000. Payment is due and payable upon execution of this agreement. The advance payment will cover expenses anticipated to be incurred by the firm such a preparing the FINRA filing, due diligence expenses, working with the Client’s SEC counsel in providing information to the extent necessary, and any other services necessary and required prior to the approval of the offering. The firm will refund a portion of the payment related to the advance to the extent it was not used, incurred or provided to the Client.

 

The Client shall also engage Dalmore as a consultant to provide ongoing general consulting services relating to the Offering such as coordination with third party vendors and general guidance with respect to the Offering. The Client will pay a one time Consulting Fee of $20,000 which will be due and payable immediately after FINRA issues a No Objection Letter and the Client receives SEC Qualification.

 

4. Regulatory Compliance

 

a. Client and all its third party providers shall at all times (i) comply with direct requests of Dalmore; (ii) maintain all required registrations and licenses, including foreign qualification, if necessary; and (iii) pay all related fees and expenses (including the FINRA Corporate Filing Fee), in each case that are necessary or appropriate to perform their respective obligations under this Agreement. Client shall comply with and adhere to all Dalmore policies and procedures.

 

 

 

 

  

 

FINRA Corporate Filing Fee for this $50,000,000, best efforts offering will be $8,000, and will be a pass- through fee payable to Dalmore, from the Client, who will then forward it to FINRA as payment for the filing.

 

b. Client and Dalmore will have the shared responsibility for the review of all documentation related to the Transaction but the ultimate discretion about accepting a client will be the sole decision of the Client. Each Investor will be considered to be that of the Client’s and NOT Dalmore.

 

c. Client and Dalmore will each be responsible for supervising the activities and training of their respective sales employees, as well as all of their other respective employees in the performance of functions specifically allocated to them pursuant to the terms of this Agreement.

 

d. Client and Dalmore agree to promptly notify the other concerning any material communications from or with any Governmental Authority or Self Regulatory Organization with respect to this Agreement or the performance of its obligations, unless such notification is expressly prohibited by the applicable Governmental Authority.

 

5. Role of Dalmore. Client acknowledges and agrees that Client will rely on Client’s own judgment in using Dalmore’ Services. Dalmore (i) makes no representations with respect to the quality of any investment opportunity or of any issuer; (ii) does not guarantee the performance to and of any Investor; (iii) will make commercially reasonable efforts to perform the Services in accordance with its specifications; (iv) does not guarantee the performance of any party or facility which provides connectivity to Dalmore; and (v) is not an investment adviser, does not provide investment advice and does not recommend securities transactions and any display of data or other information about an investment opportunity, does not constitute a recommendation as to the appropriateness, suitability, legality, validity or profitability of any transaction. Nothing in this Agreement should be construed to create a partnership, joint venture, or employer-employee relationship of any kind.

 

6. Indemnification.

 

a. Indemnification by Client. Client shall indemnify and hold Dalmore, its affiliates and their representatives and agents harmless from, any and all actual or direct losses, liabilities, judgments, arbitration awards, settlements, damages and costs (collectively, “Losses”), resulting from or arising out of any third party suits, actions, claims, demands or similar proceedings (collectively, “Proceedings”) to the extent they are based upon (i) a breach of this Agreement by Client, (ii) the wrongful acts or omissions of Client, or (iii) the Offering.

 

 

 

 

  

 

b. Indemnification by Dalmore. Dalmore shall indemnify and hold Client, Client’s affiliates and Client’s representatives and agents harmless from any Losses resulting from or arising out of Proceedings to the extent they are based upon (i) a breach of this Agreement by Dalmore or (ii) the wrongful acts or omissions of Dalmore or its failure to comply with any applicable federal, state, or local laws, regulations, or codes in the performance of its obligations under this Agreement.

 

c. Indemnification Procedure. If any Proceeding is commenced against a party entitled to indemnification under this section, prompt notice of the Proceeding shall be given to the party obligated to provide such indemnification. The indemnifying party shall be entitled to take control of the defense, investigation or settlement of the Proceeding and the indemnified party agrees to reasonably cooperate, at the indemnifying party's cost in the ensuing investigations, defense or settlement.

 

7. Notices. Any notices required by this Agreement shall be in writing and shall be addressed, and delivered or mailed postage prepaid, or faxed or emailed to the other parties hereto at such addresses as such other parties may designate from time to time for the receipt of such notices. Until further notice, the address of each party to this Agreement for this purpose shall be the following:

 

 

If to the Client:

 

Draganfly, Inc.

2108 St. George Ave

Saskatchewan, SK, S7M 0C7 Canada

Attn: Cameron Chell, CEO

Tel: 310-658-4413

cameron@businessinstincts.com

 

If to the Dalmore:

 

Dalmore Group, LLC.

525 Green Place

Woodmere, NY 11598

Attn: Etan Butler, Chairman

Tel: 917-319-3000

etan@dalmorefg.com

 

 

8.

Confidentiality and Mutual Non-Disclosure:

  

 

 

 

   

 

 

a.

Confidentiality.

  

i. Included Information. For purposes of this Agreement, the term “Confidential Information” means all confidential and proprietary information of a party, including but not limited to (i) financial information, (ii) business and marketing plans, (iii) the names of employees and owners, (iv) the names and other personally-identifiable information of users of the third-party provided online fundraising platform, (v) security codes, and (vi) all documentation provided by Client or Investor.

 

ii. Excluded Information. For purposes of this Agreement, the term “confidential and proprietary information” shall not include (i) information already known or independently developed by the recipient without the use of any confidential and proprietary information, or (ii) information known to the public through no wrongful act of the recipient.

 

iii. Confidentiality Obligations. During the Term and at all times thereafter, neither party shall disclose Confidential Information of the other party or use such Confidential Information for any purpose without the prior written consent of such other party. Without limiting the preceding sentence, each party shall use at least the same degree of care in safeguarding the other party’s Confidential Information as it uses to safeguard its own Confidential Information. Notwithstanding the foregoing, a party may disclose Confidential Information (i) if required to do by order of a court of competent jurisdiction, provided that such party shall notify the other party in writing promptly upon receipt of knowledge of such order so that such other party may attempt to prevent such disclosure or seek a protective order; or (ii) to any applicable governmental authority as required by applicable law. Nothing contained herein shall be construed to prohibit the SEC, FINRA, or other government official or entities from obtaining, reviewing, and auditing any information, records, or data. Issuer acknowledges that regulatory record-keeping requirements, as well as securities industry best practices, require Provider to maintain copies of practically all data, including communications and materials, regardless of any termination of this Agreement.

 

9.

Miscellaneous.

 

a. ANY DISPUTE OR CONTROVERSY BETWEEN THE CLIENT AND PROVIDER RELATING TO OR ARISING OUT OF THIS AGREEMENT WILL BE SETTLED BY ARBITRATION BEFORE AND UNDER THE RULES OF THE ARBITRATION COMMITTEE OF FINRA.

 

b. This Agreement is non-exclusive and shall not be construed to prevent either party from engaging in any other business activities

 

 

 

 

  

 

c. This Agreement will be binding upon all successors, assigns or transferees of Client. No assignment of this Agreement by either party will be valid unless the other party consents to such an assignment in writing. Either party may freely assign this Agreement to any person or entity that acquires all or substantially all of its business or assets. Any assignment by the either party to any subsidiary that it may create or to a company affiliated with or controlled directly or indirectly by it will be deemed valid and enforceable in the absence of any consent from the other party.

 

d. Neither party will, without prior written approval of the other party, place or agree to place any advertisement in any website, newspaper, publication, periodical or any other media or communicate with the public in any manner whatsoever if such advertisement or communication in any manner makes reference to the other party, to any person or entity that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control, with the other party and to the clearing arrangements and/or any of the Services embodied in this Agreement. Client and Dalmore will work together to authorize and approve co-branded notifications and client facing communication materials regarding the representations in this Agreement. Notwithstanding any provisions to the contrary within, Client agrees that Dalmore may make reference in marketing or other materials to any transactions completed during the term of this Agreement, provided no personal data or Confidential Information is disclosed in such materials.

 

e. THE CONSTRUCTION AND EFFECT OF EVERY PROVISION OF THIS AGREEMENT, THE RIGHTS OF THE PARTIES UNDER THIS AGREEMENT AND ANY QUESTIONS ARISING OUT OF THE AGREEMENT, WILL BE SUBJECT TO THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES. The language used in this Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction will be applied against any party

 

f. If any provision or condition of this Agreement will be held to be invalid or unenforceable by any court, or regulatory or self-regulatory agency or body, the validity of the remaining provisions and conditions will not be affected and this Agreement will be carried out as if any such invalid or unenforceable provision or condition were not included in the Agreement.

 

g. This Agreement sets forth the entire agreement between the parties with respect to the subject matter hereof and supersedes any prior agreement relating to the subject matter herein. The Agreement may not be modified or amended except by written agreement.

 

h. This Agreement may be executed in multiple counterparts and by facsimile or electronic means, each of which shall be deemed an original but all of which together shall constitute one and the same agreement.

 

[SIGNATURES APPEAR ON FOLLOWING PAGE(S)]

 

 

 

 

 

  

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

  CLIENT: Draganfly, Inc.
        
By: /s/ Cameron Chell

 

Name:

Cameron Chell  
  Its: CEO  

 

  

 

 

  Dalmore Group, LLC:  

 

  

 

 

 

By:

/s/ Etan Butler

 

 

Name:

Etan Butler

 

 

Its:

Chairman

 

  

 

 

 

 

 

Exhibit A

 

Services:

a. Dalmore Responsibilities – Dalmore agrees to:

 

 

i.

Review investor information, including KYC (Know Your Customer) data, perform AML (Anti-Money Laundering) and other compliance background checks, and provide a recommendation to Client whether or not to accept investor as a customer of the Client;

 

 

 

 

ii.

Review each investors subscription agreement to confirm such Investors participation in the offering, and provide a determination to Client whether or not to accept the use of the subscription agreement for the Investors participation;

 

 

 

 

iii.

Contact and/or notify the issuer, if needed, to gather additional information or clarification on an investor;

 

 

 

 

iv.

Not provide any investment advice nor any investment recommendations to any investor;

 

 

 

 

v.

Keep investor details and data confidential and not disclose to any third-party except as required by regulators or in our performance under this Agreement (e.g. as needed for AML and background checks);

 

 

 

 

vi.

Coordinate with third party providers to ensure adequate review and compliance.

   

 

 

EXHIBIT 6.6

 

DRAGANFLY INC.

 

SHARE COMPENSATION PLAN

 

1.

DEFINITIONS AND INTERPRETATION

 

 

1.1

Definitions: For purposes of the Plan, unless the context requires otherwise, the following words and terms shall have the following meanings:

  

 

(a)

1933 Act” means the United States Securities Act of 1933, as amended;

 

 

 

 

(b)

Account” has the meaning attributed to that term in section 4.8;

 

 

 

 

(c)

Administrators” means the Board or such other persons as may be designated by the Board from time to time;

 

 

 

 

(d)

Affiliate” has the meaning attributed to that term in the Securities Act (British Columbia);

 

 

 

 

(e)

Associate” has the meaning attributed to that term in the Securities Act (British Columbia);

 

 

 

 

(f)

Award Date” means the date or dates on which an award of Restricted Share Units is made to a Participant in accordance with section 4.1;

 

 

 

 

(g)

Blackout Period” means the period during which designated directors, officers and employees of the Corporation cannot trade the Common Shares pursuant to the Corporation’s policy respecting restrictions on directors’, officers’ and employee trading which is in effect at that time (which, for greater certainty, does not include the period during which a cease trade order is in effect to which the Corporation or in respect of an insider, that insider is subject);

 

 

 

 

(h)

Board” means the board of directors of the Corporation from time to time;

 

 

 

 

(i)

Business Day” means each day other than a Saturday, Sunday or statutory holiday in Vancouver, British Columbia, Canada;

 

 

 

 

(j)

Change of Control” means:

  

 

(i)

the acceptance of an Offer by a sufficient number of holders of voting shares in the capital of the Corporation to constitute the offeror, together with persons acting jointly or in concert with the offeror, a shareholder of the Corporation being entitled to exercise more than 50% of the voting rights attaching to the outstanding voting shares in the capital of the Corporation (provided that prior to the Offer, the offeror was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting shares in the capital of the Corporation),

 

 

 

 

(ii)

the completion of a consolidation, merger or amalgamation of the Corporation with or into any other corporation whereby the voting shareholders of the Corporation immediately prior to the consolidation, merger or amalgamation receive less than 50% of the voting rights attaching to the outstanding voting shares of the consolidated, merged or amalgamated corporation or any parent entity, or

  

 

 

  

 

(iii)

the completion of a sale whereby all or substantially all of the Corporation’s undertakings and assets become the property of any other entity and the voting shareholders of the Corporation immediately prior to that sale hold less than 50% of the voting rights attaching to the outstanding voting securities of that other entity immediately following that sale;

  

 

(k)

Code” means the U.S. Internal Revenue Code of 1986, as amended;

 

 

 

 

(l)

Common Shares” means the common shares of the Corporation;

 

 

 

 

(m)

Consultant” means an individual (other than an employee or a director of the Corporation) or company that is not a U.S. Person that:

  

 

(A)

is engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services to the Corporation or to an Affiliate of the Corporation, other than services provided in relation to an offer or sale of securities of the Corporation in a capital-raising transaction, or services that promote or maintain a market for the Corporation’s securities;

 

 

 

 

(B)

provides the services under a written contract between the Corporation or the Affiliate and the individual or the company, as the case may be;

 

 

 

 

(C)

in the reasonable opinion of the Corporation, spends or will spend a significant amount of time and attention on the affairs and business of the Corporation or an Affiliate of the Corporation; and

 

 

 

 

(D)

has a relationship with the Corporation or an Affiliate of the Corporation that enables the individual to be knowledgeable about the business and affairs of the Corporation;

  

 

(n)

Corporation” means Draganfly Inc., a corporation existing under the Business Corporations Act (British Columbia) and the successors thereof;

 

 

 

 

(o)

Effective Date” means August 19, 2019;

 

 

 

 

(p)

Eligible Person” means:

 

 

 

 

(i)

any officer or employee of the Corporation and/or any officer or employee of any Subsidiary of the Corporation and any director of the Corporation and/or any director of any Subsidiary of the Corporation; and

 

 

 

 

(ii)

a Consultant;

 

 

 

 

(q)

Event of Termination” means an event whereby a Participant ceases to be an Eligible Person and shall be deemed to have occurred by the giving of any notice of termination of employment or service (whether voluntary or involuntary and whether with or without cause), retirement, or any cessation of employment or service for any reason whatsoever, including disability or death;
  
 
- 2 -

 

  

 

(r)

Exchange” means the Canadian Stock Exchange or any other stock exchange or quotation system in Canada where the Common Shares are listed on or through which the Common Shares are listed or quoted;

 

 

 

 

(s)

Grant Date” means the date on which a grant of Options is made to a Participant in accordance with section 5.1;

 

 

 

 

(t)

insider” has the meaning attributed to that term in the Securities Act (British Columbia);

 

 

 

 

(u)

Insider Participant” means a Participant who is (i) an insider of the Corporation or any of its Subsidiaries, and (ii) an associate of any person who is an insider by virtue of (i);

 

 

 

 

(v)

Investor Relations Activities” means any activities, by or on behalf of the Corporation or shareholder of the Corporation, that promote or reasonably could be expected to promote the purchase or sale of securities of the Corporation, but does not include:

  

 

(i)

the dissemination of information provided, or records prepared, in the ordinary course of business of the Corporation:

  

 

(A)

to promote the sale of products or services of the Corporation, or

 

 

 

 

(B)

to raise public awareness of the Corporation, that cannot reasonably be considered to promote the purchase or sale of securities of the Corporation;

  

 

(ii)

activities or communications necessary to comply with the requirements of:

  

 

(A)

applicable securities laws;

 

 

 

 

(B)

the by-laws, rules or other regulatory instruments of the Exchange or any other self-regulatory body or exchange having jurisdiction over the Corporation;

  

 

(iii)

communications by a publisher of, or writer for, a newspaper, magazine or business or financial publication, that is of general and regular paid circulation, distributed only to subscribers to it for value or to purchasers of it, if:

  

 

(A)

the communication is only through the newspaper, magazine or publication, and

 

 

 

 

(B)

the publisher or writer receives no commission or other consideration other than for acting in the capacity of publisher or writer; or

  

 
- 3 -

 

   

 

(iv)

activities or communications that may be otherwise specified by the Exchange;

  

 

(w)

Market Price” means, as of any date, the closing price of the Common Shares on the Exchange for the last market trading day prior to the date of grant of the Option or if the Common Shares are not listed on a stock exchange, the Market Price shall be determined in good faith by the Administrators;

 

 

 

 

(x)

Market Value” means, on any date, the volume weighted average price of the Common Shares traded on the Exchange for the five (5) consecutive trading days prior to such date;

 

 

 

 

(y)

Offer” means a bona fide arm’s length offer made to all holders of voting shares in the capital of the Corporation to purchase, directly or indirectly, voting shares in the capital of the Corporation;

 

 

 

 

(z)

Option” means an option granted to an Eligible Person under the Plan to purchase Common Shares;

 

 

 

 

(aa)

Option Agreement” has the meaning ascribed to that term in section 3.2;

 

 

 

 

(bb)

Participant” means an Eligible Person selected by the Administrators to participate in the Plan in accordance with section 3.1 hereof;

 

 

 

 

(cc)

Payout Date” means the day on which the Corporation pays to a Participant the Market Value of the RSUs that have become vested and payable;

 

 

 

 

(dd)

Plan” means this share compensation plan, as amended, replaced or restated from time to time, including Appendix A, which is applicable to California Residents only;

 

 

 

 

(ee)

reserved for issuance” refers to Common Shares that may be issued in the future upon the vesting of Restricted Share Units which have been awarded and upon the exercise of Options which have been granted;

 

 

 

 

(ff)

Restricted Share Unit” means a right granted in accordance with section 4.1 hereof to receive one Common Share that becomes vested in accordance with section 4.3;

 

 

 

 

(gg)

Restricted Share Unit Agreement” has the meaning ascribed to that term in section 3.2;

 

 

 

 

(hh)

Share Compensation Arrangement” means a stock option, stock option plan, employee stock purchase plan or any other compensation or incentive mechanism involving the issuance or potential issuance of Common Shares to directors, officers and employees of the Corporation and any of its Subsidiaries or to Consultants;

 

 

 

 

(ii)

Subsidiary” has the meaning ascribed thereto in the Securities Act (British Columbia) and “Subsidiaries” shall have a corresponding meaning;

  

 
- 4 -

 

  

 

(jj)

United States” means the United States of America, its territories and possessions, any state of the United States and the District of Columbia;

 

 

 

 

(kk)

U.S. Participant” means a Participant who is a citizen of the United States or a resident of the United States, as defined in section 7701(a)(30)(A) and section 7701(b)(1) of the Code and any other Participant who is subject to tax under the Code with respect to compensatory awards granted pursuant to the Plan;

 

 

 

 

(ll)

U.S. Person” means a “U.S. person”, as such term is defined in Regulation S under the 1933 Act; and

 

 

 

 

(mm)

Withholding Obligations” has the meaning ascribed to that term in section 4.6.

  

1.2

Headings: The headings of all articles, sections, and paragraphs in the Plan are inserted for convenience of reference only and shall not affect the construction or interpretation of the Plan.

 

 

1.3

Context, Construction: Whenever the singular or masculine are used in the Plan, the same shall be construed as being the plural or feminine or neuter or vice versa where the context so requires.

 

 

1.4

References to this Plan: The words “hereto”, “herein”, “hereby”, “hereunder”, “hereof” and similar expressions mean or refer to the Plan as a whole and not to any particular article, section, paragraph or other part hereof.

 

 

1.5

Currency: All references in this Plan or in any agreement entered into under this Plan to “dollars”, “$” or lawful currency shall be references to Canadian dollars, unless the context otherwise requires.

 

 

2.

PURPOSE AND ADMINISTRATION OF THE PLAN

 

 

2.1

Purpose: The purpose of the Plan is to advance the interests of the Corporation and its Subsidiaries, and its shareholders by: (i) ensuring that the interests of Eligible Persons are aligned with the success of the Corporation and its Subsidiaries; (ii) encouraging stock ownership by Eligible Persons; and (iii) providing compensation opportunities to attract, retain and motivate Eligible Persons.

 

 

2.2

Common Shares Subject to the Plan:

  

 

(a)

The total number of Common Shares reserved and available for grant and issuance pursuant to this Plan, and the total number of Restricted Share Units that may be awarded pursuant to this Plan, shall not exceed 20% (in the aggregate) of the issued and outstanding Common Shares from time to time;

 

 

 

 

(b)

The aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Corporation for the sale of the securities) or amount of Common Shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) U.S.$1,000,000; (ii) 15% of the total assets of the Corporation, measured at the Corporation's most recent balance sheet date; or (iii) 15% of the outstanding amount of the Common Shares of the Corporation, measured at the Corporation's most recent balance sheet date; and

  

 
- 5 -

 

  

 

(c)

The number of Common Shares issuable pursuant to the exercise of Options under the Plan within a 12 month period to all Eligible Persons retained to provide Investor Relations Activities (together with those Common Shares that are issued pursuant to any other Share Compensation Arrangement) shall not, at any time, exceed 1% of the issued and outstanding Common Shares.

  

2.3

Administration of the Plan: The Plan shall be administered by the Administrators, through the recommendation of the Compensation Committee of the Board. Subject to any limitations of the Plan, the Administrators shall have the power and authority to:

 

 

(a)

adopt rules and regulations for implementing the Plan;

 

 

 

 

(b)

determine the eligibility of persons to participate in the Plan, when Restricted Share Units and Options to Eligible Persons shall be awarded or granted, the number of Restricted Share Units and Options to be awarded or granted, the vesting criteria for each award of Restricted Share Units and the vesting period for each grant of Options;

 

 

 

 

(c)

interpret and construe the provisions of the Plan and any agreement or instrument under the Plan;

 

 

 

 

(d)

subject to regulatory requirements, make exceptions to the Plan in circumstances which they determine to be exceptional;

 

 

 

 

(e)

require that any Participant provide certain representations, warranties and certifications to the Corporation to satisfy the requirements of applicable laws, including without limitation, exemptions from the registration requirements of the 1933 Act and applicable state securities laws; and

 

 

 

 

(f)

make all other determinations and take all other actions as they determine to be necessary or desirable to implement, administer and give effect to the Plan.

  

3.

ELIGIBILITY AND PARTICIPATION IN PLAN

 

 

3.1

The Plan and Participation: The Plan (including Appendix A, if applicable) is hereby established for Eligible Persons. Restricted Share Units may be awarded and Options may be granted to any Eligible Person as determined by the Administrators in accordance with the provisions hereof. The Corporation and each Participant acknowledge that they are responsible for ensuring and confirming that such Participant is a bona fide Eligible Person entitled to receive Options or Restricted Share Units, as the case may be.

 

 

3.2

Agreements: All Restricted Share Units awarded hereunder shall be evidenced by a restricted share unit agreement (“Restricted Share Unit Agreement”) between the Corporation and the Participant, substantially in the form set out in Exhibit A or in such other form as the Administrators may approve from time to time. All Options granted hereunder shall be evidenced by an option agreement (“Option Agreement”) between the Corporation and the Participant, substantially in the form as set out in Exhibit B or in such other form as the Administrators may approve from time to time.

  

 
- 6 -

 

  

4.

AWARD OF RESTRICTED SHARE UNITS

 

 

4.1

Award of Restricted Share Units: The Administrators may, at any time and from time to time, award Restricted Share Units to Eligible Persons. In awarding any Restricted Share Units, the Administrators shall determine:

  

 

(a)

to whom Restricted Share Units pursuant to the Plan will be awarded;

 

 

 

 

(b)

the number of Restricted Share Units to be awarded and credited to each Participant’s Account;

 

 

 

 

(c)

the Award Date; and

 

 

 

 

(d)

subject to section 4.3 hereof, the applicable vesting criteria.

 

 

 

 

Upon the award of Restricted Share Units, the number of Restricted Share Units awarded to a Participant shall be credited to the Participant’s Account effective as of the Award Date.

  

4.2

Restricted Share Unit Agreement: Upon the award of each Restricted Share Unit to a Participant, a Restricted Share Unit Agreement shall be delivered by the Administrators to the Participant.

 

 

4.3

Vesting:

  

 

(a)

Subject to subsections (c) and (d) below, at the time of the award of Restricted Share Units, the Administrators shall determine in their sole discretion the vesting criteria applicable to such Restricted Share Units.

 

 

 

 

(b)

For greater certainty, the vesting of Restricted Share Units may be determined by the Administrators to include criteria such as performance vesting, in which the number of Common Shares to be delivered to a Participant for each Restricted Share Unit that vests may fluctuate based upon the Corporation’s performance and/or the Market Price of the Common Shares, in such manner as determined by the Administrators in their sole discretion.

 

 

 

 

(c)

Each Restricted Share Unit shall be subject to vesting in accordance with the terms set out in the Restricted Share Unit Agreement.

 

 

 

 

(d)

Notwithstanding anything to the contrary in this Plan, all vesting and issuances or payments, as applicable, in respect of a Restricted Share Unit shall be completed no later than December 15 of the third calendar year commencing after the Award Date for such Restricted Share Unit.

  

4.4

Blackout Periods: Should the date of vesting of a Restricted Share Unit fall within a Blackout Period or within nine Business Days following the expiration of a Blackout Period, such date of vesting shall be automatically extended without any further act or formality to that date which is the tenth Business Day after the end of the Blackout Period, such tenth Business Day to be considered the date of vesting for such Restricted Share Unit for all purposes under the Plan. Notwithstanding section 6.4 hereof, the ten Business Day period referred to in this section 4.4 may not be extended by the Board.

  

 
- 7 -

 

  

4.5

Vesting and Settlement: As soon as practicable after the relevant date of vesting of any Restricted Share Units awarded under the Plan and with respect to a U.S. Participant, no later than 60 days thereafter, but subject to subsection 4.3(d), a Participant shall be entitled to receive and the Corporation shall issue or pay (at its discretion):

  

 

(a)

a lump sum payment in cash equal to the number of vested Restricted Share Units recorded in the Participant’s Account multiplied by the Market Value of a Common Share on the Payout Date;

 

 

 

 

(b)

the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s Restricted Share Units in the Participant’s Account, duly issued as fully paid and non-assessable shares and such Participant shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares; or

 

 

 

 

(c)

any combination of the foregoing.

  

4.6

Taxes and Source Deductions: the Corporation or an affiliate of the Corporation may take such reasonable steps for the deduction and withholding of any taxes and other required source deductions which the Corporation or the affiliate, as the case may be, is required by any law or regulation of any governmental authority whatsoever to remit in connection with this Plan, any Restricted Share Units or any issuance of Common Shares (“Withholding Obligations”). Without limiting the generality of the foregoing, the Corporation may, at its discretion: (i) deduct and withhold those amounts it is required to remit pursuant to the Withholding Obligations from any cash remuneration or other amount payable to the Participant, whether or not related to the Plan, the vesting of any Restricted Share Units or the issue of any Common Shares; (ii) allow the Participant to make a cash payment to the Corporation equal to the amount required to be remitted, pursuant to the Withholding Obligations, which amount shall be remitted by the Corporation to the appropriate governmental authority for the account of the Participant; or (iii) settle a portion of vested Restricted Share Units of a Participant in cash equal to the amount the Corporation is required to remit, pursuant to the Withholding Obligations, which amount shall be remitted by the Corporation to the appropriate governmental authority for the account of the Participant. Where the Corporation considers that the steps undertaken in connection with the foregoing result in inadequate withholding or a late remittance of taxes, the delivery of any Common Shares to be issued to a Participant on vesting of any Restricted Share Units may be made conditional upon the Participant (or other person) reimbursing or compensating the Corporation or making arrangements satisfactory to the Corporation for the payment to it in a timely manner of all taxes required to be remitted, pursuant to the Withholding Obligations, for the account of the Participant.

 

 

4.7

Rights Upon an Event of Termination:

  

 

(a)

If an Event of Termination has occurred in respect of any Participant, any and all Common Shares corresponding to any vested Restricted Share Units in the Participant’s Account shall be issued as soon as practicable after the Event of Termination to the former Participant in accordance with section 4.5 hereof. With respect to each Restricted Share Unit of a U.S. Participant, such Restricted Share Unit will be settled and shares issued as soon as practicable following the date of vesting of such Restricted Share Unit as set forth in the applicable Restricted Share Unit Agreement, but in all cases within 60 days following such date of vesting.

  

 
- 8 -

 

  

 

(b)

If an Event of Termination has occurred in respect of any Participant, any unvested Restricted Share Units in the Participant’s Account shall, unless otherwise determined by the Administrators in their discretion, forthwith and automatically be forfeited by the Participant and cancelled. With respect to any Restricted Share Unit of a U.S. Participant, if the Administrators determine, in their discretion, to waive vesting conditions applicable to a Restricted Share Unit that is unvested at the time of an Event of Termination, such Restricted Share Unit shall not be forfeited or cancelled, but instead will be deemed to be vested and settled and shares delivered following the date of vesting of such Restricted Share Unit as set forth in the applicable Restricted Share Unit Agreement.

 

 

 

 

(c)

Notwithstanding the foregoing subsection 4.7(b) and subject to the requirements of the Exchange, if a Participant retires in accordance with the Corporation’s retirement policy, at such time, any unvested performance-based Restricted Share Units in the Participant’s Account shall not be forfeited by the Participant or cancelled and instead shall be eligible to become vested in accordance with the vesting conditions set forth in the applicable Restricted Share Unit Agreement after such retirement (as if retirement had not occurred), but only if the performance vesting criteria, if any, are met on the applicable date.

 

 

 

 

(d)

For greater certainty, if a Participant’s employment is terminated for just cause, each unvested Restricted Share Unit in the Participant’s Account shall forthwith and automatically be forfeited by the Participant and cancelled.

 

 

 

 

(e)

For the purposes of this Plan and all matters relating to the Restricted Share Units, the date of the Event of Termination shall be determined without regard to any applicable severance or termination pay, damages, or any claim thereto (whether express, implied, contractual, statutory, or at common law).

  

4.8

Restricted Share Unit Accounts: A separate notional account for Restricted Share Units shall be maintained for each Participant (an “Account”). Each Account will be credited with Restricted Share Units awarded to the Participant from time to time pursuant to section 4.1 hereof by way of a bookkeeping entry in the books of the Corporation. On the vesting of the Restricted Share Units pursuant to section 4.3 hereof and the corresponding issuance of Common Shares to the Participant pursuant to section 4.5 hereof, or on the forfeiture and cancellation of the Restricted Share Units pursuant to section 4.7 hereof, the applicable Restricted Share Units credited to the Participant’s Account will be cancelled.

 

 

4.9

Record Keeping: the Corporation shall maintain records in which shall be recorded:

  

 

(a)

the name and address of each Participant;

 

 

 

 

(b)

the number of Restricted Share Units credited to each Participant’s Account;

  

 
- 9 -

 

  

 

(c)

any and all adjustments made to Restricted Share Units recorded in each Participant’s Account; and

 

 

 

 

(d)

any other information which the Corporation considers appropriate to record in such records.

  

5.

GRANT OF OPTIONS

 

 

5.1

Grant of Options: Subject to section 2.2, the total number of Common Shares reserved and available for grant pursuant to this section on exercise of Options (together with those Common Shares issuable pursuant to any other Share Compensation Arrangement, including Restricted Share Units) shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

  

 

The Administrators may at any time and from time to time grant Options to Eligible Persons. In granting any Options, the Administrators shall determine:

 

 

 

 

(a)

to whom Options pursuant to the Plan will be granted;

 

 

 

 

(b)

the number of Options to be granted, the Grant Date and the exercise price of each Option;

 

 

 

 

(c)

the expiration date of each Option; and

 

 

 

 

(d)

subject to section 5.3 hereof, the applicable vesting criteria,

 

 

 

 

provided, however that the exercise price for a Common Share pursuant to any Option shall not be less than the Market Price on the Grant Date in respect of that Option.

  

5.2

Option Agreement: Upon each grant of Options to a Participant, an Option Agreement shall be delivered by the Administrators to the Participant.

 

 

5.3

Vesting:

  

 

(a)

Subject to subsection 2.2(c) above with respect to grants to Eligible Persons providing Investor Relations Activities, at the time of the grant of any Options, the Administrators shall determine, in accordance with minimum vesting requirements of the Exchange, the vesting criteria applicable to such Options.

 

 

 

 

(b)

The Administrators may determine when any Option will become exercisable and may determine that Options shall be exercisable in instalments or pursuant to a vesting schedule. The Option Agreement will disclose any vesting conditions prescribed by the Administrators.

  

5.4

Term of Option/Blackout Periods: The term of each Option shall be determined by the Administrators; provided that no Option shall be exercisable after ten years from the Grant Date. Should the term of an Option expire on a date that falls within a Blackout Period or within nine Business Days following the expiration of a Blackout Period, such expiration date shall be automatically extended without any further act or formality to that date which is the tenth Business Day after the end of the Blackout Period, such tenth Business Day to be considered the expiration date for such Option for all purposes under the Plan. Notwithstanding section 6.4 hereof, the ten Business Day period referred to in this section 5.4 may not be extended by the Board.

  

 
- 10 -

 

  

5.5

Exercise of Option:

 

 

Options that have vested in accordance with the provisions of this Plan and the applicable Option Agreement may be exercised at any time, or from time to time, during their term and subject to the provisions of Section 5.9 hereof as to any number of whole Common Shares that are then available for purchase thereunder; provided that no partial exercise may be for less than 100 whole Common Shares. Options may be exercised by delivery of a written notice of exercise to the Administrators, substantially in the form attached to this Plan as Exhibit C, with respect to the Options, or by any other form or method of exercise acceptable to the Administrators.

 

 

5.6

Payment and Issuance:

  

 

(a)

Upon actual receipt by the Corporation or its agent of the materials required by subsection 5.5 and receipt by the Corporation of cash, a cheque, bank draft or other form of acceptable payment for the aggregate exercise price, the number of Common Shares in respect of which the Options are exercised will be issued as fully paid and non-assessable shares and the Participant exercising the Options shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares. No person or entity shall enjoy any part of the rights or privileges of a holder of Common Shares which are subject to Options until that person or entity becomes the holder of record of those Common Shares. No Common Shares will be issued by the Corporation prior to the receipt of payment by the Corporation for the aggregate exercise price for the Options being exercised.

 

 

 

 

(b)

Without limiting the foregoing, and unless otherwise determined by the Administrators or not compliant with any applicable laws, (i) cashless exercise of Options shall only be available to a Participant who was granted and is exercising such Options outside the United States as a non-U.S. Person in compliance with Regulation S under the 1933 Act at a time when the Common Shares are listed and posted for trading on an Exchange or market in Canada that permits cashless exercise, the Participant intends to immediately sell the Common Shares issuable upon exercise of such Options in Canada and the proceeds of sale will be sufficient to satisfy the exercise price of the Options, and (ii) if an eligible Participant elects to exercise the Options through cashless exercise and complies with any relevant protocols approved by the Administrators, a sufficient number of the Common Shares issued upon exercise of the Options will be sold in Canada by a designated broker on behalf of the Participant to satisfy the exercise price of the Options, the exercise price of the Options will be delivered to the Corporation and the Participant will receive only the remaining unsold Common Shares from the exercise of the Options and the net proceeds of the sale after deducting the exercise price of the Options, applicable taxes and any applicable fees and commissions, all as determined by the Administrators from time to time. The Corporation shall not deliver the Common Shares issuable upon a cashless exercise of Options until receipt of the exercise price therefor, whether by a designated broker selling the Common Shares issuable upon exercise of such Options through a short position or such other method determined by the Administrators in compliance with applicable laws.

  

 
- 11 -

 

  

5.7

Cashless Exercise: Provided that the Common Shares are listed and posted for trading on an Exchange or market that permits cashless exercise, a Participant may elect a cashless exercise in a notice of exercise, which election will result in all of the Common Shares issuable on the exercise being sold. In such case, the Participant will not be required to deliver to the Administrators a cheque or other form of payment for the aggregate exercise price referred to above. Instead the following provisions will apply:

  

 

(a)

The Participant will instruct a broker selected by the Participant to sell through the stock exchange or market on which the Common Shares are listed or quoted, the Common Shares issuable on the exercise of Options, as soon as possible upon the issue of such Common Shares to the Participant at the then applicable bid price of the Common Shares.

 

 

 

 

(b)

Before the relevant trade date, the Participant will deliver the exercise notice including details of the trades to the Corporation electing the cashless exercise and the Corporation will direct its registrar and transfer agent to issue a certificate for such Participant’s Common Shares in the name of the broker (or as the broker may otherwise direct) for the number of Common Shares issued on the exercise of the Options, against payment by the broker to the Corporation of (i) the exercise price for such Common Shares; and (ii) the amount the Corporation determines, in its discretion, is required to satisfy the Corporation withholding tax and source deduction remittance obligations in respect of the exercise of the Options and issuance of Common Shares.

 

 

 

 

(c)

The broker will deliver to the Participant the remaining proceeds of sale, net of any brokerage commission or other expenses.

  

5.8

Taxes and Source Deductions: The Corporation or an affiliate of the Corporation may take such reasonable steps for the deduction and withholding of any taxes and other required source deductions which the Corporation or the affiliate, as the case may be, is required by any law or regulation of any governmental authority whatsoever to remit pursuant to the Withholding Obligations in connection with this Plan, any Options or any issuance of Common Shares. Without limiting the generality of the foregoing, the Corporation may, at its discretion: (i) deduct and withhold those amounts it is required to remit, pursuant to the Withholding Obligations, from any cash remuneration or other amount payable to the Participant, whether or not related to the Plan, the exercise of any Options or the issue of any Common Shares; or (ii) allow the Participant to make a cash payment to the Corporation equal to the amount required to be remitted, pursuant to the Withholding Obligations, which amount shall be remitted by the Corporation to the appropriate governmental authority for the account of the Participant. Where the Corporation considers that the steps undertaken in connection with the foregoing result in inadequate withholding or a late remittance of taxes, the delivery of any Common Shares to be issued to a Participant on the exercise of Options may be made conditional upon the Participant (or other person) reimbursing or compensating the Corporation or making arrangements satisfactory to the Corporation for the payment in a timely manner of all taxes required to be remitted, pursuant to the Withholding Obligations, for the account of the Participant.

  

 
- 12 -

 

  

5.9

Rights Upon an Event of Termination:

  

 

(a)

If an Event of Termination has occurred in respect of a Participant, any unvested Options, to the extent not available for exercise as of the date of the Event of Termination, shall, unless otherwise determined by the Administrators in their discretion, forthwith and automatically be cancelled, terminated and not available for exercise without further consideration or payment to the Participant.

 

 

 

 

(b)

Except as otherwise stated herein or otherwise determined by the Administrators in their discretion (provided such determination does not exceed a maximum of one year), upon the occurrence of an Event of Termination in respect of a Participant, any vested Options granted to the Participant that are available for exercise may be exercised only before the earlier of:

  

 

(i)

the expiry of the Option; and

 

 

 

 

(ii)

six months after the date of the Event of Termination.

  

 

(c)

Notwithstanding the foregoing subsections 5.9(a) and (b), if a Participant’s employment is terminated for just cause, each Option held by the Participant, whether or not then exercisable, shall forthwith and automatically be cancelled and may not be exercised by the Participant.

 

 

 

 

(d)

For the purposes of this Plan and all matters relating to the Options, the date of the Event of Termination shall be determined without regard to any applicable severance or termination pay, damages, or any claim thereto (whether express, implied, contractual, statutory, or at common law).

  

5.10

Record Keeping: The Corporation shall maintain an Option register in which shall be recorded:

  

 

(a)

the name and address of each holder of Options;

 

 

 

 

(b)

the number of Common Shares subject to Options granted to each holder of Options;

 

 

 

 

(c)

the term of the Option and exercise price, including adjustments for each Option granted; and

 

 

 

 

(d)

any other information which the Corporation considers appropriate to record in such register.

  

6.

GENERAL

 

 

6.1

Effective Date of Plan: The Plan shall be effective as of the Effective Date.

 

 

6.2

Change of Control: If there is a Change of Control transaction then, notwithstanding any other provision of this Plan except subsection 4.3(d) which will continue to apply in all circumstances, the Administrators may, in their sole discretion, determine that any or all unvested Restricted Share Units and any or all Options (whether or not currently exercisable) shall vest or become exercisable, as applicable, at such time and in such manner as may be determined by the Administrators in their sole discretion such that Participants under the Plan shall be able to participate in the Change of Control transaction, including, at the election of the holder thereof, by surrendering such Restricted Share Units and Options to the Corporation or a third party or exchanging such Restricted Share Units or Options, for consideration in the form of cash and/or securities, to be determined by the Administrators in their sole discretion. Notwithstanding the foregoing, with respect to Options of U.S. Participants, any exchange, substitution or amendment of such Options will occur only to the extent and in a manner that will not result in the imposition of taxes under Section 409A of the Code, and with respect to Restricted Share Units of U.S. Participants, any surrender or other modification of Restricted Share Units will occur only to the extent such surrender or other modification will not result in the imposition of taxes under Section 409A of the Code.

  

 
- 13 -

 

  

6.3

Reorganization Adjustments:

  

 

(a)

In the event of any declaration by the Corporation of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of Common Shares, reclassification or conversion of Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Corporation, distribution (other than normal course cash dividends) of company assets to holders of Common Shares, or any other corporate transaction or event involving the Corporation or the Common Shares, the Administrators, in the Administrators’ sole discretion, may, subject to any relevant resolutions of the Board, and without liability to any person, make such changes or adjustments, if any, as the Administrators consider fair or equitable, in such manner as the Administrators may determine, to reflect such change or event including, without limitation, adjusting the number of Options and Restricted Share Units outstanding under this Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under this Plan, provided that the value of any Option or Restricted Share Unit immediately after such an adjustment, as determined by the Administrators, shall not exceed the value of such Option or Restricted Share Unit prior thereto, as determined by the Administrators.

 

 

 

 

(b)

Notwithstanding the foregoing, with respect to Options and Restricted Share Units of U.S. Participants, such changes or adjustments will be made in a manner so as to not result in the imposition of taxes under Section 409A of the Code and will comply with the requirements in subsection 4.3(d).

 

 

 

 

(c)

The Corporation shall give notice to each Participant in the manner determined, specified or approved by the Administrators of any change or adjustment made pursuant to this section and, upon such notice, such adjustment shall be conclusive and binding for all purposes.

 

 

 

 

(d)

The Administrators may from time to time adopt rules, regulations, policies, guidelines or conditions with respect to the exercise of the power or authority to make changes or adjustments pursuant to section 6.2 or section 6.3(a). The Administrators, in making any determination with respect to changes or adjustments pursuant to section 6.2 or section 6.3(a) shall be entitled to impose such conditions as the Administrators consider or determine necessary in the circumstances, including conditions with respect to satisfaction or payment of all applicable taxes (including, but not limited to, withholding taxes).

  

 
- 14 -

 

  

6.4

Amendment or Termination of Plan:

  

 

The Board may amend this Plan or any Restricted Share Unit or any Option at any time without the consent of Participants provided that such amendment shall:

 

 

 

 

(a)

not adversely alter or impair any Restricted Share Unit previously awarded or any Option previously granted except as permitted by the provisions of section 6.3 hereof, and, with respect to Restricted Share Units and Options of U.S. Participants, such amendment will not result in the imposition of taxes under Section 409A;

 

 

 

 

(b)

be subject to any regulatory approvals including, where required, the approval of the Exchange; and

 

 

 

 

(c)

be subject to shareholder approval, where required by the requirements of the Exchange, provided that shareholder approval shall not be required for the following amendments:

  

 

(i)

amendments of a “housekeeping nature”, including any amendment to the Plan or a Restricted Share Unit or Option that is necessary to comply with applicable laws, tax or accounting provisions or the requirements of any regulatory authority or stock exchange and any amendment to the Plan or a Restricted Share Unit or Option to correct or rectify any ambiguity, defective provision, error or omission therein, including any amendment to any definitions therein;

 

 

 

 

(ii)

amendments that are necessary or desirable for Restricted Share Units or Options to qualify for favourable treatment under any applicable tax law;

 

 

 

 

(iii)

a change to the vesting provisions of any Restricted Share Unit or any Option (including any alteration, extension or acceleration thereof);

 

 

 

 

(iv)

a change to the termination provisions of any Option or Restricted Share Units (for example, relating to termination of employment, resignation, retirement or death) that does not entail an extension beyond the original expiration date (as such date may be extended by virtue of section 5.4);

 

 

 

 

(v)

the introduction of features to the Plan that would permit the Corporation to, instead of issuing Common Shares from treasury upon the vesting of the Restricted Share Units, retain a broker and make payments for the benefit of Participants to such broker who would purchase Common Shares in the open market for such Participants;

 

 

 

 

(vi)

the amendment of this Plan as it relates to making lump sum payments to Participants upon the vesting of the Restricted Share Units;

 

 

 

 

(vii)

the amendment of the cashless exercise feature set out in this Plan; and

  

 
- 15 -

 

  

 

(d)

be subject to disinterested shareholder approval in the event of any reduction in the exercise price of any Option granted under the Plan to an Insider Participant.

 

 

 

 

For greater certainty and subject to approval by the Canadian Securities Exchange (if applicable), shareholder approval shall be required in circumstances where an amendment to the Plan would:

 

 

 

 

(a)

change from a fixed maximum percentage of issued and outstanding Common Shares to a fixed maximum number of Common Shares;

 

 

 

 

(b)

increase the limits in section 2.2;

 

 

 

 

(c)

reduce the exercise price of any Option (including any cancellation of an Option for the purpose of reissuance of a new Option at a lower exercise price to the same person);

 

 

 

 

(d)

extend the term of any Option beyond the original term (except if such period is being extended by virtue of section 5.4 hereof); or

 

 

 

 

(e)

amend this section 6.4.

  

6.5

Termination: The Administrators may terminate this Plan at any time in their absolute discretion. If the Plan is so terminated, no further Restricted Share Units shall be awarded and no further Options shall be granted, but the Restricted Shares Units then outstanding and credited to Participants’ Accounts and the Options then outstanding shall continue in full force and effect in accordance with the provisions of this Plan. Any termination of this Plan shall occur in a manner that will not result in the imposition of taxes on a U.S. Participant under Section 409A.

 

 

6.6

Transferability: A Participant shall not be entitled to transfer, assign, charge, pledge or hypothecate, or otherwise alienate, whether by operation of law or otherwise, the Participant’s Restricted Share Units or Options or any rights the Participant has under the Plan.

 

 

6.7

Rights as a Shareholder: Under no circumstances shall the Restricted Share Units or Options be considered Common Shares nor shall they entitle any Participant to exercise voting rights or any other rights attaching to the ownership of Common Shares (including, but not limited to, the right to dividend equivalent payments).

 

 

6.8

Credits for Dividends: Unless otherwise determined by the Administrators, whenever cash or other dividends are paid on Common Shares, additional Restricted Share Units will be automatically granted to each Participant who holds Restricted Share Units on the record date for such dividends. The number of such Restricted Share Units (rounded to the nearest whole Restricted Share Units) to be credited to such Participant as of the date on which the dividend is paid on the Common Shares shall be an amount equal to the quotient obtained when (i) the aggregate value of the cash or other dividends that would have been paid to such Participant if the Participant’s Restricted Share Units as of the record date for the dividend had been Common Shares, is divided by (ii) the Market Value of the Common Shares as of the date on which the dividend is paid on the Common Shares. Restricted Share Units granted to a Participant shall be subject to the same vesting conditions (time and performance (as applicable)) as the Restricted Share Units to which they relate.

  

 
- 16 -

 

  

6.9

No Effect on Employment, Rights or Benefits:

  

 

(a)

The terms of employment shall not be affected by participation in the Plan.

 

 

 

 

(b)

Nothing contained in the Plan shall confer or be deemed to confer upon any Participant the right to continue as a director, officer, employee or Consultant nor interfere or be deemed to interfere in any way with any right of the Corporation, the Board or the shareholders of the Corporation to remove any Participant from the Board or of the Corporation or any Subsidiary to terminate any Participant’s employment or agreement with a Consultant at any time for any reason whatsoever.

 

 

 

 

(c)

Under no circumstances shall any person who is or has at any time been a Participant be able to claim from the Corporation or any Subsidiary any sum or other benefit to compensate for the loss of any rights or benefits under or in connection with this Plan or by reason of participation in this Plan.

  

6.10

Market Value of Common Shares: The Corporation makes no representation or warranty as to the future market value of any Common Shares. No Participant shall be entitled, either immediately or in the future, either absolutely or contingently, to receive or obtain any amount or benefit granted to or to be granted for the purpose of reducing the impact, in whole or in part, of any reduction in the market value of the shares of the Corporation or a corporation related thereto.

 

 

6.11

Compliance with Applicable Law:

  

 

(a)

If any provision of the Plan contravenes any law or any order, policy, by-law or regulation of any regulatory body having jurisdiction, then such provision shall be deemed to be amended to the extent necessary to bring such provision into compliance therewith. Notwithstanding the foregoing, the Corporation shall have no obligation to register any securities provided for in this Plan under the 1933 Act.

 

 

 

 

(b)

The award of Restricted Share Units, the grant of Options and the issuance of Common Shares under this Plan shall be carried out in compliance with applicable statutes and with the regulations of governmental authorities and the Exchange. If the Administrators determine in their discretion that, in order to comply with any such statutes or regulations, certain action is necessary or desirable as a condition of or in connection with the award of a Restricted Share Unit, the grant of an Option or the issue of a Common Share upon the vesting of a Restricted Share Unit or exercise of an Option, as applicable, that Restricted Share Unit may not vest in whole or in part and that Option may not be exercised in whole or in part, as applicable, unless that action shall have been completed in a manner satisfactory to the Administrators. In addition, unless the Restricted Share Units, the Options and the Common Shares issuable pursuant to the Restricted Share Units and Options, as applicable, have been registered under the 1933 Act and any applicable U.S. state securities laws, all rights of a Participant under this Plan shall be subject to and conditioned upon the availability of exemptions or exclusions from the registration requirements of the 1933 Act and any applicable U.S. state securities, as determined by the Corporation in its sole discretion. Any Restricted Share Units or Options granted or issued to a person in the United States or a U.S. Person, as well as the issue of Common Shares pursuant thereto, will result in any certificate representing such securities bearing a United States restrictive legend restricting transfer of such securities under United States federal and state securities laws.

  

 
- 17 -

 

  

6.12

Governing Law: This Plan shall be governed by and construed in accordance with the laws of the Province of British Columbia and the laws of Canada applicable therein, and with respect to U.S. Participants, the Code.

 

 

6.13

Subject to Approval: The Plan is adopted subject to the approval of the Exchange and any other required regulatory approval. To the extent a provision of the Plan requires regulatory approval which is not received, such provision shall be severed from the remainder of the Plan until the approval is received and the remainder of the Plan shall remain in effect.

 

 

6.14

Special Terms and Conditions Applicable to U.S. Participants: Options issued to U.S. Participants are intended to be exempt from Section 409A of the Code pursuant to Treas. Reg. Section 1.409A-1(b)(5)(i)(A) and the Plan and such Options will be construed and administered accordingly. Options may be issued to U.S. Participants under the Plan only if the shares with respect to the Options qualify as “service recipient stock” as defined in Treas. Reg. Section 1.409A-1(b)(5)(E)(iii). Restricted Share Units awarded to U.S. Participants are intended to be compliant with Section 409A of the Code and such Restricted Share Units will be construed and administered accordingly. Any waiver or acceleration of vesting under the Plan or any Restricted Share Unit Agreement for a U.S. Participant may occur only to the extent that such acceleration or waiver will not result in the imposition of taxes under Section 409A of the Code. Any payments made under this Plan or any Restricted Share Unit Agreement to a U.S. Participant as a result of a termination of employment that are deemed to be subject to Section 409A of the Code shall occur only if such termination constitutes a “separation from service” as defined in Treas. Reg. 1.409A-1(h). Additionally, any payments resulting from a separation from service made to a U.S. Participant who is a “specified employee” as defined in Treas. Reg. 1.409A-1(i) shall be subject to the six month delay in payments required by Treas. Reg. 1.409A-1(3)(v) if such payments are deemed to be subject to Section 409A of the Code. Although the Corporation intends Options and Restricted Share Units granted to U.S. Participants to be exempt from or compliant with Section 409A, the Corporation makes no representation or guaranty as to the tax treatment of such Options and Restricted Share Units. Each U.S. Participant (and any beneficiary or the estate of the Participant, as applicable) is solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or for the account of such U.S. Participant in connection with this Plan. Neither the Corporation nor any affiliate, nor any employee or director of the Corporation or an affiliate, shall have any obligation to indemnify or otherwise hold such U.S. Participant, beneficiary or estate harmless from any or all such taxes or penalties.

 

 

ADOPTED TED the 19th day of August, 2019.

  

 
- 18 -

 

 

EXHIBIT A

 

THE RESTRICTED SHARE UNITS AND THE UNDERLYING COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR ANY U.S. STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS SUCH SECURITIES ARE REGISTERED UNDER THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS ARE AVAILABLE. THE TERMS “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED IN REGULATION S UNDER THE 1933 ACT.

 

RESTRICTED SHARE UNIT AGREEMENT

 

Notice is hereby given that, effective this ________ day of ________________, __________ (the “Restricted Share Grant Date”) Draganfly Inc. (the “Corporation”) has granted to ___________________________________________ (the “Participant”), ______________ Restricted Share Units pursuant to the Corporation’s Share Compensation Plan (the “Plan”), a copy of which has been provided to the Participant.

 

Restricted Share Units are subject to the following terms:

 

 

(a)

Pursuant to the Plan and as compensation to the Participant, the Corporation hereby grants to the Participant, as of the Restricted Share Grant Date, the number of Restricted Share Units set forth above.

 

 

 

 

(b)

The granting and vesting of the Restricted Share Units and the payment by the Corporation of any payout in respect of any Vested Restricted Share Units (as defined below) are subject to the terms and conditions of the Plan, all of which are incorporated into and form an integral part of this Restricted Share Unit Agreement.

 

 

 

 

(c)

The Restricted Share Units shall become vested restricted share units (the “Vested Restricted Share Units”) in accordance with the following schedule:

  

 

(i)

on the 6 month anniversary of the Restricted Share Grant Date;

 

 

 

 

(ii)

on the 12 month anniversary of the Restricted Share Grant Date;

 

 

 

 

(iii)

on the 18 month anniversary of the Restricted Share Grant Date; and

 

 

 

 

(iv)

on the 24 month anniversary of the Restricted Share Grant Date (each a “Vesting Date”).

  

 

(d)

As soon as reasonably practicable and no later than 60 days following the Vesting Date, or, if the Participant is not a U.S. Participant (as defined in the Plan), such later date mutually agreed to by the Corporation and the Participant, the Participant shall be entitled to receive, and the Corporation shall issue or provide, a payout with respect to those Vested Restricted Share Units in the Participant’s Account to which the Vesting Date relates (each a “Payout Date”):

  

 

 

  

 

(i)

a lump sum payment in cash equal to the number of vested Restricted Share Units recorded in the Participant’s Account multiplied by the Market Value of a Common Share on the Payout Date;

 

 

 

 

(ii)

the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s Restricted Share Units in the Participant’s Account, duly issued as fully paid and non-assessable shares and such Participant shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares; or

 

 

 

 

(iii)

any combination of the foregoing.

 

 

 

 

subject to any applicable Withholding Obligations.

 

 

(e)

The Participant acknowledges that:

  

 

(i)

he or she has received and reviewed a copy of the Plan; and

 

 

 

 

(ii)

the Restricted Share Units have been granted to the Participant under the Plan and are subject to all of the terms and conditions of the Plan to the same effect as if all of such terms and conditions were set forth in this Restricted Share Unit Agreement, including with respect to termination and forfeiture as set out in Section 4.7 of the Plan.

 

Notwithstanding anything to the contrary in this Restricted Share Unit Agreement all vesting and issuances or payments, as applicable, in respect of a Restricted Share Unit evidenced hereby shall be completed no later than December 15 of the third calendar year commencing after the Restricted Share Grant Date;

 

 

The grant of the Restricted Share Units evidenced hereby is made subject to the terms and conditions of the Plan. The Participant agrees that he/she may suffer tax consequences as a result of the grant of these Restricted Share Units and the vesting of the Restricted Share Units. The Participant acknowledges that he/she is not relying on the Corporation for any tax advice and has had an adequate opportunity to obtain advice of independent tax counsel.

 

 

The Participant represents and warrants to the Corporation that (i) under the terms and conditions of the Plan the Participant is a bona fide Eligible Person (as defined in the Plan) entitled to receive Restricted Share Units, and (ii) either (A) the Participant is not in the United States or a U.S. Person, nor is the Participant acquiring the Restricted Share Units for the benefit of a person in the United States or a U.S. Person, or (B) an exemption from the registration requirements of the 1933 Act and all applicable state securities laws is available and the Participant has provided evidence satisfactory to the Corporation to such effect. The Corporation may condition awards and elections under the Plan upon receiving from the undersigned such representations and warranties and such evidence of registration or exemption under the 1933 Act and all applicable U.S. state securities laws as is satisfactory to the Corporation, acting in its sole discretion.

  

In the event of any inconsistency between the terms of this Restricted Share Unit Agreement and the Plan, the terms of the Plan shall prevail unless otherwise determined in the Plan.

 

 
- 2 -

 

  

Draganfly Inc.

 

 

 

 

 

 

Authorized Signatory

Signature of Participant

 

 

 

 

 

 

 

Name of Participant

 

 
- 3 -

 

 

EXHIBIT B

 

THE OPTIONS AND THE OPTIONED SHARES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR ANY U.S. STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS SUCH SECURITIES ARE REGISTERED UNDER THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS ARE AVAILABLE. THE TERMS “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED IN REGULATION S UNDER THE 1933 ACT.

 

OPTION AGREEMENT

 

Notice is hereby given that, effective this ________ day of ________________, __________ (the “Effective Date”) Draganfly Inc. (the “Corporation”) has granted to ___________________________________________ (the “Participant”), Options to acquire ______________ Common Shares (the “Optioned Shares”) up to 4:30 p.m. Pacific Time on the __________ day of ____________________, __________ (the “Option Expiry Date”) at an exercise price of Cdn$____________ per Optioned Share pursuant to the Corporation’s Share Compensation Plan (the “Plan”), a copy of which is attached hereto.

 

Optioned Shares may be acquired as follows:

 

 

(f)

[insert vesting provisions, if applicable]; and

 

 

 

 

(g)

[insert hold period when required].

 

The grant of the Options evidenced hereby and the Option Expiry Date thereof, is made subject to the terms and conditions of the Plan. The Participant agrees that he/she may suffer tax consequences as a result of the grant of these Options, the exercise of the Options and the disposition of Optioned Shares. The Participant acknowledges that he/she is not relying on the Corporation for any tax advice and has had an adequate opportunity to obtain advice of independent tax counsel.

 

The Participant represents and warrants that (i) under the terms and conditions of the Plan the Participant is a bona fide Eligible Person (as defined in the Plan) entitled to receive Options, and (ii) either (A) the Participant is not in the United States or a U.S. Person, nor is the Participant acquiring the Options or any Optioned Shares for the benefit of a person in the United States or a U.S. Person, or (B) an exemption from the registration requirements of the 1933 Act and all applicable state securities laws is available and the Participant has provided evidence satisfactory to the Corporation to such effect. The Participant understands that the Options may not be exercised in the United States or by or on behalf of a U.S. Person unless the Options and the Option Shares have been registered under the 1933 Act or are exempt from registration thereunder. The Corporation may condition the exercise of the Options upon receiving from the Participant such representations and warranties and such evidence of registration or exemption under the 1933 Act and all applicable state securities laws as is satisfactory to the Corporation, acting in its sole discretion.

 

In the event of any inconsistency between the terms of this Option Agreement and the Plan, the terms of the Plan shall prevail.

 

 

 

  

Draganfly Inc.

 

 

 

 

 

 

Authorized Signatory

Signature of Participant

 

 

 

 

 

 

 

Name of Participant

 

 
- 2 -

 

 

EXHIBIT C
NOTICE OF OPTION EXERCISE

 

TO: Draganfly Inc. (the “Corporation”)

 

FROM: ___________________________

 

DATE: ___________________________

 

The undersigned hereby irrevocably gives notice, pursuant to the Corporation’s Share Compensation Plan (the “Plan”), of the exercise of the Options to acquire and hereby subscribes for:

 

[check one]

 

¨

(a) all of the Optioned Shares; or

 

 

¨

(b) _______________ of the Optioned Shares,

  

which are the subject of the Option Agreement attached hereto.

 

Calculation of total Exercise Price:

 

 

(i)

 

number of Optioned Shares to be acquired on exercise

  

__________ Optioned Shares

 

 

(ii)

 

multiplied by the Exercise Price per Optioned Share:

  

$ __________

 

TOTAL EXERCISE PRICE, enclosed herewith (unless this is a cashless exercise):

$ __________

 

A.

The undersigned (i) at the time of exercise of these Options is not in the “United States” or a “U.S. Person” (as such terms are defined in Regulation S under the United States Securities Act of 1933, as amended (the “1933 Act”) and is not exercising these Options on behalf of a person in the United States or U.S. Person and (ii) did not execute or deliver this Notice of Option Exercise in the United States.

 

 

 

B.

The undersigned has delivered an opinion of counsel of recognized standing or other evidence in form and substance satisfactory to the Corporation to the effect that an exemption from the registration requirements of the 1933 Act, and applicable state securities laws is available for the issuance of the Optioned Shares.

 

 

 

 

Note: The undersigned understands that unless Box A is checked, the certificates representing the Optioned Shares will bear a legend restricting transfer without registration under the 1933 Act and applicable state securities laws unless an exemption from registration is available.

 

 

 

 

Note: Certificates representing Optioned Shares will not be registered or delivered to an address in the United States unless Box B above is checked.

  

 

 

  

 

Note: If Box B is checked, any opinion or other evidence tendered must be in form and substance satisfactory to the Corporation. Holders planning to deliver an opinion of counsel or other evidence in connection with the exercise of Options should contact the Corporation in advance to determine whether any opinions to be tendered or other evidence will be acceptable to the Corporation.

 

 

 

I hereby:

 

 

 

(a) unless this is a cashless exercise, enclose a cheque payable to “[]” for the aggregate Exercise Price plus the amount of the estimated Withholding Obligations and agree that I will reimburse the Corporation for any amount by which the actual Withholding Obligations exceed the estimated Withholding Obligations; or

 

 

 

¨

(b) advise the Corporation that I am exercising the above Options on a cashless exercise basis, in compliance with the procedures established from time to time by the Administrators for cashless exercises of Options under the Plan. I will consult with the Corporation to determine what additional documentation, if any, is required in connection with my cashless exercise of the above Options. I agree to comply with the procedures established by the Corporation for cashless exercises and all terms and conditions of the Plan. Please prepare the Optioned Shares certificates, if any, issuable in connection with this exercise in the following name(s):

 

 

 

 

 

__________________________________________________

 

 

 

 

 

__________________________________________________

    

______________________________________

 

Signature of Participant

 

 

______________________________________

 

Name of Participant

 

Letter and consideration/direction received on ________________, 20 _____.

 

[]

  

 

 

By:    _____________________________________

[Name]

[Title]

  

 
- 2 -

 

  

[Note: if the total number of shares reserved under the Corporation’s Share Compensation Plan and under any bonus plan is at any time greater than 30% of the Corporation’s outstanding shares (treating convertible preferred shares or convertible senior common shares on an as converted basis), then the shareholders must approve the Plan by a 2/3 majority.]

 

 

[Note: the Plan must be approved by a majority of shareholders within twelve (12) months from the adoption date or the shares issued to any employee in California must be rescinded.]

 

APPENDIX A
TO THE SHARE COMPENSATION PLAN

 

For California Residents Only

 

This Appendix to the Share Compensation Plan (the “Plan”) for Draganfly Inc. (the “Corporation”) shall have application only to Participants who are residents of the State of California. Capitalized terms contained herein shall have the same meanings given to them in the Plan, unless otherwise provided in this Appendix. Notwithstanding any provision contained in the Plan to the contrary and to the extent required by applicable law, the following terms and conditions shall apply to all options to participate in the Plan granted to residents of the State of California, until such time as the common shares may become listed on a U.S. national securities exchange:

 

1.

Restricted Share Units (“RSUs”) and options to purchase shares under the Plan (“Options”) shall have a term of not more than ten (10) years from the date the RSU or Option is granted and an exercise period of not more than one hundred twenty (120) months from the date the RSU or Option is granted.

 

 

2.

RSUs or Options shall be non-transferable other than by will, by the laws of descent and distribution, to a revocable trust, or pursuant to registration under the Securities Act of 1933, as amended, and all applicable state securities laws or compliance with an exemption therefrom.

 

 

3.

The number of shares resulting from the RSUs or purchasable pursuant to an Option and the purchase price thereof shall be proportionately adjusted in the event of a stock split, reverse stock split, stock dividend, recapitalization, combination, reclassification or other distribution of the shares without the receipt of consideration by the Corporation, of or on the shares.

 

 

4.

Unless employment is terminated for cause, the right to exercise an RSU or Option in the event of termination of employment, to the extent that the Participant is otherwise entitled to exercise an RSU or Option on the date employment terminates, shall continue until the earlier of the RSU or Option expiration date or:
   
 

 

    

 

a.

at least six (6) months from the date of termination of employment if termination was caused by death or disability; and

 

 

 

 

b.

at least thirty (30) days from the date of termination if termination of employment was caused by other than death or disability.

 

5.

No RSU or Option may be granted to a resident of California more than ten (10) years after the earlier of the date of adoption of the Plan and the date the Plan is approved by the Corporation’s shareholders (“Shareholders”).

 

 

6.

Any RSU or Option exercised before Shareholder approval is obtained shall be rescinded if Shareholder approval is not obtained within twelve (12) months before or after the Plan is adopted. Such shares shall not be counted in determining whether such approval is obtained.

 

 

7.

The Corporation shall provide annual financial statements of the Corporation to each California resident holding an outstanding RSU or Option under the Plan. Such financial statements need not be audited and need not be issued to key employees whose duties at the Corporation assure them access to equivalent information.

 

 

8.

Any right of repurchase on behalf of the Corporation in the event of a Participant’s termination of employment shall be at a purchase price that is (a) not less than the fair value of the securities upon termination of employment, and the right to repurchase shall be exercised for cash or cancellation of purchase money indebtedness for the shares within six (6) months of termination of employment (or in the case of securities issued upon exercise of RSUs or Options after the date of termination, within six (6) months after the date of the exercise), and the right shall terminate when the Corporation’s securities become publicly traded; or (b) at the original purchase price, provided that the right to repurchase at the original purchase price lapses at the rate of at least 20% of the shares per year over five (5) years from the date the RSU or Option is granted (without respect to the date the RSU or Option was exercised or became exercisable) and the right to repurchase shall be exercised for cash or cancellation of purchase money indebtedness for the shares within six (6) months of termination of employment (or in the case of securities issued upon exercise of RSUs or Options after the date of termination, within six (6) months after the date of the exercise). In addition to the restrictions set forth in clauses (a) and (b), the securities held by an officer, director or consultant of the Corporation or an affiliate of the Corporation may be subject to additional or greater restrictions.

   

 
- 2 -

 

EXHIBIT 11.1

 

Consent of Independent Auditors

 

We hereby consent to the use in this Offering Circular constituting a part of this Offering Statement on Form 1-A, of our report dated June 10, 2020 relating to the consolidated financial statements of Draganfly Inc. for the years ended December 31, 2019 and 2018, which is contained in this Offering Statement. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

DALE MATHESON CARR-HILTON LABONTE LLP

 

/s/DMCL

 

Chartered Professional Accountants

Vancouver, British Columbia

June 15, 2020

EXHIBIT 12.1

 

 

[·], 2020

 

Draganfly Inc.

2108 St. George Avenue

Saskatoon, SK

S7M 0K7

 

Dear Sirs/Mesdames:

 

Re: Draganfly Inc.

 

We have acted as Canadian counsel to Draganfly Inc., a British Columbia Company (the “Company”), in connection with the Company’s filing of an offering statement on Form 1-A filed on the date hereof (the “Offering Statement”) with the Securities and Exchange Commission (the “SEC”) pursuant to Regulation A under the U.S. Securities Act of 1933, as amended (the “Act”). The Offering Statement contemplates the offering (the “Offering”) of up to [·] units (the “Units”) of the Company to raise aggregate gross proceeds of up to US$[·].

 

Each Unit consists of: (i) one common share in the capital of the Company (“Common Share”) (each, a “Share”), for an aggregate of up to [·] Shares, and (ii) one common share purchase warrant (a “Warrant”), for an aggregate of up to [·] Warrants. Each Warrant entitles the holder thereof to purchase one Common Share (each, a “Warrant Share”) at an exercise price of US$[·] per Warrant Share, and is exercisable starting from the date of issuance until any time prior to the date that is [·] years from the date of issuance. If the maximum Offering is completed and the Warrants are exercised in full, the maximum gross proceeds from the sale of Units in the Offering (including the proceeds from the issuance of all Warrant Shares upon exercise of Warrants issued in the Offering) is US$[·].

 

For the purposes of this opinion, the Units, Shares, Warrants and Warrant Shares shall be collectively referred to as the “Securities”.

 

This opinion letter is furnished to you at your request in accordance with the requirements of Item [17(12)] of Form 1-A in connection with the filing of the Offering Statement.

 

For the purposes of this opinion, we have examined and relied on, but have not participated in the preparation of, among other things, the following:

 

 

(a)

a certified copy dated [June ·], 2020 of the constating documents of the Company including, articles and notice of articles of the Company;

 

 

 

 

(b)

a Certificate of Good Standing dated [June ·], 2020 issued pursuant to the Business Corporations Act (British Columbia) with respect to the Company (the “Certificate of Good Standing”); and

 

 

 

 

(c)

resolutions of the directors of the Company relating to the Offering and the transactions contemplated thereby, including resolutions of the directors approving, among other things, the Offering, the form of subscription agreement to be entered into between the Company and purchasers of the Units and the form of the certificate representing the Warrants.

 

Gowling WLG (Canada) LLP

Suite 2300, Bentall 5, 550 Burrard Street
Vancouver BC  V6C 2B5 Canada

 

T +1 604 683 6498

F +1 604 683 3558

gowlingwlg.com

 

Gowling WLG (Canada) LLP is a member of Gowling WLG, an international law firm which consists of independent and autonomous entities providing services around the world. Our structure is explained in more detail at gowlingwlg.com/legal.

 

 
Page 1

 

 

 

We have examined originals or photostatic or certified copies of such corporate records, contracts and instruments of the Company or other corporations, certificates, permits, licenses or orders of public officials, commissions, boards and governmental bodies and authorities, certificates of officers or representatives of the Company or other corporations and such other records, contracts and instruments all as we believe necessary and relevant as the basis of the opinion set forth herein. We have relied, exclusively and without independent investigation or inquiry, upon a certificate of an officer of the Company dated as of the date hereof (the “Officer’s Certificate”) addressed to Gowling WLG (Canada) LLP, as to the facts referred to therein.

 

We have also considered such questions of law and examined such statutes, regulations and orders, certificates, records of corporate proceedings and other documents and have made such other examinations, searches and investigations as we have considered necessary for the purpose of rendering this opinion. In particular, we have not reviewed, and express no opinion on, any document that is referred to or incorporated by reference into the documents reviewed by us. As to various questions of fact material to this opinion which we have not independently established, we have examined and relied upon, without independent verification, certificates of public officials and officers of the Company including, without limitation, the Officer’s Certificate.

 

In all such examinations, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as certified, conformed, notarized or photostatic copies or facsimiles and the authenticity of all originals of such documents. We have also assumed the completeness and accuracy of all certificates of public officials and corporate officials, that the parties delivering any certificates other than those executing certificates on behalf of the Company have been duly appointed to the positions indicated and have the power, capacity and authority to certify the information contained therein and that the certificates referred to herein, if dated earlier than the date hereof, continue to be accurate as of the date hereof. To the extent that any certificates upon which we have relied are based on any assumption, are given in reliance on any other certificate or other document or are made subject to any limitation, qualification or exception, our opinion given in reliance thereon is also based on such assumption, is given in reliance on such other certificate or other document and is subject to such limitation, qualification or exception.

 

We are qualified to carry on the practice of law in the Province of British Columbia. The opinion hereinafter expressed is limited to the laws of the Province of British Columbia and the federal laws of Canada applicable therein.

 

In giving the opinion expressed below, we have assumed:

 

 

(a)

that all persons, other than the Company, executing documents on behalf of themselves or on behalf of another party have been duly authorized to do so and that such documents have been validly executed and delivered by and constitute legal, valid and binding and enforceable obligations of such parties in accordance with the terms of such documents;

 

 
Page 2

 

 

 

 

(b)

the completeness and accuracy of the Company’s corporate records as filed in the minute books of the Company;

 

 

 

 

(c)

that all cheques, bank drafts and other methods of payment delivered in consideration for the Units will be honoured upon presentation or will otherwise result in receipt by the Company of the funds represented by such cheques, bank drafts or other methods of payment;

 

 

 

 

(d)

that at the time of any distribution or trade of the Securities or the Warrant, no order, ruling or decision has been issued or granted by a securities regulatory authority or any court or other regulatory or administrative authority that has the effect of prohibiting or restricting the distribution or trade of the Offered Securities or the Warrant Shares, as the case may be, or affecting any person who engages in any such distribution or trade;

 

 

 

 

(e)

the Units will be offered, issued and sold in compliance with applicable United States federal and state securities laws, and in the manner stated in the Offering Statement; and

 

 

 

 

(f)

Whenever our opinion refers to Common Shares to be issued as being “fully paid and non-assessable”, such opinion indicates that the holder of such Securities cannot be required to contribute any further amounts to the Company by virtue of his, her or its status as holder of such Securities, either in order to complete payment for the Securities, to satisfy claims of creditors or otherwise. No opinion is expressed as to the adequacy of any consideration received for such Securities.

 

Based and relying upon and subject to the foregoing and the qualifications expressed below, we are of the opinion that:

 

1.

The Company is a valid and existing company and is in good standing with respect to the filing of annual reports with the British Columbia Registrar of Companies.

 

 

2.

The Shares have been duly authorized by all necessary corporate action on the part of the Company and, when the Shares are issued and sold in the manner and under the terms described in the Offering Statement, will be validly issued, fully paid and non-assessable.

 

 

3.

The Warrants have been duly authorized by all necessary corporate action on the part of the Company and, when issued and sold in accordance with and in the manner described in the Offering Statement, shall be validly created and issued by the Company.

 

 

4.

The Warrants constitute valid and binding obligations of the Company enforceable against the Company in accordance with their terms.

 

 

5.

The Units constitute valid and binding obligations of the Company and have been duly authorized by all necessary corporate action on the part of the Company.

 

 

6.

The Warrant Shares have been reserved and authorized for issuance and such Warrant Shares, when issued and delivered by the Company in accordance with the terms and conditions of the certificates representing the Warrants against payment of the exercise price therefor, will be validly issued as fully paid and non-assessable common shares in the capital of the Company.

 

 
Page 3

 

  

 

The opinion expressed in this letter is subject to the following exceptions and qualifications:

 

 

(a)

in expressing the opinion set forth in paragraph 1 above with respect to the existence and good standing of the Company, we have relied exclusively and without independent investigation upon the Certificate of Good Standing.

 

 

 

 

(b)

insofar as our opinion in paragraph 4 relates to the legality, validity, binding nature or enforceability of the Warrants, such opinion is subject to:

 

 

(i)

any applicable bankruptcy, insolvency, moratorium, arrangement, winding‑up laws or similar laws affecting the enforcement of creditors’ rights generally and laws regarding limitations of action;

 

 

 

 

(ii)

general principles of equity, including the principle that the granting of equitable remedies such as specific performance and injunctive relief is within the discretion of a court of competent jurisdiction;

 

 

 

 

(iii)

the powers of a court of competent jurisdiction to grant relief from forfeiture, to stay proceedings before it and to stay execution on judgments;

 

 

 

 

(iv)

the qualification that the costs of and incidental to all proceedings authorized to be taken in court are in the discretion of the court and the court has full power to determine by whom and to what extent such costs shall be paid;

 

 

 

 

(v)

the qualification that the enforceability of the Warrants will be subject to the Limitation Act (British Columbia);

 

 

 

 

(vi)

the qualification that rights to indemnity and contribution may be limited by applicable law;

 

 

 

 

(vii)

the qualification that judgment debts in the Province of British Columbia may be limited to the interest rate established pursuant to the Court Order Interest Act (British Columbia);

 

 

 

 

(viii)

the qualification that a court may require the discretionary powers expressed to be conferred on any party to such agreement or other document to be exercised reasonably and in good faith notwithstanding any provisions to the contrary and may decline to accept as conclusive factual or legal determinations described as conclusive therein;

 

 

 

 

(ix)

the qualification that any provision in such agreement or other document which purports to sever from such agreement or other document, as the case may be, any provision therein which is prohibited or unenforceable under applicable law without affecting the validity of the remainder of the agreement or other document, as the case may be, would be enforced only to the extent that the court determined that such prohibited or unenforceable provision could be severed without impairing the interpretation and application of the remainder of the agreement or other document, as the case may be; and

 

 

 

 

(x)

the qualification that the effectiveness of terms exculpating a party from liability or duty otherwise owed by it to another and certain remedial terms and waivers of equitable defences provided for in such agreement, indenture or other document are limited by law.

 

 

(c)

our opinion is based on legislation, regulations and rulings in effect on the date hereof and we disclaim any obligation or undertaking to advise any person of any change in the law or fact which may come to our attention after the date hereof.

 

We hereby consent to the filing of this opinion with the SEC as an exhibit to the Offering Statement. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the SEC promulgated thereunder.

 

 
Page 4

 

 

 

This opinion relates exclusively to the transaction outlined above and is for the sole use and benefit of the persons to whom it is addressed. Accordingly, this opinion may not be delivered to, or relied upon, by any other person or used in connection with any other transaction without our prior written consent. This opinion is limited to the matters stated herein, and no opinion or belief is implied or may be inferred beyond the matters expressly stated herein.

 

Yours truly,

 

 

 

 
Page 5

 

EXHIBIT 14.1

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM F-X

 

APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING

 

A.

Name of issuer or person filing (“Filer”): Draganfly Inc.

 

 

B.

(1)

This is [check one]:

 

 

an original filing for the Filer.

 

 

an amended filing for the Filer.

 

 

(2)

Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9) ☐

 

C.

Identify the filing in conjunction with which this Form is being filed:

 

 

Name of registrant:

Draganfly Inc.

 

Form type:

Form 1-A

 

File Number (if known):

_______________________________

 

Filed by:

Draganfly Inc.

 

Date Filed (if filed concurrently, so indicate):

June 15, 2020

 

 

D.

The Filer is incorporated or organized under the laws of British Columbia, Canada and has its principal place of business at:

 

DRAGANFLY INC.
2108 St. George Avenue
Saskatchewan, SK, S7M 0K7
Tel: (604) 398-3378

E.

The Filer designates and appoints:

 

CT CORPORATION SYSTEM

1015 15th Street, N.W., Suite 1000

Washington, DC 20005

Tel: (202) 572-3133

 

 

 

 

 

as the agent (the “Agent”) of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:

 

 

(a)

any investigation or administrative proceeding conducted by the Commission; and

 

 

(b)

any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any State or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns (i) any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form 1-A on __________, 20__ or any purchases or sales of any security in connection therewith; (ii) the securities in relation to which the obligation to file an annual report on Form 40-F arises, or any purchases or sales of such securities; (iii) any tender offer for the securities of a Canadian issuer with respect to which filings are made by the Filer with the Commission on Schedule 13E-4F, 14D-1F or 14D-9F; or (iv) the securities in relation to which the Filer acts as a Trustee pursuant to an exemption under Rule 10a-5 under the Trust Indenture Act of 1939. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that the service of an administrative subpoena shall be effected by service upon such Agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.

 

F.

The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date of the last sale of securities in reliance upon the Regulation A exemption.

 

The Filer further undertakes to advise the Commission promptly of any change to the Agent’s name or address during the applicable period by amendment of this Form, referencing the file number of the relevant form in conjunction with which the amendment is being filed.

 

G.

The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the Form 1-A; the securities to which the Form 1-A relates; and the transactions in such securities.

 

 

The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Saskatoon, Province of Saskatchewan, Country of Canada this 13th day of June, 2020.

 

 

 

  

 

DRAGANFLY INC.

 

 

By:

/s/ Cameron Chell

 

Name:

Cameron Chell

 

Title:

Chief Executive Officer

 

Date:

June 13, 2020

 

This statement has been signed by the following persons in the capacities and on the date indicated.

 

 

CT CORPORATION SYSTEM

 

By:

/s/ Scott White

 

Name:

Scott White

 

Title:

Assistant Secretary

 

Date:

June 15, 2020